{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "1120feda",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "We\n"
     ]
    }
   ],
   "source": [
    "print(\"We\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "940817e0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'d:\\\\Sample project\\\\medichatbot\\\\research'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "dde3e57b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "os.chdir(\"../\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "a3171fd5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'d:\\\\Sample project\\\\medichatbot'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "d94ecda4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.document_loaders import PyPDFLoader,DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "c8905235",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extract the data from th pdf\n",
    "\n",
    "def load_pdf_file(data):\n",
    "    loader=DirectoryLoader(data,\n",
    "                           glob=\"*.pdf\",\n",
    "                           loader_cls=PyPDFLoader)\n",
    "    documents=loader.load()\n",
    "\n",
    "    return documents\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "b037fe24",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n",
      "Advanced encoding /SymbolSetEncoding not implemented yet\n"
     ]
    }
   ],
   "source": [
    "Extracted_data= load_pdf_file(data='Data/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "id": "ce3d08b1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 0, 'page_label': '1'}, page_content='i\\nSTANDARD TREATMENT GUIDELINES\\nA Manual for Medical Therapeutics\\nFirst Edition, 2013\\nGujarat Medical Services Corporation Limited\\nHealth & Family Welfare Department\\nGovernment of Gujarat'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 1, 'page_label': '2'}, page_content='ii\\nMessage\\n(Health Minister)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 2, 'page_label': '3'}, page_content='iii\\nMessage\\n(Principal Secretary)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 3, 'page_label': '4'}, page_content='iv\\nMessage\\n(Commissionerate)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 4, 'page_label': '5'}, page_content='v\\nPREFACE TO FIRST EDITION\\nThe Rational Use of Medicinesresults into a more effective treatment at an affordable cost.\\nEssential Medicines List (EML) and the Standard Treatment Guidelines (STG) are an\\nimportant component of promoting rational use of medicines. Gujarat Medical Service\\nCorporation Limited under the auspices of Department of Health & Family Welfare,\\nGovernment of Gujarat finalizes EML and has undertakenthe taskto develop STG for the\\nState. The objective is to improve the availability of quality drugs at each health facility and\\nto achieve maximum public health improvement using available resources. B. J. Medical\\nCollege & Civil Hospital,Ahmedabad hasbeen instrumental in the preparation of the STG.\\nAn attempt has been made in this manual to provide guidelines for the treatment of common\\ndiseases, keeping in mind the rational use of medicines. It is a blend of evidence from\\nstandard text and reference books with consensus ofspecialists. The guidelines are\\ncomprehensive, concise and seek to summarize treatment plan for patients with priority\\ndiseases. It is assumed that the patient has been fully evaluated and all co-morbidities\\nidentified. Under each clinical condition, thetreatment plan has been suggested that can be\\napplied to average patient with common presentation. However, there may be great variations\\nin patient presentation, their family history, treatment preferences and tolerance for different\\nside effect. Therefore, these guidelines can be viewed as an expert consultation and weighed\\nwith respect to other information. Moreover, the recommendations do not replace clinical\\njudgment nor encroach on clinical flexibility, which must be tailored to the particular needs\\nof each clinical situation.\\nA large number of experienced clinicians have contributed in the preparation of these\\nguidelines. The manual begins with a brief introduction to the concept ofRational Use of\\nMedicinesalong with its important components. Thisis followed by chapters on common\\ndiseases and emergency conditions which may be general to all specialties. Remaining\\nchapters describe frequent clinical conditions in each specialty, for example ENT, Psychiatry,\\nObstetrics andG ynecology etc. The formatof the guidelines includes important salient\\nfeatures, diagnostic tests followed by non-pharmacological, pharmacological treatment plan\\nand patient education, if applicable. Medicines are mentioned in generic names and choice is\\nbased on the balanced criteria of efficacy,safety, suitability and cost.\\nThis manual will be useful as ready reference for the health care providers and supply\\nmanagement staff. We hope this manual will help in pursuance of the objectives ofRational\\nUse of Medicinesand make the treatment more specific and effective. We thank all the\\nexperts for sharingtheirvaluable time and expertise in developing the book.\\nDr. Mira Desai\\nDr. Samidh Shah\\nDr. Geetha Iyer'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 5, 'page_label': '6'}, page_content='vi\\nACKNOWLEDGEMENTS\\nThe standard treatment guidelines have been developed after several meetings and\\ndiscussions among the core committee members and expert clinicians. These guidelines\\ninclude material from the many sources, recommendations and advice from numerous\\nindividuals.\\nWe extend our sincere thanks to all those who havecontributed as members, subject experts\\nand provided technical and editorial expertise. The resident doctors from various departments\\nhave immensely helped in literature search, data entry, computer processing and\\ncommunication with editors.\\nThe contribution made by resident doctors Dr. R P. Pole, Dr. Saloni Shah, Dr. Trupal\\nSolanki, Dr. Falguni Parmar,Dr. Dhaval Mistry,D r. Mitali Desai, Dr Pinakin Patel, Dr.\\nAbhinav Jain, Dr. Roopesh Singhal, Dr. Satyam Satyarth, Dr. Ravi Varmora, Dr. Hardik\\nRughwani, D r. Mayank Andrepa, Dr Mayur Patil, Dr. Rachel Shah, Dr. Dharmesh\\nVaghasiya, Dr. Bhavik Prajapati, Dr. Nayan Pawnikar,Dr. Shailesh Patel, Dr. Jaydeep\\nOdhvani, Dr. Pankaj Vyas and Dr. Dhrumil Patelare gratefully acknowledged.\\nWithout theirdedication, it might have not been possible to bring out this publication. Once\\nagain we express our heartfelt gratitude to the generous support given by each and every one\\nof our team.\\nNovember, 2013\\nAhmedabad Editors'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 6, 'page_label': '7'}, page_content='vii\\nCONTRIBUTORS TO FIRST EDITION\\nCore -Committee M embers\\nShri H. K. Patel,Managing Director, GMSCL, Gandhinagar\\nDr. A. B. Solanki,General Manager, GMSCL, Gandhinagar\\nDr. B. J. Shah,Dean, B. J. Medical College, Ahmedabad\\nDr. Kamlesh Parmar,MO, Gandhinagar\\nDr. Mira Desai,Professor & Head, Department of Pharmacology, B. J. Medical College&\\nCivil Hospital, AhmedabadAhmedabad\\nMedicine\\nDr.  Asha Shah.Professor & Head,Department of Medicine,B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr.B. K. Amin,Additional Professor, Departmentof Medicine,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. B. B. Solanki, Additional Professor, Departmentof Medicine,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. K. J. Upadhyay, Additional Professor, Departmentof Medicine,B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Shivani Patel, Associate Professor, Departmentof Medicine,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nEmergency Medicine\\nDr. Samira Parikh,Professor & Head, Department of Emergency Medicine,B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Nilima Shah,Professor & Head, Department of Emergency Medicine,B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Shruti Sangani,Professor & Head, Department of Emergency Medicine,B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nSurgery\\nDr. P. N. Kantharia, Professor, Department of Surgery, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr. Subham Negi, Assistant Professor Department of Surgery, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nPharmacology\\nDr. Mira Desai,Professor& Head, Department of Pharmacology, B. J. Medical College&\\nCivil Hospital, Ahmedabad\\nDr. Samidh Shah,Assistant Professor,Department ofPharmacology,B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Geetha Iyer,Assistant Professor,Department of Pharmacology,B. J. Medical College &\\nCivil Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 7, 'page_label': '8'}, page_content='viii\\nObstetrics and Gynecology\\nDr. Malini R. DesaiProfessor & Head, Department of OB & Gy,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Tejal L. Patel,Associate Professor,Department of OB & Gy,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Dhaval Swaminarayan, Assistant Professor, Department of OB & Gy, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nDr. Pallavi Ninama,Assistant Professor,Department of OB & Gy,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Shirish Toshniwal,Assistant Professor,Department of OB & Gy,B. J. Medical College\\n& CivilHospital, Ahmedabad\\nDermatology\\nDr. Kirti Parmar,Associate Professor, Department of Dermatology,B. J. Medical College\\n& Civil Hospital, Ahmedabad\\nDr. Rima Joshi,Assistant Professor, Department of Dermatology, B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr. Brijesh Parmar, AssistantProfessor, Department of Dermatology, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad\\nOphthalmology\\nDr. Mariam Mansuri , Professor and Head of Unit- Glaucoma, M & J Institute of\\nOphthalmology, Civil Hospital, Ahmedabad.\\nDr. Purvi Bhagat, Associate Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nDr. Rupal Bhatt, Assistant Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nDr. Pooja Negi, Tutor, M & J Institute of Ophthalmology, Civil Hospital, Ahmedabad.\\nDr. Kalpit Shah, Assistant Professor, M & J Institute of Ophthalmology, Civil Hospital,\\nAhmedabad.\\nPsychiatry\\nDr. G.K. Vankar, Professor & Head, Department of Psychiatry,B. J. Medical College &\\nCivil Hospital, Ahmedabad\\nDr . Minakshi Parikh, Professor, Department of Psychiatry,B. J. Medical College & Civil\\nHospital, Ahmedabad\\nOrthopedics\\nDr. M.M. Prabhak ar, Professor & Head, Department of Orthopedics, Superintendent\\nDirector, paraplegia, B. J. Medical College & Civil Hospital, Ahmedabad\\nDr. G D Tharadara , Additional Professor, Department of Orthopedics, B. J. Medical\\nCollege & Civil Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 8, 'page_label': '9'}, page_content='ix\\nENT\\nDr. Rajesh Vishwakarma, Professor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr Kalpesh Patel,Assistant Professor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nDr. Dipesh Darji, AssistantProfessor, Department of ENT, B. J. Medical College & Civil\\nHospital, Ahmedabad\\nTB and Chest Diseases\\nDr. Rajesh N. Solanki,Add itional Professor ,Department of Pulmonary Medicine, B J\\nMedical College and Civil Hospital, Ahmedabad\\nDr. Amit R. Dedun,Assistant Professor, Department of Pulmonary Medicine, B J Medical\\nCollege and Civil Hospital, Ahmedabad\\nDr. (Mrs.) Purvi Nayak,Medical Officer (Drug Resistance TB), State TB Training and\\nDemonstration Center, Ahmedabad\\nPaediatrics\\nDr. Bela Shah,Additional Professor, Department of Paediatrics, B. J. Medical College and\\nCivil Hospital, Ahmedabad.\\nDr. Gargi Pathak,Additional Professor,Department of Paediatrics, B. J. Medical College\\nand Civil Hospital, Ahmedabad.\\nDr. Bharat Parmar,Professor, Department of Paediatrics, B. J. Medical College and Civil\\nHospital, Ahmedabad.\\nDental\\nDr. Piyush Limdiwala, Assistant Professor, Oral Medicine &Radiology Department,\\nGovernment Dental College & Hospital, Ahmedabad\\nDr. Janki Shah,Assistant Professor, Department of Preventive & Community Medicine,\\nGovernment Dental College & Hospital,  Ahmedabad.\\nDr. Girish Parmar,Dean, Government Dental College &Hospital, Ahmedabad'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 9, 'page_label': '10'}, page_content='x\\nLIST OF ABBREVIATIONS\\nAED: Automated External Defibrillator\\nAHA: American Heart Association\\nAPACHE: Acute Physiology and Chronic Health Evaluation\\nAPTT: Activated Partial Thromboplastin Time\\nBERA: Brainstem Evoked Response Audiometry\\nBPS: Bio Physical Profile Scoring\\nCIN: Cervical Intraepithelial Neoplasia\\nCRP: C -reactive protein\\nCRT: Corneal Refractive Therapy\\nCT -IVP: Computed Tomography Intravenous Pyelogram\\nDMPA: Depot Medroxy Progesterone Acetate\\nDMSA: Dimercapto Succinic Acid\\nELISA: Enzyme -Linked Immunosorbent Assay\\nFDP: Fibrin Degradation Product\\nFML: Flurometholone Ophthalmic Suspension\\nFTA -ABS: Fluorescent Treponemal Antibody-Absorption\\nHPV: Human Papilloma Virus\\nLNG IUCD:Levonornestrel Intra Uterine Contraceptive Device\\nLR SHUNT: Left to Right Shunt\\nLSD:Lysergic Acid Diethylamine\\nMHA -TP: Microhemagglutination Assay Treponema Pallidum\\nNCHS:National Center For Health Statistics\\nNET -EN: Norethisterone Enanthate\\nNLEP:National Leprosy Eradication Programme\\nNPSP: NationalPolio Surveillance Project\\nNST: Non Stress Test\\nPAIR: Puncture, Aspiration, Injection(Of A Scolicidal Agent),Reaspiration\\nPC: Product Code\\nPDA: Patent Ductus Arteriosus\\nPEA: Pulseless Electrical Activity\\nPET: Positron Emission Tomography\\nPWB: Patient Wise Box'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 10, 'page_label': '11'}, page_content='xi\\nRDA: Recommended Daily Allowance\\nRPR:  Rapid Plasma Regain\\nS.PSA: Serum Prostate Specific Antigen\\nSLE: Systemic Lupus Erythematosus\\nTAPP: Trans Abdominal Preperitoneal Meshplasty\\nTEP: Totally Extra Peritoneal Meshplasty\\nTMJ: Tempor o M andibular Joint\\nTMT: Trabecular Meatel Technology\\nTPHA: Treponema Pallidum Haemagglutination Assays\\nTT: Tetanus Toxoid\\nUSAID: Us Agency For International Development\\nUSG -Kub: Ultrasonogram Kidney Ureter Bladder\\nVDRL: Venereal Disease Research Laboratory,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 11, 'page_label': '12'}, page_content='xii\\nINDEX\\nTopic Page\\nNo.\\n1. Introduction to Rational Use of Medicines\\nConcept of essential medicines, Standard treatment guidelines, Drug formulary,\\nRational approach to therapeutics, Adverse drug effects and drug interactions,\\nPrescription writing\\n1\\n2. Common Conditions\\nAcute fever, Fever of unknown origin,Acute rheumatic fever, Anaemia, Typhoid\\nfever, Malaria, Dengue,Chikungunya,Tuberculosis and RNTCP,Epilepsy,Status\\nepilepticus, Urinary tract infection\\n11\\n3. Emergency Conditions\\nCardiopulmonary resuscitation, Anaphylaxis, Acute airway obstruction, Stridor,\\nShock, Fluid and electrolyte imbalance, Septicemia, Organophosphorus poisoning,\\nKerosene and petrol poisoning, Datura poisoning, Abdominal injury, Foreign body in\\near, Chemical injuries ofthe eye, Corneal and conjunctival foreign bodies, Traumatic\\nhyphema, Animal bites-Dog bite, Snake bite, Insect and Arachnid bites, Scorpion bite\\n47\\n4. Cardiovascular Diseases\\nInfective endocarditis, Acute pericarditis, Cardiomyopathy, Hypertension, Angina\\npectoris, Myocardial infarction, Congestive heart failure, Arrhythmias, Ventricular\\ntachycardia, Atrial fibrillation, bradyarrhythmias\\n80\\n5. Central Nervous System Diseases\\nMigraine, Tension headache, Cluster headache, Stroke, Facial palsy, Parkinsonâ€™s\\ndisease, Dementia, Guillain- Barre Syndrome, Acute bacterial meningitis, Viral\\nencephalitis, Neurocysticercosis, Paraplegia and quadriplegia, Vertigo\\n91\\n6. Genitourinary Diseases\\nNephrotic syndrome, Chronic kidney disease, Acute renal failure, Hypokalemia,\\nHyperkalemia\\n107\\n7. Endocrine Diseases\\nHypothyroidism, Hyperthyroidism, Hypocalcemia, Hypercalcemia, Diabetes\\nmellitus, Diabetes ketoacidosis\\n112'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 12, 'page_label': '13'}, page_content='xiii\\nTopic Page\\nNo.\\n8. Gastrointestinal Diseases\\nAphthous ulcers, Dyspepsia, Peptic ulcer disease, Vomiting, Irritable bowel\\nsyndrome, Acute gastroenteritis, Ulcerative colitis,Gastroesophageal reflux\\ndisorder, Upper gastrointestinal bleeding, Acute pancreatitis, Chronic pancreatitis,\\nConstipation, Amoebic liver abscess, Pyogenic liver abscess\\n125\\n9. Infections\\nTetanus, Leptospirosis, Cholera, Influenza infection, HIV and AIDS, Opportunistic\\ninfections, Amoebiasis, Giardiasis, Hookworm  infestation, Roundworm  infestation,\\nEnterobiasis, Filariasis\\n138\\n10.ENT Diseases\\nEar wax, Keratosis obturans, Furuncle, Otomycosis, Malignant otitis externa, Acute\\nsuppurative otitis media, Chronic suppurative otitis media, Serous otitis media, Acute\\nsinusitis, Epistaxis, Allergic rhinitis, Common cold, Furunculosis of nose, Acute\\ntonsillitis, Chronic tonsillitis, Acute parotitis, Bacterial parotitis\\n156\\n11.Eye Diseases\\nStye, Chalazion, Viral conjunctivitis, Allergic conjunctivitis, Atopic conjunctivitis,\\nNon gonococcal conjunctivitis, Gonococcal conjunctivitis, Trachoma, Corneal Ulcer,\\nBacterial keratitis, Fungal keratitis, Viral keratitis, Glaucoma, Primary open angle\\nglaucoma,  Primary angle closure glaucoma, Lens induced glaucoma,  Anterior\\nUveitis, Orbital cellulitis, Endophthalmitis, Optic neuritis, Diabetic retinopathy,\\nRetinal detachment, Vitamin A deficiency, Senile cataract, Refractive errors,\\nStrabismus, Computer vision syndrome\\n169\\n12.Skin Diseases\\nBacterial skin infections, Leprosy, Cutaneous tuberculosis, Scabies, Pediculosis,\\nMyiasis, Pityrosporum infections, Pityriasis, Tinea corporis, C apitis,\\nO nychomycosis, Candidiasis, Diaper dermatitis,H erpes labialis, Chickenpox, Herpes\\nzoster, Molluscum contagiosum, Wart, Acne vulgaris, Miliaria,  Eczema, Contact\\ndermatitis, Pityriasis alba, Vitiligo, Albinism, Melasma, Urticaria, Psoriasis, Lichen\\nplanus, Alopecia areata, Pemphigusvulgaris, Cutaneous  reactionstodrugs,Herpes\\ngenitalis, Syphilis, Chancroid, Lymphogranuloma venerum, Urethral discharge,\\nDermatological emergencies\\n196'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 13, 'page_label': '14'}, page_content='xiv\\nTopic Page\\nNo.\\n13.Obstetrics and Gynecology\\nNormal Pregnancy, Nausea and vomiting in pregnancy, First trimester bleeding,\\nAnaemia in pregnancy, Pregnancy induced hypertension, Pregnancy with diabetes,\\nPregnancy with heart disease, Antepartum haemorrhage, Premature rupture of\\nmembranes, Preterm labour, Normal labour, Fetal distress in labour, Meconium\\nstained liquor, Induction and augmentation of  labour, Postpartum haemorrhage,\\nPrevention of maternal to child transmission,Vaginal discharge, Pelvic inflammatory\\ndisease, Pre-Menstrual syndrome, Dysfunctional uterine bleeding, Menopause,\\nPostmenopausal bleeding, Screening guidelines for early detection of cancer,\\nContraception\\n229\\n14.Psychiatry Disorders\\nSchizophrenia and other psychotic disorders, Major depressive disorders, Bipolar\\nmood disorder, Insomnia, Generalized anxiety disorders, Panic disorder,  Obsessive\\ncompulsive disorder, Phobic disorder, Post-traumatic stress disorder,Conversion\\ndisorder, Dissociative disorder,Alcohol use disorder, Opioid use disorder, Cannabis\\nuse disorder,  Autistic disorder, Attention deficit hyperactivity disorder, Mental\\nretardation, Suicidal patient, Psychotropic drugs in special population, Management\\nof wandering mentally ill patient, Personality disorder.\\n284\\n15.Orthopedic Conditions\\nOsteoarthritis, Rheumatoid arthritis, Cervical and lumbar spondylosis, Sprains, Acute\\npyogenic osteomyelitis, Acute septic arthritis.\\n308\\n16.Surgery\\nPre-operative assessment and preparations, Post-operative care, Surgical site\\ninfection, Wound care, Sterilization and disinfection, Suturing of primary wound,\\nAcute appendicitis, Hernia, Hydrocele, Cholelithiasis, Hydatid disease of liver,\\nObstructive jaundice, Intestinal obstruction, Typhoid perforation, Small bowel\\ntuberculosis, Anal fissure, Fistula in ano, Hemorrhoids, Diabetic foot, Varicose veins,\\nDeep vein thrombosis, Cervical lymphadenopathy, Thyroid nodule, Benign breast\\ndiseases, Breast abscess, Carcinoma breast, Renal stones, Urinary retention\\n317'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 14, 'page_label': '15'}, page_content='xv\\nTopic Page\\nNo.\\n17.Respiratory Diseases\\nCommunity acquired pneumonia, Hospital acquired pneumonia,Bronchial asthma,\\nChronic obstructivepulmonary diseases, Bronchiectasis\\n348\\n18.Pediatrics\\nNewborn care, Low birth weight baby, Neonatal jaundice, Management of common\\nclinical problems in new born, Immunization schedule, Fluid and electrolyte therapy\\nin children, Iron deficiency anemia, Megaloblastic anemia, Protein energy\\nmalnutrition, Nutritional rickets, Pica, Primary nocturnal enuresis, Wheezy child,\\nAcute bronchiolitis, Pneumonia, Thrush (oral candidiasis), Constipation, Acute\\ndiarrhea, Acute viral hepatitis, Chicken pox(varicella), Measles, Mumps,  Acute\\nflaccid paralysis, Pertusis,  Cardiac failure, Diabetes mellitus, Hypothyroidism,\\nUrinary tract infection, Post streptococcal acute glomerulonephritis, Nephrotic\\nsyndrome, Febrile seizure, Acute pyogenic meningitis, Tubercular meningitis,Status\\nepilepticus,Hypovolemic shock, Diphtheria,Severe malaria, Hypertensive\\nencephalopathy,Acute severe asthma\\n365\\n19.Dental Conditions\\nTooth avulsion, Toothache, Tooth/maxillary fracture, Dental caries, Dental abscess,\\nAdult type periodontitis, Juvenile periodontitis, Inflammatory gingival enlargement,\\nDental fluorosis, Trigeminal neuralgia, Oral submucous fibrosis, Cyst of tumor of\\njaw, Oral hygiene, Antibiotic prophylaxis in dental procedure\\n416'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 15, 'page_label': '16'}, page_content=''),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 16, 'page_label': '17'}, page_content='1\\nChapter 1\\nINTRODUCTION TO RATIONAL USE OF MEDICINES\\nRational Useof Medicines requires that patients receive medications appropriate to their\\nclinical needs, in doses that meet their own individual requirements, for an adequate period of\\ntime, and at affordable cost to them and the community (WHO , 1985). In other words,\\nrational use means â€˜prescribing right medicines, in adequate dose for the sufficient duration\\nand appropriate to the clinical needs of the patient at lowest costâ€™. M edicine useis a complex\\ncyclical process and in the clinical context, rational drug use implies correct drug, appropriate\\nindication and selection with respect to efficacy, safety, suitability for the patient and cost.\\nThe concept of Rational Useof Medicinesis age old; however, it has attained more\\nsignificanceand momentum in terms of medical and socioeconomic aspects recently. Three\\ntools have been identified to implementRational Use of Medicineseffectively. These include\\nEssential Medicines List, Standard Treatment Guidelines andDrug Formulary. To be\\nmeaningful, all three tools should work in concert and subjectforperiodic review and update.\\nI. The concept of Essential Medicines\\nEssentialM edicines(EM) are those that satisfy the health care needs of the majority of\\nthe population and therefore should be available at all times in appropriate amounts and in\\nappropriate dosage forms.Following the concept of EM, WHO published the first\\nEssential Medicine List (EML) in 1977, which has been updated successively every 5\\nyear in view of changing world scenario about the medical needs and availability of new\\nand better drugs.The selection of these medicines is based on public health relevance,\\nevidence of efficacy and safety and comparative cost-effectiveness. Thesepriority\\nmedicines should be available at each functioning health care facilitywith assured quality\\nand adequate information at a price the individual and the community can afford.\\nThe selection of essential medicines depends upon level of health care facility, adequate\\ndata on the efficacy, safety, suitability and comparative cost effectiveness of available\\ntreatments. In addition, stability of the product, need for special diagnostic or treatment\\nfacilities and pharmacokinetic properties are also considered. Most essential medicines\\nare formulatedas single compound. However, fixed dose combinations are selected only\\nwhen it has proven pharmacokinetic and/or pharmacodynamic advantages over single\\ncompound administered separately. While comparing the costof medicines among the\\nalternative treatments, the cost of total treatment and not the unit cost is considered. Other\\nfactors taken into account include pattern of diseases, treatment facilities, training and\\nexperience of the available personnel, financial resources etc.\\nAdvantages of Essential Medicines\\nThe implementation of the concept of EM has several logistic and prescribing advantages.\\nFor example better management of medicines i.e. easier procurement, storage,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 17, 'page_label': '18'}, page_content='Introduction to Rational Use of Medicines\\n2\\ndistribution, more manageable stock, better qualityassurance, easier dispensing, less\\nfragmentation of budget  with improve drug availability. Moreover,prescribing improves\\ndue to focused training and drug information, better recognition of adverse drug reactions,\\ndrug interactions and focused educationefforts. The list ofEM closely relates to\\ntreatment guidelines for clinical diseases andisalso used for the procurement and supply\\nof medicines in public sector, schemes for reimburses medicines costs and local medicine\\nproduction.\\nIts implementation is intended to be flexible and adaptable to different situations; which\\nmedicines are regarded as essential remains a national responsibility.\\nII.Standard Treatment Guidelines\\nStandard TreatmentG uidelines (STGs), treatment protocols, and prescribing policies are\\ndefined assystematically developed statements designed to assist prescribers in making\\ndecisions about the appropriate treatment and health care for specific clinical problem.\\nThese guidelines usually reflect the consensus on the optimal treatment options within a\\nhealth facility or system. In fact, they represent one of the approaches to promote\\ntherapeutically effective and economically efficient use of medicines.\\nSTGs list the preferred pharmacological and non-pharmacological treatment for common\\nhealth problems experienced by people in a specific health system. The pharmacological\\ntreatment should include the name, dosage form, strength, average dose (pediatric and\\nadult), number of doses per day, and duration of treatment. Other information on\\ndiagnosis and advice to the patient may also be included. The most common diseases and\\nserious medical conditions that have high morbidity and mortality rate are selected.\\nTreatment guidelines must have the most up-to-date and evidence based information to\\ndetermine appropriate treatment options by expert authors and reviewers. Effective\\nimplementation, however, is perhaps the greatest challenge in introducing STGs. When\\nimplemented effectively, it offers several advantages to patients, health care providers,\\nsupply management personnel and policy makers as follows:\\nPatients,\\n\\uf0b7 Most cost-effective optimal therapy is provided.\\n\\uf0b7 Better compliance through consistency among prescribers.\\n\\uf0b7 Improvement in availability of drugs.\\n\\uf0b7 Overall better quality of care.\\nHealth care providers,\\n\\uf0b7 Provides standardized guidance to practitioners\\n\\uf0b7 Quality of care standard-based on expert consensus and basis for monitoring\\n\\uf0b7 Utilizes only formulary or essential medicines, so the health care system needs to\\nprovideonly the medicines in theSTGs .\\nSupply managers,\\n\\uf0b7 Identification of medicines to be available for the most commonly treated problems.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 18, 'page_label': '19'}, page_content='Introduction to Rational Use of Medicines\\n3\\n\\uf0b7 Facilitation of prepackaging of course-of-therapy quantities of commonly prescribed\\nitems.\\n\\uf0b7 Medicine demand more predictable, so forecasting more reliable\\nHealth care policy makers,\\n\\uf0b7 Provides focus therapeutic integration of special programs (diarrhea disease control,\\nacute respiratory infection)\\n\\uf0b7 Provides a system for controlling cost by using funds more efficiently\\nSTGs also have certain drawbacks. Establishing, developing and implementation of STGs\\nisa difficult, lengthy and time consuming process. Moreover, it needs to be updated\\nregularly to reflect changes in treatment strategies. If a regular schedule for updating the\\nSTGs is not followed, they lose credibility and become obsolete. The extent of\\ninformation to be provided in each medical condition is often a difficult decision.\\nHowever, the STG manual should be concise and small enough to carry it easily.\\nKey features of asuccessful STG manual\\nSimplicity- The numb er of health problem is limited to commonly observed conditions.\\nEach clinical condition list a few salient features with clear and concise information on\\npharmacological and non-pharmacological treatment.\\nCredibility- Guidelines developed by the most respectedexperienced cliniciansin the\\ncountry and revisionis based on actual experience.\\nTreatment standards for all levels of health care facility- Health care providers use the\\nsame standard treatment; however,the referral criterion differs. While the first choice\\ntreatment for a patient depends upon the patientâ€™s diagnosis and condition and not on the\\nprescriber.\\nMedicine supply based on standards- The supply of medicines must match with the\\nstandard treatment and list of essentialmedicines.\\nRegular updating- A ny change in the therapeutic options, bacterial resistance pattern\\nshould be incorporated in the revised version to reflect current recommendations.\\nUser friendly- The STGs should be published as small, durable pocket manualwhich\\nmake itconvenient to carry and use.\\nIII.Drug Formulary\\nA formulary is a compendium of practical drug information for clinical practice adapted\\nfor use at a particularhealth care facility. It is a ready reference to key information on the\\nselection, prescribing, dispensing and administration of medicines. Although the concept\\nof formulary is old, a drug formulary is considered an essential element in achieving\\nrational prescribing in addition to controllingthe costs. The task of development of a\\nformulary in a hospital is usually undertaken by Drugs and Therapeutics Committee with\\na multidisciplinary membership of doctors, pharmacists, nurses and administrative staff.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 19, 'page_label': '20'}, page_content='Introduction to Rational Use of Medicines\\n4\\nThe consultants place a request for inclusion of medicines along with its dosage\\nformulations to Drugs and Therapeutics Committee. The committee mayaccept the\\nrequest andinclude it in formularyorrejectand suggest an alternative with information to\\nthe prescriber. The committee then monitors the impact, cost and benefits of various\\nmed icines in the health care facility. Depending on the outcome,theuse of medicine is\\nextended or curtailed. Formularies have significant advantages for patients care.\\nHowever, the introduction of formularies may cause friction sinceit may beviewed as a\\nm ajor threat to their clinical freedom. Effective multidisciplinary working methods and\\nconsultation is needed to overcome this attitude. Potential advantages and disadvantages\\nof drug formularies are as follows:\\nAdvantages\\n\\uf0b7 Reduces range of products to bepurchased / stored / distributed\\n\\uf0b7 Encourages generic prescribing\\n\\uf0b7 Lowers drug costs\\n\\uf0b7 Improved knowledge of a limited number of medicines\\n\\uf0b7 Improves drug safety\\n\\uf0b7 Improves patient care\\n\\uf0b7 Provides opportunity for  multidisciplinary work\\nDisadvantages\\n\\uf0b7 Restricts prescribing choice\\n\\uf0b7 Reduces treatment options\\n\\uf0b7 Inhibits introduction of new products\\n\\uf0b7 Restricts research efforts\\nIV.Rational Approach To Therapeutics\\nMedicinesshould only be prescribed when necessary, and the benefit of administering the\\nmedicine should be considered in relation to the risks involved. Bad prescribing habits\\nlead to ineffective and unsafe treatment, exacerbation or prolongation of illness, distress\\nand harm to the patient, and higher cost.The Guideto Good Prescribing;WHO; 1994,\\nprovidesmedical undergraduates with important tools for training in the process of\\nrational prescribing.\\nThe following steps will help to remind prescribers of the rational approach to\\ntherapeutics.\\n1. Define the patientâ€™s problem\\nWhenever possible, making the right diagnosis is based on integrating many pieces of\\ninformation: the complaint as described by the patient; a detailed history; physical\\nexamination; laboratory tests; X-rays and other investigations. This will help in rational\\nprescribing, always bearing in mindthat disease are evolutionary process.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 20, 'page_label': '21'}, page_content='Introduction to Rational Use of Medicines\\n5\\n2. Specify the therapeutic objective\\nDoctors must clearly state their therapeutic objectives based on the pathophysiology\\nunderlying the clinical situation. Very often physicians must select more than one\\ntherapeuticgoal for each patient.\\n3. Selecting therapeutic strategies\\nThe selected strategy should bediscussedwith the patient.The selected treatment can be\\nnon-pharmacological and/or pharmacological; it also needs to take into account the total\\ncost of all therapeutic options.\\na. Non -pharmacological treatment\\nThe patient does not always need amedicinefor treatment of the condition. Very often,\\nhealth problems can be resolved by a change in life style, dietary habits,use of\\nphysiotherapy or exercise, provision of adequate psychological support and other non-\\npharmacological treatments; they have the same importance as a prescription drug and\\ninstructions must be written, explained and monitored in the same way.\\nb. Pharmacological treatment\\nSelecting the correct group of drugs\\nKnowledge about the pathophysiology involved in the clinical situation of each patient\\nand the pharmacodynamics of the chosen group of drugs, are two of the fundamental\\nprinciples for rational therapeutics.\\nSelecting the drug from the chosen group\\nThe selection process must consider benefit/risk/cost information. This step is based on\\nevidence about maximal clinical benefits of the drug for a given indication (efficacy) with\\nminimum production of adverse effects (safety).\\nIt must be remembered that eachdrug has adverse effects and it is estimated that up to\\n10% of hospital admissions in industrialized countries are due to adverse effects. Not all\\ndrug-induced injury can be prevented but much of it is caused by inappropriate selection\\nof drugs.\\nIn cost comparisons between drugs, the cost of total treatment and not only the unit cost\\nof the drug must be considered.\\nVerifying the suitability of the chosen pharmaceutical treatment of each patient\\nThe prescriber must checksuitability of the chosen active substance, its dosage form,\\ndosage schedule and duration of treatment are suitable for each patient. Drug treatment\\nshould be individualized to the needs of each patient.\\nPrescription writing\\nThe prescription is the link between the prescriber, the pharmacist(or dispenser) and the\\npatient so it is important for successful management of presenting medical condition. The\\nitem is covered in more detail in the following section.\\nGiving information, instructions and warnings\\nThis step is important to ensure patient adherence and is covered in detail in the following\\nsection.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 21, 'page_label': '22'}, page_content='Introduction to Rational Use of Medicines\\n6\\nMonitoring treatment\\nEvaluation of the follow up and the outcome of treatmentprovides information whether\\nthe patientâ€™s problem is solved or to reformulate , ifnecessary. This step gives riseto\\nimportant information about the effectsand adverse effectsof medicines,contributing to\\nthe evidence ofknowledge, necessaryto promote the rational useof drugs.\\nV. Adverse Drug E ffects andDrug Interactions\\nAdverse drug reactions\\nAn adverse drug reaction (ADR) may be defined as â€˜ A response to a drug which is\\nnoxious, unintended and occurs at doses normally used for prophylaxis, diagnosis or\\ntherapyof disease, or for the modification of physiological functionâ€™ . ADRs are therefore\\nunwanted or unintendedeffects of a medicine, including idiosyncratic effects, which\\noccur during its proper use.\\nAn adverse drug event (ADE) is defined asâ€˜Any untoward medical occurrence that may\\npresent during treatment with a medicine but which does not necessarily have acausal\\nrelationship with this treatmentâ€™.\\nTwo types of ADRs and their differentiating characteristicshave been identified.The\\ncommon , predictable, dose relatedreactionwith low mortality is type â€˜Aâ€™ ADR. For\\nexample,anticholinergic effect oftricyclic antidepressants anddigoxintoxicity. ADRs\\nmay also be unrelatedto the known pharmacological action of a drug. These are\\nuncommon, non-dose related bizarre â€˜Bâ€™ type reactions , for example,anaphylaxis with\\npenicillins, malignant hyperthermia with halothane.\\nThalidomide marked the first recognized public health disaster related to the\\nintroduction of a new drug. It is now recognized that clinical trials, however through,\\ncannot be guaranteed to detect all adverse effects likely to be caused by a drug. Health\\nworkers are thus encouraged to record and reportto their national pharmacovigilance\\ncentre any unexpected adverse effects with any drug to achieve faster recognition of\\nserious related problems.The Central Drugs Standard Control Organization(CDSCO),\\nDirector General of Health Services under the influence of Ministry of Health & Family\\nWelfare, has initiated a nationwide Pharmacovigilance programme for protecting the\\nhealth of the patients by assuring drug safety.\\nThe specific aims and objectives of the National Pharmacovigilance Programme are:\\n\\uf0b7 To monitor ADRs in Indian population.\\n\\uf0b7 To create awareness amongst health care professionals about the importance of  ADR\\nreporting in India\\n\\uf0b7 To ensure that the benefits of use of medicine outweighs the risks andthus safeguard\\nthe health of the Indian population\\n\\uf0b7 To generate independent, evidence based recommendations on the safety of medicines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 22, 'page_label': '23'}, page_content='Introduction to Rational Use of Medicines\\n7\\n\\uf0b7 To encourage safe, rational and cost effective use of medicines.\\nUnder the National Coordinating Center, several ADR monitoring centers operates to\\ndetect ADEs. These ADR monitoring centers are located at MCI approved medical\\ncolleges and hospitals, private hospitals, public health programmes, and autonomous\\ninstitutions such as Indian Council of Medical Research etc. The ADRmonitoring centers\\nrecord and analyze the ADEs and submit them to the National Coordinating center via\\nonline reporting system known as Vigiflow.\\nSpontaneous reporting\\nSpontaneous reporting is the reporting of ADRs by healthcare professionals (and in some\\ncountries consumers) to identify and report any suspected adverse drug reaction to a\\npharmacovigilance center and/or to the manufacturer. It is one of the important methods\\nof collecting information about ADRs.\\nAll suspected adverse reactions, known orunknown, serious or otherwise should be\\nreported. It is important to report even minor reactions of new drugs. For established\\ndrugs, the reporting of serious ADRs is important. An increased frequency of a known\\nADR to a drug is also important.\\nAdverse drug reactions may be reported or notified to the nearest ADR monitoring centre\\nunder the National Pharmacovigilance Program. The Department of Pharmacology, B. J.\\nMedical College is one of the approved ADR monitoring center in Gujarat state. The\\nADRs can be reported by the forms available at the department.Reporting is the process\\nof providing ADR information by filling in the ADR form appropriately giving details of\\nthe clinical case as well as the ADR( Appendixâ€“ I).\\nMajor factors predisposing to adversedrug effects\\nIt is well known that different patients often respond differently to a given treatment\\nregimen. For example, patients taking combinations of drugs known to interact, only a\\nsmall number show any clinical evidence of interactions. In addition to the\\npharmaceutical properties of drug therefore, there are characteristics of the patient which\\npredispose to ADRs.\\nExtremes of age:The very old and the very young are more susceptible to ADRs. Drugs\\nwhich commonly cause problems in the elderly include hypnotics, diuretics, non-steroidal\\nanti-inflammatory drugs, antihypertensives, psychotropics and digoxin.\\nAll children and particularly neonates, differfrom adults in their response to drugs. Some\\ndrugs are likely to cause problems in neonates (for example morphine), but are generally\\ntolerated in children. Other drugs (for example valproic acid) are associated with\\nincreased risk of ADRs in children of all ages. Other drugs associated with problems in\\nchildren include chloramphenicol (G rey baby syndrome), antiarrhythmics (worsening of\\narrhythmias), acetylsalicylic acid (Reye syndrome).\\nIntercurrent illness: If besides the condition being treated, the patient suffers from\\nanother disease, such as kidney, liver or heart disease, special precautions maybe'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 23, 'page_label': '24'}, page_content='Introduction to Rational Use of Medicines\\n8\\nnecessary to prevent ADRs. The genetic make-up of the individual patient may also\\npredispose to ADRs.\\nDrug interactions: May occur between drugs which compete for the same receptor or act\\non the same physiological system. They may also occur indirectlywhen a drug-induced\\ndisease or a change in fluid or electrolyte balance alters the response to another drug.\\nIncompatibilities between drugs and intravenous fluids\\nDrugs should not be added to blood, amino acid solutions or fat emulsions. Certain drugs,\\nwh en added to intravenous fluids, may be inactivated by pH changes, by precipitation or\\nchemical reaction. Benzylpenicillin and ampicillin lose potency after 6-8 hours if added\\nto dextrose solutions, due to the acidity of the solutions. Some drugs bind to plastic\\ncontainers and tubing, for example diazepam and insulin. Aminoglycosides are\\nincompatible with penicillins and heparin. Hydrocortisone is incompatible with heparin,\\ntetracycline and chloramphenicol.\\nAdverse effects caused by traditional medicines\\nPatients who have been or are taking traditional herbal remedies may develop ADRs. It is\\nnot always easy to identify the responsible plant or plant constituent. Refer to the drug\\nand toxicology information service if available or to suitable literature.\\nThe effect of food on drug absorption\\nFood delays gastric emptying and reduces the rate of absorption of many drugs; the total\\namount of drug absorbed may or may not be reduced. However, some drugs are\\npreferably taken with food, either to increase absorption or to decrease the irritant effect\\non the stomach.\\nVI.Prescription writing\\nA prescription is an instruction from a prescriber to a dispenser. Every country has its\\nown standards for the minimum information required for a prescription, and its own laws\\nand regulations to define which drugs require a prescription and who is entitled to write it.\\nMany countries have separate regulations for prescriptions for controlled drugs such as\\nopioid analgesics.The following guidelines will help to ensure that prescriptions are\\ncorrectly interpreted and leave no doubt the intension of the prescriber. The guidelines are\\nrelevant for primary care prescribing; they may, however, be adapted for use in hospitals\\nor other specialist units.\\nPrescription form\\nThe most important requirement is that the prescription beclear and legibleand indicate\\nprecisely what should be given. The local languagemay be preferred.\\nThe following details should be shown on the form:\\n\\uf0b7 The prescriberâ€™s name, address and telephone number. This will allo w either the\\npatient or the dispenser to contact the prescriber for any clarification or potential\\nproblem with the prescription.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 24, 'page_label': '25'}, page_content='Introduction to Rational Use of Medicines\\n9\\n\\uf0b7 Date of the prescription. In many countries the validity of a prescription has no time\\nlimit, but in some countries pharmacists do not dispense drugs on prescriptions older\\nthan 3 to 6 months.\\n\\uf0b7 Name, form and strength of the drug. The International Non-proprietary Name of the\\ndrug should always be used. If there is a specific reason to prescribe a special brand,\\nthe trade name canbe added. Generic substitution is allowed in some countries. The\\npharmaceutical form (for example â€˜tabletâ€™, â€˜oral solutionâ€™, â€˜eye ointmentâ€™) should also\\nbe stated.\\n\\uf0b7 The strength of the drug should be stated in standard units using abbreviations that are\\nconsistent with the System International (SI). â€˜Microgramâ€™ and â€˜nanogramâ€™ should\\nnot, however, be abbreviated. Also, â€˜unitsâ€™ should not be abbreviated. Avoid decimals\\nwhenever possible. If unavoidable, a zero should be written in front of the decimal\\npoint.\\n\\uf0b7 Specific areas for filling in details about the patient including name, address and age.\\nDirections\\nDirections specifying the route, dose and frequency should be clear and explicit; use of\\nphrases such as â€˜take as directedâ€™ or â€˜take as beforeâ€™ should be avoided.\\nFor preparations which are to be taken on an â€˜as requiredâ€™ basis, the minimum dose\\ninterval should be stated together with, where relevant, the maximum daily dose. It is\\ngood practice to qualify such prescriptions with the purpose of the medication(for\\nexample â€˜every 6 hours as required for painâ€™, â€˜at night as required to sleepâ€™).\\nIt is good practice to explain the directions to the patient; these directions will then be\\nreinforced by the label on the medicinal product and possibly by appropriate counseling\\nby the dispenser. It may be worthwhile giving a written note for complicated regimens\\nalthough it must be borne in mind that the patient may lose the separate note.\\nQuantity to be dispensed\\nThe quantity of the medicinal product to be supplied should be stated such that it is not\\nconfused with either the strength of the product or the dosage directions.\\nAlternatively, the length of the treatment course may be stated (for example â€˜for 5 daysâ€™).\\nWherever possible, the quantity should be adjusted to match the pack sizes available.\\nFor liquid preparations the quantity should be stated in milliliters (abbreviated as â€˜mlâ€™) or\\nlitres (preferably not abbreviated since the letter â€˜lâ€™ could be confused with the figure â€˜1â€™).\\nNarcotics and controlled substances\\nThe prescribing of a medicinal product that is liable to abuse requires special attention\\nand may be subject to specific statutory requirements. Practitioners may need to be\\nauthorized to prescribe controlled substances; in such cases it might be necessaryto\\nindicate details of authority on the prescription.\\nIn particular, the strength, directions and the quantity of the controlled substance to be\\ndispensed should be stated clearly, with all quantities written in words as well as in'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 25, 'page_label': '26'}, page_content='Introduction to Rational Use of Medicines\\n10\\nfigures to prevent alteration. Other details such as patient particulars and date should also\\nbe filled in carefully to avoid alteration.\\nReferences\\n1. The Guide to Good Prescribing;Geneva: WHO; 1994\\n2. WH0 Model Formulary 2008.\\n3. www.cdsco.nic.in/pharmacovigilance.htm'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 26, 'page_label': '27'}, page_content='11\\nChapter 2\\nCOMMON CONDITIONS\\nFEVER\\nA body temperature greater than 37.7Â°C is defined as fever. Fever may be continuous,\\nintermittent or remittent.\\nInvestigations\\nA meticulous history of chronology of symptoms, any associated focal symptom(s), exposure to\\ninfectious agents and occupational history may be useful. A thorough physical examination\\nrepeated on a regular basis may provide potentially diagnostic clues.\\n\\uf0b7 If there are no clinical clues, the tests include a complete haemogram with ESR, smear for\\nmalaria parasite, blood culture, Widal test andurine analysis including urine culture.\\n\\uf0b7 If the febrile illness is prolonged to more than 2 weeks, anX -ray chest is indicated even in\\nthe absence of respiratory symptoms. Any abnormal fluid collection should besampled.\\nTreatment\\nRoutine use of antipyretics in low-grade fever is not justified. This may mask important clinical\\nindications. However, in acute febrile illnesses suggestive of viral or bacterial cause, fever\\nshould be treated.\\nNon pharmacological treatment\\nHydrotherapy and rest\\nPharmacological treatment\\nNon -specific\\n\\uf0b7 Tab. paracetamol 500-1000 mg 6-8 hourly. Or Tab. ibuprofen 400-600 mg 8 hourly.\\nSpecific\\n\\uf0b7 Antibiotics/antimalarials depending upon the cause suggested by clinical andlaboratory\\nevaluation.\\nOutcome\\nIn most cases of fever, patient may either recover spontaneously or a diagnosis is reached after\\nrepeated clinical evaluation and investigations. If no diagnosis is reached in up to 3 weeks,\\npatient is said to be having feverof unknown origin (FUO) and should be managed accordingly.\\nPatient education\\n\\uf0b7 Self medication should be avoided.\\n\\uf0b7 Antibiotics should be taken only on advice of a physician.\\n\\uf0b7 Avoid covering the patient having high fever with blanket etc.\\n\\uf0b7 Plenty of fluids should be taken. Stay in cool environment. Cold sponging of face and limbs\\nshouldbe done repeatedly.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 27, 'page_label': '28'}, page_content=\"Common Conditions\\n12\\n\\uf0b7 Common causes include\\n- Infections, particularly extrapulmonary tuberculosis, typical and atypical mycobacterial\\ninfections,Pneumocystis cariniipneumonia, toxoplasmosis, lymphoma etc. In neutropenic\\npatients, gram negative bacterial, staphylococcal and fungal infections are important causes.\\n- Neoplastic conditions\\n- Noninfectious inflammatory causes collagen vascular diseases, drug fevers\\n\\uf0b7 Prolonged unexplained fever, often with no localizing clue on history, physical examination\\nand basic laboratory investigations.\\nReferences\\n1. Alterations in Body Temperature. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E,\\nFauci AS et al (eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 104-25.\\n2. Physiological Changes in Infected Patients. In: Oxford Textbook of Medicine. Warrell DA, Cox TM, Firth\\nJD, Benz EJ Jr (eds), 4th Edition, 2003. Oxford University Press, 1289-92.\\nFEVER OF UNKNOWN ORIGIN (FUO)\\nFUO is defined as thepresence of fever of 38.3Â°C or more recorded on several occasions,\\nevolving for at least 3 weeks with no diagnosis reached even after one week of relevant and\\nintelligent investigations. FUO is usually an uncommon presentation of common diseases.\\nSalient features\\nInvestigations\\n\\uf0b7 A detailed clinical history, repeated physical examination to provide potentially\\ndiagnostic clues (PDC).\\n\\uf0b7 No single algorithmic approach to diagnosis can be recommended for all patients of FUO\\nand diagnostic approach needs to beindividualized.\\n\\uf0b7 A complete haemogram including peripheral blood smear for malaria parasite, serum\\nbiochemistry particularly liver function tests, a tuberculin test and an X-ray of chest\\nshould be done in every patient with prolonged fever.\\n\\uf0b7 Other investigations which are often helpful include tests related to collagen vascular\\ndiseases, an ultrasonographyto localize intra-abdominal foci of infections and a contrast\\nenhanced computed tomography (CECT) of chest and abdomen in detecting mediastinal\\nlymph nodes and parenchymal lung abnormalities not seen on conventional chest X-ray.\\n\\uf0b7 Further, diagnostic approach should take into consideration the PDCs from the evaluation\\nof history, results of repeated physical examination, basic investigations and any\\ninvestigations done prior to this episode. If any abnormal or doubtful lesion is detected\\nFNAC/biopsy should be obtained.\\nTreatment\\nSometimes evaluation may need discontinuation of all drugs being taken by the patient to rule\\nout drug fever as the cause of FUO.\\nSymptomatic treatment for fever(for details see section on fever)\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 28, 'page_label': '29'}, page_content=\"Common Conditions\\n13\\n\\uf0b7 Major criteria are pancarditis,polyarthritis,chorea,erythema marginatumand subcutaneous\\nnodule.\\n\\uf0b7 Minor criteria arearthralgia,fever,raised PR interval.\\n\\uf0b7 Cold sponging may be done if fever produces discomfort. The emphasis in patients with\\nclassic FUO is on continued observation and examination.\\n\\uf0b7 (Caution: Avoid 'shotgun' trials. Empirical therapies consisting of therapeutic trials\\ncommonly used in patients with FUO are: antibiotics, anti-tubercular treatment (ATT)\\nand corticosteroids).\\n\\uf0b7 The ability of glucocorticoids and NSAIDs to mask fever while permitting the spread of\\ninfection dictates thattheir use should be avoided unless infection has been largely ruled\\nout.\\n\\uf0b7 If on the basis of clinical evaluation and inability to reach a definitive diagnosis, a\\ntherapeutic trial is started, the following principles must be kept in mind:\\n- Give only one setof trial at a given time\\n- The doses of drugs and period of therapeutic trial must be adequate-\\n- The patient must be followed closely for response\\nPatient education\\n\\uf0b7 Self medication should be avoided.\\n\\uf0b7 Antibiotics should be taken only on advice of a physician.\\n\\uf0b7 Plenty of fluids should be taken. Stay in a cool environment.\\nACUTE RHEUMATIC FEVER\\nRheumatic fever is due to an autoimmune reaction to group streptococci and involves many\\norgans, primarily the heart, the joints and the central nervous system.\\nSalientfeatures\\nNon pharmacological treatment\\n\\uf0b7 Bed rest for two weeks followed by gradual ambulation\\nPharmacological treatment\\n\\uf0b7 Tab.  penicillin V 500 mg BD  for 10 days or Inj. benzathine penicillin G- 1.2 million\\nunits in single does orTab. erythromycin 250 mg QID for 10 daysâ€“ if patient is allergic\\nto penicillin.\\n\\uf0b7 For secondary prophylaxis for rheumatic fever, giveInj. benzathine penicillin 1.2 million\\nunits every 3 weeks or Tab. penicillin V 250 mg BD daily or Tab. erythromycin 250 mg\\ntwice daily.\\n\\uf0b7 Duration of prophylaxisis given in Table 1.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 29, 'page_label': '30'}, page_content='Common Conditions\\n14\\nTable 1. Duration of secondary prophylaxis in acute rheumatic fever\\nCategory of Patient Duration of Prophylaxis\\nRheumatic fever without carditis For 5 years after the last attack or 21 years of\\nage (whichever islonger).\\nRheumatic fever with carditis but no\\nresidual valvular disease\\nFor 10 years after the last attack, or 21 years of\\nage (whichever is longer).\\nRheumatic fever with persistent valvular\\ndisease, evident clinically or on\\nechocardiography\\nFor 10 yearsafter the last attack, or 40 years of\\nage (whichever is longer). Sometimes lifelong\\nprophylaxismay be required.\\n\\uf0b7 Arthritis:Tab. aspirin 2 g QID in adults and 80-100 mg/kg/day in children till symptoms\\npersist or Tab. naproxen: 10-20 mg/kg/day can alsobe used.\\n\\uf0b7 Carditis: Tab. prednisolone 1-2 mg/kg/day can be used for short periods or up to a\\nmaximum of 3 weeks.\\n\\uf0b7 Chorea: It occursas a long term sequelae (3-6 months). Carbamazepine or sodium\\nvalproate is preferred to haloperidol(0.05 mg/kg/day) to reducethe abnormal movements\\nbut response may take up to 2 weeks. Treatment should continue up to 1-2 weeks after\\nsymptoms subside.\\nANAEMIA\\nAnaemia is defined as a low haemoglobin level (less than 13.5 g/dl in males and less than\\n13.5 gm/dl in females).The common causes of anaemia in Indiaincludes,reduced production\\ndue to deficiency of iron, folic acid, rarely vitamin B12, or an ineffective erythropoiesis\\nsecondary to many causes (anaemia of chronic disease, secondary to infections and\\ninflammation, endocrinal disorders, primary bone marrow disorders like infiltration or\\nhypoplasia),  blood loss (whichalso leads to iron deficiency) and increased destruction of\\nRBCs (haemolysis due to many causes of which thalassaemia is the commonest).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 30, 'page_label': '31'}, page_content='Common Conditions\\n15\\nSalientfeatures\\nPharmacological treatment\\nIron deficiency anaemia\\n\\uf0b7 Treat the underlying cause: menorrhagia in women, gastrointestinal blood loss in all age\\ngroups including hookworm infestation, dietary deficiency, rarely malabsorption.\\n\\uf0b7 Tab. ferrous sulfate 200 mg 3 times a day.\\n\\uf0b7 Reduce the dose as haemoglobin rises to over 10 g/dl. Once haemoglobin is normal,\\ncontinue with 1 tablet daily for at least three months.\\n\\uf0b7 Other preparations of iron are not superior, but they can be tried ifpatient does not find\\nferrous sulfate suitable. These include ferrous fumarate and ferrous gluconate. The rate of\\nrise of haemoglobin should be 1 g/dl per week.\\n\\uf0b7 If this does not occur, consider ongoing blood loss, noncompliance,and associated\\nhaemoglobinopathy like thalassaemia carrier status, malabsorption, or an incorrect\\ndiagnosis.\\n\\uf0b7 Parenteral iron does not lead to a faster rise in haemoglobin. It is indicated in the\\nfollowing situations: (i)m alabsorption of iron, (ii)intolerance of oral iron, (iii)in late\\npregnancy to ensure that foetal stores of iron are replenished rapidly, (iv)if ongoing\\nblood loss exceeds the capacity to absorb oral iron(like in inoperable malignancy) and(v)\\nin noncompliant patient. There is danger of anaphylactoid reactions;hence facilities to\\nmanage these should be readily available.\\nFolic acid deficiency\\n\\uf0b7 Treat the cause: Dietary deficiency, increased requirement as in pregnancy and children,\\nhaemolytic anaemia.\\n\\uf0b7 Tab. folic acid 5 mg daily. This dose is adequate even in malabsorption syndrome.\\nVitamin B12 deficiency\\n\\uf0b7 Tiredness, weakness and lack of desire to work.\\n\\uf0b7 Nails and tongue look pale. Severe anaemia produces general pallor and swelling of feet.\\n\\uf0b7 Most aetiologies may be determined on the basis of MCV performed in an accurate cell\\ncounter as follows:\\n\\uf0b7 Low MCV -Iron deficiency or haemoglobfnopathy like thalassaemia.\\n\\uf0b7 High MCV - Folic acid or B12 deficiency. Less commonly alcohol intake, liver disease,\\nhaemolysis and hypothyroidism.\\n\\uf0b7 Normal MCV - Anaemia of chronic disease, primary bone marrow disorders, renal\\nfailure, haemolysis.\\n\\uf0b7 In case of associated leucocyte and platelet abnormalities or if anaemia does not respond\\nto therapy in 4 weeks despite correcting the apparent cause, a bone marrow examination\\nby aspiration/biopsy should be performed.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 31, 'page_label': '32'}, page_content='Common Conditions\\n16\\n\\uf0b7 The onset of fever is typically gradual, continuous (temperature upto 40Âº C)\\nconstitutional symptoms such as malaise, anorexia, lethargy, headache.\\n\\uf0b7 Constipation or diarrhea (pea-soup stools) which may be associated with abdominal\\npain and tenderness.\\n\\uf0b7 Hepatomegaly and splenomegaly may be observed.\\n\\uf0b7 Complications such as hepatitis, meningitis, pneumonitis and myocarditis can occur\\nafter the first week.\\n\\uf0b7 Treat the cause: Dietary deficiency in vegetarians, pernicious anaemia. Although\\nuncommon, it is also under diagnosed due to lack of facilities.\\n\\uf0b7 Tab. vitamin B complex, as in haematinic tablets. Or Inj. B12 1000 mcg IM, one injection\\non alternate days for total 5 injections, then once a week for 5 weeks, then once in 3 to 6\\nmonths will be adequate for most patients.\\nPatient education\\n\\uf0b7 Educate the patient about preventive measures for worm infestation.\\n\\uf0b7 Inform about importance of taking adequate food with green leafy vegetables to meet the\\nnutritional requirement.\\n\\uf0b7 Cooking food in iron utensils may increase iron content in the diet.\\n\\uf0b7 Instruct the patient to take iron tablets after food; iron tablets sometimes produce stomach\\nupset.\\n\\uf0b7 Inform the patient that the stools could turn black during iron therapy\\n\\uf0b7 Reduce the dose of iron if it produces stomachache, diarrhoea or constipation.\\n\\uf0b7 Explain that the response to iron therapy is gradual and it takes weeks or months for\\nblood to become normal. Continue iron tablets for six months.\\n\\uf0b7 Keep iron tablets out of the reach of children. They may swallow the tablets as candies\\ncausing adverse reactions including death.\\nTYPHOID FEVER\\nIt is caused bySalmonella typhiand Salmonella paratyphi.Salmonella typhicauses a variety\\nof illnesses including asymptomaticcarrier state, gastro-enteritis andenteric fever.\\nSalient features\\nInvestigations\\n\\uf0b7 Diagnosis is suggested by\\n- Rising of O antibodies (W idal test) and\\n- Confirmed by isolation of organism in blood, bone marrow, urine or stool\\nPharmacological treatment\\n\\uf0b7 Most patients with uncomplicated enteric fever can be managed at home with oral\\nantibiotics and antipyretics.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 32, 'page_label': '33'}, page_content='Common Conditions\\n17\\n\\uf0b7 Patients with persistent vomiting, diarrhea, and/or abdominal distension should be\\nhospitalized and given supportive therapy as well as a parenteral third-generation\\ncephalosporin or fluoroquinolone, depending on the susceptibility profile(Table 2).\\n\\uf0b7 Therapy should be administered for at least 10 days or for 5 days after feverresolution.\\nTable 2. Dosage schedule of antibiotics in treatment of typhoid fever\\nIndication Agent Dosage (Route) Duration, Days\\nEmpirical\\nTreatment\\nCeftriaxonea 1-2 g/d IV 7â€“14\\nFully\\nSusceptible\\nCiprofloxacinb (first line)500 mg BD (PO) or 400\\nmg BD (IV)\\n5â€“7\\nAmoxicillin (second line)1 g TDS (PO) or 2 g QID\\n(IV)\\n14\\nChloramphenicol 25 mg/kg TDS (PO or IV) 14â€“21\\nTrimethoprim-\\nsulfamethoxazole\\n160/800 mg BD (PO) 7â€“14\\nCiprofloxacin 500 mg BD (PO) or 400\\nmg BD (IV)\\n5â€“7\\nMultidrug-\\nResistant\\nCeftriaxone 2â€“3 g/day (IV) 7â€“14\\nAzithromycin 1 g/day (PO)c 5\\nCeftriaxone 2â€“3 g/d (IV) 7â€“14\\nAzithromycin 1 g/d (PO) 5\\nNalidixic Acidâ€“\\nResistant\\nHigh-dose ciprofloxacin750 mg bid (PO) or 400\\nmg q8h (IV)\\n10â€“14\\naOr another third-generation cephalosporin [e.g., cefotaxime, 2 g TDS (IV); or cefixime, 400 mg\\nbid (PO)].\\nbOr ofloxacin 400 mg bid (PO) for 2â€“5 days.\\ncOr 1 g on day 1 followed by 500 mg/day PO for 6 days.\\n\\uf0b7 The 1â€“5% of patients who develop chronic carriage ofSalmonellacan be treated for 4â€“6\\nweeks with an appropriate oral antibiotic.\\n\\uf0b7 Treatment with oral amoxicillin,cotrimoxazole, ciprofloxacin, or norfloxacin is 80%\\neffective in eradicating chronic carriage of susceptible organisms.\\n\\uf0b7 However, in cases of anatomic abnormality (e.g., biliary or kidney stones), eradication\\noften requires both antibiotic therapy and surgical correction.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 33, 'page_label': '34'}, page_content='Common Conditions\\n18\\n\\uf0b7 It is an acute and chronic illness characterized by paroxysms of fever, chills, sweats,\\nfatigue, anemia and splenomegaly.P. falciparummalaria (severe and complicated\\nmalaria) is associated in varying degrees with the following clinical signs.\\n\\uf0b7 Symptoms of cerebral malariaincludemental clouding,coma, convulsions,delirium\\nand occasionally localizing signs, hyperpyrexia (more than 40.5ÂºC), haemolysis,\\noliguria,anuria,pulmonary edemaand macroscopic haemoglobinuria.\\nMALARIA\\nParastitic infection due to protozoa of genusPlasmodium transmitted by the female anopheles\\nmosquito. There are four plasmodia species:Plasmodium falciparum, Plasmodium vivax,\\nPlasmodium malaria, Plasmodium ovale.\\nSalient features\\nInvestigations\\nDiagnosis is made by presence of protozoa in the blood in thick and thin smear slides (thick\\nsmear for easy detection of parasite and thin smear for identification of species).\\nNote: That blood films may be negative even in a severe attack because of parasites in the\\ndeep capillaries.\\nPharmacological treatment(Figure 1, 2 and 3)\\nFigure1. Treatment where microscopy result is available within 24 hours'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 34, 'page_label': '35'}, page_content='Common Conditions\\n19\\nFigure 2. Treatment where microscopy result is not available within 24 hours and\\nmonovalent RDT is used\\nFigure3. Treatment where microscopy result is not available within 24 hours and\\nbivalent RDT is used'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 35, 'page_label': '36'}, page_content='Common Conditions\\n20\\nTreatment ofP.vivaxm alaria\\n\\uf0b7 Tab. chloroquine:25 mg/kg body weight divided over three days i.e.\\n\\uf0d8 10 mg/kg on day 1\\n\\uf0d8 10 mg/kg on day 2\\n\\uf0d8 5 mg/kg on day 3\\n\\uf0b7 Tab. primaquine:0.25 mg/kg body weight daily for 14 days.\\n\\uf0b7 Primaquine is contraindicated in infants, pregnant women and individuals with G6PD\\ndeficiency.14 day regimen of primaquine should be given under supervision.\\nTreatment ofP.falciparumm alaria\\n\\uf0b7 Artemisinin based Combination Therapy (ACT-SP) â€“ Tab.artesunate 4 mg/kgbody weight\\ndaily for 3 days plussulfadoxine (25 mg/kg body weight)- pyrimethamine (1.25 mg/kg\\nbody weight) on first day.\\n\\uf0b7 Tab.primaquine:0.75 mg/kg body weight on day 2\\nTreatment of mixed infections(P.vivax+ P.falciparum)cases\\nAll mixed infections should be treated with full course of ACT andprimaquine 0.25 mg per\\nkg body weight daily for 14 days(Table 3).\\nTable 3. Dosage schedule for treatment of mixed infection(P.vivax+ P.falciparum)\\nAge\\nDay 1 Day 2 Day 3 Days 4-14\\nAS\\n(50 mg)\\nSP\\n(500 mg +\\n25 mg)\\nPQ\\n(2.5 mg)\\nAS tablet\\n(50 mg)\\nPQ\\n(2.5 mg)\\nAS tablet\\n(50 mg)\\nPQ\\n(2.5 mg)\\nPQ\\n(2.5 mg)\\nLess than 1 yr 1/2 1/2 0 1/2 0 1/2 0 0\\n1-4 years 1 1 1 1 1 1 1 1\\n5-8 years 2 1 .5 2 2 2 2 2 2\\n9-14 years 3 2 4 3 4 3 4 4\\n15 yrs or more 4 3 6 4 6 4 6 6\\nAS â€“ artesunate, SPâ€“ sulfadoxine-pyrimethamine, PQ-primaquine'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 36, 'page_label': '37'}, page_content=\"Common Conditions\\n21\\nT reatment of complicated or severe malaria (Table 4)\\nTable 4. Treatment of severe and complicated malaria\\nInitial parenteral treatment for at least 48hrs.\\nChoose any one of the following\\nFollow-up treatment, when patient\\ncan take oral medications following\\nparenteral  treatment\\nQuinine:20mg quinine salt/kg body weight\\non admission (IV infusion or divided IMinjection)\\nfollowed by maintenance dose of 10 mg/kg 8 hourly;\\ninfusion rate should notexceed 5 mg/kg per hour.\\nLoading dose of20mg/kg should not be given, if the\\npatienthas already received quinine.\\nQuinine10 mg/kg three times a day\\nplusdoxycycline 100 mg once a day\\norclindamycin in pregnant women\\nand childrenunder 8 years of age, to\\ncomplete 7 days oftreatment.\\nArtesunate:2.4 mg/kgIV or IM given onadmission,\\nthen at 12 h and 24 h, thenonce a day or\\nArtemether: 3.2 mg/kgIM given onadmission then\\n1.6 mg/kg per dayor\\nArteether:150 mg dailyIM for 3 days inadults only\\n(not recommended for children).\\nTreat with: ACT-SP for 3days + PQ\\nsingle dose on second day to\\ncomplete 7 days of treatment.\\nNote: The parenteral treatment in severe malaria cases should be given for minimum of 24 hours once started\\n(irrespective of the patient's ability to tolerate oral medication earlier than 24 hours).\\nChemoprophylaxis of malaria\\nShort term chemoprophylaxis (up to 6 weeks)\\nDoxycycline: 100 mg once daily for adults and 1.5 mg/kg once daily for children\\n(contraindicated in children below 8 years). The drug should be started 2 days before travel\\nand continued for 4 weeks after leaving the malarious area.\\nChemoprophylaxis for longer stay (more than 6 weeks)\\nMefloquine:250 mg weekly for adults and should be administered two weeks before, during\\nand four weeks after exposure.\\nDENGUE\\nDengue is the mostimportant emerging tropical viral disease of human beings in the world\\ntoday.  All four dengue virus (Dengue 1, 2, 3 and 4) infections maybe asymptomatic, may\\nlead todengue fever (DF),dengue hemorrhagic fever (DHF)or when associated withplasma\\nleakage may lead to hypovolemic shock and dengue shock syndrome (DSS).\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 37, 'page_label': '38'}, page_content='Common Conditions\\n22\\nSalient features\\nDengue hemorrhagic fever(DHF) ,if one or more of the following are present\\n\\uf0b7 Positive tourniquet test\\n\\uf0b7 Petechiae, purpura or ecchymosis\\n\\uf0b7 Bleeding from mucosa\\n\\uf0b7 Haematemesis, melena\\n\\uf0b7 Thrombocytopenia (platelets 100,000cells/mm 3 or less) and evidence of plasma leakage.\\nDengue shock syndrome (DSS)\\n\\uf0b7 All the above criteria of DHF plus signs of circulatory failure.\\nNotes: The tourniquet test is performedby inflating a blood pressure cuff to mid way\\nbetweenthe systolic and diastolic pressure.\\nNon pharmacological treatment\\n\\uf0b7 Bed rest is advisable during the acute phase.\\n\\uf0b7 Use cold sponging to keep temperature below 39ÂºC\\nPharmacological treatment\\n\\uf0b7 Management ofdengue fever is symptomatic and supportive\\n\\uf0b7 Antipyretics may be used to lower the body temperature. Aspirin/NSAIDs likeibuprofen\\netc should be avoided since it may cause gastritis, vomiting, acidosisand platelet\\ndysfunction.\\n\\uf0b7 Paracetamol is preferablein the doses as follows:1-2 years: 60â€“120 mg/doses,3-6 years:\\n120 mg/dose,7-12 years: 240 mg/dose,Adult : 500mg/dose\\nNote: In children the dose is calculated as per 10mg/kgbody w eight per dose which can\\nbe repeated at the interval of 6hrs.\\n\\uf0b7 Oral fluid and electrolyte therapy are recommended for patients with excessivesweating\\nor vomiting.\\n\\uf0b7 Patients should be monitored in DHF endemic area until they become afebrilefor one\\nday without the use of antipyretics and after platelet and haematocrit determinations are\\nstable, platelet count is more than 50,000/mm 3.\\nManagement of Dengue Hemorrhagic Fever (Febrile Phase)\\n\\uf0b7 The management of febrile phase is similar to that of DF.\\n\\uf0b7 Paracetamol isrecommended to keep the temperature below 39O C. Copious amount of\\nfluidshould be given orally, to the extent the patient tolerates, oral hydration solution\\n(ORS), such as those used for the treatment of diarrhoeal diseases and/or fruitjuices are\\npreferable to plain water\\n\\uf0b7 Dengue fever is an acute febrile illness of 2-7 days with two or more of the following\\nmanifestations. Headache, retro orbital pain, myalgia, arthralgia, rash.\\n\\uf0b7 Hemorrhagic manifestation (petechiae and positivetourniquet test) and Leucopenia'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 38, 'page_label': '39'}, page_content='Common Conditions\\n23\\n\\uf0b7 IV fluid may be administered if the patient isvomiting persistently or refusing to feed.\\n\\uf0b7 Patients should be closely monitored for the initial signs of shock. The criticalperiod is\\nduring the transition from the febrile to the afebrile stage and usuallyoccurs after the\\nthird day of illness.\\n\\uf0b7 Serial haematocrit determinations are essentialguide for treatment, since they reflect the\\ndegree of plasma leakage and need forintravenous administration of fluids.\\n\\uf0b7 Haematocrit should be determined daily fromthe third day until the temperature has\\nremained normal for one or two days. Ifhaematocrit determination is not possible,\\nhaemoglobin determination may becarried out as an alternative.\\n\\uf0b7 The details of IV treatment when required for patientsare given inFigure 4.\\nFigure 4. Treatment algorithm of dengue'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 39, 'page_label': '40'}, page_content='Common Conditions\\n24\\nManagement of DHF Grade I and Grade II:\\n\\uf0b7 Any person who has dengue fever with thrombocytopenia and haemoconcentrationand\\npresents with abdominal pain, black tarry stools, epistaxis, bleeding from thegums and\\ninfection etc needs to be hospitalized.\\n\\uf0b7 All these patients should beobserved for signs of shock. The critical period for\\ndevelopment of shock istransition from febrile to abferile phase of illness, which usually\\noccurs after third day of illness.\\n\\uf0b7 A rise of haemoconcentration indicates need for IV fluid therapy. Ifdespite the treatment,\\nthe patient develops fall in BP, decrease in urine output orother features of shock, the\\nmanagement for Grade III/IV DHF/DSS should beinstituted.\\n\\uf0b7 Oral rehydration should be given along with antipyretics likeparacetamol sponging,etc.\\nas described above.\\n\\uf0b7 The detailed treatment for patient with DHF Grade Iand II is given atFigure 5. Common\\nsigns of complications are observed during the afebrile phase of DHF.Immediately after\\nhospitalization, the haematocrit, platelet count and vital signsshould be examined to\\nassess the patientâ€™s condition and intravenous fluid therapy should be started. The patient\\nrequires regular and sustained monitoring.\\nFigure 5. Volume replacement flow chart for patients with dengue haemorrhagic fever\\ngrade I and II'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 40, 'page_label': '41'}, page_content='Common Conditions\\n25\\nFluid requirement\\n\\uf0b7 The volume of fluid required to be replaced should be just sufficient to maintaineffective\\ncirculation during the period of plasma leakage. To ensure adequate fluidreplacement\\nand avoid over-fluid infusion, the rate of intravenous fluid should beadjusted throughout\\nthe 24 to 48 hour period of plasma leakage by periodichaematocritdeterminations and\\nassessment of vital signs.\\n\\uf0b7 The required regimen of fluid should be calculated on the basis of body weightand\\ncharted on a 1-3 hourly basis, or more frequently in the case of shock. Theflow of fluid\\nand the time of infusion are dependent on the severity ofDHF. The schedule given below\\nis a guidelineand calculatedfor moderate dehydration of about 6% deficit(plus\\nmaintenance)(Table 5).\\nTable 5. Fluid requirement as per body weight of the patient\\nWeight on\\nadmission (kg)\\nFluid requirement/kg body\\nweight/day (ml/kg)\\n<7 220\\n7-11 165\\n12-18 130\\n>18 90\\n\\uf0b7 In older children who weigh more than 40 kg, the volume needed for 24 hoursshould be\\ncalculated as twice that required for maintenance (using the Holidayand Segar formula).\\nThe maintenance fluid should be calculated as follows:\\nTable 6. Maintenance fluid requirement according to Holiday and Segar formula\\nBody weight in kg Maintenance volume for 24 hours\\n<10kg\\n10-20kg\\n>20kg\\n100 ml / kg\\n1000+50 ml / kg\\n1500+20 ml / kg\\nFor a child weighing 40 kgs, the maintenance is: 1500 + (20x20) = 1900 ml. Thismeans that\\nthe child requires 3800 ml IV fluid during 24 hours.\\nIndications of red cell transfusion\\n\\uf0b7 Loss of blood(overt blood)-10% or more of total blood volume\\n\\uf0b7 Preferably whole blood/ component to be used\\n\\uf0b7 Refractory shock despite adequate fluid administration and declininghaematocrit-\\nreplacement volume should be 10 ml/kg body wt at a time andcoagulogram should be\\ndone.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 41, 'page_label': '42'}, page_content='Common Conditions\\n26\\n\\uf0b7 Acute self limiting illness Incubation period is of 2 to 4 days. Abrupt onset presenting\\nas fever with severe joint pain\\n\\uf0b7 After 1â€“ 4 days, fever subsides, there will be a afebrileperiod 3 days, fever returnswith\\nan itching maculopapular rash on trunk and extensor surfaces of limbs.\\n\\uf0b7 Afteranother3-6 days fever subsides and there is complete recovery.\\n\\uf0b7 Cripping arthropathycan occur intermittently for upto 4 months, in somecases even\\nupto 5 years.\\n\\uf0b7 If fluid overload is present,PCV is to be given\\nIndications of platelet transfusion\\n\\uf0b7 In general there is no need to give prophylactic platelets even atlessthan 20,000\\ncells/mm 3.\\n\\uf0b7 Prophylacticplatelet transfusion may be given at level ofless than 10,000 cells/mm 3 in\\nabsence of bleeding manifestations.\\n\\uf0b7 Prolonged shock; with coagulopathy and abnormal coagulogram.\\n\\uf0b7 In case ofsystemic massive bleeding, platelet transfusion may be needed in addition to\\nred cell transfusion.\\nCHIKUNGUNYA\\nChikungunya is caused by an alpha virus closely related to Oâ€™ nyong â€“ nyong virus.The main\\nvector isAedes aegyptimosquito.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Mild exercises and physiotherapy may be suggested in recovering persons.\\n\\uf0b7 Exposure to warm environment may be suggested\\n\\uf0b7 Non weight bearing exercises\\n\\uf0b7 Surgery in severely damaged joints\\nPharmacological treatment\\n\\uf0b7 Acute stage of illness\\n\\uf0b7 Treat symptomatically (Tab. paracetamol 1gm 3-4 times a day for fever, headache and\\npain.)\\n\\uf0b7 Avoid aspirin and steroid becauseof risk of GI side effects and Reyeâ€™s syndrome with\\naspirin.\\n\\uf0b7 Tab. hydroxychloroquinine 200mg orally once daily or Tab. chloroquinine phosphate\\n300mg per day for aperiod of 4 weeks in cases where arthralgia is refractory to other\\ndrugs.\\n\\uf0b7 Sideeffects of hydroxychloroquinine includeretinal damageand elevated liver enzymes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 42, 'page_label': '43'}, page_content='Common Conditions\\n27\\nPulmonary tuberculosis(PTB): The most common symptom of PTB is a persistent cough\\nof two weeks or more, with or without expectoration.It may be accompanied by one or\\nmore of the following symptoms,\\n\\uf0b7 Fever, night sweats, weightloss\\n\\uf0b7 Chest pain, hemoptysis, shortness of breath, tiredness and loss of appetite\\nSuch patients should be selected and subjected for sputum examination. This enhances the\\nchances of detection of the bacilli in the smear microscopy.\\nExtra pulmonary tuberculosis: A person with extra-pulmonary TB may have symptoms\\nrelated to the organs affected along with constitutional symptoms stated above.\\n\\uf0b7 Enlarged cervical lymph nodes with or without discharging sinuses (TB Lymphadenitis)\\n\\uf0b7 Chest pain with or withoutdyspnoea in pleural TB\\n\\uf0b7 Pain and swelling of the joints in bone tuberculosis (fever, backache, deformity in spinal\\nTB).\\n\\uf0b7 Signs of raised intra-cranial tension like irritability, headache, vomiting, fever, stiffness\\nof the neck and mental confusion in TBmeningitis\\n\\uf0b7 Painless haematuria or sterile pyuria in renal tuberculosis and, infertility in genito-\\nurinary TB.\\nTUBERCULOSIS\\nSalient features\\nInvestigations\\n\\uf0b7 Pulmonary TB in adults (Figure6)\\n- Sputum smear microscopy\\n- Chest x-ray\\n- Sputum culture and drug sensitivity testing(DST) for diagnosis of Drug Resistant TB.\\n- Newer rapid diagnostic tools for detection of multidrug resistant(MDR) TB .\\n- Newer tools under evaluation for diagnosis of MDR/XDR TB'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 43, 'page_label': '44'}, page_content='Common Conditions\\n28\\nFigure6. Algorithm for diagnosis of pulmonary tuberculosis\\n\\uf0b7 Paediatric TB patients (Figure 7)\\n- In all children with presumptive intra-thoracic TB, microbiological confirmation\\nshould be sought through examination of respiratory specimens (like sputumby\\nexpectoration, gastric aspirate, induced sputum, bronchio-alveolar lavage or any other\\nappropriate specimen) with diagnostic test like smear microscopy or rapid molecular\\ntest or culture.\\n- In the event of negative or unavailable microbiological results,a diagnosis of\\nprobable TB in children should be based on the presence of abnormalities consistent\\nwith TB on radiography, a history of exposure to an infectious case, evidence of TB\\ninfection and clinical findings suggestive of TB.\\n- For children with presumptive extra-pulmonary TB, appropriate specimens from the\\npresumed sites of involvement should be obtained for microscopy, culture and DST,\\nrapid molecular test and histopathological examination.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 44, 'page_label': '45'}, page_content='Common Conditions\\n29\\nFigure7. Diagnostic algorithm for pediatric pulmonary tuberculosis\\n\\uf0b7 Extra-pulmonary TB\\n- Demonstration of AFB bacilli in a smear from extra pulmonary site is often difficult\\nbecause of low bacillary load. The clinical features pertaining to the system affected\\nshould be considered in the diagnosis of extra pulmonary tuberculosis.\\n- However, the following are some of the special investigations which are helpful in\\ndiagnosing extra pulmonary tuberculosis. These may be radiological, cytological /\\npathological, biochemical and immunological (Figure8).\\n(a)Fine Needle Aspirations Cytology and direct smear examination\\n(b)Excision / Biopsy of specimen for histopathological examination\\n(c)Fluid for cytology , biochemical analysis and smear examination\\n(d)X -ray of the involved region\\n(e)Ultrasonography for abdominal tuberculosis\\n(f)Culture forMycobacterium tuberculosis\\n(g)Computerized tomography (CT) and  magnetic resonance imaging (MRI)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 45, 'page_label': '46'}, page_content='Common Conditions\\n30\\nFigure8. Diagnostic algorithm for TB lymphadenitis\\n\\uf0b7 Diagnosis of Pleural TB\\n- Tubercularpleural effusion is consideredas extra pulmonary tuberculosis. TB\\nPatients presenting with chest pain with or without difficulty in breathing for more\\nthan two weeks should be referred for chest radiograph.\\n- In pleural effusion, chest X-ray features may include obliteration of costophrenic\\nangle and varying degree of effusion.\\n- Biochemical and cytological analysis of the aspirated pleura fluid will help in\\nconfirming the diagnosis. Pleural fluid is generally an exudate with mainly\\nlymphocytes and few mesothelial cells.\\n- Pleural biopsy is confirmatory in a high proportion of patients.\\nPharmacological treatment\\nRevised National Tuberculosis Control Programme (RNTCP) uses short course\\nchemotherapy given intermittently- thrice weekly underDirect Observationfor both\\npulmonary and extrapulmonary tuberculosis patients.\\nTreatment regimens\\nFor the purpose of treatment regimen to be used, TB patients are classified into two groups,\\nnamely, â€œNewâ€ or â€œPreviously Treatedâ€, based on the history of previous treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 46, 'page_label': '47'}, page_content='Common Conditions\\n31\\n\\uf0b7 Regimen for New cases : This regimen is prescribed to all new pulmonary (smear\\npositive and negative) and extra pulmonarytuberculosis.The regimen is2H 3R 3Z3 E 3 / 4\\nH 3R 3.\\n\\uf0b7 Regimen for Previously Treated cases: This regimen is prescribed for TB patients who\\nhave had more than onemonth anti-tuberculosis treatment previously. These patients are\\nat a higher risk of having drug resistance. Hence, 5 drugs are prescribed in the intensive\\nphase and the total duration of treatment is 8 months. Relapses, treatment after Default,\\nFailures and Others are treated with this regimen.The regimen is2S3H 3R3Z3 E3 / 1H3R3Z3\\nE3 / 5 H3R3 E3. The table below indicates the treatment regimen, type of patients and\\nregimens prescribed(Table 6).\\nTable 6. Treatment regimens recommended by RNTCP for treatment of Tuberculosis\\nTreatment\\ngroups\\nType of patient Regimen1\\nIntensive\\nPhase (IP)\\nContinuation\\nPhase (CP)\\nNew* Sputum smear-positive\\nSputum smear-negative\\nExtra-pulmonary\\nOthers\\n2H 3R 3Z3E3 4H 3R 3\\nPreviously\\nTreated**\\nSmear-positive relapse\\nSmear-positive failure\\nSmear-positive treatment after default\\nOthers1\\n2H 3R 3Z3E3S3\\n/ 1H3R 3Z3E3\\n5H 3R 3E3\\n* New includes former categories I and III\\n** Previously treated is former category II.\\n1 -In rare and exceptional cases, patients who are sputum smear-negative or who have extra-\\npulmonary disease can have recurrence or non-response. This diagnosis in all such cases\\nshould always be made by an MO and should be supported by culture or histological\\nevidence of current, active TB. In these cases, the patient shouldbe typed as â€˜Othersâ€™ and\\ngiven treatment regimen for previously treated\\n\\uf0b7 The number before the letters refers to the number of months of treatment. The subscript\\nafter the letters refers to the number of doses per week.\\n\\uf0b7 The dosage strengths are as follows: isoniazid (H) 600 mg, rifampicin (R) 450 mg,\\npyrazinamide (Z) 1500 mg, ethambutol (E) 1200 mg, streptomycin (S) 750 mg.\\n\\uf0b7 Patients who weigh 60 kg or more receive additional rifampicin 150 mg.\\n\\uf0b7 Patients more than 50 years old receive streptomycin 500 mg.Patients who weigh less\\nthan 30kg, receive drugs as per paediatric weight band boxes according to body weight\\n(Table 7).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 47, 'page_label': '48'}, page_content='Common Conditions\\n32\\nTable 7. Drug dosages for adults in the blister packs\\nDrugs Dose\\n(thrice a week)\\nNumber of tablets in blister\\npack\\nIsoniazid (H) 600mg 2 x 300 mg\\nRifampicin     (R) 450mg 1 x 450 mg\\nPyrazinamide (Z) 1500mg 2 x 750 mg\\nEthambutol     (E) 1200mg 2 x 600 mg\\nStreptomycin  (S) 0.75g -\\n\\uf0b7 Treatment of Pediatric TB(Table 8, 9 and 10, Figure 9)\\nPediatric cases are to be treated under RNTCP with the same thrice weekly short course\\nchemotherapy regimens (â€œNewâ€ or â€œPreviously treatedâ€) given under Directly Observed\\nTreatment Short Course (DOTS) as for adult patients.  They are to be registered in the\\nrespective RNTCP TB Register. Pediatric patient-wise boxes are available with different\\ndosages under two weight bands for children weighing 6 to 10 kgand 11 to 17 kg.\\nWherever possible, before a child is started on the â€œPreviously Treatedâ€ regimen, she/he\\nshould be examined by a pediatrician or TB expert.\\nTable 8. Pediatric patient wise boxes (PWB) with dosages\\nIP â€“ Intensive phase,CP â€“ Continuation phase\\nTable 9. Pediatric patient wise boxes (PWB) for new cases according to weight band\\nWeight band\\nFor New cases Prolongation of IP\\nIP CP\\n6-10 Kg PC 13 PC 15\\n11-17 Kg PC 14 PC 16\\n18-25 Kg PC 13 + PC 14 PC 15 + PC16\\n26-30 kg* PC 14 x 2 PC 16 x 2\\n* For children weighing >30 kgs, adult PWB are tobe used\\nIP â€“ Intensive phase,CP â€“ Continuation phase\\nDRUGS\\nProduct code(PC) -13 Product code(PC) -14 PC -15 PC -16\\nIP\\n24 blisters\\nCP\\n18 blisters\\nIP\\n24 blisters\\nCP\\n18 blister 12 blisters 12 blisters\\nIsoniazid 75 mg 75 mg 150 mg 150 mg\\nProlongation\\nof IP for PC\\n13\\nProlongation\\nof IP for PC\\n14\\nRifampicin 75 mg 75 mg 150 mg 150 mg\\nPyrazinamide 250 mg 500 mg\\nEthambutol 200 mg 400 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 48, 'page_label': '49'}, page_content='Common Conditions\\n33\\nTable 10. Pediatric patient wise boxes for previously treated cases according to weight\\nband\\nWeight For previously treated cases Prolongation\\nof IPIP (Intensive phase) CP (Continuation phase)\\n6-10 Kg\\n(PC 13+ PC15)\\n+\\n(24 vialsInj sm*)\\n(PC 13 + 54 Tab E 200 mg)\\n+\\n(PC 15 without Z)\\nPC 15\\n11-17 Kg\\n(PC 14 + PC16)\\n+\\n(24 vialsInj sm*)\\n(PC 14 + 54 E  400 mg)\\n+\\n(PC 16 without Z)\\nPC 16\\n18-25 Kg\\n(PC 13 + PC 14 + PC 15\\n+ PC 16)\\n+\\n(24 vialsInj sm*)\\n(PC 13 + PC14 + 54 Tab E 600 mg)\\n+\\n(PC 15+ PC 16 without Z)\\nPC 15 + PC\\n16\\n26-30 kg\\n(PC 14 x 2)+ (PC 16 x 2)\\n+\\n(24 vialsInj sm*)\\n(PC 14 x 2+ 54 Tab E 800 mg)\\n+\\n(PC 16 x 2 without Z)\\nPC 16 x 2\\n* Injection streptomycin 15mg/kg body weight\\nFigure 9.Clinical monitoring of children with Tuberculosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 49, 'page_label': '50'}, page_content='Common Conditions\\n34\\nNon DOTS (ND) treatment regimen under RNTCP\\nIn rare and exceptional situations, non-DOTS treatment (with a self-administered non-\\nrifampicin containing regimen) may be needed in a few TB cases. Examples include:\\n- Those with adverse reactions to rifampicin and / or pyrazinamide\\n- â€œNewâ€ patients who refuse DOTS despite all efforts\\nThis is a treatment regimen of 12-month duration comprising 2 months of SHE and10\\nmonths of HE (2SHE / 10HE).Dosages administered perday in the regimen are:\\nIsoniazid - 300 mg\\nEthambutol - 800 mg\\nStreptomycin - 750 mg (500 mg for those >50 years of age)\\nThose who weigh lessthan 30 kgreceive dosages calculated as per body-weight.\\n\\uf0b7 Drug resistant tuberculosis (MDR/XDR-TB)\\nMDR TB suspect: A patient suspected of drug-resistant tuberculosis, based on RNTCP\\ncriteria for submission of specimens for drug-susceptibility testing.\\nMDR TB suspect criteria\\nCriteria A\\n- All failures of new TB cases\\n- Smear positive previously treated cases who remain smear positive at 4th month\\nonwards\\n- All pulmonary TB caseswho are contacts of known MDR TB case\\nCriteria B(in addition to Criteria A)\\n- All smear positive previously treated pulmonary TB cases at diagnosis\\n- Any smear positive follow up result in new or previously treated cases\\nCriteria C(in addition to Criteria B)\\n- All smear negative previously treated pulmonary TB cases at diagnosis,\\n- HIV TB co-infected cases at diagnosis\\nIn other words, for districts implementing MDR Suspect Criteria B, any smear-positive\\ndiagnostic (except in a new patient) or any smear-positive follow-up result, should prompt a\\nreferral for DST.\\nMDR -TB case: A TB patient whose sputum is culture positive forMycobacterium\\ntuberculosisand is resistantin-vitroto isoniazid and rifampicin with or without other anti-\\ntubercular drugs based on DST results from an RNTCP-certified culture and DST laboratory\\nExtensive Drug Resistant Tuberculosis(XDR TB) case: An MDR TB case whose\\nrecovered M. tuberculosisisolate is resistant to at leastisoniazid, rifampicin, a\\nfluoroquinolone (ofloxacin, levofloxacin, or moxifloxacin) and a second-line injectable anti-\\nTB drug (kanamycin, amikacin, or capreomycin) at a RNTCP-certified culture and DST\\nlaboratory. A patient is confirmed to have MDR or XDR TB only when the results are from a\\nRNTCP quality-assured culture and DST Laboratory and by a RNTCP-endorsed testing\\nmethod mentioned as below:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 50, 'page_label': '51'}, page_content='Common Conditions\\n35\\nChoice of Diagnostic Technology\\nCurrently, the programme is scaling up the laboratory capacity of various cultureand DST\\nlaboratories at state level IRLs and other laboratories. The choice of technology to be used for\\ndiagnosis of MDR TB has been determined as per recommendations of the National\\nLaboratory Committee. Thus, for DST at certified laboratory,wherever available Molecular\\nDST (e.g. Line Probe Assay (LPA)) is preferred diagnostic methodbecause of the rapid and\\nhighly-accurate rifampicin results, followed in preference by Liquid C-DST and then Solid\\nC -DST.\\nMDR Diagnostic Technology Choice\\nFirst Molecular DST (e.g. LPA DST)\\nSecond               Liquid culture isolation and LPA DST\\nThird                 Solid culture isolation and LPA DST\\nFourth                Liquid culture isolation and Liquid DST\\nFifth                   Solid cultureisolation and DST\\nSimilarly for follow up cultures, wherever available, liquid culture will be preferred over\\nsolid culture. However, this will be liquid cultures for at least the crucial months of follow-up\\n(IP-3, 4, 5, 6 and CP-18, 21, 24) and over andbeyond this, it will be determined by the\\nworkload of individual laboratories.\\nTable 11. Grouping anti-TB agents (first line and second line drugs)\\nGrouping Drugs\\nGroup 1: First-line oral anti-TB\\nagents\\nIsoniazid (H); Rifampicin (R); Ethambutol (E);\\nPyrazinamide(Z)\\nGroup 2: Injectable anti-TB\\nagents\\nStreptomycin (S); Kanamycin (Km); Amikacin (Am);\\nCapreomycin (Cm); Viomycin (Vm).\\nGroup 3: Fluoroquinolones\\nCiprofloxacin (Cfx); Ofloxacin (Ofx); Levofloxacin\\n(Lvx);\\nMoxifloxacin (Mfx); Gatifloxacin (Gfx)\\nGroup 4: Oral second-line anti-\\nTB agents\\nEthionamide (Eto); Prothionamide (Pto); Cycloserine\\n(Cs);\\nTerizadone (Trd); para-aminosalicylic acid (PAS)\\nGroup 5: Agents with unclear\\nefficacy (not recommended by\\nWHO for routine use in MDR-TB\\npatients)\\nClofazimine (Cfz); Linezolid (Lzd); Amoxicillin/\\nClavulanate\\n(Amx/Clv); thioacetazone (Thz); imipenem/cilastatin\\n(Ipm /Cln);\\nhigh-dose isoniazid (high-dose H); Clarithromycin (Clr)\\n- All drugs should be given in a single daily dosage under directly observed treatment (DOT)\\nby a DOT Provider. All patients will receive drugs under direct observation on 6 days of the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 51, 'page_label': '52'}, page_content='Common Conditions\\n36\\nweek. On Sunday, the oral drugs will be administered unsupervised whereas injection\\nkanamycin will be omitted.\\n- If intolerance occurs to the drugs, ethionamide, cycloserine and PAS may be split into two\\ndosages and the morning dose administered under DOT. The evening dose will be self-\\nadministered. The empty blister packs of the self-administered doses will be checked the next\\nmorning during DOT.\\n- Pyridoxine should be administered to all patients on an RNTCP Category IV regimen.\\nDrug dosages for MDR-TB cases are base on the weight bands as shown in below(Table 12).\\n\\uf0b7 Treatment of MDR TB (Category IV regimen)\\n- RNTCP will be using a standardised treatmenttegimen (Cat IV) for the treatment of\\nMDR -TB cases (and those with rifampicin resistance) under the programme.\\n- Cat IV regimen comprises of 6 drugs(Table 11)kanamycin, high dose levofloxacin,\\nethionamide,pyrazinamide, ethambutol and cycloserine during6-9 months of the intensive\\nphase (IP) and 4 drugs- high dose levofloxacin, ethionamide, ethambutol and cycloserine\\nduring the 18 months of the continuation phase (CP).\\n- P-aminosalicylic acid (PAS) is included in the regimen as a substitute drug in case of\\nintolerance i.e. severe ADR leading to discontinuation of drug to any of the drug in the Cat\\nIV regimen.\\n- For management of patients with Km mono resistance, the committee recommended\\nreplacement of Km with capreomycin, If Km is intolerant, substitute amikacin (AK) if\\npossible, or PAS if injectable agent not feasible.\\n\\uf0b7 Drug dosages and administration\\nTable 12. Dosage and weight band recommendationsof second line drugs\\nS.No Drugs 16-25 Kgs 26-45 Kgs 46-70 Kgs\\n1\\n2\\n3\\n4\\n5\\n6\\n7\\n8\\nKanamycin\\nLevofloxacin (High Dose)\\nEthionamide\\nEthambutol\\nPyrazinamide\\nCycloserine\\nPAS (80% Bioavailability)1\\nPyridoxine\\n500 mg\\n250 mg\\n375 mg\\n400 mg\\n500 mg\\n250 mg\\n5 gm\\n50 mg\\n500 mg\\n750 mg\\n500 mg\\n800 mg\\n1250 mg\\n500 mg\\n10 gm\\n100mg\\n750 mg\\n1000 mg\\n750 mg\\n1200 mg\\n1500 mg\\n750 mg\\n12 gm\\n100mg\\n1 In case of PAS with 60% bioavailability the dose will be increased to 7 gm (16-25 Kg); 14\\ngm (26-45 Kg) and 16 gm (> 45 Kg)\\n- If a patient gains 5 kgor more in weight during treatment and crosses the weight-band\\nrange, the DOTSâ€“Plus site committeemay consider moving the patient to the higher\\nweight-band drug dosages.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 52, 'page_label': '53'}, page_content='Common Conditions\\n37\\n- Similarly if a patient loses 5 kgs or more in weight during treatment and crosses the\\nweight band the DOTS Plus site committee may consider moving the patient to the lower\\nweight band.\\n- The new higher/lower dosages are provided whenever the patient is due for the next\\nsupply of drugs in the normal course of treatment and not as soon as change of weight is\\nnoted.\\n- The dosages of 2nd line drugs for MDR TB cases in paediatric age group weighing< 16\\nkg as per the Table 13.\\nTable 13. Dosage of 2nd line drugs for treatment of pediatric MDR TB cases\\nDrug Daily Doseâ€“ mg/kg body weight\\nKanamycin 15-30\\nLevofloxacin 7.5-10\\nEthionamide 15-20\\nCycloserine 15-20\\nPAS 150\\nEthambutol 25\\nPyrazinamide 30-40\\n- The dosages for higher weight patients include use additional dosages of some 2nd line\\ndrugs for MDR TB cases in patients weighing > 70 kg taking the dosage to kanamycin (1\\ngm), ethionamide (1 gm), cycloserine (1 gm), ethambutol (1.6 gm) and pyrazinamide (2\\ngm). All these are well within the maximum permissible dosage for each drug as per the\\nWHO guidelines.\\n\\uf0b7 Treatment of XDR-TB (C ategory V)\\nAll XDR -TB patients who are considered for category V regimen, will be screened by the\\nDOTS -Plus  committee and if found suitable will be referred to a thoracic surgeon for\\nconsideration of surgery to improve the treatment outcomes. Identification must be done for\\nthe site (tertiary centres) with such surgical facilities.\\nXDR Regimen (Table 14)\\n6-12 months Cm, PAS, Mfx, High doseâ€H, Cfz, Lzd, Amx/Clv\\n18 months PAS, Mfx, High doseâ€H, Cfz, Lzd, Amx/Clv\\n- The Category V treatment regimen consists of 7 drugs, with 2 reserve/substitute drugs.\\nThe dosage of the drugs would vary as per the weight of the patient(â‰¤ 45Kg or > 45Kg).\\nAll drugs are to be given on a daily basis. Injections of capreomycin will be given for 6\\ndays/week (not on Sundays).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 53, 'page_label': '54'}, page_content='Common Conditions\\n38\\n- All morning doses are to be supervised by the DOT Provider except on Sundays. After\\ntaking DOT for morning doses onSaturday, next day medicines would be given to the\\npatient to be taken at home on Sunday.\\n- Empty blisters of medicines taken unsupervised in evening and on Sundays are to be\\ncollected by DOT Provider.\\n- The change from IP to CP will be done only after achievement of culture conversion i.e.\\n2 consecutive negative cultures taken at least one month apart. In case of delay in culture\\nconversion, the IP can be extended from6 months up to a maximum of 12 months. In\\ncase of extension, the DOTSâ€“ Plus site Committee, which will beresponsible for\\ninitiating and monitoring the Category V regimen, can decide on administering\\ncapreomycin injection intermittently (3 times/week) for the months 7 to 12.\\nTable 14. Drugs and Dosages for management of XDR TB\\nDrugs Dosage/day\\n< 45 Kgs > 45 Kgs\\nInj. Capreomycin (Cm) 750 mg 1000 mg\\nPAS 10 gm 12 gm\\nMoxifloxacin (Mfx) 400 mg 400 mg\\nHigh dose INH (High dose-H) 600 mg 900 mg\\nClofazimine (Cfz) 200 mg 200 mg\\nLinezolid (Lzd) 600 mg 600 mg\\nAmox iclav(Amx/Clv) 875/125 mg BD 875/125 mg BD\\nPyridoxine 100 mg 100 mg\\nReserve/Substitute drugs\\nClarithromycin (Clr) 500 mg BD 500 mg BD\\nThiacetazone (Thz)# 150 mg 150 mg\\n# Depending on availability, not to be given to HIV positive cases\\nThe reserve/substitute drugs would be usedin the following conditions:\\n- In case the patient was on PAS in Category IV, PAS will be replaced with one of\\nthe reserve drugs in the Category V regimen\\n- If the patient is unable to tolerate one or more of the drugs\\n- If the patient is found to be resistant to capreomycin\\n\\uf0b7 HIV co-infection with TB\\n- TB patients living with HIV should receive the same duration of TB treatment with\\ndaily regimen as HIV negative TB patients.\\n- Antiretroviral therapy (ART) must be offered to all patients with HIV and TB as well\\nas drug-resistant TB requiring second-line anti-TB drugs, irrespective of CD4 cell-\\ncount, as early as possible (within the first 8 weeks) following initiation of anti-TB\\ntreatment. Appropriate arrangements for access to antiretroviral drugs should be made'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 54, 'page_label': '55'}, page_content='Common Conditions\\n39\\nfor patients. However, initiation of treatment for TB should not be delayed. Patients\\nwith TB and HIV infection should also receive co-trimoxazole as prophylaxis for\\nother infections.\\n- People living with HIV should be screened for TB using four symptom complex\\n(current cough or, fever or weight loss or night sweats) at HIV care settings and those\\nwith any of these symptoms should be evaluated for ruling out active TB. Such\\npatients in whom active TB is ruled out, Isoniazid Preventive Therapy (IPT) in the\\ndosage of10 mg/Kg body weight should be offered to them for 6 months.\\n\\uf0b7 Adherence\\n- Supervision and support should be individualized.\\n- Ensuring Adherence in M/XDR TB patients: Patient support systems, including direct\\nobservation of treatment, are required to ensure adherence. It should be ensured that\\nthe patient consumes all the dosages of the drugs.\\n- Trained treatment supporter for treatment adherence: Such measures may include\\nidentification and training of a treatment supporter (for TB and, if appropriate, for\\nHIV, diabetes mellitus etc.) who is acceptable, accessible and accountable to the\\npatient and to the health system.\\n- Information Communication Technology to promote treatment literacy and\\nadherence: Optimal use of Information Communication Technology (ICT) should be\\ndone to promote treatment literacy and adherence\\nOther important points to remember\\n\\uf0b7 Public Health Responsibility- Any practitioner treating a TB patient is assuming an\\nimportant public health responsibility to prevent ongoing transmission of the infection\\nand the development of drug resistance. To fulfill this responsibility the practitioner must\\nnot only prescribe an appropriate regimen, but also utilize local public health services /\\ncommunity health services, and other agencies including NGOs whennecessary, to assess\\nthe adherence of the patient and to address poor adherence when it occurs.\\n\\uf0b7 Maintain Records for all TB patients:A written record of all medications given,\\nmicrobiological response and adverse reactions should be maintained for all patients.\\nEvery patientâ€™s clinical outcome should be recorded in the case register and available for\\npublic health monitoring.\\n\\uf0b7 Notification of TB Cases: All health establishments must report all TB cases and their\\ntreatment outcomes to public health authorities (District Nodal Officer for Notification).\\nProper feedback need to be ensured to all health care providers who refer cases to public\\nhealth system on the outcome of the patients which they had referred.\\n\\uf0b7 Contact Investigation:\\nAll providers of care for patients with TB should ensure all household contacts (including\\nchildren) and other persons who are in close contact with TB patients are screened for TB\\nas per defined diagnostic standards.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 55, 'page_label': '56'}, page_content='Common Conditions\\n40\\nIn case of pediatric TB patients, reverse contact tracing for search of any active TB case in\\nthe household of the child must be undertaken.\\nThe highest priority contacts of known TB cases for intensive case finding (such as are:\\n- Persons with symptoms suggestive of TB\\n- Children aged <6 years\\n- Known or suspected immune-compromised patient, particularly HIV infection.\\n- Diabetes Mellitus\\n- Other higher risks including pregnancy, mental disorders, smokers and alcoholics etc.\\n- Patients with DR-TB - In case of contact with a DR-TB index case, close clinical\\nmo nitoring should be provided, as there is no evidence that treatment of latent\\ninfection with available drugs is presently effective\\nFollow up\\nFollow up smear and culture schedule during treatment\\n- For follow up examination two sputum specimens will be collected and examined by\\nsmear and culture at least 30 days apart from the 3rd to 7th month of treatment (i.e. at\\nthe end of the months 3, 4, 5, 6 and 7) and at 3-monthly intervals from the 9th month\\nonwards till the completion of treatment (i.e. at the end ofthe months 9, 12, 15, 18, 21\\nand 24).\\n- The two specimens for smear and culture at the RNTCP accredited lab (one early\\nmorning and one supervised spot) will be collected and transported from the\\nrespective DTC to the RNTCP accredited laboratory.\\n- If any ofthe cultures in the last three quarters becomes positive, it will be followed up\\nby monthly cultures in the following 3 months.\\nTable 15. Common adverse effects of 2nd line drugs and management strategies\\nAdverse effects Suspected agent(s) Suggested management strategies\\nGastrointestinal\\nNausea and\\nvomiting\\nPAS, isoniazid, moxifloxacin\\nlinezolid, clofazamine\\namoxyclav, alarithromycin\\nthioacetazone\\n\\uf02d Assess for dehydration; initiate rehydration\\nif indicated\\n\\uf02d Initiate anti-emetic therapy\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimenâ€“\\nrarely necessary\\nGastritis\\nPAS, moxifloxacin\\nisoniazid, linezolid\\namoxiclav, clarithromycin\\nthioacetazone\\n\\uf02d H2 -blockers, proton-pump inhibitors, or\\nantacids\\n\\uf02d Stop suspected agent(s) for short periods of\\ntime (e.g., one to seven days)\\n\\uf02d Lower dose of suspected agent, if this can\\nbe done without compromising regimen\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimen\\nHepatitis Isoniazid, PAS, moxifloxacin\\nlinezolid\\n\\uf02d Stop all therapy pending resolution of\\nhepatitis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 56, 'page_label': '57'}, page_content='Common Conditions\\n41\\n\\uf02d Eliminate other potential causes of hepatitis\\n\\uf02d Consider suspending most likely agent\\npermanently. Reintroduce remaining drugs,\\none at a time with the most hepatotoxic\\nagents last, while monitoring liver function\\nCutan eous and hypersensitivity reactions\\nHypersensitivityPAS, linezolid,\\nclarithromycin\\n\\uf02d Withhold all drugs and treat\\nsymptomatically with antihistamines/\\nsteroids till the reaction subsides.\\n\\uf02d Identify offending drug in severe forms\\n\\uf02d Attempt desensitization ofthe offending\\ndrug\\n\\uf02d Discontinue suspected agent and substitute\\nwith the reserve drug\\nCutaneous Linezolid,\\nclofazamine\\n\\uf02d Treat symptomatically with antihistamines\\ntill the reaction subsides.\\n\\uf02d Patient should be counseled on the skin\\ndiscoloration with long term use of\\nclofazamine\\nPsychiatric\\nDepression\\nSocio-economic\\ncircumstances,\\nchronic disease,\\nmoxifloxcin,\\nisoniazid\\n\\uf02d Improve socioeconomic conditions\\n\\uf02d Group or individual counseling\\n\\uf02d Initiate antidepressant therapy\\n\\uf02d Lower dose of suspected agent if this canbe\\ndone without compromising the regimen\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimen\\nNeurological\\nPeripheral\\nneuropathy\\nIsoniazid, linezolid\\n\\uf02d Increase pyridoxine to maximum daily dose\\n(200 mg per day)\\n\\uf02d Initiate therapywith tricyclic\\nantidepressants such as amitriptyline. Non-\\nsteroidal anti-inflammatory drugs or\\nacetaminophen may help alleviate\\nsymptoms\\n\\uf02d Lower dose of suspected agent, if this can\\nbe done without compromising regimen\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimen\\nConvulsions Isoniazid, moxifloxacin,\\nlinezolid\\n\\uf02d Suspend suspected agent pending resolution\\nof convulsions\\n\\uf02d Initiate anticonvulsant therapy (e.g.\\nphenytoin, valproic acid)\\n\\uf02d Increase pyridoxine to maximum daily dose\\n(200 mg per day).\\n\\uf02d Restart suspected agent or reinitiate\\nsuspected agent at lower dose, if essential to\\nthe regimen'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 57, 'page_label': '58'}, page_content='Common Conditions\\n42\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimen\\nHearing loss Capreomycin\\nclarithromycin\\n\\uf02d Document hearing loss and compare with\\nbaseline audiometry if available\\n\\uf02d Change parenteral treatment to\\ncapreomycin if patient has documented\\nsusceptibility to capreomycin\\n\\uf02d Increase frequency and/or lower dose of\\nsuspected agent if this can be done without\\ncompromising the regimen(consider\\nadministration three times per week)\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising the regimen\\nOcular Linezolid In consultation with the ophthalmologist\\nMusculoskeletal\\nArthralgia Moxifloxacin\\n\\uf02d Initiate therapy with non-steroidal anti-\\ninflammatory drugs.\\n\\uf02d Lower dose of suspected agent, if this can\\nbe done without compromising regimen.\\n\\uf02d Discontinue suspected agent if this can be\\ndone without compromising regimen\\nMusculoskeletal Moxifloxacin In consultation with the orthopedician\\nHaematological\\nHaematalogic Capreomycin, PAS,\\nlinezolid, clarithromycin\\nMonitor for anemia, bleeding tendency and cell\\ncounts\\nRenal\\nRenal toxicity\\nCapreomycin\\nlinezolid\\nclarithromycin\\n\\uf02d Discontinue suspected agent\\n\\uf02d Consider using capreomycin if an\\naminoglycoside had been the prior\\ninjectable in regimen\\n\\uf02d Consider dosing 2 to 3 times a week if drug\\nis essential to the regimen and patient can\\ntolerate (close monitoring of creatinine)\\n\\uf02d Adjust all TB medications according to the\\ncreatinine clearance\\nMet abolic and Electrolytes\\nMetabolic and\\nelectrolyte\\nCapreomycin, linezolid\\nmoxifloxacin\\nPeriodic monitoring of serum electrolytes and\\nblood sugar\\nEndocrine\\nThyroid\\ndysfunction PAS Supplement with thyroxine\\nCardiovascular\\nQT prolongation Moxifloxacin, clarithromycin \\uf02d Monitor for QT prolongation, monitor\\nplatelet count, bleeding tendencies'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 58, 'page_label': '59'}, page_content='Common Conditions\\n43\\n\\uf0b7 Chemoprophylaxis of contacts of MDR-TB cases\\nAmong contacts of patients with MDR-TB, the use of isoniazid may reasonably be\\nquestioned. Although alternative prophylaxis treatments have been suggested, there is no\\nconsensus regarding the choice of the drug(s) and the duration of treatment. Prompt\\ntreatment of MDR-TB is the most effective way of preventing the spread of infection to\\nothers. The following measures should be taken to prevent spread of MDR-TB infection:\\n- Early diagnosis and appropriate treatment of MDR-TB cases;\\n- Screening of contacts as per RNTCP guidelines\\n- Further research into effective and non-toxic chemoprophylaxis in areas of high\\nMDR -TB prevalence.\\nPatient education\\n- Providing counseling and health education to the MDR-TB patient and their family\\nmembers about the disease and about the necessity of taking regular and adequate\\ntreatment is of utmost importance.\\n- Health education and counseling is provided to all patients and family members at\\ndifferent levels of health care, right from one at the periphery to those at the DOTS-Plus\\nsite facility. It is started at the initial point of contact and carried on a continuous basis at\\nall visits by the patientto a health facility. The counseling and motivation is required to\\nbe done not only of the patient but also of the family members.\\nEPILEPSY\\nA seizureis a paroxysmal event due to abnormal excessive or synchronous neuronal activity\\nin the brain.Epilepsydescribes a condition in which a person hasrecurrentseizures due to a\\nchronic, underlying process.\\nClassification of Seizures\\n\\uf0b7 Generalized seizures\\nTonic clonic, clonic, tonic, absence (typical/ atypical), atonic and myoclonic\\nMay be focal, generalized, or unclearepileptic spasms\\n\\uf0b7 Focal seizures(can be further described as having motor, sensory, autonomic, cognitive,\\nor other features)with andwithout dyscognitivefeatures\\nInvestigations\\nIt should be made sure that the patient had a seizure and other differentials should be ruled\\nout.  In the patient with prior seizures or a known history of epilepsy, the evaluation is\\ndirected toward (1) underlying cause and precipitating factors (2) adequacy of current\\ntherapy.\\nPharmacological treatment\\n\\uf0b7 Treatment of underlying conditions\\n- Metabolic imbalancessuch as abnormal serum electrolytes and glucose, medications\\n(theophylline), illicit drug use (e.g., cocaine),structural CNS lesion such as a brain\\ntumor, vascular malformation, or brain abscess.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 59, 'page_label': '60'}, page_content='Common Conditions\\n44\\n\\uf0b7 Av oidance ofprecipitating factors like sleep deprivation, alcohol, bright light, etc.\\n\\uf0b7 Antiepilepticdrug therapy mainstay of treatment for most patients with epilepsy.\\nTable 16.Selection of antiepileptic drugsaccording to classification of epilepsy\\nGene ralized tonic\\nclonic seizures Focal seizures Typical absence\\nseizures\\nAtypical absence,\\nmyoclonic and atonic\\nseizures\\nFirst line drugs\\nValproic acid Lamotrigine Valproic acid Valproic acid\\nLamotrigine Capbamazepine Ethosuximide Lamotrigine\\nTopiramate O xcarbazepine Topiramate\\nPhenytoin\\nLevetiracetam\\nAlternatives\\nZonisamide Topiramate Lamotrigine Clonazepam\\nPhenytoin Zonisamide Clonazepam Felbamate\\nCapbamazepine Valproic acid\\nOxcarbazepine Tiagabine\\nPhenobarbitone Gabapentin\\nPrimidone Lacosamide\\nFelbamate Phenobarbitone\\nPrimidone\\nFelbamate\\nPregnancy\\n\\uf0b7 Most women with epilepsy who become pregnant will have an uncomplicated gestation\\nand deliver a normal baby. Since the potential harm of uncontrolled convulsive seizures\\non the mother and fetus is considered greater than the teratogenic effects of antiepileptic\\ndrugs, it is currently recommended that pregnant women be maintained on effective drug\\ntherapy. Patients should take folic acid(1â€“4 mg/d), to prevent development ofneural tube\\ndefects.\\nContraception\\n\\uf0b7 Drugs such as carbamazepine, phenytoin, phenobarbital, and topiramate can significantly\\ndecrease the efficacy of oral contraceptives via enzyme induction and other mechanisms.\\nPatients should be advised to consider alternative forms of contraception.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 60, 'page_label': '61'}, page_content='Common Conditions\\n45\\nSTATUS EPILEPTICUS\\nStatus epilepticus refers to continuous seizures or repetitive, discrete seizures with impaired\\nconsciousness in the interictal period. The duration of seizure activity sufficient to meet the\\ndefinitionof status epilepticus has traditionally been specified as 15â€“30 minutes.The\\ntreatment plan for an adult with status epilepticus is as in Figure 10.\\nFigure 10. Treatment algorithm for generalized tonic clonic status epilepticus in adults'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 61, 'page_label': '62'}, page_content='Common Conditions\\n46\\n\\uf0b7 Burning micturition, urinary frequency, flank pain, fever\\n\\uf0b7 Predisposing factors are diabetes mellitus, large prostate, and circumcision.\\n\\uf0b7 Common organisms areE.coli, Pseudomonas, Klebsiella.\\nURINARY TRACT INFECTION\\nUrinary tract infections include infection of any part of urinary tract from kidneys to urethra.\\nIt can be caused by unhygenic lifestyle, sexually transmitted, per urethral catheterization,\\nrenal calculus disease and vesicoureteric reflux.\\nSalient features\\nInvestigations\\n\\uf0b7 TC with DC,X -ray KUB ,USG -KUB ,Urine (routine and microbiological examination)\\n\\uf0b7 Urine culture and sensitivityto be done if bacterial colony count is more than1000.\\nNon pharmacologicaltreatment\\nPlenty of fluids orally, maintain hygiene\\nPharmacologicaltreatment\\n\\uf0b7 Tab.ciprofloxacin 500 mg twice a day for five days.\\n\\uf0b7 In resistance cases 3rd generation cephalosporins (cefixime) followed by antibiotics as per\\nculture and sensitivity report.\\n\\uf0b7 If fever then Tab. paracetamol 500 mgthrice a day for three days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 62, 'page_label': '63'}, page_content='47\\nChapter 3\\nEMERGENCY CONDITIONS\\nCARDIOPULMONARY RESU SCITATION\\nCardiopulmonary resuscitation (CPR) consists of a series of maneuvers by which oxygenated\\nblood supply to brain and vital organs is maintained during cardiopulmonary arrest (CPA) i.e.\\ncessationof respiration and circulation. In children, CPA is not sudden but end result of long\\nperiod of hypoxaemia secondary to inadequate ventilation, oxygenation or circulation. Therefore,\\nprompt management of these is essential to prevent CPA, the outcome of which is poor.\\nDiagnosis of cardiopulmonary and cardiac arrest\\n1. Absence of pulse in major arteries (carotid or femoral in older children and\\nfemoral or brachial in infants as carotid is difficult to palpate due to short neck).\\n2. Absence of heart sounds on auscultation.\\n3. Asystole /ventricular fibrillation on ECG.\\nRespiratory arrest\\nAbsence of respiration on examination (absent chest movements), listening (absent air flow on\\nbringing ears in front of mouth) and feeling (absent air flow on keeping hands in frontof mouth\\nor nose).\\nLevels of CPR\\nBasic life support (BLS):The elements of CPR areprovided without additional equipment.\\nSkill and speed are most essential.\\nAdvanced cardiac life support (ACLS):Use of equipment and drugs for assisting ventilation\\norcirculation.\\nPrimary survey to assess the patient\\'s condition:\\n\\uf0b7 Tap the patient on the shoulder and ask, \"Are you all right?\"\\n\\uf0b7 If the patient does not respond, call for help.\\n\\uf0b7 Give 2 minutes (5 cycles) of CPR before leaving patient to call for help.\\n\\uf0b7 Check forpulse or any other signs of life;begin CPR, 30 compressions to 2 respirations\\n(push hard and fast--100/minuteand release chest completely).\\n\\uf0b7 Open airway and check for breathing. Give 2 breaths that make the chest rise.\\n\\uf0b7 Start an IV line.\\n\\uf0b7 Begin oxygen.\\n\\uf0b7 Attach a monitor\\n\\uf0b7 Intravenous / Intra osseous (IO) access is a priority over advanced airway management. If an\\nadvanced airway is placed, change to continuous chest compressions without pauses for\\nbreaths. Give 8 to 10 breaths per minute and check rhythm every2 minutes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 63, 'page_label': '64'}, page_content='Emergency Conditions\\n48\\nCHART\\nSIMPLIFIED ADULT BLS\\nSource 2010 American Heart Association  Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 64, 'page_label': '65'}, page_content='Emergency Conditions\\n49\\nADULT BLS HEALTHCARE PROVIDERS\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 65, 'page_label': '66'}, page_content='Emergency Conditions\\n50\\nAHA ACLS ADULT CARDIAC ARREST ALGORITHM\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 66, 'page_label': '67'}, page_content='Emergency Conditions\\n51\\nAHA ACLS ADULT CARDIAC ARREST ALGORITHM\\nSource 2010 American Heart Association   Guidelines'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 67, 'page_label': '68'}, page_content='Emergency Conditions\\n52\\nANAPHYLAXIS\\nIt is a generalized hypersensitivity reaction characterized by hypotension, peripheral\\ncirculatory collapse and respiratory difficulty in the form of stridor and dyspnoea.\\nAnaphylaxis can be due to food, inhaled/ingested allergens or drugs. Symptoms occur\\ninstantaneously or within a few minutes following exposure to the offending agent.\\nAnaphylaxis to oral drugs may take 1-2 hours, but in many patients it can be instantaneous. A\\nsevere anaphylactoid reaction is a life-threatening emergency. Effective treatment depends on\\nprompt diagnosis and rapid supplementation of appropriate therapy.\\nClinical criteria for diagnosis\\nAnaphylaxis is highly likely when any one of the following three criteria is fulfilled:\\n1. Acute onset of an illness (minutes to several hours) with involvement of the skin, mucosal\\ntissue, or both (e.g., generalized urticaria, itching or flushing, swollen lips/tongue/uvula)\\nwith one of the following,\\n\\uf0b7 Respiratory compromise (e.g., dyspnoea, wheeze-bronchospasm, stridor, reduced\\npeak expiratoryflow (PEF),hypoxemia)\\n\\uf0b7 Reduced blood pressure or associated symptoms of end-organ dysfunction (e.g.\\nhypotonia, collapse, syncope, incontinence)\\n\\uf0b7 Involvement of the skin-mucosal tissue\\n\\uf0b7 Persistent gastrointestinal symptoms (e.g., crampingabdominal pain, vomiting) or\\n2. R educed blood pressure after exposure to known allergen,\\n\\uf0b7 Infants and children- low systolic blood pressure (age-specific) or greater than 30%\\ndecrease in systolic blood pressure\\n\\uf0b7 Adults- systolic blood pressure of less than 90 mm Hg or greater than 30% decrease\\nfrom baseline'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 68, 'page_label': '69'}, page_content='Emergency Conditions\\n53\\nSkin, subcutaneous tissue, and mucosa\\n\\uf0b7 Flushing, itching, urticaria (hives), angioedema, morbilliform rash, piloerection\\n\\uf0b7 Periorbital itching, erythema and edema, conjunctival erythema, tearing\\n\\uf0b7 Itching of lips, tongue, palate, and external auditory canals; and swelling of lips, tongue,\\nand uvula\\n\\uf0b7 Itching of genitalia, palms, and soles\\nRespiratory\\n\\uf0b7 Nasal itching, congestion, rhinorrhea, sneezing\\n\\uf0b7 Throat itching and tightness, dysphonia, hoarseness, stridor, dry staccato cough\\n\\uf0b7 Lower airways: increased respiratory rate, shortness of breath, chest tightness, deep cough,\\nwheezing/bronchospasm, decreased peak expiratory flow\\n\\uf0b7 Cyanosis,respiratory arrest\\nGastrointestinal\\n\\uf0b7 Abdominal pain, nausea, vomiting (stringy mucus), diarrhea, dysphagia\\nCardiovascular system\\n\\uf0b7 Chest pain\\n\\uf0b7 Tachycardia, bradycardia (less common), other arrhythmias, palpitations\\n\\uf0b7 Hypotension, feeling faint, urinary orfecal incontinence, shock\\n\\uf0b7 Cardiac arrest\\nCentral nervous system\\n\\uf0b7 Aura of impending doom, uneasiness (in infants and children, sudden behavioral change,\\ne.g. irritability, cessation of play, clinging to parent); throbbing\\n\\uf0b7 H eadache (pre-epinephrine), alteredmental status, dizziness, confusion, tunnel vision\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Remove exposure to trigger if possible (discontinue intravenous diagnostic or therapeutic\\nagent that seems to triggering symptoms). Place the patient supine and elevate the\\nextremities.\\n\\uf0b7 Ob serve vital signs frequently and if possible, monitor electrocardiogram and pulse\\noximetry.\\n\\uf0b7 For severe anaphylaxis with shock, initial management should be directed at the ABC of\\nresuscitation, namely maintenance of adequate airway- suction, breathing, and\\ncirculation. If working alone, call for assistance.\\nPharmacological treatment\\n\\uf0b7 Inj. adrenaline 1:1000 (1mg/ml), 0.01 ml/kg (maximum 0.3 ml in children and 0.5 ml in\\nadults) IM (mid anterolateral aspect of thigh). If necessary, dose can be repeated every15\\nminutes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 69, 'page_label': '70'}, page_content='Emergency Conditions\\n54\\n\\uf0b7 If the anaphylaxis is due to an allergen extract or to a hymenoptera sting intoan\\nextremity, half the dose of adrenaline can be infiltrated locally, subcutaneously after\\ndilution with 2 ml saline.\\n\\uf0b7 High flow oxygen (4-6 lit/min by face mask ororopharyngeal airway).\\n\\uf0b7 Establish two wide bore intravenous lines. Commence rapid fluid resuscitation with Inj.\\nNS (0.9% normal saline) at rate of 5-10 ml/kg in 5 to 10 minutes. One to two litres of\\nfluid bolus can be given.\\n\\uf0b7 Intubate and commence intermittent positive pressure ventilation if severe laryngeal\\nobstruction, bronchospasm, circulatory shock or coma.\\n\\uf0b7 If no response to the initial intramuscular dose of adrenaline, administer adrenaline 5\\nmcg/kg slowly in to the intravenous line. Repeat at 5 minutes intervals depending on\\nresponse. If the patient remains in shock, start an adrenaline infusion (preferably via a\\ncentral venous line), commencingat0.1 mcg/kg/min in children and 0.2 mcg/kg/min in\\nadults with titration required to restore blood pressure. Large doses of adrenaline may\\nbe needed.\\n\\uf0b7 Commence cardiopulmonary resuscitation, if necessary.\\n\\uf0b7 If the only manifestation of anaphylaxis is urticaria or angioedema, initial IM dose of\\nadrenaline should be given in addition to antagonists. If no other manifestation, patient\\ncan be kept under observation for at least 12 hours and then discharged.\\nAdditional measures\\n\\uf0b7 IV infusion of chlorpheniramine 10 mg (adult), 2.5-5 mg (child) or diphenhydramine 25-\\n50 mg (adult) (1 mg/kg, maximum 50 mg [child]).\\n\\uf0b7 Inj. salbutamolsolution, 2.5to 5mg/3 mlgiven by nebulizer and face mask.\\n\\uf0b7 IV hydrocortisone infusion 200 mg (adult), maximum 100 mg (child); or\\nmethylprednisolone 50-100 mg (adult); 1 mg/kg, maximum 50 mg (child).\\nSupportive treatment\\nAll patients with severe anaphylactic reaction must be hospitalized. Patients who remain\\nclinically unstable after initial resuscitation should be admitted tointensivecare unit (ICU).\\nPatientsrespondingto the initial treatmentshould be observed forpossible late reaction.\\nPatient education\\nTo check and look for the cause (food, drugsetc.) and to avoid it in future\\nACUTE AIRWAY OBSTRUCTION\\nThe cause of acute airway obstruction can be underlying malignancy, abscess, laryngeal cyst\\nor laryngocele. It is necessary to assess the severity of the condition before initiating the\\ntreatment.\\nEmergency treatment\\n\\uf0b7 Head extension with lower jaw thrust forward\\n\\uf0b7 Suctioning for clearing secretions'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 70, 'page_label': '71'}, page_content='Emergency Conditions\\n55\\n\\uf0b7 Ventilatory mask with 100% oxygen\\n\\uf0b7 Endotracheal intubation or tracheostomy\\nIn stable patient\\n\\uf0b7 Plain X-ray neck\\n\\uf0b7 Fibre optic endoscopy / micro-laryngoscopy / bronchoscopy to find out the cause\\nTreatment guidelines\\nAssess Severity of airway\\nPortableradiographic ultrasonography\\nECG m onitoringand supplemental oxygen\\nPulse oximetry,blood pressure\\nCricothyrotomy Tracheostomy\\nEmergency intubation\\nSTRIDOR\\nStridor is noisy, harsh and difficult breathing due to obstruction of the airway. It is classified\\ninspiratory, expiratory and biphasic type. Inspiratory stridor occurs due to an obstruction at or\\nabove the level of vocal cords. Expiratory stridor is due to obstruction at bronchiolar level\\nsuch as bronchial asthma while biphasic stridor occurs in tracheal and subglottic stenosis. In\\nchildren the stridor of laryngo-tracheo-bronchitis has a crowing quality and is called â€˜Croupâ€™.\\nSalient features\\nPharmacologicaltreatment\\n\\uf0b7 Humidified oxygen\\n\\uf0b7 Inj. hydrocortisone 100 mgIV stat and can be repeated as required.\\n\\uf0b7 Inj. ampicillin 500mgQID IV/for5-7 days\\n\\uf0b7 Inj. adrenaline 0.2-0.5mg subcutaneously if necessary.\\nâ€¢ Restlessness, anxiety and distress, labored/ noisy breathing, predominantly on\\ninspiration\\nâ€¢ Difficulty in swallowing and speaking\\nâ€¢ In children: cyanosis, chest retraction, tachypnea, altered level of consciousness,\\nfeeding difficulties'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 71, 'page_label': '72'}, page_content='Emergency Conditions\\n56\\nSHOCK\\nShock is defined as a circulatory insufficiency that creates an imbalance between tissue\\noxygen supply and demand.\\nClassification and causes of shock\\n1. Haemorrhagic shock\\n\\uf0b7 Traumaticâ€“ blunt or penetrating injury, fractures of long bones and pelvis\\n\\uf0b7 Non -traumatic- GI bleeds (e.g. peptic ulcer, gastric mucosalerosions, oesophageal\\nvarices, typhoid bleeds,disseminatedintravascular coagulation (DIC),aortic\\ndissection, rupture of aneurysmof a large vessel\\n2. Hypovolaemic shock\\n\\uf0b7 Fluid loss from vomiting and/or diarrhoea e.g.in cholera, other GI infections\\n\\uf0b7 Fluid loss in diabetes mellitus, adrenal insufficiency, excessive sweating, exfoliative\\ndermatitis, diabetes insipidus, reaccumulation of ascites after tapping\\n\\uf0b7 Sequestration of fluid e.g. in intestinal obstruction, pancreatitis, burns, crush injuries\\n3. Cardiogenic shock\\n\\uf0b7 Acute myocardial infarction\\n\\uf0b7 Cardiomyopathy, cardiac arrhythmias\\n\\uf0b7 Mechanical causes e.g. valvular disease, outflow tract obstruction, ruptured\\nventricular septum\\n4. Distributive or vasogenic (relative hypovolaemia)\\n\\uf0b7 Septic shock; toxic shock syndrome\\n\\uf0b7 Anaphylactic\\n\\uf0b7 Neurogenic\\nShock is a progressive disorder, if untreated can lead to severe haemodynamic and metabolic\\ndeterioration causing multi-organ failure. Stages of shock can be arbitrarily classified as:\\n\\uf0b7 Early compensated shock-Vital organ function is maintained by intrinsic compensatory\\nmechanisms. Blood pressure is usually normal, there is increasing tachycardia and\\nhypotension. The skin is cold and clammy, increased capillary refill time (>3 sec). If there\\nis delay in treatment it may-lead to decompensated shock.\\n\\uf0b7 Decompensated shock - There is fall in blood pressure and cardiac output. Features of\\nperipheral poor perfusion are compounded with manifestations of vital organ impairment.\\nPatient may have alteration of mentation (impaired cerebral perfusion), oliguria (renal\\nhypoperfusion) and myocardial ischaemia (coronary flow impairment). Patient has\\nacrocyanosis, cold and damp extremities and a pale look. If untreated, progress to\\nirreversible state of shock.\\n\\uf0b7 Irreversibleshock is a term applied to the clinical situation in which even\\nhaemodynamic correction does not halt the progressive organ failure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 72, 'page_label': '73'}, page_content='Emergency Conditions\\n57\\n\\uf0b7 Tachycardia, blood pressure may be normal or elevated due to compensatory\\nmechanisms, later falls as cardiovascular compensation fails. Neck veins may be\\ndistended or flattened, depending on the etiology of shock. Decreased coronary\\nperfusion pressures can lead to ischemia, decreased ventricular compliance, and\\nincreased left ventricular diastolic pressure and pulmonary edema.\\n\\uf0b7 Tachypnea, increased minute ventilation, and increased dead space are common.\\nBronchospasm, hypocapnia with progression to respiratory failure, and adult\\nrespiratory distress syndrome can be seen.\\n\\uf0b7 Skin pale, dusky, clammy skin with cyanosis, sweating, altered temperature, and\\ndecreased capillary refill, oliguria.\\nSalient features\\nTreatment\\n\\uf0b7 Start oxygen 4-6 L/min\\n\\uf0b7 Airway control, endotracheal intubation\\n\\uf0b7 Adequate venous access. Large-bore peripheral intravenous catheters for adequate fluid\\nresuscitation.Central venous accessmay be necessary for monitoring and employing\\npulmonary artery catheters, venous pacemakers, and long-term vasopressor therapy.\\n\\uf0b7 Volume replacement. Isotonic, intravenous crystalloid fluids (0.9%NaCl, Ringerâ€™s\\nlactate) are preferred for the initial resuscitation phase. Initial bolus volume is 20 to 40\\nm l/kg over 10 to 20 min (rapid infusion). Colloids (dextran, hetastarch, etc.) can be used\\ntill blood is available.\\n\\uf0b7 Blood is the ideal resuscitative fluid for hemorrhagic shock or in the presence of\\nsignificant anemia. Fully cross-matched blood is preferred, but if more rapidintervention\\nis required, type specific or type O negative blood may be employed. The decision to use\\nplatelets or fresh frozen plasma (FFP) should be based on evidence of impaired\\nhemostasis and on frequent monitoring of coagulation parameters. Plateletsare generally\\ngiven if there is ongoing hemorrhage and the platelet count is 50,000 or less; FFP is\\nindicated if the prothrombin time is prolonged more than 1.5 times.\\n\\uf0b7 Vasopressors should be used if there is persistent hypotension after adequate volume\\nresuscitation. Inj. dobutamine 2.0 to 20.0 Âµg/kg/min for systolic BP over 100 mmHg,\\ndopamine 2.5 to 20.0 Âµg/kg/min for systolic BP 70 to 100 mmHg, andInj.norepinephrine\\n0.5 to 30.0 Âµg/min for systolic BP under 70 mmHg.\\n\\uf0b7 Acidosis should be treated with adequate ventilation and fluid resuscitation. Use of\\nsodium bicarbonate (1 meq/kg) is controversial. If it is used, it is given only in the setting\\nof severe acidosis refractory to ventilation and fluid resuscitation.\\n\\uf0b7 Early surgical or medical consultation for admission or transfer as indicated.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 73, 'page_label': '74'}, page_content='Emergency Conditions\\n58\\nMonitoring\\nSpecial care in ICUshould be takenby careful and continuous monitoring of BP, pulse rate\\nand respiratory rate, urine output and mental status frequently. Sedated patients should be\\nallowed to awaken (\"drugholiday\") daily to assess their neurologic status and to shorten\\nduration of ventilator support.\\nManagement guidelines for common causes of shock\\nHemorrhagic Shock\\n\\uf0b7 Ensure adequate ventilation/oxygenation\\n\\uf0b7 Provide immediate control of hemorrhage (e.g., traction for long bone fractures, direct\\npressure)\\n\\uf0b7 Initiate judicious infusion of isotonic crystalloid solution (10â€“20 ml /kg) or colloid\\nsolution\\n\\uf0b7 With evidence of poor organ perfusion and 30-minute anticipated delay to hemorrhage\\ncontrol, begin packed red blood cell (PRBC) infusion (5â€“10 ml/kg)\\n\\uf0b7 Treat coincident dysrhythmias (e.g., atrial fibrillation with synchronized cardioversion)\\nCardiogenic Shock\\n\\uf0b7 Ameliorate increased work of breathing; provide oxygen and positive end-expiratory\\npressure (PEEP) for pulmonaryedema\\n\\uf0b7 Begin vasopressor or inotropic support; Inj. norepinephine (0.5 Âµg/min) and Inj.\\ndobutamine (5 Âµg/kg/min)\\n\\uf0b7 Seek to reverse the insult (e.g., initiate thrombolysis, arrange percutaneous transluminal\\nangioplasty)\\n\\uf0b7 Consider intra-aortic balloon pump counterpulsation for refractory shock\\nSeptic Shock\\n\\uf0b7 Ensure adequate oxygenation\\n\\uf0b7 Administer 20 ml/kg of crystalloid (0.9% normal saline or RL) or 5 ml/kg of colloid\\n(hemaccel or hetastarch), and titrate infusion to adequate central venous pressure and\\nurine output\\n\\uf0b7 Begin antimicrobial therapy; attempt surgical drainage or dÃ©bridement\\n\\uf0b7 Begin packedRBC infusion for hemoglobin < 8 g/dL\\n\\uf0b7 If volume restoration fails to improve organ perfusion, begin vasopressor support; initial\\nchoice includes dopamine infusion at 5â€“15 Âµg/kg/min\\nFLUID AND ELECTROLYTE IMBALANCE AND REPLACEMENT (IN ADULTS)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 74, 'page_label': '75'}, page_content=\"Emergency Conditions\\n59\\nDisturbances in fluid and electrolyte balance occur in a wide spectrum of diseases such as\\nfollowing burns, trauma and major surgery. The conventional and easy method of evaluating\\ndisturbances in fluid and electrolyte balance is the frequent measurement of the concentration\\nof serum electrolytes. It is crucial to remember that intracellular and extracellular electrolytes\\nare normally constant, and that major shifts in and out of 'compartments' can occur in disease\\nwith minimal changes in serum electrolyte. Compositional changes also involve disturbances\\nin acid-base balance.\\nI. Volume deficit\\n\\uf0b7 Obvious causes\\nVomiting, diarrhoea, intestinal fistulae, nasogastric suction, fluid loss following burns,\\nsequestration of fluid in soft tissue injuries and infections, diuretics, renal disease/adrenal\\ninsufficiency\\n\\uf0b7 Less obvious causes\\nInadequate fluid intake, fluid loss through excessive sweating as in high fever, hot humid\\ntemperature, haemodialysis, haemofiltration fromsurgical incisions and tetanus\\nTreatment\\nThe first principle is to restore circulating volume through infusion of intravenous fluids.\\nOnce this is satisfactorily achieved, disturbances in electrolytes and acid-base balance if\\npresent need to be rectified. Various fluids used for volume replacement are given below:\\nReplacement fluids\\n\\uf0b7 Replacement fluids are used to replace abnormal loss of blood, plasma or other\\nextracellular fluids as first line treatment for hypovolemia in:\\n- Patients with established hypovolemia e.g. haemorrhagic shock.\\n- Maintenance of normovolaemia in patients with ongoing fluid losses e.g. surgical\\nblood loss.\\n\\uf0b7 Intravenous replacement fluids are the first line of treatment for hypovolemia.\\n\\uf0b7 Crystalloid maintenance fluids, which contain dextrose, are not suitable for use as\\nreplacement fluids. However, crystalloid solutions with a similar concentration of\\nsodium to plasma (normal saline or balanced salt) solutions (Ringer's lactate or\\nHartmann's solutions) are effective as replacement fluids. These should be available in\\nall hospitals where intravenous replacement fluids are used. Crystalloids should be\\ninfused in a volume at least three times the volume lost in order to correct hypovolemia.\\n\\uf0b7 All colloid solutions (albumins, dextran, gelatins and hydroxyethyl starch solutions) are\\nreplacement fluids. However, they have not been shown to be superior to crystalloids in\\nresuscitation.Colloid solutions should be infused in a volume equal to the blood\\nvolume deficit.\\n\\uf0b7 Plasma should never be used as a replacement fluid.\\n\\uf0b7 Plain water should never be infused intravenously as it can cause haemolysis.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 75, 'page_label': '76'}, page_content='Emergency Conditions\\n60\\n\\uf0b7 In addition to the intravenous route, the intraosseous, oral, rectal or subcutaneous routes\\ncan be used for the administration of fluids, blood and certain drugs. However, with the\\nexception of intraosseous route, other routes are generally unsuitable in severely\\nhypovolemic patients.\\n\\uf0b7 Rectal fluids are administered through a plastic or rubber enema tube which is inserted\\ninto the rectumand connected to a bag or bottle of fluid. A safe and effective solution\\nfor a rectal rehydration is 1 liter of clean drinking water with teaspoon of table salt.\\n\\uf0b7 Subcutaneous fluidscan be used when other route of administration of fluids are\\nunavailable.A cannula or needle is inserted into the subcutaneous tissue (the abdominal\\nwall is a preferred site) and sterile fluids are administered in a conventional manner. Do\\nnot give dextrose-containing solutions subcutaneously as they can cause sloughing of\\ntissues.\\n\\uf0b7 Oral and nasogastric fluids: Oral rehydration can often be used in mildly hypovolemic\\npatients if the oral route is not contraindicated. Do not use if:\\n- The patient is unconscious.\\n- The patient has gastrointestinal lesions or reduced gut motility e.g. obstruction.\\n- General anaesthesia and surgery is planned imminently.\\nWHO/UNICEF formula for oral rehydration fluid:\\nDissolve in one litre of drinkable water\\nSodium chloride 2.6 g/L\\nTrisodium citrate, dihydrate 2.9 g/L\\nPotassium chloride 1.5 g/L\\nGlucose anhydrous 13.5 g/L\\nResulting concentrations\\nNa 75 mmol/L, CI65 mmol/L, K 20 mmol/L, Glucose anhydrous75 mmol/ L, Citrate 10\\nmmol/L, total osmolarity 245 mmol/L.\\nMaintenance fluids\\nMaintenance fluids are used to replace the normal physiological loss that occurs through skin,\\nlung, faeces and urine. Since a considerable proportion of the loss is water, maintenance\\nfluids are mainly composed of water in the form of a dextrose solution. Some electrolytes\\nmay also be included in these solutions.\\nBefore giving any intravenous infusion:\\n\\uf0b7 Check that the seal of the infusion fluid bottle or bag is not broken.\\n\\uf0b7 Check the expiry date.\\n\\uf0b7 Check that the solution is clear and free from visible particles.\\nII. Volume excess\\nVolume excess is often iatrogenic when the fluid intakehas consistently exceeded the\\noutput. Excessive intravenous infusions of saline and blood transfusions are important'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 76, 'page_label': '77'}, page_content='Emergency Conditions\\n61\\ncauses of hypervolemia. Renal insufficiency, congestive heart failure, liver disease and\\nother causes of sodium retention, or excessive sodium administration can all produce\\nincrease in extracellular fluid content and hypervolemia.\\nSalientfeatures\\nTreatment\\nIn moderate volume excess, salt restriction, restriction of fluid intake and the use of\\nfrusemide as a diuretic will solve the problem. Fulminant pulmonary oedema secondary to\\nover hydration from over transfusion of blood or fluids is more appropriately dealt with by\\nphlebotomy in stages so that pulmonary capillary wedge pressure is reduced below 15 mm\\nHg. Rarely ultrafiltration (dialysis) may be required.\\nReferences\\n1. Anaesthesia at the District Hospital. In: World Health Organization in collaboration with the World\\nFederation of Societies of Anesthesiologists, Geneva, 2nd Edition, 2000, WHO.\\n2. Drugs Used in Anaesthesia. In: WHO Model Prescribing Information, 1989, World Health Organization.\\n3. Anaesthesia at the District Hospital. In: World Health Organization in collaboration with the World\\nFederation of Societies of Anesthesiologists, Geneva, 1988, World Health Organization.\\nSEPTICEMIA\\nSepticemia is a clinical syndrome caused by invasion of bloodstream by microorganisms.\\nGram -negative and gram-positive bacteria account for most common sepsis cases.\\nDefinitions\\n\\uf0b7 Bacteremia (fungemia): presence of viable bacteria (fungi) in the blood, as evidenced by\\npositive blood cultures.\\n\\uf0b7 Systemic Inflammatory Response Syndrome (SIRS): at least two of the following\\nconditions: (1) oral temperature of >38Â° C or <35Â° C, (2) respiratory rate of >20\\nbreaths/min or partial pressureof arterial carbon dioxide (PaCO2) of <32 mm Hg, (3)\\nheart rate of >90 beats/min, (4) leukocyte count of >12,000/dl or <4000/dlor >10%\\nbands.\\n\\uf0b7 Severe sepsis: sepsis with one or more signs of organ dysfunction, hypoperfusion, or\\nhypotension, such as metabolic acidosis, alteration in mental status, oliguria, or adult\\nrespiratory distress syndrome.\\n\\uf0b7 Oedema, ascites, pleural effusion,neck veins full, pulmonary congestion,\\nhyperdynamic circulation with tachycardia, a warm skin, and a bounding pulse.\\n\\uf0b7 Increase in the systolic pressure and pulse pressure.\\n\\uf0b7 Central venous Pressure (CVP) > 12 mmHg, Pulmonary Capillary Wedge Pressure\\n(PCWP) > 20 mmHg in the presence of pulmonary oedema.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 77, 'page_label': '78'}, page_content='Emergency Conditions\\n62\\n\\uf0b7 Septic shock: sepsis with hypotension that is unresponsive to fluid resuscitation plus\\norgan dysfunction or perfusion abnormalities as listed for severe sepsis.\\n\\uf0b7 Multiple Organ Dysfunction Syndrome (MODS): dysfunction of more than one organ,\\nrequiring intervention homeostasis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 78, 'page_label': '79'}, page_content='Emergency Conditions\\n63\\n\\uf0b7 Fever or hypothermia may be seen in sepsis. Hypothermia is more often seen in patients\\nat the extremes of age and in immunocompromised patients.\\n\\uf0b7 Other signs include tachycardia, wide pulse pressure, tachypnea,and hypotension.\\n\\uf0b7 Mental status changes ranging from mild disorientation to coma are commonly seen.\\n\\uf0b7 Ophthalmic manifestations include retinal hemorrhages, cotton-wool spots, and\\nconjunctival petechiae.\\n\\uf0b7 Cardiovascular manifestations initially include vasodilation, resulting in warm\\nextremities.\\n\\uf0b7 Cardiac output is maintained early in sepsis through a compensatory tachycardia. As\\nsepsis progresses, hypotension may occur. Patients in septic shock may demonstrate a\\ndiminished response to volume replacement.\\n\\uf0b7 Renal manifestations include azotemia, oliguria, and active urinary sediment due to\\nacute tubular necrosis.\\n\\uf0b7 Hepatic dysfunction present as cholestatic jaundice, increases in transaminases, alkaline\\nphosphatase, and S.bilirubin. Painless mucosal erosions may occur in the stomach and\\nduodenum and cause upper GI bleeds.\\n\\uf0b7 Skin findings include cellulitis, erysipelas, and fasciitis. Hypotension and disseminated\\nintravascular coagulation (DIC) can also produce skin changes, including acrocyanosis\\nand necrosis of peripheral tissues.\\n\\uf0b7 Hematologic changes include neutropenia, neutrophilia, thrombocytopenia, and DIC.\\nThrombocytopenia occurs in over 30 percent of patients with sepsis. DIC is more often\\nassociated with gram-negative sepsis. Decompensated DIC presents with clinical\\nbleeding and thrombosis. Laboratory studies can show thrombocytopenia, prolonged\\nprothrombin time (PT) and partial prothromboplastin time (PTT), decreased fibrinogen\\nlevel and antithrombin levels, and increased fibrin monomer, fibrin split values,and D-\\ndimer values.\\n\\uf0b7 Hyperglycemia may be the result of increased catecholamines, cortisol, and glucagon.\\nIncreased insulin resistance, decreased insulin production, and impaired utilization of\\ninsulin may further contribute to hyperglycemia.\\n\\uf0b7 Arterial bloodgas (ABG) studies in early sepsis may reveal hypoxemia and respiratory\\nalkalosis. As perfusion worsens and glycolysis increases, a metabolic acidosis results.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Aggressive airway management with high-flow oxygen and endotracheal intubation\\n\\uf0b7 Rapid infusion of crystalloid IV fluid (Ringerâ€™s lactate or normal saline) at 500 m l (20\\nm l/kg in children) every 5 to 10 min; 4 to 6 L (60 ml/kg in children)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 79, 'page_label': '80'}, page_content='Emergency Conditions\\n64\\n\\uf0b7 Remove source of infection-remove indwellingIV catheters and send the tips for\\nquantitative culture. Replace urinary drainage catheters if obstructed. Consult the\\nappropriate specialist for drainage of intra-abdominal, sinus, or soft tissue abscesses.\\n\\uf0b7 Monitor blood pressure, pulse, capillary refill, central venous pressure, pulmonary\\ncapillary wedge pressure, and urine output (>30 ml/h in adults, 1 ml/kg/h in children) to\\nevaluate therapy. If blood loss is suspected, blood replacement may be necessary\\nPharmacological treatment\\n\\uf0b7 Inj. dopamine 5 to 20 Âµg/kg/min, titrated to response, if hypotension is refractory to IV\\nfluid.\\n\\uf0b7 If blood pressure remains <70 mmHg despite preceding measures,Inj.norepinephrine 8-\\n12 Âµg/min loading dose and a 2-4 Âµg/min infusion to maintain mean arterial blood\\npressure of at least 60 mmHg should be started.\\n\\uf0b7 Empiric antibiotic therapy. Dosages should be the maximum allowed and given\\nintravenously. When source is unknown, therapy should be effective against both gram-\\npositive and gram-negative organisms.\\n\\uf0b7 In adults, a third-generation cephalosporin (ceftriaxone 1 g IV, cefotaxime 2 g IV, or\\nceftazidime 2 g IV) or an antipseudomonal beta lactamaseâ€“susceptible penicillin can also\\nbe used. Addition of an aminoglycoside (gentamicin 2 mg/ kg IV, tobramycin 2 mg/kg\\nIV) to this regimen is recommended.\\n\\uf0b7 In immunocompromised adults, ceftazidime 2g IV, imipenem 750 mg IV, or meropenem\\n1 g IV alone is acceptable. If gram-positive infection is suspected (indwelling catheter or\\nIV drug use), oxacillin 2 g IV or vancomycin 15 mg/ kg IV should be added. If an\\nanaerobic source is suspected (intraabdominal, genital tract, odontogenic, and necrotizing\\nsoft tissue infection), metronidazole 7.5 mg/kg IV or clindamycin 900 mg IV should\\nadditionally be administered. IfLegionellais a potential source, erythromycin 500 mg IV\\nshould be added.\\n\\uf0b7 Acidosis to be treated with oxygen, ventilation, and IV fluid replacement. If acidosis is\\nsevere, administration of sodium bicarbonate 1 meq/kg IV is acceptable as directed by\\nABGs.\\n\\uf0b7 DIC should be treated withfresh-frozen plasma 15 to 20 ml/kg initially to keep PT at 1.5\\nto2 times normal and treated with platelet infusion to maintain serum concentration of 50\\nto 100,000.\\n\\uf0b7 Inj.hydrocortisone(100 mg IV)  for adrenal insufficiency\\nORGANOPHOSPHOROUS POISONING\\nOrganophosphorous(OP) insecticides are highly lipid soluble and are rapidly absorbed via\\ndermal, gastrointestinal and respiratory routes. Common agents for OP poisoning are\\nmalathion, parathion, chlorpyrifos, dichlorvos, methylparathionwhich are used as\\ninsecticides.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 80, 'page_label': '81'}, page_content='Emergency Conditions\\n65\\n\\uf0b7 Clinical features include dyspnoea, tightness around chest, nausea, vomiting, diarrhea,\\nabdominal pain, excessive sweatingand salivation, miosis, blurred vision, lacrimation,\\nheadache, giddiness, drowsiness, bradycardia, arrhythmias, QT prolongation,\\nhypotension, fasciculation, muscle weakness, seizures and coma.\\n\\uf0b7 Diagnosis can be confirmed byred blood cell (RBC) cholinesterase and plasma\\ncholinesterase level which is reduced to 20% of the normal values.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Maintain patent airway: oral airway/intubation/mechanical ventilation if required\\n\\uf0b7 Monitor vitals-temperature, pulse, blood pressure, respiratory rate\\n\\uf0b7 Start intravenous line placement: maintenance IV fluids\\n\\uf0b7 Decontamination: remove of all clothes\\n\\uf0b7 Gastric lavage with activated charcoal and sample collection\\n\\uf0b7 Wash  skin with soap and water\\nPharmacological treatment\\n\\uf0b7 Inj. atropine 2 mg IV bolus, repeat every 5-10 minutes until atropinization (pulse\\n>80/min, pupillary dilation and drying of secretions)followed by atropine IV infusion at\\n0.02-0.08 mg/kg/min to maintain atropinasation (glycopyrronium can be used in place\\natropine to avoid CNS toxicity).\\n\\uf0b7 Inj. pralidoxime IV 30mg/kg immediately followed by 8 mg/kg/hr continued for at least\\n24 hours. If an infusion cannotbe used, 30 mg/kg every 4 hourly.\\n\\uf0b7 Inj. obidoxime 4 mg/kg bolus initially followed by 0.5 mg/kg/hr infusion Alternatively,4\\nmg/kg bolus followed by 2 mg/kg every 4 hourly.\\n\\uf0b7 IV crystalloids: normal saline/ringerâ€™s lactate.\\n\\uf0b7 Benzodiazepines: midazolam/lorazepam/diazepam for treatment and prophylaxis of\\nseizures\\nKEROSENE AND PETROL POISONING\\nSalient features\\n\\uf0b7 Most common accidental poisoning in children.\\n\\uf0b7 Inhalational of vapours or pulmonary aspiration can cause toxicity. The lethal dose is 30-100\\nml.\\n\\uf0b7 Mild- breathing difficulty, throat pain, nausea / vomiting, vision loss, low blood pressure,\\nconvulsions, headache, weakness, burns / irritation.\\n\\uf0b7 Severe: pulmonary edema, hemoptysis, mental confusion, hallucination, stupor, cyanosis,\\nconvulsions, coma, death (due to ventricular fibrillation / respiratory failure).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 81, 'page_label': '82'}, page_content='Emergency Conditions\\n66\\n\\uf0b7 Gastric irritation within half an hour of taking the poison.\\n\\uf0b7 Bitter taste, dry mouth and throat, burning pain in the stomach and difficulty in swallowing\\nand talking.\\n\\uf0b7 Giddiness, ataxia, incoordination of muscles, flushed appearance of the face, dry hot skin,\\nrise in temperature, diplopia, dilated pupils with loss of accommodation, reddening of the\\nconjunctiva and drowsiness. Sometimes, an erythematous rash appears all over the body.\\n\\uf0b7 Full, bounding pulse which later becomes weak and irregular.\\n\\uf0b7 Muttering delirium, tries to run away from the bed, picks at bed clothes, tries to pull\\nimaginary threads from the tips of his fingers and develops dreadful hallucinations of sight\\nand hearing. The conditionmay pass on to stupor, convulsions, coma and sometimes death\\nfrom respiratory failure.\\n\\uf0b7 Death may occur within 4-24 hours.\\nInvestigations\\nChest x ray: perihilar densities, basal pneumonitis, atelectasis, consolidation\\nTreatment\\n\\uf0b7 Remove all contaminated clothes of the patient\\n\\uf0b7 Flush the skin and oral cavity for at least 15 minutes\\n\\uf0b7 If the chemical is swallowed, immediately give the person water or milk\\n\\uf0b7 If the person breathed in the poison, immediately move him or her to fresh air with patent\\nairwaywith head low position\\n\\uf0b7 Do not induce emesis\\n\\uf0b7 Put the patient on monitor for vital signsâ€“ temperature, pulse, blood pressure, respiratory\\nrate\\n\\uf0b7 Provide oxygen through nasal cannula or face mask\\n\\uf0b7 Take IV lineâ€“ start intravenous crystalloids as a supportive therapy\\n\\uf0b7 Patients should be monitored for respiratory complications.\\nDATURA POISONING\\nDatura stramonium(thorn apple) grows in India at high altitudes. The seeds and fruits are the\\nmost poisonous parts of the plant with hyoscine, hyoscyamine and traces of atropine,as the\\nactive principles.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Stomach wash with 1:10,000 potassium permanganate solution or 5% tannic acid\\nsolution.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 82, 'page_label': '83'}, page_content='Emergency Conditions\\n67\\n\\uf0b7 Decontamination of the patient must be individualized, based on time since exposure,\\ntype of anticholinergic agent involved, route of exposure, probable amount ingested, and\\nseverity of the clinical condition.\\n\\uf0b7 Early gastric emptying (within 1 hour) may be considered for large ingestions, when an\\nasymptomatic patient presents immediatelyafter ingestion.\\n\\uf0b7 Measure core body temperature with a flexible rectal probe. Aggressive temperature\\nreduction with ice water or evaporative cooling with mist and fans should be the first\\npriority in the severely hyperthermic patient. Antipyretic agents and simple cooling\\nblankets are ineffective.\\nPharmacological treatment\\n\\uf0b7 Benzodiazepines like midazolam or lorazepam can be used to control agitation and\\nsedation.\\nInj. midazolam 0.01-0.1 mg/kg IV or Inj. lorazepam 0.05-0.1 mg/kg IV\\n\\uf0b7 In severe poisoning, Inj. physostigmine 1.2 mg IM or IV, to be repeated after half an\\nhour, if necessary. Watch for side effects (bradycardia, heart block, excessive secretions).\\n\\uf0b7 Inj. diazepam 10 mg IV diluted slowly may be given for convulsions.\\nABDOMINAL INJURY\\nAbdominal injuries arequitecommon in this new eraand it is must for a surgeon to quickly\\nassess and promptly manage such injuries which can be fatal. They can be broadly classified\\nas penetrating abdominal injury and blunt abdominal injury.\\nI. Penetrating abdominal injury\\n\\uf0b7 Penetrating abdominal injuriescaused by sharp weapon injury, missile injury/gunshot\\ninjury etc\\n\\uf0b7 History oftime and place of injury,nature of injury,direction of injuring weapon\\n\\uf0b7 Physical examinationassess vitals, assess wound thoroughly, look for peritoneal breach\\nInvestigations\\n\\uf0b7 Generally no investigations are required before proceeding for laparotomy.\\n\\uf0b7 X -rayabdomen standing can be done in cases where peritoneal breach is in doubt\\nTreatment\\n\\uf0b7 Resuscitate the patient, secure airway, maintain breathing, maintain circulation, arrange\\nfor compatibleblood.\\n\\uf0b7 Emergency exploratory laparotomy and further management according to organ injured.\\nII.Blunt abdominal injury\\nBlunt abdominal injuries can be due to assault by blunt objects, road traffic accidents and\\nfalls.\\nInvestigations\\n\\uf0b7 H aemoglobin levels,  hematocrit, X-ray abdomen standing'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 83, 'page_label': '84'}, page_content='Emergency Conditions\\n68\\n\\uf0b7 The common agents causing chemical injuries are alkalis (lime, cement, plasters),\\nacids, solvents, detergents and irritants. Alkalis tend to penetrate more deeply than\\nacids, as the latter coagulate surface proteins, forming a protective barrier.\\n\\uf0b7 Symptoms include redness, pain, photophobia, blepharospasm and watering of eyes.\\n\\uf0b7 Corneal epithelial defects ranging from scattered superficial punctate keratopathy\\n(SPK), to focal epithelial loss, to sloughing of the entire epithelium may occur.\\n\\uf0b7 Focal areas of  conjunctival  chemosis, hyperemia, hemorrhages, or a combination of\\nthese\\n\\uf0b7 Mild eyelid edema, mild anterior chamber (AC) reaction andfirst- and second-degree\\nburns of the periocular skin.\\n\\uf0b7 USG -abdomen, CECT -abdomen and pelvis.\\nTreatment\\n\\uf0b7 Resuscitate the patient, secure airway, maintain breathing, maintain circulation, arrange\\nfor compatibleblood.\\n\\uf0b7 Temperature, pulse,respiratoryrate,blood pressure (TPRBP) charting, abdominal girth\\n(AG) charting.\\n\\uf0b7 Management of blunt abdominal trauma depends upon vitals of the patients and organs\\ninvolved as per seen in USG- Abdomen and Contrast Enhanced Computed Tomography\\n(CECT ) abdomen.\\n\\uf0b7 All patients whose vitals are unstableare to be explored. Emergency exploratory\\nlaparotomy and followed by management according to organ involved.\\n\\uf0b7 All patients whose vitals arestable are reviewed by CECT-abdomen and pelvis and\\nmanaged according to organs involved and grade of injury.\\nFOREIGN BODY IN EAR\\nOccasionallya fly or an insect gets trapped in the external canal and cause distress and\\ndiscomfort. The foreign body could be animate-insects orinanimate, organic-seeds or\\ninorganic-stones, beads, cotton buds, match sticks etc.\\nTreatment\\n\\uf0b7 Insects-immobilized using oil and remove with forceps\\n\\uf0b7 Vegetable foreign bodiesâ€“ remove with foreign body hook (syringingisnot advisable).\\n\\uf0b7 Non -organic foreign bodies-remove with syringing and foreign body hook.\\n\\uf0b7 Impacted foreign bodies-remove under general anesthesia using the microscope\\nCHEMICAL INJURIES OF EYE\\nSalient features\\nInvestigations'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 84, 'page_label': '85'}, page_content='Emergency Conditions\\n69\\n\\uf0b7 History: Time of injury? Specific type of chemical? Time between exposure and irrigation\\nof eyes? Duration and type of irrigation? Was the patient wearing eye protection?\\n\\uf0b7 Slit-lamp examination with fluorescein staining.\\n\\uf0b7 If you suspect an epithelial defect but do not see one with fluorescein staining, repeat the\\nfluorescein application to the eye. Sometimes the defect is slow to take up the dye. If the\\nentire epithelium sloughs off, only Bowman membrane remains, which may take up\\nfluorescein poorly.\\n\\uf0b7 Eyelid eversion to search for foreign bodies.\\n\\uf0b7 Evaluate for conjunctival ulcerations/defects.\\n\\uf0b7 Check the intraocular pressure (IOP). In the presence of a distorted cornea, IOP may be\\nmost accurately measured with atonometer.\\nGrading of severity\\n\\uf0b7 Grade 1 is characterized by clear cornea (epithelial damage only) and no limbal ischemia\\n(excellent prognosis).\\n\\uf0b7 Grade 2 shows hazy cornea but with visible iris details and less than one-third of the\\nlimbus being ischemic (good prognosis).\\n\\uf0b7 Grade 3 manifests total loss of corneal epithelium, stromal haze obscuring iris details and\\nbetween one-third and half limbal ischemia(guarded prognosis).\\n\\uf0b7 Grade 4 shows opaque cornea and more than half limbal ischemia (very poor prognosis).\\nNon pharmacological treatment\\nA. Copious irrigation\\n\\uf0b7 Place an eyelid speculum and instill topical anesthetic.\\n\\uf0b7 Copious irrigation using saline or ringerlactate solution for at least 30 minutes. Tap water\\ncan be used in the absence of these solutions and may be more efficacious in inhibiting\\nelevated intracameral pH than normal saline for alkali burns.\\n\\uf0b7 Check pH and ifnot neutral, repeat irrigation.\\n\\uf0b7 NEVER use acidic solutions to neutralize alkalis or vice versa.\\nB. Double-eversion of the upper eyelid:\\n\\uf0b7 It should be performed so that any retained particulate matter trapped in the fornices is\\nidentified and removed with cotton tip applicator.\\n\\uf0b7 Calcium hydroxide particles may be more easily removed with a cotton-tipped applicator\\nsoaked in disodium ethylenediaminetetraacetic acid (EDTA).\\nC. Debridement: Necrosed area of conjunctiva and cornea should be debrided topromote\\nhealing.\\nD. Hospitalization: It is required for severe injuries to ensure regular eye drop instillation.\\nPharmacological treatment\\nThe main aims of treatment of chemical burns are to reduce inflammation, promote epithelial\\nregeneration and prevent corneal ulceration.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 85, 'page_label': '86'}, page_content='Emergency Conditions\\n70\\n\\uf0b7 Symptoms include foreign body sensation, watering and redness with history of\\ntrauma\\n\\uf0b7 Conjunctival or corneal foreign body with or without rust ring, conjunctival injection,\\neyelid edema, mild anterior chamber reaction, and superficial punctuate keraptopathy.\\n\\uf0b7 Steroids\\n- It reduces inflammation. However, they also impair stromal healing by reducing\\ncollagen synthesis and inhibiting fibroblast migration.\\n- So topical steroids may be used initially (usually 4â€“8 times daily, strength depending\\non injury severity) but must be tapered off after 7â€“10 days when sterile corneal\\nulceration is most likely to occur.\\n- Steroids may be replaced by topical NSAIDs, which do not affect keratocyte function.\\n\\uf0b7 Cycloplegiamay improve comfort.\\n\\uf0b7 Topical antibioticdrops are used for prophylaxis of bacterial infection\\n\\uf0b7 Ascorbic acid\\nImproves wound healing and promotes the synthesis of mature collagen by corneal\\nfibroblasts. Topical sodium ascorbate 10% is given 2-hourly in addition to a systemic\\ndose of 1â€“2 g vitamin C(L-ascorbic acid) QID (not in patients with renal disease).\\n\\uf0b7 Tetracyclinesshould be considered if there is significant corneal melting and can be\\nadministered both topically (tetracycline ointment QID) and systemically (doxycycline\\n100 mg BD tapering to once daily).\\n\\uf0b7 Symblepharonshould be prevented by lysis of developing adhesions with a sterile glass\\nrod or damp cotton bud.\\nSurgical treatment\\n\\uf0b7 Earlysurgery may be necessary to promote revascularization of the limbus, restore the\\nlimbal cell population and re-establish the fornices.\\n\\uf0b7 Keratoplasty should be delayed for at least 6 months and preferably longer to allow\\nmaximal resolution of inflammation.\\n\\uf0b7 Keratoprosthesis may be required in very severely damaged eyes because the results of\\nconventional grafting are poor.\\nCORNEAL AND CONJUNCTIVAL FOREIGN BODIES IN EYE\\nSalient features\\nInvestigations\\n\\uf0b7 Determine the mechanism of injury [e.g., metal striking metal, power tools or weed-\\nwhackers may suggest an intraocular foreign body (IOFB)]. Attempt to determine the\\nsize, weight, velocity, force, and shape of the object. Document visual acuity before any\\nprocedure is performed.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 86, 'page_label': '87'}, page_content='Emergency Conditions\\n71\\n\\uf0b7 Examine closely for iris tears and transillumination defects, lens opacities, AC\\nshallowing, and asymmetrically low IOP.\\n\\uf0b7 If there is no evidence of perforation, evert the eyelids and inspect the fornices for\\nadditional foreign bodies.\\n\\uf0b7 Dilate the eye and examine the posterior segment for a possible intraocular foreign body\\n\\uf0b7 Avoid magnetic resonance imaging (MRI) if there is a history of possible metallic foreign\\nbody.\\nTreatment\\nCorneal foreign body\\n\\uf0b7 Apply topical anesthetic (e.g., proparacaine 0.5% eye drops).\\n\\uf0b7 Remove the corneal foreign body with a cotton tip applicator, 26 no needle or fine forceps\\nat a slit lamp.\\n\\uf0b7 Multiple superficial foreign bodies may be more easily removed by irrigation.\\n\\uf0b7 Remove the rust ring as completely as possible on the first attempt. This may require an\\nophthalmic drill. It is sometimes safer to leave a deep, central rust ring to allow time for\\nthe rust to migrate to the corneal surface, at which point it can be removed more easily.\\n\\uf0b7 Measure the size of the resultant corneal epithelial defect.\\n\\uf0b7 Treat epithelial defect with antibiotics and carboxy methyl cellulose(CMC) eyedrops, if\\nnecessary pad it.\\n\\uf0b7 Alert the patient to return as soon as possible if there is any worsening of symptoms.\\nConjunctival foreign body\\n\\uf0b7 Remove foreign body under topical anesthesia.\\n- Multiple or looseforeign bodies can often be removed with saline irrigation.\\n- A foreign body can be removed with a cotton-tipped applicator soaked in topical\\nanesthetic or with fine forceps.\\n- For deeply embedded foreign bodies, consider pretreatment with a cotton-tipped\\napplicator soaked in phenylephrine 2.5% to reduce conjunctival bleeding.\\n- Small, relatively inaccessible, buried subconjunctival foreign bodies may sometimes\\nbe left in the eye without harm unless they are infectious or proinflammatory.\\nOccasionally, they willsurface with time, at which point they may be removed more\\neasily.\\n\\uf0b7 Sweep the conjunctival fornices with a glass rod or cotton-tipped applicator soaked with a\\ntopical anesthetic to catch any remaining pieces.\\n\\uf0b7 A topical antibiotic (e.g., bacitracin ointmentBD; trimethoprim/polymyxin B or\\nmoxifloxacin/ciprofloxacin/ofloxacindrops QID) may be used.\\n\\uf0b7 Artificial tears may be given for irritation.\\nFollow-up'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 87, 'page_label': '88'}, page_content='Emergency Conditions\\n72\\n\\uf0b7 Corneal foreign body: Follow up as with corneal abrasion. If residual rust ring remains,\\nreevaluate in 24hours.\\n\\uf0b7 Conjunctival foreign body: Follow up as needed, or in 1 week if residual foreign bodies\\nwere left in the conjunctiva.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 88, 'page_label': '89'}, page_content='Emergency Conditions\\n73\\n\\uf0b7 The patient presents with blurred vision, history of blunt trauma and pain in eye.\\n\\uf0b7 Blood orclot or bothcan be observedin theanterior chamber, usually visible without a\\nslit lamp.\\n\\uf0b7 A total (100%) hyphema may be black or red. When black, it is called an â€œ8 -ballâ€ or\\nâ€œblack ballâ€ hyphema.\\n\\uf0b7 When red, the circulating blood cells may settle with time to become less than a 100%\\nhyphema.\\nTRAUMATIC HYPHEMA\\nSalient features\\nInvestigations\\n\\uf0b7 History of traumatic event including force, velocity, type, and direction of injury should\\nbe taken.\\n\\uf0b7 Use of medications with anticoagulant properties [aspirin, NSAIDs, warfarin  or\\nclopidogrel], personal or family history of sickle cell disease/trait, symptoms of\\ncoagulopathy (e.g., bloody nose-blowing, bleeding gums with tooth brushing, easy\\nbruising)\\n\\uf0b7 Ocular examination, first ruling out a ruptured globe. Document the extent (e.g., measure\\nthe hyphema height) and location of any clot and blood.\\n\\uf0b7 Measure the IOP. Perform a dilated retinal evaluation without scleral depression.\\n\\uf0b7 Co nsider a CT scan of the orbits and brain (axial and coronal views, with 1- to 3-mm\\nsections through the orbits) when indicated (e.g., suspected orbital fracture or IOFB, loss\\nof consciousness).\\nTreatment\\n\\uf0b7 Confine either to bed rest with bathroom privilegesor to limited activity. Elevate head of\\nbed to allow blood to settle.\\n\\uf0b7 Place a shield (metal or clear plastic) over the involved eye at all times. Do not patch\\nbecause this prevents recognition of sudden visual loss in the event of a rebleed.\\n\\uf0b7 Atropine 1% solution BD to TDS or scopolamine 0.25% BD to TDS.\\n\\uf0b7 No aspirin-containing products or NSAIDs.\\n\\uf0b7 Mild analgesics only (e.g., acetaminophen). Avoid sedatives.\\n\\uf0b7 Use topical steroids (e.g., prednisolone acetate 1% four to eight times per day) if any\\nsuggestion of iritis (e.g., photophobia, deep ache, ciliary flush), evidence of lens capsule\\nrupture, any protein (e.g., fibrin), or definitive white blood cells in anterior\\nchamber. Reduce the frequency of steroids as soon as signs and symptoms resolve to\\nreduce the likelihood of steroid-induced glaucoma.\\n\\uf0b7 For increased IOP:\\n- Start with a beta-blocker (e.g., timolol 0.5% or levobunolol 0.5% BD).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 89, 'page_label': '90'}, page_content='Emergency Conditions\\n74\\n- If IOP still high, add topical alpha-agonist (e.g., apraclonidine 0.5%, or brimonidine\\n0.2% TDS) or topical carbonic anhydrase inhibitor (e.g., dorzolamide 2%, or\\nbrinzolamide 1% TDS). Avoid prostaglandin analogs and miotics (may increase\\ninflammation). In children under 5, topical alpha-agonists are contraindicated.\\n- If topical therapy fails, add acetazolamide (500 mg orally, BD foradults, 20\\nmg/kg/day divided three times per day for children) or mannitol [1 to 2 g/kg\\nintravenously IV over 45 minutes once a day]. If mannitol is necessary to control the\\nIOP, surgical evacuation may be imminent.\\n\\uf0b7 If hospitalized, use antiemetics for severe nausea or vomiting [e.g., prochlorperazine 10\\nmg IM TDS or 25 mg BD].\\n\\uf0b7 Indications for surgical evacuation of hyphema:\\n- Corneal stromal blood staining.\\n- Significant visual deterioration.\\n- Hyphema that does not decrease to <50% by 8 days [to prevent peripheral anterior\\nsynechiae (PAS)].\\n- IOP >60 mm Hg for >48 hours, despite maximal medical therapy (to prevent optic\\natrophy).\\n- IOP >25 mm Hg with total hyphema for >5 days (to prevent corneal stromal blood\\nstaining).\\nFollow up\\n\\uf0b7 The patient should be seen daily for 3 days after initial trauma to check visual acuity,\\nIOP, and for a slit-lamp examination.\\n\\uf0b7 Look for new bleeding, increased IOP, corneal blood staining, and other intraocular\\ninjuries as the blood clears (e.g., iridodialysis; subluxated, disclocated, orcataractous\\nlens). Hemolysis, which may appear as bright red fluid, should be distinguished from a\\nrebleed, which forms a new, bright red clot. If the IOP is increased, treat as described\\nearlier.\\n\\uf0b7 The patient should be instructed to return immediately if asudden increase in pain or\\ndecrease in vision is noted (which may be symptoms of a rebleed or secondary\\nglaucoma). If a significant rebleed or an intractable IOP increase occurs, the patient\\nshould be hospitalized.\\n\\uf0b7 After the initial close follow-up period, the patient may be maintained on a long-acting\\ncycloplegic (e.g., atropine 1% solution OD to BD, scopolamine 0.25% OD to BD),\\ndepending on the severity of the condition. Topical steroids may be tapered as the blood,\\nfibrin, and white blood cells resolve.\\n\\uf0b7 Glasses or eye shield during the day and eye shield at night. As with any patient,\\nprotective eyewear (polycarbonate or Trivex lenses) should be worn any time a\\nsignificant potential for an eye injury exists.\\n\\uf0b7 The patient must refrain from strenuous physical activities (including bearing down or\\nvalsalva maneuvers) for 1 week after the initial injury or rebleed. Normal activities may'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 90, 'page_label': '91'}, page_content='Emergency Conditions\\n75\\nbe resumed 1 week from the date of injury or rebleed. This period should be extended if\\nblood remains in the anterior chamber.\\n\\uf0b7 If patient was hospitalized, see 2 to 3 days after discharge. If not hospitalized, see several\\ndays to 1 week after initial daily follow-up period, depending on severity of condition\\n(amount of blood, potential for IOP increase, other ocular or orbital pathologic\\nprocesses).\\nDOG BITE (RABIES)\\nRabies can be transmitted by dog bite or following non-bite exposure to mucous membrane\\nor an open wound (one that has bled within 24 hours) with saliva. Bites from dogs in\\ndeveloping countries should always be considered high risk, and prophylaxis should be given\\nwithout waiting for test results.\\nSalient features\\nGuidelines for Determining Need for Rabies Prophylaxis (Adapted from Human rabies\\npreventionâ€”United States, 1999. Recommendations of the Advisory Committee on\\nImmunization Practices)\\nAnimal type & evaluation Post-exposure prophylaxis recommendations\\n\\uf0b7 Dogs, cats, and ferrets Do not start vaccination unless animal develops\\n(healthy and available for 10-days) clinical signs of rabies during observation\\nperiod*\\n\\uf0b7 Rabid or suspected rabid Immediately vaccinate.\\n\\uf0b7 Unknown (escaped) Consult public health officials.\\n* 10-days observation period, begin postexposure prophylaxis at the first sign of rabies. If the\\nanimal exhibits clinical signs of rabies, it should be euthanized immediately and tested.\\nTreatmentof dog bite andPost-exposure prophylaxis of rabies\\nThree steps: wound care, passive immunization, and active immunization.\\nImmediate measures\\n\\uf0b7 Early treatment is essential (less than 3 hours after the bite/injury occurred).\\n\\uf0b7 Prodromal symptoms- such as headache, malaise, sore throat and fever last about 3-4\\ndays. Pain and tingling at the bitten site.\\n\\uf0b7 Stage of excitation- patient is intolerant to noise, bright light or a cold draught.\\nAerophobia may be present. Hydrophobia is a characteristic symptom of rabies.\\nExamination shows increased reflexes, dilatation of pupils, increased sweating,\\nlacrimation and salivation. Mental changes include fear of death, anger, irritability and\\ndepression.\\n\\uf0b7 Convulsions may occur resulting in death, paralysis and coma. The total duration of\\nillness lasts for 2-3 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 91, 'page_label': '92'}, page_content='Emergency Conditions\\n76\\n\\uf0b7 Scrub the wound and its edges with soap and water.\\n\\uf0b7 If the wound is a puncture, swab deeply in the wound and around its edges.\\n\\uf0b7 Follow with application of a virucidal agent: 1% or 2% benzalkonium chlorideor\\npovidone-iodine andrinse.\\n\\uf0b7 Tetanus prophylaxis should be given as indicated by patientâ€™s current immunization\\nstatus.\\n\\uf0b7 Do not suture bite wounds immediately. If suturing is required, hold it for 24-48 hours,\\napplying minimum number of stitches under the cover of antirabies immunoglobulin\\nlocally.\\nNon immunized persons\\n\\uf0b7 Human rabies immuno globulin (HRIG)-full dose should be infiltrated around wound(s),\\nand the  remaining volume should be administered IM at an anatomic site distant from\\nvaccine administration. Do not administer vaccine in the same syringe as HRIG may\\npartially suppress active production of antibody.\\n\\uf0b7 Vaccine Huma n diploid cell vaccine (HDCV) injected IM (deltoid area), one each on\\ndays 0, 3, 7, 14, and 28.The vaccine should be administered in the deltoid rather than the\\ngluteal region, to avoid accidental injection into fat, which will prevent antibody\\nformation.\\n\\uf0b7 Rabies vaccine adsorbed (RVA) and purified chick embryo culture (PCEC) vaccine-\\nadministered for prophylaxisby the intramuscular route and should have antibody titers\\nchecked at 2 to 4 weeks.  It is associated with fewer hypersensitivity reactions in patients\\nreceiving boosters and prophylaxis during pregnancy does not increase in fetal wastage,\\ncongenital defects, should not be withheld when indicated.\\n\\uf0b7 Corticosteroids, antimalarials, and other immunosuppressives can interfere with the\\ndevelopment of active immunity and should be withheld during the course of treatment if\\npossible.\\n\\uf0b7 Patients with a history of hypersensitivity should nevertheless be cautiously given\\nimmunoprophylaxis in a controlled setting, with antihistamines and epinephrine available\\nPreviously immunized persons\\n\\uf0b7 HRIG should not be administered.\\n\\uf0b7 Vaccine HDCV or PCECV 1.0 ml, IM (deltoid area),on days 0 and 3.\\nReferences\\n1. Human rabies preventionâ€”United States, 1999. Recommendations of the Advisory Committee on\\nImmunization Practices (ACIP).\\n2. MMWR Morb Mortal Wkly Rep 48:1, 1999.\\n3. http://www.cdc.gov/rabies/exposure/types.html; 2008.\\n4. Centers for Disease Control and Prevention: Rabies post-exposure.\\n5. http://www.cdc.gov/rabies/exposure/postexposure.html; 2008.\\n6. Rosenâ€™s Textbook of Emergency Medicine, 7th edition'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 92, 'page_label': '93'}, page_content=\"Emergency Conditions\\n77\\nSNAKE BITE\\nIndia is estimated to have the highest snakebite mortality in the world, with WHO estimates\\nplacing the number of bites at 83,000 per annum with 11000 deaths. Most of the fatalities are\\ndue to the victim not reaching the hospital in time where definite treatment can be\\nadministered.\\nSnakes inIndia\\nThere are about 236 species of snakes in India, most of which are non-poisonous, however,\\nthere are 13 known species that are poisonous and four of these, namely Indian cobra,\\nRussell's viper, saw-scaled viper and Indian krait are highly venomous and are believed to be\\nresponsible for mostof the poisonous bites in India\\nSalient features\\nInvestigations\\n\\uf0b7 Identification of snake, local swelling within few minutes after bite is an important sig of\\nviper envenomization.\\n\\uf0b7 Blood stained sputum and non clotting of blood are diagnostic criteria for Russel viper\\nand Saw scaled viper poisoning.\\n\\uf0b7 Ptosis and glossopharyngeal palsy are diagnostic criteria for Cobra and Indian Krait\\npoisoning.\\n\\uf0b7 Investigations include\\n- 20 minute whole blood clotting test\\n- Hb/ plateletcount/peripheralsmear/PT/ APTT/ FDP/ D-Dimer\\n- Urine examination for proteinuria/RBC/ hemoglobinuria/ myoglobinuria\\n- Serum creatinine/urea/potassium\\n- Oxygen saturation/ PR/BP/ RR/posturalbloodpressure\\n- ECG/ X -Ray/ CT/ ultrasound (the use of X-Ray and ultrasoundare of unproven\\nbenefit,       apart from identification of bleeding in viperine bites).\\n- ELISA to confirm snake species\\nTreatment\\nFirst aid measures (RIGHT approach)\\nR : reassure patient and control anxiety\\nI: immobilize bitten part by splinting the limb\\n\\uf0b7 Viper envenomization (haemovasculotoxic): swelling and local pain, tender\\nenlargement of local lymph nodes, bleeding from any orifice,epistaxis, vomiting,\\nhypotension, petechiae, purpura, ecchymoses\\n\\uf0b7 Elapid envenomization (neurotoxic): swelling and local pain, local necrosis and\\nblistering, descending paralysis, ptosis, diplopia, ophthalmoplegia,paralysis of\\njaw and tongue, numbness around the lip and mouth, inadequate ventilation,\\nparadoxical respiration.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 93, 'page_label': '94'}, page_content='Emergency Conditions\\n78\\nG -H: get to hospital-transfer the victim to the nearest treatment facility\\nT : tell the doctor about any symptoms\\nDo Not: Apply tourniquet, wash the bite site with soap and any other solution, make cuts or\\nincision on or near bitten area, apply extreme cold or herbal and folk remedies, suck venom,\\ngive  the victim drink, alcohol or drugs\\n\\uf0b7 Ensure airway, breathing and shock management\\n\\uf0b7 Pain can be relieved with non sedating analgesic-oral paracetamol\\n\\uf0b7 Anti-snake venom (ASV) is the mainstay of treatment. In India polyvalent ASV is\\navailable which is effective against all the four common species.ASV should be\\nadministered only when there are definite signs of envenomation i.e. coagulopathy or\\nneurotoxicity\\n\\uf0b7 Mild and severe envenomation requires 8 to 10 vials.Each vial is 10ml of reconstituted\\nASV. Children should receive the same ASV dosage as adults.ASV should be\\nadministered over 1 hour at constant speed and patient should be closely monitored for 2\\nhours.\\n\\uf0b7 ASV reactions:Anaphylaxis may be life-threatening.if anaphylaxis is evident, ASV\\nshould be discontinued. Inj. hydrocortisone 100 mg + antihistamine or Inj. adrenaline\\nsubcutaneouslycan be administered for ASV reaction\\n\\uf0b7 Repeat dose of 5-10 vials of ASV i.e. half to one full dose, should continue 6 hourly till\\ncoagulation is restored unless a species is identified against which polyvalent ASV is\\nineffective.Only for snakes which inject massive amounts of venom, such as the King\\nCobra or Australian elapids, massive doses of 50+ vials are required.\\nFollow up\\nA snakebite victim discharged within 24 hrs should be advised to return if there is any\\nworsening of symptoms or signs such as bleeding, pain or swelling at the site of bite,\\ndifficulty in breathing, altered sensorium etc. Explain about the signs and symptoms of serum\\nsickness which may manifest after 5-10 days.\\nINSECT AND ARACHNID BITES\\nInsect arachnid (spider, scorpion) bites and stings are common and usually cause minor\\nirritation. However, some stings can be painful and trigger a serious allergic reaction.\\nSalientfeatures\\n\\uf0b7 Skin around the bite becomesred, swollen and itchy. The venom from a sting often\\ncauses a swollen, itchy, red mark (a weal) to form on the skin. This can be painful and\\nitchy for a few days, but is harmless in most cases.They can usually be treated at\\nhome.\\n\\uf0b7 The severity of bites andstings varies depending on the type of insect and sensitivity\\nof the person. In rare cases, some people can have a serious allergic reaction\\n(anaphylaxis) to a bite or sting that requires immediate medical treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 94, 'page_label': '95'}, page_content='Emergency Conditions\\n79\\nNon pharmacological treatment\\n\\uf0b7 Remove a sting-by scraping it out with fingernails. Be careful during removing the sting,\\nprevent further spread the venom into the skin and do not puncture venomous sac.\\n\\uf0b7 Minor bites and stings can be treated by washing theaffected areawith soap and water,\\nplacing a cold compress (a cloth cooled with cold water) over the affected area to reduce\\nswelling\\n\\uf0b7 Do not scratch thearea becauseit can become infected.\\n\\uf0b7 Wrap an ice pack  in a towel andplace it on the swelling\\nPharmacologicaltreatment\\nIf the bite or sting is painful or swollen\\n\\uf0b7 Tab.paracetamoloribuprofen(children under 16 years old should not be given aspirin)\\n\\uf0b7 Apply a spray or cream that contains local anesthetic,antihistamineormild\\nhydrocortisone (1%)on the affected area to prevent itching and swelling\\n\\uf0b7 Tab. cetrizine 10mg once a day and topical administration of calamine lotionto relieve\\npruritus\\n\\uf0b7 Systemic corticosteroids may be appropriate if there are severe side-effects.\\n\\uf0b7 Any person who collapses, or complains of wheezing, feeling of anxiety or faintness,\\ngeneralized itching, or tightness in the chest within 1 hour of being stung by an insect\\nshould be treated as having anaphylactic shock. Inj. adrenaline1 mg (as hydrogen\\ntartrate) 0.5-1.0 ml IM injection (1:1000 solution), repeat every 15-20 min if required. All\\npatients should be observed at least for 24 hours for recurrent anaphylaxis (see section on\\nanaphylactic shock).\\nSCORPIONS BITE\\n\\uf0b7 Simple analgesics, such as paracetamol and aspirin, can be given to relieve pain.\\nHowever, because of the potential for severe reactions, every effort should be made to get\\nthe patient to a hospital as soon as possible.\\n\\uf0b7 Vasodilators, administered in a hospital setting within 24 hours of the attack, may\\nattenuate the cardiovascular response and possibly reduce mortality.\\n\\uf0b7 In endemic area, species-specific antiscorpions sera may be available locally and this can\\nbe of value if administered within few hours.\\nReference\\n1. Drugs used in Skin Diseases. In: WHO Model Prescribing Information, 1997, WHO, Geneva.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 95, 'page_label': '96'}, page_content='80\\n\\uf0b7 Symptoms include fever, night sweats, weight loss, anorexia, cough, dyspnoea,\\narthralgia,chest pain.\\n\\uf0b7 Signs are murmur, splenomegaly, clubbing, embolic feature and signs of immune\\ncomplex deposition, like Janewaylesions,Roth spots, splinter hemorrhages\\nChapter 4\\nCARDIOVASCULAR DISEASES\\nINFECTIVE ENDOCARDITIS\\nIt is a microbial infection of endothelial surface of heart. Acute bacterial endocarditis is\\ncaused byS. aureus,group A hemolytic streptococci, pnuemococci or gonococci. Sub acute\\nbacterial endocarditis is caused by virulentS. Viridansor otherstreptococci.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Empirical therapy: Pending the availability of diagnostic data, blood cultureâ€“negative sub\\nacute native valveendocarditis is treated either with Inj. ampicillin-sulbactam  12 g every\\n24 h or with Inj. ceftriaxone 1 gmOD plus Inj. gentamicin 3 mg/kg QIDIV; Tab.\\ndoxycycline 100 mg twice dailyis added forBartonellacoverage.\\n\\uf0b7 After blood culture report organism specific antibiotic therapy are as underStreptococci:\\n- Penicillin sensitive: Inj. penicillin G  2â€“3 M U IV q4h or Inj. ceftriaxone  2 g IVQID\\nfor 2 weeksplusInj. gentamicin 3 mg/kg QID IV or IM, as a single doseor divided\\ninto equal doses TDS for 2 weeks.\\n- Penicillin resistant: Inj. ceftriaxone 2 g IV QID for 4 weeksplusInj. gentamicin 3\\nmg/kg QID  IV or IM, as a single dose or divided into equal doses TDS  for 2 weeks\\n\\uf0b7 Enterococci:  Inj. penicillin G 4â€“5 MU IV every 4 hoursplusInj. gentamicin 1 mg/kg IV\\nTDS, both for 4â€“6 weeks.\\n\\uf0b7 Staphylococci: Inj. nafcillin or oxacillin 2 g IV q4h for 4â€“6 weeks or Inj. cefazolin 2 g IV\\nTDS for 4â€“6 weeks. If methicillin resistant: Inj. vancomycin 15 mg/kg IV 12 hours for 4\\nto 6 weeks.\\n\\uf0b7 HACEK group : Inj. ceftriaxone 2 gOD  IV for 4 weeks\\n\\uf0b7 Prophylaxisfor infective endocarditis in patients with vulnerable heart valve.Dental\\nprocedures wherein there is manipulation of gingival tissue or peri-apical regions of the\\nteeth or perforation of the oral mucosa (including surgery on the respiratory track).\\nAntibiotic regimens for prophylaxis\\n\\uf0b7 Tab. amoxicillin 2 g 1 hour before procedure\\n\\uf0b7 Inability to take oral medication: Inj. ampicillin 2gm IV/IM 1 hour before procedure\\n\\uf0b7 Penicillin allergy:  Tab. clarithromycin or azithromycin 500 mg 1 hour before procedure\\nor Tab. cephalexin 2 gm, 1 hour before procedure or Tab. clindamycin 600 mg 1 hour\\nbefore procedure'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 96, 'page_label': '97'}, page_content='Cardiovascular Diseases\\n81\\n\\uf0b7 May be caused by viruses, bacteria, mycobacteria, connective tissue disorders, uremia,\\nmalignancy, radiation or trauma.\\n\\uf0b7 Pleuritic chest pain which relieves on bending forward breathlessness, tachycardia\\n\\uf0b7 Fever, pleural rub, elevated ESR, irregular pulse, symmetric enlargement of cardiac\\nsilhouette\\n\\uf0b7 Fever, chest pain, basal rales, pedal edema, cardiomegaly, syncope, ventricular\\nectopy,\\n\\uf0b7 LVH, raised Jugular Venous Pressure(JVP ), diffuse dyskinetic apex beat, S3,\\nhepatomegaly, peripheral edema, murmurs of mitral and tricuspid regurgitation\\n\\uf0b7 Penicillin allergy, inability to tolerate oral medication:Inj. cefazolin or ceftriaxone 1 gm\\nIV/IM,30 min before procedure or clindamycin 600 mg IV/IM, 1 hour beforeprocedure.\\nACUTE PERICARDITIS\\nInflammation of pericardium is called as pericarditis.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Tab. aspirin 650 mg orally every 3-4 hours or other NSAIDs likeTab. indomethacin 100-\\n150 mg orally daily in divided dosesare usually effective.\\n\\uf0b7 Tuberculosis pericarditis: Anti tuberculosis  treatment\\n\\uf0b7 Uremic pericarditis: dialysis\\n\\uf0b7 Usually with antibiotics patients have to be carefully observed as they may develop\\npericardial effusion. If cardiac tamponade develops, pericardiocentesis must be carried\\nout at once.\\nCARDIOMYOPATHY\\nThe cardiomyopathies are a group of diseases that affect the heart mused itself and are not the\\nresult of hypertension, congenital or acquired valvular, coronary or pericardial abnormalities.\\nSalientfeatures\\nNon pharmacological treatment\\n\\uf0b7 Salt restriction, alcohol discontinuation\\nPharmacological treatment\\nStandard therapy for heart failure with following drugs:\\n\\uf0b7 Diuretics-hydrochlorothiazide 6.25â€“50 mg  orchlorthalidone 25â€“50 mg,loop diuretics-\\nfurosemide 40â€“80 mg, aldosterone antagonists-spironolactone 25â€“100 mg\\n\\uf0b7 Beta blockers:atenolol 25â€“100 mg, metoprolol 25â€“100 mg,  propranolol 40â€“160 mg\\n\\uf0b7 ACE inhibitors:captopril 25â€“200 mg,lisinopril 10â€“40 mg,ramipril 2.5â€“20 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 97, 'page_label': '98'}, page_content=\"Cardiovascular Diseases\\n82\\n\\uf0b7 Nonspecific symptoms are fatigue, headache, epistaxis.\\n\\uf0b7 Uncontrolled hypertension can lead to target organ damage (TOD) such as coronary\\nartery disease (CAD), left ventricular hypertrophy (LVH), cerebrovascular accidents\\n(CVA), transient ischemicattacks (TIA), retinopathy, peripheral vascular diseases\\nincluding dissecting aneurysm, renal disease.\\n\\uf0b7 Associated risk factors are- age >55 years in males and>65 years in females, smoking,\\ndiabetesmellitus, microalburninuria or GFR <60 ml/hr, hyperlipidemia, family history,\\nobesity, sedentary life-style and ethnic group.\\n\\uf0b7 Angiotensin II antagonists:losartan 25â€“100 mg, valsartan 80â€“320 mg, candesartan 2â€“32\\nmg\\n\\uf0b7 Calcium antagonists:nifedipine (long-acting) 30â€“60 mg, verapamil (long-acting)120â€“\\n360 mg, diltiazem (long-acting) 180-420 mg\\nHypertrophic cardiomyopathy\\n\\uf0b7 Î² blockers is the first line of drug.\\n\\uf0b7 Calcium channel blockers, especially verapamil, have also been effective in symptomatic\\npatients. Diuretics for heart failure\\n\\uf0b7 Dual chamber pacing for refractory cases\\n\\uf0b7 Nonsurgical septal ablation with alcohol injectionin septal branches.\\nDrugs to be avoided\\n\\uf0b7 Calcium channel blockers and NSAIDs â€“ in dilated cardiomyopathy\\n\\uf0b7 Digitalis, Nitrates, Vasodilators, B-agonists- avoided in Hypertrophic obstructive\\ncardiomyopathy (HOCM)\\nHYPERTENSION\\nUsually asymptomatic and discovered on routine measurement of blood pressure. Secondary\\nhypertension (HT) presents as a part of a symptom complex as in acromegaly, Cushing's\\ndisease, renovascular or renal parenchymal disease, connective tissue disorders (SLE,\\nscleroderma, etc.), or coarctation of aorta.\\nSalient features\\nInvestigations\\nRoutine laboratory tests recommended before initiating therapy include,\\n\\uf0b7 Electrocardiogram\\n\\uf0b7 Urinalysis;\\n\\uf0b7 Blood glucose and hematocrit; serum potassium, creatinine (or the corresponding\\nestimated GFR, and calcium;\\n\\uf0b7 Lipid profile (after a 9-12 hour fast) that includes high-density lipoprotein, cholesterol,\\nlow-density lipoprotein cholesterol, and triglycerides.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 98, 'page_label': '99'}, page_content='Cardiovascular Diseases\\n83\\n\\uf0b7 Optional tests include measurement of urinary albumin excretion or albumin/creatinine\\nratio. More extensive testing for identifiable causes is not indicated generally unless BP\\ncontrol is not achieved.\\nPrecautions to be taken while measuring BP\\n\\uf0b7 The auscultatory method of BP measurement with a properly calibrated and validated\\ninstrument should be used. BPshould be measured using an appropriate size cuff in both\\nupper limbs and at least one lower limb in both supine and erect posture.\\n\\uf0b7 Patient should have been resting for at least 5 minutes and should not have consumed\\ncoffee, smoked during the last 30 minutes before measuring the blood pressure. At least 2\\nmeasurements should be made. Systolic BP is the point at which the first of 2 or more\\nsounds are heard (phase 1) and diastolic BP is the point before the disappearance of\\nsounds (phase 5).\\nNon pharmacologicaltreatment\\n\\uf0b7 Reduce dietary sodium intake to no more than 100 mmol per day (2.4 g sodium or 6 g\\nsodium chloride).\\n\\uf0b7 Adopt DASH eating plan- diet rich in fruits, vegetables, with low fat dairy products\\nwith a reduced content of saturated and total fat.\\n\\uf0b7 Life-style modification- exercise consisting of vigorous aerobic exercise like brisk\\nwalking, swimming or jogging at least 20 to 30 minutes on most days of the weekwith\\nthe heart rate reaching 65-70% of maximal heart rate.\\n\\uf0b7 Weight control using a combination of dietary and exercise measures to maintainnormal\\nbody weight (body mass index 18.5-24.9 kg nr).\\n\\uf0b7 Moderation of alcohol consumption- limit alcohol to no more than 2 drinks (1 oz or30\\nml ethanol; e.g., 24 oz beer, 10 oz wine, or 3 oz 80-proof whiskey) per day in most men\\nand to no more than 1 drink per day in women and lighter weight persons.\\n\\uf0b7 Cessation of smoking.\\n\\uf0b7 Yoga\\nPharmacological treatment\\n\\uf0b7 Preâ€“ hypertension:behavioral modification follow up\\nStage 1: thiazide diuretics OR calcium channel blockers   or beta blockers or ACEI\\nStage 2: Combination therapy(dosages to be adjusted according to blood pressure\\nresponse)\\n\\uf0b7 Diuretics preferred in obese, elderly, CCF\\n\\uf0b7 Beta blockers in young, coronary artery disease(CAD), vascular headache, atrial\\nfibrillation\\n\\uf0b7 Calcium channel blockers in  elderly, CAD, ACEI in  diabetic, LVF, young\\n\\uf0b7 Alpha blockers:prostatitism, dyslipidemia\\n\\uf0b7 Alpha methyl dopa-pregnancy'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 99, 'page_label': '100'}, page_content='Cardiovascular Diseases\\n84\\nDose of commonly usesantihypertensive drugs\\n\\uf0b7 Tab. hydrochlorothiazide 12.5-25 mg OD or BD\\n\\uf0b7 Tab. frusemide 20-40 mg twice day\\n\\uf0b7 Tab. frusemide 20 + spironolactone  50 mg 1-2 times day\\n\\uf0b7 Tab. indapamide 2-5 mg daily\\n\\uf0b7 Tab. atenolol 25-100 mg daily or Tab. metoprolol 25-150 mg BD\\n\\uf0b7 Tab. amlodipine 2.5-20 mg OD or Cap. nifedipine 20-80 mg as sustained release daily\\n\\uf0b7 Tab. enalapril 2.5 mg OD or Tab.  lisinopril 2.5 mg OD or Tab. ramipril1.25-10 mg OD\\n\\uf0b7 Tab. losartan 25-50 mg OD or BD\\n\\uf0b7 Tab. prazosin 1-20 g OD at bed time\\n\\uf0b7 Tab. clonidine 0.05-0.6 mg  BD or Tab. methyldopa 250-1000 mg OD\\nAccelerated hypertension\\nPatients presenting with BP 200/140 mmHg or more without papilledema\\n\\uf0b7 Inj. enalapril 1.25-5 mg IV 6 hourly Or Inj. nitroprusside 0.25-1.0 mcg/Kg/min IV\\ninfusion (dose to be titrated with BP, maximum dose for 10 meg only) Or\\n\\uf0b7 Inj. nitroglycerine 5-100mcg/min infusion Or\\n\\uf0b7 Inj. hydralazine 10-20 mg IV or IM, if no response at 20 mg change the drug Or\\n\\uf0b7 Inj. labetalol 20-80 mg IV every 5-10 min up to a total of 300 mg, infusion 0.5-2 mg/min,\\noral 100-600 mg 2 times a day. Or\\n\\uf0b7 Inj. phentolamine 5-15 mg IV (especially useful in pheochromocytoma)\\nMalignant hypertension\\n\\uf0b7 Patients presenting with BP 200/140 mm Hg and evidence of vascular damage like\\npapilledema, deranged renal function, should be referred to a tertiary care centre.\\nResistant hypertension\\n\\uf0b7 Resistant hypertension is the failure to reach goal BP in patients who are adhering to full\\ndoses of an appropriate 3-drug regimen that includes a diuretic. Refer these patients to\\nhypertension specialist.\\nFollow up\\n\\uf0b7 Regular BP monitoring to ensure optimal or normal BP in young or middleaged or\\ndiabetic subjects (130/80 mm Hg) and at least high normal BP in elderly patients (140/90\\nmm Hg).\\n\\uf0b7 Monitor all risk factors for coronary artery disease.\\n\\uf0b7 Ensure compliance with life-style modification.\\n\\uf0b7 Assess for complications and target organ damage.\\n\\uf0b7 In accelerated or malignant HT, avoid sudden fall in diastolic BP to below 100 mm Hg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 100, 'page_label': '101'}, page_content='Cardiovascular Diseases\\n85\\n\\uf0b7 Precordial chest pain due to stress or exertions, palpitation, breathlessnesssymptoms\\nare typically associated with exertion and emotional upset and are relieved quickly by\\nrest and/or sublingual nitratesECG shows  ST depression, T wave inversion, LVH.\\nHypertension in children and adolescents\\n\\uf0b7 In children and adolescents, hypertension is defined as BP that is, on repeated\\nmeasurement, at the 95th percentile or greater adjusted for age, height, and gender. The\\nfifth Korotkoff sound is used to define diastolic BP.\\n\\uf0b7 Be alert for possibility of identifiable causes of hypertension in younger children (i.e.,\\nkidney disease, coarctation of aorta).\\n\\uf0b7 Life style interventions are strongly recommended, with pharmacological therapy\\ninstituted for a higher levels of BP or if there is insufficient response to lifestyle\\nmodification.\\n\\uf0b7 Choices of antihypertensive drugs are similar in children and adults, but effective doses\\nfor children are often smaller and should be adjusted carefully.\\nPatient education\\n\\uf0b7 Explain consequences of uncontrolled HT and the need for the long-term control with\\nmedication.\\n\\uf0b7 Advice regarding control of other risk factors likes diabetes, hyperlipidemia, etc.\\n\\uf0b7 Diuretics should be taken in the morning and if two doses a day are required second dose\\nshould be given before 4 PM.\\n\\uf0b7 Manage target organ damage- referral to a higher centre for CAD (PTCA/ CABG),\\nnephropathy (prepare for dialysis or transplant), carotiddoppler to determine presence of\\natheroma and possibility of end arterectomy\\nANGINA PECTORIS\\nIt is clinically syndrome due to myocardial ischemia, caused by critical obstruction in\\ncoronary arteries due to atherosclerosis, calcific arotic stenosis, or due to spasm or emboli.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Avoid heavy exertion, take rest during acute stage,stop smoking, weight reduction.\\nPharmacological treatment\\n\\uf0b7 Tab. isosorbide dinitrate5 mg sublingual during the attack, dose repeated as required or\\nTab nitroglycerine 0.3-0.6 mg sublingual\\n\\uf0b7 If attackoccurs twice in week, chronic prophylaxis is recommendedwith Tab. metoprolol\\n50 mg BD or Tab.  atenolol 50 mg OD\\n\\uf0b7 If beta blockers are contraindicated or angina persists-Tab. diltiazem -60-120 mg/day\\n\\uf0b7 Tab. aspirin 100-150 mg/ day or Tab. clopidogrel 75 mg/day'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 101, 'page_label': '102'}, page_content='Cardiovascular Diseases\\n86\\n\\uf0b7 Chest pain, breathlessness, perspiration, syncope, tachy or bardycardia, hypo or\\nhypertension, sudden cardiac arrest, ECG changes showing ischemia or infarction, raised\\ncardiac markers\\nMYOCARIDAL INFRACTION\\nMyocardial Infarction (MI) is due to the formation of occlusive thrombus at the site of\\nrupture of an atheromatous plaque in a coronary artery.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Hospitalization and compete immobilization\\n\\uf0b7 Oxygen â€“ 4-6 liters / min\\n\\uf0b7 Oral  uncoated chewable Tab. aspirinâ€“ 325 mg\\n\\uf0b7 Tab.  isosorbide dinitrateâ€“ 5 mg up to 3 times sublingually\\n\\uf0b7 Tab. atorvastatinâ€“ 80 mg\\n\\uf0b7 Tab. clopidogrelâ€“ 300 mg\\n\\uf0b7 Inj. morphine sulphate 10 mg or Inj. diamorphine 5 mg IV\\n\\uf0b7 Consider thrombolysis with intravenous streptokinase or alteplase. Thrombolysis to be\\ndone within 30 minsoftime of admission.\\n\\uf0b7 Inj. streptokinase1.5 million units in 100 ml of saline as an intravenous infusion over 1\\nhour.The drug may cause hypotension, which can be managed with fluids and restricting\\nthe infusion at a slower rate. Or\\n\\uf0b7 Inj. alteplase- rTPA (Recombinant tissue plasminogen activator):  The regimen is given\\nover 90 minutes (bolus dose of 15 mg followed by 0.75 mg/kg of body weight and then\\n0.5 mg/kg body weight over 60 minutes)\\n\\uf0b7 Inj. metoprolol 5 mg IV every 2-5 minutes for 3 doses and changed to Tab. metoprolol 50\\nmg  every 6 hours for 48 hours, followed by 100 mg every 12 hours.\\n\\uf0b7 Inj. Nitroglycerine IV  0.6â€“ 1.2 mg/hour\\n\\uf0b7 Inj. heparin 200 units/Kg  SC twice daily for 5 days is given in addition to oral aspirin\\nmay prevent reinfarction after successful thrombolysis and reduce the risk of\\nthromboembolic complications.\\n\\uf0b7 Moni tor ECG, blood pressure and cardiac enzymes\\nC ontraindications to thrombolytic therapy\\n\\uf0b7 Absolute contraindications are active internal bleeding, previous sub-arachnoid or intra-\\ncerebral hemorrhage, non hemorrhagic stroke within the last 1 year, uncontrolled\\nhypertension (systolic > 180mm Hg, diastolic > 110mmHg)\\n\\uf0b7 Relative contra-indications are current use of anti-coagulants, recent (< 2 weeks) invasive\\nsurgical procedure, recent prolonged (> 10 min) cardiopulmonary resuscitation, known\\nbleeding diathesis, pregnancy, hemorrhage prone ophthalmic conditions, active peptic ulcer'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 102, 'page_label': '103'}, page_content='Cardiovascular Diseases\\n87\\n\\uf0b7 Cough expectoration, breathlessness, pedaledema, hypo or hyper tension, easy fatigability.\\n\\uf0b7 Raised jugular venous pressure, positive abdominojugular reflex, basal rales, pulmonary\\nedema, orthopnea, paroxysmal nocturnal dyspnea (PND). S3, hepatomegaly, ascites, sinus\\ntachycardia.Chest X ray shows cardiomegaly, pulmonary congestion.\\ndisease, recent history of severe hypertension.Notes: Streptokinase should not be used, if\\ngiven in the preceding 5 days to 2 years because of the risk of allergic reactions.\\nCONGESTIVE HEART FAILURE (CHF)\\nCHF is critical syndrome of inadequate cardiac output resulting in fluid retention in the\\nlungs, abdominal organs and peripheral tissue.\\nSalient features\\nPatients of heart failure are divided in 4 categories for management(Figure 1).\\nFor category Aâ€“ No further treatment needed\\nFor category Bâ€“ Diuretics and vasodilators\\nFor category Câ€“ Ionotropic agents\\nFor category Lâ€“ Fluid challenge can be given\\nFigure 1. Categories of heart failurefor ease of management\\nNon pharmacological treatment\\n\\uf0b7 Restrict physical activity, bed rest in propped up position with a back rest. Dietary salt\\n(sodium) restriction(2â€“ 3 g/day).\\n\\uf0b7 Avoid and discontinue NSAIDs, high dose Beta blockers and calcium channel blocker.\\nFluid restriction depending on output and other conditions.\\nPharmacologicaltreatment\\n\\uf0b7 Treatment consists of judicious mix of vasodilators, diuretics and inotropic support\\n\\uf0b7 Inj.furosemide 40â€“ 80 mg IV stat every 2 to 3 hours with maximum up to 200 mg/day.\\nMaintenance dose is 40 mg IV 12 hourly.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 103, 'page_label': '104'}, page_content='Cardiovascular Diseases\\n88\\n\\uf0b7 Palpitation, breathlessness, syncope, chest pain, â€œgabharamanâ€, visual disturbances.\\ntachy or bradycardia, hypo or hypertension. ECG changes according to type of\\narrhythmia\\n\\uf0b7 Tab. spironolactone 25â€“ 200 mg/day or Tab. chlorthiazide 250â€“ 500 mg/day or Tab.\\nindapamide 2.5â€“ 5 mg/day orTab. benzthiazide 25 mg plus Tab. triamterene 50 mg/day.\\n\\uf0b7 Tab. enalapril 2.5-20 mg/day or Tab. lisinopril 2.5â€“ 10 mg/day\\n\\uf0b7 Tab. isosorbidemononitrate 60 mg/day as slow releasepreparation at night\\n\\uf0b7 Digoxin is indicatedin fast ventricular rate (e.g. atrialfibrillation) and LVEF < 30 %.\\nTab. digoxin 0.5 mg first day followed  by 0.25 mg/day 5 days/week\\n\\uf0b7 Tab. carvedilol 3.15â€“ 25 mg per day in one or two divided doses is useful in all\\nsymptomatic or asymptomatic heart failure and in case of reduced ejection fraction (40%)\\n\\uf0b7 Inj. heparin 5000 IU 12 hourly SC if patients is bedridden\\nMonitoring of CHF patient\\n\\uf0b7 Strict intakeâ€“ output charting\\n\\uf0b7 Daily weight and abdominal girth measurement\\n\\uf0b7 Serum electrolytes and uric acid\\nARRHYTHMIAS\\nArrhythmias are divided into supraventricular tachycardia, ventricular tachycardia,\\nbradyarrhythmias\\nSalient features\\nSUPRAVENTRICULAR TACHYCARDIA\\nPharmacological treatment\\n\\uf0b7 Depends on the hemodynamic status of the patient.\\n\\uf0b7 If he is haemodynamically stable:\\n- Treatment of acute episode includes vagal maneuvers (carotid sinus massage,valsalva\\nmaneuver)\\n- If the measure fails, AV nodal blocking drugs are tried.Inj. adenosine 6 mg IV bolus\\nfollowed by 10 ml saline flush is given.12 mg IV bolus can be repeated if no\\nresponse after 2 minutes.Contraindicationsincludesick sinus syndrome or second or\\nthird degree AVblock.\\n- Inj.metoprolol 5m g IV can be repeated after 5 minutes or\\n- Inj. verapamil 5-10 mg IV bolus over 2-3 min. can be repeated after 15 minsor Inj.\\ndiltiazem 0.25 mg/kg IV bolus over 2 min. followed by IV infusion at a rate of\\n10mg/hour.\\n- If haemodynamically unstable, prompt synchronized direct current (DC).\\nCardioversion (using 10 to 100 joules) has to be done.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 104, 'page_label': '105'}, page_content='Cardiovascular Diseases\\n89\\nMaintenance therapy\\nOnce sinus rhythm is established, chronic maintenance therapy includes,\\n\\uf0b7 Tab.  diltiazem 30 mg TDS or Tab. verapamil-40 mg TDS OR\\n\\uf0b7 Tab. metoprolol 25-100 mg BD or Tab.  atenolol 25-100 BD OR\\n\\uf0b7 Tab. digoxin 0.125-0.5 mg OD\\nCurative therapy\\nFor supraventricular tachycardia involving accessary pathway is radio-frequency ablation.\\nVENTRICULAR TACHYCARDIA\\nRuns of three or more consecutive idioventricular beats exceeding a rate of 100 beats per\\nminute.\\nTypes:\\n\\uf0b7 Sustainedâ€“ If ventricular tachycardia(VT) persists for > 30 seconds.\\n\\uf0b7 Non -sustainedâ€“ 3 beats to 30 seconds.\\n\\uf0b7 Monomorphic -Configurations uniform\\n\\uf0b7 Polymorphicâ€“ Configuration varies from beat to beat\\nPharmacological treatment\\n1. Patients with nonsustained arrhythmias, without organic cardiac disease are\\nasymptomatic-need not be treated.\\n2. Patients with sustained VT in the absence of cardiac disease are symptomatic and require\\ntherapy with  Tab. amiodarone 200-400 mg /day TDS\\n3. In patients with VT with organic cardiac disease, if haemodynamic instability,\\nunsynchronized the arrhythmia.\\n4. If haemodynamically stable, the following drugs can be administered:\\n5. Inj. lidocaineâ€“ 1 mg/kg IV bolus,0.5-1 mg/kg boluses may be repeated at 5 min intervals\\nfollowedby 2-4 mg/min maintenance Infusion.\\n\\uf0b7 Inj. amiodarone may be tried.\\n\\uf0b7 If   these drugs fail, over drive padding has to be done.\\n\\uf0b7 To prevent recurrences, sustained VT-ICD implantation is effective.\\nATRIAL FIBRILLATION\\nCommon arrhythmia, a variant of supraventricular tachycardia.\\nSalient features\\nPharmacological treatment\\nAcute atrial fibrillation\\n\\uf0b7 Palpitation, breathlessness, gabharaman, giddiness. Tachycardia, irregularly\\nirregular pulse, hypotension is commoner than hypertension'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 105, 'page_label': '106'}, page_content='Cardiovascular Diseases\\n90\\n\\uf0b7 Treat the precipitating factors like thyrotoxicosis\\n\\uf0b7 If the patient is haemodynamically unstable, electrical cardio version using 200 joules is\\nthe treatment of choice.\\n\\uf0b7 If  haemodynamically stable, ventricular rate control is adequate by Tab. metaprolol 25-\\n100 mg BD\\n\\uf0b7 Tab. warfarin 5 mg OD and dose adjust as per INR\\nSurgical treatment\\n\\uf0b7 Ablation around pulmonary veins.\\nBRADYARRHYTHMIAS\\nSinus bradycardiaâ€“ regular heart rate < 60/min.\\nTypes: sinoatrial blockand atrioventricular block\\nPharmacological treatment\\n\\uf0b7 Inj.atropine 0.6 mg IV repeated 4-6 hourly orInj. isoproterenol 2-10 mcg/min infusion\\nSurgical treatment\\n\\uf0b7 Temporary pacemaker\\n\\uf0b7 If needed permanent pacemaker insertion.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 106, 'page_label': '107'}, page_content='91\\n\\uf0b7 Repeated attacks of headache lasting 4â€“72 h in patients with a normal physical\\nexamination, no other reasonable causefor the headache, and at least 2 of the\\nfollowing features\\n\\uf0b7 Unilateral pain, throbbing pain aggravated by movement, moderate or severe intensity\\nalong withone of the following features:\\n\\uf0b7 Nausea/vomiting and orphotophobia and phonophobia\\nChapter 5\\nCENTRAL NERVOUS SYSTEM DISEASES\\nMIGRAINE\\nMost often begins at puberty and most affects those aged between 35 and 45 years.\\nSalient features\\nN on pharmacological treatment\\n\\uf0b7 Avoidance of factors that triggers a migraine attack and suitable life-style modification.\\nPharmacological treatment\\n\\uf0b7 The combination of acetaminophen, aspirin, and caffeine has been use for the treatment of\\nmild to moderatemigraine.\\n\\uf0b7 If NSAIDs/analgesicsfail, Tab. sumatriptan 50 mg or 100 mg PO or Tab. zolmitriptan 2.5\\nmg PO can be used.\\n\\uf0b7 If  early nausea or difficulties taking tablets,zolmitriptan 5 mg nasal spray or  sumatriptan 20\\nmg nasal spray is used.\\n\\uf0b7 Parenteral administration of drugs such as dihydroergotamine and sumatriptan is used for the\\nrapid relief of a migraine attack.\\n\\uf0b7 Patients with an increasing frequency of migraine attacks, or with attacks that are either\\nunresponsive or poorly responsive to abortive treatments, are good candidates for preventive\\nagents. In general, a preventive medication should be considered in the subset of patients\\nwith five or more attacks a month. The drugs that have been used for the prophylactic\\ntreatment of migraine include\\n- Tab. propranolol  40â€“120 mg BD or Tab. sodium valproate: 400â€“600 mg BD\\n- Tab. topiramate :25â€“200 mg/d OD\\nPatient education\\n\\uf0b7 Identify the triggers for the migraine attack (lack of sleep, chocolates, wine etc) and avoid\\nthem.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 107, 'page_label': '108'}, page_content='Central Nervous System Diseases\\n92\\n\\uf0b7 Episodic TTH attacks usually last a few hours, but can persist for several days.\\n\\uf0b7 This headache is described as pressure or tightness, like a band around the head,\\nsometimes spreading into or from the neck.\\n\\uf0b7 CH is relatively uncommon, more common in males.Most people developing CH are\\nin their 20s or older.\\n\\uf0b7 It is characterized by frequent recurring, brief but extremely severe headache\\nassociated with pain around the eye with tearing and redness, the nose runs or is\\nblocked on the affected side and the eyelid may drop.\\nTENSION -TYPE HEADACHE (TTH)\\nTTH often begins during the teenage years.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 The pain of TTH can gen erally be managed with simple analgesics such as\\nacetaminophen, aspirin, or NSAIDs.\\n\\uf0b7 Behavioral approaches including relaxation can also be effective.\\n\\uf0b7 For chronic TTH, Tab. amitriptyline 10â€“75 mg at night time is the only proven treatment\\nCLUSTER HEADAC HE (CH)\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Cluster headache attacks peak rapidly, and thus a treatment with quick onset is\\nrequired.  Many patients with acute cluster headache respond very well to oxygen\\ninhalation. This should be given as 100% oxygen at 10â€“12 L/min for 15â€“20 min.\\n\\uf0b7 Inj.sumatriptan 6 mg SC is rapid in onset and will usually shorten an attack to 10â€“15\\nmin. Sumatriptan (20 mg) and zolmitriptan (5 mg) nasal sprays are both effective in\\nacute cluster headache.\\nPreventive treatments of cluster headache\\nShort-Term prevention Long -term prevention\\n\\uf0b7 Episodic Cluster Headache \\uf0b7 Episodic Cluster Headache  and  Prolonged\\nChronic Cluster Headache\\n\\uf0b7 Prednisone 1 mg/kg up to 60 mg daily,\\ntapering over 21 days\\n\\uf0b7 Methysergide 3â€“12 mg/d\\n\\uf0b7 Verapamil 160â€“960 mg/d\\n\\uf0b7 Methysergide 3-12mg.d\\n\\uf0b7 Verapamil 160â€“960 mg/d\\n\\uf0b7 Greater occipital nerve injection'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 108, 'page_label': '109'}, page_content='Central Nervous System Diseases\\n93\\n\\uf0b7 Symptoms include weakness, numbness, paresthesia, dysphasia, dysarthria, dysphagia,\\ndyspraxia, hemianopia, falls, change in personality, ataxia, reduced sensationsand\\nimpaired sensorium.\\nSTROKE\\nStroke is the abrupt onset of neurologic deficit that is attributable to a focal vascular cause.\\nTIA (Transient Ischemic Attacks)requires that all neurologic signs and symptoms resolve\\nwithin 24 hours regardless of whether there is imaging evidence of new permanent brain\\ninjury. However, a newly proposed definition classifies those with new brain infarction as\\nischemicstrokes regardless of whether symptoms persist.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Rapid evaluation is necessary for the use of time sensitive treatments such as\\nthrombolysis. Close attention is paid to the ABCâ€™s i.e. Airway, Breathing and Circula tion\\nof the patient and treat hypoglycemia or hyperglycemia if identified. Once the diagnosis\\nof stroke is made, a brain imaging study is necessary to determine if the cause of stroke is\\nischemia or hemorrhage. CT is useful in identifying early hemorrhagewhile MRI is\\nuseful in identifying early infarct.\\n\\uf0b7 Blood pressure should be lowered if there is malignant hypertension or concomitant\\nmyocardial ischemia or if blood pressure is >185/110 mm Hg and thrombolytic therapy is\\nanticipated (See section of hypertension)\\n\\uf0b7 Fever is treated with antipyretics and surface cooling.\\n\\uf0b7 Euglycemia is to be maintained.\\n\\uf0b7 Between 5 and 10% of patients develop enough cerebral edema to cause herniation. Other\\nanti-edema measures such as head elevation, Tab. furosemide 40 mg OD and\\nhyperventilation are useful.\\n\\uf0b7 Common complications of bedridden patientsâ€”infections (pneumonia, urinary, and skin)\\nand deep venous thrombosis (DVT) with pulmonary embolism are to be prevented.\\n\\uf0b7 Intravenous thrombolysis(Table 1):\\n\\uf0b7 Tab. aspirin 75 mg OD\\n\\uf0b7 Inj.heparin 5000 IU SC\\n\\uf0b7 Proper rehabilitation of the stroke patient includes early physical, occupational, and\\nspeech therapy.\\nSecondary prevention of stroke and TIA\\n\\uf0b7 Control of risk factors such as hypertension, diabetes, dyslipidemia, smoking cessation.\\n\\uf0b7 Tab.aspirin 75-325 mg/day is recommended for stroke prevention.\\n\\uf0b7 Tab. warfarin is useful for stroke prevention with a target INR of 2-3 in patients with\\nchronic nonvalvular AF as well as untreated rheumatic heart disease with AF.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 109, 'page_label': '110'}, page_content='Central Nervous System Diseases\\n94\\nTreatment of haemorrhagic stroke\\n\\uf0b7 Inj. mannitol 20% 1g/kg stat followed by 0.5 g/kgIV infusion, Inj. furosemide 40 mg IV\\nstat, elevation of head end and hyperventilation are useful.\\n\\uf0b7 Antihypertensiveagents are instituted if BP is more than180mmHg systolic or\\n>130mmHg diastolic. Goalis to keep a mean arterial pressure of less than130mmHg.\\n\\uf0b7 With thrombocytopenia (platelet countless than50,000/Âµl), transfusion of fresh platelets\\nis indicated.\\n\\uf0b7 Patients with cerebellar hemorrhages or with depressed mental status and radiographic\\nevidence of hydrocephalus should undergo urgent neurosurgical evaluation.\\n\\uf0b7 Thrombolytic agents are the mainstay (Table 1).\\nTable 1. Indications, contraindications and dosage schedule of thrombolytic agents in\\nstroke\\nIndications Contraindications\\n\\uf0b7 Clinical diagnosis of stroke\\n\\uf0b7 Onset of symptom to drug\\nadministration <3 hours\\n\\uf0b7 CT scan showing no haemorrhage\\nor edema of >1/3 rd of middle\\ncerebral artery (MCA) territory\\n\\uf0b7 Age >18 years\\n\\uf0b7 Consent of patient\\n\\uf0b7 Sustained BP >185/110 mm Hg despite\\ntreatment\\n\\uf0b7 Platelets <100,000; HCT <25%; glucose\\n<50 or >400 mg/dl\\n\\uf0b7 Use of heparin within 48 h and prolonged\\nPTT, or elevated INR\\n\\uf0b7 Rapidly improving symptoms\\n\\uf0b7 Prior stroke or head injury within 3\\nmonths; prior intracranial hemorrhage\\n\\uf0b7 Major surgery in preceding 14 days\\n\\uf0b7 Minor stroke symptoms\\n\\uf0b7 G Ibleeding in preceding 21 days\\n\\uf0b7 Recent myocardial infarction\\n\\uf0b7 Coma or stupor\\nAdministration\\n\\uf0b7 Administer rtPA (recombinant tissue plasminogen activator like alteplase or\\ntenecteplase) 0.9 mg/kg IV (maximum 90 mg) IV as 10% of total dose by bolus,\\nfollowed byremainder of total dose over 1 h\\n\\uf0b7 Frequent cuff blood pressure monitoring\\n\\uf0b7 No other antithrombotic treatment for 24 h\\n\\uf0b7 For decline in neurologic status or uncontrolled blood pressure, stop infusion, give\\ncryoprecipitate, and reimage brain emergently\\n\\uf0b7 Avoid urethral catheterization for 2 h'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 110, 'page_label': '111'}, page_content=\"Central Nervous System Diseases\\n95\\n\\uf0b7 Presence of Bellâ€™s phenomenon, affection of upper as well as lower part of face, involvement\\nof taste and lacrimation,\\n\\uf0b7 A bsence of emotional facial movements and absence of other neurological findings favour a\\ndiagnosis of peripheral or LMN facial palsy, the commonest cause being Bellâ€™s palsy.\\n\\uf0b7 Cardinal features include bradykinesia, rest tremor, rigidity, gait disturbance and\\npostural instability.Other motor features include micrographia, masked facies, reduced\\neye blink, soft voice (hypophonia) and dysphagia.\\n\\uf0b7 N on motor features include anosmia, sensory disturbances (e.g., pain), mood disorders\\n(e.g., depression), sleep disturbances, autonomic disturbances, orthostatic hypotension,\\ngastrointestinal disturbances, genitourinal disturbances, sexual dysfunctionand\\ncognitive impairment/dem entia.\\nFACIAL PALSY\\nIt can be caused by upper motor neuron (UMN) or lower motor neuron (LMN) lesion.\\nSalient features\\nInvestigations\\n\\uf0b7 In a typical case, no investigations are required.\\n\\uf0b7 In uncertain cases, it is necessary to getan ESR, blood sugar, workup for sarcoidosis or\\nMRI scanning maybe indicated. MRI often shows swelling and enhancement of the facial\\nnerve in idiopathic Bell's palsy.\\n\\uf0b7 Electromyography may aid in diagnosis as well as prognosis\\nNon -pharmacological treatment\\n\\uf0b7 Use of paper tape to depress the upper eyelid during sleep and prevent corneal drying.\\n\\uf0b7 Massage of the weakened muscles.\\n\\uf0b7 Splinting of lower part of face to prevent drooping.\\n\\uf0b7 Facial retraining (mime therapy)\\nPharmacological treatment\\n\\uf0b7 Tab. prednisone 60-80 mg daily during the first 5 days and then tapered over the next 5\\ndays modestly shortens the recovery period and improves the functional outcome.\\n\\uf0b7 Tab. acyclovir 400 mg five times daily for 10 days in combination with prednisone.\\nPARKINSON'S DISEASE\\nParkinson's disease (PD) is the second commonest neurodegenerative disease.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Levodopa\\n- Tab. carbidopa/levodopa (1:4) 10/100mg-25/200mg 4-6 times a day\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 111, 'page_label': '112'}, page_content=\"Central Nervous System Diseases\\n96\\n\\uf0b7 Most common c auses ofdementia are Alzheimer's disease, vascular dementia (multi\\nin fact/ diffuse whitematter disease (Binswanger's), alcoholism, parkinsonâ€™s disease,\\ndrug ormedical intoxication\\n\\uf0b7 Brief screening tools such as the mini-mental status examination (MMSE) help to\\nconfirm the presence of cognitive impairment.\\n- Adverse effects: Acute side effects include nausea, vomiting, andorthostatic\\nhypotension.\\n- Motor complications like wearing-off effect, dyskinesia, on-off phenomenon develop\\nwith long-term therapy.\\n\\uf0b7 Dopamine Agonists-Tab. pramipexole 0.25â€“1.0 mg TDS, Tab. ropinirole 6â€“24 mg/d\\n\\uf0b7 Adverse effect: Acute side effects include nausea, vomiting, and orthostatic hypotension,\\nhallucination.\\n\\uf0b7 MAO -B Inhibitors-Tab. selegiline 5 mg BD\\n\\uf0b7 COMT Inhibitors- Tab. entacapone 200 mg with each levodopa dose or Tab.tolcapone\\n100â€“200 mg TDS\\n\\uf0b7 Adverse effects: Primarily dopaminergic (nausea, vomiting, increased dyskinesia). Cases\\nof fatal hepatic toxicity have been reported with tolcapone.\\n\\uf0b7 Central-acting anticholinergic agents-Tab.trihexyphenidyl 2 mg TDS\\n\\uf0b7 NMDA -receptor antagonist-Tab. amantadine 100-300 mg/day.\\nDEMENTIA\\nIt is defined as an acquired deterioration in cognitive abilities that impairs the successful\\nperformance of activities of daily living. Memory is the most common cognitive ability lost\\nwith dementia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 The major goals of dementia management are to treat correctable causes and to provide\\ncomfort and support to the patient and caregivers.\\n\\uf0b7 Treatment of underlying causes might include thyroid replacement for hypothyroidism;\\nvitamin therapy for thiamine or B12 deficiency or for elevated serum homocysteine;\\nantimicrobials for opportunistic infections or antiretroviral for HIV; ventricular shunting\\nfor NPH; or appropriate surgical, radiation, and/or chemotherapeutic treatment for CNS\\nneoplasm.Drugs used for dementia are listedbelow:\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 112, 'page_label': '113'}, page_content='Central Nervous System Diseases\\n97\\nTable 2. Drugs used in the treatment of dementia\\nDrug Dose Side effect\\nTab.donepezil 10 mg daily nausea, diarrhea, abdominal cramps, altered\\nsleep with unpleasant or vivid dreams,\\nbradycardia, muscle cramps\\nTab. rivastigmine6 mg twice daily\\nTab. galantamine 24 mg daily\\nTab. memantine 10 mg twice dailydizziness, confusion, headache, syncopeor\\nhypotension\\nGUILLAIN -BARRÃ‰ SYNDROME (GBS)\\nGBS manifests as a rapidly evolving areflexic motor paralysis with or without sensory\\ndisturbance.\\nDiagnostic criteriafor GBS\\nI. Required for Diagnosis\\n1. Progressive weakness of variable degree from mild paresis to complete paralysis\\n2. Generalized hypo-or areflexia\\nII. Supportive of Diagnosis\\n1. Clinical features\\n\\uf0b7 Symptom progression: Motor weakness rapidlyprogresses initially but ceases by 4\\nweeks.\\n\\uf0b7 Demonstration of relative limb symmetry regarding paresis.\\n\\uf0b7 Frequent cranial nerve involvement: Facial (cranial nerve VII) 50% and typically bilateral\\nbut asymmetric; occasional involvement of cranial nerves XII,X, and occasionally III,\\nIV, and VI as well as XI.\\n\\uf0b7 Autonomic dysfunction can include tachycardia, other arrhythmias, postural hypotension,\\nhypertension, other vasomotor symptoms.\\n\\uf0b7 A preceding gastrointestinal illness (e.g., diarrhea) or upper respiratorytract infection is\\ncommon.\\n2. Cerebrospinal fluid features supporting diagnosis\\n\\uf0b7 Elevated or serial elevation of CSF protein.\\n\\uf0b7 CSF cell counts are <10 mononuclear cell/mm3.\\n3. Electrodiagnostic medicine findings supportive of diagnosis\\n\\uf0b7 NCV slowing/conduction block at some time during disease process.\\n\\uf0b7 Distal motor latency increase may reach 3 times normal values.\\n\\uf0b7 F-waves indicate proximal NCV slowing.\\nIII. Findings reducing possibility of diagnosis\\n1. Asymmetric weakness\\n2. Failure of bowel/bladder symptoms to resolve'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 113, 'page_label': '114'}, page_content='Central Nervous System Diseases\\n98\\n\\uf0b7 Fever with headache, neck stiffness, photophobia, nausea , vomiting and altered mental\\nstatus.It is associated with a CNS inflammatory reaction that may result in decreased\\nconsciousness, seizures, raised intracranial pressure (ICP), and stroke.\\n\\uf0b7 Comm on organisms are Streptococcus pneumonia, Haemophilus influenza, Neisseria\\nmeningitides,Listeria monocytogenes, Group B streptococcus, less frequent organism\\nare Staph. Aureusand coagulase negativeStaphylococcus group A & group B\\nStreptococcus, enteric gram negativebacilli.\\n3. Severe bowel/bladder dysfunction at initiation of disease\\n4. Greater than 50 mononuclear cells/mm3 in CSF\\n5. Well-demarcated sensory level\\nIV. Exclusion criteria\\n1. Diagnosis of other causes of acute neuromuscularweakness (e.g., myasthenia gravis,\\nbotulism, poliomyelitis, toxic neuropathy).\\n2. Abnormal CSF cytology suggesting carcinomatous invasion of the nerve roots\\nNon pharmacological treatment\\n\\uf0b7 Monitor Airway, Breathing and Circulation. Also includes mechanical ventilator support,\\nmanagement of autonomic dysfunction and physical therapy.\\nPharmacological treatment\\n\\uf0b7 The available treatment modalities are plasma exchange and intravenous immunoglobulin\\n(IVIG). Both are equally effective. Corticosteroids are notrecommended for treatment of\\nGBS.\\n\\uf0b7 Plasma exchange:\\n- The advised regimen of plasma exchange removes a total of 200 to 250 ml/kg of\\nplasma in four to six treatments on alternate days, or over a shorter period if there is\\nno coagulopathy. The replacement fluid is saline combined with 5% albumin.\\n\\uf0b7 IVIG:\\n- 0.4 g/kg per day for 5 consecutive days\\n- It is both easier to administer and probably safer because there is no need for large\\nintravenous access.\\n- Disadvantage is the higher cost of therapy.\\nACUTE BACTERIAL MENIN GITIS\\nItis an acute purulent infectionof the meningeswithin the sub-arachnoid space.\\nSalient features\\nInvestigations\\nCSF analysis(Table 3)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 114, 'page_label': '115'}, page_content='Central Nervous System Diseases\\n99\\nTable 3. Cerebrospinal fluid characteristics of different etiologiesof meningitis\\nCharacteristics Normal Bacterial Viral Fungal/TB\\nPressure(cmH2O) 5-20 >30 Normal or mildly\\nincreased -\\nAppearance Normal Turbid Clear Fibrin web\\nProtein(g/L) 0.18-0.45 >1 <1 0.1-0.5\\nGlucose(mmol/L) 2.5-3.5 <2.2 Normal 1.6-2.5\\nGram Stain Normal 60-90% positive Normal -\\nGlucose-\\nCSF: Serum ratio 0.6 <0.4 >0.6 <0.4\\nWCC <3 >500 <1000 100-500\\nOthers - 90% PMN\\nMonocytes\\n10% have>90%PMN\\n30%have>50%PMN\\nMonocytes\\nPharmacological treatment\\nFollowing table shows choice of antibiotic as per patient characteristics and their dose and\\nfrequencyinempiricaltherapy ofbacterialm eningitis andfocal CNSinfections\\nTable 4. Choice of antibiotics for the treatment of bacterial meningitis as per patient\\ncharacteristics\\nIndication Antibiotic\\nPreterm infants to infants <1 month Ampicillin + cefotaxime\\nInfants 1â€“3 month Ampicillin + cefotaxime or ceftriaxone\\nImmunocompetent children >3 months and adults <55Cefotaxime, ceftriaxone or cefepime +\\nvancomycin\\nAdults >55 and adults of any age with alcoholism or\\nother debilitating illnesses\\nAmpicillin + cefotaxime, ceftriaxone or\\ncefepime + vancomycin\\nHospital-acquired meningitis, posttraumatic or post\\nneurosurgery meningitis, neutropenic patients, or\\npatients with impaired cell-mediated immunity\\nAmpicillin + ceftazidime or meropenem\\n+ vancomycin\\nAntimicrobial Agent Total Daily Dose and Dosing Interval\\nAmpicillin 12 g/d, every 4 hourly\\nCefipime 6 g/d, every 8 hourly\\nCefotaxime 12 g/d, every 12 hourly\\nCeftriaxone 4 g/d, every 12 hourly\\nCeftazidime 6 g/d, every 8 hourly\\nGentamicin 7.5 (mg/kg)/d, every 8 hourly'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 115, 'page_label': '116'}, page_content=\"Central Nervous System Diseases\\n100\\n\\uf0b7 Acute or subacute onset of fever, headache,altered consciousness, focal neurological\\nsymptoms\\n\\uf0b7 C ommon cause areHerpes simplexIvirusand Varicella zostervirus.\\nMeropenem 3 g/d, every 8 hourly\\nMetronidazole 1500â€“2000 mg/d, every 6 hourly\\nPenicillin G 20â€“24 million U/d, every 4 hourly\\nVancomycin 2 g/d, every 12 hourly\\n\\uf0b7 Once culture report comes therapy should be changed accordingly\\n\\uf0b7 Inj. dexamethasone 0.15 mg/kg every 6 hourly IV for 2 days. It should be started shortly\\nbefore the antibiotic.\\n\\uf0b7 Emergency treatment of increased ICP includes elevation of the patient's head to 30â€“45Â°,\\nintubation and hyperventilation (PaCO 2 25â€“30 mm Hg), and Inj. mannitol 20% 1 g/kg stat\\nfollowed by 0.5g/kg every 4-6 hourly.\\n\\uf0b7 A 7 -day course of intravenous antibiotic therapy is adequate for uncomplicated\\nmeningococcal meningitis.\\n\\uf0b7 The index case and all close contacts should receive chemoprophylaxis with a 2-day\\nregimen of rifampin (600 mg every 12 h for 2 days in adults and 10 mg/kg every 12 h for\\n2 days in childrenmore than1 yearof age).\\n\\uf0b7 A 2-week course of intravenous antimicrobial therapy is recommended for pneumococcal\\nmeningitis. Meningitis due toL. monocytogenes is treated with ampicillin for at least 3\\nweeks. Gentamicin is added in critically ill patients (2 mg/kg loading dose, then 7.5\\nmg/kg per day given every 8 h and adjusted for serum levels and renal function). A 3-\\nweek course of intravenous antibiotictherapy is recommended for meningitis due to\\ngram-negative bacilli.\\n\\uf0b7 Tuberculousmeningitisis treatedas per RNTCP protocol.\\nVIRAL ENCEPHALITIS\\nIn encephalitis the brain parenchyma is also involved. Many patients with encephalitis also\\nhave evidence of associated meningitis (meningoencephalitis).\\nSalient features\\nInvestigations\\nC SF analysisasinacute bacterialmeningitis(Table 3)\\nPharmacological treatment\\n\\uf0b7 Specific antiviral therapy should be initiated when appropriate.\\n\\uf0b7 Following table shows drugs, dose duration and their common side effects(Table 5).\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 116, 'page_label': '117'}, page_content='Central Nervous System Diseases\\n101\\nTable 5. Dosages and side effects of antivirals in the treatment of viral encephalitis\\nDrug Dose Duration Etiology Side effect\\nAcyclovir 10 mg/kg\\nevery 8 hrly\\n14 to 21\\ndays\\nHSV,VZV,EBV nausea, vomiting,diarrhea  and\\nNeurotoxicity (lethargy or\\nobtundation, disorientation,\\nconfusion, agitation, hallucinations,\\ntremors, seizures)\\nGanciclovir 5mg/kg every\\n12 hrly,\\nfollowed by 5\\nmg/kg\\nIndefinite CMV Granulocytopenia and\\nthrombocytopenia, Gastrointestinal\\nside effects, including nausea,\\nvomiting, diarrhea, and abdominal\\npain\\nRibavirin 15 mg/kg in\\ndivided doses\\nevery 8 hrly\\nCalifornia\\nencephalitis\\n(LaCrosse)\\nvirus, severe\\nadenovirus or\\nrotavirus\\nencephalitis.\\nHemolysis, nausea, vomiting,\\ndiarrhea, andabdominal pain\\n\\uf0b7 Basic management and supportive therapy should include careful monitoring of ICP, fluid\\nrestriction, avoidance of hypotonic intravenous solutions, and suppression of fever.\\n\\uf0b7 Seizures should be treated with standard anticonvulsant regimens,and prophylactic\\ntherapy should be considered in view of the high frequency of seizures in severe cases of\\nencephalitis.\\nNEUROCYSTICERCOSIS\\nNeurocysticercosis is the most common parasitic disease of the CNS worldwide. Humans\\nacquire cysticercosis by the ingestion of food contaminated with the eggs of the parasiteT.\\nsolium.\\nDiagnostic criteria for cysticerosis\\nAbsolute criteria\\n\\uf0b7 Demonstration of cysticercus by histologic or microscopic exam of biopsy material\\n\\uf0b7 Visualization of the parasite in the eye by fundoscopy\\n\\uf0b7 Neuro-radiologic demonstration of cystic lesion containing a characteristic scolex.\\nMajor criteria\\n\\uf0b7 Neuro-radiologic lesions suggestive of neuro-cysticercosis.\\n\\uf0b7 Demonstration of antibodies to cystic in serum.\\n\\uf0b7 Resolution of intracranial cystic lesionsspontaneously or after therapy withalbendazole\\nor praziquantel alone.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 117, 'page_label': '118'}, page_content='Central Nervous System Diseases\\n102\\nMinor criteria\\n\\uf0b7 Lesions compatible with neuro-cysticercosis detect by neuro-imagining studies.\\n\\uf0b7 Clinical manifestations suggestive of neuro-cysticercosis.\\n\\uf0b7 Demonstration of antibodies tocysticerd or cycticercal antigen in CSF by ELISA.\\n\\uf0b7 Evidence of cysticercosis outside the central nervous system.\\nEpidemiologic criteria\\n\\uf0b7 Residence in a cysticercosis endemic area\\n\\uf0b7 Frequent travel to a cysticercosis endemic area\\n\\uf0b7 Household contact with an individual infected withTaenia sodium\\nDiagnosis is confirmed by either one absolute criteria or a combination to two major criteria\\none minor criterion and one epidemiologic criterion.\\nInvestigations\\n\\uf0b7 Enzyme -linked immunoelectrotransfer blot(EITB ) of serum for cysticercal antibodies.\\nELISA of serum and CSF\\n\\uf0b7 CT scan shows the cyst and granuloma stages of neuro-cysticercosis. Located in the\\ncortex or the gray white junction and present as punctuate hyperdense lesion with ring\\nenhancement with edema around the cyst, associated with the death of the organism.\\n\\uf0b7 MRI use of contrast shows cysticerus death, visibleas enhancement of the cyst wall,\\nwhich indicates that the cyst has changed into a granuloma. In addition MRI shows\\nvasogenic edema around the cyst.\\n\\uf0b7 Soft tissue radiography can be performed to look for extraneural cysts.\\n\\uf0b7 Electro encephalography (EEG): in children with intractable seizures.\\n\\uf0b7 Stoolexamination: Presence of ova may be the sole diagnostic confirmation in children.\\nPharmacological treatment\\n\\uf0b7 Treatment with anthelminthic drugs can result in complete resolution or significant\\nregression 80-90% of patients.\\n\\uf0b7 Tab. praziquantel 5-10 mg/kg single dose can be administered to individuals found to\\nhave T solium tapeworms in their stool.\\n\\uf0b7 Tab. albendazole 400 mg PO BD for 14 days with meals.\\n\\uf0b7 Tab. phenytoin300 mg PO, pediatric dose: 4-8 mg / kg / day PO divided BD / TDSto\\nprevent seizures.\\n\\uf0b7 To avoid inflammatory response in the CNS, the patient must be started on\\nanticonvulsants and high dose glucocorticoids.\\nSurgical treatment\\n\\uf0b7 Reserve neurosurgical intervention for cases of cysts that have failed to resolve with anti-\\nhelminthic treatment and are causing severe neurologic sequelae.\\nPatient education\\n\\uf0b7 Prolonged freezing or thorough cooking of pork to kill the parasite.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 118, 'page_label': '119'}, page_content='Central Nervous System Diseases\\n103\\n\\uf0b7 Paraplegia is weakness of both lower limbs and quadriplegia is weakness of all four\\nlimbs. Paraplegia or quadriplegia maybe caused by lesions of cerebrum, spinal cord,\\nmotor roots, peripheral nerves, myoneural junction or muscles. The lesions of the\\nspinal cord may be compressive or non-compressive.\\n\\uf0b7 Personal hygiene or through washing and avoiding unpeeled fruits and vegetables in\\nendemic areas.\\nPARAPLEGIA AND QUADRIPLEGIA\\nSalient features\\nPharmacological treatment\\n\\uf0b7 The treatment depends on the underlying etiology.E.g. compressive myelopathiesusually\\nrequire urgent surgical intervention.\\n\\uf0b7 Indications for corticosteroids in paraplegia:neoplastic spinal cord compression,\\ntraumatic spinal cord injuries, acute transverse myelitis, multiple sclerosis, neuromyelitis\\noptica, sarcoid myelitis, ADEM. The dose is Inj. methylprednisolone 1 g IV for 3-5 days.\\nContinuation of steroids depends on the underlying cause.\\n\\uf0b7 Fever: The loss of normal thermoregulation and inability to maintain normal body\\ntemperature can produce recurrent fever (quadriplegic fever),although most episodes of\\nfever are due to infection of the urinary tract, lung, skin, or bone.\\n\\uf0b7 Bladder dysfunction: It generally results from loss of supraspinal innervation of the\\ndetrusor muscle of the bladder wall and the sphincter musculature.\\n- Detrusor spasticity is treated with anticholinergic drugs likeTab. oxybutynin 2.5â€“5\\nmg QID or tricyclic antidepressants that have anticholinergic properties, Tab.\\nimipramine, 25â€“200 mg/d.\\n- Failure of the sphincter muscle to relax during bladder emptying (urinary\\ndyssynergia) may be managed with theadrenergic blocking agent Tab. terazosin\\nhydrochloride 1â€“2 mg TDS or QID, with intermittent catheterization, or, if that is not\\nfeasible, by use of a condom catheter in men or a permanent indwelling catheter.\\n- Bladder areflexia due to acute spinal shock or conus lesions is best treated by\\ncatheterization.\\n- Surgical options include the creation of an artificial bladder.\\n\\uf0b7 Bowel regimens and disimpaction are necessary in most patients to ensure at least\\nbiweekly evacuation and avoid colonic distention or obstruction.\\n\\uf0b7 During the first 2 weeks, use of calf-compression devices and anticoagulation with Inj.\\nheparin 5000 U SC every 12 h or Tab.warfarin (INR, 2â€“3) are recommended. In cases of\\npersistent paralysis, anticoagulationshould probably be continued for 3 months.\\n\\uf0b7 Prophylaxis against decubitus ulcers: frequent changes in position in a chair or bed, the\\nuse of special mattresses such as water or air beds, and cushioning of areas where'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 119, 'page_label': '120'}, page_content=\"Central Nervous System Diseases\\n104\\npressure sores often develop, such as the sacral prominence and heels. Early treatment of\\nulcers with careful cleansing, surgical or enzyme debridement of necrotic tissue, and\\nappropriate dressing and drainage.\\n\\uf0b7 Spasticity: stretching exercises are recommended to maintain mobility of joints. Tab.\\nbaclofen 15â€“240 mg/d in divided doses is effective. Tab. diazepam 2-4 mg at bed time\\nacts by a similar mechanism and is useful for leg spasms that interrupt sleep. Tab.\\nTizanidine 2â€“8 mg TDS is another option.\\nVERTIGO\\nVertigo is defined as the hallucination of movement, either of self (subjective) or the\\nenvironment (objective). When patient presents with this type of dizziness, the next step is to\\ndetermine whether the symptom is central (brain) or peripheral (inner ear, 8th cranial nerve) in\\norigin(Table 6).\\nInvestigations\\nPatients are to be subjected to thorough history, clinical examination and various tests such as\\nhead thrust test,head shaking test, Dix Hallpickâ€™s test, calorie test, CT and MRI brain, X-ray\\nneck,blood sugar andcarotid vertebraldoppler.\\nTable 6. Features of Peripheral and Central Vertigo\\nClinical features Peripheral\\n(Labyrinth or Vestibular Nerve)\\nCentral (Brainstem\\nOr   Cerebellum)\\nDirection of associated\\nnystagmus\\nUnidirectional;\\nfast phase opposite lesion\\nBidirectional (direction-\\nchanging) or Unidirectional\\nPurely horizontal\\nnystagmus without\\ntorsional component\\nUncommon May be present\\nPurely vertical or purely\\ntorsional nystagmus\\nNever present May be present\\nVisual fixation Inhibits nystagmus No inhibition\\nTinnitus and/or Deafness Often present Usually absent\\nAssociated central\\nnervous system\\nabnormalities\\nNone Extremely common  (e.g.,\\ndiplopia, hiccups, cranial\\nneuropathies, dysarthria)\\nCommon causes Benign paroxysmal positional\\nvertigo, labyrinthitis, vestibular\\nneuritis, MÃ©niÃ¨re's disease,\\nlabyrinthine ischemia, trauma,\\ntoxin\\nVascular, demyelinating,\\nneoplasm\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 120, 'page_label': '121'}, page_content=\"Central Nervous System Diseases\\n105\\nPharmacological treatment\\nThese medications should be reserved for short-term control of active vertigo. They are less\\nhelpful for chronic dizzinessand may hinder central compensation.\\n\\uf0b7 Antihistamines likeTab. meclizine (25â€“50 mg 3 times daily),Tab. dimenhydrinate (50\\nmg 1 â€“2 times daily) andTab. promethazine (25 mg 2â€“3 times daily,also can be given\\nrectally and IM)\\n\\uf0b7 BenzodiazepineslikeTab.diazepam (2.5 mg 1â€“3 times daily) andTab.clonazepam (0.25\\nmg 1 â€“ 3 times daily.\\n\\uf0b7 Anticholinergicagents like scopolamine transdermal patch (for motion sickness only)\\n\\uf0b7 Physical therapylike repositioningmanoeuvres(for BPPV)\\n\\uf0b7 Diuretics and/or low-sodium (1 g/d) diet(for MÃ©niÃ¨re's disease)\\n\\uf0b7 Antimigrainous drugs(for vestibular migraine)\\n\\uf0b7 Selective serotonin reuptake inhibitors(for psychosomatic vertigo)\\nBenign Paroxysmal Positional Vertigo (BPPV)\\n\\uf0b7 A common cause of recurrent vertigo\\n\\uf0b7 Episodes are brief (less than1 min and typically 15â€“20 s)\\n\\uf0b7 Always provoked by changes in head position relative to gravity, such as lying down,\\nrolling over in bed, rising from a supine position, and extending the head to look upward.\\n\\uf0b7 With posterior canal BPPV, the nystagmus beats upwardand torsionally\\n\\uf0b7 Horizontal canal BPPV resulting in a horizontal nystagmus\\n\\uf0b7 Superior (also called anterior) canal involvement is rare.\\n\\uf0b7 BPPV is treated with repositioning maneuvers that utilize gravity to remove the otoconia\\nfrom the semicircular canal.\\n\\uf0b7 For posterior canal BPPV, the Epley maneuver is the most commonly used procedure.\\nVestibular Migraine\\n\\uf0b7 Usually part of migraine aura but can occur independently. The duration of vertigo may\\nbe from minutes to hours. Vestibular migraine typically is treatedwith medications that\\nare used for prophylaxis of migraine headaches.\\n\\uf0b7 Antiemetics may be helpful to relieve symptoms at the time of an attack.(See vomiting\\nsection)\\nMÃ©niÃ¨re's Disease\\n\\uf0b7 Attack consists of vertigo, hearing loss, & pain, pressure or fullness in affected ear.\\n\\uf0b7 Diuretics and sodium restriction are the initial treatments.\\n\\uf0b7 If attacks persist, injections of gentamicin into the middle ear or full ablative procedures\\nare required.\\n\\uf0b7 Tab. betahistine 24-48 mg/day relieves pressure from excess fluid. Initial dose 16 mg\\nTDS initially with maintenance.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 121, 'page_label': '122'}, page_content='Central Nervous System Diseases\\n106\\nPsychosomatic Dizziness/vertigo\\n\\uf0b7 Important role in chronic dizziness\\n\\uf0b7 Dizziness may be a somatic manifestation of a psychiatric condition such as major\\ndepression, anxiety, or panic disorder.\\n\\uf0b7 Thus, treatment with antianxiety medications and cognitive/behavioral therapy may be\\nhelpful.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 122, 'page_label': '123'}, page_content='107\\n\\uf0b7 Periorbital andgeneralized pitting edema, transudative  pleural effusion, ascites, xanthomata\\n\\uf0b7 Diseases confined to kidney:Min imal change disease, membranous nephropathy, focal\\nsegmental glomerulosclerosis,membranoproliferative GN,mesangioproliferative GN\\n\\uf0b7 Systemic diseases diabetes mellitus, SLE , amyloidosis, H enoch Schonlein purpura,\\npreeclampsia\\n\\uf0b7 Hereditary diseases like congenital nephritic syndrome and Alports syndrome\\nChapter 6\\nGENITOURINARY DISEASES\\nNEPHROTIC SYNDROME\\nNephrotic syndrome is definedas proteinuria more than 3.5 gm/day in adultsand more than\\n40mg/m 2/hr in children. Associated features are hypoalbuminemia, hyperlipidemiaand\\nedema.\\nSalient features\\nInvestigation\\n\\uf0b7 Urine analysis : Dipstick test for proteinuria\\n\\uf0b7 Urinemicroscopic examination for deposits\\n\\uf0b7 24 hrs.urinary protein: more than 3.5 gm/day establishes the diagnosis.\\n\\uf0b7 Renal function tests: Blood urea, Serum creatinineâ€“ Usually normal in isolated nephrotic\\nsyndrome.\\nIndications for renal biopsy in nephroticsyndrome\\n\\uf0b7 Age > 10 yrs.,Micro â€“ hematuria in urine analysis.,No response to steroid therapy in\\nadequate doses for a period of 4 weeks.,Associated renal failure,Low C3 levels,ANA\\npositive,Evidence of systemic diseases.\\nNon pharmacological treatment\\n\\uf0b7 Diet: Protein 0.8g/kg/day and  1 g protein per gm lost in urine, 35 kcals/kg/day\\ncarbohydrates\\nPharmacological treatment\\n\\uf0b7 In children less than 10 yrs., without hematuria, without renal failure, start empirical\\nsteroids viz. Tab. prednisolone 2mg/kg/day for 4weeks, taper over next 4 weeks.\\n\\uf0b7 Tab. atorvastatin 10-20mg/day for hyperlipidemia\\n\\uf0b7 Tab  furosemide  40-80 mg BD\\n\\uf0b7 Tab. enalapril  1.25-5 mg/day\\n\\uf0b7 Treatment of infections\\nCHRONIC KIDNEY DISEASE\\nAn irreversible, sustainable and usually gradual loss of renalfunction leading to clinical and\\nlaboratory symptom of uraemia. The important underlying diseases arediabetes mellitus,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 123, 'page_label': '124'}, page_content='Genitourinary Diseases\\n108\\nhypertension, chronic glumerulonephritis, chronic pylonephritis, analgesic nephropathy and\\npolycystic disease.\\nSalient features\\n.\\nInvestigations\\n\\uf0b7 High risk-obesity,smoking,diabetes,hypertensionand family history of renal disease.\\n\\uf0b7 Measure BP,Urine for proteinuria, hematuria and other sediments.\\n\\uf0b7 Estimate serum creatinine, screen themat least yearly.\\nDiagnosis\\n\\uf0b7 Either one of the following establishes the diagnosis;Kidney damage for more than 3\\nmonths as defined by any structural or functional abnormalities of the kidney with or\\nwithout decreasedglomerular filtration rate(GFR ).Decrease in GFR to < 6.0ml/min for\\nmore than 3 months. The formula for calculation ofGFR = (140â€“ age) x (Wt. in kg) x\\n(0.85 if female) / (72 x Cr in mg/dl)\\nStaging: Chronickidney disease has been divided into five stages(Table 1).\\nTable 1. Stages ofchronic kidney disease\\nStage Description GFR\\n(ml/1.73m2/min)\\nStage-I Kidney damage with normal or GFR > 90\\nStage-II Kidney damage with mild GFR 60 â€“ 89\\nStage-III Moderate in GFR 30 â€“ 59\\nStage-IV Severe in GFR 15 â€“ 29\\nStage-V End stage renal disease < 15\\nNon pharmacological treatment\\n\\uf0b7 Decrease protein intake to 0.6/kg/day\\n\\uf0b7 Moderates sodium restriction to 60mmol/day\\n\\uf0b7 Phosphate restriction to 1000mg/day\\n\\uf0b7 Obesity: Aim for ideal body mass index of <25\\n\\uf0b7 Cessation of smoking\\nPharmacological treatment\\nStep â€“ 1 Look for clues with respect to etiology:\\n\\uf0b7 History of hypertension or diabetes mellitus.\\n\\uf0b7 Symptoms related to lower urinary tract, recent infections.\\n\\uf0b7 Features of connective tissue disease.\\n\\uf0b7 The symptom of uremia developed gradually and late. Fatigue, dyspnoea, anorexia,\\nvomiting, ankle edema, pruritus, and neuromuscular disturbances.\\n\\uf0b7 Examination shows presence of pallor, nail dystrophy, purpura, hypertension,\\ncardiomegaly, CHF, features of pulmonary edema, pleural effusion and pericarditis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 124, 'page_label': '125'}, page_content='Genitourinary Diseases\\n109\\n\\uf0b7 Past medical record suggestive of proteinuria.\\n\\uf0b7 Pregnancy related problems.\\n\\uf0b7 Past renal evaluation\\n\\uf0b7 Family history of hereditary kidney disease like ADPKD / Alports syndrome.\\nStep â€“ 2 Reversible factors in CKD\\n\\uf0b7 Obstructive nephropathy, urinary tract infections,extra renal infections\\n\\uf0b7 Nephrotoxic drugs,hypovolemia\\n\\uf0b7 Congestive cardiac failure,pericardial temponade\\n\\uf0b7 Hypokalemia / Hyperuricemia\\nStep -3\\n\\uf0b7 In patients with proteinuria > 1g/day, BP target is <125/75mmHg\\n\\uf0b7 If proteinuria <1g/day, BP target is <135/85 mmHg\\n\\uf0b7 Tab. frusemide40-160 mg/ day or Tab. amlodipine 5-20 mg/day\\n\\uf0b7 In diabetic nephropathy-Tab. enalapril 1.25-5 mg/day\\n\\uf0b7 If hyperlipidemiaâ€“ Tab. atorvastatin 10-20 mg/day\\n\\uf0b7 If anemic. Inj. EPO 80-120unit/kg/week  SC\\nStep â€“ 4 Prevent and treat complications\\nMalnutrition\\n\\uf0b7 Dietary protein intake of 0.6g/kg body weight/day\\n\\uf0b7 Dietary calorie intake of 30-35 kcal/kg/day\\nCardiovascular disease\\n\\uf0b7 C ommonest cause of mortality in CKD patients.Risk for IHD increases by 30% for every\\nincrease in serum creatinine by 0.23mg/dl.\\n\\uf0b7 At least yearly screening for cardiovascular disease should be done.\\nR enalosteodystrophy\\n\\uf0b7 Target calciumâ€“ 8.8 to 9.7mg/dl, Phosphorousâ€“ 3.5 to 5.5 mg/dl, Calciumâ€“\\nPhosphorous product < 55 mg2/dl.\\n\\uf0b7 This is achieved by phosphate restricted diet.Tab. calcium carbonate 1 g/dayand Tab.\\nvitamin D3-0.25-2 mcg/day\\nStep â€“ 5 Prepare for renal replacement therapy\\n\\uf0b7 Early referral to Nephrologists\\n\\uf02d Vaccination- Hepatitis B vaccine 40 micro grams 3 doses 0, 1st and 2nd month\\nfollowed by booster dose at 6th months.\\n\\uf0b7 Early creation of arterio-venous fistula when the GFR is <25 ml/minor serum creatinine\\n> 4.0meg/l.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 125, 'page_label': '126'}, page_content='Genitourinary Diseases\\n110\\nACUTE RENAL FAILURE (ARF)\\nAcute renal failure is defined as a rapid decline in renal function reflected by GFR over hours\\nto days as evidenced by raising creatinine values.\\nSalient features\\nEtiology\\n\\uf0b7 Pre-renalâ€“ 70%\\n\\uf02d H ypovolemia â€“ diarrhea, persistant, vomiting, burns, haemorrhage.\\n\\uf02d Low cardiac outputâ€“ CCF\\n\\uf02d Systemic vasodilatationâ€“ Sepsis, Hepato renal syndrome.\\n\\uf02d Drugs â€“ NSAIDs\\n\\uf0b7 Renal-â€“ 25%\\n\\uf02d Can occur due to disease process in glomeruli/ tubules / interstitial / vasculature.\\n\\uf02d Acute tubular necrosis can occur due to Ischemic kidney injuryâ€“ can occur with any\\ncause of pre renal failure if prolonged.\\n\\uf02d Nephrotoxic drugs (commonly used) NSAIDs, aminoglycosides, amphotericin-B.\\n\\uf0b7 Post renalâ€“ 5%\\n\\uf02d Prostatic hyperplasia with obstruction, Renal stone disease, Carcinoma of cervix\\nInvestigations\\n\\uf0b7 Blood : Urea, Creatinine, Serum Electrolytes, Serum Calcium, Serum PO 4, Serum\\nAlbumin\\n\\uf0b7 Urine Analysis\\n\\uf02d Pre-renal: occasional hyaline and granular casts.\\n\\uf02d Post-renal: Few hyaline casts.\\n\\uf02d Proteinuria usually small amounts, WBCâ€™s, epithelial cells, muddy brown appearance.\\n\\uf02d Calculate FeNa (Fractional Excretion of Sodium)\\n\\uf02d Urine Na x Serum Creatinine x Serum Na x Urine Creatinine x 100\\n< 1â€“ Pre-renal;> 2â€“ Renal\\nPharmacological treatment\\n\\uf0b7 Preâ€“ Renal- Hydration by Inj . normal saline 0.9% , eliminate toxins and  treat\\nunderlying cause\\n\\uf0b7 Renal:  Eliminate toxins,  Nephrology consultation\\n\\uf0b7 Post renal : Relieve obstruction, Urology consultation\\n\\uf0b7 Anorexia, fatigue, mental status changes, nausea/vomiting, pruritus, shortness of breaths\\n\\uf0b7 Signs arepericardialrub,pedal edema,pulmonary rales,raised JVP,seizures. Look for clues\\nfor etiology of renal failure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 126, 'page_label': '127'}, page_content='Genitourinary Diseases\\n111\\n\\uf0b7 As serum potassium increases ECG becomes progressively abnormal viz.\\n\\uf02d Tenting of T waves.\\n\\uf02d Prolonged PR and QRS interval\\n\\uf02d Flattened P waves, sine wave and asystole.\\n\\uf0b7 Muscle paralysis can also be a feature of hyperkalemia.\\n\\uf0b7 Indications for Dialysis arehyperkalemia,metabolic Acidosisvolume Overload,\\nencephalopathy, and pericarditis.\\nHYPOKALEMIA\\nDefined as serum potassium <3.5 meq/l.\\nSalient feature\\nNon -pharmacological treatment\\n\\uf0b7 Dietary-Potassium rich food in form of fruit juices, banana, coconut water, dryfruits.\\nPharmacological treatment\\n\\uf0b7 Urgent treatment is required in rare situations like periodic paralysis, ventricular ectopics\\nor in the setting of myocardial infarction.\\n\\uf0b7 IV KCL only required when patient not able to take orallyand Potassium <2.5 mEq/l\\n\\uf0b7 Oral potassium chloride 15ml TDS is usually sufficient if there are no cardiovascular or\\nneurological emergencies.\\nHYPERKALEMIA\\nHyperkalemia is definedby serum potassium > 5.5meq/l.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Inj. calcium gluconate 10mlof 10% solution over 10 min. Effect lasts for 30-60 mins.\\nRepeat hourly.\\n\\uf0b7 Infuse 25% dextrose 100ml + 10 units of regular insulin. The effect lasts for 4-6 hours.\\n\\uf0b7 Salbutamol nebulization 10mg (2-8 times the normal dose).\\n\\uf0b7 Inj. sodium bicarbonate 7.5%   50-100 ml is given bolus i.v. slowly over 10-20 mins\\nfollowed by drip.\\n\\uf0b7 Cation exchange resins- sodium polystyrene sulphonate(Keyxalate), usual dose is 25-30\\ngm mixed with 100 ml 20% sorbitol 3-4 times daily.\\n\\uf0b7 Note: All three steps are to be combined. All thesecan buy time before patient reaches\\nthe tertiary care center for dialysis.\\n\\uf0b7 It can present with muscular symptoms like flaccid paralysis, cardiovascular\\nproblems like ventricular arrhythmias and renal involvement like polyuria.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 127, 'page_label': '128'}, page_content='112\\n\\uf0b7 Tiredness, weakness, dry skin, feeling cold, hair loss, difficulty concentrating and poor\\nmemory , constipation, w eight gain with poor appetite, dyspnea, hoarse voice,\\nm enorrhagia (later oligomenorrhea or amenorrhea), paresthesia, impaired hearing\\n\\uf0b7 Examination shows dry coarse skin; cool peripheral extremities, puffy face, hands, and\\nfeet (myxedema), diffuse alopecia, bradycardia, peripheral edema, delayed tendon\\nreflex relaxation, carpal tunnel syndrome, serous cavity effusions\\nChapter7\\nENDOCRIN E DISEASES\\nHYPOTHYROIDISM\\nHypothyroidism may be primary; common causes are autoimmune, iatrogenic due to I131,\\nantithyroid drugs, lithium treatment, thyroidectomy. It may besecondary to pituitary or\\nhypothalamic disorders.\\nSalient features\\nInvestigation:diagnosis is confirmed by\\n\\uf0b7 Low serum free T3 and T4\\n\\uf0b7 Elevated S. TSH in thyroid types and low in suprathyroid types.\\n\\uf0b7 Thyroid peroxidase (TPO) Anti TPO antibody in autoimmune hypothyroidism.\\nPharmacological treatment\\n\\uf0b7 Tab. levothyroxine 50-100 mcg/day. Dose to be adjusted based on TSH level. Measure\\nTSH level after about 2 months of instituting therapy\\n\\uf0b7 Adjust by 12.5 mcg/day with similar increment every 2-3 months until TSH level is\\nnormalized.\\n\\uf0b7 When full replacement is achieved,follow up measurement at annual intervals and later\\nby a 2-3 yearly interval.\\n\\uf0b7 Special treatment considerations- A hypothyroid woman should be euthyroid prior to\\nconception and during early pregnancy. Maintain FT4 0.8 to 1.2.\\n\\uf0b7 Elderly required lessthyroxine (20%) especially those with CAD, starting dose 12.5\\nmcg/day with similarincremen t every 2-3 months until TSH level is normalized.\\nPatient education\\n\\uf0b7 L-thyroxine should be taken as a single daily dose, ideally on awakening, at least 30\\nminutes before breakfast.\\n\\uf0b7 Fiber andbran products may impair absorption\\n\\uf0b7 Metabolism of L-thyroxine is increased by phenytoin, rifampicin and carbamazepine.\\n\\uf0b7 Explain to the patient that the treatment is lifelong.\\n\\uf0b7 Over treatment may lead to decreased bone mineral density and adverse cardiac\\ncom plications.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 128, 'page_label': '129'}, page_content='Endocrine Diseases\\n113\\n\\uf0b7 Hyperactivity, irritability, dysphoria, heat intolerance and sweating, palpitations, fatigue and\\nweakness, weight loss with increased appetite, diarrhea, polyuria, oligomenorrhea, loss of\\nlibido.\\n\\uf0b7 Examinations shows tachycardia; atrial fibrillation in the elderly\\n\\uf0b7 Tremor, goiterw arm, moist skin.Muscle weakness, proximal myopathy, lid retraction or lag\\nMyxedema coma\\nNon -pharmacological treatment\\n\\uf0b7 Warm blanket, mechanical ventilation for respiratory failure.\\n\\uf0b7 Correction of metabolic disturbances and treat precipitating factors.\\nPharmacological treatment\\n\\uf0b7 Inj. L-thyroxine 500 mcgIV bolus, then 50-100 mcg IV daily.\\n\\uf0b7 If intravenous preparation is not available, the same dose is administered through Ryleâ€™s\\ntube.\\n\\uf0b7 Once acute phase is over, maintain L-thyroxine as above.\\n\\uf0b7 Inj. hydrocortisone 100 mg IV stat, 25-50 mg 8 hourly.\\n\\uf0b7 Caution: Avoid sedative and anesthetic agents.\\nHYPERTHYROIDISM\\nClassically occurs in Graveâ€™s disease, which is characterized by diffuse goitre,\\nopthalmopathy and dermopathy in varying combinations. Other causes are toxic muti-\\nnodular goitre and toxic adenomas.\\nSalient features\\nInvestigations\\n\\uf0b7 Low or undetectable S.TSHand increased S. Free T3 and Free T4.\\nPharmacological treatment\\nAdjunctive treatment\\n\\uf0b7 For adrenergic symptoms, Tab. propranolol 40-120 mg a day.\\n\\uf0b7 Tab. propylthiouracil 100-150 mg every 6-8 hours (Drug of choice for hyperthyroidism in\\npregnancy) orTab. carbimazole 10-20 mg   every 8-12 hours.\\n\\uf0b7 After euthyroid state is achieved in 6-8 weeks once daily dosage.\\n\\uf0b7 Review with serum TSH and FT3 after 3-4 weeks treatment has been initiated.\\n\\uf0b7 Once controlled reduce to the smallest effective dose orcontinue initial dose combined\\nwith L-thyroxin.\\n\\uf0b7 Drugs are given for an average of 2 years.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 129, 'page_label': '130'}, page_content='Endocrine Diseases\\n114\\nDefinitive treatment is Surgery/ Ablation of thyroid tissue\\n\\uf0b7 Subtotal thyroidectomy in younger patients in whom antithyroidtherapy has been\\nunsuccessful and in very large goiters.\\n\\uf0b7 Radioactive iodine (I131) method of choice in elderly, younger patients who have\\ncompleted family with recurrent thyrotoxicosis following surgery or when surgery is\\nrefused or contraindicated.\\n\\uf0b7 Caution :  Pregnancy\\nOp hthalmopathy\\n\\uf0b7 Refer to ophthalmologist.\\n\\uf0b7 Mild cases: diuretic to decrease edema, tinted sunglasses and 1% methyl cellulose eye\\ndrops.\\n\\uf0b7 Refer patients with severe and progressive exopthalmos to an ophthalmologist.\\nThyrotoxic crisis or thyroidstorm\\n\\uf0b7 Tab. propylthiouracil 600 mg loading doses, then 200-300 mg every 6 hourly orally or\\nthrough Ryleâ€™s tube.\\n\\uf0b7 Tab. carbimazole 15-25 mg 6 hourly.\\n\\uf0b7 1 hour after the 1stdose of antithyroid drug, saturated solution of potassium iodide (SSKI)\\n5drops every 6hourly  or\\n\\uf0b7 Lugolâ€™s iodine 10 drops 3 times a day or Sodium iodide 1 g IV slowly\\n\\uf0b7 Tab. propranolol 40-60 mg 4 hourly or 0.5-2.0 mg every 4 hours,\\n\\uf0b7 Inj. dexamethasone 2 mg IV 6 hourly.\\n\\uf0b7 Supportive treatment: Cooling, antipyretics, antibiotics, IV fluids.\\n\\uf0b7 Once euthyroid states are achieved, manage as already outlined.\\nHYPOCALCEMIA\\nCaused by hypoparathyrodism, pseudohypoparathyrodism, vitamin D deficiency states,\\nchronic renal failure, malabsorption syndrome, and hypomagnesemia.\\nSalient features\\n.\\nInvestigation\\n\\uf0b7 Total S.calcium <8.5 mg/dl\\n\\uf0b7 ECG : Prolongation of QTc\\n\\uf0b7 In hypoalbuminemia, add 1 mg/dl of calcium to the estimated level for every 1 gm fall\\nof albumin below 4 gm/dl ( Correct S. Calcium)\\n\\uf0b7 Treatment depends on the cause, the severity, the presence of symptoms, and how\\nrapidly the hypocalcemia developed.\\n\\uf0b7 Circumoral paresthesias, muscle cramps, confusion, tetany, convulsion. Positive\\nchovstek,s sign and trousseauâ€™s sign'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 130, 'page_label': '131'}, page_content='Endocrine Diseases\\n115\\n\\uf0b7 Fatigue, depression, confusion, anorexia, nausea, vomiting and constipationand\\npolyurea\\n\\uf0b7 Severe hypocalcemia may result in seizures, tetany, refractory hypotension or\\narrhythmias that require a more aggressive approach\\nPharmacological treatment\\n\\uf0b7 Severe symptomatic hypocalcaemia: 20 ml of 10% Inj. ca.gluconate solution over 10-\\n15 mins followed by 60-80ml of 10% solution in 1lt of 5% distilled water (0.5-0.25\\nmg/kg/hr elemental calcium)\\n\\uf0b7 Caution: Should not be mixed with bicarbonate as it may result in precipitation of\\ncalcium carbonate.\\n\\uf0b7 If associated with hypomagnesemia : Inj. magnesium sulphate 1-2 gm IV day 1\\nfollowed by oral magnesium oxide 600-1200 mg 3 times a day to replenish stores.\\nAsymptomatic hypocalcemia/ maintenance treatment\\n\\uf0b7 Treat underlying condition if possible. Long term treatment is required in conditions\\nsuch as hypoparathyroidism, pseudohypoparathyroidism and chronic vitamin D\\ndeficiency states.\\n\\uf0b7 Tab. calciumcarbonate (40% elemental ca) 1-2 gm elementalcalciumorally 3 times a\\nday initially and subsequently maintenance dose of 0.4-1.5 g 3 times a day.\\n\\uf0b7 In CRF , calcium alone gives inadequate results. Correct concomitant hyper-\\nphosphatemia before instituting following therapy: Vit D 50000 IU/day for 1-2 weeks,\\nthen weekly or bimonthly.\\n\\uf0b7 Calcitriol 0.25 mcg orally daily-more expensive and less toxic.\\n\\uf0b7 Advise low Phosphate diet and Phosphate binding agents.\\nHYPERCALCEMIA\\nThe common causes are hyperparathyroidism and malignancy. Others include excessive\\nvitaminD action, high bone turnover rate or renal failure. Hypercalcemia is defined as10.5\\nmEq/L.\\nSalient features\\nInvestigation\\n\\uf0b7 Symptoms appear when S. Ca >11.5-12.0mg/dl. Severe hypercalcemia >15-18 mg/dl can\\nresult in death.\\n\\uf0b7 ECG : Short QTc and occasionally arrhythmias\\nPharmacological treatment\\nA. Mild\\n\\uf0b7 Rehydrationâ€“ isotonic saline 2-4 lt/day increase calcium excretion.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 131, 'page_label': '132'}, page_content='Endocrine Diseases\\n116\\n\\uf0b7 After correcting dehydration administer Inj. frusemide 20-40 mg BD.\\n\\uf0b7 Monitor electrolytes especially potassium and magnesium and replace accordingly.\\nB. Moderate to severe\\n\\uf0b7 Aggressive preceding approach- isotonic saline 6 lt plus Inj.frusemideup to 100 mg\\nevery 1 to 2 hours.\\n\\uf0b7 Inj. calcitonin 2-8 U/kg IV/SC/IM every 6-12 hr: rapid but mild action.\\n\\uf0b7 Inj. pamindronate 30-90 mg IV infusion in 0.9% saline over 4-24 hrs: response last for\\nwks OR Tab. alendronate sodium 10 mg orally in the morning with full glass of water at\\nleast 30 mins before any food or drink: remain in upright position for at least 30 mins. OR\\nInj. zolendronate 1-4 mg IV in few mins.\\n\\uf0b7 Tab. prednisolone 40-100 mg/day in 4 divided doses. Useful in osteolytic malignancies,\\nVit. D intoxication and sarcoidosis.\\n\\uf0b7 Tab. phosphorus (sodium and potassium phosphate) 1-1.5 g/day in 4 divided doses for\\nseveral days when hypophosphatemia is present.\\n\\uf0b7 Peritoneal/Hemo dialysis with calcium free dialyses is useful especially in cases\\ncomplicated by renal failure.\\nDIABETES MELLITUS\\nDiabetes mellitus (DM) refers to a group of common metabolic disorders that share the\\nphenotype of hyperglycemia. Several distinct types of DM are caused by a complex\\ninteraction of genetics and environmental factors.The factors contributing to hyperglycemia\\ninclude reduced insulin secretion, decreased glucose utilization, and increased glucose\\nproduction.\\nSalient features\\nClassification\\n\\uf0b7 Polydypsia, polyuria, polyphagia and unexplained weight loss.\\n\\uf0b7 Random blood sugar >200 mg/dl, Fasting plasma glucose >126 mg/dl\\n\\uf0b7 Two hour plasma glucose >200 mg/dl after 75 g glucose load\\n\\uf0b7 Impaired fasting glucose (IFG) 100-125 mg/dl  and impaired glucose toleranceâ€“ 2 h\\nplasma glucose  140-199 mg/dl are considered as pre diabetics.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 132, 'page_label': '133'}, page_content='Endocrine Diseases\\n117\\nNon -pharmacologicaltreatment\\nCaloric requirement for normal weight individual: according to the nature of work\\nSedentary Moderate Heavy\\nMale 1800-2000 1800-2000 2200-3000\\nFemale 1200-1500 1400-1600 1600-2400\\n\\uf0b7 Caloric distribution : Carbohydrate : 45-65%, Proteinâ€“ 10-35% , 20-35% from fat,\\nsaturated fat <7%, Polyunsaturated fat 10% of Kcal/day\\n\\uf0b7 Exercise: Regular physical exercise for half and one hour (for sedentary workers) is\\nrecommended to have better control of diabetes. At least 150 min/ week of moderate\\nintensity aerobic physical activity.\\nPharmacological treatment\\nType 1 DM - Insulin therapy(Table 1)\\n\\uf0b7 Dose of human insulinâ€“ 0.5 units/kg/day to 1.0 units/kg/day\\n\\uf0b7 Combination of regular + lente/semilente insulin should be used\\n\\uf0b7 One third of the total insulin requirement is given as regular and two third as lente/semi\\nlente\\n\\uf0b7 One third of the total dose is used before dinner and two third before breakfast\\n\\uf0b7 Insulin is given SC 30-45 min before meals\\n\\uf0b7 Medial aspect of thigh and abdominal wall are generally used for injection.  Rotate\\ninjection site frequently\\n\\uf0b7 Dose, type and timing of insulin is adjusted according preprandialblood sugar levels\\n\\uf0b7 Patient must be trained for administration of SC injections\\n\\uf0b7 Ensure mealsafter injection andexplain features of hypoglycaemia to the patient'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 133, 'page_label': '134'}, page_content='Endocrine Diseases\\n118\\nTable 1. A list of various insulin preparations\\nTime of Action\\nInsulin Preparation Onset, h Peak, h Effective\\nDuration, h\\nShort-acting\\nAspart <0.25 0.5â€“1.5 3â€“4\\nGlulisine <0.25 0.5â€“1.5 3â€“4\\nLispro <0.25 0.5â€“1.5 3â€“4\\nRegular 0.5â€“1 2â€“3 4â€“6\\nLong -acting\\nDetemir 1â€“4 â€” Up to 24\\nGlargine 1â€“4 â€” Up to 24\\nNPH 1â€“4 6â€“10 10â€“16\\nInsulin combinations\\n75/25â€“75% protamine lispro, 25% lispro<0.25 1.5 h Up to 10â€“16\\n70/30â€“70% protamine aspart, 30% aspart<0.25 1.5 h Up to 10â€“16\\n50/50â€“50% protamine lispro, 50% lispro<0.25 1.5 h Up to 10â€“16\\n70/30â€“70% NPH, 30% regular 0.5â€“1 Dual 10â€“16\\nType 2 DM (Figure 1)\\n\\uf0b7 If non pharmacological measures not sufficient, oral agents may be used alone and in\\ncombination.\\n\\uf0b7 Level of hyperglycemia influence the initial choice of oral hypoglycaemic agents(Table\\n2).\\n\\uf0b7 Therapy can be started with either sulfonylureas or Metformin. Metformin has the\\nadvantage of promoting mild weight loss in obese patients.\\n\\uf0b7 Treatment may be started with any of the following drugs: Tab. glimipride l-8mg/day Or\\nTab. glipizide 2.5- 40 mg/day. Or Tab. glipizide extended release 5-10 mg/day Or Tab.\\nglyburide (glibenclamide) 1.25-20 mg/day. Or Tab. metformin 500 mg once or twice a\\nday in obese patients and increase the dose to 1000 mg 2 times a day; The dose can be\\nincreased every 2-3 weeks. All drugs should be taken 30-45 min before meals.\\n\\uf0b7 Combination therapy, following combination can be given if inadequate glycaemic\\ncontrol with single oral hypoglycaemic agent: Sulphonylurea + metformin\\n\\uf0b7 Insulin may be required in patients with primary or secondary failure to oral agents; often\\nas single dose of intermediate acting insulin 0.3-0.4 units/kg/day either before breakfast'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 134, 'page_label': '135'}, page_content='Endocrine Diseases\\n119\\nor at bedtime in combination with Tab. metformin. Insulin is also required in situations\\nlike pregnancy, surgery, infection, etc.\\nFigure1. Algorithm for management of Type 2 DM\\nT able2. Oral hypoglycaemic drugs with their dose and their common ADRs\\nDrugs Dose HbA1c\\nreduction\\n(%)\\nAdvantages Disadvantages Contraindications\\nBiguanides\\nMetformin Initially\\n500mg OD to\\nmax 2000\\nmg/d\\n1-2 Weight\\nneutral,\\nDo not cause\\nhypoglycemia\\n, inexpensive\\nDiarrhoea,\\nnausea, lactic\\nacidosis\\nSerum creatinine\\n>1.5 mg/dl (men)\\n>1.4 mg/dl\\n(women), CHF,\\nradiographic\\ncontrast studies,\\nseriously ill patients,\\nacidosis\\nInsulin secretagogues: Sulfonylureas\\nGlimepiride\\nGlipizide\\nGlyburide\\n1-8mg/d\\n5-40mg/d\\n1.25-20mg/d\\n1-2 Inexpensive Hypoglycemia,\\nweight gain\\nRenal/liver disease\\nInsulin secretagogues: Non-sulfonylureas\\nRepaglinide 0.5-16mg/d 1-2 Short onset of\\naction, lower\\npostprandial\\nglucose\\nHypoglycemia Renal/liver disease\\nThiazolidinediones\\nPioglitazone15-45 mg/d 0.5-1.4 Lower insulin\\nrequirements\\nPeripheral\\nedema, CHF,\\nCHF, liver disease'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 135, 'page_label': '136'}, page_content='Endocrine Diseases\\n120\\nweight gain,\\nfractures,\\nmacular edema\\nÎ± -Glucosidase inhibitors\\nAcarbose\\nVoglibose\\n50-100mg\\n0.2-0.3mg\\n(per meal)\\n0.5-0.8 Reduce\\npostprandial\\nglycemia\\nGI flatulence,\\nliver function\\ntests\\nRenal/liver disease\\nDipeptidyl peptidase IV inhibitors\\nSaxagliptin\\nSitagliptin\\nVildagliptin\\n2.5-5mg/d\\n100mg/d\\n50-100mg/d\\n0.5-0.8 Do not c ause\\nhypoglycemia\\nReduce dose with\\nrenal disease\\nPatient education\\n\\uf0b7 Education topics important for optimal diabetes care include self-monitoring of blood\\nglucose; urine ketone monitoring (type 1 DM); insulin administration; guidelines for\\ndiabetes management during illnesses; prevention and management of hypoglycaemia,\\nfoot and skin care; diabetes management before, during, and after exercise; and risk\\nfactorâ€“modifying activities.\\n\\uf0b7 Medical nutrition therapy(MNT) is a term used to describe the optimal coordination of\\ncaloric intake with other aspects of diabetes therapy (insulin, exercise, weight loss).\\nPrimary prevention measures of MNT are directed at preventing or delaying the onset of\\ntype 2 DM in high-risk individuals (obese or with prediabetes) by promoting weight\\nreduction.\\n\\uf0b7 Explain about the warning symptoms and signs of hypoglycaemia and need to take\\nsweets/candies/drinks in such a situation.\\n\\uf0b7 Regular follow up to monitor BP (quarterly), HbA1C testing (2-4 times/year), eye\\nexamination (annual), foot examination (1-2 times/year by physician; daily by patient);\\nscreening for diabetic nephropathy (annual); lipid profile (annual).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 136, 'page_label': '137'}, page_content='Endocrine Diseases\\n121\\nFigure 2. Diabetes algorithm for achieving glycemic control\\nAbbreviations: MET: Metformin , DPP4: dipeptidyl peptidase-4 inhibitors , TZD:\\nthiazolidinediones , GLP-1 : glucagon-like peptide-1 , FPG : fasting plasma glucose ,PPG:\\npost prandial glucose, AGI:alfa glucosidase inhibitors, SU : sulfonylureas\\nDIABETIC KETOACIDOSIS\\nDiabetic ketoacidosis is an acute complication of diabetes. It consists of hyperglycemia,\\nketosis (positive serum ketones) and metabolic acidosis (with increased anion gap).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 137, 'page_label': '138'}, page_content='Endocrine Diseases\\n122\\n\\uf0b7 Nausea, vomiting, abdominal pain, dehydration and altered sensorium.\\n\\uf0b7 DKA results from relative or absolute insulin deficiency combined with counter\\nregulatory hormone excess (glucagon, catecholamines, cortisol, and growth hormone).\\n\\uf0b7 Precipitating factors for DKA include noncompliance, infection, trauma,infarction,\\npregnancy and drug abuse.\\nSalient features\\nDiagnosis\\n\\uf0b7 Demonstration of ketones in urine (or elevated levels in blood), hyperglycaemia, low\\narterial pH, low bicarbonate (>15 mmol/1) and high anion gap (>15 mmol/1).\\nPharmacological treatment\\n\\uf0b7 Admit to hospital; intensive-care setting may be necessary for frequent monitoring or if\\npH <7.00 or unconscious. If the patient is vomiting or has altered mental status, a\\nnasogastric tube should be inserted to prevent aspiration of gastric contents.\\n\\uf0b7 Assess: Serum electrolytes (K+, Na+, Mg2+, Clâ€“, bicarbonate, phosphate),acid-base\\nstatus- pH, HCO3 â€“, PCO2, Î² -hydroxybutyrate (orS.acetone),renal function (creatinine,\\nurine output)\\n\\uf0b7 Replace fluids: 2â€“3 L of 0.9% saline over first 1â€“3 hr (15â€“20 m l/kg per hour);\\nsubsequently, 0.45% saline at 250â€“500 ml/h; change to 5% glucose and 0.45% saline at\\n150â€“250 m l/h when plasma glucose reaches 200 mg/dl. Fluid replacement needs to be\\nclosely monitored in elderly and those with cardiac or renal compromise.\\n\\uf0b7 Administer short-acting insulin: IV (0.1units/kg), then 0.1 units/kg per hour by\\ncontinuous IV infusion; increase two- to threefold if no response by 2â€“4 h. If the initial\\nserum potassium is <3.3 mEq/L, do not administer insulin until the potassium is\\ncorrected. If the initial serum potassium is >5.2 mEq/L, do not supplement K+ until the\\npotassium is corrected.\\n\\uf0b7 Assess patient: Initiate appropriate workup for precipitating event (cultures, CXR, ECG).\\n\\uf0b7 Replace K+: 10 meq/h when plasma K+< 5.0â€“5.2 mEq/L (or 20â€“30 mEq/L of infusion\\nfluid), ECG normal, urine flow and normal creatinine documented; administer 40â€“80\\nmEq/h when plasma K+< 3.5 mEq/L or if bicarbonate is given. The goal is to maintain the\\nserum potassium at >3.5 mEq/L.\\n\\uf0b7 Bicarbonate replacement: Despite a bicarbonate deficit, bicarbonate replacement is not\\nusually necessary. However, inthe presence of severe acidosis (arterial pH <6.9), it is\\nadvised to administer bicarbonate [50 mEq/L of sodium bicarbonate in 200 mlof sterile\\nwater with 10 mEq/L KCl per hour for 2 h until the pH is >7.0].\\n\\uf0b7 Phosphate and Magnesium: If the serum phosphate < 1 mg/dl, then phosphate supplement\\nshould be considered and the serum calcium monitored. Hypomagnesemia may develop\\nduring DKA therapy and may also require supplementation.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 138, 'page_label': '139'}, page_content='Endocrine Diseases\\n123\\n\\uf0b7 Monitoring: Measure capillary glucose every 1â€“2 h; measure electrolytes (especially K+,\\nbicarbonate, phosphate) and anion gap every 4 h for first 24 h. Monitor blood pressure,\\npulse, respirations, mental status, fluid intake and output every 1â€“4 hrs.\\n\\uf0b7 Hyperglycemia usually improves at a rate of 75â€“100 mg/dl per hour. As ketoacidosis\\nimproves, Î²-hydroxybutyrate is converted to acetoacetate. Ketone body levels may appear\\nto increase if measured by laboratory assays that use the nitroprusside reaction, which\\nonly detects acetoacetate and acetone.\\n\\uf0b7 Continue above until patient is stable, glucose goal is 150â€“250 mg/dl, and acidosis is\\nresolved. Insulin infusion may be decreased to 0.05â€“0.1 units/kg per hour.\\n\\uf0b7 Administer long-acting insulin as soon as patient is eating. Allow for overlap in insulin\\ninfusion and SC insulin injection.\\nHyperglycemic Hyperosmolar Nonketotic Coma\\n\\uf0b7 It is an acute metabolic derangement whose notable features are marked hyperglycemia,\\nhyperosmolality (>350 mOsmol/L), and prerenal azotemia.\\n\\uf0b7 In HONC, fluid losses and dehydration are usually more pronounced than in DKA due to\\nthe longer duration of the illness.\\n\\uf0b7 The patients are usually older, more likely to have mental status changes, even with\\nproper treatment, HHS has a substantially higher mortality rate than DKA.\\nChronic Complications of DM\\nMicrovascular\\nComplications\\nTreatment\\nDiabetic Retinopathy\\uf0b7 Proliferative retinopathy is usually treated with panretinal\\nlaser photocoagulation, whereas macular edema is treated\\nwith focal laser photocoagulation.\\n\\uf0b7 Regular fundus examination is required to monitor the\\nretinopathy.\\nDiabetic Nephropathy \\uf0b7 Administration of ACE inhibitors or ARBs\\n\\uf0b7 Insulin and other OHA requirement may decrease\\n\\uf0b7 give drugs according to renal clearance\\nDiabetic Neuropathy \\uf0b7 Once fully developed is difficult to treat.\\n\\uf0b7 The following drugs can be tried amitriptylin, pregabalin,\\ngabapentin, carbamazepine, SSRI\\n\\uf0b7 Can lead to autonomic dysf unction and orthostatic\\nhypotension.\\n\\uf0b7 Foot and joints most be examined for presence of injury.\\nDiabetic Gastropathy \\uf0b7 Smaller, more frequent meals that are easier to digest.\\n\\uf0b7 Dopamin e antagonistâ€™s metoclopramide, 5 â€“10 mg, and'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 139, 'page_label': '140'}, page_content='Endocrine Diseases\\n124\\ndomperidone, 10â€“20 mg, before each meal. Erythromycin\\nmay promote gastric emptying.\\n\\uf0b7 Diabetic diarrhoea treated with loperamide and may respond\\nto octreotide (50â€“75 g three times daily, SC).\\nDiabetic Cystopathy \\uf0b7 Timed voiding or self-catheterization, possibly with the\\naddition of bethanechol.\\n\\uf0b7 Drugs that inhibit type 5 phosphodiesterase are effective for\\nerectile dysfunction\\nMacrovascular Complication- Atherosclerotic cardiovascular disease are the common\\ncause ofdeath in diabetic population\\nAtherosclerotic CVD are the common cause of death in diabetic population.\\nRisk factor reduction is important. The important lipid target are as follows\\n\\uf0b7 LDL < 2.6 mmol/l(100 mg/dl);\\n\\uf0b7 HDL >1 mmol/ l(40 mg/dl) in men and >1.3 mmol/l(50 mg/dl) in women; and\\n\\uf0b7 Triglycerides<1.7 mmol/l(150 mg/dl).\\nIf the patient is known to have CHD, an LDL goal of <1.8 mmol/L (70 mg/dl).\\nGestationalD iabetes\\nPlease refer Obstetrics andG ynecologychapterâ€“ Pregnancy with diabetes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 140, 'page_label': '141'}, page_content=\"125\\n\\uf0b7 Recurrent, painful, rounded ulcer with yellowish gray fibrinoid centre.\\n\\uf0b7 Ulcer typically has recurrent appearanceeven after successful treatment\\nChapter 8\\nGASTROINTESTINAL DISEASES\\nAPHTHOUS ULCERS\\nSalient features\\nRule out secondary causes like malabsorption syndrome, inflammatory bowel disease,\\nBehcet's disease and recurrent trauma from tooth/denture and treat accordingly\\nNon -pharmacological treatment\\nOral hygiene-repeated mouthwash with plain water specially after eating any thing\\nPharmacological treatment\\n\\uf0b7 Symptomatic treatment with application of any gel containing local anaesthetic before\\ntaking meals.\\n\\uf0b7 Only in severe cases with large multiple ulcers.\\n\\uf0b7 Pelletshydrocortisone 5mg to be kept on the ulcer and sucked every 4 hours for 3-5 days.\\nOr Tab. prednisolone 0.5 mg/kg/day in a single dose for 3-5 days.\\nPatient education\\n\\uf0b7 Maintain good oral hygiene.\\n\\uf0b7 Avoid precipitating factors, if any.\\n\\uf0b7 Ensure toothbrush has aligned bristles.\\n\\uf0b7 Avoid chewing betel leaf and other condiments,excessive carbonated drinks and spicy or\\nsharp/crispy foods.\\n\\uf0b7 Take plenty of green leafy vegetables.\\nDYSPEPSIA\\nIt is a non-specific group of symptoms related to the upper gastrointestinal tract.  It is also\\nreferred to as non-ulcer dyspepsia / functional dyspepsia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Cap. omeprazole 20 mg once a day 45 minutes before breakfast for 4 to 6 weeks or\\n\\uf0b7 Tab. ranitidine 150 mg twice a day 45 min. before breakfast and dinner for 4 to 6 weeks.\\n\\uf0b7 Antacids 2 to 3 teaspoon or 2 tabs (chewable) when symptomatic despite above\\nmedication.\\n\\uf0b7 For those with dysmotility symptoms,\\n\\uf0b7 Epigastric burning pain, early satiety,post prandial fullness, hiccups, halitosis.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 141, 'page_label': '142'}, page_content='Gastrointestinal Diseases\\n126\\n- Tab. domperidone 10 mg three times a day 30 minutes Before breakfast, lunch and dinner\\n\\uf0b7 Duration: Short courses of therapy (4 to 6 weeks) of the drug may be repeated or long-\\nterm treatment may be continued for up to a year.  Intermittent therapy or biweekly PPI is\\nalso recommended in those requiring long-term treatment\\n\\uf0b7 Anti-H .pyloritreatment is recommended for those on long term NSAIDs or those with\\nDuodenal / gastric ulcers (complicated e.g. bleeding). Combination of Cap.omeprazole 20\\nmg twice a day with Cap. amoxicillin 500 mg thrice a day with Tab. metronidazole 400\\nmg thrice day Followed by Cap. omeprazole 20 mg once a day for three weeks. It is\\ndesirable that the anti-H pylori regimen is taken for at least 14 days.\\nPatient education\\n\\uf0b7 Avoid excess tea, coffee, fried food items andabstain from alcohol and smoking.\\n\\uf0b7 Avoid unn ecessary NSAIDs: preferparacetamol especially those with ulcer like\\nsymptoms or those with documented duodenal/gastric ulcer.\\n\\uf0b7 Follow meals at regular intervals:4 hourly (including snacks)\\n\\uf0b7 Daily exercise to maintain optimum weight.\\nPEPTIC ULCER DISEASE\\nThere is ulceration of the gastric or duodenal mucosa due to acid and pepsin.\\nSalient features\\nPharmacological treatment\\nR ecommended for patients on long term NSAIDs, bleeding peptic ulcer. Preferred two-week\\ntriple therapy (Table1), followed byProton Pump Inhibitor(PPI)for 3 weeks.\\nTable 1. Preferred regimen for eradication ofH.pylori\\nDrug Dose(mg) Frequency Duration\\nBismuth subsalicylate\\nTetracycline\\nMetronidazole\\n2 tab\\n250 mg\\n500 mg\\nQID\\nQID\\nQID\\nTwo\\nWeek\\nBismuth citrate\\nAmoxicillin\\nMetronidazole\\n400 mg\\n500 mg\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\nOmeprazole\\nAmoxicillin\\nClarithromycin\\n20 mg\\n1 gm\\n500 mg\\nBD\\nBD\\nBD\\nTwo\\nWeek\\n\\uf0b7 Heart burn, relation with foods.In advance cases upper abdominal pain, weight loss,\\nanorexia, cachexia may develop.\\n\\uf0b7 History of NSAIDs or steroid ingestion.\\n\\uf0b7 In case of perforation: severe abdominalpain, guarding, rigidity, shock.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 142, 'page_label': '143'}, page_content='Gastrointestinal Diseases\\n127\\n\\uf0b7 A bdominal pain,alternatediarrheaand constipation.\\n\\uf0b7 Abdominal distension, relief of abdominal symptoms with bowel motions, increased\\nfrequency of stool, sense of incomplete evacuation.\\n\\uf0b7 Pencil thin stool, heart burn, bloating, back pain, weakness, faintness, palpitation\\nNon -Helicobacterpyloripeptic ulcer\\n\\uf0b7 Any PPI for 4 to 6 weeks, 45 minutes before breakfast.\\n\\uf0b7 Tab. ranitidine 150 mg BD OR Tab. famotidine 40 mg OD equally efficacious but takes\\nlonger time for symptom relief.\\nPatient education\\n\\uf0b7 Stop smoking.\\n\\uf0b7 Curtail alcohol intake.\\n\\uf0b7 Avoid NSAIDs, preferparacetamol.\\n\\uf0b7 Avoid foods which aggravate symptoms; no ride for bland diet or excess milk.\\n\\uf0b7 Meals at regular intervals.\\nVOMITING\\nVomiting is the forceful expulsion of the gastric contents due to contraction of abdominal\\nmusculature and simultaneous relaxation of gastric funds and lower esophageal sphincter.\\nPharmacological treatment\\n\\uf0b7 Hospitalize the patientto give intravenous fluids in case of dehydration.  Start oral fluids\\nas soon as the patient can tolerate.  Appropriate analgesics if patient has severe pain.\\n\\uf0b7 Acute vomiting : Rule out gastric outlet obstruction then Inj. odansetron 8 mg IV repeat 8\\nhourly if neededor  Inj. metoclopramide 10 mg IM,repeat after 6 hours if needed or Tab.\\ndomperidone 10 mg three times a dayor Tab. metoclopramide 10 mg three times a day\\n\\uf0b7 In pregnancy avoid all drugs, if possible. Tab.  promethazine 25 mg oral/injection is safe\\nin the first trimester\\n\\uf0b7 If there is history of motion sickness then give Tab. cyclizine 50 mg 3 times daily.\\nPatient education\\n\\uf0b7 Avoid stale food, cut vegetables, fruits kept in open, drink potable water only.\\n\\uf0b7 Avoid NSAIDS, especially if ulcer symptoms are present.\\n\\uf0b7 Prevent dehydration: Encourage patients to take sips of liquids at short intervals to\\nprevent dehydration.\\n\\uf0b7 Endoscopy is necessary, if symptom persists.\\n\\uf0b7 Prevent motion sickness by avoiding heavy meal before travel.\\nIRRITABLE BOWEL SYNDROME (IBS)\\nA constellation of gastrointestinal symptoms associated with lower bowel symptoms that\\noccur in absence of an organic disease.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 143, 'page_label': '144'}, page_content='Gastrointestinal Diseases\\n128\\n\\uf0b7 Watery profuse loose motions which are unaffected by fasting, nausea and vomiting,\\nabdominal cramps, dehydration, hypotension\\nPharmacological treatment\\n\\uf0b7 Ifpain is predominant: Tab. mebeverine hydrochloride 270 mg three times a day given\\nfor long term or Tab. drotaverine 40 to 80 mg3 times a day\\n\\uf0b7 In those with depressive symptom: Tab. amitriptyline 10 mg HS for 4 to 6 weeks\\n\\uf0b7 In those with diarrheal symptoms Tab. loperamide 2 to 4 mg daily for several days /\\nweeks depending on the criticalresponse.\\n\\uf0b7 In those with constipation symptoms: Isotonic polyethylene glycol (PEG electrolyte)\\nsolution 125-250 ml. Or Lactulose solution 15 to 20 ml at night\\nPatient education\\n\\uf0b7 Diet should contain high fiber and supplemented with bulk forming agents such as\\nisaphghul husk.\\n\\uf0b7 Avoid caffeine and alcohol.\\n\\uf0b7 Avoid milk and other dietary constituents, which worsen the symptoms.\\n\\uf0b7 Psychotherapy may be helpful in selected cases\\nACUTE GASTRO ENTERITIS\\nIt is a self-limiting illness characterized by diarrhoea, abdominal cramps, nausea and\\nvomiting, usually caused by viruses or bacteria(E. coli,V. cholerae, Staph, aureus, Bacillus\\ncereus,etc). Most of these are noninvasive or toxic diarrhoea. Less commonly patients\\npresent mainly with diarrhoea with passage of mucous and/or blood in stools. This may be\\nassociated with significant systemic symptoms like fever, malaise, etc.\\nSalient features\\nPharmacological treatment(Figure 1)\\n\\uf0b7 In acute gastro enteritis the aim is to correct dehydration and electrolyte imbalance.\\nThere is usually no need to investigate for the etiology immediately.\\n\\uf0b7 Further investigations are necessary if there is bloody diarrhea, clinical evidence of\\ntoxicity or prolonged diarrhea.\\n\\uf0b7 Oral rehydration salt (ORS ): given in mild tomoderate dehydration ,75 ml/kg in 4 hours\\nin case of moderate dehydration\\n\\uf0b7 IV fluid given inpatients with severe dehydration (100 ml/kg). 30 ml/kg to be given in 30\\nminutes followed by 70 ml/kg in2Â½ hours\\n\\uf0b7 Tab ciprofloxacin 500 mg two times a day for 3 to 5 days. Indicated only in very ill\\npatients with systemic symptoms associated with bloody diarrhea\\n\\uf0b7 In amoebic dysentery Tab. metronidazole 400mg three times a day for 5 to 7 days. Oral\\nTab. tinidazole 600 mg twice a day for 3 to 5 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 144, 'page_label': '145'}, page_content='Gastrointestinal Diseases\\n129\\n\\uf0b7 In acute giardiasis Tab. tinidazole 1000 mg single dose or Tab. metronidazole 400 mg\\nthree times a day for 3 days.  Hospitalization is needed when there are clinical signs of\\ndehydration especially in young children or in the elderly, suspected cholera, immune\\nsuppressed patients and those with severe systemic symptoms.\\nPatient education\\n\\uf0b7 In the absence of vomiting patient should be asked to take sips of fluid.\\n\\uf0b7 Fluids used at home can be juices, soups and ORS.\\n\\uf0b7 Milk and related products are avoided for at least 2 weeks, because of secondary lactase\\ndeficiency.\\nFigure 1. Algorithm for the treatment of acutediarrhea\\nAcute Diarrhea (< 7 days)\\nAre the following present?\\n1. Severeillness: T >38.50C, abdominal pain,\\nbloody diarrhea, >6 stool / 24 hrs,\\ndehydration\\n2. Immunocompromised patients: AIDS, post\\ntransplantation\\n3. Elderly patients\\nNo Yes\\nSymptomatic therapy\\nAntidiarrheal agents:\\nLoperamide,\\nBismuth Subsalicylate\\nSend stool for following:\\n1. Fecal leukocytes\\n2. Routine stool culture\\n3. C. difficileassay, if recent\\nhospitalization of antibiotics\\n4. Ova and parasitetesting, if:\\na. Diarrhea > 10 days\\nb. Travels to endemic region\\nc. Community water borne\\noutbreak\\nd. HIV infection of men who\\nhave sexwith men\\n&\\nConsider empireantibiotic therapy while\\nawaiting culture, if:\\n1. Fecal leukocyte positive\\n2. Bloody diarrhea, fever, abdominal\\npain\\nIllness\\nresolves\\nIllness persists\\nfor 7-10 days\\nor worsens'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 145, 'page_label': '146'}, page_content=\"Gastrointestinal Diseases\\n130\\n\\uf0b7 Patient may present in acute stage with bloody diarrhoea, may be associated with\\nsystemic symptoms of low to moderate fever, backache, arthralgias.\\n\\uf0b7 The diagnosis is confirmed by sigmoidoscopic examination and mucosal biopsies.\\n\\uf0b7 The disease almost always involves rectum and rest of the colon may be involved to\\nvariable length.\\n\\uf0b7 Ac ute disease is graded as mild (2-4 stool/day), moderate (4-6 stools/day) or severe (> 6\\nstools/day). During remission patient may be asymptomatic or may have extra-intestinal\\nsymptoms.\\nULCERATIVE COLITIS (UC)\\nSalient features\\nNon -pharmacological treatment\\nThere is no specific dietary restriction but patient may avoid any food if the patient is\\nuncomfortable.\\nPharmacological treatment\\nMild to moderate acute ulcerative colitis (distal/left colonic involvement)\\n\\uf0b7 Tab. sulphasalazine 1 g 3-4 times a day. Or Tab. mesalazine 800 mg 3-4 times a day. Or\\nTab. olsalazine 1-3 g/day in divided doses.\\n\\uf0b7 Prednisolone phosphate enema, 20 mgin 100 ml saline 1-2 time a dayor Hydrocortisone\\nenema 100-125 mg in 100 ml saline 1-2 times a day (to be prepared fresh).\\n\\uf0b7 Or if disease limited to rectum, Hydrocortisone foam 125 mg 1-2 times a day.\\nModerate to severe or extensive acute disease\\n\\uf0b7 Start as above.\\n\\uf0b7 Tab. prednisolone 20-60 mg/day in single or divided doses.\\nFollow-up\\nIf the symptoms do not improve or worsen, patient will need hospitalization.\\nAcute severe disease with systemicsym ptoms (requires hospitalization under the care of\\nspecialist)\\n\\uf0b7 Inj. hydrocortisone 100 mg IV 4 times a dayor Inj. dexamethasone 4 mg IV 3-4 times a\\nday.\\n\\uf0b7 Patient should be kept 'nil by mouth' and should be given adequate intravenous fluids and\\nelectrolytes.\\n\\uf0b7 Blood transfusion to be given as per requirement.\\n\\uf0b7 Patient switched over to oral steroids and aminosalicylates to be started as in I after 5\\ndays when patient is allowed to take orally.\\n\\uf0b7 If patient fails to respond to steroids, refer the patient to gastroenterologist for\\nimmunosuppressive therapy or surgery.Once the remission is induced, steroids are\\ntapered slowly over 4-6 weeks period. For acute attack, there is no use of giving steroids\\nfor more than 12 weeks.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 146, 'page_label': '147'}, page_content='Gastrointestinal Diseases\\n131\\n\\uf0b7 Heartburn, regurgitation, anddysphasia. However, a diagnosis of GERDbased on the\\npresence oftypical symptoms is correct in only 70% of patients.\\n\\uf0b7 In addition to these typical symptoms, abnormal reflux can cause atypical\\n(extraesophageal) symptoms,such as coughing, chest pain, and wheezing.\\n\\uf0b7 For patients with symptoms and history consistent with uncomplicated GERD, the\\ndiagnosis of GERDmay be assumed and empirical therapy begun. Patients who show\\nsigns of GERD complications or other illness or who do not respond to therapy should be\\nconsidered for further diagnostic testing.\\nFollow-up\\n\\uf0b7 Close clinical/biochemical/radiological monitoring is required for any complications like\\ntoxic megacolon/perforation.\\nMaintenance of remission\\n\\uf0b7 Any of the drugs used in I should be given lifelong.\\nPatient education\\n\\uf0b7 Patient should be followed up at 6 monthly intervals and maintenance treatment should be\\ncontinued.\\n\\uf0b7 In any patient who has disease for more than 10 years, a regular sigmoidoscopy and rectal\\nbiopsy should be done at 6 monthly intervals to look for any dysplasia and total\\ncolonoscopic examination should be done at 2-3 year interval.\\n\\uf0b7 Patient should be explained about chronic nature of the disease and continuation of\\nmaintenance treatment for life long with regular follow-up and risk of colonic cancer after\\n10 years of onset of disease\\nGASTROESOPHAGEAL REFLUX DISEASE\\nGastro esophageal reflux is a normal physiologic phenomenon experienced intermittently by\\nmost people, particularly after a meal. Gastro esophageal reflux disease (GERD) occurs when\\nthe amount of gastric juice that refluxes into the esophagus exceeds the normal limit, causing\\nsymptoms with or without associated esophageal mucosal injury (i.e., esophagitis).\\nSalient features\\nInvestigations\\n\\uf0b7 Upper GI endoscopy - Endoscopy can help confirm the diagnosis of reflux by\\ndemonstrating complications of reflux (esophagitis, strictures, Barrett oesophagus) and\\ncan help in evaluating the anatomy (e.g., hiatal hernia, masses, strictures)\\n\\uf0b7 Manometry helps surgical planning by determining the lower esophageal sphincter (LES)\\npressure and identifying any oesophageal motility disorders.\\n\\uf0b7 Optional studies include: 24-hour pH probe test  and  nuclear medicine gastric emptying\\nstudy\\nTreatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 147, 'page_label': '148'}, page_content=\"Gastrointestinal Diseases\\n132\\n\\uf0b7 Treatment of GERD involves a stepwise approach. The goals are to control symptoms, to\\nheal esophagitis, and to prevent recurrent esophagitis or other complications.\\n\\uf0b7 The treatment is based on lifestyle modification and control of gastric acid secretion\\nthrough medical therapy with antacids or PPIs or surgical treatment with corrective anti\\nreflux surgery.\\nPharmacological treatment\\n\\uf0b7 Omeprazole 40 mg twice day half an hour before meals. Along with domperidone 30 mg\\nsustained release\\n\\uf0b7 This therapy causes resolution of GERD symptoms at 4 weeks and healing of esophagitis\\nat 8 weeks so the treatment should be continued up to 8 weeks.\\nSurgical Treatment\\nIndications for surgical treatment include the following:\\n\\uf0b7 Patients with symptoms that are not completely controlled by PPI therapy can be\\nconsidered for surgery.\\n\\uf0b7 The presence of Barrett esophagus\\n\\uf0b7 The presence of extraesophageal manifestations of GERD may indicate the need for\\nsurgery; these include the following: (1) respiratory manifestations (e.g., cough,\\nwheezing, aspiration); (2) ear, nose, and throat manifestations (e.g., hoarseness, sore\\nthroat, otitis media); and (3) dental manifestations (e.g., enamel erosion)\\n\\uf0b7 Young patients\\n\\uf0b7 Poor patient compliance with regard to medications\\n\\uf0b7 Postmenopausal women with osteoporosis\\n\\uf0b7 Patients with cardiac conduction defects\\n\\uf0b7 Cost of medical therapy\\n\\uf0b7 Types of surgery:Open / Laparoscopic Nissen fundoplication\\nPatient education\\n\\uf0b7 Lifestyle modifications include the following losing weight (if overweight), avoiding\\nalcohol, chocolate, citrus juice, and tomato-based products. Recent guidelines also\\nsuggest avoiding peppermint, coffee, and possibly the onion family as well.\\n\\uf0b7 Avoidinglarge meals and waiting 3 hours after a meal before lying down, elevating the\\nhead of the bed 8 inches.Lifestyle modification is as effective as antacid therapy.\\nUPPER GASTROINTESTINAL BLEEDING\\nUpper gastrointestinal haemorrhage remains a major medical problem. Causes includes\\nesophageal, gastric, duodenal ulcer ,erosions of esophageal,  gastric, duodenal,M allory\\nW eiss tear, oesophageal varices,tumour,vascular lesion, e.g. dieulafoy's diseaseand others\\nInvestigations\\n\\uf0b7 Hb, Abo-Rh, PT,APTT, Upper G.I.Scopy, Ultrasonography\\nTreatment:Primary and general management includes\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 148, 'page_label': '149'}, page_content=\"Gastrointestinal Diseases\\n133\\n\\uf0b7 Epigastric pain, history of alcoholism, gall stone disease, Cholesterol andmetabolic\\nabnormalities, history of similar complains in family.\\n\\uf0b7 Per abdomen examination- look for tenderness, guarding, rigidity. Look for fever,\\ntachycardia, tachypnoea,shock.\\nPharmacological treatment\\n\\uf0b7 Get wide bore access with IV cannula (16G preferable) for rapid fluid resuscitation,\\nR yle's tube insertion, catheterization,\\n\\uf0b7 Inj. pantoprazole 40 mg IV 12 hourly, Inj. tranexamic acid  500 mg TDS\\n\\uf0b7 Inj. octreotide 100 mcg IV 6 hourly, banding-in oesophageal varices, gastric balloon of\\nSengstaken blackmore tube-in oesophageal varices,\\n\\uf0b7 Injection sclerotherapy-in oesophageal varices, argon diathermy-in pepticulcers, laser-in\\npeptic ulcers\\nSurgical treatment\\n\\uf0b7 Exploratory laprotomy and search for the cause and treat the cause or TIPPS(Tran\\njugular intrahepatic portosystemic shunts)-in uncontrolled portal hypertension cases.\\nACUTE PANCREATITIS\\nAcute pancreatitis is the most common pathology of pancreas. It ranges from self limiting\\nmild pancreatitis to life threatening necrotizing pancreatitis which accounts for 10-20% of\\ntotal cases. Causes of acute pancreatitis: alcoholism gall stone disease, hypercholesterolemia\\nhypercalcemia, hypermagnesemia pancreatic divism, viral infections, familial pancreatitis,\\nothers, idiopathic\\nSalient features\\nInvestigations\\nTC with DC which shows increased with neutrophillia, S.amylase, increased more than 3 fold\\nnormal value, S. lipase (more specific), increased more than 3 fold of normal value, S.\\ncalcium below normal values, USG- Abdomen, shows edema of pancreas, necrosis, CECT-\\nAbdomen (in unresolving and severe cases), delineates pancreatic anatomy more clearly,\\nChest X Ray,to rule out systemic complications likeAcute Respiratory Distress Syndrome\\n(ARDS )\\nPrognostic indicators: Ranson's score, Glasgow score, APACHE II score\\nNon pharmacological treatment\\nNil by mouth, nasogastric tube insertion,avoidalcohol\\nPharmacological treatment\\n\\uf0b7 Fluid resuscitation, Correction of electrolyte imbalance\\n\\uf0b7 Inj. diclofenac sodium 75 mg IM 8 hourly and gradually proceeding towards opioid\\nanalogue like  Inj. tramadol  50 mg once day\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 149, 'page_label': '150'}, page_content='Gastrointestinal Diseases\\n134\\n\\uf0b7 Dull epigastric pain,Weight loss,Malnutrition,Pancreatic diabetes\\n\\uf0b7 History of alcoholism,History of previous attacks of acute pancreatitis.\\n\\uf0b7 Usually non specific,Signs of cachexia and malnutrition\\n\\uf0b7 Inj. pantoprazole 40 mg IV 12 hourly  and  Inj. octreotide100 microgram IV/SC 6 hourly\\nto 12 hourly till resolution of symptoms\\nSurgical treatment\\n\\uf0b7 Usually no surgical intervention is required for acute non necrotising pancreatitis.\\n\\uf0b7 Cholecystectomy for gall stone pancreatitis after acute pancreatitis is resolved\\nAcute necrotising pancreatitis\\nNon pharmacological treatment\\n\\uf0b7 ICU monitoring, oxygen by mask, nil by mouth, nasogastric tube insertion per urethral\\ncatheterization\\nPharmacological treatment\\n\\uf0b7 Fluid resuscitation, correction of electrolyte imbalance\\n\\uf0b7 Inj.meropenem 1 gm IV 8 hourly\\n\\uf0b7 Inj. diclofenac sodium  75 mg IM 8 hourly\\n\\uf0b7 Inj. pantoprazole 40 mgIV 12 hourly\\n\\uf0b7 Inj. octreotide 100 microgramIV/SC every 6 hourly to 8 hourly\\nSurgical treatment\\n\\uf0b7 Pancreatic necrosectomy,  distal pancreatectomy ( for disease inbody and tail)\\n\\uf0b7 Cholecystectomy for gall stone pancreatitis after acute pancreatitis is resolved.\\nCHRONIC PANCREATITIS\\nChronic pancreatitis is a disease of pancreas characterized by pancreatic atrophy, fibrosis,\\ncalcification and at times ductal dilatation. It is most commonly caused by repeated alcoholic\\npancreatitis.\\nSalient features\\nInvestigations\\nS. amylaseand S. Lipase has usually no role. X-ray abdomen, may show calcification in\\npancreatic region. USG- Abdomen shows atrophic pancreas with or without foci of\\ncalcification and ductal dilatation.Magnetic Resonance Cholangiopancreatography(MRCP )\\ngives excellent anatomy of ductal system.Endoscopic Retrograde Cholangiopancreatography\\n(ERCP ), reserved for chronic pancreatitis due to peri ampullary obstruction\\nNon -pharmacological treatment\\n\\uf0b7 Avoidance of alcohol, low fat, Low protein diet\\nPharmacological treatment\\n\\uf0b7 Enteric coated pancreatic enzymes, for replacement of pancreatic function,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 150, 'page_label': '151'}, page_content=\"Gastrointestinal Diseases\\n135\\n\\uf0b7 Constipation is defined as decrease in frequency and liquidity of stool compared to the\\nnormal pattern in a particular individual.\\n\\uf0b7 Important complaints suggesting constipation include straining at defaecation >25% of\\ntime, lumpy/hard stools, sensation of incomplete evacuation, or less than 3 bowel\\nactions per week.\\n\\uf0b7 Inj. diclofenac sodium 75 mg IM 8 hourly  and gradually proceedingtowards opioid\\nanalogue like Inj. tramadol  50 mg\\n\\uf0b7 Inj. pantoprazole 40 mg IV 12 hourly\\nSurgical treatment\\n\\uf0b7 Indicated in severe pain non responding to pharmacological therapy\\n\\uf0b7 Peustaw procedure ( LPJ, Longitudinal Pancreatico-jejunostomy), Frey's procedure( LPJ\\nwith coring out of head ), Duval procedure ( Distal Pancreatico-jejunostomy ), Distal\\npancreatectomy, for lesion confined to body and tail,\\n\\uf0b7 Duodenum preserving pancreatic head resection, DPPHR, Beger's procedure, for lesion\\nconfined to head region.Endoscopic stenting, for obstruction in pancreatic duct, coeliac\\nblock, for patients unfit for surgery.\\nCONSTIPATION\\nCommonest cause is habitual, the important contributory factors being insufficient dietary\\nfiber, physical inactivity, suppression of defaecatory urges occurring at inconvenient\\nmoments, prolonged travel etc. Constipation may also occur following an attack of diarrhoea\\non the day after taking a purgative; this needs no treatment.The important secondary causes\\nmay include neurological, hormonal, colonic, malignancy, depression. Secondary causes\\nshould be looked for in case of recent onset or constipation of severe symptoms.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Reassurance-since many patients with normal stools and in pregnancy,imagine that they\\nare constipated.\\n\\uf0b7 High fiber diet and increased intake of fluid with decrease in consumption of caffeinated\\ndrinks.\\n\\uf0b7 Retraining of bowels (avoiding suppression of urge to defecate, making a regular habit).\\n\\uf0b7 Bulk forming agents like 'isapghula husk' or 'psyllium seeds' also help to relieve mild\\nconstipation.\\n\\uf0b7 Regular physical exercise such as walk for 1/2 to 1 hour daily and abdominal exercises.\\nPharmacologicaltreatment\\n(Usually required for moderate to severe constipation).\\n\\uf0b7 Lactulose Soln 15-20 ml orally at night. Or Susp. magnesium sulphate 15-20 ml at night.\\nOr Tab. sodium picosulphate 10 mg at night. Or\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 151, 'page_label': '152'}, page_content='Gastrointestinal Diseases\\n136\\n\\uf0b7 Abdominal pain in right upper quadrant,fever,history of diarrhea in past 7-10 days.\\n\\uf0b7 Physical examination revelstenderness in right hypochondriac region, Palpable liver\\nand signs of jaundice.\\n\\uf0b7 Isotonic polyethylene glycol (PEG) electrolyte solution 125-250 ml.\\n\\uf0b7 Any of these may be given 2-4 times a week. Some patients may requiretreatment for\\nseveral weeks or months if there is no improvement.\\n\\uf0b7 Tab. mosapride 5 mg 2 or 3 times a day. In some patients may be required for several\\nweeks.\\n\\uf0b7 Phosphate enemas to be used on as and when required basis in patients having acute\\nproblem with severe constipation or sub-acute intestinal obstruction.\\nFollow-up\\n\\uf0b7 If patient continues to have severe constipation or symptoms worsen, refer the patient to a\\nspecialist for investigations to rule out secondary causes.\\n\\uf0b7 Recent unexplained constipation (not acute) in an elderly person whose bowel habits were\\nalways regular should be investigated.\\n\\uf0b7 Acute constipation especially when the patient is vomiting and has not passed even wind\\nand appears ill, suspect GIT obstruction and refers immediately to a higher centre.\\nPatient education\\n\\uf0b7 Do not use purgative frequently to treat constipation as it may form a habit.\\n\\uf0b7 Do not use purgatives to treat constipation with fever and following heart attack. A\\nsuppository or simple enema is preferred.\\n\\uf0b7 In pregnancy ispaghula is preferred.\\nAMOEBIC LIVER ABSCESS\\nAmoebic liver abscess is most common type of liver abscess in tropical countries. It is caused\\nby infection byEntamoeba histolyticumthrough feco-oral route which reaches liver via portal\\ncirculation, causing necrosis of liver tissue resulting in what is known as anchovy sauce pus.\\nSalient features\\nInvestigations\\n\\uf0b7 TC with D increased, PT, APTT: elevated, Liver Function Tests (S. Billirubin, SGPT, and\\nAlbumin).\\n\\uf0b7 Chest X Ray (elevated right diaphragm, rules out perforation). USG Abdomen,  CECT\\nAbdomen ( if rupture of abscess is suspected extra peritoneal )\\n\\uf0b7 Diagnostic aspiration of abscess  followed by routine microscopic and culture-sensitivity\\nof pus\\nNon -pharmacologicaltreatment\\n\\uf0b7 High glucose diet, Low protein diet'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 152, 'page_label': '153'}, page_content='Gastrointestinal Diseases\\n137\\n\\uf0b7 Abdominal pain in right upper quadrant (RHC) ,fever,tenderness in RHC.\\n\\uf0b7 Palpable liver and jaundice\\nPharmaco logicaltreatment\\n\\uf0b7 Tab. metronidazole 800 mg TDS for 2 weeks followed by Tab. diloxanide furoate 500 mg\\nBD for 10 days.\\n\\uf0b7 Inj. diclofenac sodium 75 mg IM 8 hourly.\\n\\uf0b7 Inj. pantoprazole 40 mg IV 12 hourly.\\n\\uf0b7 Vit.K injections if PT/APTT is altered.\\nSurgical treatment\\n\\uf0b7 Amoebic liver abscess usually does not require drainage.Percutaneus aspiration can be\\ndone in abscess having large size (>100 cc).\\n\\uf0b7 Exploratory laparotomy with drainage of abscess is required in suspected ruptured liver\\nabscess\\nPYOGENIC LIVER ABCES S\\nIt isthe most common type of liver abscess in western world. It can be caused by ascending\\ninfection from biliary tract, infection via portal blood supply, hematogenous via hepatic\\nartery,  direct spread ( gall bladder, duodenum, colon ) or cryptogenic.\\nSalient features\\nInvestigations\\n\\uf0b7 TC with DC, elevated with neutrophillia, PT, APTT is elevated\\n\\uf0b7 Liver Function Tests (S. bilirubin, SGPT, albumin), Chest X Ray ( elevated right\\ndiaphragm, rules out perforation ),USG Abdomen, CECT Abdomen ( if rupture of\\nabscessis suspected extra peritoneally).\\n\\uf0b7 Diagnostic aspiration of abscess followed by routine microscopic and culture- sensitivity\\nof pus\\nNon -pharmacologicaltreatment\\n\\uf0b7 High glucose diet,  low protein diet\\nPharmacological treatment\\n\\uf0b7 Inj. ceftrioxone 1-2 g IV BD\\n\\uf0b7 Inj. diclofenac sodium 75 mg IM 8 hourly\\n\\uf0b7 Inj. pantoprazole 40 mg IV 12 hourly\\n\\uf0b7 Vit.k injections if PT/APTT are altered\\nSurgicaltreatment\\n\\uf0b7 Percutaneous aspiration can be done in abscess cavity and usually requires 2-3 settings of\\naspirations donealternate day.Percutaneus pigtail catheter can be used to avoid repeated\\naspirations.Laparoscopic drainage of liver abscess if site of abscess permits.\\n\\uf0b7 Exploratory laparotomy with drainage of abscess is required in suspected ruptured liver\\nabscess.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 153, 'page_label': '154'}, page_content='138\\n\\uf0b7 Generalized tetanus starts with trismus or lockjaw followed by rigidity, violent, painful,\\ngeneralized muscle spasms and seizures provoked by slightest stimulation. Generalized\\nmuscle spasm may compromise respiration, fever and tachycardia may be present.\\n\\uf0b7 Prognosis and management depends on grade.\\nC hapter 9\\nINFECTIONS\\nTETANUS\\nIt is anacute neurological disorder resulting from contamination of a wound by an obligate\\nanaerobic organismClostridium tetani.\\nSalient features\\nInvestigations\\n\\uf0b7 C linical- culture ofC. tetanifrom a wound provides supportive evidence. The few\\nconditions that mimic generalized tetanus include strychnine poisoning and dystonic\\nreactions to antidopaminergic drugs. Abdominal muscle rigidity is characteristically\\ncontinuous in tetanus but is episodic in the latter two conditions. Cephalic tetanus can be\\nconfused with other causes of trismus, such as oropharyngeal infection.\\n\\uf0b7 Hypocalcemia and meningoencephalitis are included in the differential diagnosis of\\nneonatal tetanus.\\nGrading\\n\\uf0b7 Mild or grade 1â€“ muscle rigidity with few or no spasms.\\n\\uf0b7 Moderate or grade 2-trismus, dysphagia, rigidity and short lasting spasms.\\n\\uf0b7 Severe or grade 3- frequent explosive spasms, autonomic dysfunction particularly\\nsympathetic over activity may be present.\\n\\uf0b7 Very severe orgrade4-features of grade 3 plus violent autonomic disturbances involving\\nthe CVS â€“ severe hyper or hypotension.\\nNon -pharmacological treatment\\n\\uf0b7 Admit in a quiet roomorICU with minimum stimulation.\\n\\uf0b7 Protection of airways (intubation/tracheostomy) withor without mechanical ventilation.\\nMonitorcardiovascular parameters.\\n\\uf0b7 Cleaning/exploration/debridement of wound\\n\\uf0b7 Maintain hydration and enteral/parentral nutrition with high calorie and high protein diet.\\nPharmacological treatment\\nGrade 1\\n\\uf0b7 Tab. diazepam 5-20 mg 3 times a day; slow IV infusion in moderate to severe tetanus; not\\nexceed a dose of 80-100mg in 24 hours.\\n\\uf0b7 If spasms not controlled, Inj.phenobarbitone 200mg IM every 8-12 hours or Inj.\\nchlorpromazine 50 mg IM in adults 4 times a day.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 154, 'page_label': '155'}, page_content='Infections\\n139\\n\\uf0b7 Rodents are the important reservoirs. Leptospires may enter the host through abrasions in the\\nskin or intact mucosa, the conjunctive and the liningof oro-and naso-pharynxin contact with\\nwater contaminated withleptospira.\\n\\uf0b7 90% of symptomatic persons have the mild and usual anicteric form of leptospirosis, with or\\nwithout meningitis. Severe leptospirosis with profound jaundiceâ€“ Weilâ€™s syndrome-occurs\\nin 5 to 10% of patients.The common finding in anicteric leptospirosis is fever with\\nconjunctival suffusion. Mild jaundice may be present.\\n\\uf0b7 The ideal sedative and muscle relaxant schedulefor each patient should be individualized.\\nAn objective guide to decrease in rigidity is relaxation of abdominal muscles.\\nGrade 2\\n\\uf0b7 Tracheostomy\\nGrade 3 and 4\\n\\uf0b7 Ventilatory support\\n\\uf0b7 Inj.pancuronium 2-4mg or gallamine 20-40mg IV.\\n\\uf0b7 Ifhypotension, give vasopressor support andifhypertension, give antihypertensive.\\n\\uf0b7 For bradyarrythmias,Inj.atropine 0.6-1.2 mg IV.\\nIn addition,give following to all patients;\\n\\uf0b7 Inj. crystalline 2 mega units 6 hourly IV for 10 days or Inj. metronidazole 500mg 8 hourly\\nor 1gm 12 hourly.Requirement may beaccording totheinfected wound.\\n\\uf0b7 Inj. human tetanus immunoglobulin (TIG) 3000-5000 units IV or IM or Inj. equine\\nantiserum 10000 units by slow IV injection after sensitivity test when human TIG is not\\navailable.\\n\\uf0b7 Antiserum should be given before local manipulation of the wound.\\nLEPTOSPIROSIS\\nLeptospirosis is an infectious disease caused by thespirocheteLeptospira.\\nSalient features\\nInvestigations\\n\\uf0b7 Culture- B lood, CSF and urine is the definite way of confirming the diagnosis of\\nleptospirosis\\n\\uf0b7 Micro agglutination (MAT )\\n- Seroconversion / four fold rise in the titera\\n\\uf0b7 ELISA / MSAT\\n- Positive\\nPharmacological treatment\\n\\uf0b7 All clinically suspected leptospirosis patients in endemic area during rainy season should\\nbe given presumptive treatment of leptospirosis andm alaria. Tab. doxycycline 100 mg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 155, 'page_label': '156'}, page_content='Infections\\n140\\n\\uf0b7 A symptomatic or have mild diarrhoea;some may have sudden onset of explosive and life-\\nthreatening diarrhoea (cholera gravis). In a non-immune individual, after 24 to 48h\\nincubation period, characteristicsudden onset of painless wateryvoluminous diarrhoea.\\nPatients often vomit. In severe cases, volume loss can exceed 250 ml/kg in the first 24 h. If\\nfluids and electrolytes are not replaced, hypovolemic shock and death may ensue.\\n\\uf0b7 Fever is usually absent. Muscle cramps due to electrolyte disturbances are common. The\\nstool has a characteristic appearance: a nonbilious, gray, slightly cloudy fluid with flecks of\\nmucus, no blood, and a somewhat fishy, inoffensive odour,known as \"rice-water\" stool.\\n\\uf0b7 Clinical symptoms parallel volume contraction: At losses of <5% of normal body weight,\\nthirst develops; at 5â€“10%, postural hypotension, weakness, tachycardia, and decreased skin\\nturgor are documented; and at >10%, oliguria, weak or absent pulses, sunken eyes (and, in\\ninfants, sunken fontanelles), wrinkled (\"washerwoman\") skin, somnolence, and coma.\\n\\uf0b7 Complications due to volume and electrolyte depletion-renal failure.\\ntwice daily for 7 days and  Tab. chloroquine 600mg (base) stat followed by 600 mg after\\n24 hours and  300 mg after another 24 hours in malaria endemic areas in adults.\\nNote: In children less than 6 years 30-50 mg/kg/day of Cap.amoxicillin/ Cap. ampicillin\\nshould be given in divided doses 6 hourly for 7 days in place of doxycycline.\\nDefinitive treatment\\n\\uf0b7 Inj. crystalline penicillin 20 lacs IU IV 6 hourlyafter negative test dose (ANTD) for 7\\ndays. For children the dose of crystalline penicillin should be 2-4 lacs IU/kg/day for 7\\ndays.\\n\\uf0b7 For penicillin sensitive patients,Inj.ceftrioxone 1 gm IV. once daily for 7 daysor\\nInj.cefotaxime 1 gm. IV. 6 hours daily for 7 days\\nSymptomatic and supportive treatment\\n\\uf0b7 Care of fluid and electrolyte balance. Hypovolemia and hypotension need prompt\\ntreatment withIV fluids.Patients with oligouria, if prerenal azotemia is suspected,\\nprompt diuresis should be attempted with fluid therapy.\\n\\uf0b7 Headache and myalgiato betreated with analgesic.Fever with antipyretic.\\n\\uf0b7 Restlessness and anxiety with sedatives and anemia with blood transfusion.\\n\\uf0b7 Peritoneal dialysis has been found to be safe, simple and effective procedure for\\nmanagement of renal failure due to leptospirosis. If there is contraindication to peritoneal\\ndialysis, hemodialysis can be done.\\nC HOLERA\\nIt is an acute diarrheal disease thatoccurs in few hours, result in profound, rapidly\\nprogressive dehydration and death.C aused byV. choleraeserogroup O1 or O139â€”i.e., the\\nserogroups with epidemic potential.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 156, 'page_label': '157'}, page_content='Infections\\n141\\nInvestigation\\n\\uf0b7 Identification ofV. choleraein stool examination directly by dark-field microscopy on a\\nwet mount of fresh stool, and its serotype by immobilization with specific antiserum.\\nLaboratory isolation of the organism requires the use of a selective medium such as\\ntaurocholate-tellurite-gelatin (TTG) agar or thiosulfateâ€“citrateâ€“bile saltsâ€“sucrose (TCBS)\\nagar.Standard microbiologic biochemical testing forEnterobacteriaceaewill suffice for\\nidentification ofV. cholerae. All vibrios are oxidase-positive.\\n\\uf0b7 A point-of-care antigen-detection cholera dipstick assay is now commercially available\\nfor use in the field or where laboratory facilities are lacking.\\nNon -pharmacological treatment\\n\\uf0b7 ORS may be made by adding safe water to prepackaged sachets containing salts and\\nsugar or by adding 0.5 teaspoon of table salt (NaCl; 3.5 g) and 4 tablespoons of table\\nsugar (glucose; 40 g) to 1 L of safe water.\\n\\uf0b7 Potassium intake in bananas or green coconut watershould be encouraged.\\nPharmacological treatment\\n\\uf0b7 Euvolemia should first be rapidly restored, and adequate hydration should then be\\nmaintained to replace ongoing fluid losses(Table1& 2).\\n\\uf0b7 WHO recommends \"low -osmolarity\" ORS for treatment of dehydrating diarrhea. If\\navailable, rice-based ORS is considered superior to standard ORS in the treatment of\\ncholera. ORS can be administered via a nasogastric tube to individuals who cannot ingest\\nfluid.\\n\\uf0b7 O ptimal managementforsevere dehydration includes the administration of IV fluid and\\nelectrolytes. Ringer\\'s lactate is the best choice among commercial products. It must be\\nused with additional potassium supplements, preferably given by mouth. The total fluid\\ndeficit in severely dehydrated patients (>10% of body weight) can be replaced safely\\nwithin the first 3â€“6 h of therapy, half within the first hour. Transient muscle cramps and\\ntetany are common. Thereafter, oral therapy can usually be initiated, with the goal of\\nmaintaining fluid intake equal to fluid output.\\n\\uf0b7 Patients with continued large-volume diarrhea may require prolonged IV treatment to\\nmatch gastrointestinal fluid losses. Severe hypokalemia can develop but will respond to\\npotassium given either IV or orally. In the absence of adequate staff to monitor the\\npatient\\'s progress, the oral route of rehydration and potassium replacement is safer than\\nthe IV route.\\nTable 1.Assessing the Degree of Dehydration in Patients with Cholera\\nDegree of Dehydration Clinical Findings\\nNone or mild, but diarrheaThirst in somecases; <5% loss of total body weight\\nModerate Thirst, postural hypotension, weakness, tachycardia,\\ndecreased skin turgor, dry mouth/tongue, no tears; 5â€“10%\\nloss of total  body weight'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 157, 'page_label': '158'}, page_content='Infections\\n142\\nSevere Unconsciousness, lethargy, or \"floppiness\"; weak or absent\\npulse; inability to drink; sunken eyes (and, in infants,\\nsunken fontanelles); >10% loss of total body weight\\nTable 2.Treatment of Cholera, Based on Degree of Dehydration\\nDegree of Dehydration,\\nPatient\\'s Age (Weight)\\nTreatment\\nNone or Mild, but Diarrhea\\n<2 years 1/4â€“1/2 cup (50â€“100 ml) of ORS, to a maximum of 0.5\\nL/d\\n2 â€“ 9 years 1/2â€“1 cup (100â€“200 ml) of ORS, to a maximum of 1 L/d\\nMore than 10 years As much ORS as desired, to a maximum of 2 L/d\\nModerate\\n<4 months (<5 kg) 200â€“400 ml of ORS\\n4â€“11 months (5â€“<8 kg) 400â€“600 ml of ORS\\n12â€“23 months (8â€“<11 kg) 600â€“800 ml  of ORS\\n2â€“4 years (11â€“<16 kg) 800â€“1200 ml  of ORS\\n5â€“14 years (16â€“<30 kg) 1200â€“2200 mlof ORS\\n15 years (â‰¥30 kg) 2200â€“4000 ml of ORS\\nSevere\\nAll ages and weights IV fluid replacement with Ringer\\'s lactate (or, if not\\navailable, normal saline): 100 ml/kg in first 3-h period\\n(or first 6-h period for children <12 months old); start\\nrapidly,then slow down; total of 200 ml/kg in first 24 h;\\ncontinue until patient is awake, can ingest ORS, and no\\nlonger has a weak pulse\\n\\uf0b7 Tab. doxycycline (a single dose of 300 mg) or tetracycline (12.5 mg/kg four times a day\\nfor 3 days) may be effective in adults but is not recommended for children <8 years of\\nage because of possible deposition in bone and developing teeth. Pregnant women and\\nchildren are usually treated with erythromycin or azithromycin (10 mg/kg in children).\\nINFLUENZA INFECTION\\nIt isa respiratory disease of pigs affecting human beings, caused by types A influenza viruses\\nwith regular outbreaks in pigs.  Source of the virus in swine are avian, human and swine.  All\\nthree viruses re-assort and form a new virus which is a mixture of all three.  At present there\\nare four types H1N1, H1N2, H3N2 and H3N1.  The present pandemic is by influenza AH1N1\\ntype.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 158, 'page_label': '159'}, page_content='Infections\\n143\\n\\uf0b7 Symptoms in clude fever, headache, cough, sore throat, rhinorrhea, myalgia, fatigue,\\nvomiting, or diarrhea.Patients appear flushed and the skin ishot and dry.  Pharynx is normal\\ndespite a severe sore throat.\\n\\uf0b7 There may be mild cervical lymphadenopathy.  Illness generally resolves over 2-5 days and\\nrecovery occurs in 1 week.  Cough may persist 1-3 weeks longer and post influenza asthenia\\nmay persist for several weeks.\\n\\uf0b7 Frank dyspnoea, hyperpnoea, cyanosis, diffuse rales and signs of consolidation are indicative\\nof pulmonary complications. Symptoms of severe disease may include apnea, tachypnoea,\\ndyspnoea, cyanosis, dehydration, altered mental status and extreme irritability.\\nCase Definitions\\n\\uf0b7 A confirmed case of H1N1 infection is defined as a person with an acute febrile respiratory\\nillness with laboratory confirmed H1N1 infection at CDC byone or more of the following\\ntests: realtime RT-PCR, viral culture or four fold increase in H1N1 virus specific neutralizing\\nantibodies.\\n\\uf0b7 A probable case of H1N1 is a defined as a person with acute respiratory illness who is\\npositive forinfluenza A but negative to H2 and HB by RT-PCR.\\n\\uf0b7 A suspected case of H1N1 is defined a person with an acute febrile respiratory illness who\\nhas had dose contact with a person who is a swine-origin influenza confirmed case or\\ntravelled to a community one or more confirmed swine origin influenza cases or resides in a\\ncommunity where there are one or more confirmed swine origin influenza A(H1N1) cases.\\nSalient features\\nInvestigations\\nUpper respiratory specimens, nasopharyngeal swab or wash, nasal, aspirateor tracheal\\naspirate should be tested by the state public health laboratory. Real time RT-PCR, viral\\ncultures are to be performed to confirm the H1N1 infection.\\nPharmacological treatment\\nThe guiding principles are:\\n\\uf0b7 Early implementation of infection control precautions to minimize nosocomical /\\nhousehold spread of disease\\n\\uf0b7 Prompt treatment to prevent severe illness & death.\\n\\uf0b7 Early identification and follow up of persons at risk.\\n\\uf0b7 Tab. oseltamivir is the recommended drug both for prophylaxis and treatment.Dose for\\ntreatment is as follows:  Byw eight  <15kg 30 mg BD for 5 days , 15-23kg 45 mg BD for\\n5 days , 24â‰¤ 40kg 60 mg BD for 5 days ,  >40kg 75 mg BD for 5 days\\n\\uf0b7 For infants < 3 months 12 mg BD for 5 days, 3-5 months 20 mg BD for 5 days  6-11\\nmonths 25 mg BD for 5 days.If needed dose & duration can be modified as per clinical\\ncondition.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 159, 'page_label': '160'}, page_content='Infections\\n144\\nCaution:Oseltamiviris generally well tolerated, gastrointestinal side effects (transient\\nnausea, vomiting) may increase with increasing dose.\\nSupportive therapy\\n\\uf0b7 IV fluids, parentral nutrition.\\n\\uf0b7 Oxygen therapy/ ventilatory support.\\n\\uf0b7 Antibiotics for secondary infection.\\n\\uf0b7 Vasopressors for shock.\\n\\uf0b7 Paracetamol or ibuprofen is prescribed for fever, myalgia and headache. Patient is advised\\nto drink plenty of fluids. Smokers should avoid smoking. For sore throat, short course of\\ntopical decongestants, saline nasal drops, throat lozenges and steam inhalation may be\\nbeneficial.\\n\\uf0b7 Salicylate / aspirin is strictly contra-indicated in any influenza patient due to its potential\\nto cause Reyeâ€™s syndrome.\\n\\uf0b7 The suspected cases would be constantly monitored forclinical / radiological evidence of\\nlower respiratory tract infection and for hypoxia (respiratory rate, oxygen saturation, level\\nof consciousness).\\n\\uf0b7 Patients with signs of tachypnea, dyspnea, respiratory distress and oxygen saturation less\\nthan 90 per cent should be supplemented with oxygen therapy. Types of oxygen devices\\ndepend on the severity of hypoxic conditions which can be started from oxygen cannula,\\nsimple mask, partial re-breathing mask (mask with reservoir bag) and non re-breathing\\nmask. In children, oxygen hood or head boxes can be used.\\n\\uf0b7 Patients with severe pneumonia and acute respiratory failure (SpO2 < 90% and PaO2 <60\\nmmHg with oxygen therapy) must be supported with mechanical ventilation. Invasive\\nmechanical ventilation is preferred choice. Non invasive ventilation is an option when\\nmechanical ventilation is not available. To reduce spread of infectious aerosols, use of\\nHEPA filters on expiratory ports of the ventilator circuit / high flow oxygen masks is\\nrecommended.\\n\\uf0b7 Maintain hydration,electrolyte balance and nutrition.\\n\\uf0b7 If the laboratory reports are negative, the patient would be discharged after giving full\\ncourse of oseltamivir. Even if the test results are negative, all cases with strong\\nepidemiological criteria need to be followedup.\\n\\uf0b7 Immunomodulating drugs have not been found to be beneficial in treatment of ARDS or\\nsepsis associated multi organ failure. High dose corticosteroids in particular have no\\nevidence of benefit and there is potential for harm. Low dose corticosteroids(Tab.\\nhydrocortisone 200-400 mg/ day) may be useful in persisting septic shock (SBP < 90).\\n\\uf0b7 Suspected cases not having pneumonia do not require antibiotic therapy. Antibacterial\\nagents should be administered, if required, as per locally accepted clinicalpractice\\nguidelines. Patient on mechanical ventilation should be administered antibiotics\\nprophylactically to prevent hospital associated infections.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 160, 'page_label': '161'}, page_content='Infections\\n145\\nMajor signs and symptoms:\\n\\uf0b7 Weight loss (> 10 kg or > 20% of original weight)\\n\\uf0b7 Diarrhoea (> 1 month)\\n\\uf0b7 Fever for more than 1 month\\nMinor signs:\\n\\uf0b7 Herpes zoster (shingles),Pruritic popular rash.\\n\\uf0b7 Kaposiâ€™s sarcoma\\n\\uf0b7 Persistent generalized lymphadenopathy (PGL)\\n\\uf0b7 Oral candidiasis,Oral hairy leukoplakia\\n\\uf0b7 Persistent painful genital ulceration\\n\\uf0b7 The persistence ofeither Kaposiâ€™s sarcoma or cryptococcal meningitis is sufficient for the\\ncase definition of AIDS.\\nHIV disease is characterized by three phase.\\n\\uf0b7 Acute primary illness,Asymptomatic chronic illness,Symptomatic chronic illness\\nHIV AND AIDS\\nH uman immunodeficiency virus (HIV)infection leads to progressive immunodeficiency and\\nincreased susceptibility to infections, includingtuberculosis.  The rate of disease progression\\nis highly variable between individuals, ranging from 6 months to than 20 yrs. The median\\ntime to developAcquired Immunodeficiency Syndrome (AIDS ) after transmissionis 10 yrs\\nin the absence of Antiretroviral therapy (ART). The case definition of AIDS is fulfilled at\\nleast 2 major signs and at least 1 minor sign are present where HIV testing facilities are not\\navailable.  In children if 2 major and 2 minor signs are present (if no other causes for\\nimmunosuppression)\\nSalient features\\nInvestigations\\n\\uf0b7 HIV serology\\n\\uf0b7 CD4 + T lymphocytes counts (if available)\\n\\uf0b7 Complete blood count and chemistry of profile andpregnancy test\\nSupplementary test indicated by history and physicalexamination\\n\\uf0b7 Chest x-ray\\n\\uf0b7 Urine for routine and microscopic examination\\n\\uf0b7 Hepatitis C Virus IHCV) and Hepatitis B Virus (HBV) serology (depending on test\\navailability and resources)\\nImportant note: It is most important to confirm the diagnosis of HIV infectionby tests\\nperformed by a trained technician, preferably in a diagnostic laboratory.   The test results\\nshould include the type of test performed to establish the diagnosis based on WHO\\nguidelines.  In case there is any doubt, the test should be repeated ina standard/referral\\nlaboratory.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 161, 'page_label': '162'}, page_content='Infections\\n146\\nWHO Clinical staging of HIV Disease for Adults\\nPrimary HIV Infection\\n\\uf0b7 Asymptomatic\\n\\uf0b7 Acute retroviral syndrome\\nClinical stage I\\n\\uf0b7 Asymptomatic\\n\\uf0b7 Persistent generalized lymphadenopathy (PGL)\\nClinical Stage 2\\n\\uf0b7 Moderate unexplained weight loss (< 10% of presumed or measured body weight)\\n\\uf0b7 Recurrent respiratory tract infections.\\n\\uf0b7 Sinusitis,Bronchitis, otitis media, pharyngitis\\n\\uf0b7 Herpes zoster, angular cheilitis,recurrent oral ulcerations.\\n\\uf0b7 Papularpruritic eruptions,seborrhoeic dermatitis\\n\\uf0b7 Fungal nail infections of fingers.\\nClinical stage 3- Conditions where a presumptive diagnosis can be made on the basis of\\nclinical signs or simple investigations.\\n\\uf0b7 Severe weight loss (> 10% of presumed or measured body weight)\\n\\uf0b7 Unexplained chronic diarrheafor longer than one month.\\n\\uf0b7 Unexplained persistent fever (intermittent or constant for longer than one month)\\n\\uf0b7 Oral candidiasis,Oral hairy leukoplakia\\n\\uf0b7 Pulmonary tuberculosis (TB), Severe bacterial infections (e.g. pneumonia, emphysema,\\npomposities, bone orjoint infection, meningitis, bacteraemia)\\n\\uf0b7 Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis\\nClinical stage 4-Conditions where the diagnosis can be made on the basis of clinical signs or\\nsimple investigations.\\n\\uf0b7 HIV wasting syndrome\\n\\uf0b7 Pneumo cystic  pneumonia, recurrent severe or radiological bacterial pneumonia.\\n\\uf0b7 Chronic herpessimplex infection (orolabial, genital or anorectal of more than one\\nmonthâ€™s duration)\\n\\uf0b7 Esophageal candidiasis\\n\\uf0b7 Extra-pulmonary tuberculosis including tuberculous lymphadenopathy.\\n\\uf0b7 Kaposi sarcoma\\n\\uf0b7 Central nervous system (CNS) toxoplasmosis\\n\\uf0b7 HIV encephalopathy.\\nConditions where confirmatory diagnostic testing is necessary:\\n\\uf0b7 Extraâ€“ pulmonary crytococcosis including meningitis.\\n\\uf0b7 Disseminated nontuberculous mycobacterial infection.\\n\\uf0b7 Progressive multifocal leukoencephalopathy (PML)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 162, 'page_label': '163'}, page_content='Infections\\n147\\n\\uf0b7 Candida of trachea, bronchi or lungs\\n\\uf0b7 Crytosporiodiosis,isosporiasis\\n\\uf0b7 Visceral herpes simplex infection.\\n\\uf0b7 Cytomegalovirus (CMV) infection (retinitis or of an organ other than liver, spleen or\\nlymph nodes)\\n\\uf0b7 An y disseminated mycosis (e.g. histoplasmosis, coccidiomycosis, penicilliosis)\\n\\uf0b7 Recurrent non-typhoidal salmonella septicaemia\\n\\uf0b7 Cerebral or B-cell Non-Hodgkin lymphoma\\n\\uf0b7 Invasive cervical carcinoma\\n\\uf0b7 Visceral leishmaniasis\\nTable 3.Initiation of ART in Adults andAdolescents National Guidelines, 2011\\nBased on WHO Clinical Staging and CD4 Count\\nWHO Clinical Staging CD4 (cells/cu.mm)\\nI and II Treat if CD4 Count <350\\nIII and IV Treat irrespective of CD4 Count\\nInitiation of ART in PLHIV with Pregnancy(Table 4): Same as above.Avoid efavirenz\\nduring first trimester.Strict Monitoring for Adverse effects of Nevirapine is neededifCD4\\ncount is >250.\\nTable 4.Initiation of ART in Person living withHIV (PLHIV) with TB Co-infection\\nType of Tuberculosis Eligible\\nClinical Staging and CD4\\nCounts\\nTiming of ART\\nin relation to start of\\nTB treatment\\nPulmonary TB\\n(Stage III)\\nStart ART irrespective of any\\nclinical stage\\nand\\nirrespective of CD4 counts\\nStart ATT first;\\nStart ART as soon as\\nTB treatment is tolerated\\nafter2 wks & before 2mth.\\nExtra pulmonary TB\\n(Stage IV)\\nTable 5.Initiation of ART in PLHIV with Hepatitis B or Hepatitis C Co-infection\\nCo -infection WHO Clinical Staging CD4 (cells/cu.mm)\\nHIV -HBV or HIV -HCV\\nco-infection without\\nevidence of chronic active\\nHepatitis\\nI and II Start ART at CD4 Count <350\\nIII & IV Start ART irrespective\\nof CD4 Count\\nHIV -HBV or HIV -HCV\\nco-infection with\\ndocumented evidence of\\nchronic active Hepatitis\\nAll Clinical stages Start ART Irrespective\\nof anyCD4 count'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 163, 'page_label': '164'}, page_content='Infections\\n148\\n\\uf0b7 Sub-acute onset of symptoms over a period of weeks.\\n\\uf0b7 Typically fever, dry cough and progressive difficulty in breathing, also weight loss,night\\nsweats and fatigue.\\nTable 6. First line ART Regimens National AIDS Control Organization (NACO )\\nGuidelines 2009\\nRegimen National ART Regimen Preference\\nRegimen I Zidovudine + Lamivudine +\\nNevirapine\\nPreferred regimen\\nfor patients with Hb >9 gm/dl\\nRegimen I (a) Tenofovir + Lamivudine +\\nNevirapine\\nFor patients with Hb <9 gm/dl\\nRegimen II Zidovudine + Lamivudine +\\nEfavirenz\\nPreferred for patients  on anti-\\ntuberculosis treatment, if Hb >9\\ngm/dl\\nRegimen II (a) Tenofovir + Lamivudine +\\nEfavirenz\\nFor patients on anti-tuberculosis\\ntreatment and Hb <9 gm/dl\\nTable 7.Second line ART Regimen for Adults and Adolescents in India\\nSecond\\nLine ARVs\\nDosage Dosing schedule\\nTDF + 3TC Fixed dose combination\\nof TDF 300 mg + 3TC 300 mg\\n0 â€“0 â€“1\\n(One tablet in the night)\\nATV/r\\nC ap. atazanavir 300 mg 0 â€“0 â€“1\\n(One tablet in the night)\\nTab.ritonavir 100 mg 0 â€“0 â€“1\\n(One tablet in the night)\\nOPPORTUNISTIC INFECTIONS\\nThe common conditions and diseases related to AIDS include tuberculosis,pneumocystis\\ncarinii pneumonia, oesophagea l candidiasis, cryptococcosis, toxoplasmosis,\\ncryptosporidiosis, cytomegalovirus (CMV), andm ycobacterium avium complex (MAC).\\nDiagnosis and management of common opportunistic infections is given herewith.\\nI. PNEUMOCYSTIS CARINII PNEUMONIA (PCP)\\nPneumocystisCarinii is a fungus that infects the lungs\\nSalient features\\nInvestigations\\n\\uf0b7 X -ray\\n\\uf0b7 Induced sputum examination or bronchoscopy,CD -4 count <200'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 164, 'page_label': '165'}, page_content='Infections\\n149\\n\\uf0b7 Difficulty in swallowing or retrosternal discomfort.Weight loss is common\\n\\uf0b7 CD4 count < 100\\n\\uf0b7 Usually made directly in presence of oral candidiasis and dysphagia.Endoscopy is indicated\\nwho fail to respond to a clinical trial of appropriate treatment.\\n\\uf0b7 The diagnosis of esophageal candidiasis should be reconsidered if oral candidiasis is not\\npresent.\\n\\uf0b7 Associated fever and oral ulceration are not common.\\nPharmacologicaltreatment\\n\\uf0b7 Severe disease â€“ hospitalization, intravenous trimethoprim/sulphamethoxazole\\n(TMP/SMX) (15mg/kg/day for 21 days), supplemental oxygen for patients with severe\\nhypoxemia (PaO2 < 70 mmHg breathing room air at rest).Corticosteroids,prednisolone,\\n40 mg twice daily for 5 days followed by 40 mg once daily for 5 days, followed by 20 mg\\nonce daily for 11 days.\\n\\uf0b7 For m oderate disease, an oral agent may be used on outpatient basis, although\\nhospitalization should be considered.While mildcases,oral TMP/SMX can be givenas\\nabove.\\nPreventive therapy\\n\\uf0b7 Tab. dapsone 100 mg once a day for 21 daysâ€“ preferred second-line option.\\n\\uf0b7 Tab. clindamycin 450 mg 4 times a day + primaquine 15 mg once daily for 21 days.\\n\\uf0b7 Tab. atovaquone 750 mg once a day for 21 days.\\n\\uf0b7 Inj. pentamidine (intravenous) 3-4 mg/kg/day for 21 days.\\nII.OESOPHAGEAL CANDIDIASIS\\nCandidiasis is a fungal infection that frequently occurs in the mouth and vagina.  It is\\nconsidered to be an opportunistic infection when it occurs in the oesophagus.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Preventive therapy: not recommended because current drugs effectively treat\\n(prophylaxis) disease\\n\\uf0b7 Antifungal resistance may develop and drug-drug interactions may occur\\n\\uf0b7 Tab. fluconazole 100-400 mg once a day for 2 weeks is the treatment of choice.\\nAlternative treatment is Inj. amphotericin B 0.3-0.5 mg/kg/day.\\n\\uf0b7 Maintenance therapy by Tab. fluconazole 50â€“ 100 mg once a day\\n\\uf0b7 Stopping maintenance therapy when there is evidence that patient who achieves CD4\\ncounts > 100 on ART may cease treatment.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 165, 'page_label': '166'}, page_content='Infections\\n150\\n\\uf0b7 Headache, nausea, fever, malaise, altered mental status, irritability and seizures, cough, chest\\npain, breathlessness\\n\\uf0b7 Presentation:Sub-acute with progressive symptoms over weeks to months or acute with\\nsymptoms over days.\\n\\uf0b7 CD4 count: < 100\\n\\uf0b7 Altered mental state (confusion, unusual behavior),headaches, fever, seizures, paralysis,\\ncoma .\\n\\uf0b7 Presentation: acute to sub acute over days to weeks, CD4 count <100\\nIII.CRYPTOCOCCOSIS\\nCryptococcosis is a fungus that is inhaled andcan cause meningitis.\\nSalient features\\nInvestigations\\n\\uf0b7 Lumbar puncture to test for the presence ofCryptococcusor cryptococcal antigen in\\ncerebral spinal fluid.  ICP is often raised.\\n\\uf0b7 CSF protein and glucose are generally normal and there may be few white blood cells.\\nPh armacological treatment\\n\\uf0b7 Inj. amphotericin B 0.5â€“ 0.8 mg/kg/day + flucytosine 100 mg/day 4 times a day for 2\\nweeks then 8 to 10 weeks.Alternative treatment isliposomal amphotericin.\\n\\uf0b7 Maintenance therapy by  flucanozole 200 mg once a day.Cohort studiessuggest that\\nmaintenance therapy can be ceased in patients with sustained CD4 response to ART (CD4\\n> 200) for > 3 months\\nIV.TOXOPLASMOSIS\\nToxoplasmosis is a parasite that has a predilection for the brain.\\nSalient features\\nInvestigations\\n\\uf0b7 Typical appearance on CT or MRI scans.\\n\\uf0b7 Diagnosis is usually presumptive on the basis of appearance on scan.  May show ring\\nshaped contrast enhancing lesions.\\nPharmacological treatment\\n\\uf0b7 Tab. pyrimethamine 100â€“ 200 mg loading dose and then 50â€“ 75 mg once a day given in\\ncomb ination with sulphadiazine 4â€“ 6 g/day, 4 times a day or  Tab.  clindamycin 2â€“ 4\\ng/day, 4 times a day for 6â€“ 8 weeks duration depending upon response.If sulphadiazine\\nis used, Tab. folinic acid 25 mg once a day should be given in the presence of cerebral\\nedema.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 166, 'page_label': '167'}, page_content='Infections\\n151\\n\\uf0b7 Lower abdominal pain. Mild diarrhea develops gradually and may lead to full blown\\ndysentery. 0-12 stools per day with blood and mucus and little fecal matter.\\n\\uf0b7 Caecal involvement may mimic acute appendicitis. Chronic form i.e. amoebic colitis,\\ncan be confused with inflammatory bowel disease.\\n\\uf0b7 Untreated or incompletely treated intestinal infection may result in amoebic liver\\nabscess and involvement of other extra intestinal site.\\n\\uf0b7 Acute giardiasis-although diarrhea is common, upper intestinal manifestations such as\\nabdominal pain, bloating, belching, flatus, nausea and vomiting may predominate.\\n\\uf0b7 Chronic giardiasisâ€“ history of one or more episodes of acute diarrhea, increased flatus, loose\\nstools, abdominal distension, borborygmi, eructation of foul tasting gas and passage of foul\\nsmelling flatus, and weight loss.\\n\\uf0b7 Symptoms could be intermittent, recurring and gradually debilitating: severe diseasemay\\nresult in malabsorption, weight loss, growth retardation and dehydration.\\n\\uf0b7 Alternative treatment:pyrimethamine in combination with one of the following: Tab.\\nazithromycin 1â€“ 15 mg/day or  Tab. atovaquone 3 g/day or Tab. dapsone 100 mg/day or\\nTab. clarithromycin 2 g/day\\n\\uf0b7 Maintenance therapy is therapy by Tab.pryimethamine (25 â€“ 75 mg once a day) +\\nsulphadiazine (50â€“ 100 mg 4 times a day for several days with leucovorin)\\nAMOEBIASIS (INTESTINAL)\\nIt is an infection caused by intestinal protozoaEntamoeba histolytica,which usually spreads\\nby infective cysts in stoolthatcontaminate food and drinking water.\\nSalient features\\nInvestigations\\n\\uf0b7 D emonstration of cysts and/or trophozoites ofEntamoeba histolyticain the stool.\\nPharmacological treatment\\n\\uf0b7 Asymptomatic cyst passers- Tab. diloxanide furoate 500 mg TDS for 10 days\\n\\uf0b7 A cute amoebic dysentery and chronic infection\\n- Tab. metronidazole 400â€“ 800 mg 8 hourly PO for 10 days. In children 15 mg/kg divided\\nin three doses for 7 daysor Tab. tinidazole (300 mg, 500 mg and 1 g) 2 g orally as single\\ndose. In children 50 mg/kg/day inthree divided doses for 10 days\\n- Followed by Tab. diloxanide furoate 500 mg 8 hourly for 10 days\\nGIARDIASIS\\nIt is an intestinal disease caused by parasiteGiardia lambliathatspreadsby direct faeco-oral\\ntransmission.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 167, 'page_label': '168'}, page_content='Infections\\n152\\n\\uf0b7 Asymptomatic or present with symptoms of anemia (Hypochromic microcytic).\\n\\uf0b7 Pruritic maculopapular dermatitis (ground itch) at site of skin penetration by infective larvae,\\nserpigenous tracts of subcutaneous migration in previously sensitized host.\\n\\uf0b7 Mild transient pneumonitis because of larvae migration through lungs.\\n\\uf0b7 Intestinal manifestationsâ€“ epigastric pain often with post-prandial accentuation,\\ninflammatory diarrhea.\\n\\uf0b7 Major consequencesâ€“ progressive iron deficiency anemia and hypoproteinemia\\nInvestigations\\n\\uf0b7 D emonstration of cysts and or trophozoites in the stools.\\nPharmacological treatment\\n\\uf0b7 Tab. tinidazole 2 g as single dose in adults.  In children 50 mg/kg as a single dose Or\\n\\uf0b7 Tab. metronidazole 400 mg every TDS for 7 days in adults. In children 15 mg/kg divided\\nin three doses for 7 days.\\nPatient education\\n\\uf0b7 Infections spread by ingestion of food or water contaminated with cysts.Properly cooked\\nfood, use of clean drinking water, proper sanitation and good personal hygiene- hand\\nwashing with soap after defecationand before meals may prevent infection.\\n\\uf0b7 Infection can be minimized by avoiding unpeeled fruits and vegetables.\\n\\uf0b7 Side effects are usually mild and transient and include nausea, vomiting, abdominal\\ndiscomfort, metallic taste and a disulfiram like reaction, therefore, avoid use of alcohol\\nduring treatment.\\nHOOKWORM INFESTATION\\nThe majority of worm infestations are asymptomatic Infections causedby A.duodenaleand\\nN.americanus. The infective larvae penetrate through skin usually the food and travel\\nthrough subcutaneous issue to the intestines.  The adult forms live in the jejunum and feed on\\nblood, thus leading to chronic blood loss and anemia.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Tab. mebendazole 100mg BD for 3 days in children above 2 years of age.\\n(Caution: contraindicated in children less than 2 years)or\\n\\uf0b7 Tab.pyrantel pamoate(250mg); once daily for 3 days.\\n(Caution; not used in children below 1 year of age)\\n\\uf0b7 In children more than 1 year, susp. pyrental palmoate 10mg/kg as a single dose orTab\\nalbendazole 400mg to be given as a single dose.In children between 1-2 years of age\\nsyrup albendazole 200mg as a single dose. In children more than2 years of age syrup\\nalbendazole 400 mg as a single dose.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 168, 'page_label': '169'}, page_content='Infections\\n153\\n\\uf0b7 Most individuals are asymptomatic.Features of pulmonary involvement because of larval\\nmigration include irritating nonproductive cough, bronchospasm or pneumonitis and burring\\nsubsternaldiscomfort aggravated by coughing or deep inspiration, dyspnoea, fever,\\neosinophilic pneumonities.\\n\\uf0b7 Small bowel obstruction may get complicated by perforation intussusceptions or volvulus.\\n\\uf0b7 Aberrant migration of a large worm may cause biliary colic, cholangitis, cholecystitis\\npancreatic and oral expulsion of the worm.\\n\\uf0b7 Most infestations are asymptomatic.Cardinal symptoms are perianal pruritis, worse at night\\ndue to migration of female worms. Excessive itching can lead to perianal excoriation and\\nbacterial superinfection.H eavy infection causes abdominal pain and weight loss.\\n\\uf0b7 Rarely, in femaleâ€™s vulvovaginitis and pelvic or peritoneal granulomas occur. Eosinophilia.\\nPatient education\\n\\uf0b7 Hookworm infestation occursthrough skin penetration by the infective larvae.\\n\\uf0b7 The disease can be prevented by use of boots and gloves while working in the fields.\\nASCARIASIS (ROUNDWORM INFESTATION)\\nAscariasis is caused byAscaris lumbricoides, the largest nematode parasite of humans\\nreaching up to 40 cm in length.  The worm is located in the large intestine.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Tab mebendazole 100 mg 12 hourly for 3 days in children above 2 years of age. (Caution:\\ncontraindicated in children < 2 years)\\n\\uf0b7 Tab.pyrantel pamoate 11 mg/kg as a single dose or Tab.  albendazole 400 mg as a single\\ndose. In heavy infestation, however, a 2-3 day course is indicated. (Caution:\\ncontraindicated in pregnancy)\\n\\uf0b7 In children between 1â€“ 2 years of age Syr. albendazole 200 mg asa single dose. In\\nchildren more than 2 years, Syr. albendazole 400 mg as a single dose.\\nPatient education\\nProper sanitation and good personal hygiene- hand washing with soap after defecation and\\nbefore meals may prevent infection.A void unpeeled fruits and vegetables and use of clean\\ndrinking water.\\nENTEROBIASIS\\nInfection is caused byEnterobius vermicularis(Pin worm). Adult pinworm is around 1 cm\\nlong and dwells in the bowel lumen in the small and large intestine around caecum area.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 169, 'page_label': '170'}, page_content='Infections\\n154\\n\\uf0b7 In acute presentation episodicattacks of fever with lymphadenitis and lymphangitis.\\nOccasionally adult worms may be felt subcutaneously.\\n\\uf0b7 Chronic presentation as a case of lymphatic obstruction due to worm or fibrosis causing\\nmassive lower limb oedema, non pitting type, with skin thickening, hydrocele,\\nchyluria, chylous ascitis,  chylothorax.\\nInvestigations\\nD emonstration of the ova ofEnterobius vermicularisin perianal swabs or a cellophane tape\\nshould be pressed against perianal skin. In the morning, when the child gets up, eggs stick to\\nthe tape and can be examined under the microscope.\\nPha rmacological treatment\\n\\uf0b7 Tab. mebendazole 100 mg as a single dose in adults and children more than 2 years of\\nage. (Contraindicated in pregnancy and in children below one year of age). Or Tab.\\npyrantel pamoate 11 mg/kg body weight as a single dose. Or Tab. albendazole 400 mg as\\na single dose.\\n\\uf0b7 Children (1-2 years) Syr. albendazole 200 mg as a single dose; More than 2 years 400 mg\\nas a single dose.\\n\\uf0b7 Repeat treatment after two weeks.\\nAssessment of response of worm infestation to therapy\\n\\uf0b7 Repeat stool, perianal swab examination for ova ofEnterobius vermicularis.\\n\\uf0b7 Absolute eosinophil count, haemoglobin and peripheral blood smear examination at\\nmonthly intervals for 3-6 months.\\n\\uf0b7 Serum albumin level in hookworm infection.\\nPatient education\\n\\uf0b7 Treatment of all family members is required to eliminate asymptomatic reservoirs of\\npotential re infection.\\n\\uf0b7 Proper sanitation and good personal hygiene, hand washing with soap after defecation\\nand before meals may prevent infection.\\n\\uf0b7 Infection can be minimized by avoidance of unpeeled fruits and vegetables and use of\\nclean drinking water. Regular washing and disinfection of linen.\\nFILARIASIS\\nFilariasis iscaused bywuchereria bancroftiin 90% of cases.Lymphatics are mainly affected,\\nresulting in gross limb swellings.\\nSalient features\\nInvestigations: Total and differential count shows eosinophilia. Immature worms\\n(microfilaria) seen in nocturnal peripheral blood smears.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Manual lymphoedema drainage'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 170, 'page_label': '171'}, page_content='Infections\\n155\\n\\uf0b7 Multilayer lymphoedema bandage\\n\\uf0b7 Compression garments,exercise\\n\\uf0b7 Skin care to prevent athlete foot with 3% benzoic acid, for dry skin paraffin ointment, for\\nhyperkeratosis 5% salicylic acid,\\nPharmacological treatment\\nTab.diethylcarbamazine 6mg/kg for 21 days .for acute cases and antipyretics for fever\\nSurgical treatment\\n\\uf0b7 Bypass procedures\\n\\uf0b7 Omental pedicle\\n\\uf0b7 Nodovenous shunt\\n\\uf0b7 Limb reduction procedures'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 171, 'page_label': '172'}, page_content=\"156\\n\\uf0b7 Blocked ear andpain\\n\\uf0b7 Tinnitus,reflex cough on manipulation,vertigo\\nChapter10\\nENT DISEASES\\nEAR -WAX\\nExternal ear wax is the accumulated secretion from ceremonious gland situated in outer part\\nof meatus may form a solid, often hard mass giving rise to deafness and discomfort in the ear.\\nSalient features\\nInvestigations\\n\\uf0b7 Otoscopy\\n\\uf0b7 Brownish-black mass in external auditory canal.\\nPharmacological treatment\\n\\uf0b7 For severe pain Tab. ibuprofen 400 mg SOS, in children 20 g/kg/day divided into 3 doses.\\n\\uf0b7 Wax softener (turpentine oil- 15%, benzocaine - 2.7%), chlorbutol- 5%,\\nparadichlorobenzene-2%) 3-4 days before cleaning the ear when the wax is hard.\\n\\uf0b7 Followed by surgical removal (to be carried out by an Otolaryngologist).\\n\\uf0b7 Syringing with sterile saline solution at body temperature pushed along the posterior wall\\nof the meatus to take out the wax. The meatus should be mopped dry after syringing.\\n(Caution: if there is previous history of ear discharge or perforated drum or instrumental\\nmanipulation with ringprobe, hook or forceps and suction cleaning).\\nPatient education\\n\\uf0b7 Wax is a normal secretion and provides protection to the ear drum and should be removed\\nonly if it disturbs hearing.\\n\\uf0b7 Avoid cleaning the ear with buds as it can push the wax to the deepercanal.\\nReferences\\n1. Diseases of the External Ear. In: Logan Turner's Diseases of the Nose, Throat and Ear, 10th Edition, pp\\n265-67.\\nKERATOSIS OBTURANS\\nCollection of desquamated epithelium mixed with wax in external auditory canal causing\\nballooning of the canal is known as Keratosis obturans.\\nSalient features\\n\\uf0b7 Difficulty in hearingand severe pain\\n\\uf0b7 Serosanginuous discharge\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 172, 'page_label': '173'}, page_content='ENT Diseases\\n157\\n\\uf0b7 Blocked ear,m ovement of pinna painful\\n\\uf0b7 Severe pain and occasionally discharge\\n\\uf0b7 Regionallymphadenitis\\nInvestigations\\nOtoscopy- cerumen admixed with desquamated debris, external canal granulations and bone\\nerosion\\nTreatment\\n\\uf0b7 Initially soften the mass with sodium bicarbonate ear drops daily for several days\\nfollowed by syringing.\\n\\uf0b7 Removal under general anaesthesia using microscope.\\nFURUNCLE\\nFuruncle is the infection of the root of a hair follicle caused bystaphylococcus aureusin\\ncartilaginous external auditory canal.\\nSalient features\\nInvestigations\\n\\uf0b7 History of recent cold and influenza, sign of middle ear infection\\n\\uf0b7 Otoscopy examination may reveal boils\\n\\uf0b7 Maximum tenderness over tragus and post-auricular lymphadenitis\\n\\uf0b7 Obliteration of post aural sulcus with forward displacement of aurical\\n\\uf0b7 Mastoid radiograph show well developed clear cell on affected side\\nNon -pharmacological treatment\\n\\uf0b7 Local heat\\nPharmacological treatment\\n\\uf0b7 10% ichthamol in glycerine wick pack or  antibiotic steroid cream wick pack (polymyxin\\nB sulphate 500 IU, neomycin sulphate 3400 IU, zinc bacitracin 400 IU, hydrocortisone 10\\nmg, per g) wick packing to be done on alternate day till swelling subsides followed by/or\\n\\uf0b7 Local ear drops (polymyxin B sulphate 1000 U, neomycin sulphate 3400 U,\\nhydrocortisone 10 mg/ml).\\n\\uf0b7 Systemic antibacterial like Cap. amoxicillin 500mgTDS 5-7 days or azithromycin 500mg\\nOD for 3-5 days  antibiotics\\n\\uf0b7 Tab. ibuprofen 400 mg as and when requiredorTab. nimesulide 100 mg twice a day.\\n\\uf0b7 Incision and drainage may be necessary in some cases.\\nPatient education\\n\\uf0b7 Patients with recurrent boils, diabetes mellitus should be ruled out\\n\\uf0b7 Avoid ear picking.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 173, 'page_label': '174'}, page_content=\"ENT Diseases\\n158\\n\\uf0b7 Irritation and itching of ear discharge (thick white debris like.)\\n\\uf0b7 If the discharge isw hitelikeblotting paperâ€“ candida, black mass with myceliaâ€“\\naspergillus Nigerand pale blue and greenâ€“ aspergillus fumigatus.\\nOTOMYC OSIS\\nOtomycosis is the fungal infection of the ear canal. Secondary growth occurs in patients\\nusing topical antibiotics for otitis externa or middle ear suppuration.\\nSalient features\\nInvestigations\\n\\uf0b7 Direct otoscopic examination\\n\\uf0b7 Microscopic examination in10% KOH\\n\\uf0b7 Culture in sabourdâ€™s Dextrose agar\\nNon -pharmacological treatment\\n\\uf0b7 Regular ear toilet-by suction/dry mopping/instrumentation.\\nPharmacological treatment\\n\\uf0b7 Topical clotrimazole as 1% powder or liquid 3-4 times a day to be continued for at least\\na week after clinical resolution of the infection.\\n\\uf0b7 Tab. ibuprofen 400 mg as and when required. In children 20 mg/kg/day in 3 divided\\ndoses.\\nPatient education\\n\\uf0b7 Ear is to be kept dry; entry of water into the ear should be prevented.\\nReferences\\n1. Diseases ofthe External Ear. In: Logan Turner's Diseases of the Nose, Throat and Ear, 10th Edition, pp 274-\\n75.\\n2. External Auditory Meatus. In: Scott- Brown's Otolaryngology, JB Booth (ed) Vol 3, 6th Edition, 1997,\\nButterworth-Heinemann, pp 3/6/14-15.\\nMALIGNANT OTI TIS EXTERNA\\nExternal otitis in diabetic patients or those who are using immunosuppressive drugs due to\\nPseudomonas aeruginosainfection\\nSalient features\\nInvestigations\\n\\uf0b7 Otoscopy shows external canal inflammation and granulation\\n\\uf0b7 Cranial nerve paralysisor  facial palsy is common\\n\\uf0b7 To exclude diabetes / CT scan temporal bone to rule out osteomyelitis of temporal bone.\\n\\uf0b7 Severe pain andswelling around the ear / facial weakness\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 174, 'page_label': '175'}, page_content=\"ENT Diseases\\n159\\n\\uf0b7 Pain, feverand ear discharge\\n\\uf0b7 Hearing impairmentand tinnitus\\n\\uf0b7 Symptoms in childrenincludefever, vomiting, diarrhea,sleeplessness, incessant cryand\\nirritability\\nPharmacological treatment\\n\\uf0b7 Topical anti-pseudomonal antibacterials (ciprofloxacin, carbenicillin, amikacin,\\ntobramycin, ticarcillin, third generation cephalosporins)\\n\\uf0b7 Surgical debridement of devitalised tissue and bone to be done judiciously.\\nACUTE SUPPURATIVE OTITIS MEDIA\\nIt is an acute inflammation of middle ear caused by pyogenic organism. It is common in\\nchildren, associated with upper respiratory infection and exanthematous fevers.\\nSalient features\\nInvestigations\\n\\uf0b7 Otoscopy shows congested and bulging tympanic membrane\\n\\uf0b7 Mucopurulent discharge\\nNon pharmacological treatment\\n\\uf0b7 Steam inhalation and to keep the ear clean in case of pus discharge.\\nPharmacological treatment\\n\\uf0b7 Tab. paracetamol 500 mg SOS\\n\\uf0b7 Cap. amoxicillin 250-500 mg 8 hourly for 7 days. In complicated cases and children <2\\nyears duration of treatment 10 days or Cap. cephalexin 250-500 mg 8 hourly. In children\\n20-40 mg/kg/day in 3 divided doses. Switch antibiotics if no clinical improvement by 3rd\\nday.\\n\\uf0b7 Xylometazoline HC1 0.1% 1 -2 nasal drops in each nostril 1-2 times daily.\\nIn Children (0.05%) 1-2 nasal drops 1-2 times daily or oxymetazoline 0.05% 1-2 nasal\\ndrops in each nostril 2 times daily. In Children (0.01%) 1-2 drops 2 times daily.\\n\\uf0b7 Refer to an Otolaryngologist if there is intense pain, bulging of the ear drum or persisting\\nfever despite treatment for myringotomy.\\nPatient education\\n\\uf0b7 Treat upper respiratory and sinus infections atthe earliest.\\nReferences\\n1. Acute Suppurative Otitis Media and Acute Mastoiditis. In: Scott Brown's Otolaryngology, Vol 3, JB Booth\\n6th Edition, pp 3/9/1-15.\\n2. Acute Otitis Media in Adults. In: Logan Turner's Diseases of the Nose, Throat and Ear 10th Edition, pp 280-\\n81.\\n3. Diseases of the Middle Ear Cleft. In: A Synopsis of Otolaryngology, 4th Edition, 91-109.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 175, 'page_label': '176'}, page_content='ENT Diseases\\n160\\n\\uf0b7 Ear discharge-Mucopurulent / intermittent / not foul smelling / profuse / not blood\\nstained. Associated withupper respiratory tract infection\\n\\uf0b7 Hearing loss (conductive) and Tinnitus\\n\\uf0b7 There are two stages-active and inactive (no discharge, only hearing loss)\\n\\uf0b7 Proteus,Pseudomonas, K lebsiella,E. Coli.,Staphylococcusaureus are the most\\ncommon organisms. While anaerobes organisms includeBacteroidesfragilis(most\\ncommon) and anaerobicStreptococci.\\nCHRONIC SUPPURATIVE OTITIS MEDIA\\nChronic Suppurative Otitis Media(CSOM)  a long standing infection of middle ear clef,\\ncharacterized by ear discharge and permanent perforation of tympanic membrane.It is\\nclassified as tubo tympanic disease (safe ear)and attico-antral disease (unsafe ear).\\nSalient features\\nInvestigations\\n\\uf0b7 Otoscopy showsdischarge mucopurulent / mucoid / dry,perforationâ€“ central perforation\\n\\uf0b7 Conductive deafness (tuning fork test) (confirm degree and type of hearing loss)\\n\\uf0b7 Middle ear mucosa-normal in quiescent stage, edematous and velvety in active stage\\n\\uf0b7 Examination under microscope,audiogram\\n\\uf0b7 Pus culture and sensitivity\\n\\uf0b7 X -ray mastoids-both ears sclerotic. May be pneumatised with clouding of air cells to\\nassess co-morbid status\\n\\uf0b7 HRCT temporal bone which help in (1) establishing cholesteatoma (2) operative planning\\nNon -pharmacological treatment\\n\\uf0b7 Aural toilet by dry mopping orcareful suction.\\nPharmacological treatment\\n\\uf0b7 Topical antibiotics like ciprofloxacin HC1 0.3% w/v ear drops 2-3 drops 3-4 times daily\\n\\uf0b7 When associated with marked inflammation, addprednisolone 0.5% + chloramphenicol\\n5% + lignocaine 2% + acetic acid 2% to beused as 3-4 drops 3-4 times daily.\\n\\uf0b7 For profuse mucopurulent discharge and associatedupper respiratory tract infection\\n(URTI), Cap. amoxicillin 750-1500 mg in 3 divided doses.In children 20-40 mg/kg in 3\\ndivided doses. The choice of antibiotic depends onthe culture and sensitivity report.\\nSurgical treatment\\n\\uf0b7 O nce the ear is dry and any local nidus of infection has been treated the ear can be taken\\nup for myringoplasty after assessing the hearing status.\\nPatient education\\n\\uf0b7 Avoid water or dust to enter the ear.Explain the patient to take immediate treatment in\\ncase ofURTI. N ot to instill oil if there is a discharge from the ear or if the patient is\\nknown to have perforation of ear drum.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 176, 'page_label': '177'}, page_content=\"ENT Diseases\\n161\\n\\uf0b7 Deafness, sensation of fluid, tinnitus.Earache and ear drum appear to be normal,\\nlusterless retracted or fluid level or air bubbles may be seen behind the drum.\\n\\uf0b7 Headache, nasal obstruction, hawking andpostnasal drip.Fever, malaise,congested\\nnasal mucosa, pus in the middle meatus and tendersinuses.\\nReferences\\n1. Diseases of the External Ear. In: Logan Turner's Diseases ofthe Nose, Throat and ear 10th Edition, pp 271-\\n73.\\n2. Management of Chronic Suppurative Otitis Media. In: Scott Brown's Otolaryngology', JB Boothy (ed), Vol\\n3, 6th Edition, 1997, pp 3/10/1-11.\\nSEROUS OTITIS MEDIA\\nIt is characterized by the presence of non-purulent fluid in middle ear cleft which maybe due\\ntoEustachian tube dysfunction, unresolved acute otitis media or viral infection. It is one stage\\nfurther then Eustachian tube catarrh where fluid having a consistency of glue collects in the\\nmiddle ear producing conductive deafness.\\nSalient features\\nInvestigations\\n\\uf0b7 Audiogram reveal conductive deafness\\n\\uf0b7 Impedance audiometry show flat type of curve (B curve)\\nPharmacological treatment\\n\\uf0b7 Cap. amoxycillin 250 mg with clavulanic acid 375 mg,TDS beforemeals for 21days.\\n\\uf0b7 Tab.pseudoephedrine120 mg 8 hourly. In children 1-2 mg/kg twice daily.\\nSurgical treatment\\n\\uf0b7 For patients not responding to long term pharmacological measures. This include\\nmyringotomy with or without grommet insertion, adenoidectomy, treatment forsinusitis\\nand even mastoidotomy in refractory cases.\\nPatient education\\n\\uf0b7 Do not instill oil in the ear.\\nReferences\\n1. Management of Chronic Otitis Media. In: Scott Brown's Otolaryngology, JB Booth (ed), Vol. 3, 6th\\nEdition, 1997, Butterworth-Heinemann, pp 3/9/1-15.\\nACUTE SINUSITIS\\nItisinflammation of paranasal sinuses. Acute maxillary sinusitisis the commonest type of\\nsinusitis while acute ethmoidal sinusitis is more common in infants and children.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 177, 'page_label': '178'}, page_content=\"ENT Diseases\\n162\\nInvestigations\\n\\uf0b7 X ray paranasal sinusesâ€“ Waterâ€™s view -haziness or opacity /fluid level.\\n\\uf0b7 C T-para nasal sinuses in selectedcases where WBC, ESR, Positive blood culture confirm\\n\\uf0b7 Trans illumination test reveal opaque sinuses\\nNon -pharmacological treatment\\n\\uf0b7 Steam inhalation vianose 2-3 times/dayfor 2-3 days andrest.\\nPharmacological treatment\\n\\uf0b7 Tab. paracetamol 500 mg 3-4 times a day for 5days (children 10 kg/dose) or Tab.\\nibuprofen 400 mg-600 mg 3 times a day for 5 days (children 10 mg/kg/dose.)\\n\\uf0b7 Cap. amoxicillin 500 mg 8 hourly for 5-7 days(children 50 mg/kg/day).\\nSinusitis of dental origin\\n\\uf0b7 Cap. amoxicillin 500 mg 3 times a day for 5-7 days.\\n\\uf0b7 Tab. metronidazole 400 mg 3 times a day for 5-7 days.\\n\\uf0b7 Tab. bromhexine 8 mg 3 times a day for 7 days.\\nIf nasal obstruction or rhinorrhoea,\\n\\uf0b7 Normal saline nasal 1-2 drops in each nostril 2-3 times a day.Or ephedrine 0.75% nasal\\ndrops in isotonic saline 1-2 drops in each nostril 2 times a day. In children 0.5% 1-2 drops\\nin each nostril 2 times daily. Or oxymetazoline HCl 0.05% nasal drops. 1-2 drops in each\\nnostril 2 times a day. In children 0.025% 1-2 drops in each nostril 2 times daily.\\n\\uf0b7 Xylometazoline 0.1% nasal drops 2-3 drops in each nostril 2-3 times a day. In Children\\n0.05% 1-2 drops in each nostril 2 times daily.\\n(Caution:Medicated nasal drops shouldnot be used for more than 7 days).\\nImprovement is seen in symptoms viz. pain tenderness, nasal obstruction and discharge\\nwithin 48-72 hours after initiation of therapy. If there is no desirable response patient should\\nbe referred to an Otolaryngologist.\\nPatient education\\n\\uf0b7 To take full course of systemic antibiotics to avoid the risk of developing antimicrobial\\nresistance.\\n\\uf0b7 Prolonged use of topical decongestants more than a week to be avoided as it can cause\\natrophic rhinitis, anosmia and rhinitis medicamentosa.\\nReferences\\n1. Acute Rhinosinusitis. In: Logan Turner's Diseases of Nose, Throat and Ear. 10th Edition pp 34-6.\\nEPISTAXIS\\nEpistaxis is defined as bleeding through the nose. The common cause in children may be due\\nto nose picking, in adolescents (especially males) due to juvenile nasopharyngeal\\nangiofibroma and hypertension /neoplasm in elderly.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 178, 'page_label': '179'}, page_content=\"ENT Diseases\\n163\\n\\uf0b7 Sneezing, itching, watery nasal discharge and a feeling of nasal obstruction.  It may be\\nassociated with allergic conjunctivitis and bronchial asthma.\\n\\uf0b7 Sneezing, itching watery rhinorrhoea and conjunctivitis areprominent symptoms  in seasonal\\nallergic rhinitis (SAR/Hay fever) while perennial allergic rhinitis (PAR) due  to long standing\\nnasal mucosal congestion with purulent nasal dischargeassociated with  nasal blockage, post\\nnasal discharge and hyposmia.\\nInvestigations\\n\\uf0b7 Baseline investigations including complete hemogram, coagulation profile, blood\\ngrouping and typing\\n\\uf0b7 X rayparanasal sinuses and  CT para nasal sinusesâ€“ if necessary\\nTreatment\\n\\uf0b7 Resuscitative measures if clinical parameters suggestive of hemodynamic compromise\\n\\uf0b7 Cauterization\\n\\uf0b7 Anterior and posterior nasal packing\\n\\uf0b7 Surgicalâ€“ endoscopic cautery and ligation of vessels\\nPatient education\\n\\uf0b7 Avoid insertingfingers into the nose, especially children.\\n\\uf0b7 As first aid, explain how to pinch the nose tightly and apply ice pack over the nose, while\\nwaiting for proper medical attention.\\nReferences\\n1. Epistaxis. In: Scott Brown's Otolaryngology, IS MacKay and TR Bull (eds) Vd4, 6th Edition, 1997,\\nLondon: Buttcrworths. pp 4/18/1-19.\\nALLERGIC RHINITIS\\nAllergic rhinitis is an IgE mediated type I hypersensitivity reaction of mucus membrane of\\nnasal cavity sometimes affecting paranasal sinuses due to mucosal continuity.\\nSalient features\\nInvestigations\\n\\uf0b7 Peripheral blood eosinophilia\\n\\uf0b7 Nasal smearâ€“ shows eosinophilia\\n\\uf0b7 X ray nose and para nasal sinuses\\n\\uf0b7 Intranasal provocation test\\n\\uf0b7 Specific IgE antibody test\\nNon -pharmacologicaltreatment\\n\\uf0b7 Avoid allergens.\\nPharmacological treatment\\n\\uf0b7 Tab. cetrizine 10-20 mg in a single daily dose for 7 days In children 5 mg od or\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 179, 'page_label': '180'}, page_content=\"ENT Diseases\\n164\\n\\uf0b7 Nasal stuffiness, rhinorrhea, sneezing and low grade fever.Nasal obstruction, profuse\\nmucopurulant secretions\\n\\uf0b7 Sore throat for 1 or 2 days followed by cough and nasal discharge.\\n\\uf0b7 Tab. chlorpheniramine maleate 4 mg 6-8 hourly for 7 days. (Caution: Not recommended\\nfor children under 1 year)  Or\\n\\uf0b7 Tab. pheniramine maleate 25-50 mg 8 hourly for 7 days.In children 0.5mg/kg/day\\ndivided in 3 doses. The duration of treatment may need to be extended depending upon\\nthe response of the patient.\\n\\uf0b7 If nasal obstruction and rhinorrhoea,Normal saline nasal drops 1-2 drops in each nostril 2\\ntimes daily or  xylometazoline 0.1% nasal drops 1-2 drops 2-3 times daily for 5-7 days. In\\nchildren 0.05% 1-2 drops 2 times daily. or oxymetazoline 0.5% nasal drops 2-3 drops 2-3\\ntimes daily for 5-7 days. In children 0.025% 1-2 drops 2 times in each nostril\\n\\uf0b7 If the signs and symptoms are persistent,Betamethasone/ hydrocortisone nasal drops 2-3\\ntimes/ day.Beclomethasone inhaler (50 mcg/puff) 2 puffs 12 hourlyor budesonide (50-\\n100 mcg/puff) 1-2 puffs a day or fluticasone 150 meg/puff 1-2 puffs a day. OrTopical\\nazelastine intranasal spray 2-3 times a day.\\n\\uf0b7 In case of no response to the above treatment,Tab. prednisolone 5-60 mg/day in3-4\\ndivided doses for 5-7 daysor Tab. dexamethasone 0.5-5.0 mg/day in 3-4 divided doses\\nfor 5-7 days. Or Tab. betamethasone 0.5-5.0 mg/day in 3-4 divided doses for 5-7 days.\\nPatient education\\n\\uf0b7 This disease is due to hypersensitivity and there is no cure but symptoms can be controlled\\neffectively by the judicious use of drugs and the patient can lead a normal life.\\n\\uf0b7 Avoid prolong use of topical decongestant nasal drops as it can cause atrophic rhinitis,\\nanosmia and rhinitis medicamentosa.\\n\\uf0b7 Chlorpheniramine, pheniramine etc. can cause sedation, cognitive impairment. Patient\\nshould avoid tasks requiring alertness and skill. These drugs can also cause dryness of the\\nmouth and urinary hesitancy.\\n\\uf0b7 Systemic steroids should not be stopped abruptly. Dose to be tapered off before cessation\\nof therapy.\\n\\uf0b7 Medicated nasal drops should not be used for more than seven days.\\nReferences\\n1. Mechanism and Treatment of Allergic Rhinitis. In: Scott Brown's Otolaryngology. JB Booth (ed), 6th\\nEdition, 1997. Butterworthâ€™s-Heinemann, pp 4/6/1-16.\\nCOMMON COLD (CORYZA)\\nIt is one of the most common viral infection affecting upper respiratory tract.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 180, 'page_label': '181'}, page_content=\"ENT Diseases\\n165\\n\\uf0b7 Sever pain and tenderness over the tip of nose.There may be headache, malaise and\\npyrexia.Examination reveals congestion and swelling of vestibule.\\nNon -pharmacological treatment\\n\\uf0b7 Steam inhalation 2-3 times/day\\n\\uf0b7 For nasal obstruction, saline nasal drops 1-2drops in each nostril 2-3 times daily\\nPharmacological treatment\\n\\uf0b7 Tab. chlorpheniramine 4mg 8 hourly for 5-7 days. (in children 0.35mg/kg/day in 3 equal\\ndoses)  or  Tab. pheniramine 25mg 2-3 times daily for 5-7days ( in children 0.5mg/kg/day\\ndivided in equal doses)  or  Tab. cetirizine dihydrochloride 10mg once a day 5-7days (in\\nchildren 5mg once per day).\\n\\uf0b7 If patient has malaise and fever,\\n\\uf0b7 Tab. paracetamol 1500mg 3-4 times aday for 2-3 days and then as when required (in\\nchildren 40-60mg/kg/day divided in 4 doses)\\nIf nasal obstruction is severe,\\n\\uf0b7 Ephedrine 0.75% nasal drop,1-2drops in each nostril 3 times a day for 2-3 days or\\noxymetazoline HCL 0.05% nasal drops,1-2drops in each nostril 3 times a day for 2-3\\ndays( in children 0.025% nasal drops,1 drop 2 times daily or  xylometazoline 0.1%, 1-\\n2drops in each nostril 3 times a day for 2-3 days( in children 0.05%, 1-2 drops 2 times\\ndaily)  (Caution: Not recommended in children below 6yrs of age, medicated nasal drops\\nshould not used for more than 7 days)\\nPatient education\\n\\uf0b7 This is a self-limiting viral infection and usually subsides in one week requiring only\\nsymptomatic relief.\\n\\uf0b7 Antibiotics have no role.\\n\\uf0b7 Chlorpheniramine and pheniramine can cause sedation and cognitive impairment,\\ntherefore should be avoided for tasks requiring alertness and skill.\\n\\uf0b7 Medicated nasal drops used for longer periods can cause rebound congestion and rhinitis\\nmedicamentosa.\\nReferences\\n1. Acute Rhinosinusitis. In: Logan Turner's Disease of the Nose, Throat and Ear. 10th Edition, PP 34\\nFURUNCULOSIS OF NOSE (VESTIBULITS)\\nFurunculosis is acute infection of hair follicle withStaphylococcus aureus.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Local applicationof moist heat will enhance the localization of infection and promote\\ndrainage.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 181, 'page_label': '182'}, page_content='ENT Diseases\\n166\\n\\uf0b7 Throat pain, difficulty in swallowing.\\n\\uf0b7 Pyrexia, cervical lymphadenopathy.\\n\\uf0b7 Inflamed tonsils with exudates\\nPharmacological treatment\\n\\uf0b7 Cap. amoxicillin 500mg 8hrly for 5-7 days (in children 25-50mg /kg/day in 3 divided\\ndose)  or Cap. amoxicillin 250/500mg plus clavulanic acid 125mg 8hr for 5-7days\\n\\uf0b7 Tab ibuprofen 400-600mg 3 times in a day for 5 days (In children 10mg/kg/dose orTab\\nparacetamol 500 mg 6hrly for 2-3days then as and when required till pain and fever\\nsubsides (in children 10mg/kg/dose 6-8hrly).\\n\\uf0b7 Usually improvement in pain,tenderness and inflammation occur within 24-48hr after\\nimitation of treatment, patient should be monitored regularly. However, if there is flaring\\nof infection in the form of spreading facial cellulitis then patient should be hospitalized\\nand shifted to systemic IV antibiotics. If patient is having recurrent furunculosis, then the\\npatient must be investigated for diabetes mellitus.\\nPatient education\\n\\uf0b7 Do not fidget with the furuncle as this lies in the dangerous area of the face and cause\\nserious complications.\\n\\uf0b7 Complete antibiotic therapy to avoid risk of developing antimicrobial resistance\\nReferences\\n1. Disease of external nose and nasal vestibule. In diseases of ear nose and throat, PL Dhingraâ€™s 2 nd edition.\\nACUTE TONSILLITIS\\nThe common cause is viral infection due toadenovirus and Epstein-Barr virus. Secondary\\nbacterial infection due to Group AÎ² haemolytic S treptococci,H aemophilus influenza,\\nStaphylococcusalso occurs.\\nSalient features\\nPharmacologicaltreatment\\nâ€¢ Tab. paracetamol 500 mg 3-4 times a day for5 days (children 10 kg/dose) or Tab.\\nibuprofen 400 mg-600 mg 3 times a day for 5 days (children 10 mg/kg/dose.)\\nâ€¢ Cap.amoxicillin 500mgTDS for 5 days. Or Tab. erythromycin 500mgQID for 5-7\\nCHRONIC TONSILLITIS\\nChronic inflammation of tonsil starts asan acute inflammation. Minute abscesses get walled\\nby chronic inflammation.It can be chronic parenchymatous or hypertrophic type tonsillitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 182, 'page_label': '183'}, page_content='ENT Diseases\\n167\\n\\uf0b7 Tonsils are uniformly enlarged and congested.Chronic follicular tonsillitis shows beads of\\nwhite discharge on surface of tonsil.Tonsils are small and inflamed, occur in adults,\\nanterior pillars are congested inchronic fibrotic tonsillitis\\nSymp toms\\n\\uf0b7 Repeated attacks of sore throat with little remission between attacks\\n\\uf0b7 Odynophagia, fever,cough and irritation in throat. Halitosisâ€“foul breath. Thick speech,\\ndifficulty in breathing, swallowing and snoring\\nSigns\\n\\uf0b7 Hypertrophied tonsils, congestionof anterior pillar, enlarged non-tender jugulodigastric\\nnodes\\n\\uf0b7 Extrusion of purulent discharge on pressure over the tonsil with a tongue depressorâ€“ Irwin\\nMooreâ€™s sign\\n\\uf0b7 Bilateral parotid swelling,pain over gland, ear pain\\n\\uf0b7 Low -grade fever, arthralgia, malaise,headache\\n\\uf0b7 Pain, swelling, tenderness,indurationsof gland.Erythema of skin and oral mucosa, fever.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Cap. amoxicillin 500mgTDS / tab. azithromycin 500mgOD for 5-7 days\\n\\uf0b7 Tab. paracetamol 500mgTDS for 5 days\\n\\uf0b7 Bed rest\\n\\uf0b7 Surgeryâ€“ tonsillectomy for  recurrent episodes of tonsillitis\\nACUTE PAROTITIS\\nKnown as mumps, caused by paramyxovirus. It usually affects children less than 15 years.\\nthe incubation periodâ€“2-3 weeks.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Supportive measures-bed rest, adequate hydration, antipyretics\\n\\uf0b7 Preventionâ€“ Measles Mumps Rubella (MMR) vaccine\\nBACTERIAL PAROTITIS\\nMechanical blockage of salivary duct or due to stasis of salivary secretions coupled with\\nsecondary infection results in bacterial parotitis. It is prevalent in debilitated patients.\\nRetrograde migration of intra-oral bacteria contributes to development of acute bacterial\\nparotitis. Sialolithiasis is the cause of acute parotitis in non-debilitated patients.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 183, 'page_label': '184'}, page_content='ENT Diseases\\n168\\nInvestigations\\n\\uf0b7 Leucocytosis\\n\\uf0b7 Milking of gland for purulent discharge through the duct for culture and sensitivity\\n\\uf0b7 Palpation and X-ray for stone\\nNon -pharmacological treatment\\n\\uf0b7 Adequate hydration, goodoral hygiene\\n\\uf0b7 Warm compression and repeated massage of the gland. Stone in the distal ductâ€“\\nexpressed manually or removed after enlarging the duct orifice with a small incision.\\nFailure indicates an abscess, which is confirmed by CT scan or USG.\\nPharmacological treatment\\n\\uf0b7 Cap. amoxicillin 500mg thrice a day /Tab. amoxicillin with clavulanic acid 625 mg (in\\nadult)TDS for 7 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 184, 'page_label': '185'}, page_content='169\\n\\uf0b7 A gradually enlarging painless nodule. Very rarely a largeupper lid chalazion may press\\non the cornea, induce astigmatism and cause blurred vision.A â€˜marginalâ€™ chalazion is\\nsimilar except that it involves a gland of Zeis and is therefore located not in the tarsal\\nplate but on the anterior lid margin.\\n\\uf0b7 Patientswith meibomian gland disease or rosacea are at increased risk of chalazion\\nformation which may be multiple and/or recurrent.\\n\\uf0b7 Acute pain and tenderness over inflamed Zeis gland,seen as a localised painful and\\nhard swelling seen near the lid margin.The lid margin is red and oedematous.\\n\\uf0b7 An abscess may form which points near the base of the lash.The pain subsides after\\nevacuation of the pus.\\nChapter 11\\nEYE DISEASES\\nSTYE (EXTERNAL HORDEOLUM)\\nStye is an acute suppurative inflammation of glands of Zeisdue tostaphylococciinfection\\nand is common in young adults and debilitated persons.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Dry hot fomentation applied frequently in early stage is useful.\\nPharmacologicaltreatment\\n\\uf0b7 Evacuation of the pus by pulling the involved lash or incising the abscess.\\n\\uf0b7 Antibiotic eye drops and ointment-to control and prevent spread of infection\\n(fluoroquinolones e.g.m oxifloxacin 0.5% eye drops4 to 6 hourlyuntil infection subsides)\\n\\uf0b7 Systemic antibiotics (e.g. Tab.amoxicillin withclavulanic acid 625 mg TDSfor 5 days)\\n\\uf0b7 For  pain andinflammatione.g. Tab.ibuprofen 400 mg TDS till inflammation subsides.\\nPatient education\\n\\uf0b7 Maintain ocular hygiene to prevent recurrence.\\nCHALAZION\\nA chalazion (meibomian cyst) is a chronic, sterile, granulomatous inflammatory lesion\\ncaused by retained sebaceous secretion leaking from the meibomian or other sebaceous\\nglands into adjacent stroma. A chalazion secondarily infected is referred as an internal\\nhordeolum.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 185, 'page_label': '186'}, page_content='Eye Diseases\\n170\\n\\uf0b7 Common symptoms include itching, foreign body sensation, watering of eyes. It can also\\npresent as pharyngoconjunctival fever and acute haemorrhagic conjunctivitis.\\n\\uf0b7 Frequently a history of recent upper respiratorytract infection or contact with a patient. It\\noften starts in one eye and involves the fellow eye a few days later.\\n\\uf0b7 On examination, inferior palpebral conjunctival follicles and pinpoint subconjunctival\\nhaemorrhages are observed.The common organism responsible isAdenovirus.\\n\\uf0b7 Conjunctival cultures/swabs are not needed unless the discharge is excessive or the\\ncondition becomes chronic.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Treatment may not be required because at least a third of chalazia resolve spontaneously\\nand an internal hordeolummay discharge and disappear. Persistent lesions may be treated\\nas follows:\\n\\uf0b7 Dry hot fomentation applied frequently in early stage is useful.\\nPharmacologicaltreatment\\n\\uf0b7 Steroid injectioninto the lesion is preferable if close to the lacrimal punctum becauseof the\\nrisk of surgical damage.\\n- Between 0.2 and 2m lof 5mg/mL triamcinolone diacetate aqueous suspension diluted with\\nlidocaine (or equivalent) to a concentration of 5mg/mL is injected through the\\nconjunctiva into the tissue around the lesion with a 30-gauge needle.\\n- The success rate following one injection is about 80%. In unresponsive cases a second\\ninjection can be given 2 weeks later.\\n\\uf0b7 Cap. doxycycline (100 mg BD for 7 days)may be required as prophylaxis in patients with\\nrecurrent chalazia, particularly if associated with acne rosacea.\\n\\uf0b7 Incision and curettage, in case of large chalazia, if present for more than 3â€“ 4 months or\\nif cosmetically unacceptable.\\nPatient education\\n\\uf0b7 Recurrence mayoccur;common causes are uncorrected refractive error, blepharitis and\\ndiabetes.\\nVIRAL CONJUNCTIVITIS\\nSalientfeatures\\nNon -pharmacologicaltreatment\\nSelf-limiting condition that typically gets worse for the first 4 to 7 days after onset and may\\nnot resolve for 2 to 3 weeks or longer if there is corneal involvement. It is highly contagious,\\nusually for 10 to 12 days from onset as long as the eyes are red (when not on steroids).\\n\\uf0b7 Use dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7 Restrict work and school for patients with significant exposureto others.\\n\\uf0b7 Frequent handwashing and cool compresses several times per day.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 186, 'page_label': '187'}, page_content='Eye Diseases\\n171\\n\\uf0b7 The patient present with marked itching and watery discharge. History of allergy is\\nusually present.\\n\\uf0b7 On examination, conjunctival papillae and edema over eyelids is seen.\\nPharmacologicaltreatment\\n\\uf0b7 Preservative-free artificial tears (carboxy methyl cellulose 0.5% eye drops) four to eight\\ntimes per day for 1 to 3 weeks. Use single-use vials to limittip contamination and spread\\nof disease.\\n\\uf0b7 Antihistamine (e.g., epinastine 0.05% BD) if itching is severe. Anti-inflammatory drops\\nlikeketorolac 0.5% may also be used if needed.\\n\\uf0b7 If a membrane / pseudomembraneare present, use a steroid in form of drops withor\\nwithout ointment (e.g.loteprednol 0.5% QID,flurometholone 0.1% ointment QID or\\ndexamethasone 0.3% ointment QID). Steroid treatment is maintained depending upon the\\nresponse and then slowly tapered.\\n\\uf0b7 Routine / unsupervised use of topical antibiotics or steroids should be discouraged.\\nPatient education\\n\\uf0b7 Patients should avoid touching their eyes, shaking hands, sharing handkerchiefs, towels\\nwith family members.\\n\\uf0b7 Patientâ€™s drops or ointment must not be used by other members of the family.\\nALLERGIC CONJUNCT IVITIS\\nIt occurs as a result of hypersensitivity reaction due exposure toallergicsubstances.\\nSalientfeatures\\nNon -pharmacologicaltreatment\\n\\uf0b7 Cool compresses several times per day and avoid offending agents.\\nPharmacological treatment\\n\\uf0b7 Topical anti-inflammatory and anti-histaminic drops, depending on the severity\\n(olopatadine 0.1% OD/BD,nedocromil 2% TDS, or ketotifen 0.025%BD, ketorolac\\n0.5% QID).\\n\\uf0b7 In severe cases, mild topical steroid (e.g.,loteprednol 0.2% orfluorometholone 0.1%,\\nQID for 1 to 2 weeks)may have to be added. Steroids are gradually tapered as patient\\nresponds to medications.\\n\\uf0b7 Preservative free artificial tears four to eight times per day.\\n\\uf0b7 Investigate for offending agents and avoidance of the same.\\n\\uf0b7 Oral antihistamine (e.g.,diphenhydramine 25 mg TDS/QID. or cetrizine/\\nlevocetrizine/m ontelukast/loratadine 10 mg OD) can be helpful in severe cases and in\\ncases with associated systemic allergy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 187, 'page_label': '188'}, page_content='Eye Diseases\\n172\\nVERNAL / ATOPIC CONJUNCTIVITIS\\nVernal keratoconjunctivitis (VKC) is a recurrent bilateral disorder in which both IgE- and\\ncell-mediated immune mechanisms play important roles. It primarily affects boys and onset is\\ngenerally from about the age of 5 years onwards (mean age 7 years).\\nSalient features\\nTreatment\\n\\uf0b7 Treat as for allergic conjunctivitis.\\n\\uf0b7 Mast cell stabilizer (e.g.sodium chromoglycate QID) or a dual action mast cell stabilizer\\nand antihistamine (e.g.,olopatadine 0.1% OD/BD) orketotifen 0.025%, orazelastine\\n0.05% for 2 to 3 weeks, prophylactically, before the season starts).\\n\\uf0b7 If a shield ulcer is present, add topical steroid (e.g.,loteprednol 0.5% orflurometholone\\n0.1%, prednisolone 1%, etc) four to six times per day. Taper steroids over 4 week as\\ncondition of patient improves. Shield ulcers may need to be scraped to remove superficial\\nplaque-like material before re-epithelialization will occur.\\n\\uf0b7 Topical antibiotic (e.g.,m oxifloxacin 0.3% eye drop,tobramycin 1% QID) is given if\\nassociated infection is there or steroids are prescribed\\n\\uf0b7 Cycloplegic agent (e.g.,cyclopentolate 1%BD drops or atropine 1% TDS in form of\\ndrops or ointment) if cornea is involved, when there is much pain due to ciliary spasm.\\n\\uf0b7 Consider cyclosporine 0.05% BD if not responding to the preceding treatment. Maximal\\neffect may not be seen for several weeks.\\n\\uf0b7 Follow-up should be done every 1 to 3 days in the presence of a shield ulcer; otherwise,\\nevery few weeks. Steroids are tapered slowly as improvement is noted.\\n\\uf0b7 Anti-allergy drops are maintained for the duration of the season and are often reinitiate a\\nfew weeks before the next spring.\\n\\uf0b7 Patients on topical steroids should be monitored regularly, including IOP monitoring,\\neven if used only on the skin.\\n\\uf0b7 Patients and relatives of children should be strictly instructed not to use or continue\\nsteroids, in any form, withoutmedical advice\\nPatient education\\n\\uf0b7 Avoid exposure to substances causing atopy. Maintain hygiene to preventsecondary\\ninfection.\\n\\uf0b7 Common symptoms include marked itching, thick ropy discharge and seasonal\\noccurrence (during spring/summer)\\n\\uf0b7 History of atopy may be present. Usually seen in young patients, especially boys.\\n\\uf0b7 Large conjunctival papillae seen under the upper eyelid or along the limbus (limbal\\nvernal). Often they are so large as to give a cobble stone appearance.\\n\\uf0b7 Superior corneal â€œshieldâ€ ulcer (a well-delineated, sterile, grayâ€“white infiltrate) maybe\\nseen in some cases.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 188, 'page_label': '189'}, page_content='Eye Diseases\\n173\\n\\uf0b7 The patient complains of redness, foreign body sensation, mucoid or mucopurulent\\ndischarge. Itching is much less prominent.\\n\\uf0b7 On examination, purulent discharge, conjunctival papillae and chemosis are seen.\\n\\uf0b7 If severe or recurrent, conjunctival swab for routinecultures and sensitivities and\\nimmediate Gram stain to evaluate for gonococcus.\\n\\uf0b7 Clinical symptoms start within 12 to 24 hours and include severe purulent discharge,\\nswelling of eyelids\\n\\uf0b7 On examination, conjunctival papillae, marked chemosis and preauricular adenopathy is\\nobserved.Examination of entire cornea for peripheral ulcers (especially superiorly) should\\nbe done because of the risk for rapid perforation.\\n\\uf0b7 Conjunctival scrapings for immediate Gram stain and for culture and sensitivities (e.g.,\\nbloodagar and chocolate agar) should be taken.\\nBACTERIAL CONJUNCTIVITIS (NON -GONOCOCCAL)\\nAcute bacterial conjunctivitis is a common and usually self-limiting condition caused by\\ndirect eye contact with infected secretions. The most common isolates areS. pneumoniae,\\nS.aureus, H. influenzaeand Moraxella catarrhalis.\\nSalientfeatures\\nNon -pharmacological treatment\\n\\uf0b7 Patients should avoid touching their eyes, shaking hands, sharing handkerchiefs, towels,\\netc.\\n\\uf0b7 Restrict work and school for patients with significant exposure to others.\\n\\uf0b7 Frequent hand washing.\\nPharmacologicaltreatment\\n\\uf0b7 Use topical antibiotic therapy [m oxifloxacin 0.5% drops QID or more frequent in severe\\ncases] for 5to 7 days.\\n\\uf0b7 H. influenzaeconjunctivitis should be treated with oralamoxicillin/clavulanic acid (20 to\\n40 mg/kg/day in three divided doses) because of occasionalextra ocularinvolvement\\n(e.g., otitis media, pneumonia, and meningitis). Antibiotic therapy is adjusted according\\nto culture and sensitivity results.\\n\\uf0b7 If associated with dacryocystitis, systemic antibiotics are necessary.\\nPatienteducation\\n\\uf0b7 Follow up every 2 to 3 days initially, then every 5 to 7 days until resolved.\\n\\uf0b7 Maintain ocular hygiene\\nGONOC OCCAL CONJUNCTIVITIS\\nSalientfeatures\\nPharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 189, 'page_label': '190'}, page_content='Eye Diseases\\n174\\n\\uf0b7 Complaints of mild itching and irritation of the eyes and eyelids, purulent or mucoid\\ndischarge from the eyes, photophobia, blurred vision and eye pain are common.\\n\\uf0b7 Diseases progresses slowly, and the more painfulsymptoms may not emerge until\\nadulthood.\\n\\uf0b7 Presence of at least two of the following signs: superior tarsal follicles, limbal follicles\\n(Herbertâ€™s pit), typical conjunctival scarring and vascular pannus.\\n\\uf0b7 Transmission of the disease occurs vial ocular and nasal secretions (direct spread, indirect\\nvia fomites, coughing/sneezing).\\nInitiated if the Gram stain shows gram negative intracellular diplococci or there is a high\\nsuspicion clinically of gonococcal conjunctivitis.\\n\\uf0b7 Inj. ceftriaxone 1 g intramuscularly in a singledose.\\n\\uf0b7 If corneal involvement exists, or cannot be excluded because of chemosis and eyelid\\nswelling, hospitalize the patient and treat withInj.ceftriaxone 1 g intravenously every 12\\nto 24 hours.\\n\\uf0b7 In penicillin-allergic patients, consider an oralfluoroquinolone (e.g.,Tab. ciprofloxacin\\n500 mg, for 5 days) or a single oral dose ofTab.azithromycin 1 g.\\n\\uf0b7 Topicalciprofloxacin ointment QID orfluoroquinolone dropsevery two hours(e.g.,\\ngatifloxacin,m oxifloxacin, orciprofloxacin).\\n\\uf0b7 Saline irrigation QIDuntil the discharge resolves.\\n\\uf0b7 Treat for possible chlamydial co-infection (e.g.,Tab.azithromycin 1 g single dose orTab.\\ndoxycycline 100 mg BD for 7 days).\\n\\uf0b7 Treat sexual partners with oral antibiotics for both gonorrhea and chlamydia as described\\npreviously.\\nPatient education\\n\\uf0b7 The patient should be followed daily until consistent improvement is noted, and then\\nevery 2 to 3 days until the condition resolves.\\n\\uf0b7 The patient and sexual partners should be evaluated by their medical doctors for other\\nsexually transmitted diseases.\\nTRACHOMA\\nTrachoma is an infectious disease caused by theChlamydia trachomatistype A, type B, type\\nC bacterium which produces a characteristicrougheningof the inner surface of the eyelids. It\\nis also calledgranular conjunctivitisand Egyptianophthalmia and is theleading cause of\\ninfectiousblindnessin the world.\\nSalientfeatures\\nGrading of severity'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 190, 'page_label': '191'}, page_content='Eye Diseases\\n175\\nMacCallan Classification\\n\\uf0b7 Stage 1: Superior tarsal follicles, mild superior SPK, and pannus, oftenproceededby\\npurulent discharge andtender preauricular nodes.\\n\\uf0b7 Stage 2: Florid superior tarsal follicular reaction (2a) or papillary hypertrophy (2b)\\nassociated with superior corneal SEIs, pannus, and limbal follicles.\\n\\uf0b7 Stage 3: Follicles and scarring of superior tarsal conjunctiva.\\n\\uf0b7 Stage 4:No follicles, extensive conjunctival scarring.\\n\\uf0b7 Late complications: Severe dry eyes, trichiasis, entropion, keratitis, corneal scarring,\\nsuperficial fibrovascular pannus, Herbert pits (scarred limbal follicles), corneal bacterial\\nsuperinfection, and ulceration.\\nWorld Health Organization (WHO) Classification\\n\\uf0b7 TF (Trachomatous inflammation: follicular): More than five follicles on the upper tarsus.\\n\\uf0b7 TI (Trachomatous inflammation: intense): Inflammation with thickening obscuring more\\nthan 50% of the tarsal vessels.\\n\\uf0b7 TS (Trachomatous scarring): Cicatrization of tarsal conjunctiva with fibrous white bands.\\n\\uf0b7 TT (Trachomatous trichiasis): Trichiasis of at least one eyelash.\\n\\uf0b7 CO (Corneal opacity): Corneal opacity involving at least part of the pupillary margin.\\nTreatment\\nThe SAFE strategy for trachoma management supported by the WHO and other agencies\\nencompasses\\nS Surgery for trichiasis,\\nA A ntibiotics for active disease,\\nF Facial hygiene and\\nE Environmental improvement\\n\\uf0b7 Antibioticsshould be administered to those affected and to all family members. Single\\nantibiotic course is not always effective in eliminating infection in an individual, and\\ncommunities may need to receive annual treatment to suppress infection.\\n- A single dose of azithromycin (20 mg/kg up to 1g) is the treatment of choice.\\n- Topical 1% tetracycline ointment is less effective than oral treatment; it should be given\\nfor 6 weeks.\\n\\uf0b7 Facial cleanlinessis a critical preventative measure.\\n\\uf0b7 Environmental improvementsuch as access to adequate water and sanitation,as well as\\ncontrol of flies, is important.\\n\\uf0b7 Surgeryis aimed at relieving entropion and trichiasis and maintaining complete lid closure\\nwith bilamellar tarsal rotation.\\nCORNEAL ULCER'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 191, 'page_label': '192'}, page_content=\"Eye Diseases\\n176\\n\\uf0b7 Source of infection can be exogenous or endogenous (from other ocular structures)\\n\\uf0b7 Patient presents with history of trauma to the eye with pain and redness. Concomitant\\nphotophobia,discharge and dimness of vision can also be present.\\n\\uf0b7 On examination, conjunctival and circumcorneal vessels may be engorged and inflamed\\nwith localized epithelium disintegrated and cast off.  Ulcer is saucer shaped, walls project\\nabove the normal cornealsurface. Surrounding area shows grey discoloration (cloudiness)\\nsuggestive of the progressive stage of the ulcer-microscopic tissue examination reveals\\nleucocytic infiltration.In severe cases there is pronounced anterior chamber reaction, often\\nwith hypopyon.\\nDefect in the integrity of corneal epithelium along with infiltrationof underlying stroma is\\ndefined as corneal ulcer. It can be due to direct corneal trauma, chronic eyelid disease, tear\\nfilm abnormalities, hypoxic trauma from contact lens wear, and deficient nutrition as in\\nkeratomalacia or neuroparalytic keratitis (Bell's palsy).It is classified as;\\n1. Infective keratitis may be bacterial, fungal or viral.\\n2. Non infective like traumatic (chemical/thermal/radiation), neoplastic or immune mediated\\nBACTERIAL KERATITIS\\nSalientfeatures\\nInvestigations\\n\\uf0b7 Conjunctival swab and ulcer scrapings can be tested with Gram stain, KOH preparation\\nand culture to determine the etiology.\\n\\uf0b7 Routine investigations like complete blood count, blood sugar, urine examination should\\nbe done. Septic foci should be found.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Maintain proper ocular hygiene by cleaning discharge twice a day.\\n\\uf0b7 Removal of contributory factors like trichiasis, foreign body etc.\\n\\uf0b7 The eye can be covered with a pad, unless the discharge is copious. In such case, shield\\nthe eye with dark goggles.\\n\\uf0b7 Prevention and treatment of complicationsâ€“ secondary glaucoma\\nPharmacologicaltreatment\\n\\uf0b7 Control of infection with antibiotics-Start with empirical broad spectrum antibiotics,\\nwhich can be changed according to sensitivity report(Table 1).\\nTable 1. Indication and doses of antibacterials in treatment of bacterial corneal ulcer\\nName Special\\nIndication\\nDose\\nSystemic Subconjunctival Topical\\nGentamicin Gm -ve org. and\\nStaph.species\\n3-5 mg/kg/day I/V or\\nI/M in divided doses\\n20 mg 0.3% drops and\\nointment\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 192, 'page_label': '193'}, page_content='Eye Diseases\\n177\\n8 hourly\\nTobramycin Same as\\ngentamicin\\nSame as gentamycin 5-20 mg 0.3% drops\\nCefazolin Gm +ve cocci\\nand Gm -ve rods\\n25-50 mg/kg/day IV\\nor IM divided doses\\n8hrly\\n100 mg 5% concentration\\nused as topical drops\\nCeftazidime Gm -ve specially\\nPseudomonas\\n1-2 gm IV 8-12\\nhourly\\n100 mg\\nCiprofloxacinBroad spectrum\\nincluding most\\naerobic Gm-ve\\norg.,S. aureus\\nand S.\\nepidermidis\\n500 mg orally 12\\nhourly, 200 mg IV\\n12 hourly\\n0.3% drops and\\nointment\\nOfloxacin Broad spectrum 200-800 mg/day\\norally 200 mg I/V 12\\nhourly\\n0.3% drops\\nNorfloxacin Gm +ve and Gm\\n-ve org. including\\nPseudomonas.\\nNot effective\\nagainst anaerobes\\n400 mg orally 12\\nhourly\\n0.3% drops\\nLomefloxacinGood coverage of\\nGm -ve. Less\\npotent against\\nGm +ve\\n400 mg orally or IV\\n12 hourly\\nInitially 5 drops in\\n20 min or 1 drop\\nevery hour for 6/10\\nhours. Then 1 drop\\n2-3 times a day.\\nSparfloxacinBroad spectrum.\\nGm +ve and Gm\\n-ve org. including\\nanaerobes\\n400 mg orally on\\nday 1, followed by\\n200 mg once a day\\n0.3% drops\\nAmpicillin\\nGm +ve org.\\n(except\\npenicillinase\\nproducingStaph.)\\nand some Gm -ve\\norg.\\n500 mg orally 6\\nhourly, 3-6 g/day IV\\nor IM divided doses\\n6 hourly\\n50-100 mg\\nCloxacillin Penicillinase 250-500 mg orally, 6'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 193, 'page_label': '194'}, page_content='Eye Diseases\\n178\\n\\uf0b7 Common organisms are aspergillus, penicillium, fusariumand candida.Risk factors are\\nleukemia and diabetes, pre existing corneal disease like dry eye, vegetative injury and long\\nterm treatment with antibiotic and steroids.\\n\\uf0b7 On examination, definite white ring in the mid periphery of the cornea with healthy cornea\\nbetween the ring and ulcer margin is seen (Immune ring-diagnostic of fungal infection)\\n\\uf0b7 Presence of hypopyon is the rule. Higher the hypopyon more ominous the sign and chances\\nof perforation.\\nproducingStaph.hourly\\nCephalexin Gm +ve cocci\\nand Gm -ve rods\\n500 mg orally 6\\nhourly\\n\\uf0b7 Use atropine 1% eye drops or ointment for controlling iridocyclitis, to relieveciliary\\nspasm and to prevent synechia formation.\\n\\uf0b7 Other measures like scraping andcauterization. If the ulcer progresses inspite of the\\npharmacological treatment, the removal of the necrotic material may be hastened by\\nscraping or ulcer may be cauterized with 100% carbolic acid, 10% trichloracetic acid 10%\\nor 5% povidone iodine.\\n\\uf0b7 In case of non resolving ulcers, surgical methods like vasculoplasty, conjuctival hooding\\nand patch graft, tectonic penetrating keratoplasty and tarsorraphycan be considered.\\nPatient education\\n\\uf0b7 Use dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7 Restrict work and school for patients with significant exposure to others.\\n\\uf0b7 Frequenthandwashing\\nFUNGAL KERATITIS\\nSalientfeatures\\nNon -pharmacologicaltreatment\\n\\uf0b7 Use dark goggles and avoid close contact with other persons for two weeks.\\n\\uf0b7 Restrict work and school for patients with significant exposure to others.\\n\\uf0b7 Frequent handwashing\\nPharmacologicaltreatment\\n- Treatment should be instituted promptly with topical antifungal drops, initially every hour\\nduring the day tapered to 4 hrly interval for 3-4 days, then reduced to 4 times a day for at\\nleast 14-21 days or till there is resolution of active stage(Table 2).\\n- Subconjunctival injections also may be used in cases of severe keratitis, or when poor\\ncompliance exists.\\n- An oral antifungal (eg,ketoconazole,fluconazole 100mg) should be considered for cases\\nof deep stromal infection.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 194, 'page_label': '195'}, page_content='Eye Diseases\\n179\\n- Fluconazolehas been shown to penetrate better into the cornea after systemic\\nadministration compared to other azoles and is associated with fewer adverse effects.\\nTable 2. Doses of antifungal drugs used in the treatment of fungal infections\\nDrugs Topical Sub conjunctival/oralIntravitreal\\nAmphotericinâ€“B 1-10mg/ml drops 0.37mg sc 5-10Âµg\\nNatamycin 5% drops 25Âµg\\nMiconazole 1% drops\\n2% oint\\nKetokonazole 1% 200-800mg oral/day 0.5mg\\nFluconazole 0.2%-2% 100-200mg  6 hourly 0.1mg\\nIntra-cameral\\n\\uf0b7 Inj. amphotericin-B (5-7.5% Âµg in 0.1ml in 5% dextrose)\\nIntra-corneal\\n\\uf0b7 Inj. amphotericin-B (5Âµg in 0.1ml) four to five places around the lesion intrastromaly, not\\nin thin area\\n\\uf0b7 Inj. voriconazole (50 Âµg in 0.1% in RL solution)\\nSystemic antifungal\\nOral fluconazole and ketoconazole are absorbed systemically with good levels in the anterior\\nchamber and cornea-therefore they should be considered in the management of   deep fungal\\nkeratitis fungal abscess, endothelial plaque.\\n\\uf0b7 Cycloplegics are mandatory and antiglaucoma drugs maybe added to the treatment\\ndepending on the intraocular pressure etc.\\n\\uf0b7 Frequent corneal debridement with a spatula is helpful. It debulks fungal organisms and\\nepithelium, and enhances penetration of the topical antifungal agent\\n\\uf0b7 Surgery is considered in thosepatients whofail to respond to medical treatment and may\\nresult in corneal perforation. The treatment of choice is therapeutic penetrating\\nkeratoplasty.\\nV IRAL KERATITS\\nCommon viruses that cause corneal disease areHerpes simplexvirus (HSV ), Varicella zoster,\\nEpstein Barr and Adenovirus. Cytomegaloviruscan also cause keratitis and is more\\ncommonly associated with AIDS.\\nHERPES SIMPLEX K ERATITIS\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 195, 'page_label': '196'}, page_content='Eye Diseases\\n180\\n\\uf0b7 Herpessimplex keratitis occurs in two formsâ€“ primary and recurrent\\n\\uf0b7 Primary infection of any of the 3 branches (ophthalmic, maxillary, mandibular) of cranial\\nnerve V leads to latent infection of nerve cells in trigeminal ganglion.\\n\\uf0b7 Interneuronal spreadof HSV within ganglion allows patients to develop ocular disease\\nwithout ever having had primary ocular HSV infection\\n\\uf0b7 Recurrent infection has been thought of as reactivation of virus in the sensory ganglion.\\n\\uf0b7 The disease manifests as vesicular blepharoconjunctivitis occasionally with corneal\\ninvolvement as punctate keratitis.\\n\\uf0b7 The patient presents with irritation, photophobia, reduction in vision (when central cornea is\\naffected) and corneal anaesthesia.\\n\\uf0b7 Corneal ulceration and scarring can occasionally be theonly sign of recurrent herpetic\\ninfections. Typical branching, linear pattern with feathery edges and terminal bulbs at ends\\nare visualized by fluorescein staining.\\nPharmacologicaltreatment\\n\\uf0b7 Antiviral drugs\\n- Trifluridine and acyclovir are much more effective in epithelial disease than others.\\n- Idoxuridine and trifluridine are frequently associated with toxic reactions.\\nTable 3. Antiviral drugs used in the treatment of viral keratitis\\nDrug Strength Frequency\\nTrifluridine 1% solution Every 2 hours while awake\\nAcyclovir 3% ointment 5 times daily\\nIdoxuridine 0.1% solution Hourly while awake\\nVidarabine 3% ointment 5 times daily\\n- Oral acyclovir may be useful in treatment of severe herpetic eye disease particularly in\\natopic individuals.\\n- For active treatment 400 mg five times daily in non immunocompromised patients.\\n- 800 mg five times daily in compromised and atopic patients.\\n- Prophylactic dosage in recurrent disease is 400 mg twice daily.\\n- Famciclovir or valacyclovir may also be used.\\n\\uf0b7 Topical corticosteroids accelerate corneal thinning, increasing risk of corneal perforation\\n\\uf0b7 Epithelial debridement is an effective way to treat dendritic keratitis before acyclovir.\\nInfected epithelium is easy to remove with tightly wound cotton tip applicator.\\nAdjunctive therapy with topical antiviral accelerates epithelial healing\\n\\uf0b7 Surgical management like penetrating keratoplasty is indicated for visual rehabilitation in\\npatients with severe corneal scarring. It should not be undertaken until herpetic disease\\nhas been inactive for many months.\\nGLAUCOMA'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 196, 'page_label': '197'}, page_content='Eye Diseases\\n181\\n\\uf0b7 The disease is insidious and usually asymptomatic, until it has caused a significant loss\\nof visual field. Patients may experience mild headache,eye acheand visual field defect\\nin late cases.\\n\\uf0b7 Reading and close work often present increasing difficulties owing to accommodative\\nfailure due to constant pressure on the ciliary muscle and its nerve supply. Therefore,\\npatients usually complain offrequent changes in presbyopic glasses.\\n\\uf0b7 Ocular examination including slit-lamp biomicroscopy may reveal normal anterior\\nsegment. In late stages pupil reflex becomes sluggish and cornea may show slight haze.\\n\\uf0b7 In the initial stages the IOP may not be raised permanently, but there is an exaggeration\\nof the normal diurnal variation. Therefore, repeated observations of IOP (every 3-4hour),\\nfor 24 hours is required during this stage (Diurnal variation test).Applanation tonometry\\nshould be preferred over Schiotz tonometry.\\n\\uf0b7 Gonioscopy reveals open angles.Optic disc changes are typically progressive,\\nasymmetric and present a variety of characteristic clinical patterns. It is essential,\\ntherefore, to record the appearance of the nerve head in such a way that will accurately\\nreveal subtle glaucomatous changes over the course of follow-up period.\\nThe classical triad of increasedintraocular pressure (IOP), optic nerve head cupping and\\nvisual field changes are always present and are signs of progress of the disease and bench\\nmark for assessing response totherapy.\\nPRIMARY OPEN ANGLE GLAUCOMA\\nIn open angle glaucoma the structure of the trabecular meshwork appears normal but offers\\nan increased resistance to the outflow of aqueous which results in an elevated ocular pressure.\\nSalient features\\nInvestigations\\n\\uf0b7 Perimetryto detect the visual field defects.\\n\\uf0b7 Nerve fibre layer analysis and disc topography analysisto detect early damage and for\\nprogression analysis.\\nPharmacologicaltreatment\\n\\uf0b7 Identification of target pressure.From the baseline evaluation data a â€˜target pressureâ€™\\nshould be identified for each patient. Progression of disease is uncommon if IOP is\\nmaintained at less than 16 to 18 mm of Hg in patients having mild to moderate damage\\nand 10 to 12 mmHg in patients with severe damage.\\n\\uf0b7 Single drug therapy. One topical antiglaucoma drug should be chosen after due\\nconsideration to the patientâ€™s personal and medical factors. If the initial drug chosen is\\nineffective or intolerable, it should be replaced by the drug of second choice.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 197, 'page_label': '198'}, page_content='Eye Diseases\\n182\\n\\uf0b7 Combination therapy.If one drug is not sufficient to control IOP then a combination\\ntherapy with two or more drugs should be tried.\\n\\uf0b7 Monitoring of therapyby disc changes, field changes and tonometry is most essential on\\nregular follow-up. In the event of progression of glaucomatous damage, the target\\npressure should be reset at a lower level and any risk factors should be evaluated(Table\\n4).\\nTable 4.Drugs used for treatment of glaucoma\\nTopical agent Side effects\\nBeta-blockers\\n(timolol 0.5%, levobunolol 0.5%,\\nbetaxolol 0.5% -selective)\\nExacerbate asthma and chronic airway disease,\\nhypotension, bradycardia\\nParasympathomimetic\\n(pilocarpine 2%)\\nVisual blurring in young patients, in patient with\\ncataracts, headache due to ciliary spasm\\nSympathomimetic (adrenaline\\n0.5%, dipivefrine 0.1%)\\nRedness, headache, mydriasis\\nAlpha-2 agonist (brimonidine\\n0.2%)\\nRedness, headache, drowsiness, allergic reaction\\nCarbonic anhydrase inhibitors\\n(Systemicâ€“acetazolamide, topical\\nâ€“ dorzolamide 2%, brinzolamide\\n1%)\\nStinging, bitter test\\nProstaglandin analogues\\n(latanoprost 0.005%, bimatoprost\\n0.3%, travoprost 0.004%)\\nRedness, aggravation of inflammation, increased\\npigmentation of iris and peri ocular skin, lengthening of\\ncilia, rarely macular edema.\\nHyper osmotic agents 1-1.5g/kg\\nglycerol, mannitol 1-2g/kg\\nMannitol contraindicated in hypertensives and in patient\\nwith pulmonary edema. Glycerol not to be given in\\ndiabetics\\nLasertreatment\\nArgon laser trabeculoplasty (ALT) or selective laser trabeculoplasty (SLT) are indicated in\\npatients intolerant to topical medication, failure of medical therapy or non compliance to\\ntreatment. Since IOP reduction with laser is seldom greater than 30%, an IOP higher than 28\\nmmHg is unlikely to be adequately controlled by laser alone.\\nSurgicaltreatment\\n\\uf0b7 Uncontrolled glaucoma despite maximal medical therapy and laser trabeculoplasty.\\n\\uf0b7 Non -compliance of medical therapy and\\n\\uf0b7 Intolerance to medical therapy\\n\\uf0b7 Eyes with advanced disease i.e., having very high IOP, advanced cupping and advanced\\nfield loss should be treated with filtration surgery as a primary line of management.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 198, 'page_label': '199'}, page_content='Eye Diseases\\n183\\n\\uf0b7 Patient presents acutely (congestive glaucoma) with coloured halos around lights due to\\ncorneal oedema, ocular pain and headache.\\n\\uf0b7 The IOP rise maybe often be so severe as to cause nausea and vomiting and mimic a case of\\nacute abdomen.\\n\\uf0b7 Precipitating factors include watching television or movie in a darken room, reading,\\npharmacological mydriasis or miosis, acute emotional stress and rarely systemic medications\\nlike parasympathetic antagonists or sympathetic agonists (e.g. inhalers, motion sickness\\npatches and cold remedies) and topiramate.\\n\\uf0b7 On examination,IOP is usually very high (> 40 - 50 mmHg) with conjunctival hyperaemia,\\ncorneal edema, unreactive mid dilated vertically oval pupil.\\n\\uf0b7 Fellow eye generally shows an occludable angle.\\n\\uf0b7 Types of surgeries-trabeculectomy, shunt & valve surgeries, non penetrating glaucoma\\nPatient education\\n\\uf0b7 Treatment of glaucoma whether medical or surgical is aimed to decrease further damage\\nto optic nerve. Once damage has occurred, it is irreversible\\nPRIMARY ANGLE -CLOSURE GLAUCOMA\\nThe term â€˜angle-closureâ€™ refers to occlusion of the trabecular meshwork by the peripheral iris,\\nobstructing aqueous outflow.\\nI. ACUTE ANGLE CLOSURE GLAUCOMA\\nSalientfeatures\\nPharmacologicaltreatment\\nTreatment intensity should be individualized dependent on severity. Hospital admission is\\nusually required in an acute presentation.\\n\\uf0b7 The patient should assume a supine position to encourage the lens to shift posteriorly\\nunder the influence of gravity.\\n\\uf0b7 Inj. mannitol 20% 1â€“2 g/kg intravenously over half hour or glycerol 50% 1 g/kg orally,\\nhaving checked for contraindications.\\n\\uf0b7 Pilocarpine 2â€“4% one drop to the affected eye, repeated after half an hour, and one drop\\nof 1% as prophylaxis into the fellow eye. Some practitioners prefer to omit pilocarpine in\\nan acutely presenting eye with very high IOP until a significant IOP fall has taken place,\\nas the associated ischaemia will compromise the action of pilocarpine on the pupillary\\nsphincter and it may also aggravate the pupillary block.\\n\\uf0b7 An additional oral dose ofTab.acetazolamide 500 mg may be given.\\n\\uf0b7 Topical timolol 0.5%, prednisolone 1% or dexamethasone 0.1% to the affected eye,\\nleaving 5 minutes between each instillation.\\n\\uf0b7 Analgesia and an antiemetic may often be required.\\nSubsequent medical treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 199, 'page_label': '200'}, page_content='Eye Diseases\\n184\\n\\uf0b7 Many patients with angle-closure maybe asymptomatic, including those with intermittently\\nor chronically elevated IOP.\\n\\uf0b7 They may have intermittent milder symptoms of blurring (â€˜smoke -filled roomâ€™)\\nunassociated with pain.\\n\\uf0b7 Pilocarpine 2%QID to the affected eye and 1%QID to the fellow eye.\\n\\uf0b7 Topical steroid (prednisolone 1% ordexamethasone 0.1% QID) if the eye is acutely\\ninflamed.\\n\\uf0b7 Any or all of the following should be continued as necessary according to response:\\ntimolol 0.5%BD and oralacetazolamide 250 mgQID may be required.\\nSurgical treatment\\n\\uf0b7 Definitive treatment is laser iridotomy or iridoplasty after corneal oedema clears. Topical\\nsteroids and any necessary hypotensives canbe continued for at least a week. Surgical\\noptions in resistant cases include surgical peripheral iridectomy, lens extraction,\\ngoniosynechialysisand trabeculectomy.\\nPatient education\\n\\uf0b7 Do not ignore headache or chronic ache in the eyes and report to the ophthalmologist if\\ncoloured halos around light appear.\\nII. CHRONIC ACUTE ANGLE CLOSURE GLAUCOMA\\nSalientfeatures\\nPharmacological treatment\\n\\uf0b7 Timolol 0.5% or betaxolol0.5% eye drops twice a day usually required lifelong.\\nSurgical treatment\\n\\uf0b7 Laser or surgical iridotomy is done to eliminate any element of pupillary block in\\naffected as well as fellow eye.\\nIII.LENS INDUCED GLAUCOMA\\nLens induced glaucoma is classified into phacolytic, phacomorphic, phacoanaphylactic\\nglaucoma, lens particle glaucoma and glaucoma due to dislocated lens. In addition to\\nmedically lowering the IOP, the cataractous lens needs to be removed, under steroid cover to\\nsuppress the inflammatory element.\\nANTERIOR UVEITIS\\nIt is the inflammation of the uveal tract i.e. iris, ciliary body and choroid. Inflammation of iris\\nand ciliary body constitutes iridocyclitis and anterior uveitis.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 200, 'page_label': '201'}, page_content='Eye Diseases\\n185\\n\\uf0b7 Symptoms of acute uveitis include pain, redness, photophobia, consensual photophobia\\n(pain in the affected eye when a light is shown in the fellow eye), excessive tearing and\\ndecreased vision.\\n\\uf0b7 Symptoms of chronic uveitis include decreased vision (from vitreous debris, cystoid\\nmacular edema (CME), or cataract, periods of exacerbations and remissions with few\\nacute symptoms [e.g. juvenile idiopathic (rheumatoid) arthritis].\\n\\uf0b7 Cells andflare in the anterior chamber, ciliary flush and keratic precipitates (KP) are\\nobserved by slit lamp microscopy.\\n\\uf0b7 Complete ocular examination, including an IOP check and a dilated fundus examination.\\nThe vitreous should be evaluated for cells.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Wear dark glasses\\nPharmacological treatment\\n\\uf0b7 Cycloplegic e.g.,cyclopentolate 1% eye drops BD for mild to moderate inflammation;\\natropine ointment 1% TDS for severe inflammation.\\n\\uf0b7 Topical steroid likeprednisolone acetate 1% one drop1 to 6 hourly, depending on the\\nseverity. Most cases of moderate to severe acute uveitis require1 to 2 hourlydosing\\ninitially. Consider FML(flurometholone) 1% ophthalmic ointment at night.\\n\\uf0b7 If the anterior uveitis is severe and is not responding to topical steroids, then consider\\nperiocular repository steroids (e.g.,triamcinolone 20 to 40 mgsubtenon injection).\\n\\uf0b7 If there is no improvement on maximal topical and repository steroids, or if the uveitis is\\nbilateral and severe, consider systemic steroids(Tab. prednisolone 1mg/kg), or\\nimmunosuppressive therapy.\\n\\uf0b7 Treat secondary glaucoma with betablockers, not withpilocarpine orprostaglandin\\nanalogues.\\n\\uf0b7 If an exact etiology for the anterior uveitis is determined (herpes, tuberculosis, ankylosing\\nspondylitis etc.), then appropriate systemic management is required.\\n\\uf0b7 Follow-up is done every 1 to 7 days in the acute phase, depending on the severity and\\nevery 1 to 6 months when stable. At each visit, the anterior chamber reaction and IOP\\nshould be evaluated.\\n\\uf0b7 If the anterior chamber reaction is improving, then the steroid drops can be slowly tapered\\n[usually one drop per day every 3 to 7 days (e.g.,QID for 1 week, thenTDS for 1 week,\\nthenBD for 1 week)].\\nPatient education\\n\\uf0b7 Recurrent nature of the disease which may interfere with vision should be explained and\\npossible complications like cataract and glaucoma should be mentioned.\\n\\uf0b7 Possible side effects of long term topical, periocular andsystemic corticosteroidtherapy\\nshould be explained.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 201, 'page_label': '202'}, page_content='Eye Diseases\\n186\\n\\uf0b7 Common caus es includeStreptococcus pneumoniae, Staphylococcus aureus, Streptococcus\\npyogenesand Haemophilus influenzae.\\n\\uf0b7 Symptoms include swelling of eyelids, severe pain which is increased by movements of eye\\nor pressure and fever, nausea, vomiting and sometimes loss of vision.\\n\\uf0b7 A marked swelling of lids with chemosis of conjunctiva is observed. Restriction of ocular\\nmovements is also seen.\\n\\uf0b7 Fundus examinationmay show congestion of retinal veins and signs of papillitis or\\npapilloedema\\n\\uf0b7 Bacterial culturesshould be performed from nasal and conjunctival swabs and blood\\nsamples,X -ray to identify associated sinusitis and orbital ultrasonographyto detect intra-\\norbital abscess should be done.\\nORBITAL CELLULITIS\\nOrbital cellulitis refers to an acute infection of the soft tissues of the orbit behind the orbital\\nseptum. The infection can be exogenous (trauma, foreign body), endogenous (septicemia)or\\nextension of infection from neighbouring structures (paranasal sinuses, teeth, face, eyelids).\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Warm compresses\\nPharmacologicaltreatment\\n\\uf0b7 Intensive antibiotic therapy:\\n- After obtaining nasal, conjunctival and blood culture samples, intravenous higher broad\\nspectrum antibiotics should be administered.\\n- Tab.amoxicillin andclavulanic acid 625mg TDS should be given OR\\n- Inj. cefotaxime 1-2 gm every 12 hours in adults and 100-150 mg/kg in 2 to 3 divided\\ndoses in children are given. Antibacterials are changed according to the culture sensitivity\\nreports and continued till resolution of symptoms.\\n- Ciprofloxacin orvancomycinmay be used an alternative.\\n\\uf0b7 Analgesic and anti-inflammatory drugsare helpful in controlling pain and fever.\\n\\uf0b7 Surgical intervention is needed when the patient isunresponsive to antibacterials,\\ndecrease in vision and presence of an orbital or subperiosteal abscess.\\nPatient education\\n\\uf0b7 Any ear, sinus or dental infection especially in children should be treated promptly\\n\\uf0b7 Any patient presenting with unexplained lid edema or cellulitis should be immediately\\nreferred to an ophthalmologist.\\nENDOPHTHALMITIS'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 202, 'page_label': '203'}, page_content='Eye Diseases\\n187\\n\\uf0b7 Etiological agents includeStaphylococcus aureus, coagulase negativeStaphylococci,\\nStreptococci, Pseudomonas aeruginosa, Hemophilus influenzaand fungus likeCandida,\\nAspergillus, Histoplasmaetc.\\n\\uf0b7 History of eye surgery, penetrating injury, fever, infection or predisposing systemic diseases\\nleading to metastatic endophthalmitis.\\n\\uf0b7 Sym ptoms include visual loss, pain, discharge, photophobia, lid swelling. Signs include\\nconjunctival congestion, hypopyon, vitrous exudates and loss of red fundus reflex.\\n\\uf0b7 Smear of aqueous humour, vitreous humour can be taken for smear and culture testing.\\nAn tibiotic susceptibility testing can also be done.\\nIt is an inflammation of the internal coats of the eye along with inflammatory conditions of\\nintraocular cavities, aqueous and vitreous humour, retina and uvea. Endophthalmitis can be\\nendogenous (due to hematogenous spread of infective agents) and exogenous (direct\\ninoculation of infecting agents through breach in continuity of ocular coats e.g. post\\ntraumatic).\\nSalientfeatures\\nPharmacologicaltreatment\\n\\uf0b7 Post operative endophthalmitis\\n- Intravitreal injection of antibiotics- Inj. vancomycin hydrochloride 1 mg in0.1 ml plus\\nInj.ceftazidime 2 mg in 0.1 ml or Inj.amikacin sulfate 0.4 mg in 0.1 ml.\\n- Subconjunctival Inj.vancomycin 25 mg/0.5 ml plusInj.ceftazidime 100 mg/0.5 ml plus\\ndexamethasone 0.25 mg/0.5 ml.\\n- Vancomycin eye drops 50 mg/ml plus amikacin eye drops15 mg/ml 1 drop every 6\\nhours.\\n- Homatropine 2% eye drops 3 times a day oratropine 1% eye ointment 2 times a day.\\n- Prednisolone acetate 1% eye drops ordexamethasone orbetamethasone 0.1% eye drops\\nevery 6 hours.\\n- Tab.prednisolone 1 mg/kg/day in a single morning dose after 24 hours of antibiotic use\\nand continue for 10-14 days 2 times a day for 5-10 days.\\n- Parenteral antibiotics are of questionable value and given only as a supportive therapy.\\nSurgical treatment\\nPars plana vitrectomy is indicated if visual acuity is limited to light perception or if there is\\npoor response to above treatment in 30-36 hours.\\n\\uf0b7 T raumatic endophthalmitis\\n- Hospitalize the patient and give immunization for tetanus.\\n- Inj. vancomycin 1 g IV infused over 1 hour, 12 hourly.\\n- Inj. gentamicin 2 mg/kg every 12 hour or Inj. ceftazidime 2 g IV every 12 hour or inj.\\nceftriaxone 2 g IV/day.\\n- Topical fortified eye drops, subconjunctival injection and intravitreal injection\\nand cycloplegic drops as in cases of postoperative bacterial endophthalmitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 203, 'page_label': '204'}, page_content='Eye Diseases\\n188\\n\\uf0b7 Surgery\\n- Repair the ruptured eyeball at the earliest.\\n- Pars plana vitrectomy- indications are similar to that of postoperative bacterial\\nendophthalmitis.\\n\\uf0b7 Treatment for fungal endophthalmitis\\nExogenous fungal infections may occur postoperatively or secondary to trauma.\\nEndogenous bacterial endophthalmitis should be treated as an emergency treatment.\\n- Vitrectomy to debulk the vitreous of fungi.\\n- IntravitrealInj.amphotericin B 5-10 mcg/0.1 ml orInj.fluconazole 25 mcg/0.1 ml.\\n- Inj. amphotericin B 0.5-1.5 mg/kg/day slow infusion over 2-6 hours. (50 mg vial in\\npowder form and is dissolved in 5% dextrose) for 10-14 days. Or\\n- Tab. fluconazole 400 mg loading dose followed by 200 mg daily, total dose should not\\nexceed 600 mg/day.In children 12 mg/kg loading dose followed by 6 mg/kg/day.Or\\n- Tab. ketoconazole 200 mg orally 2 times a day or daily. In children above 2 years of age,\\n3.3-6.6 mg/kg/day.\\n- Homatropine 2% eye drops 4 times a day or a tropine 1% eye ointment 2\\ntimes a day.\\nPatient education\\n\\uf0b7 All patients with open globe injury must contact an ophthalmologist after getting initial\\ntreatment.\\n\\uf0b7 Cataract operated cases should never ignore pain, tearing and photophobia and decrease in\\nvision in the operated eye and must consult the ophthalmologist at the earliest.\\nOPTIC N EURITIS\\nOptic neuritis includes inflammatory and demyelinating disorders of the optic nerve like\\npapillitis (inflammation of the optic disc), retrobulbar neuritis (inflammation of retro-ocular\\nportion of optic nerve) and neuroretinitis (when bothoptic nerve and retina are inflamed).\\nEtiology may be hereditary, systemic bacterial/viral infections, endophthalmitis, orbital\\ncellulitis, demyelinating disorders or idiopathic in nature.\\nSalientfeatures'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 204, 'page_label': '205'}, page_content='Eye Diseases\\n189\\n\\uf0b7 Sudden, progressive and profound visual loss is the hallmark of acute optic neuritis.\\n\\uf0b7 Decreased dark adaptation and impairment of colour vision, visual obscuration in bright light\\nand episodic obscurationon physical exertion, hot bath, fatigue etc.\\n\\uf0b7 Depth perception,particularly for the moving object may be impaired (Pulfrichâ€™s\\nphenomenon). Patient may complain of mild dulleye ache. It is more marked in patients\\nwith retrobulbar neuritis than with papillitis. Pain is usually aggravated by ocular\\nmovements, especially in upward or downward directions due to attachment of somefibers\\nof superior rectus to the dura mater.\\n\\uf0b7 Marked abnormality in papillary responses to light reflex (sluggish or afferent pupildefect).\\n\\uf0b7 Fundus examination revealshyperaemia of the disc and blurring of the margins. Disc\\nbecomes oedematous and physiological cup is obliterated. Retinal veins are congested and\\ntortuous. Splinter haemorrhages and fine exudates may be seen on the disc.\\n\\uf0b7 Slit-lamp examination may reveal inflammatory cells in the vitreous. The most common\\nfield defect in optic neuritis is a relative central or centrocaecal scotoma.\\nPharmacological treatment\\n\\uf0b7 Efforts should be made to find out and treat the underlying cause. There is no effective\\ntreatment for idiopathic and hereditary optic neuritis and that associated with\\ndemyelinating disorders.\\n\\uf0b7 Corticosteroid therapymay shorten the period of visual loss, but will notinfluence the\\nultimate level of visual recovery in patients with optic neuritis.\\n\\uf0b7 Oralprednisolone therapy alone is contraindicated in the treatment of acute optic neuritis,\\nsince, it did not improve visual outcome and was associated with a significant increase in\\nthe risk of new attacks of optic neuritis.\\n\\uf0b7 Indications for intravenousm ethylprednisolone in acute optic neuritis patients with a\\nnormal brain MRI scan are:\\n- Visual loss in both eyes simultaneously or subsequently within hours or days of each\\nother.\\n- When the only good eye is affected.\\n- When the slow progressive visual loss continues to occur.\\n\\uf0b7 Inj. m ethylprednisolone 1gm/day (or 15 mg/kg/day) intravenously in 2-4 divided doses\\nfor 3 days followed byTab.prednisolone 1 mg/kg/day orally for 11 days tapered over the\\nnext week.\\nPatient education\\n\\uf0b7 Explain the recurrent nature of the disease and that permanent vision loss can occur.\\n\\uf0b7 Avoid factors provoking transient visual obsurations like physical exertion, hot weather,\\nstress, anger etc.\\nDIABETIC RETINOP ATHY'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 205, 'page_label': '206'}, page_content='Eye Diseases\\n190\\n\\uf0b7 Rhegmatogenous RD is characterized by formation of a tear in the retina. Symptoms include\\nflashes of light, presence of floaters in visual field and loss of central vision, if macula is\\ninvolved. The diagnosis is done by examination of the fundus with indirect ophthalmoscopy.\\nThe retina appears grey wit oscillating folds.\\n\\uf0b7 Tractional RD is caused by gliotic bands on retina.\\n\\uf0b7 Exudative RD is caused by collection of serous fluid between neurosensory retina and retinal\\npigment epithelium.\\nItis the microangiopathy of retinal vasculature occurring in long standing diabetes mellitus\\nclassified as non proliferative and proliferative. Itisthe sixth leading cause of blindness in\\nthe world. Risk factors include increased duration of diabetes, uncontrolled diabetes,\\nabnormal lipid profile, smoking, renal disease etc.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Early diagnosis, proper diabetic control, regular follow up and fundus examination are\\nimportant. In certain cases laser photocoagulation and vitrectomy surgery can help.\\nPharmacological treatment\\n\\uf0b7 No tested or proven pharmacological treatment exists which can delay, prevent or\\ncurdiabetic retinopathy.\\nPatient education\\n\\uf0b7 Explain the importance of yearly fundus examination. Laser treatment can prevent\\ndeterioration of vision but cannot correct existing visual defects.\\nRETINAL DETACHMENT\\nRetinal detachment (RD) is the separation of the sensory retina from retinal pigment\\nepithelium. It may be localized or entire retina may be involved. Retinaldetachment that\\nincludes the macula results in significant visual loss.The three types areRhegmatogenous\\nRD, exudative RD and tractional RD.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Treatment of choice is reattachment surgery involving identification ofall retinal breaks\\nareas of vitreous or retinal tractions and induction of aspectic chorioretinal inflammation\\naround the breaks to seal them.\\n\\uf0b7 Ensuring chorioretinal apposition by approximating choroid/retinal pigment epithelium to\\nneurosensory retina by external tamponade, internal tamponade and drainage of subretinal\\nfluid\\n\\uf0b7 Adhesion between retinal pigment epithelium and retina can be achieved by cryotherapy,\\ndiathermy or photocoagulation.\\nPharmacologicaltreatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 206, 'page_label': '207'}, page_content='Eye Diseases\\n191\\nN o pharmacological treatment which canprevent or cure rhegmatogenous RD.Exudative RD\\ndue to inflammatory conditions like panuveitis can be treated with systemic corticosteroids as\\ndescribed in treatment of uveitis. The refractory patients can be treated with\\nimmunosuppresants.\\nPatient education\\n\\uf0b7 Patients with high myopia, family history of RD, post cataract surgery, past episodes of\\nchorioretinal inflammation should be warned about the premonitory signs of impending\\nRD (sudden onset of floaters, flashes of light and sudden obscuration of one part of visual\\nfield). In such cases, an opthalmologist should be contacted immediately.\\nVITAMIN A DEFICIENCY\\nThe term xerophthalmia is now reserved (by a joint WHO and USAID Committee, 1976) to\\ncover all the ocular manifestations of vitamin A deficiency,including not only the structural\\nchanges affecting the conjunctiva, cornea and occasionally retina, but also the biophysical\\ndisorders of retinal rods and cones functions.\\nSalient features\\nWHO Classification\\nPrimary signs Secondary signs\\nX1: Conjunctival Xerosis: XN: Night blindness\\nX1A -without Bitot spot XF: Fundal changes\\nX1B -with Bitot spot XS: Corneal scarring\\nX2: Corneal Xerosis\\nX3: Cornel ulceration\\nX3A: < 1/3 of corneal ulceration\\nX3B: > 1/3 of corneal ulceration\\nPharmaco logicaltreatment\\n\\uf0b7 Vitamin A deficient diet is the main reason especially in young growing children of\\ndeveloping countries. It is usually associated with protein energy malnutrition.\\n\\uf0b7 In some cases, decreased absorption of vitamin A due to gastro-intestinal disorders like lipid\\nmalabsorption or chronic alcoholism can occur.\\n\\uf0b7 Presentation can be as\\n- Nyctalopia-night blindness is the earliest presenting symptom.\\n- Conjunctival xerosis\\n- Bitot spot: It is a metaplastic keratinisation of conjunctiva.\\n- Persistent epithelial defect (usually in chronic alcoholics) and corneal ulcer\\n- Keratomalacia:a diffuse corneal necrosis occurring in severevitamin A deficiency.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 207, 'page_label': '208'}, page_content='Eye Diseases\\n192\\n\\uf0b7 Severe xerophthalmia is a medical emergency, so treatment should begin as early as\\npossible.\\n\\uf0b7 Treatment is aimed at restoring vitamin A level to normal and addressing associated\\nprotein energy malnutrition.\\n- Oral vitamin A:\\n0-6 month of age : 50,000 IU (on 0 day, 1stday & after 4 weeks)\\n6-12 month of age : 1 lakh IU (on 0 day, 1stday & after 4 weeks)\\nMore than 1 year of age : 2 lakh IU (on 0 day, 1stday & after 4 weeks)\\n\\uf0b7 Intramuscular water soluble vitamin A is given to children with persistent vomiting or\\nsevere malabsorption.\\n\\uf0b7 Topical preservative free lubricating eye drops and antibiotic drops (e.g.m oxifloxacin\\neye drops1 to 6 hourly) to prevent secondary infection can be given.\\nPatient education\\n\\uf0b7 Regular consumption of VitaminA rich foods particularly fresh dark green leafy\\nvegetables which constitute very rich and cheap sources.\\n\\uf0b7 Pregnant women and lactating mothers should also consume Vitamin A rich diet\\nregularly.\\n\\uf0b7 Breast feeding including feeding of new born with rich colostrum.\\n\\uf0b7 High dose universal distribution schedule for prevention of Vitamin A deficiency.\\n- Infants less than 6 months of ageâ€“ 50,000 IU orally\\n- Infants 6-12 months of age-100,000 IU orally.\\n- Children more than 12 months-200,000 IU orally every 4-6 months till 5 years of age.\\n\\uf0b7 Mothers-200,000 IU orally within 8 weeks of delivery.\\nSENILE CATARACT\\nIt isage related opacification of crystalline lensaffecting persons of either sex usually above\\nthe age of 50 years. By 70 years, over 90% of the individuals develop senile cataract. The\\ncondition is usually bilateral, but almost always one eye is affected earlier than the other.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 208, 'page_label': '209'}, page_content='Eye Diseases\\n193\\n\\uf0b7 Gradual painless progressive diminution of vision in one or both eyes. Symptoms include\\nglare, uniocular diplopia or polyopia, coloured haloes, distortion of images and misty vision\\nand fixed black spots in visual field.Ocular examination reveals greyish white to white\\nlenticular opacity on torch light examination which depends on the stage of cataract.\\nDepending upon the location and maturation of cataract, the visual acuity may range from\\n6/9 to just perception of light.\\n\\uf0b7 Slit-lamp examinationshould be performed with a fully-dilated pupil. The examination\\nreveals complete morphology of opacity (site, size, shape, colour pattern and hardness of the\\nnucleus).\\n\\uf0b7 Hypermetropia (hyperopia) or long-sightedness is the refractive state of the eye wherein\\nparallel rays of light coming from infinity are focused behind the retina with accommodation\\nbeing at rest. Symptoms include astheopic symptoms (tiredness and watering of eyes, frontal\\nheadache) and defective vision, more for near vision.\\n\\uf0b7 M yopia or short-sightedness is a type of refractive error in which parallel rays of light\\ncoming from infinity are focused in front of the retina when accommodation is at rest.\\n\\uf0b7 Astigmatism- The optical power of the cornea in different planes is not equal.Parallel rays\\nof light passing through these different planes are brought to different points of focus.\\nSurgical treatment\\nNo medical management can halt the progression of cataract.Surgery in the form of small\\nincision cataract surgery or phacoemulsification is the preferred option.\\nPatient education\\n\\uf0b7 Do not wait for maturation of cataract for undergoing lens extraction.\\n\\uf0b7 Secondary glaucoma or other complications can develop if total cataract remains\\nunoperated fora long time.\\n\\uf0b7 Visual rehabilitation in early post operative period is faster in small incision cataract\\nsurgery.\\nREFRACTIVE ERRORS\\nRefractive errors (ametropia) are the optical defects of eye in which the parallel rays of light\\nentering the eye do not come to focus on the fovea centralis. Ametropia includes myopia,\\nhypermetropia and astigmatism.\\nSalient features\\nSurgicaltreatment\\n\\uf0b7 No pharmacological treatment is available for ametropia.\\n\\uf0b7 Accurate retinoscopy and corrective spectacles or contact lens.Keratorefractive surgery\\nSTRABIS MUS (SQUINT)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 209, 'page_label': '210'}, page_content='Eye Diseases\\n194\\nAny child presenting with strabismus should have the following conditions ruled out:\\n\\uf0b7 Refractive error-refraction should be done under full cycloplegia i.e. Atropine Ointment 1%\\n3 times a day for 3 days prior to performing retinoscopy. If any refractive error is present,\\nthat should be fully corrected by spectacles for at least 3-6 months, before performing\\ndefinitive surgical therapy for strabismus.\\n\\uf0b7 An y opacity in the media e.g. cataract, corneal opacity, retinoblastoma etc.\\n\\uf0b7 Amblyopia element whether induced by strabismus or vice versa should be treated with\\nocclusion therapy or other modality before treating strabismus.\\n\\uf0b7 C haracterized by visual symptoms which result from interaction with a computer display\\nor its environment. In most cases, symptoms occur because the visual demands of the\\ntask exceed the visual abilities of the individual to comfortably perform the task.\\n\\uf0b7 C ontributing factors: Decreased blinking reflex, prolonged near focusing efforts,\\nrepeated head posture change/fixation in a wrong posture,  Environmental factors of\\ncomputer workstations like contrast and resolution of the display, viewing distances and\\nangles, room lighting, sustained viewing etc.\\n\\uf0b7 Symptoms include tiredness of eyes, headache, blurred near and distant vision, dry or\\nirritated eyes, neck pain and/or backaches, diplopia (double vision), difficulty in re-\\nfocusing the eyes.Diagnostic tests include tear film break-up timeand Schirmer test.\\nCervical spondylitis, anxiety and migraine are the differential diagnosis.\\nSalient features\\nSurgicaltreatment\\n\\uf0b7 Correct the refractive error or associated cataract, corneal opacity etc. Fusion exercises\\nfor intermittent exotropia and other orthoptic exercises.Definitive therapy is surgical\\nrealignment of axis once other associated features have been treated.\\nPatient education\\nFunctional improvement in strabismus is best between 3-5 years of age.It is a misconception\\nthat squint is spontaneously corrected as the child grows.\\nCOMPUTER VIS ION SYNDROME\\nComputer Vision Syndrome (CVS) is the complex of eye and vision problems related to near\\nwork which are experienced during or related to computer use.\\nSalient features\\nNon -pharmacological treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 210, 'page_label': '211'}, page_content='Eye Diseases\\n195\\n\\uf0b7 Counselling regarding the syndrome andwork environment modification\\nSteps for relieving computer eye strain\\n- Get a computerized eye exam before start using computer. Repeat once a year.\\n- Use proper lighting. Eliminate exterior light by closing drapes, shades or blinds. Reduce\\ninterior lightingby using lower intensity bulbs and tubes.\\n- Minimize glare: To install an anti-glare screen on your monitor. Paint bright white walls a\\ndarker color with a matt finish.\\n- Upgrade your display. Use LCD monitor instead of a CRT monitor.\\n- Adjust the brightnessand contrast of your computer screen.\\n- Blink more often.\\n- Exercise your eyes: Follow 20-20-20 rulei.e.after every 20 minutes, look at 20 feet\\ndistance for 20 seconds.\\n- Take frequent breaks- two 15-minute breaks-four additional five-minute \"minibreaks\"\\nthroughout the work day (6-8 hrs).\\n- Modify your workstation. Proper posture during computer work. Position computer\\nscreen 20 to 24 inches from your eyes. The center of your screen should be about 10 to 15\\ndegrees below your eyes. Top of the screen tiltedback slightly (10-20 degree) away from\\nthe operator.\\n- Consider customized eyeglasses specific for use during work on a computer screen. Anti-\\nreflective coating in the lenses should be used and avoid contact lens use during computer\\nwork.\\nPharmacological treatment\\n\\uf0b7 Tear substitute should be considered if symptoms are aggravated during computer work.\\nCommercially available tear substitutes include sodium carboxymethylcellulose and\\nhydroxypropyl methylcellulose.\\nReferences\\n1. Kanski, Clinical Ophthalmology 7th edition\\n2. Ready reckoner in ophthalmology by AIOS\\n3. Wills Eye Manual, The: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th Edition\\n4. Shields textbook of glaucoma; 6th editionOrbit, Eyelids, and Lacrimal SystemSection 72011-2012 by\\nAmerican Academy of Ophthalmology.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 211, 'page_label': '212'}, page_content='196\\n\\uf0b7 Impetigo(Figure 1)-commonly seen in childhood at muco-cutaneous junctions and presents\\nwith bullae that evolves into yellow or honey colored crusts.\\n\\uf0b7 Ecthyma (Figure 2)â€“ it is deeper variant ofimpetigo.-characterised by thick chocolate\\ncolored crust with indurated base that heals with scar.\\n\\uf0b7 Folliculitis(Figure 3)â€“ inflammation of the ostium of hair follicle. Commonly affects scalp\\nhair margin, beard and extremities.\\n\\uf0b7 Boil/ furuncle(Figure 4)â€“ inflammation of entire hair follicle, perifollicular region and\\nsubcutaneous tissue. Seen as inflammatory indurated nodule associated with fever and\\nmalaise.\\n\\uf0b7 Carbuncle(Figure 5)â€“ group of multiple furuncles, commonly seen in diabetics at back of\\nneck, shoulder.\\n\\uf0b7 Erysipelas(Figure 6)- it involves upper subcutaneous tissue and lymphatic vessels. Skin\\nbecomes tense, erythematous and slightly elevated which later on becomes brown and\\nedematous giving peau dâ€™ orange appearance.\\n\\uf0b7 Cellulitis(Figure 7)- it involves deeper subcutaneous tissue, involves larger area and\\nassociated with fever and malaise\\n\\uf0b7 Diagnosis is mainly clinical; if required gram stain and culture-sensitivity.\\nChapter 12\\nSKIN DISEASES\\nBACTERIAL SKIN INFECTIONS\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Good personal hygiene and propernutrition.\\n\\uf0b7 Wash with soap and water, drainage of pus.\\nPharmacological treatment\\n\\uf0b7 Topical antibacterial creams like neomycin or silver sulfadiazine or framycetin to be applied\\non the affected sites twice a day for 7-10day\\n\\uf0b7 Systemic antibacterial like Tab. azithromycin 500 mgOD for 3-5 days or\\nCap. amoxicillin 250 mg QID/ 500 mg TDS for 7 days or Tab.erythromycin (500 mg QID)\\nfor  5 days.\\nLEPROSY\\nIt is a chronic bacterial infection caused byMycobacterium lepraethat primarily affects skin and\\nperipheral nerves.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 212, 'page_label': '213'}, page_content='Skin Diseases\\n197\\n\\uf0b7 Hypopigmented / erythmatous skin lesion with or without loss / impairment of sensation,\\nsweating  and hair(Figure 8)\\n\\uf0b7 Thickening / tenderness of  peripheral nerves with or without loss / impairment of sensation\\n\\uf0b7 Slit skin smear show acid fast bacilli (M. Leprae)\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical examination of skin and peripheral nerves including sensation.\\n\\uf0b7 Slit skin smear and biopsy.\\nPharmacological treatment\\nWHO Classification for treatment purpose(Table 1)\\nPaucibacillary (PB) leprosy-â‰¤5 skin lesions and/or single nerve involvement, slit skin smear\\nnegative.\\nMultibacillary (MB) leprosy- â‰¥5 skin lesions and/or more than one nerve involvement, slit\\nskin smear positive.\\nTable 1.Treatment as per NLEP guideline\\nType of\\nleprosy\\nDrugs Supervised Supervised Duration for\\nblister pack\\nMB (adult) Dapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly\\nClofazimine\\n(300mg) monthly\\n+ 50 mg daily\\n12 months\\nPB (adult) Dapsone\\n(100mg) daily\\nRifampicin\\n(600mg) monthly\\n6 months\\nMB (pediatric)Dapsone (50mg)\\ndaily\\nRifampicin\\n(450mg) monthly\\nClofazimine\\n(150mg) monthly\\n+ 50 mg alternate\\nday\\n12 months\\nPB (pediatric)Dapsone (50mg)\\ndaily\\nRifampicin\\n(450mg) monthly\\n6 months\\nNon -pharmacological treatment\\n\\uf0b7 Care of insensitive hands and feetâ€“ emollient application, avoidance of trauma, burn,\\ndaily inspection, and rest.\\n\\uf0b7 Care of eyesâ€“ protective glasses.\\n\\uf0b7 Proper nutrition.\\n\\uf0b7 Active and passive exercises.\\n\\uf0b7 In case of deformityâ€“ use correct splints, modula grip aids for household works, MCR\\n(Micro cellular rubber) shoes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 213, 'page_label': '214'}, page_content='Skin Diseases\\n198\\nLepra reaction\\n\\uf0b7 It is immunologically mediated episodes of acute or chronic inflammation which interrupt\\nthe chronic course of disease affecting skin, nerves, mucous membrane and systemic\\ninvolvement.\\n\\uf0b7 Type 1 reaction:Characterized by pain, tenderness of pre-existing lesions with or without\\nnew lesions/ peripheral nerves (neuritis).\\n\\uf0b7 Type 2 reaction: Characterized by sudden appearance of tender nodules or plaques which\\nare evanescent, neuritis, pain and swelling of joints with or without systemic\\ninvolvement.\\nTreatment\\nType 1 reaction\\n\\uf0b7 Mild reaction- NSAIDS like Tab. paracetamol (500 mg) TDS/Tab. aspirin (375-625 mg)\\nBD\\n\\uf0b7 Severe reaction-corticosteroids like Tab.prednisolone (1-2 mg/kg/day) in tapering dose\\n\\uf0b7 Surgical decompression of nerves SOS\\nType 2 reaction\\n\\uf0b7 Mild to moderate reaction-Rest and NSAIDs like Tab. paracetamol (500 mg) TDS\\n/Tab.aspirin (375-625 mg) BD\\n\\uf0b7 Severe reaction : As above plus,\\n- Cap.clofazimine 300 mg daily.\\n- Corticosteroids (in tapering dose) such as Tab.prednisolone 40 mg daily for 15 days\\nfollowed by 30 mg daily for 15 days, 20 mg daily for 15 days, 15 mg daily for 15\\ndays,10 mg daily for 15 days and 5 mg daily for 15 days.\\n- Thalidomide (to be used with caution especially in chronic recurrent and steroid\\ndependent cases at tertiary care centre).\\n\\uf0b7 Surveillance / follow up for 2 years and 5 years period for PB and MB cases respectively\\nfor relapse and reactions.\\nPatient education\\n\\uf0b7 Leprosy is curable disease. The treatment is widely available and free of chargeunder\\nNLEP (National leprosy eradication programme).\\n\\uf0b7 Risk of developing disease is very low. Children and elderly are more prone.\\n\\uf0b7 Early detection and proper treatment prevents disabilities.\\n\\uf0b7 Disease can be managed easily.The patient should not suffer any discrimination.Patient\\nshould be encouraged and supported by the family and society so that they are able to live\\na normal life.\\n\\uf0b7 Explain the importance of multidrug treatment and patient compliance,ADRs of drugs.\\nAll members of family and close contacts should be examined.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 214, 'page_label': '215'}, page_content='Skin Diseases\\n199\\n\\uf0b7 Lupus vulgarisâ€“ occurs in high immunity host having granulomatous lesion with marginal\\nactivation, central clearing andatrophy.\\n\\uf0b7 Scrofulodermaâ€“ seen in low immunity host,involvement of skin overlying any internal\\ntuberculous focus such as bone, lymph node and joint.\\n\\uf0b7 Tuberculosis veruccosa cutis(Figure 9)- occurs in high immunity host with\\nverrucous plaque.\\n\\uf0b7 Characterized by nocturnal itching,excoriated papules, papulo vesicles, burrows on inter\\ndigitalcleftso fhands, wrist, axillary folds, breasts, periumblical region, medial side of\\nthigh andgenitals.Face, palms, soles and scalp involvement in infants\\nCUTANEOUS TUBERCULOSIS\\nIt is caused bymycobacterium tuberculaeand has varied manifestations depending on the\\nhost immunity and root of entry.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 CBC, ESR, mantoux test, chest x-ray\\n\\uf0b7 Sputum AFB and  biopsy\\nNon -pharmacological treatment\\n\\uf0b7 Proper nutrition\\nPharmacological treatment\\nAccording tothe National TBmanagement guidelines, treatment isgiven intwo phases:\\nCategory 1: newly diagnosed cases\\n\\uf0b7 Initialphase -2 HRZE\\n\\uf0b7 Continuation phase-4 HR\\nCategory 2: recurrence, relapse, defaulter\\n\\uf0b7 Initial phase : 1HRZES + 2HRZE\\n\\uf0b7 Continuation phase: 5HRE\\nH â€“ isoniazid    R-rifampicin  Z-pyrazinamide  E-ethambutol   S-streptomycin\\nPatient education\\n\\uf0b7 Explain that it is a curable disease.\\n\\uf0b7 Counselling for regular follow up and adherence to treatment.Screening of close contacts\\nfor tuberculosis.\\nSCABIES\\nScabies is caused by arthropod mite(sarcoptesscabiei),transmittedby close personal\\ncontact.Family historyispositive.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 215, 'page_label': '216'}, page_content='Skin Diseases\\n200\\n\\uf0b7 Pediculosis capitis- localised to scalp, mainly confined to sub-occipital region predominant\\nsymptom is itching,-nits are attached to hair shaft.\\n\\uf0b7 Pediculosis corporis â€“ characterised by intense itching accompanied by\\nerythematous macules, excoriated papules and scratch marks.\\n\\uf0b7 Phthiriasis pubisâ€“ itching of pubic region, Peduculli and nits are seen in pubic region, blue\\ngrey macules (maculae caeruleae) are seen in lower abdomen and upper thigh.\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Inspection of mites from scabetic burrows.\\nNon pharmacological treatment\\n\\uf0b7 Maintenance ofpersonal hygiene.\\n\\uf0b7 Disinfection ofbedding and clothing.\\n\\uf0b7 Allfamily members should be treated simultaneously.\\nPharmacological treatment\\n\\uf0b7 Tab. ivermectin 200 mcg/kg asa single stat doseto be repeated after2 weeks.\\n\\uf0b7 Antihistamines like Tab. cetirizine 10 mg daily\\n\\uf0b7 Gamma benzene hexachloride (GBHC) lotion1%. Singleovernight application below\\nneck on  entirebody surfaceaftera thorough scrub bath,to be washed offnext\\nmorning.\\n\\uf0b7 For infants, neonates, children,pregnant and lactating mothers.\\n\\uf0b7 Permethrin 5% to be applied generously,afterbath,at bedtime, covering entire\\nsurfaceof thebody below neck (except face).\\n\\uf0b7 Systemic and topical antibacterial SOS\\nPEDICULOSIS (LICE INFESTATION)\\n\\uf0b7 Three different species namelypediculosis humanuscorporis(body louse),pediculosis\\nhumanus capitis(head louse),pediculosis humanus pubis(pubic louse).\\n\\uf0b7 Transmission occurs bypersonal contact, sharing of combs, infectedclothing, poor\\npersonal hygiene while transmission ofpubic liceisby sexual-contact.\\nSalient features\\nDiagnosis\\n\\uf0b7 Finding lice in occipital region inP. capitis, in sieves of clothes inP. corporis and in\\npubic region in phthiriasis pubis.\\nNon -pharmacological treatment\\n\\uf0b7 Maintenance ofpersonal hygiene.\\n\\uf0b7 Disinfection ofbedding and clothing.\\n\\uf0b7 All the family member should be treated simultaneously.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 216, 'page_label': '217'}, page_content='Skin Diseases\\n201\\nThree formsseen:\\n\\uf0b7 Creeping myiasisâ€“ most superficial\\n\\uf0b7 Furuncle myiasisâ€“ boil like lesion and\\n\\uf0b7 W ound myiasis\\n\\uf0b7 Asymptomatic hypo or hyperpigmented irregular maculeswith branny scales usually seen on\\nupper trunk.Recurrence is common.\\n\\uf0b7 To shave pubic hair.\\n\\uf0b7 Treatment of partner in case of pubic lice infestation.\\nPharmacological treatment\\n\\uf0b7 Antihistamines likeTab. cetirizine 10mg daily or Tab. pheniramine maleate 25mg 3\\ntimesa day for7 days.\\n\\uf0b7 Lotion GBHC/ permethrin1% to be applied onscalp(inhead louseinfestation) fora\\nperiodof more than 30 minutes tobe washed offlater.\\nMYIASI S (MAGGOTS)\\nMyiasisis the infestation of the body byflylarvae that feed on body tissues in people with\\npoor hygiene.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Apply liquid paraffin, turpentine oil.\\n\\uf0b7 Remove mechanically by forceps.\\n\\uf0b7 Explain the patient about personal hygiene and proper care of wound.\\nPharmacological treatment\\n\\uf0b7 Systemic antihelminthics like Tab. albendazole 400mg stat.\\n\\uf0b7 Systemic antibiotics if secondary infection present.\\n\\uf0b7 Wound ma nagement.\\nITYROSPORUM  INFECTIONS\\nMild superficial fungal infection of stratum corneum characterised by scaly hypo or\\nhyperpigmented irregular macules caused by mycelial form of malassezia species(Fig.10).\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Woodâ€™s lamp â€“ yellowish fluorescence.\\n\\uf0b7 10 % KOH mount - non branching mycelia and yeasts giving â€œbanana and grapesâ€\\nappearance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 217, 'page_label': '218'}, page_content='Skin Diseases\\n202\\n\\uf0b7 Sharply marginated patches with active scaly border and central clearing.\\n\\uf0b7 Extremely pruritic condition\\nPharmacological treatment\\n\\uf0b7 Topical antifungal cream likeâ€“ ketoconazole or miconazole or clotrimazole or terbinafine\\n\\uf0b7 Topical selenium sulfide 2.5% shampoo or lotion\\n\\uf0b7 Systemic antifungals like Cap. fluconazole 400 mg stat\\n\\uf0b7 For recurrence Tab.ketoconazole 400 mg once per month\\nPITYRIASIS CAPITIS (DANDRUFF)\\nMild superficial fungal infection of stratum corneum caused by yeast form of malassezia.\\nSalient features\\n\\uf0b7 Diffuse itchy scaly lesions over scalp, eyebrows, eyelashes and naso-labial folds\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Frequent hair washes by shampooing with light massage.\\n\\uf0b7 Avoid oil and soap application.\\nPharmacologicaltreatment\\n\\uf0b7 Antifungal lotions / shampoos that contain antifungals like ketoconazole or econazole,\\nkeratolytics like salicylic acid or coal tar that should be applied 15 min before bath to the\\naffected areas.\\n\\uf0b7 Topical steroids like betamethasone lotion in combination with antifungal lotion after hair\\nwash.\\nTINEA CRURIS AND CORPORIS\\nTinea cruris is a superficial fungal infection of groin and axilla, also known as dhobiâ€™s itch.\\nTinea corporis involves trunk and extremities. It is more common in obese and diabetics.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and  KOH mount\\nNon -pharmacological treatment\\n\\uf0b7 Maintain hygiene and avoid tight clothing.\\nPharmacological treatment\\n\\uf0b7 Topical antifungals likeâ€“ clotrimazole or miconazole or ketoconazole cream to be applied\\ntwice daily.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 218, 'page_label': '219'}, page_content='Skin Diseases\\n203\\n\\uf0b7 Gray patch: Circular patches of partial hair loss thatare broken off, dull gray and lusterless\\nin appearance\\n\\uf0b7 Black Dot: Multiple, polygonal areas of sparse hair, broken hair follicles are seen as black\\ndots.\\n\\uf0b7 Kerion: Inflamed, boggy, indurated and tender swelling studded with vesicles and pustules\\n(Figure 11).\\n\\uf0b7 Favus: Rare type of tinea capitis presenting with cup shaped scutula around the hair orifice.\\n\\uf0b7 Characterized by involvement of only a few nails, brownish or yellowish streaks,\\nonycholysis and thickend nail plate.\\n\\uf0b7 Types- distal and lateral subungual onychomycosis(Figure 12), w hite superficial\\nonychomycosis, proximal subungual onychomycosis, total dystrophic onychomycosis.\\n\\uf0b7 Extensive casesâ€“ in addition to topicals, systemic antifungals like Cap.fluconazole-150\\nmg/ week x 2-4 weeks or Tab. terbinafine (62.5 mg daily for <20 kg weight, 125 mg daily\\nfor 20-40 kg weight, 250 mg daily for >40 kg weight) for 2 weeks.\\n\\uf0b7 Cap. itraconazole-200 mg daily for 1 week.\\nTINEA CAPITIS\\nTinea capitis is a dermatophyte infection of the scalp most commonly seen in childhood.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Woodâ€™s lamp: greenish yellow fluorescence\\n\\uf0b7 KOH mount and  hair mount\\nNon -pharmac ological treatment\\n\\uf0b7 Not to share caps and combs.\\n\\uf0b7 Removal of matted crusts.\\nPharmacological treatment\\n\\uf0b7 Tab.griseofulvin: 15-25 mg / kg per day with food preferably at night for 4-6 weeks.\\n\\uf0b7 Tab.fluconazole:3-6 mg / kg per day administered for 6 wks.\\n\\uf0b7 Tab.terbinafine: according to weight of the patient.\\n\\uf0b7 Cap.itraconazole-5mg/kg/d for 7 days.\\nONYCHOMYCOSIS\\nOnychomycosis is fungal infection of nail.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 219, 'page_label': '220'}, page_content='Skin Diseases\\n204\\n\\uf0b7 Neonatal candidiasis (due to infection acquired during delivery or postnatally) is\\ncharacterized by oral thrush as well as pinkâ€“red patches with satellite papules and pustules\\nthat favor the diaper area, other intertriginous sites and the face.\\n\\uf0b7 Oral candidiasis is characterized by curdy white patches covered by pseudomembrane over\\nthe gums, teeth, cheeks and palate(Figure 13).\\n\\uf0b7 Flexural candidiasis (candidal intertrigo) it is characterized by moist erythematous exudates\\ndeep in the folds and gradually develops characteristic fringed erosions. Satellite popular or\\npustular lesions are characteristic.\\n\\uf0b7 Balanoposthitis(candidabalanitis) is acquired through direct sexual contact with a partner\\nwho has vulvovaginal candidiasis presents with intense erythema wit h\\ndesquamation/superficial erosions, maculopapular rash over glans and foreskin is seen a\\nwhite subpreputial discharge, increased skin marking, fissuring of glans and foreskin may be\\nseen.\\n\\uf0b7 Vulvovaginitis:vulvar pruritus, vaginal discharge, dysuria, and dyspareunia physical\\nexamination findings include a vagina and labia that are usually erythematous, a thick curd\\nlike discharge, and a normal cervix upon speculum examination.\\n\\uf0b7 Microscopy-KOH mount.\\n\\uf0b7 Culture-sabouraudâ€™s dextrose agar.\\nNon pharmacological treatment\\n\\uf0b7 Avoid tight fitting footwear and working in wet areas.\\nPharmacological treatment\\n\\uf0b7 Topical antifungal agents like clotrimazole, miconazole or tolnaftate.\\n\\uf0b7 Oral antifungal agents such as Tab.fluconazole:150-300mg once a week for 6-12 months\\nor Tab.terbinafine: 250mg daily for 6-12 weeks or Cap.itraconazole200mg daily for 2-3\\nmonths.\\nCANDIDIASIS\\nCandidiasis is an infection caused by the yeast candida albicans or sometimes other species of\\ncandida.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Microscopy-demonstration of candida by 10% KOHâ€“yeast cells, mycelia is seen.\\nNon -pharmacological treatment\\n\\uf0b7 Daily bath and maintain personal hygiene.\\n\\uf0b7 Keep the affected area dry and clean.\\n\\uf0b7 Control of diabetes mellitus.\\n\\uf0b7 Care of dental prosthesis.\\n\\uf0b7 Avoid prolonged use of diaper.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 220, 'page_label': '221'}, page_content='Skin Diseases\\n205\\n\\uf0b7 Diaper dermatitisis characterized by joined patches of erythema and scaling mainly seen on\\nthe convex surfaces, with the skin folds spared.\\n\\uf0b7 Signs and symptoms are restricted in most individuals to the area covered by diapers.\\n\\uf0b7 Diagnosis is mainly clinical.\\n\\uf0b7 Most common form occurring between 1-5 years.\\n\\uf0b7 Disease starts with fever and malaise and subsequently small vesicles develop.\\n\\uf0b7 Vesicular lesions rupture to form shallow ulcers with yellow exudative base and\\nerythematous halo.\\nPharmacological treatment\\nTopical antifungals (1% clotrimazole, 1% ciclopirox, 2% miconazole nitrate etc) creams.\\nClotrimazole vaginal pessaries for vulvovaginal candidiasis.\\nSystemicâ€“ Cap.fluconazole 150mg single dose.\\nDIAPER DE RMATITIS\\nKnown as napkin dermatitis or diaper rash is a prototypical example of irritantcontact\\ndermatitis; caused by overhydration of the skin, maceration, prolonged contact with urine and\\nfeces, retained diaper soaps, and topical preparations and oftentriggered by an episode of\\ndiarrhoea; commonly seen in infants; induced by occlusion of areas covered by impermeable\\ndiapers.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Avoid impermeable diapers and keep affected skin dry.\\n\\uf0b7 Maintain personal hygiene.\\n\\uf0b7 Avoid use of topical antiseptics and medicated soaps.\\nPharmacological treatment\\n\\uf0b7 Zinc oxide paste.\\n\\uf0b7 A ntifungal (clotrimazole 1% cream; econazole nitrate cream; miconazole 2%) cream after\\nevery diaper change or at least 4 times per day can be applied.\\n\\uf0b7 Topical corticosteroids e.g. hydrocortisone 1% can be used for the first 1-2 days.\\nHERPES LABIALIS\\n\\uf0b7 It is an infection of the lip by herpes simplex virus (HSV-1)(Figure14).\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Microscopy-Tzanck smear showing multinucleategiant cells.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 221, 'page_label': '222'}, page_content='Skin Diseases\\n206\\n\\uf0b7 Generalized pruritic vesicular rash, preceded by 2-3 days of fever, chills, headache, malaise,\\nanorexia.Characterized by polymorphic vesicular lesions with central haemorrhagic\\ncrusting, centripetal in arrangement, mainly over trunk\\n\\uf0b7 Prodromal symptoms fever, malaise, paraesthesia.Characterized by unilateral radicular\\nsevere pain and grouped vesicular eruption involving dermatome, not crossing the midline.\\nMucous membrane of the affected dermatome is also involved.\\nPharmacological treatment\\n\\uf0b7 1% silver sulphadiazine cream.\\n\\uf0b7 Tab. acyclovir 200 mg 5 times daily for 5/7 days or Tab.famcyclovir 250 mg TDS for 7\\ndays or Tab.valacyclovir 1000 mg BD for 7 days.\\n\\uf0b7 Tab.paracetamol 500mg TDS for 5 days.\\nPatient education\\n\\uf0b7 Patient should avoid contact until all the lesions are crusted.\\nCHICKEN POX\\nIt is a febrile illness characterized by generalized pruritic vesicular rash, caused by varicella\\nzoster virus, providing lifelong immunity and is most prevalent in childhood.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and microscopy-Tzanck smear.\\nNon -pharmacological treatment\\n\\uf0b7 Rest, cold compresses,  tepid baths\\nPharmacological treatment\\n\\uf0b7 Symptomatic treatment with rest, analgesics, antibiotics and topical calamine lotion.\\n\\uf0b7 In severe varicella and immune-compromised oral acyclovir: children 20 mg/ kg QID,\\nadults 800 mg 5 times for 10 days.\\nHERPES ZOSTER\\nLocalized disease caused by reactivation of varicella zoster virus lying dormant in sensory\\nganglia(Figure15).\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and microscopyâ€“ Tzanck smear.\\nNon -pharmacological treatment\\n\\uf0b7 Rest and isolation\\nPharmacological treatment\\n\\uf0b7 Topical like calamine lotion till symptoms resolve.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 222, 'page_label': '223'}, page_content='Skin Diseases\\n207\\n\\uf0b7 The lesions are generally multiple, occur on exposed part.\\n\\uf0b7 It is characterized by shiny, pearly white, hemispherical, umbilicated papule which may\\nshow a central pore(Figure16).\\n\\uf0b7 Manifest as common warts, flat warts, filiform warts; depending on the site, palmar and\\nplantar warts. Characterised by asymptomatic skin coloured verrucous papules or plaques.\\n\\uf0b7 Tab. acyclovir 15-20 mg/kg 5 times daily for 5/7 days or Tab. valacyclovir1000 mg BD\\nfor 7 days.\\nMOLLUSCUM CONTAGIOSUM\\nIt is a viral infection of the skin caused by molluscum contagiosum virusseen inchildren.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Extraction of molluscum body and  biopsy\\nNon -pharmacological treatment\\n\\uf0b7 Avoid scratching.\\n\\uf0b7 Avoid shared towels, contact sports and communal bathing.\\nPharmacological treatment (at tertiary care centres)\\n\\uf0b7 Chemical cauterisation by trichloroacetic acid 10-20%, phenol or salicylic acid or\\npotassium hydroxide 10% solution (to be applied onthe lesion with application of liquid\\nparaffin over surrounding area).\\n\\uf0b7 Surgical removal by curettage.\\nWART\\nIt is a viral infection of the skin caused by different groups of human papilloma viruses.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and biopsy\\nNon pharmacological treatment\\n\\uf0b7 Avoid scratching.\\n\\uf0b7 Avoid shared towels, contact sports and communal bathing.\\n\\uf0b7 Safe sex practice in case of genital warts.\\nPharmacological treatment\\n\\uf0b7 Podophyllotoxin 0.5% solution or 0.15% cream twice daily for 3 days followed by 4 days\\nrest-give for 3 cycles.\\n\\uf0b7 Cryotherapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 223, 'page_label': '224'}, page_content='Skin Diseases\\n208\\n\\uf0b7 Peak in 14-17 years in women and16-19 years in men\\n\\uf0b7 Characterized by comedones (mild), papules (moderate), nodules (severe) over face, back\\nand shoulders(Figure17).\\n\\uf0b7 Sequelae are hyperpigmentation, acne excoriee and different types of scars\\n\\uf0b7 Miliaria crystalline is characterized by itchy, discrete or confluent transparent thin walled\\nvesicles.Milaiaria rubra ischaracterized by discrete erythematous macules and papules.\\nMiliaria profunda-characterized by flesh coloured 1-3 mm sized papules.\\n\\uf0b7 Trichloroacetic acid application.\\n\\uf0b7 Podophyllin 10%-25%.\\nACNE VULGARIS\\nIt is chronic, self limiting, inflammatory disease of pilosebaceous unit, manifesting generally\\nin adolescence. In addition to pathogens- the p.acnes, hormonal, immunological,\\nenvironmental and genetic factors also play a role.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical.\\n\\uf0b7 Hormonal assay if severe acne, menstrual irregularity, hirsutism is present.\\nNon -pharmacological treatment\\n\\uf0b7 Avoid sugar rich diet, milk, etc.\\n\\uf0b7 Avoid use of drugs causing acne like steroid, androgens, halogens.\\n\\uf0b7 Avoid use of oils, pomades and cosmetics.\\n\\uf0b7 Patient education about premenstrual flare and stress.\\n\\uf0b7 Washing or cleaning of face to keep skin dry, shampooing of scalp.\\nPharmacological treatment\\n\\uf0b7 Mild â€“ benzoyl peroxide (2.5%) cream or azelaic acid 10% cream.\\n\\uf0b7 Moderateâ€“ Topical retinoids like tretinoin 0.025% gel or adapelene 0.1% gel and topical\\nantibacterials clindamycin 1% cream or nadifloxacin 1% cream.\\n\\uf0b7 Severeâ€“ in addition to topical therapy, systemic antibiotics like Tab. azithromycin 500\\nmg daily for 5 days in a month or Cap. doxycycline 100mg BD or, Tab. minocycline\\n50/100 mg daily or Tab. isotretinoin 0.5-1mg/kg for 3-6 months (tertiary care centre).\\n\\uf0b7 Hormonal therapy for unresponsive female patients with menstrual irregularity.\\nMILIARIA\\nMiliaria is a common ailment in hot and humid conditions during the summer season.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 224, 'page_label': '225'}, page_content='Skin Diseases\\n209\\n\\uf0b7 Lesionsare characterized by itching, redness, edema, and papulovesicles in acute stage,\\nedema and scaling in subacute stage and lichenification in chronic stage.\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Cool baths, aeration.\\n\\uf0b7 Avoid heat and occlusion dueto tight clothing, oils, creams, cosmetics etc.\\nPharmacological treatment\\n\\uf0b7 Calamine lotionand talc.\\n\\uf0b7 Systemic antibacterial if infection present.\\nECZEMA\\nEczema is an inflammatory response of the skin to various exogenous and endogenous\\nallergens. Exogenous allergens cause irritant contact dermatitis, allergic contact dermatitis,\\nphotodermatitis and infective dermatitis. The endogenous allergens result into atopic\\ndermatitis, seborrheic dermatitis, nummular eczema, asteatotic eczema, stasis dermatitis.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and skin biopsy.\\nNon -pharmacological treatment\\n\\uf0b7 Avoid allergens, cold compresses, emollients.\\nPharmacological treatment\\n\\uf0b7 Topical corticosteroids like betamethasone valerate 0.05 % cream and mometasone\\nfuroate 0.05% cream/ointment.\\n\\uf0b7 Topical and /or oral antibacterial in case of secondary infection.\\n\\uf0b7 Oral antihistaminics like Tab.cetirizine (10mg/day) and Tab. Chlorpheniramine 4mg/day\\n\\uf0b7 Severe cases Tab. prednisolone 0.5-1 mg/kg/day.\\n\\uf0b7 Regular follow up of the patient.\\nPatient education\\n\\uf0b7 Explain about the side effects of local and systemic corticosteroids\\nCONTACT DERMATITIS\\nInflammatory response of skin to an exogenous substance immunologically or none\\nimmunologically mediated(Figure18).Common allergens are cement (nickel, chromium,\\ncobalt), epoxy resins, rubber, plastics, photographic chemicals, paints, flowers, clothing, shoe\\nmaterials, watches, jewellery, cosmetics (bindi, lipstick, sindoor, hair dyes), topical\\nmedications (antibacterials, antifungals and antiseptic lotions), plants, fertilizers, insecticides,\\npesticides, soap, detergents, vegetables, toothpaste.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 225, 'page_label': '226'}, page_content='Skin Diseases\\n210\\n\\uf0b7 Irritation, itching, pain.Erythema, papules, vesicles, erosions, scaling and crusts can be seen.\\n\\uf0b7 Lesions may or may not be confined to the site of contact.\\n\\uf0b7 Diagnosis is clinical\\n\\uf0b7 A typical lesion is well-defined depigmented patch, which shows depigmented hair without\\nany change in skin texture.\\n\\uf0b7 Common sites are extensors body surfaces such as pre tibial lesion, sides of ankle, knees,\\nelbows and skin overlying the digits, periocular region located generally bilaterally\\nsymmetrical.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Evaluation of alleged contactants and their avoidance.\\n\\uf0b7 Wet compresses and soaks for exudative lesions.\\nPharmacologicaltreatment\\n\\uf0b7 Topical corticosteroids like betamethasone valerate 0.05 % cream or mometasone furoate\\n0.05% cream/ointment.\\n\\uf0b7 Topical and oral antibacterial in case of infection.\\n\\uf0b7 Oral antihistaminics like Tab.cetrizine (10mg/day) or Tab. chlorpheniramine (4mg/day).\\n\\uf0b7 Severe cases Tab. prednisolone 0.5-1 mg/kg/day.\\n\\uf0b7 Regular follow up.\\nPITYRIASIS ALBA\\nUsually found in children, mostly on face.They present as asymptomatic hypopigmented,\\nmildly scaly lesions, generally over face. Diagnosis is clinical.\\nTreatment\\n\\uf0b7 Em ollient\\n\\uf0b7 Topical steroids:  fluticasone (0.005%) or fluocinolone (0.05%) or mometasone (0.1%) to\\nbe applied till the lesion heal.\\nVITILIGO\\nIt is an acquired primary, progressive melanocytopenia of unknown etiology and\\ncharacterized by asymptomatic depigmented lesions.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Counselling and reassurance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 226, 'page_label': '227'}, page_content='Skin Diseases\\n211\\n\\uf0b7 It can be acute(less than 6 weeks) or chronic (>6 weeks).C haracteristic wheals with or\\nwithout angioedema.Dermatographism may be present.\\n\\uf0b7 Good general health and balanced nutritious diet enriched with adequate proteins, vitamin\\nB complex, vitamin E, minerals such as copper, zinc and iron.\\n\\uf0b7 Avoid trauma.\\n\\uf0b7 Avoid soaps and detergents containing phenolic compound and rubber goods.\\nPharmacological treatment\\n\\uf0b7 Topical steroids like mometasone furoate 0.1 % cream, betamethasone valerate 0.05%\\ncream ointment.\\n\\uf0b7 Topical calcineurin inhibitors like tacrolimus 0.03% or 0.1% ointment.\\n\\uf0b7 PUVA therapy Tab. methoxsalen (0.6mg/kg) or topical psoralens followed by sun\\nexposure.\\nALBINISM\\nAlbinism (from latin albus, \"white\") is a congenital disorder characterized by the complete or\\npartial absence of pigmentin the skin, hair and eyes due to absence or defect of  tyrosinase.\\nThere is generalisedand diffuse depigmentation ofskin with white hair from birth.Diagnosis\\nis clinical.\\nTreatment\\n\\uf0b7 Reassurance, patient education,protection from sunlight.\\nMELASMA\\nIt is a pigmentary disorder of the skincharacterized by malar hyperpigmentation. It is\\nparticularly common in women, especially during pregnancy and those taking oral\\ncontraceptives or hormone replacement therapy.\\nDiagnosis\\nClinical and woodslamp examination\\nNon -pharmacological treatment\\n\\uf0b7 Reassurance in pregnancy induced melasma.\\n\\uf0b7 Avoid sun exposure and causative factor like hormonal therapy.\\nPharmacological treatment\\n\\uf0b7 Topical agents like hydroquinone 2-5% cream or azelaic acid 10-20% cream or glycolic\\nacid 6-12% cream or hydroquinone + tretinoin + steroid (fluticasone, mometasone,\\nfluocinolone).\\n\\uf0b7 Photoprotection.\\nURTICARIA\\nUrticaria is characterized by transient erythematous wheals with burning or stinging\\nsensation. Most common causes are idiopathic, infections, food and drugs.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 227, 'page_label': '228'}, page_content='Skin Diseases\\n212\\n\\uf0b7 Chronic plaque psoriasis(Figure19) is clinically characterized by erythematous scaly\\nplaques with micaceous scaling predominantly over extensorsurfaces of body, scalp scaling\\nand nail pitting is seen (when involved). Winter aggravation is a feature.\\n\\uf0b7 Scalp psoriasis-erythematous scaly plaques on the scalp with itching.\\n\\uf0b7 Guttate psoriasis- dew drop like crop of erythematous scaly papules and plaques all over\\nbody. Associated with preceding streptococcal infection.\\n\\uf0b7 Psoriatic arthritis-asymmetrical oligoarticular arthritis involving distal interphalangeal joints\\nof fingers and toes.\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Eradicate the etiological factor if any.\\n\\uf0b7 Avoid the food causing urticaria.\\n\\uf0b7 Cold water sponging and soothing applications.\\n\\uf0b7 Clearance of airway in case of laryngeal oedema.\\nPharmacological treatment\\n\\uf0b7 Acute urticaria with/without angioedema- Inj. chlorpheniramine maleate, Inj.\\ndexamethasone IV or IM.\\n\\uf0b7 Chronic urticaria with/without angioedema- Tab. levocetrizine 5mg OD and/or Tab.\\nchlorpheniramine maleate 4mg HS.\\n\\uf0b7 Laryngopharyngeal edema Inj. epinephrine 0.5 to 1 ml SC and Inj. hydrocortisone 100mg\\nIV immediately.\\nPSORIASIS\\nPsoriasis is characterized by hyperproliferation and abnormal differentiation of epidermal\\nkeratinocytes, lymphocyte infiltration and various endothelialvascular changes in the dermis.\\nIt is a multifactorial condition where both genetic and environmental factors act together.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and skin biopsy.\\nNon -pharmacological treatment\\n\\uf0b7 Identify and avoid triggering factors.\\n\\uf0b7 Avoid stress, alcohol and smoking.\\n\\uf0b7 Avoid beta blockers and chloroquine.\\nPharmacological treatment\\n\\uf0b7 Topical agents( if< 10% BSA is involved) such as emollients- liquid paraffin, vaseline,\\nlight liquid paraffin, white soft paraffin, clobetasol and betamethasone either alone or in\\ncombination and salicylic acid 3-6%.\\n\\uf0b7 Vitamin D3 analogues-calcitriol, calcipotriol (SOS).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 228, 'page_label': '229'}, page_content='Skin Diseases\\n213\\n\\uf0b7 Erythematous to violaceous, flat topped, polygonal papules associated with intense pruritus\\n(Figure20).\\n\\uf0b7 Sites-Dorsal surface of the hands, flexor surfacesof the wrists and forearms; anterior aspect\\nof the lower legs, neck and sacral area are also common sites.\\n\\uf0b7 Asymptomatic, smooth, well defined round to oval totally bald patch slightly depressed\\nbelow the surface.\\n\\uf0b7 Paraesthesia or mild erythema may precede. At the margins of the expanding lesion, the\\ncharacteristic â€˜exclamationâ€™ mark hair can be found.\\n\\uf0b7 Systemic therapy  ( if > 20%  BSA is involved) at tertiary care centre-Tab. methotrexate\\n5-7.5 mg/week orTab. cyclosporine 100-200 mg/day(SOS) or Tab. acitretin 25 mg/day.\\n\\uf0b7 Phototherapy SOS.\\nLICHEN PLANUS\\nIt is an inflammatory autoimmune, papulosquamous disorder affecting skin, nails and/or\\nmucous membranes.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and skin biopsy\\nPharmacological treatment\\n\\uf0b7 Mild â€“ topical fluocinonide 0.05% or clobetasol propionate 0.05% cream and calcineurin\\ninhibitors like tacrolimus ointment 0.03%.\\n\\uf0b7 Moderate or severe cases- Tab. prednisolone 0.5-1 mg/kg) in gradually tapering doses\\nover 6 weeks.\\n\\uf0b7 Inj. triamcinolone acetonide (0.5-1 mg/kg) per month for 3-6 months.\\n\\uf0b7 Retinoidsâ€“ Tab. acitretin (25-50 mg / day for 6-8 weeks).\\nPatient education\\n\\uf0b7 Inform the patient that condition is non-infectious, self limiting and recurrence may\\noccur.\\nALOPECIA AREATA\\nIt is a common condition characterized by patchy loss of hair without scarring.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Biopsyâ€“ peribulbar lymphocytic infiltrate in â€œswarm of beesâ€ pattern.\\nNon -pharmacological treatment\\n\\uf0b7 Counselling and reassuranceâ€“ disease is self limiting.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 229, 'page_label': '230'}, page_content='Skin Diseases\\n214\\nPharmacologicaltreatment\\n\\uf0b7 Procedures is done at tertiary care centres with topical application of  irritants-anthralin,\\nphenol, tazarotene, azelaic acid, tincture iodine or contact sensitizers-squaric acid dibutyl\\nester, diphencyprone or\\n\\uf0b7 Intralesional-Triamcinolone acetonide 10 mg/ml 0.2-0.5ml per patch every 3 weeks.\\n\\uf0b7 Topical therapy by hydrocortisone acetate ointments or cream 1% or fluticasone\\ndipropionate 0.1% or psoralen or minoxidil.\\nSystemic therapyâ€“ for progressive lesions, not responding to topical agents.\\n\\uf0b7 Systemic corticosteroids-pulsed therapy in form of monthly Inj. triamcinolone (40mg/ml)\\nor oral mini pulse Tab. prednisolone 40mg two successive days in a week.(duration of the\\ntherapy depends on the response).\\n\\uf0b7 Systemic immunomodulatorsâ€“ Tab. cyclosporine(2mg/kg/day)\\n\\uf0b7 Oral phototherapy (PUVA) (should be given at tertiary centres because it is associated\\nwith side effects and cumulative dose dependent toxicities).\\nPEMPHIGUS VULGARIS\\nA group ofblisteringautoimmune diseasesthat affect theskinand mucous membranes.It is\\ncharacterised by mucosal involvement, flaccid blister over apparently normal skin(Figure21)\\nand positive Nikolsky sign.\\nDiagnosis\\n\\uf0b7 Clinical\\n\\uf0b7 Tzanck smear to demonstrate acantholysis\\n\\uf0b7 Biopsy or anti-desmoglein autoantibodies to confirm\\nNon -pharmacological treatment\\n\\uf0b7 Hospitalization.\\n\\uf0b7 Fluid replacement.\\nPharmacological treatment (only at tertiary care centre)\\n\\uf0b7 Oral: to prevent infection(Tab. azithromycin  500 mg OD for 5 days/ Tab.cotrimoxazole\\n2 BD for 7 days  according to culture sensitivity if there is infection).\\n\\uf0b7 IV dexamethasone (1mg/kg-2mg/kg bw).\\nCUTANEOUS ADVERSE DRUG REACTIONS\\nI. MACULOPAPULAR RASH\\nIt is milder form of drug reaction also known as scarletiniform rash or morbilliform rash.\\nDugs causing maculopapular rash are penicillin, sulfonamides, aspirin, phenytoin,\\nphenylbutazone, tetracycline, digitalis, thiacetazone, quinine, pas, rifampicin, ibuprofenetc.\\nIt is confluent erythematous maculopaplar rash with itching.\\nDiagnosis\\n\\uf0b7 Clinical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 230, 'page_label': '231'}, page_content='Skin Diseases\\n215\\n\\uf0b7 Classical iris or target lesions (central dusky erythema, purpura or blister middle ring of pale\\nedema with erythematous halo) are present in an acral distribution, may involve palms, dorsa\\nof hands, feet, elbows and knees.\\n\\uf0b7 Lesions usually fade in one to two weeks.\\n\\uf0b7 Mucosal lesions-lips palate and gingivae are common sites.\\nPharmacological treatment\\n\\uf0b7 Stop the causal drug.\\n\\uf0b7 Topical calamine lotion and Tab. cetirizine (10 mg/ day).\\nII.ERYTHEMA MULTIFORME\\nA self-limited but potentially recurrent disease characterised by appearance of dull red\\nerythematous maculopapular lesions with a central vesicle and sometimes with a marginal\\nring of vesicle usually acral (hands and feet) distribution.Most common cause is infection\\nwith herpes simplex virus and drugs.\\nCommon drugs causing erythema multiforme are penicillin, sulfonamides, aspirin, phenytoin,\\nphenylbutazone, tetracycline, codeine, digitalis, thiacetazone, quinine, isoniazid, PAS,\\nrifampicin, glucocorticoids, methotrexate, clindamycin, ibuprofen, minoxidil, griseofulvin,\\nstreptomycin, piroxicam, anticholinergic eye drops, perfumes topical like vitamin E,  5-\\nfluorouracil, nitrogen mustard.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical and Complete blood count, liver function tests.\\nNon -pharmacological treatment\\n\\uf0b7 Discontinue the causal drug.\\nPharmacological treatment\\n\\uf0b7 Topical antiseptics for eroded skin lesions.\\n\\uf0b7 Antiseptic and local anaesthetic solutions for oral lesion in case of herpes simplex.\\n\\uf0b7 Topical ophthalmic preparations like normal saline or lubricating eye drops for eye\\nlesions.\\n\\uf0b7 Tab. cetirizine (10 mg) or Tab.chlorpheniramine (4 mg) for 3 or 4 days.\\n\\uf0b7 Tab. prednisone [0.5â€“1 mg/kg/day].\\nIII.FIXED DRUG ERUPTION\\nCharacteristically recur at the same site following the administration of the offending drug or\\noccasionally member of the same group of drugs. Occur in 30 mins to 8 hours after drug\\nadministration. Common drugs include sulfonamides, NSAIDs, tetracycline, dapsone,\\nchlordiazepoxide, barbiturates, ciprofloxacin, phenytoin, codeine, quinine, griseofulvin,\\nmebendazole, metronidazole, ampicillin and antituberculous drugs.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 231, 'page_label': '232'}, page_content='Skin Diseases\\n216\\n\\uf0b7 Round, sharply demarcated erythematous/ hyperpigmented patches are seen, sometimes with\\na central blister or detached epidermis(Figure22).\\n\\uf0b7 Sites: lips, face, hands, feet and genitalia.\\n\\uf0b7 Generalised bullous FDE is characterized by multiple, sharply defined, deep red macules and\\nblisters with bilateral symmetrical distribution.\\n\\uf0b7 Lesions consist of wide spread flat atypical target or purpuric macules distributed centrally\\nwith involvement of at least two mucosal sites.\\n\\uf0b7 Cutaneous lesions are preceded by fever, arthralgia, malaise, headache, vomiting, diarrhea\\nand myalgia. Mucosae involved are eyes, mouth and genitalia.\\n\\uf0b7 In TEN, confluent erythema is present, the epidermis separates in a set forming raised,\\nflaccid bullae. Pain, burning and tenderness of the skin are marked.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Stop the offending drug.\\n\\uf0b7 Enlist the drugs to be avoided.\\nPharmacological treatment\\n\\uf0b7 Topical calamine lotion.\\n\\uf0b7 Tab. cetirizine (10 mg/ day) or Tab. chlorpheniramine (4 mg/day).\\n\\uf0b7 Tab. prednisolone 0.5-1 mg/kg/ day) for generalized bullous FDE.\\nIV.STEVENS JOHNSON SYNDROME/ TOXIC EPIDERMAL NECROLYSIS\\nStevens Johnson Syndrome is an adverse cutaneous drug reactions, characterized by<10%\\nbody surface area of epidermal detachment and mucocutaneous tendernessand erythema\\n(Figure23). Toxic epidermal necrolysis (TEN) is an adverse cutaneous drug reactions,\\ncharacterized by>30% body surface area of epidermaldetachment and mucocutaneous\\ntenderness and erythema.\\nCommon drugs causing SJ Syndrome/TEN are ampicillin, allopurinol, carbamazepine,\\ncotrimoxazole, isoniazid, lamotrigine, nevirapine, NSAIDs, phenobarbitol, phenylbutazone,\\nphytoin, ciprofloxacin, rifampicin, salicylates, tetracyclines, thiacetazone\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\nNon -pharmacological treatment\\n\\uf0b7 Withdraw offending drug.\\n\\uf0b7 Oral liquid diet with protein supplements.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 232, 'page_label': '233'}, page_content='Skin Diseases\\n217\\n\\uf0b7 Characterized by grouped vesicles followed by erosive lesions associated with burningand\\npain.Primary genital herpes-systemic symptoms are prominent and prolonged\\n\\uf0b7 Recurrent genital herpes-recurrent episodes are milder lasting only for 5-7 days\\n\\uf0b7 Primary syphilis-characterized by single well defined painless indurated ulcer and enlarged,\\ndiscrete, non tender firm lymphnodes with rubbery consistency.\\n\\uf0b7 Secondary syphilis- begins after 2-12 weeks after the primary chancre.Presentation-\\nmacular, papular, pustular, annular, follicular, mucus membrane lesions and lues maligna\\n(Figure24(a)). Tertiary syphilis-Gummatous lesions of covering structures / viscera,\\nCardiovascular syphilis, Neurosyphilis-Meningeal/ Parenchymatous / Gummatous\\n\\uf0b7 Oral care: oral hygiene should be maintained with antiseptic mouth washes.\\n\\uf0b7 Maintain optimum temperature of 30-32Â° C.\\nPharmacological treatment (tertiary care centre)\\n\\uf0b7 Hospitalisation.\\n\\uf0b7 Management of fluid and electrolytes.\\n\\uf0b7 Measures to prevent secondary infections.\\n\\uf0b7 Ophthalmic care: saline or antibiotic eye drops\\n\\uf0b7 Systemic antibiotics to prevent infection according to culture sensitivity: Macrolides-\\nTab. azithromycin 500mg OD for3/5days/ Tab.erythromycin 500mg QID for 5/7 days.\\n\\uf0b7 Tab. prednisolone (1-2 mg/kg/day),parentral (Inj. dexamethasone 8-16mg/day). It should\\nbe started within 72hr   of onset and continued for 3-5days with rapid tapering.\\n\\uf0b7 Tab. cyclosporine (3-5 mg/kg/day) for two weeks followed by weaning over another two\\nweeks SOS.\\nHERPES GENITALIS\\nHerpes genitalis most commonly caused by HSV 2.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical andTzank smear and serological-HSV IgM antibody.\\nTreatment(Table 2)\\n\\uf0b7 Kit 5 by NACO.\\nPatient education\\n\\uf0b7 Avoid sexual contact and treatment of the partner.\\nSYPHILLIS\\nSyphilis is a systemic disease caused by the spirochete,treponema pallidum.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 233, 'page_label': '234'}, page_content='Skin Diseases\\n218\\n\\uf0b7 Multiplepainful, non indurated genital ulceration with painful inguinal lymphaedenopathy\\n(Figure24(b)).\\n\\uf0b7 Diagnosis is mostly clinicaland confirmation with gram stain andbacterial culturecan be\\ndone.\\n\\uf0b7 Small transient painless papule or herpetiform ulcer develops at the site of inoculation, most\\noften goes unnoticed by the patient.\\n\\uf0b7 The primary ulcer resolves without treatment after 2 to 6 weeks. The second stage of the\\ndisease is known as the inguinal syndrome/ano rectal genital syndrome.\\nDiagnosis\\n\\uf0b7 Dark field microscopy\\n\\uf0b7 Direct fluorescent antibody test for treponema pallidum\\n\\uf0b7 Non treponemal test-VDRL, RPR and Treponemal test-FTA -ABS,TPHA,MHA -TP\\nTreatment(Table 2)\\n\\uf0b7 K it 3 by NACO\\nPatient education\\n\\uf0b7 Regular follow up and serological examination\\n\\uf0b7 Treatment of partner\\n\\uf0b7 Counseling about safe sex practice\\nCHANCROID\\nChancroid is caused by the small gram-negative rod,Haemophilus Ducreyi.\\nSalient features\\nTreatment(Table 2)\\n\\uf0b7 K it 4 by NACO\\nLYMPHOGRANULOMA VENERUM\\nLymphogranuloma venereum (LGV ) is caused bychlamydia trachomatisserovars l1, l2, or\\nl3.\\nSalient features\\nDiagnosis\\n\\uf0b7 Clinical\\nTreatment(Table 2)\\n\\uf0b7 Kit 4 by NACO\\nURETHRAL DISCHARGE\\nCaused by N eisseria gonnorhoe, Chlamydia trachomatis,M ycoplasma and U reaplasma\\nurealyticum.Manifestsas thick whitish-yellow discharge per urethra associated with dysuria.\\nDiagnosis\\n\\uf0b7 Clinical'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 234, 'page_label': '235'}, page_content='Skin Diseases\\n219\\n\\uf0b7 Gram stain and Culture\\nTreatment(Table 2)\\n\\uf0b7 Kit 1 by NACO.\\nNon -pharmacological treatment\\n\\uf0b7 Educate and counsel the client and sexual partner regarding sexually transmitted\\ninfection/ reproductive tract infection safer sex practices and importance of taking\\ncomplete treatment.\\n\\uf0b7 Treat partner.Advice sexual abstinence or condom use during the course of treatment.\\nProvide condoms, educate about correct and consistent condom use.\\n\\uf0b7 Refer all patients to ICTC.\\n\\uf0b7 Follow up after 7 days for all sexually transmitted infections; on 3rd, 7th and 14th day for\\nlower abdominal pain and on 7th, 14th and 21stday for inguinal bubo.\\n\\uf0b7 If symptoms persist, re-assess for re-infection and advice prompt reference.\\n\\uf0b7 Consider immunization against Hepatitis B.\\nTable 2.Drug kits provided byNACO\\nDERMATOLOGICAL EMERGENCY\\nSevere acute allergic reactions include urticaria, angioedema, anaphylaxis, Steven Johnson\\nSyndrome, toxic epidermal necrolysis, life threatening stings andbites. Life threatening\\ninfections include necrotizing soft tissue infections, fungal and viral infections with\\ncomplications. Severe dermatological conditions include: autoimmune vesiculo bullous\\nKit Color Composition of kit Syndrome/disease\\n1 Grey Tab. azithromycin 1g stat +\\nTab cefixime 400 mg stat\\nUrethral discharge , cervical\\ndischarge , anorectal discharge,\\npainful scrotal swelling\\n2 Green Tab. secnidazole 2g stat +\\nCap. fluconazole 150mg stat\\nVaginal discharge\\n3 White Inj. benzathine penicillin 2.4 mu IM\\nstat + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non herpetic)\\n4 Blue Cap. doxycycline 100mg BD for 15\\ndays + Tab. azithromycin 1g stat\\nGenital ulcerative disease\\n(non-herpetic)\\n5 Red Tab. acyclovir 400mg TDS for 7\\ndays\\nGenital ulcerative disease  (herpetic)\\n6 Yellow Tab. cefixime 400mg stat +\\nTab. metronidazole 400mg BD for\\n15 days + Cap. doxycycline 100mg\\nBD for 14 days\\nLower abdominal pain (lap)\\n7 Black Cap. doxycycline 100mg BD for 21\\ndays + Tab. azithromycin 1g stat\\nInguinal bubo'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 235, 'page_label': '236'}, page_content='Skin Diseases\\n220\\ndisorders, collagen vascular disorders, psoriasis- unstable, cutaneous involvement in\\nparaneoplastic disorders and systemic infections.\\nTreatment\\nDermatological emergencies can only be managed at tertiary care centre.\\nNon -pharmacological treatment\\n\\uf0b7 Treat the primary cause.\\n\\uf0b7 Maintain CAB (circulation, airway and breathing).\\n\\uf0b7 Careful monitoring of the vitals.\\n\\uf0b7 Fluid and electrolyte management.\\n\\uf0b7 Input and output chart.\\nPharmacological treatment (only at tertiary centres)\\n\\uf0b7 Systemic corticosteroids for autoimmune blistering and collagen vascular disorders (dose\\ndepending on the severity of involvement and taper according to the response on follow\\nup).\\n\\uf0b7 Appropriate antibiotics likeTab .azithromycin 500 mg OD for 3/5days/Tab .erythromycin\\n500 mg QID for 5/7 days., antiviral like Tab. acyclovir 400 mg TDS for 7 days ;\\nantifungals like Cap. fluconazole 50-100 mg/day for 7-10 days(depending on severity).\\n\\uf0b7 Immunosuppressant drugs used with caution and monitoring like cyclophosphamide 1-\\n1.5mg/kg/day, azathioprine 1-2mg/kg/day, cyclosporine (2mg/kg/day).\\n\\uf0b7 IV Immunoglobulin and biological agents (rarely used).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 236, 'page_label': '237'}, page_content=\"229\\nChapter 13\\nOBSTETRICS AND GYNECOLOGY\\nNORMAL PREGNANCY\\nIt is a transient physiological state during a woman's reproductive years.H owever, it requires\\nutmost antenatal care regarding diet, lifestyle and drug therapies to achieve a good foetal\\noutcome with minimal maternal morbidity and mortality.\\nInstruct the woman regarding\\n\\uf0b7 Diet\\nCaloric requirements depend on the physical work done by the women. The increased\\nrequirement of 300 cals for the pregnancy state is to be made available by exogenous supply\\nof diet. An ideal pregnancy diet should be light, nutritious, easily digestible and rich in\\nproteins, vitamins and minerals. The diet should consist of at least half-a-liter of milk, plenty\\nof green leafy vegetables (one katori serving in each meal)and fruits as available, in addition\\nto normal Indian diet consisting of a balanced cereals and pulses combination. Foods rich in\\niron like green vegetables, jaggery, and protein rich foodslike nuts should be stressed upon.\\nFat consumption can be predominantly of animal source so as to take care of vitamins A & D.\\n\\uf0b7 Exercise\\nAny exercise, the woman is accustomed to can be continued, but not to the point of fatigue.\\nAntenatal exercises doneunder medical supervision are useful in pregnancy and labour. No\\nnew exercise should be initiated during pregnancy. Sedentary women should be allowed only\\nwalking. Women with multiple foetuses and complications like heart disease, pregnancy\\ninduced hypertension, intrauterine growth retardation, history of preterm labour, anti partum\\nhemorrhage (APH), threatened abortion should not exercise.\\n\\uf0b7 C lothing\\nShould be non-constricting.\\n\\uf0b7 Travel\\nRoad travel is allowed with safety belt. Traveling in a pressurized aircraft is of no risk,should\\nwalk about every 2 hours.\\n\\uf0b7 Employment\\nJobs requiring prolonged standing (>8 hours/day) are associated with a minimum risk of pre-\\nterm delivery.\\n\\uf0b7 Clinical check up\\nDuring each antenatal visit, BP, weight-gain, oedema feet, cardio-vascular, respiratory and\\nbreast examination symphyseal-fundal height, presentation, foetal heart rate(s), amniotic fluid\\nvolume, inquiry about daily foetal movement charting, and pelvic assessment at 38 weeks. Rh\\nnegative women (with Rhpositive husband) need to be monitored on similar lines with\\nadditional testing with Indirect Coomb's test (ICT) at first visit, 28 weeks and 34-36 weeks.\\nImmunoglobulin 300 mcg IM is recommended in ICT negative patients at 28 weeks of\\npregnancy and postpartum 300 mcg IM ifbaby is Rhpositive. ICTpositive patients are to be\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 237, 'page_label': '238'}, page_content='Obstetrics andGy necology\\n230\\nmanaged only at centers with facilities for amniocentesis and/or cordocentesis, amniotic fluid\\noptical density estimation and intrauterine foetal transfusions.\\nTab. folic acid 5 mg once daily, at least 3 months before conception, and continue till 12\\nweeks of gestation. Dose of iron (60-100 mg elemental iron) and folic acid (Tab. iron folic\\nacid) once daily and Tab. calcium gluconate 500 mg tablet twice daily from 16 weeks till 3\\nmonths postpartum.\\n\\uf0b7 Immunization\\n2 doses of tetanus toxoid 4-6 weeks apart,(MMR vaccinesiscontraindicated).Rest of the\\nvaccines can be administered, if indicated as in nonpregnant state.\\n\\uf0b7 Investigations during pregnancy\\nHaemoglobin, urine (routine and microscopy),blood groups andRh typing, screen for\\nsyphilis, hepatitis B infection, HIV, cervical cytology, ultrasound forfoetal anomalies if\\nindicated, diabetes screening\\nPatient education\\n\\uf0b7 Advise the woman on how to prepare for delivery, when to go, what to bring and where to\\ngo in emergency.Explain the danger signals when she should report to the healthcenter\\nimmediately,day or night, without waiting such as vaginal bleeding, convulsions, severe\\nheadaches with blurred vision, severe abdominal pain, fast or difficult breathing, escape of\\nfluid from vagina or change in frequency or intensity of foetal movements, persistent\\nvomiting, oliguria. She should go to the health centre as soonas possible if any of the\\nfollowing signs: swelling on face or hands, abdominal pain, fever, dysuria, feels ill.\\n\\uf0b7 Explain about black staining of stools due to oral iron, therefore, not to worry about it.Iron\\nand calcium supplements should be taken at different times of the day at least 2 hours\\napart.\\n\\uf0b7 Discuss birth spacing after delivery and counsel on the importance of family planning.\\nGive advice on correct and consistent use of condoms for dual protection from sexually\\ntransmitted infections or HIV and pregnancy\\n\\uf0b7 Sexual intercourse should be avoided when abortion/pre-term labour threatens, and during\\nlast 4 weeks in any pregnancy.\\n\\uf0b7 Bowel: constipation, fissures and haemorrhoids are common during pregnancy and should\\nbe treated with fluids, exercise and bulk laxatives and stool softeners.\\n\\uf0b7 Smoking, alcohol and drug abuse are contraindicated. Caffeine is best avoided.\\n\\uf0b7 Daily foetal movement charting (DFMC): After 28 weeks, the woman should keep foetal\\nmovement count.\\n\\uf0b7 Follow-up visits: every 4 weeks till 28 weeks, every 2 weeks till 36 weeks and weekly\\nthereafter.\\nNAUSEA AND VOMITING IN EARLY PREGNANCY\\nNausea and vomiting of mild to moderate intensity are especially common complaints in\\nearly pregnancy until about 16 weeks. In few cases it may progress to hyperemesis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 238, 'page_label': '239'}, page_content=\"Obstetrics andGy necology\\n231\\n\\uf0b7 Common complaint on rising in the morning but sometimes occurs at other times of the day;\\nvomitus is usually small and clear and doesn't produce any impairment of health or restrict the\\nnormal activities of the pregnant woman.\\n\\uf0b7 Severe nausea and persistent vomiting progress to hyperemesis leading to weight loss, ketosis\\nand there may be muscle wasting. There are usually signs of dehydration with postural\\nhypotension and tachycardia.\\n\\uf0b7 Diagnosis is by exclusion of medical and surgical causes of vomiting like liver or GIT\\ndisorders, pyelonephritis, diabetes mellitus etc. and molar (and multiple) pregnancy should be\\nruledout in all cases of hyperemesis by ultrasound.\\nSalient features\\nMild and moderate cases\\nNon pharmacologicaltreatment\\n\\uf0b7 Reassurance and advice to take frequent small, dry carbohydrate rich meals and avoid\\nfatty orspicy foods, especially avoid large volume of drinks in the morning.\\nPharmacological treatment\\n\\uf0b7 Tab. doxylamine succinate 10 mg + Tab. pyridoxine HC1 10 mg 1-2 tablets at bed time.\\nIf required one more tablet can be added in the morning and afternoon. Or\\n\\uf0b7 Tab. metoclopramide 10 mg 2-4 times a day in moderately severe cases.\\nHyperemesis gravidium\\nNon pharmacological treatment\\nAdmit all cases in the hospital away from a stressful home environment.\\n\\uf0b7 Stop oral intake of fluids and nutrition.\\n\\uf0b7 Serum electrolytes and urinary ketones to be checked at admission and 6 hourly.\\n\\uf0b7 Emotional support, psychiatric referral if required.\\n\\uf0b7 Rule out multiple or molar pregnancy and liver disorders.\\nPharmacological treatment\\nAdequate and appropriate fluid and electrolyte replacement. Normal saline or Ringer's lactate\\nsolutions are appropriate solutions and KC1 is added as required.\\nIf urinary ketones are present, then 1 liter of 10% dextrose is transfused over 3-4 hours.\\nFor prolonged vomiting\\n\\uf0b7 Tab. thiamine 25-50 mg 3 times a day (if orally tolerated). If vomiting are not controlled\\nwith fluid and electrolytes replacement in 6-8 hours.\\n\\uf0b7 Inj. metoclopramide 10 mg IV or IM 8 hourly\\n\\uf0b7 Inj. ranitidine 50-100 mg 6 hourly.\\n\\uf0b7 If not controlled, Inj. promethazine chloride 25-50 mg IM or IV 8 ho urly or Inj.\\nchlorpromazine 25-50 mg IM 4-6 hourly.\\n\\uf0b7 Once vomiting is controlled for 24 hours, oral intake is gradually started. If well tolerated\\nthen only IV fluids are omitted. At first dry carbohydrate foods are given in the form of\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 239, 'page_label': '240'}, page_content='Obstetrics andGy necology\\n232\\n\\uf0b7 Bleeding in first trimester of pregnancy can be due to pregnancy related complications\\nsuch as abortion (threatened/inevitable/ incomplete/missed), ectopic pregnancy and molar\\npregnancy or due to local causes such as trauma, erosion, polyp, infection, premalignant\\nor malignant lesions.\\n\\uf0b7 Local lesions are diagnosed on per speculum examination.\\nsmall meals at frequent intervals. Gradually full diet is introduced. In prolonged and\\nsevere disease, parenteral nutrition may be necessary. Give Tab. metoclopramide 10 mg\\nTDS and Tab. ranitidine 150 mg BD\\n\\uf0b7 If well tolerated for 48 hours, patient can be discharged from the hospital with dietary\\nadvice, reassurance and continue Tab. metoclopramide for 5-7 days or longer depending\\non the response.\\nPatient education\\n\\uf0b7 Adjust timing of medication in relation to the time of sickness.\\n\\uf0b7 This is a benign disorder and gets relieved by 14-16 weeks of pregnancy\\nFIRST TRIMESTER BLEEDING\\nSalient features\\nTreatment\\n\\uf0b7 Abortion can be treated at a primary centre.\\n\\uf0b7 Molar and ectopic pregnancy should be treated at a secondary/tertiary centre(Table 1)\\n\\uf0b7 Check Bleeding time, clotting time, CRT in missed abortion\\nSurgical treatment\\n\\uf0b7 Manual vacuum aspiration or suction evacuation, dilatation and evacuation or only\\nevacuation in all cases of abortion and molar pregnancy except threatened abortion.\\n\\uf0b7 Laparotomy/laparoscopic removal of ectopic pregnancy except a few selected cases of\\nunruptured ectopic pregnancy.\\nTable 1. Diagnosis of etiology of first trimester bleeding\\nDiagnosis Clinical findings USG/ HCG\\nThreatened abortionUterine size = period of gestation\\n(POG) Internal Os closed\\nConsistent with live foetus\\nInevitable abortionUterine size = POG\\nInternal Os open, excessive\\nbleeding and pain\\nCardiac activity + Internal\\nOs dilated\\nIncomplete abortionHistory of passing products of\\nconception (POC) Uterine size < POG\\nInternal Os open/ closed\\nPOC in uterine cavity\\nMissed abortion Uterine size < POG Internal Os closed\\nBrownish discharge +\\nCardiac activity absent'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 240, 'page_label': '241'}, page_content=\"Obstetrics andGy necology\\n233\\nMolar pregnancy History of passing vesicles\\nÂ± Uterine size > or = or < than POG\\nInternal Os open/closed\\nHoneycomb appearance\\nhCG levels very high\\nEctopic pregnancy Cervical excitation +\\nUnilateral tender fornix,\\nadnexal mass\\nPseudogestational sac\\nempty uterine cavity\\nadenexal  mass, HCG rise\\n<66% in 48 hours\\nPatient education\\n\\uf0b7 Exactetiology of abortions is not always apparent.Very early abortions are often nature's\\nselection to abort a nonviable, chromosomally abnormal conceptus.\\n\\uf0b7 Increased abortions are seen with increasing parity and maternal age.Recurrent abortions\\n3 or more consecutive abortions should beinvestigated before planning the next\\npregnancy.\\n\\uf0b7 Effective contraception should be initiated soon after abortion as ovulation can occur as\\nearly as 2-3 weeks after an abortion.\\nTHREATENED ABORTION\\nNon -pharmacological treatment\\nBed rest\\nPharmacological treatment\\n\\uf0b7 Inj. pentazocin 15 mg and Inj. promethazine 12.5 mg IM stat for those who have pain and\\nare anxious. If not available Inj. diazepam 10 mg IM or Tab. alprazolam 0.5 mg.\\n\\uf0b7 Tab. folic acid 5 mg daily.\\n\\uf0b7 Monitor for the continuation of pregnancy after confirming cardiac activity by USG.\\n\\uf0b7 Discharge the patient 48 hours after bleeding stops.\\n\\uf0b7 Progesterone supplementation if serum progesterone < 15 ng/ml only afterconfirming\\ncardiac activity in cases of spontaneous conception.\\nPatient education\\n\\uf0b7 To report immediately if bleeding recurs or it is more than normal periods.Continue bed\\nrest for at least 2 weeks.\\n\\uf0b7 Abstinence till at least two follow-up visits in the next 4 weeks when normal continuation\\nof pregnancy is documented.High fiber diet to be givento avoid constipation.\\n\\uf0b7 Need of follow up after 2 weeks for fetal growth by clinical and/or USG parameters.\\nAfter suction evacuation for abortion\\n\\uf0b7 Reassurance if no living child.\\n\\uf0b7 Need for contraceptive- can be started immediately after evacuation.Can resume coitus\\nafter 4 weeks if no complications.\\n\\uf0b7 When to attempt conception-after at least 6 months\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 241, 'page_label': '242'}, page_content=\"Obstetrics andGy necology\\n234\\n\\uf0b7 Fever, tachycardia, abdominal distension and tenderness, pelvic tenderness, and purulent\\nvaginal discharge. In severe cases there may be endotoxic shock and end organ failure.\\n\\uf0b7 Complications like injury to viscera like uterus and bowel, internal or external\\nhaemorrhage, peritonitis, disseminated intravascular coagulation, renal failure, hepatic\\nfailure, endotoxic shockand tetanus can occur.\\nSEPTIC ABORTION\\nAny abortion associated with fever and signs of pelvic or generalized sepsis are considered\\nseptic abortion. Most septic abortions result from illegal abortions but sepsis may follow\\nspontaneous and elective abortions\\nSalient features\\nBefore starting antibiotic therapy, high vaginal or cervical swab and blood culture should be\\nobtained.\\nPharmacological treatment\\n\\uf0b7 IV fluids for correction of electrolyte imbalance\\n\\uf0b7 Oxygen by facemask in severe cases. In cases of adult respiratory distress syndrome\\nintubation and ventilatory support is required, and hydrotherapy if required.\\n\\uf0b7 If blood pressure is not controlled with fluid replacement, Inj. dopamineinfusion in 5%\\nDextrose2 -5 mcg/kg/min and dose titrated according to clinical and haemodynamic\\nresponse.\\n\\uf0b7 In case of shock, acidosis is corrected by IVsodium bicarbonate 50-100 mEq in normal\\nsaline.\\n\\uf0b7 Inj. ampicillin 2 g stat followed by 500 mg IV 6 hourly(after test dose)Or\\n\\uf0b7 Inj. cefuroxime or ceftazidime 1-2 g IV 2 times a day (after test dose).\\n\\uf0b7 Inj. gentamicin 1.5mg/kg then1mg/kg IV 8hourly or Inj. amikacin 250- 500 mg IV 8\\nhourly.\\n\\uf0b7 Inj. metronidazole 500mg IV 8hourly or Inj. clindamycin 600 mg IV 6 hourly\\n\\uf0b7 Continue antibiotic therapy for 48-72 hours until culture sensitivity results provide an\\nindication for changing the initial antibiotic regimens or patient does not respond to\\ntherapy. Monitor pulse, temperature, blood pressure, respiratory rate, urine output, and\\nserum electrolytes.In severe cases,central venous pressure (CVP ) and arterial blood gas\\n(ABG )monitoring is required. Therapeutic goals are to maintain systolic BP >90 mmHg,\\nurine output >30 ml/min, arterial PO, >60 mmHg, and CVP 6 -12 cm of H2O .\\nSurgical treatment\\n\\uf0b7 Uterine curettage: if patient's condition is stable, within 1 hour of antibiotic therapy,\\nevacuation of the uterus by gentle curettage to remove infected products. If general\\ncondition is low at admission, curettage after 6-8 hours of antibiotic therapy and treat\\nhypovolaemia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 242, 'page_label': '243'}, page_content='Obstetrics andGy necology\\n235\\n\\uf0b7 Laparotomy in case of injury to the uterus, suspected injury to the gut, presence of\\nforeign body in the abdomen as evidenced by X ray or feltthrough the fornix, peritonitis\\nor  colpotomy in cases of pelvic abscess.\\nECTOPIC PREGNANCY\\nTreatment of ectopic pregnancy should be undertaken at a secondary/tertiary care level set\\nup. Laparoscopic surgery or laparotomy is done in all cases of ectopic pregnancy except in a\\nfew selected cases that are highly compliant and reliable and fulfill the following criteria:\\n\\uf0b7 Unruptured ectopic pregnancy in haemodynamically stable patient.\\n\\uf0b7 Gestational sac size <3.5 cm in greatest diameter.\\n\\uf0b7 Serum hCG titer < 10,000 mlU/ml.\\n\\uf0b7 Gestation <6 weeks.\\n\\uf0b7 Absence of foetal cardiac activity.\\nPharmacologicaltreatment(for unruptured ectopic pregnancy)\\n\\uf0b7 Obtain pretreatment hCG titers, haemogram, liver and renal function tests.\\n\\uf0b7 Inj. methotrexate 50 mg/sq meter body surface area IM given on day 1.\\n\\uf0b7 Repeat hCG titers on day 4 and 7.\\n\\uf0b7 If day 7, hCG titers reflect a drop of at least 15% from maximum levels then weekly hCG\\ntiters till negative.\\n\\uf0b7 If fall <15% or there is rise then repeat Inj. methotrexate.\\nPatient education\\n\\uf0b7 Resolution of ectopic pregnancy may take up to 6 weeks.\\n\\uf0b7 5-10% cases require surgery despite medical therapy.\\n\\uf0b7 Signs and symptoms of tubal rupture such as vaginal bleeding, abdominal pain, weakness,\\ndizziness or syncope must be reported promptly.\\n\\uf0b7 Patient should refrain from alcohol and folic acid containing vitamins during this period.\\n\\uf0b7 Sexual intercourse should be avoided during therapy.\\nMEDICAL TERMINATION OF PREGNANCY\\nThe government of India has legalized Medical Termination of Pregnancy (MTP) up to 20\\nweeks of gestation by MTP Act 1971. Under this act, pregnancy can be terminated under\\nfollowing clauses:\\nClauses and requirements\\n1. Damage to the life of the pregnant woman.\\n2. Grave injury to the physical or mental health of the pregnant woman.\\n3. Pregnancy caused by rape.\\n4. Substantial risk, that if the child wasborn, it would suffer from such physical or mental\\nabnormalities as to be seriously handicapped.\\n5. Failure of any contraceptive method or device.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 243, 'page_label': '244'}, page_content='Obstetrics andGy necology\\n236\\nNecessary consent form as laid down in the Act should be duly filled and signed. Opinion of\\ntwo registered medical practitioners is mandatory for second trimester MTP (>12 weeks).\\nFirst trimester MTP methods\\nMedical methods\\n\\uf0b7 It can be done up to 49 days amenorrhoea after proper counseling and excluding\\ncontraindications.\\n\\uf0b7 Tab. mifepristone 200-600 mg given on day 1.\\n\\uf0b7 On day 3 Tab. misoprostol 400mcg orally or 800 mcg vaginally in hospital. Woman\\ngenerally aborts in next 4-8 hours and USG on day 14 to confirm complete abortion.\\n\\uf0b7 Asked to report if excessive bleeding anytime in between. The procedure should be done\\nonlyin centers approved under MTP Act.\\nSurgical method\\n\\uf0b7 Suction and evacuation done in all centers approved under MTP Act. Manual Vacuum\\nAspiration (MVA) can be done in all PHCs.\\nPatient education\\n\\uf0b7 Details of the method and small risk of complications should be explained. Medical\\nmethod fails in around 5% cases and these will require surgical curettage.\\n\\uf0b7 Patient should be motivated for concurrent contraception and option of all available\\nmethods both temporary and permanent should be discussed.\\nSecond trimesterMTP methods\\n\\uf0b7 To be conducted in secondary and tertiary care level. None of the second trimester\\nmethods are 100% safe and effective. That is why many methods both surgical and\\nmedical, are available and being used. For second trimester MTP medical methods are\\npreferred.\\n\\uf0b7 Methods are usually combined so as to increase the success rate and to shorten induction\\nabortion interval. Most commonly extra amniotic0.1% ethacridine lactate 10 ml per week\\nof gestation (maximum 150 ml) with IV oxytocin after 6-24 hours or IM 15 methyl\\nPGF2Î±. Abortion is induced in 32 â€“ 36 hours with a success rate of 75-80%.\\n\\uf0b7 Better results if some method for cervical ripening is used 6-12 hours before.\\n\\uf0b7 If some method fails switch over to other method or surgical method\\nANEMIA IN PREGN ANCY\\nPrevalence of anaemia in pregnancy in India is 80% and severe anaemia is 10-15%. Causes\\nof anaemia in pregnancy are the same as those encountered in the non pregnant state.\\nHowever, iron deficiency anaemia is commonest in pregnancy. In about 40-50% of cases\\nthere is associated folic acid deficiency. Anaemia in pregnancy is defined as haemoglobin\\nconcentration of less than 11 g/dl and haematocrit of less than 33%. It is further classified\\ndepending on Hb levels as mild 10-11 g%, moderate 7-10 g% and severe <7 g%.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 244, 'page_label': '245'}, page_content='Obstetrics andGy necology\\n237\\n\\uf0b7 M ild to moderate cases- weakness, exhaustion, lassitude, anorexia, glossittis, and\\nstomatitis, while severe cases present with palpitation, dyspnoea, oedema and cardiac\\nfailure.\\n\\uf0b7 Important basic investigations required are haemoglobin, haematocrit, total RBC counts,\\nperipheral smear for type of anaemia and haematological indices, plasma proteins and\\nstool for ova and cyst.\\nSalient features\\nIron deficiency anemia\\nAll cases of severe anaemia to be admitted especially those with features of anoxia or cardiac\\ninsufficiency.\\nNon pharmacological treatment\\n\\uf0b7 Diet rich in iron- jaggery, green leafy vegetable, sprouted pulses, meat, cooking food in\\niron utensils.\\n\\uf0b7 Diet rich in protein-pulses, lentils, milk and milk products, nuts, eggs and meat.\\nPharmacological treatment\\n\\uf0b7 Oral iron therapy- ferrous sulfate andferrous fumarate. Recommended dose is 200 mg\\nelemental iron daily in divided doses. Not to be taken with meals, milk, coffee or tea.\\nContinue therapy till blood picture returns to normal and then continue with 100 mg\\nelemental iron for 3 months to build up the stores. Government of India recommends\\nminimum of 100 mg of elemental iron and 5 mg folic acid for 100 days starting at 20\\nweeks (Common side effects are epigastric pain, nausea, vomiting, constipation, and\\ndiarrhoea).\\n\\uf0b7 Deworming to be done after first trimester, if necessary. Tab. mebendazole 100 mg 2\\ntimes a dayfor 3 daysor Tab. albendazole 400 mg single dose.\\nMonitoring of response to therapy\\nSubjective improvement of feeling better, weight gain and improved appetite is seen after 1-2\\nweeks. Reticulocyte response observed in 5-10 days (increases to 5-6%) and rise in\\nHb/haematocrit in 2-3 weeks. The concentration is expected to rise at the rate of 0.1-0.25\\ng/dl/day or 0.8-1 g/dl/week.If no improvement in 3 weeks, reevaluate for: incorrect\\ndiagnosis, non compliance, defective absorption, continuing loss, associated deficiencies.\\nRole of parenteral therapyis limited as rate of rise of haemoglobin with parenteral iron is\\nsimilar to oral iron preparation.\\nSpecific indications\\nSevere intolerance to oral iron, malabsorption, non compliance and moderate to severe\\nanaemia inadvanced pregnancy\\nTotal dose of iron to be given is calculated using following formulae:\\n2.4 Xweight in kgX deficit in Hb in gm + 500mg should be added for pregnancy.\\n(Caution:Oral iron is suspended at least 24 hours prior to therapy to avoid reaction).\\nIntravenous routeisto be given after hospitalization.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 245, 'page_label': '246'}, page_content='Obstetrics andGy necology\\n238\\n\\uf0b7 Patients may be asymptomatic or may have vomiting, diarrhoea, pallor,hepatosplenomegaly,\\nand polyneuropathy.\\n\\uf0b7 Diagnosis: is byMCV > 96.11 mc, MCH > 33 pg and MCHC normal. Peripheral smear\\nmacrocytic anaemia with hypersegmentation of neutrophils, neutropenia and\\nthrombocytopenia.\\n\\uf0b7 Inj. iron dextran is diluted in 5% dextrose. Initial infusion is given slowly at 8 drops per\\nmin. for half an hour to watch for reaction, and thenincrease gradually to 40 drops/min.\\nTotal iron dose is administered in a single sitting. If >2000 mg then only half dose is\\ngiven in one day. Monitor for adverse reactionslikerigors, chest pain, and hypotension. If\\npresent stop the infusion.\\n\\uf0b7 Inj.iron dextran oriron sorbitol complex (available as 50 mg ml) IM after an initial test\\ndose of 0.5 ml intramuscularly, the injections are given daily or on alternate days in doses\\nof 2 ml IM using Z technique. To prevent staining of skin one can pass small amount of\\nsaline/air down the needle before withdrawing it.\\n\\uf0b7 Inj.iron sucrose intravenously given in each infusion 200mg of elemental iron in100 ml\\nof 0.9% NaCl infused over 20-30 minutes. No test dose required. Two infusion of each\\n200 mg of elemental iron is recommended twice in a week.\\n(Caution:Emerg ency drugs to be kept ready for resuscitation in case of anaphylactic\\nreaction).\\nIndications for blood transfusion\\nSevere blood loss, severe anemia beyond 36 weeks of pregnancy or anemia refractory to oral\\nand parental therapy or anemic patient with anoxiaor cardiac failure. Management of anemic\\npatients during labour:\\n\\uf0b7 Propped up position, oxygen therapy.\\n\\uf0b7 Sedation and pain relief.\\n\\uf0b7 Cut short 2nd stage of labour byforceps.\\n\\uf0b7 Active management of 3rd stage of labour with Inj.m ethylergometrine maleate 0.2 mgIV\\nat the delivery of anterior shoulder or injection oxytocin 10 UIM .\\n\\uf0b7 Inj. methylergometrine to be avoided in patients of anaemia with cardiac failure.\\n\\uf0b7 Packed cell transfusion if necessary and ifHb < 5 g after giving diuretics.\\nMEGALOBLASTIC ANAEMIA IN PREGNANCY\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Tab.folic acid 5 mg daily to be continued for at least 4 weeks in puerperium.\\n\\uf0b7 Inj. cyanocobalamine 250 mcg intramuscular every month.\\nDimorphic anaemia\\n\\uf0b7 Both iron and folic acid in therapeutic doses.\\nPatient education'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 246, 'page_label': '247'}, page_content=\"Obstetrics andGy necology\\n239\\n\\uf0b7 Hypertension (blood pressure > 140/90 mmHg recorded at 4-6 hours interval) with\\nproteinuria and/or non-dependant oedema, developing after 20 weeks of gestation in a\\npreviously normotensive nonproteinuric patient.\\n\\uf0b7 Pre-eclampsia is considered mild if diastolic BP < 100 mmHg, protineuria trace to 1+ with\\nminimal elevation of liver enzymes.\\n\\uf0b7 Signs of severe pre eclampsia are: BP > 160/110, 24 hour's urinary proteins >2 g, elevated\\nserum uric acid,   thrombocytopenia (platelet count <50,000/ mm3), microangiopathic\\nhaemolysis, raised liver enzymes, has diastolic BP 110 mmHg and foetal growth retardation.\\n\\uf0b7 Dietary advice as mentioned earlier.\\n\\uf0b7 Common side effects of therapy should be explained to the patient. Explain to the patient\\nthat stools turn black after oral iron therapy, so no need for concern.\\n\\uf0b7 Iron supplementation should continuefor at least 3 months in postpartum period.\\n\\uf0b7 Adequate spacing of at least 3 years between two pregnancies.\\nPREGNANCY INDUCED HYPERTENSION (PIH)\\n\\uf0b7 Hypertension is diagnosed whendiastolic blood pressure is 90 mm Hg or moreon two\\nconsecutive readings taken four hours or more apart.\\n\\uf0b7 If hypertension occursafter20 weeks of gestation,during labour and/or within 48hours\\nof deliveryit is classified as pregnancy inducedhypertension.\\n\\uf0b7 If hypertension occursbefore 20 wksof gestation, it is classified as chronichypertension.\\n\\uf0b7 Diastolic blood pressure alone is an accurate indicator of hypertension in pregnancy.\\nElevated blood pressure with proteinuria, is defined as pre-eclampsia.\\n\\uf0b7 Women with pregnancy-induced hypertension disorders may progress from mild disease\\nto a more serious condition. The classes of pregnancy-induced hypertension are:\\nhypertension without proteinuria; mild pre-eclampsia; severe pre-eclampsia; eclampsia.\\n\\uf0b7 Mild pre-eclampsia often has no symptoms.\\n\\uf0b7 Increasing proteinuria is a sign of worsening pre-eclampsia.\\n\\uf0b7 Oedema of the feet and lower extremities is not considered a reliable sign of pre-\\neclampsia.\\n\\uf0b7 In pregnancy-induced hypertension, there may be no symptoms and the only sign may be\\nhypertension.\\nPRE -ECLAMPSIA\\nPre-eclampsia is one of the commonestcauses of maternal and perinatal morbidity and\\nmortality. It affects around 5-8% of all pregnancies. Pre-eclampsia is principally a syndrome\\nof signs, occurring more frequently in primigravida. When superimposed with convulsions it\\nis termed as eclampsia.Other high risk factors are- multiple pregnancy, hydramnios, and\\nmolar pregnancy.\\nSalient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 247, 'page_label': '248'}, page_content='Obstetrics andGy necology\\n240\\nTreatment\\nHospitalize all cases. Definitive therapy is to terminate pregnancy. The choice between\\nimmediate delivery and expectant management depends on:severity of disease, condition of\\nmother and foetus and period of gestation (POG).\\nMild pre-eclampsia\\nExpectant management: in cases of mild pre-eclampsia without foetal and maternal\\ncompromise, with gestational ageless than37 weeks.\\nNon pharmacologicaltreatment\\n\\uf0b7 Complete bed rest preferably in left lateral position and regular diet adequate in proteins\\nand calories with omission of extra table salt.\\nPharmacological treatment\\n\\uf0b7 Antihypertensive treatment is started if there is persistent diastolic bloodpressure over\\n100 mmHg. Aim of treatment is to achieve a systolic BP about 130 mmHg and diastolic\\nBP around 90 mmHg. Tab. methyldopa 250 mg 8 hourly or 6 hourly (maximum dose 2\\ng/day)orTab. atenolol 50-100 mg once a day.\\n\\uf0b7 If BP is not controlled in 72 hours with the above, add any of the following:\\nCap. nifedipine 10 mg 8 hourly or Tab. nifedipine retard 10 mg 12 hourly (maximum 30\\nmg 12 hourly) orTab. labetalol 100-200 mg 8 hourly (maximum 600 mg 6 hourly).\\n\\uf0b7 Daily monitoring of weight gain, BP, urine albumin, urine output.\\n\\uf0b7 Weekly lab investigations- haemogram with platelet count, liver and kidney function\\ntests specially serum uric acid, fundoscopy.\\n\\uf0b7 Foetal monitoring by clinical and USG growth assessment, daily foetal movement count,\\nnon stress test twice weeklyand biophysical score weekly, doppler studies in IUGR.\\n\\uf0b7 In case of mild pregnancy induced hypertension without proteinuria, if after\\nhospitalization BP is controlled with rest without any antihypertensive drug, patient can\\nbe discharged afterinitial evaluation if no maternal/foetal compromise is detected. It can\\nbe practiced only in reliable patients who will follow instructions for monitoring as\\nabove, and also will reportominous symptoms immediately (ominous symptoms are\\npersistent severeheadache, visual disturbances such as dimness of vision, double vision\\nor blindness, epigastric pain, nausea, vomiting and oliguria).\\nDefinitive management\\nInduction of pregnancy by labour induction/caesarean section in the following conditions:\\n\\uf0b7 Gestational age 37 weeks, foetal compromise like severe growth retardation,\\noligohydramnios, abnormal non-stress test or biophysical score, maternal compromise\\nlike development of features of severe pre-eclampsia, onset of labour, rupture of\\nmembrane or bleeding.\\nSevere pre-eclampsia\\nTreatment is preferably done in a tertiary care center.\\nNon pharmacological treatment\\n\\uf0b7 Observation in intensive care unit for 24 hours.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 248, 'page_label': '249'}, page_content=\"Obstetrics andGy necology\\n241\\n\\uf0b7 Assessment of maternal and foetal conditions. BP monitoring 2-4 hourly, hourly urine\\noutput monitoring, watch for sign and symptoms of impending eclampsia and foetal\\ndistress.\\n\\uf0b7 Lab Investigations: haemogram with platelet count, liver and kidney function tests,\\nurinary proteins, coagulation profile, fundus examination, obstetric ultrasound with BPS.\\n\\uf0b7 Intravenous fluids Ringer's lactate at rate of 60 ml/h (maximum 125 ml/h).\\nPharmacological treatment\\nThe aim of the treatment is gradual lowering of blood pressure so that diastolic BP is\\nmaintained between 90-100 mmHg.\\nImmediate management\\n\\uf0b7 Tab. nifedipine 10 mgorally can be repeated after 30-60 min. (maximum dose 20 mg 4\\nhourly).\\n(Caution:Side effects-Tachycardia, headache, flushing, and aggravation of angina. Rapid\\nfall in BP can cause foetal distress).\\n\\uf0b7 If BP is not controlled with oral treatment then IV drugs are started with intensive\\nmonitoring.\\n\\uf0b7 Inj. labetalol initial dose is 50 mg slow IV followed by infusion at 60 mg/h, doubling\\nevery 15 min until BP is controlled or maximum dose 220 mg in 24 hours is reached.\\nMaintenance therapy\\n\\uf0b7 After initial control ofacute hypertension, patient is started on maintenance therapy with\\nantihypertensives as described in management of mild pre-eclampsia.\\n\\uf0b7 Manage with antihypertensives, bed rest and more frequent maternal and foetal\\nmonitoring.\\nDefinitive management is induction of pregnancy\\nPregnancy beyond 34 weeks-stabilize maternal condition and induce pregnancy.\\nPregnancy less than 24 weeks-stabilize maternal condition and induce pregnancy.\\nPatient on expectant management develops following features: uncontrolled hypertension\\ndespite maximum dose of 2 antihypertensive drugs, eclampsia, raised liver enzyme >2 time\\nwith right upper quadrant pain and tenderness, pulmonary oedema, platelet < 1 lac/mm1,\\ncreatinine > 1 mg/dl over baseline\\nAfter delivery, intensive monitoring should be continued for 72 hours with prophylactic\\nanticonvulsant continued till 24 hours postpartum. Dose of antihypertensives should be\\ngradually reduced.\\nProphylactic anticonvulsants\\n\\uf0b7 Required in women with severe pre-eclampsia especially in cases with signs and\\nsymptoms of impending eclampsia. Dose is same as for eclampsia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 249, 'page_label': '250'}, page_content='Obstetrics andGy necology\\n242\\n\\uf0b7 Loading dose is magnesium sulfate-4g IV as 20% solution over 20 minutes and 10 g IM\\nas (50% solution, 10 ml (5 g) in each buttock (total of 14 g) followed by second dose in\\nalternate buttocks every 4 hours.\\n\\uf0b7 Before each dose, monitor for presence of patellar reflex, respiratory rate >16/min and\\nurine output > 25 ml/h. It should be discontinued after 24 hours after BP is lowered.\\n\\uf0b7 After initial evaluation and stabilization of thepatient further management is decided\\ndepending on foetal maturity and maternal response.\\n\\uf0b7 Expectant management- Considered if pregnancy is between 24-34 weeks and\\nhypertension controlled with maximum of two drugs, urine output is normal, lab\\ninvestigations are normal and no foetal compromise. Patient should be hospitalized till\\ndelivery.\\nECLAMPSIA\\nSalient features\\nTreatment (to be managed at a tertiary care level)\\nPrinciples of management are control and prevention of recurrence of convulsion andcontrol\\nof hypertension. Treat any complication that arise and deliver safely as soon as possible.\\nContinue anticonvulsant therapy 24 h after delivery or last fit whichever is latest.\\nNon pharmacological treatment\\n\\uf0b7 Place the patient in left lateral position in a separate, quiet room.\\n\\uf0b7 Secure and maintain airway.\\n\\uf0b7 Use mouth gag or airway to prevent tongue biting/tongue falling back.\\n\\uf0b7 Intubate if patient is deeply unconscious, poor arterial blood gases, extensive laryngeal\\noedema, and extreme restlessness.\\n\\uf0b7 Suction to remove oropharyngeal secretions. Oxygen by face mask.\\n\\uf0b7 Set up IV access.\\n\\uf0b7 Monitor heart rate and respiration, BP, urine output.\\n\\uf0b7 Laboratory investigations: haemogram with platelet count, liver and kidney function tests,\\nurinary proteins, coagulation profile, serum electrolytes, fundus examination.\\nPharmacological treatment\\n\\uf0b7 Inj. magnesium sulphate loading dose of 14 g of which, 4 g as 20% solution given slowly\\nIV over 5-10 minutes and 5 g as 50% solution given deep IM in each buttock (total 10 g\\n\\uf0b7 Occurrence of generalized convulsions associated with signs of pre eclampsia during\\npregnancy, labour or within 7 days of delivery and not caused by epilepsy or other\\nconvulsive disorders.\\n\\uf0b7 Eclampsia occurs antepartum in 46%, intrapartumin 16% and postpartum in 36%\\ncases.\\n\\uf0b7 Patient may develop acute left ventricular failure, cerebral haemorrhage, renal cortical\\nnecrosis, DIC, foetal distress, abruptio placentae, foetal death and maternal death.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 250, 'page_label': '251'}, page_content='Obstetrics andGy necology\\n243\\nIM) Iffits are not controlled in 15 min, give 2 g magnesium sulfate as 20% solution slow\\nIV.\\n\\uf0b7 Maintenance dose 5 g magnesium sulfate as 50% solution deep IM every 4 hours in\\nalternate buttock Or Continuous IV regimen 4 g loading dose over 20 minutes followed\\nby 1 g/h slow continuous IV infusion.(Caution:Side effects are respiratory depression\\nand neuromuscular depression in mothers. Neonatal respiratory and neuromuscular\\ndepression). If respiratory depression occurs, give calcium gluconate 1 g IV as 10% sol. If\\nrespiratory arrest occurs, immediate endotracheal intubation and ventilation is to be done.\\nMonitor: Check for respiratory rate to be more than 16/min, patellar reflex to be present\\nand urine output >25 ml/h before giving magnesium sulfate. Or\\n\\uf0b7 Inj. phenytoin loading dose of 15-25 mg/kg slow IV not exceeding 25 mg/ min diluted in\\nnormal saline for first 750 mg and then 12.5 mg/min followed by 100 mg IV 8 hourly.\\no ECG tracing to be taken every minute for 10 min during infusion of first 750 mg.\\no Fluid management should be closely monitored to prevent complications such as\\npulmonary oedema, left ventricular failure and adult respiratory distress\\nsyndrome.\\n\\uf0b7 Antihypertensives: as described in pre-eclampsia. Aim is to gradually lower the BP to\\n140-150/90-100 mm Hg.\\nDefinitivemanagement is termination of pregnancy irrespective of the foetal maturity.\\nTermination is by labour induction and vaginal delivery or caesarean section.\\nIndications of caesarean section are: all deeply unconscious patients unless delivery is\\nimminent, uncooperative patient due to restlessness, if vaginal delivery is unlikely to occur\\nwithin 6-8 hours from the onset of 1st eclamptic seizure or eclamptic seizures are not\\ncontrolled in 6-8 hours, and other obstetric indications.\\nCare after delivery\\n\\uf0b7 Patients of eclampsia and severe pre-eclampsia need intensive monitoring for at least\\ninitial 72 hours.\\n\\uf0b7 Continue anticonvulsant till 24 hours after delivery or fit, whichever occurs later.\\nGraduallydecrease the dose of antihypertensives.\\n\\uf0b7 Patient is discharged after 10-14 days of delivery or earlier if BP controlled without\\nantihypertensives.\\n\\uf0b7 Follow up after 6 weeks for reevaluation.\\nPatient education\\n\\uf0b7 Delivery is the only definitive treatment. Underlying disease remains till delivery and\\ncomplications canarise despite control of BP on treatment.\\n\\uf0b7 Symptoms of severe pre-eclampsia like headache, vomiting, epigastric pain, decreased\\nurine output, blurring of vision should be immediately reported.\\n\\uf0b7 Need for prolonged hospitalization.\\n\\uf0b7 Early booking in next pregnancy as there is 25-30% risk of recurrence.\\n\\uf0b7 Prophylactic measures like low-dose aspirin can be started in early pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 251, 'page_label': '252'}, page_content='Obstetrics andGy necology\\n244\\n\\uf0b7 Need for reevaluation at 6 weeks postpartum for reclassification and investigations of\\nhypertension and need for long-term antihypertensives. High risk of development of\\nchronic hypertension in later life.\\nPREGNANCY WITH DIABETES\\nPregnancy can be complicated by pre-existing insulin dependent or noninsulin-dependent\\ndiabetes or gestational diabetes. Gestational diabetes is defined as the carbohydrate\\nintolerance of variable severity with onset or first recognition during pregnancy.\\nNormal values-FBS less than 90 mg%, 2 hrs post prandial less than 120 mg%, RBS  less\\nthan 100.  All pregnancies in diabetic females should be managed at atertiary care center.\\nNon pharmacologicaltreatment\\nDietary advice\\n\\uf0b7 Total daily calorie intake should be 30Cal/kg.\\n\\uf0b7 Complex carbohydrates should provide about 50% of the total calories, which should be\\nwell distributed throughout the day.\\n\\uf0b7 Meals should besplit in 3 major meals and 3-4 snacks.\\n\\uf0b7 High fiber diet is beneficial with 30-50 g fibers daily. Total diet should be distributed in 3\\nmajor meals and 3 mid meal snacks.\\nGeneral measures\\n\\uf0b7 Ultrasound assessment of foetal gestational age is to be done as earlyas possible.\\n\\uf0b7 Foetal congenital anomalies should be ruled out bylevel II USG scan at 16-18 weeks,\\nfoetal echo at 22 weeks.\\n\\uf0b7 Serial USG for foetal growth monitoring and biophysical scoring for assessment of foetal\\nwell being after 32 weeks of gestation.\\nPharmacologicaltreatment\\n(I) Antenatal management.\\nInitial evaluationshould include blood sugarand fundoscopy.\\n(a)Pre-existingdiabetes\\n\\uf0b7 Oral hypoglycaemic agents are contraindicated during pregnancy. If patient is on oral\\nhypoglycaemics, switch over to insulin therapy as soon as pregnancy is diagnosed.\\n\\uf0b7 Inj.Insulin: 0.6-0.8 U/kg in 1st trimester, 0.7- 0.9 U/kg in 2nd trimester and 0.8- 1.2\\nU/kg in 3rd trimester.\\n\\uf0b7 Usually a combination of intermediate acting and regular insulin in proportion of 2:1 is\\ngiven. 2/3 of the total requirement is given in the morning before breakfast and 1/3 is\\ngiven at night with regular insulin before dinner and intermediate at bedtime.\\n\\uf0b7 Dose adjustment is done to maintain blood sugar level between fasting <95 mg% and\\npostprandial between 70 and 120 mg%.\\n\\uf0b7 Sampling of blood should be done initially fasting, pre and post breakfast, pre and post\\nlunch, pre and post dinner and 2 AM regularly till controlled and then daily monitoring by\\nfasting and postmeal sugars.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 252, 'page_label': '253'}, page_content='Obstetrics andGy necology\\n245\\n\\uf0b7 Hospitalization is required in cases of excessive vomiting, infections, maternal\\ncomplications like hypertension, retinopathy, nephropathy, foetal compromise like\\nmacrosomia or intra uterine growth retardation (IUGR) or poor diabetic control.\\n(b) Gestational diabetes.\\nGeneralmanagement is same as outlined above.\\n\\uf0b7 Patient is reassessed after 1 week. If control not achieved, insulin therapy is started.\\nConfirmation of blood sugar and regular insulin if required may be given before\\nbreakfast, before lunch and before dinner or combination of regular and long acting can\\nbe given before breakfast and dinner. Hypoglycaemia should be avoided.\\n\\uf0b7 If fasting plasma sugar is > 105 mg% insulin is usually required for control. Regular\\ninsulin is adjusted to normalize post breakfast glucose andintermediate for post lunch\\nglucose control. If evening or fasting glucose is elevated, 2nd daily injection is added. If\\nboth are elevated, mixture of intermediate and regular insulin before dinner is added. If\\nonly fasting is elevated, add intermediate acting insulin at bedtime. Or\\n\\uf0b7 Inj. regular insulin 3 times a day before each main meal which can be combined with one\\ndose of intermediate acting insulin at bed time in case there is fasting hyperglycaemia.\\n\\uf0b7 Apart from routine antenatal monitoring, blood sugar monitoring is required throughout\\npregnancy. Therapeutic goal is to achieve plasma blood sugar levels fasting <95 mg% and\\n2 hour postprandial <120 mg%. When levels are high daily monitoring with insulin dose\\nadjustment is required. Once control is achieved, patient can be managed at home with\\nweekly blood sugar profile.\\n\\uf0b7 Glycosylated Hb (HbA lc) to be done in 1st trimester. Value of 9% or above\\nindicates poor glycemic control, carries higher risk of congenitalmalformation; MTP may\\nbe offered after properevaluation.\\n(II)Management during labour\\n\\uf0b7 In uncomplicated case with good glycaemic control pregnancy can be continued till\\nexpected date of delivery.\\n\\uf0b7 In presence of complications or foetal compromise pregnancy is terminated at 38 weeks\\nor earlier if required.\\n\\uf0b7 If estimated foetal weight is >4 kg, caesarean section is performed.\\n\\uf0b7 Labour is managed with intensive monitoring. Blood sugars are monitored 3-4 hourly aim\\nis to keep blood sugars between 100-120 mg%, using the sliding scale method using\\nregular insulin.In the postpartum period, the requirement of insulin is decreased.\\nPatient education\\n\\uf0b7 In known diabetics, good blood sugar control should be achieved in preconception period\\nto avoid high risk of congenital anomalies.\\n\\uf0b7 Strict adherence to the dietary advice and insulin therapy is essential throughout\\npregnancy. As insulin requirements change throughout pregnancy therefore, frequent\\nblood sugar monitoring is required throughout pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 253, 'page_label': '254'}, page_content='Obstetrics andGy necology\\n246\\n\\uf0b7 All pregnant women with heart disease shouldbe managed at a tertiary level center\\nwith multidisciplinary approach. Depending on the limitation of physical activity\\npatient is classified into class I to IV of New York Heart Association (NYHA).\\n\\uf0b7 Severe or progressive dyspnoea, progressive orthopnoea,paroxysmal nocturnal\\ndyspnoea, haemoptysis, syncope with exertion or chest pain related to effort or\\nemotions.Echocardiography is diagnostic\\n\\uf0b7 Clinical approach to the pregnant women with heart disease is according to NYHA\\nclass irrespective of the aetiology of the heart disease.\\n\\uf0b7 Patient on insulin therapy should be told about symptoms of hypoglycaemia like\\npalpitations, sweating, dizziness, and its management.\\n\\uf0b7 In cases of gestational diabetes, there is risk of recurrence in subsequent pregnancies and\\nlater on risk of frank diabetes is there.\\nContraceptive advice\\nCombined oral contraceptive pills and intrauterine devices are preferably avoided. Barrier\\nmethods, progestogen only pills/ implants/injectables or sterilization can be offered.\\nPREGNANCY WITH HEART DISEASE\\nOrganic heart disease in pregnancy is commonly due to rheumatic heart disease or congenital\\nheart disease. Pregnancy with its increased cardiovascular stress is a potential cause for\\nworsening of the existing heart disease.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 NYHA class III and IV patients are to be hospitalized throughout the pregnancy while\\nclass I and II can be managed as outdoor patients with more frequent antenatal visits and\\nadmission at 38 weeks.\\n\\uf0b7 Rest for 10 hours each night and 1 to 2 hour after each meal. Light housework and\\nwalking without climbing stairs is permitted. No heavy work is allowed.\\n\\uf0b7 Avoid high salt intake.\\n\\uf0b7 Screen and treat at the earliest for excessive weight gain, abnormal fluid retention,\\nanaemia, pregnancy induced hypertension, infections.\\nPharmacological (in consultation with the cardiologist)\\nIn caseof rheumatic heart disease,\\n\\uf0b7 Inj. benzathine penicillin 1.2 mega units IM 3 weekly.\\n\\uf0b7 Treat any infections with appropriate antibiotics.\\n\\uf0b7 In patients with mechanical prosthetic valves, give Inj. heparin throughout pregnancy to\\nmaintain PTT at 1.5 to 2.5 times the normal control.\\n(Caution:Oral anticoagulants are not safe during pregnancy because of risk of congenital\\nanomalies in the foetus. But if required, can be given after first trimester and continued till 4\\nweeks before delivery. However, oral anticoagulants are safe during lactation).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 254, 'page_label': '255'}, page_content='Obstetrics andGy necology\\n247\\nLabour management\\nCaesarean is performed for only obstetrical indications.\\n\\uf0b7 Pain relief is important during labour. Best option is to give continuous epidural\\nanalgesia. It is contraindicated in women with intra cardiac shunts, aortic stenosis,\\npulmonary hypertension, and hypertrophic cardiomyopathy. Inj. morphine can also be\\ngiven for pain relief.\\n\\uf0b7 Fluids should be restricted to 75 ml/min. Bolusoxytocin andm ethyl ergometrine should\\nbe avoided.\\n\\uf0b7 Antimicrobial prophylaxis forinfective endocarditis required in all patients with cardiac\\nlesions undergoing any operative procedure or in labour.\\n\\uf0b7 Inj. ampicillin 2 g andInj. gentamicin 1.5 mg/kg (maximum 120 mg) IV or IM 30 min\\nbefore procedure followed by Cap. ampicillin 1 g IM orIV; or Cap. amoxycillin I g orally\\n6 hours after initial dose.\\n\\uf0b7 If patient is allergic to penicillin Inj. vancomycin 1 g IV (over 1-2 hours) plus Inj.\\ngentamicin 1.5 g/kg (maximum 120 mg). Infusion to be completed within 30 min before\\nprocedure.\\nPatient education\\n\\uf0b7 Depending on the type and severity of cardiac lesion maternal risk of pregnancy should\\nbe discussed with the patient ideally before pregnancy\\n\\uf0b7 Option of corrective surgery preferably before pregnancy.\\n\\uf0b7 2 -5% risk of congenital heart disease in foetus if mother has congenital heart disease.\\n\\uf0b7 Contraceptive advice: sterilization after 2 weeks, progestogen only method or barrier\\nmethod. Counsel husband for male sterilization preferably by nonscalpel vasectomy.\\n\\uf0b7 In severe cases option of medical terminationof pregnancy if pregnancy <12 weeks.\\nANTEPARTUM HEMORRHAGE (APH)\\nAntepartum haemorrhage is defined as bleeding from genital tract after 20 weeks of\\npregnancy and before completion of second stage of labour. It is a major cause of maternal\\nmorbidity, mortality and perinatal loss. APH is due to placental cause in as high as 70% cases\\nand in 25-30% of cases cause may remain undetermined.\\nSalient features\\n\\uf0b7 Clinical presentation varies depending on the severity of blood loss and cause of\\nbleeding\\n\\uf0b7 In mild haemorrhage there may be no maternal or foetal compromise, while massive\\nhaemorrhage can lead to hypovolaemic shock, coagulation failure, renal failure, foetal\\ndistress and may result in maternal and foetal death.\\n\\uf0b7 Ultrasound is confirmatory for placenta praevia.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 255, 'page_label': '256'}, page_content=\"Obstetrics andGy necology\\n248\\nClinical presentation and severity of blood loss\\nAcute blood loss Clinical findings\\n1000 ml None\\n1000-1500 ml Orthostatic blood pressure changes, positive tilt test,\\nPulse Pressure = 30 mmHg, reduced peripheral perfusion,\\nprolong capillary refill time\\n1500-2000 ml Cold clammy skin, tachycardia, tachypnoea, hypotension\\n> 2000 ml Profound shock, non-palpable pulse, intrauterine death of the\\nfoetus\\nCauses of bleeding\\nPlacenta praevia Abruptio placentae\\nPainless recurrent bleedingAssociated pain abdomen\\nRelaxed non-tender uterus Tense tenderuterus\\nFree-floating presenting partFoetal parts not easily palpable\\nAbnormal lie Foetal heart irregular or absent\\nPregnancy induced hypertension\\nTreatment\\nAll patients of APH should be hospitalized in a well equipped center with facilities for blood\\ntransfusion, emergency caesarean section and neonatal care unit.\\n(I) Massive hemorrhage\\nFollowing resuscitative measures are started immediately in massive hemorrhage.\\nSimultaneously prepare the patient for induction of labour by vaginal, caesarean section\\ndepending on thecause of bleeding.\\nNon -pharmacological treatment\\n\\uf0b7 Establish intravenous line (one or two 14/16 gauge cannula\\n\\uf0b7 Draw 20 ml blood for cross-match, haemogram, coagulation profile.\\n\\uf0b7 Start fluid therapy rapidly as described below.\\n\\uf0b7 Head down tilt, keep the patientwarm.\\n\\uf0b7 Oxygen by mask at 8 liters/minute.\\n\\uf0b7 Empty bladder (Foley's catheter for urine output).\\nPharmacological treatment\\n\\uf0b7 IV fluids and blood replacement therapy.\\n\\uf0b7 Definitive treatment is induction of labour by caesarean section in cases of placenta\\npraevia andby vaginal/caesarian section in cases of abruptio placentae.\\n(II) Mild APH\\nExpectant management\\n\\uf0b7 In a case of placenta praevia without maternal and foetal compromise, expectant\\nmanagement is planned if pregnancy is less than 37 weeks and patient is not havingactive\\nbleeding and labour pains.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 256, 'page_label': '257'}, page_content='Obstetrics andGy necology\\n249\\n\\uf0b7 Hospitalize and bed rest with foetal and maternal monitoring.\\n\\uf0b7 Inj. dexamethasone 12 mg IM 12 hourly for 2 doses should be given for foetal lung\\nmaturity if POG < 35 weeks.\\n\\uf0b7 Definitive treatment is induction of labour in case of following: occurrence of life-\\nthreatening bleeding, pregnancy > 37 weeks, patient is in labour, in all cases of abruptio\\nplacentae, baby is dead, congenitally malformed baby and bleeding recurring or\\npremature rupture of membranes on expectant management leading to maternal or foetal\\ncompromise.\\n\\uf0b7 Indications for caesarean section are:m ajor degree placenta praevia,non vertex\\npresentation,case of abruptio placentae with live foetus if cervix is unfavourable (labour\\nis likely to be longer than 6 hours),Failure to progress after amniotomy and oxytocin\\ninfusion and other obstetrical indications for caesarean section.\\n\\uf0b7 Indications for vaginal delivery inAPH are: Minor degree placenta praevia with vertex\\npresentation and slight bleeding with favourable cervix and abruptio placentae with mild\\nbleeding and no increased uterine tone, foetus is dead or has major congenital\\nmalformation incompatible with life.\\n\\uf0b7 For induction artificial rupture of membranes followed by oxytocin infusion is done.\\nOxytocin infusion is continued in the postpartum period to prevent postpartum\\nhaemorrhage. In abruptio placentae monitoring is done to detect maternal complication\\nearly (pulse,BP, uterine height girth chart, vaginal bleeding, urinary output,BT, CT, clot\\nretraction time).\\nPatient education\\n\\uf0b7 APH irrespective of type and cause results in increased perinatal morbidity and mortality.\\n\\uf0b7 Incidence of placental abruption and placenta praevia are both increased with increasing\\nage and parity.\\n\\uf0b7 Hypertension, cigarette smoking, cocaine abuse etc. predispose to placental abruption.\\nPREMATURE RUPTURE OF MEMBRANES\\nPrelabour rupture of membranes (PROM) is rupture of the membranes before labor has\\nbegun. PROM can occur either when the fetus is immature (preterm or before 37 weeks) or at\\nterm.\\nGeneral management\\n\\uf0b7 Confirm accuracy of calculated gestational age, if possible.\\n\\uf0b7 Per speculum examination to assess vaginal discharge (amount, colour, odour) and\\nexclude urinary incontinence.\\nDiagnosis of vaginaldischarge(Table 2)\\na) Light bleeding: takes longer than five minutes for a clean pad or cloth to be soaked.\\nb) Determine cause and treat accordingly.\\nConfirm diagnosis\\n\\uf0b7 The typical odour of amniotic fluid confirms the diagnosis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 257, 'page_label': '258'}, page_content='Obstetrics andGy necology\\n250\\n\\uf0b7 Ifmembrane rupture is not recentor whenleakage is gradual, confirming the diagnosis\\nmay be difficult:\\n\\uf0b7 Place a vaginal pad over the vulva and examine it (visually and by odour) one hour later.\\n\\uf0b7 On per speculum examination: Fluid may be seen coming from the cervix or forming a\\npool in theposterior fornix; and on coughing; there may a gush of fluid.\\n\\uf0b7 If available, perform tests:\\n-The nitrazine testdepends upon the fact that vaginal secretions and urine are acidic while\\namniotic fluid is alkaline.\\n- For theferning test, spread some fluidon a slide and let it dry. Examine it with a\\nmicroscope. Amniotic fluid crystallizes and may leave a fern-leaf pattern. False\\nnegatives are frequent.\\nTable 2. Clinical presentation of patients with vaginal discharge in pregnancy\\nPresenting symptoms\\nand symptoms & signs\\nPresent symptoms and signs sometimes\\npresent\\nProbable\\ndiagnosis\\nWatery vaginal discharge â€¢ Sudden gush or intermittent leaking of fluid\\nFluid seen at introitus\\nâ€¢No contractions within 1 hour\\nPremature\\nrupture of\\nmembranes\\nFoul smelling watery\\ndischarge after 22 weeks\\nâ€¢ Fever/chills\\nâ€¢ Abdominal pain\\nâ€¢ History of loss of fluid\\nâ€¢ Tender uterus\\nâ€¢ Rapid fetal heart rate\\nâ€¢ Light vaginal bleeding\\nAmnionitis\\nFoul smelling\\nvaginal discharge\\nâ€¢ No history of loss of fluid\\nâ€¢ Itching, Frothy/curdish discharge\\nâ€¢ Abdominal pain\\nâ€¢ Dysuria\\nVaginitis\\nor cervicitis\\nBloody vaginal discharge â€¢Abdominal pain\\nLoss of fetal movements\\nâ€¢ Heavy, prolonged vaginal bleeding\\nAntepartum\\nhaemorrhage\\nTreatment\\n\\uf0b7 If there isvaginal bleeding with intermittentor constant abdominal pain, suspect abruptio\\nplacentae.\\n\\uf0b7 If there aresigns of infection(fever, foul-smelling vaginal discharge), give antibiotics as\\nfor amnionitis\\n\\uf0b7 If there areno signs of infectionand thepregnancy is less than 37 weeks(when fetal\\nlungs are more likely to be immature):give antibiotics to reduce maternal and neonatal\\ninfective morbidity and to delay delivery\\n\\uf0b7 Pre-labourrupture of membranes'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 258, 'page_label': '259'}, page_content='Obstetrics andGy necology\\n251\\n- Tab. erythromycin 250 mg by mouth three times per day for seven daysoramoxicillin\\n500 mg by mouth three times per day for seven days;\\n- Consider transfer to the most appropriate service for care of the newborn, if possible\\n- Give corticosteroids to the mother to improve fetal lung maturity:betamethasone 12\\nmg IM , two doses 24 hours apartor Inj.  dexamethasone 6 mg IM, four doses 12\\nhours apart.\\nNote: Corticosteroids should not be used in the presence of frank infection.\\n\\uf0b7 Induce labour using oxytocin at 37 weeks and give prophylactic antibiotics to help reduce\\nGroup B streptococcus infection in the neonate, even if the woman received antibiotics\\npreviously: penicillin G 2 million units IV every six hours until delivery; or Inj.\\nampicillin 2 g IV every six hours until delivery.\\n\\uf0b7 If there arepalpable contractions andblood-stained mucus discharge, suspect preterm\\nlabour.\\n\\uf0b7 If there areno signs of infectionand thepregnancy is 37 weeks or more:\\n- If themembranes have been ruptured for more than 18 hours, give prophylactic\\nantiboitics to help reduce Group B streptococcusinfection in the neonate.\\n- Assess the cervix\\n- If thecervix is favourable(soft, thin, partly dilated), induce labour using oxytocin.\\n- If the cervix is unfavourable(firm, thick, closed), ripen the cervix using\\nprostaglandins and    infuse oxytocin or deliver by caesarean section.\\nAmnionitis\\n\\uf0b7 Give a combination of antibiotics until delivery\\n-Inj. ampicillin 2 g IV every six hours; plus gentamicin 5 mg/kg body weight IV every 24\\nhours\\n-If thewoman delivers vaginally, discontinue antibiotics postpartum\\n-Ifthewoman has a caesarean section, continue antibiotics and give Inj. metronidazole\\n500 mg IV every eight hours until the woman is fever-free for 48 hours.\\n\\uf0b7 Assess the cervix\\n-If thecervix is favorable(soft, thin, partly dilated), induce labour using oxytocin\\n-If thecervix is unfavourable(firm, thick, closed), ripen the cervix using prostaglandins\\nand infuse oxytocin or deliver by caesarean section.\\n\\uf0b7 Ifmetritis is suspected(fever, foul-smelling vaginal discharge), give antibiotics.\\n\\uf0b7 Ifnewborn sepsisis suspected, arrange for a blood culture and antibiotics.\\nPRETERM LABOR\\nOnset of labour pains in pregnant women after 20 weeks and before 37 weeks of gestation\\nassociated with progressive dilatation and effacement of the cervix is known as preterm\\nlabour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 259, 'page_label': '260'}, page_content='Obstetrics andGy necology\\n252\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Hospitalization with complete bed rest, preferably in a centre with neonatal intensive care\\nunit.\\n\\uf0b7 Laboratory investigations: haemogram, urine culture,endocervical swab for culture and\\nsensitivity.\\nPharmacological treatment\\n\\uf0b7 Inj. pentazocine 15mg + Inj. promethazine 25 mg IM stat and can be repeated 8 hourly.\\n\\uf0b7 Immediate tocolysis in pregnancies <35 week\\n\\uf0b7 If membranes are intact and labour is not advanced (cervical dilatation <4 cm), there is no\\nindication for immediate delivery and no contraindication for tocolysis.\\n\\uf0b7 Inj. isoxsuprine HCl 10 mg IM every 6 hours in case of mild contraction; Intravenous\\ninfusion if strong contractions are established 0.2-0.4 mcg/min in 5% dextrose. Maximum\\ndose is 0.8 mcg/min to be continued at least 2 hours after the contractions cease.\\nFollowed by IM therapy for 24 hours.\\n(Caution: Side effects tachycardia and hypotension, hypokalaemia, neonatal tachycardia,\\nhypotension and rarely pulmonary oedema and acute respiratorydistress syndrome). Or\\n\\uf0b7 Inj. ritodrine infusion 3 ampoules (150 mg) in 500 ml of 5% dextrose or ringer lactate at\\n50- 100 mcg/min (5-6 drops/min), increase by 50 mcg every 10 min till contractions\\ncease or side effects appear (maximum dose 350 mcg/min), continue for 12 hour after\\ncontractions stop. This is followed by oral treatment- 10 mg every 2 hours for 24 hours\\nthen 10-20 mg every 4-6 hours.(Contraindications: Poorly controlled diabetes or thyroid\\ndisease, sickle cell disease). Or\\n\\uf0b7 Cap. Nifedipine 30mg loading dose followed by 10-20 mg every 4-6 hours.\\n(Caution: Do not administer along with magnesium sulfate; contraindicated in maternal\\nhypotension (< 90/50 mmHg), cardiac disease. Use with caution in renal disease.\\nMaternal side effects include flushing, headache, nausea, dizziness, and hypotension.) Or\\n\\uf0b7 Inj. magnesium sulfate 4-6 g as 20% solution bolus over 30 minutes followed by infusion\\nof 4-6 g/h.(Contraindicated in patients with myasthenia gravis, cardiac decompensation.\\nUse with caution in renaldisease. It can cause flushing, lethargy, headache, muscle\\n\\uf0b7 Uterine contraction of duration of 30 sec or more at interval of 10 minutes or less\\naccompanied by cervical dilatationand effacement with or without leaking or\\nbleeding per vaginum.\\n\\uf0b7 Risk factors include: low socioeconomic status,  heavy manual labour, extremes of\\nage (<20 years and >40 years),  previous history of abortion or preterm delivery,\\ncervical or vaginal infection, multiple gestation or over distended uterus, hypoxic\\nconditions like anaemia, heart disease, preeclampsia, IUGR, foetal congenital\\nmalformations and antepartum haemorrhage in present pregnancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 260, 'page_label': '261'}, page_content='Obstetrics andGy necology\\n253\\nweakness, dryness of mouth, nausea and foetal distress, transient non-reactive non-stress\\ntest (NST).\\n\\uf0b7 Monitor pulse, BP, and cessation of the uterine contractions. If pulse rate >120/min and\\nBP < 90/50 mmHg stop tocolysis. Monitoring in magnesium sulfate therapy is as outlined\\nin eclampsia. Monitor for onset of chorioamnionitis (fever, tachycardia with uterine\\ntenderness).\\nMaintenance therapy\\n\\uf0b7 Tab. isoxsuprine orally 10 mg 6 hourly or 20 mg 12 hourly (maximum daily-dose is 40 to\\n80 mg/day) to be continued till 34 weeks of pregnancy (long term therapy is\\ncontroversial).\\n\\uf0b7 In pregnancies at 28-34 weeks of maturity, steroids are given for foetal lung maturity.\\n\\uf0b7 Inj. betamethasone 12 mg IM 2 doses 24 hours apartor  Inj. dexamethasone 6 mg IM four\\ndoses 12 hours apart or 12 mg IM two doses 12 hours apart.\\n(Caution:Contraindicated if clinical or laboratory evidence of chorioamnionitis is\\npresent).\\n\\uf0b7 Cap. ampicillin 500 mg or erythromycin 500 mg 4 times a dayfor 5-7 days, only if\\nPROM is present.\\n\\uf0b7 Patient may be discharged after 1 week of tocolysis followed by regular antenatal\\nsurveillance.\\nDelivery\\nIn cases of ineffective tocolysis or with contraindications for tocolysis, labour is allowed to\\nprogress and mode of delivery is decided as per obstetric indications. Careful foetal\\nmonitoring required throughout labour.  If any sign of hypoxia, caesarean section is better but\\nfoetus should have a fairly good chance of survival depending on neonatal care facility.\\nPatient education\\n\\uf0b7 Restricted physical activity after discharge.\\n\\uf0b7 Sexual abstinence till at least 34 weeks of gestation.\\n\\uf0b7 Explain the risk of recurrence in subsequent pregnancy. Therefore need for early booking\\nand prophylactic measures in next pregnancy.\\nNORMAL LABOUR\\nDiagnosis\\n\\uf0b7 Painful uterine contractions after 22 weeks gestation;\\n\\uf0b7 Pain associated with blood-stained mucus vaginal discharge (show);\\n\\uf0b7 Watery vaginal discharge or a sudden gush of water.\\n\\uf0b7 Cervical dilatation and effacement'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 261, 'page_label': '262'}, page_content='Obstetrics andGy necology\\n254\\nTable 3. Stagesof normal labour\\nStages of\\nlabour\\nDefinition Duration\\nFirst stage Cervical dilatation Nullipara Multipara\\nLatent phase\\nActive phase\\n< 3 cm 12h 8h\\n> 3 cm 6-8 h or rate of cervical\\ndilatation 1 cm/h\\n4-6 h or rate of cervical\\ndilatation 1.5 cm/h\\nSecond stage Full dilatation of cervix to\\nexplusion of foetus\\n1 h 30 min\\nThird stage From expulsion of foetus\\nto the delivery of placenta\\n15 min 15 min\\nManagement of labour\\nWhen thepatient reports to the hospital with labour pains, examination should be conducted\\nby a doctor on duty and risk category to be assigned(Table 4).\\nTable 4.Common risk factors during labour\\nMaternal\\nfactors\\nPast reproductive\\nhistory Present pregnancy Associatedmedical/\\nsurgical problem\\nAge < 16, >35 >1 abortion Bleeding in\\npregnancy\\nHeart disease\\nParity-0, >5 Previous stillbirth Prematurity, PROM Diabetes\\nObesity Previous caesarean\\nsection\\nPostmaturity Anaemia\\nHeight < 145 cmPrev  PPH/MRP PIH Jaundice\\nPIH, Eclampsia IUGR Hypertension\\nIUGR Multiple pregnancy Renal disease\\nCongenital anomaly in\\nbaby\\nMalpresentation Thyroid disease\\nPrevious early neonatalMalposition Epilepsy\\nDeath Asthma\\nGeneral examination\\n\\uf0b7 Record height and weight.\\n\\uf0b7 Pulserate (PR), blood pressure (BP), respiratory rate (RR), temperature.\\n\\uf0b7 Look for pallor, pedal oedema, jaundice and cyanosis.\\n\\uf0b7 Auscultate cardiovascular and respiratory system.\\nPer abdomen examination\\n\\uf0b7 Height of the uterus/POG.\\n\\uf0b7 Presentation, attitude, palpable foetal head (rule of fifths).\\n\\uf0b7 Foetal heart rate.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 262, 'page_label': '263'}, page_content='Obstetrics andGy necology\\n255\\n\\uf0b7 Uterine contractions-+/-, intensity, duration and frequency per 10 minutes.\\n\\uf0b7 Amount of liquor.\\n\\uf0b7 Size of the baby/estimated baby weight.\\n\\uf0b7 Look for overriding of foetal head over symphysis pubis.\\n\\uf0b7 Features of obstructed labour and contour of the uterus.\\nPer vaginum examination\\n\\uf0b7 Observe aseptic precautions-hand washing and sterile gloves. Note:\\n\\uf0b7 Cervical dilatation and effacement.\\n\\uf0b7 Presentation and station of presenting part.\\n\\uf0b7 Position and degree of flexion (suturesand fontanelle).\\n\\uf0b7 Status of membranes and if leaking present then colour of liquor.\\n\\uf0b7 Cord prolapse or presentation to be ruled out.\\n\\uf0b7 Pelvic adequacy and rule out cephalopelvic disproportion (CPD).\\n\\uf0b7 Vaginal examination should be carried out atleast once every 4hours during first\\nstage of labour and after rupture of membranes.\\nInvestigations\\n\\uf0b7 Minimum investigations required during labour are:\\n\\uf0b7 Hb, urine albumin and sugar, blood grouping.\\n\\uf0b7 Urine acetone in prolonged/obstructed labour.\\nASSESSMENT OF PROGRESS OF LABO UR\\n\\uf0b7 Measure changes in cervical effacement and dilatation  during the latent phase\\n\\uf0b7 Measure the rate of cervical dilatation and fetal descent during the active phase\\n\\uf0b7 Assess further fetal descent during the second stage.\\n\\uf0b7 Progress of the first stage of labourshould be plotted on a partograph once the patient\\nenters the active phase of labour.\\nPARTOGRAPH\\nThe WHO partograph has been modified to make it simpler and easier to use. The latent\\nphase has been removed and plotting on the partograph begins in the active phase when the\\ncervix is 4 cm dilated.  Record the following on the partograph:\\nPatient information\\n\\uf0b7 N ame, gravida, para,\\n\\uf0b7 H ospital number, date and time of admission,\\n\\uf0b7 Time of ruptured membranes or time elapsed since rupture of membranes (if rupture\\noccurred before charting on the partograph began).\\nFetal heart rate: Record every half hour.\\nAmniotic fluid: Record the colour of amniotic fluid at every vaginal examination:\\n\\uf0b7 I: membranes intact;\\n\\uf0b7 R: membranes ruptured;'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 263, 'page_label': '264'}, page_content='Obstetrics andGy necology\\n256\\n\\uf0b7 C: membranes ruptured, clear fluid;\\n\\uf0b7 M: me conium-stained fluid;\\n\\uf0b7 B: blood-stained fluid.\\nMoulding:\\n\\uf0b7 1: sutures apposed;\\n\\uf0b7 2: sutures overlapped but reducible;\\n\\uf0b7 3: sutures overlapped and not reducible.\\nCervical dilatation:Assessed at every vaginal examination and marked with a cross (X ).\\nBegin plottingon the partograph at 4 cm.\\nAlert line: A line starts at 4 cm of cervical dilatation to the point of expected full dilatation at\\nthe rate of 1 cm per hour.\\nAction line: Parallel and four hours to the right of the alert line.\\nDescent assessed by abdominal palpation: Refers to the part of the head (divided into five\\nparts) palpable above the symphysis pubis; recorded as a circle (O ) at every abdominal\\nexamination. At 0/5, the sinciput (S) is at the level of the symphysis pubis.\\nHours:Refers to the time elapsed since onset of active phase of labour .\\nTime:Record actual time.\\nContractions:Chart every half hour; count the number of contractions in a 10-minute time\\nperiod, and their duration in seconds.\\n\\uf0b7 Less than 20 seconds:\\n\\uf0b7 Between 20 and 40 seconds:\\n\\uf0b7 More than40 seconds:\\nOxytocin:Record the amount of oxytocin per volume IV fluids in drops per minute every 30\\nminutes when used.\\nDrugs given: Record any additional drugs given.\\nPulse:Record every 30 minutes and mark with a dot (!).\\nBlood pressure: Record every four hours and mark with arrows.\\nTemperature: Record every two hours.\\nProtein, acetone and volume: Record when urine is passed.\\nPartograph passes to the right ofAlert line- reassess and consider criteria for referral; call\\nsenior person, if available.\\nPartograph passes to the right ofAction line- refer urgently to hospital unless birth is\\nimminent.\\nDrugs and IV fluids if administered are recorded.\\nMaintain intake-output chart\\nSECOND STAGE OF LABOUR\\n\\uf0b7 Shift the patient to delivery table.\\n\\uf0b7 Inform the paediatrician. Ensure all delivery equipment and supplies, including newborn\\nresuscitation equipment, are available, and place of delivery is clean and warm(25Â°C).\\n\\uf0b7 Put her in dorsal/squatting position.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 264, 'page_label': '265'}, page_content=\"Obstetrics andGy necology\\n257\\n\\uf0b7 Observe universal precautions\\n\\uf0b7 Clean and drape the parts.\\n\\uf0b7 Infiltrate the perineum with local anaesthetic agent if episiotomy is planned.\\n\\uf0b7 Woman is encouraged to bear down.\\n\\uf0b7 Episiotomy is given if required\\n\\uf0b7 To control birth of the head, keep the baby's head flexed and gently support the perineum\\nas the head delivers. Suction of the nose and mouth.\\n\\uf0b7 After external rotation, deliver the shoulders one at a time followed by rest of the foetus.\\n\\uf0b7 Clamp and cut the umbilical cord.\\n\\uf0b7 Ensure establishment of respiration in baby or institute resuscitation if required.\\n\\uf0b7 Administration of oxytocin 5 Units IM at the delivery of the anterior shoulder to prevent\\nPPH.\\nTHIRD STAGE OF LABOUR\\n\\uf0b7 Recognize signs of placental separation: Uterus becomes globular and firmer, suprapubic\\nbulge appears, sudden gush of blood and permanent lengthening of cord.\\n\\uf0b7 Deliver the placenta by controlled cord traction. As the placenta passes through the\\nintroitus, care is taken to prevent the membranes from being torn off and left behind.\\n\\uf0b7 Examine the placenta for its completeness and anomalies.\\n\\uf0b7 Administer Inj.oxytocin 5-10 U IM.\\n\\uf0b7 Active management of third stage should be done unless contraindicated.\\n\\uf0b7 Examine the woman for any tears and repair if any. Stitch the episiotomy. Observe the\\nwoman closely for one hour after delivery, record her PR and BP.\\n\\uf0b7 Evaluate the uterusfrequently, and inspect the perineum to detect excessive bleeding and\\nhaematoma formation.\\nTransfer from labour room\\n\\uf0b7 Observe for 2 hours\\n\\uf0b7 Check the following before transfer: pulse rate, BP, uterus, bleeding pre vaginum, inspect\\nexternal genitalia for condition of stitches and any haematoma, passed urine.\\nEpisiotomy (Incision of the perineum)\\n\\uf0b7 Not to be performed routinely.\\n\\uf0b7 Applied selectively for: breech, forceps or vacuum delivery, occiput posterior positions,\\nrigid perineum, scarred perineum, and shoulderdystocia.\\n\\uf0b7 Clean the area with antiseptic solution.\\n\\uf0b7 Infiltrate beneath the vaginal mucosa, beneath the skin and deeply into the perineal\\nmuscle using 10 ml of 0.5-1% lignocaine.\\n\\uf0b7 Check at the incision site for effect of local anaesthetics by pinching witha forceps before\\ngiving incision.\\n\\uf0b7 Perform episiotomy at crowning. Place two fingers between the baby's head and the\\nperineum and cut 3-4 cm of perineum in mediolateral direction.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 265, 'page_label': '266'}, page_content='Obstetrics andGy necology\\n258\\n\\uf0b7 After delivery of the baby and placenta, carefully examine for extensions oftears.\\n\\uf0b7 Repair the episiotomy with vicryl rapide 2-0 suture (chromic catgut if vicryl is not\\navailable). Close the vaginal mucosa with continuous suture starting 1 cm above the apex.\\nPerineal muscles are approximated using interrupted sutures. Skin is closed with\\nsubcuticular (or interrupted) sutures.\\nCare of episiotomy\\nPerineal hygiene: Clean the area with antiseptic solution after urination and defaecation.\\nAnalgesics are prescribed for allaying pain.\\nRespond to following problems during labour and delivery\\nAssess facilities and expertise available and appropriate timely referral iffoetal heart rate <\\n120 or> 160 beats per minute, prolapsed cord, breech presentation, stuck shoulders, multiple\\nbirths\\nFETAL DISTRESS IN LABOR\\nAbnormal fetal heart rate (less than 100 or more than 180 beats per minute) with thick\\nmeconium -stained amniotic fluid.\\nGeneral management\\n\\uf0b7 If a maternal cause is identified(e.g. maternal fever, drugs), initiate appropriate\\nmanagement.\\n\\uf0b7 If amaternal cause is not identifiedand thefetalheart rate remains abnormalthroughout\\nat least three contractions, perform a vaginalexamination to check for explanatory signs\\nof distress:\\n\\uf0b7 If there isbleedingwith intermittent or constant pain, suspect abruptio placentae.\\n\\uf0b7 If there aresigns of infection(fever, foul-smelling vaginal discharge) give antibiotics as\\nfor amnionitis.\\n\\uf0b7 A normal fetal heart ratemay slow during a contraction but usually recovers to normal as\\nsoon as the uterus relaxes.\\n\\uf0b7 A very slow fetal heart ratein the absence of contractions or persisting after contractions\\nis suggestive of fetal distress.\\n\\uf0b7 A rapid fetal heart ratemay be a response to maternal fever, drugs causing rapid maternal\\nheart rate (e.g. terbutaline or ritodrine), hypertension or amnionitis. In the absence of a\\nrapid maternal heart rate, a rapid fetal heart rate should be considered a sign of fetal\\ndistress.\\n\\uf0b7 If thecord is below the presenting part or in the vagina, manage as prolapsed cord .\\n\\uf0b7 Iffetal heart rate abnormalities persistor there areadditional signs ofdistress(thick\\nmeconium -stained fluid), plan delivery:\\n\\uf0b7 If thecervix is fully dilatedand thefetal head is not more than 1/5 abovethe symphysis\\npubis or the leading bony edge of thefetal head is at 0 station, deliver by vacuum\\nextraction or forceps'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 266, 'page_label': '267'}, page_content='Obstetrics andGy necology\\n259\\n\\uf0b7 If thecervixis not fully dilatedor thefetal head is more than 1/5 abovethe symphysis\\npubis or the leading bony edge of thefetal head is above 0 station, deliver by caesarean\\nsection\\nMECONIUM STAINED LIQUOR\\nMeconium staining of amniotic fluid is seenfrequently as the fetus matures and by itself is\\nnot an indicator of fetal distress. A slight degree of meconium without fetal heart rate\\nabnormalities is a warning of the need for vigilance.Thick meconium suggests passage of\\nmeconium in reduced amnioticfluid and may indicate the need for expedited delivery and\\nmanagement of the neonatal upper airway at birth to prevent meconium aspiration. Inbreech\\npresentation, meconium is passed in labour because of compression of the fetal abdomen.\\nThis is not a signof distress unless it occurs in early labour\\nManagement\\n\\uf0b7 Prop up the woman or place her on her left side.\\n\\uf0b7 Stop oxytocin if it is being administered.\\n\\uf0b7 Give oxygen 4â€“6 L by mask or nasal cannulae.\\nAdvice on postpartum care\\n\\uf0b7 To always have someone near her forthe first 24 hours to respond to any change in her\\ncondition.\\n\\uf0b7 Not to insert anything into the vagina.\\n\\uf0b7 To have adequate rest and sleep.\\n\\uf0b7 The importance of hand washing to prevent infection of the mother and her baby.\\n\\uf0b7 To wash perineum daily and after faecalexcretion.\\n\\uf0b7 To avoid sexual intercourse until the perineal wound heals.\\n\\uf0b7 Counsel for birth spacing and family planning (for details see section on contraception).\\n\\uf0b7 Advise on routine postpartum care visits-within the first week, preferably within 2-3 days\\nand second visit after 4-6 weeks. Earlier if problems- fever, UTI, perineal infection,\\nhypertension, urinary incontinence, severe anaemia, postpartum blues, HIV positive.\\nCounsel on exclusive breastfeeding\\n\\uf0b7 Babies should start breastfeeding within 1 hour of birth. The baby should not be given\\nany other food or drink before breastfeeding.\\n\\uf0b7 Babies should be exclusively breastfed for the first 6 months of life.\\n\\uf0b7 Breast milk contains exactly the nutrients a baby needs, is easily digested and protects the\\nbaby againstinfection.\\nINDUCTION AND AUGMENTATION OF LABOUR\\nInduction of labourrefers tostimulating the uterus to begin labour. While augmentation of\\nlabourmeans stimulating the uterus during labour to increase the frequency, duration and\\nstrength of contractions.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 267, 'page_label': '268'}, page_content='Obstetrics andGy necology\\n260\\nA good labour pattern is established when there are three contractions in 10 minutes, each\\nlasting more than 40 seconds. If themembranes are intact, it is recommended practice in both\\ninduction and augmentation of labour to first perform artificial rupture of membranes (ARM).\\nIn some cases, this is all that is needed to induce labour. Membrane rupture, whether\\nspontaneous or artificial, often sets off the following chain of events:\\n-Amniotic fluid is expelled;\\n-Uterine volume is decreased;\\n-Prostaglandins are produced, stimulating labour;\\n- Uterine contractions begin (if the woman is not in labour) or become stronger (if she is\\nalready in labour).\\nArtificial rupture of membranes\\n\\uf0b7 Note: In areas where HIV and/or hepatitis are highly prevalent, it is prudent to leave the\\nmembranes intact for as long as possible to reduce perinatal transmission of HIV\\n\\uf0b7 Monitor the fetal heart rate.\\n\\uf0b7 Ask the woman to lie on her back with her legs bent, feet together and knees apart.\\n\\uf0b7 Wearing sterile gloves, use one hand to examine the cervix and note the consistency,\\nposition, effacement and dilatation.\\n\\uf0b7 Use the other hand to insert an amniotic hook or a Kocher clamp into the vagina.\\n\\uf0b7 Guide the clamp or hook towards the membranes along the fingers in the vagina.\\n\\uf0b7 Place two fingersagainst the membranes and gently rupture the membranes with the\\ninstrument in the other hand. Allow the amniotic fluid to drain slowly around the fingers.\\n\\uf0b7 Note the colour of the fluid (clear, greenish, bloody). Ifthick meconium is present,\\nsuspect fetaldistress.\\n\\uf0b7 After ARM, listen to the fetal heart rate during and after a contraction. If thefetal heart\\nrate is abnormal(less than 100 or more than 180 beats per minute), suspect fetal distress.\\n\\uf0b7 If membranes have been ruptured for 18 hours, give prophylactic antibiotics to help\\nreduceGroup B streptococcusinfection in the neonate- penicillin G 2 million units IV; ,\\nor  Inj. ampicillin 2 g IV, every six hours until delivery\\n\\uf0b7 Ifgood labour is not established one hour after ARM, begin oxytocin infusion\\n\\uf0b7 Iflabour is induced because of severe maternal disease(e.g. sepsis or eclampsia), begin\\noxytocin infusion at the same time as ARM.\\nAssessment of the cervix\\n\\uf0b7 The success of induction of labour is related to the condition of the cervix at the start of\\ninduction. To assess the condition of the cervix, a cervical exam is performed and a score\\nis assigned based on the criteria(Table5):\\n\\uf0b7 If thecervix is favourable(has a score of 6 or more), labour is usually successfully\\ninduced with oxytocin alone.\\n\\uf0b7 If the cervix is unfavourable(has a score of 5 or less), ripen the cervix using\\nprostaglandins or a Foley catheterbefore induction.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 268, 'page_label': '269'}, page_content='Obstetrics andGy necology\\n261\\nTable 5.Assessment of cervix for induction of labour\\nRating\\nfactor\\nDilatation Length of\\ncervix\\nConsistency Position Descent by\\nstation of head\\n0 Closed More than 4 Firm posterior -3\\n1 1-2 3-4 Average Mid -2 to-1\\n2 3-4 1-2 Soft Anterior 0+1\\n3 More than 5 Less than 1 Soft Anterior +2\\nOxytocin\\n\\uf0b7 Use oxytocin with great caution, as fetal distress can occur from hyperstimulation and,\\nrarely, uterine rupture can occur. Multiparous women are at higher risk for uterine\\nrupture.\\n\\uf0b7 The effective dose of oxytocin varies greatly between women. Cautiously administer\\noxytocin in IV fluids (dextrose or normal saline), gradually increasing the rate ofinfusion\\nuntil good labour is established (three contractions in 10 minutes, each lasting more than\\n40 seconds). Maintain this rate until delivery. The uterus should relax between\\ncontractions.\\n\\uf0b7 Monitor the womanâ€™s pulse, blood pressure and contractions, a nd check the fetal heart\\nrate.\\n\\uf0b7 When oxytocin infusion results in a good labour pattern, maintain the same rate until\\ndelivery.\\n\\uf0b7 Carefully observe women receiving oxytocin.\\n\\uf0b7 Record the following on a partograph every 30 minutes rate of infusion of oxytocin.\\n\\uf0b7 Look forfetal heart rate. Listen every 30 minutes, always immediately after contraction.\\nIf thefetal heart rate is less than 100 beats perminute, stop the infusion and manage for\\nfetal distress.\\n\\uf0b7 Infuse oxytocin 2.5 units in 500 mL of dextrose (or normalsaline) at 10 drops per minute\\nin case of multigravida. In case of primigravida start with 5 unit oxytocin in 500 ml of\\ndextrose.\\n\\uf0b7 Increase the infusion rate by 10 drops per minute every 30 minutes until a good\\ncontraction pattern is established (three contractions in 10 minutes, each lasting more than\\n40 seconds).\\n\\uf0b7 Maintain this rate until delivery is completed.\\n\\uf0b7 Ifhyperstimulation occurs(any contraction lasts longer than 60 seconds) or if there are\\nmore than four contractions in 10 minutes, stop the infusion and relax the uterus using\\ntocolytics:\\n- terbutaline 250mcg IV slowly over five minutes or\\n- salbutamol 10 mg in 1 L IV fluids (normal saline or Ringerâ€™s lactate) at 10 drops per\\nminute.\\nâ€¢ If a good contraction pattern has not been established with the infusion rate at 60 drops per\\nminute:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 269, 'page_label': '270'}, page_content='Obstetrics andGy necology\\n262\\n- Increase the oxytocin concentration to 5 units in 500 mlof dextrose (or normal saline)\\nand adjust the infusion rate to 30 drops per minute (15 mIU per minute);\\n- Inmultigravidaand inwomen with previous caesarean scars,induction has failed; deliver\\nby caesarean section.\\nProstaglandins\\nProstaglandins are highly effective in ripening the cervix during induction of labour.\\n\\uf0b7 Monitor the womanâ€™s pulse, blood pressure and contractions, and check the fetal heart\\nrate.Record findings on a partograph.\\n\\uf0b7 Prostaglandin E2 (PGE2) is available in several forms (3 mg pessary or 2â€“3 mg gel). The\\nprostaglandin is placed high in the posterior fornix of the vagina and may be repeated\\nafter six hours if required.\\n\\uf0b7 Discontinue use of prostaglandins and begin oxytocin infusion if: membranes rupture;,\\ncervical ripening has been achieved;, good labour has beenestablished;,  or 12 hours have\\npassed.\\nMisoprostol\\n\\uf0b7 Use misoprostol to ripen the cervixonly in highly selected situationssuch asseverepre-\\neclampsia or eclampsia when the cervix is unfavourable and safe caesarean section is not\\nimmediately available or the baby is too premature to survive; fetal death in-utero if the\\nwoman has not gone into spontaneous labour after four weeks and platelets are\\ndecreasing.\\n\\uf0b7 Place misoprostol 25 mcg in the posterior fornix of the vagina. Repeat after six hours, if\\nrequired.\\n\\uf0b7 If there isno response after two doses of 25 mcg, increase to 50 mcg every six hours;\\n\\uf0b7 Do not use more than 50 mcg at a time and do not exceed four doses (200 mcg).\\n\\uf0b7 Monitor uterine contractions and fetal heart rate of all women undergoing induction of\\nlabour with prostaglandins.\\nFoley catheter (mechanical dilation)\\nThe Foley catheter is an effective alternative to prostaglandins for cervical ripening and\\nlabour induction. It should, however, be avoided in women with obvious cervicitis or\\nvaginitis.\\n\\uf0b7 Gently insert a high-level disinfected or sterile speculum into the vagina.\\n\\uf0b7 Hold the catheter with a high-level disinfected or sterile forceps and gently introduce it\\nthrough the cervix. Ensure that the inflatable bulb of the catheter is beyond the internal\\nos.\\n\\uf0b7 Inflate the bulb with 30ml of water. Give traction to rest of the catheter and strap it with\\nthe thigh. Leave the catheter in place until contractions begin, or for at least 12 hours.\\n\\uf0b7 Deflate the bulb before removing the catheter and then proceed with oxytocin infusionto\\naugment induction of labour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 270, 'page_label': '271'}, page_content=\"Obstetrics andGy necology\\n263\\n\\uf0b7 Primary PPH i.e. bleeding within 24 hours of delivery is commonly due to atonic uterus\\n(90% cases) or cervical/vaginal tears (traumatic PPH). It can also be due to occult uterine\\ninversion, rupture uterus or coagulation defect.\\n\\uf0b7 Abnormal bleeding can also occur between 24 hours and 6 weeks of delivery (secondary\\nPPH) due to sepsis, retained placental bits, or placental polyp, choriocarcinoma.\\n\\uf0b7 PPH requires prompt and effective management, failing which it may result in\\ncomplications like hypovolaemic shock, coagulation failure, renal failure, hepatic failure,\\nadult respiratory distress syndrome and may also result in maternal death.\\nâ€¢ Monitor pulse rate, blood pressure, respiratory rate and urine output. While resuscitative\\nmeasures are underway, a thorough clinical examination is made toascertain the cause of\\nPPH and definitive treatment is planned accordingly.\\nPOSTPARTUM HAEMORRHAGE (PPH )\\nPostpartum haemorrhage is excessive blood loss from the genitaltract after delivery of the\\nfoetus exceeding 500 ml or affecting the general condition of the mother.\\nSalient features\\nPharmacologicaltreatment\\nIV fluids and blood replacement therapy\\nATONIC PPH\\nPrevention\\nIdentify risk factors and anticipate the problem.\\nActive management (oxytocin 5 units intramuscularly at the birth of anterior shoulder or after\\ndelivery of placenta) should be done in all cases unless contraindicated.\\nNon pharmacological treatment\\nPlacental removal with cord traction if already separated uterine massage and bimanual\\ncompression.\\nPharmacological treatment(Table6)\\n\\uf0b7 Oxytocin infusion (10-40 units in 500 ml Ringer's lactate/normal saline at125 ml/min)\\n\\uf0b7 Methyl ergometrine maleate0.2 mg IV may be repeated IM after5-10 min. (Caution:\\nContraindicated in heart disease, hypertension).\\nTable 6. Drugs used in the treatment of post partum haemorrhage\\nDrug Dose and Route Continuing Dose Maximum Dose Precautions and\\nContraindications\\nOxytocin IV: Infuse 20\\nunits in 1 L IV\\nfluids at 60\\ndrops per minute\\nIM:  5-10 units\\nIV: Infuse 20\\nunits in 1 L IV\\nfluids at 40 drops\\nper minute\\nNot more than 3\\nL of IV fluids\\ncontaining\\noxytocin\\nDo not give as an\\nIV bolus\\nErgometrine/ IM or IV Repeat 0.2 mg Five doses (TotalHigh blood\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 271, 'page_label': '272'}, page_content='Obstetrics andGy necology\\n264\\n\\uf0b7 Prostaglandins shouldnot be given intravenously. It  may be fatal\\n\\uf0b7 If bleeding is not controlled15-methyl PGF2 A 0.25 mg IM intramyometrial, may be\\nrepeated every15-90 min up to a maximum of 2 mg. (Caution:Contraindicated in\\nbronchial asthma, epilepsy).\\n\\uf0b7 In patients with bronchial asthma and epilepsy, administer with caution Tab. misopristol\\n600 mcg per rectum.\\nIndication for referral\\nIf patient is still bleeding despite medical therapy and if facilities for transfusion and further\\nmanagement are not available arrange for transfer to a higher center. Intrauterine packing\\nmay be done in the mean time.\\nSurgical treatment\\n\\uf0b7 Retained placenta-Manual removal of placenta under general anaesthesia (GA)\\n\\uf0b7 Cervical/ vaginal tears-Exploration and repair\\n\\uf0b7 Rupture uterus-Laparotomy with repair/ hysterectomy\\n\\uf0b7 Uterine inversion-Reposition under GA\\n\\uf0b7 Atonic PPH not controlled-Laparotomy with uterine artery ligation with medical measures\\n\\uf0b7 Internal artery ligation/Hysterectomy\\nPatient education\\n\\uf0b7 Higher parity and previous atonic PPH predispose to PPH.\\n\\uf0b7 Hospital delivery is mandatory in women with PPH in a previous pregnancy, grand\\nmultipara, multiple pregnancy, APH and severe anaemia.\\nPREVENTION OF MATERNAL TO CHILD TRANSMISSION\\nTransmission rate during pregnancy 5-10%, during labor and delivery10-15% and during\\nbreastfeeding   5-20%.\\nRisk factors for vertical transmission\\n\\uf0b7 Viral load >50000 RNA copies/ml at time of delivery\\n\\uf0b7 CD4 count <700/cumm\\n\\uf0b7 Chorioamnionitis\\n\\uf0b7 Duration of ruptured membranes over 4 hrs doubles the risk\\n\\uf0b7 Intrapartum haemorrhage\\nMethyl-\\nErgometrine\\n(slowly): 0.2 mg IM after 15\\nminutes. If\\nrequired, give 0.2\\nmg IM or IV\\n(slowly) every\\nfour hours\\n1.0m g) pressure, pre-\\neclampsia, heart\\ndisease\\n15-Methyl\\nProstaglandinF2\\nIM: 0.25 mg 0.25 mg every 15\\nminutes\\nEight doses\\n(Total 2 mg)\\nAsthma'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 272, 'page_label': '273'}, page_content='Obstetrics andGy necology\\n265\\n\\uf0b7 Mod e of delivery\\n\\uf0b7 Invasive fetal monitoring\\n\\uf0b7 Breastfeeding\\nBasic mechanism for mother to child transmission\\n\\uf0b7 Transplacental\\n\\uf0b7 Exposure to maternal blood and vaginal secretion at the time of delivery.\\n\\uf0b7 Postnatal exposure to maternal secretions such as breast milk.\\n2006 guidelinesrecommended that only women with a low CD4 count should receive a\\ncombination ofHIV and AIDS drugs to prevent mother-to-child transmission and all HIV-\\npositive mothers were advised to exclusively breastfeed for 6 months and then rapidly wean\\nto avoid transmitting HIV to their infant.\\nNew 2010 guidelines, recommended that all HIV-positive mothers, identified during\\npregnancy, should receive a course of antiretroviral drugs to prevent mother-to-child\\ntransmission. All infants born to HIV-positive mothers should also receive a course of\\nantiretroviral drugs and should be exclusively breastfed for 6 months and complementary fed\\nfor up to a year.\\nFour key strategies for preventing mother-to-child transmission\\n1. Keeping women of reproductive age and their partners HIV -negative through\\nreproductive health and HIV prevention services.\\n2. Avoiding unwantedpregnanciesamong HIV -infected women and women at risk of HIV,\\nthrough family planning and HIV testing and counselling services.\\n3. Ensuring HIVtestingof pregnant women and timely access to effective antiretroviral\\ntherapy, both for the health of HIV-infected mothers and for PMTCT, during pregnancy,\\ndelivery and breastfeeding.\\n4. Better integration of HIV care,treatmentand support for HIV-infected women and their\\nfamilies.\\nFollowing should be avoided\\n\\uf0b7 Artificial rupture of membranes\\n\\uf0b7 Routine use of fetal scalp electrodes for fetal monitoring\\n\\uf0b7 Operative delivery with forceps or a vacuum extractor and/or episiotomy\\nCD4 count has to be done.  If CD4 count less than or equal to 350 cells/mm3 start\\nantiretroviral drugs for their own health. CD4 count higher than 350 cells/mm3 â€“ no need of\\nART for motherâ€™s health. But helps in preventing transmission.\\nMothers, when identified in pregnancy as being HIV positive, should begina triple\\nantiretroviral regimen immediately after being diagnosed, irrespective of their CD4 count.\\nMothers should remain on the same triple antiretroviral regimen throughout pregnancy and\\ncontinuing for life.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 273, 'page_label': '274'}, page_content='Obstetrics andGy necology\\n266\\nInfants born to HIV positive mothers shouldreceive a course of medication for PMTCT.\\nUnder the infant should receive daily NVP or AZT from birth until age 4-6 weeks, regardless\\nof infant feeding method.\\nThree options for PMTCT(Table7):\\nTable 7. Treatment options for prevention of mother to child transmission of HIV\\nTreatment\\n(for CD4 count <350\\ncells/mm3)\\nProphylaxis\\n( for CD4 count >350\\ncells/mm3)\\nInfant recieves\\nOption A Triple ARVs starting as\\nsoon asdiagnosed,\\ncontinued for life\\nAntepartum:AZT\\nstarting asearly as 14\\nweeks gestation\\nIntrapartum:at onset of\\nlabour\\n-single-dose NVP and\\nfirst doseof AZT/3TC\\nPostpartum:daily\\nAZT/3TC through 7\\ndays postpartum\\nDaily NVP from birth\\nuntil 1week after\\ncessation of all\\nbreastfeeding; or, if not\\nbreastfeeding or if\\nmother ison treatment,\\nthrough age4â€“6 weeks\\nOption B Triple ARVs starting as\\nsoon asdiagnosed,\\ncontinued for life\\nTriple ARVs starting as\\nearly as14 weeks\\ngestation and\\ncontinued intrapartum\\nand through childbirth if\\nnotbreastfeeding or\\nuntil 1 weekafter\\ncessation of all\\nbreastfeeding\\nDaily NVP or AZT\\nfrom birththrough age\\n4â€“6 weeks\\nregardless of infant\\nfeeding method\\nOption B+ Triple ARVs starting as\\nsoon asdiagnosed,\\ncontinued for life\\nTriple ARVs starting as\\nsoon asdiagnosed,\\ncontinued for life\\nDaily NVP or AZT\\nfrom birththrough age\\n4â€“6 weeks\\nregardless of infant\\nfeedingmethod\\nAZT: Zidovudine,  sd-NVP: Single-dose Nevirapine,  NVP: Nevirapine,\\nAZT: Zidovudine,  3TC: Lamivudine\\nVA GINAL DISCHARGE\\nReproductive tract infections (RTI), including sexually transmitted infections(STI), represent\\na major public health problem. Syndromic management of symptomatic individuals is\\nrecommended.  NACO algorithm for the management of vaginal discharge (Figure1, Table\\n8):'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 274, 'page_label': '275'}, page_content='Obstetrics andGy necology\\n267\\nFigure 1. NACO algorithm for the management of vaginal discharge\\nTable 8.NACO algorithm for the management of vaginal discharge\\nThere are seven pre-packed colour coded STI/RTI drug kits under NACP for syndromic\\nmanagement of STI/RTI and procured by NACO. These drug kits have been developed based\\non the National Guidelines on Prevention, Management and Control of Reproductive Tract\\nInfections including Sexually Transmitted Infections, Ministry of Health & FW, August\\n2007.Syndromic Case Management Protocol\\nKit No. Syndrome Colour Contents\\nKit 1 Cervicitis\\nUrethral Discharge\\nPresumptive treatment\\nGrey T. Azithromycin 1 g (1) and\\nT. Cefixime 400 mg (1)\\nKit 2 Vaginitis Green T. Secnidazole 2g (1) and\\nT. Fluconazole 150 mg (1)\\nKit 3 Genital Ulcer Diseaseâ€“ Non\\nHerpetic\\nWhite Inj. Benzathine Penicillin 2.4 MU (1)\\nand T.Azithromycin 1 g (1)\\nKit 4 Genital Ulcer Diseaseâ€“ Non\\nHerpetic (for patients allergic to\\nPenicillin)\\nBlue T. Doxycycline 100 mg (30) and\\nT. Azithromycin 1 g (1)\\nKit 5 Genital Ulcer Disease-Herpetic Red T. Acyclovir 400 mg (21)\\nKit 6 Lower Abdominal Pain (PID) Yellow T. Cefixime 400 mg (1) and\\nT. Doxycycline 100 mg (28) and\\nT. Metronidazole 400 mg (28)\\nKit 7 Inguinal Bubo Black T. Doxycycline 100 mg (42) and\\nT. Azithromycin 1 g (1)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 275, 'page_label': '276'}, page_content='Obstetrics andGy necology\\n268\\n\\uf0b7 Lower abdominal pain, cervical motion tenderness and adenexal tenderness,fever,\\ncervical discharge and leucocytosis.\\n\\uf0b7 In severe cases patient may be toxic with high-grade fever, vomiting,dehydration,\\nand abdominal distension.\\n\\uf0b7 Long term sequelae can be infertility, ectopic pregnancy, chronic pelvic pain.\\n\\uf0b7 Failure of acute PID to resolve completely results in chronic PID with featuresof\\nsevere, persistent and progressive pelvic pain, repeated acute exacerbationof PID,\\ntubo-ovarian inflammatory mass, dyspareunia or bilateral ureteralobstruction from\\nligamentous cellulitis.\\nPELVIC INFLAMMATORY DISEASE (PID)\\nPelvic inflammatory disease (PID)results frominfection of cervix, uterus,tubes, ovaries\\nand pelvic peritoneum. The disease may have acute or chronic presentation. The\\ncommonest cause is sexually transmitted diseases, however, other causes include post\\nabortaland puerperal sepsis, operative procedures like dilatation and curettage, endometrial\\nbiopsy, and insertion of intrauterine device.\\nSalient features\\nInvestigations\\n\\uf0b7 Haemogram with ESR, LFT, RFT, serum electrolytes,blood culture, endocervical\\nswab culture, ultrasonography if adenexal mass.\\nTreatment (Acute PID)\\nThe patient can be treated as an outpatient or inpatient depending on the severityof clinical\\nfeatures.\\nI. Outpatient treatment- mild PID\\nEither of the following two regimens can be given:\\nRegimen A\\n\\uf0b7 Inj. cefoxitin 2 g IM, plusprobenecid 1 g orally, as a single doseor Inj. ceftriaxone\\n250 mg IM as a singledose or Inj. ceftizoxime or cefotaxime 500 mg IM as a single\\ndose.\\n\\uf0b7 Cap. doxycycline 100 mg 2 times a day for 14 days.\\nRegimen B\\n1. Tab. ofloxacin 400 mg oral 2 times a day for4 days.\\n2. Tab. Clindamycin 450 mg oral 4 times a day for 14 daysor Tab. metronidazole 400\\nmg 2 times a day for 14 days\\nFollow up after 2- 3 days of initiation of therapy; patient is reevaluated forclinical\\nresponse. If poor response, patient is to be admitted for intravenous antibiotics.\\nII. Indoor treatment- severe illness or nausea and vomiting, HIV positive, unable to\\nfollowor tolerate an outpatient regimen and outpatient therapy failed.\\n\\uf0b7 Bed Rest. Hydrotherapy, if febrile.\\n\\uf0b7 IV fluids in cases of vomiting and dehydration and correction of electrolyteimbalance.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 276, 'page_label': '277'}, page_content=\"Obstetrics andGy necology\\n269\\nMonitoring\\nClinical condition, vital monitoring, signs and symptoms of pelvicabscess and peritonitis.\\nEither of the following regimens may be instituted at the earliest without waitingfor culture\\nreports:\\nRegimen A\\n\\uf0b7 Inj. cefoxitin 2 g IV every 6 hoursorInj. cefotetan 2 g IV every 12 hours.\\n\\uf0b7 Inj. doxycycline 100 mg IV or orally every 12 hours.\\n\\uf0b7 Inj. metronidazole 500 mg IV 8 hourly.\\nRegimen B\\n\\uf0b7 Inj. clindamycin 900 mg IV every8 hours.\\n\\uf0b7 Inj. gentamicin 2 mg/kg IV followed by 1.5 mg/kg every 8 hours.\\n\\uf0b7 Inj. diclofenac sodium 75 mg deep IM 8 hourlyorInj. paracetamol 500 mg IM SOS.\\n\\uf0b7 Inj. metronidazole 500 mg IV 8 hourly.\\nInjectable regimen should be continued for at least 48 hours after the patientdemonstrates\\nclinical improvement (becomes afebrile, decrease in lowerabdomen and pelvic tenderness,\\nimprovement in constitutional symptoms).After this, doxycycline 100 mg 2 times a day\\norally or clindamycin 450mg oral 4 times a day should be continued for total of14 days.\\nClinical improvement should occur within 3 days of initiation of therapy.  Considerfurther\\ndiagnostic tests /laparoscopy if symptoms do not improve or worsen.Different procedures\\nmay be required in the following situations:\\n\\uf0b7 Colpotomy for drainage of midline pelvic abscess\\n\\uf0b7 Dilatation and evacuation of septic products of conception in post abortal sepsis.\\n\\uf0b7 Laparotomy in cases of pyoperitoneum, resistant peritonitis, intestinalobstruction,\\nruptured tubo-ovarian abscess,enlarging pelvic mass despite medical therapy,\\n\\uf0b7 Laparoscopy: if diagnosis is uncertain, no response to treatment,to reconfirm the\\ndiagnosis, obtain cultures from cul de sac and fallopian tubes and drain pus if necessary.\\nTreatment of the sexual male partner\\nAsymptomatic male partner:Inj. ceftriaxone 125 mg IM followed by oral doxycycline 200\\nmg 2 times aday for 14 days.\\nTreatment (ChronicPID)\\nTreatment is surgical, considering pathological lesion, patient's age, and desire for child\\nbearing. Definitivesurgery is total abdominal hysterectomywith bilateral salpingo-\\noophorectomy, but in young females conservative surgery is preferred.Chronic PID can be\\ndue to pelvic tuberculosis.\\nTreatment (Pelvic tuberculosis)\\nPrimary treatment is medical therapy withanti tubercular drugs for 6 months. Daily dose of\\nthe drugs is:\\n\\uf0b7 Tab. isoniazid 5 mg/kg (maximum 300 mg).\\n\\uf0b7 Cap. rifampicin 10 mg/kg (maximum 600 mg).\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 277, 'page_label': '278'}, page_content=\"Obstetrics andGy necology\\n270\\n\\uf0b7 Somatic symptoms include feeling of bloating, bodyaches, breasttenderness,\\nheadache, food cravings and poor concentration.\\n\\uf0b7 Emotional symptoms include emotional hypersensitivity, depression, irritability,\\nmood swings, anxiety, tension, fear of loss of control and confusion.\\n\\uf0b7 Diagnosis is confirmed by excluding the concomitant medical or psychiatric\\ndisorders with which it may be confused(depending on the symptoms).\\n\\uf0b7 Tab. pyrazinamide 15-30 mg/kg (maximum 2 g).\\n\\uf0b7 Cap. ethambutol 15-25 mg/kg (maximum 2.5 g).\\nAll 4 drugs are given in the initial phase for 2 months followed by INHand rifampicin for\\n4 months.\\nIndications of surgery are: primary unresponsiveness,persistence or enlargement of\\nadenexal mass after 4- 6 months of treatment,persistence or recurrence of pelvic painon\\ntreatment. Definitive surgery is totalabdominal hysterectomy with bilateral salpingo-\\noophorectomy.\\nPatient education\\n\\uf0b7 Emphasize behavioural and contraceptive methods to prevent the acquisition of STDs.\\n\\uf0b7 Encourage to complete the antibiotic treatment forthe full course i.e. 14 days.\\n\\uf0b7 Sexual abstinence until complete treatment. Sexual partner of patientdiagnosed with\\nPID must be treated to prevent reinfection.\\nPR E M E NS T R U AL  S Y N D RO ME\\nP r em en s t r u a l  s yn d ro m e  ( P M S )  is a cyclic recurrence of physical, psychological or\\nbehavioural symptoms after ovulation and resolve after the onsetof menstruation. It\\nrequirestreatment when the symptoms are severe to interfere with the woman'slifestyle,\\nrelationships and occupational functioning.\\nSalient features\\nNon -pharmac ological treatment\\nLife-style advice should be offered to all women as first line of treatment.\\n1. Daily charting of symptoms for two months.\\n2. Dietary modifications like: increase complex carbohydrate meals, reduce or eliminate,\\nespecially in the luteal phase- salts, chocolate, caffeine and alcohol;and several small\\nmeals per day.\\n3. Moderate regular aerobic exercise like brisk walk 1-2 miles per day for 4-5 days/week.\\n4. Stress management courses/counseling.\\nPharmacological treatment\\n1. Tab. pyridoxine 100 mg/dayfor 10-14 days (during luteal phase) (maximumdaily dose is\\n150 mg) or Tab. Eveningprimrose oil 500 mg 3 times a day.\\n2. NSAIDs like mefenamic acid 500 mg 3 times a day for premenstrual dysmenorrhea.\\n3. In case of predominantly physical symptoms (bloatedness, irritabilityswelling,\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 278, 'page_label': '279'}, page_content=\"Obstetrics andGy necology\\n271\\n\\uf0b7 Disturbances of the menstrual cycle, regular andirregular uterine bleeding and\\nalteration in the amount or duration of the menstrual blood loss.\\n\\uf0b7 Due to anovulatory cycles but can also occur in the ovulatory cycles. Anovulatory\\ncycles are usual in postmenarche, premenopausal agegroups and are usually irregular,\\nvariable in duration and amount of bleeding.\\nweight gain, breast tenderness), Tab. spironolactone 100 mg/dayOr Tab. bromocriptine\\n1.25- 5 mg/day in the luteal phase for mastalgia. (Common side effects are nausea and\\nvomiting. Tablet can be given vaginallyif side effects are very severe.)\\n4. If no relief in symptoms with above measures in 2- 3 cycles and symptoms are\\npredominantly emotional, then the following drugs are used preferablyin consultation\\nwith a psychiatrist:Tab. fluoxetine 5-20 mg/day\\n5. In non-responders to the above therapy, ovulation suppression may bebeneficial; any\\nof the following can be used:Low dose combined oral contraceptive pills, 1 pill daily\\nfrom 5th to 25thday of the cycle.\\nD YSFUNCTIONAL UTERINE BLEEDING (DUB)\\nDysfunctional uterine bleeding (DUB) is an abnormal uterine bleeding in the absence\\nof organic disease of the genital tract.\\nSalient features\\nTreatment (Acute bleeding-first episode)\\nI.Severe bleeding (hemodynamically unstable patient)\\n\\uf0b7 IV line, fluid replacement, blood transfusion, oxygen inhalation and monitoring of vitals.\\n\\uf0b7 Dilatation and curettage to arrest bleeding except incases of puberty menorrhagia where\\nmedical management is preferred. IVtranexamic acid can be tried before resorting to\\nsurgical intervention.\\nII. Less severe bleeding (haemodynamically stable patient)\\n\\uf0b7 High dose progestogen: norethisterone 10 mg 3 times a day until bleeding stops(not >3\\ndays) followed by norethisterone 5-10 mg or medroxyprogesterone acetate 10 mg per\\nday for 21 days. Withdrawal bleedingoccurs after 2-4 days of stopping the drug and\\nstops in 4-5 days. Or combined oral contraceptive pills (OCs) containing 50 mcg\\nethinyloestradiol 1pill 2 times a day for 7-10 days followed by progestins for 7-10 days,\\nfollowed by withdrawal bleeding.\\nIII.If bleeding is not controlled with progestogens\\nPatient is having heavy bleeding for many days, endometrial curettage yieldsminimal\\ntissue, or when the patient has been on progestogen medication (OC's orDepot MPA) and\\nthe endometrium is shallow and atrophic.\\nTreatment schedules of high dose oestrogens, depending on the severity of thebleeding the\\nfollowing can be used:\\n1. Conjugated oestrogen 25 mg IV every 4 h till bleeding abates or for 12 h.Progestin\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 279, 'page_label': '280'}, page_content=\"Obstetrics andGy necology\\n272\\ntreatment is started at the same time.\\n2. Oral treatmentconjugated oestrogen 1.25 mg or 2 mg oestradiol valerate given\\norally every 4 h for maximum of 24 h followed by single daily dose for 7-10 days.\\nAll treatments must he followed by progestin coverage (10 mg MPA daily) alongwith\\noestrogen for 7 days.\\nMoni toring\\nClinical monitoring by vital charting and observation of blood loss per vaginum\\nTreatment (Chronic DUB - not actively bleeding)\\n\\uf0b7 Iron therapy: elemental iron maximum 60 mg 3 times a day\\n\\uf0b7 Histopathological diagnosis is must before starting hormonal therapy in allcases except\\npuberty menorrhagia.\\nI. Anovulatory DUB\\n\\uf0b7 If contraception is desired: OCPs for 3-6 cyclesor norethisterone 5-10 mg.\\n\\uf0b7 Medroxyprogesterone acetate (MPA) 10 mg 16-25th day of the cycle for3-6 cycles.\\n\\uf0b7 In cases of endometrial hyperplasia without atypia on histology norethisteroneacetate 5 mg\\nthree times a day or MPA 10 mg twice a day 5-25th day of cycle for 3-9 cycles\\nfollowed by repeat endometrial biopsy.\\n\\uf0b7 If fertility desired: ovulation induction is advised.\\n\\uf0b7 Levonorgestrel IUD can be offered after counseling and is beneficial in DUB.\\nII. Ovulatory DUB\\n\\uf0b7 NSAIDs: mefenamic acid 500 mg 3 times a day for 3-5 days during periods. Or\\n\\uf0b7 Oral combined contraceptive pills if contraception is desired.\\nIf the above treatment is not effective in first cycle patient should be referredfor\\ntertiary care. Following treatment can be considered as analternative to surgery:\\n\\uf0b7 Tab. danazol 200 mg daily for 3 months.\\n\\uf0b7 Levonorgestrel IUCD can be offeredafter counseling and is beneficial in DUB.\\nFollow up\\nAfter 1, 3, 6 months of therapy. Treatment is stopped after3-6 months. If symptoms\\nrecur medical treatment is to be continued or surgery canbe offered.\\nSurgical treatment- endometrial curettage\\n\\uf0b7 Acute bleeding in haemodynamically unstable patient to quickly control thebleeding.\\n\\uf0b7 In acute episode, if bleeding doesn't decrease significantly in 12-24 hours with\\nmedical treatment, then reevaluation is mandatory and surgical curettageshould be\\ndone.\\n\\uf0b7 If age is >35 years- premenstrual dilatation and curettage for endometrialhistology is\\na must to rule out endometrial pathology.\\nIf medical therapy is not effective then endometrial ablation or hysterectomy isto be\\nperformed.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 280, 'page_label': '281'}, page_content='Obstetrics andGy necology\\n273\\n\\uf0b7 Hot flushes, night sweats, palpitations, vaginal dryness, itching, atrophy ofthe\\nbreast and skin, urethral syndrome, stress incontinence, mood changeslike anxiety,\\nirritability, depression, insomnia and joint pains.\\n\\uf0b7 Diagnosis is always clinical. However, in doubt, estimateserum FSH levels and\\noestradiol levels may be helpful.\\nPatient education\\n\\uf0b7 Common side effects of high dose oestrogens are: nausea, vomiting,headache,\\ndepression, and fluid retention. Contraindicated in liver disease,history of\\nthromboembolic disorder, cardiovascular disease, and oestrogen dependant neoplasm.\\n\\uf0b7 Common side effects of progestogens are depression, fluid retention, fatigue,insomnia,\\ndizziness, nausea, and breast tenderness.\\nMENOPAUSE\\nPermanent cessation of menses for one year is known as menopause. The usual age is\\nbetween 40 to 50 years, mean age being 48 years. Long term consequences due to\\ndecreased oestrogens can increase the risk of ischaemic heart disease due to adverselipid\\nprofile and pathological fractures due to osteoporosis.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Balanced diet with fruits, vegetables, semi-skimmed milk adequate in vitaminsand\\nminerals. A reduction or avoidance of smoking and alcohol consumption.\\n\\uf0b7 Exercise: walking or swimming for 20-30 min every day.\\nPharmacological treatment\\n\\uf0b7 Tab. calcium 1500 mg daily.\\n\\uf0b7 Hormone replacement therapy (HRT). Rule out contraindications to HRT like\\nendometrial/breast cancer, acute phase myocardial infarction,undiagnosed breast\\nlump/abnormal vaginal bleeding and acute liver disease.Hypertension and diabetes if\\npresent should be controlled before HRT isprescribed.\\nOestrogen therapy\\n\\uf0b7 For hysterectomized patients- conjugated equineoestrogen 0.625-1.25 mg.or oestriol\\n1-2 mg is given daily 1-25th day every month or daily without anybreak. If symptoms\\nrecur during drug free period then give continuoustherapy. Or\\n\\uf0b7 Transdermal oestradiol patch 50 or 100 mcg/day applied twice a week away from breast,\\npreferably on the shaved skin of buttock, thigh or legs (Limitingfactor is local skin\\nreactions).Transdermal oestradiol patch is preferred in case of gall bladder disease,\\nhypertriglyceridimea, history of thromboembolism, poorly-controlled hypertension,\\nrecent myocardial infarction, vascular diseases, migraine,chronic hepatic dysfunction,\\nmalabsorption syndrome.\\n\\uf0b7 Combined therapy with oestrogens and progestin in women with intact uterus.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 281, 'page_label': '282'}, page_content=\"Obstetrics andGy necology\\n274\\n\\uf0b7 Obese women and women taking hormone replacement therapy (HRT),vaginal atrophy,\\nlesions and cracks on the vulva may bleed.Bleeding from the upper reproductive system\\ncan be caused by hormone replacements, endometrial cancer (5-10%), endometrial\\npolyps, cervicalcancer, cervical lesions, uterinetumours, ovarian cancer or oestrogen\\nsecreting tumors in other parts of the body.\\n\\uf0b7 Diagnosis is confirmed by endometrial or cervical biopsy. Non-invasive testsinclude saline\\ninfusion sonography (SIS), a refinement of vaginal probeultrasound.Dilatation and\\ncurettage(D & C) is often necessary for definitive diagnosis.\\ni. Oestrogen therapy as above.\\nii.Progestogen-medroxyproge sterone acetate 5- 10 mg, or dihydrogesterone 10- 20\\nmg or norethisterone 2.5 mgor 200 ml micronized progesterone is added from 13th to\\n25th days in cyclicsequential regimen and 1st to 12th of every month in continuous\\nsequential regimen.\\nIf withdrawalbleeding is not acceptable then give continuous combinedtreatment (0.625 mg\\nconjugated equine oestrogen + 2.5 mg medroxyprogesterone acetate or 1 mg micronized\\noestrogen + 100 mgmicronized progesterone).\\nIf conventional HRT is contraindicated\\n\\uf0b7 Tab. Tibolone 2.5 mg per day (major side effects are weight gain, oedema, breasttenderness,\\nGIT symptoms and vaginal bleeding).\\n\\uf0b7 In symptomatic elderly women with atrophic vaginitis and other urogenital symptoms who\\ndo not desire long term HRT:Oestriol cream dailyapplication of 0.5 g delivering 0.5 mg of\\noestriol for 3 weeksfollowed by twice weekly application for 3- 4 weeks.(Key indicator\\nof response to therapy is improvement in symptoms).\\n\\uf0b7 Follow up at 2-3 months then at 6 monthly intervals. Yearly mammography,Pap'ssmear,\\npelvic USG and serum oestradiol are advisable.\\nShort term treatment is advocated for acute symptoms and oestrogen use forlong term\\nbenefits is controversial.\\nPatient education\\n\\uf0b7 Explain about the side effectsof estrogen andprogestogens\\n\\uf0b7 Follow up visits at 2-3 months then at 6 monthly intervals are necessary.\\nPOSTMENOPAUSAL BLEEDING\\nPostmenopausal bleeding (PMB) is bleeding that occurs after menopause has beenestablished\\nfor at least one year. It is different from infrequent, irregular periods thatoccur around the time\\nof menopause. Salient features\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 282, 'page_label': '283'}, page_content=\"Obstetrics andGy necology\\n275\\nTreatment\\nTreatment of postmenopausal bleeding according tocause\\nCause Treatment\\nBenign & malignant neoplasm of vulvaRefer to higher center or treatcervix,vagina,\\nuterus or ovaries according to cause and\\nfacilities available.\\nIndiscriminate use of oestrogen for HRTStop oestrogen therapy\\nInfections Antibiotics\\nInjuries Repair\\nCoagulation disorder Treat accordingly\\nEndometritis Antibiotics\\nPostmenopausal atrophic vaginitis Vaginal oestrogen cream/ointment\\nIndication for referral to a higher level of care\\nUrgent referrals:\\n\\uf0b7 Palpable pelvic mass or lesions suspicious of cancer on vulva or vagina orcervixon\\nexamination or on ultrasound.\\n\\uf0b7 More than one or a single heavy episode of PMB in women aged >55 years (not onHRT).\\n\\uf0b7 Postcoital bleeding (PCB) in a woman aged >35 years that has persisted for morethan 4\\nweeks.\\n\\uf0b7 Prolonged or unexpected bleeding thatpersists for more than 4 weeks afterstopping\\nHRT.\\nEarly Referral(within 4-6 weeks)\\nAny other woman with PMB not on HRT who does not satisfy the criteria for`urgent\\nreferral'of postmenopausal bleeding\\n\\uf0b7 Unexplained repeated postcoital bleeding.\\nNote - in women over 45 years with persistent abdominal distension or pain, ovarian\\ncancer should be considered and therefore a pelvic examination shouldbe performed.If\\nexcessive bleeding, give hemostatic drugs (oral or intravenous)Postmenopausal bleeding\\nthat is not due to cancer and cannot be controlled byany other treatment usually requires a\\nhysterectomy.\\nEARLY DETECTION OF CANCER\\nScreening for Breast Cancer (ACS Guidelines)\\n\\uf0b7 Early detection of breast cancer in average risk women begins at 20 years and consist of a\\ncombination of clinical breast examination (CBE), counseling to raise awareness of breast\\nsymptoms and regular mammography beginning at age 40.\\n\\uf0b7 Between 20 and 39 years, women should undergo clinical breast examination every 3\\nyears. The average risk women should begin annual mammography at 40years and should\\ncontinue to be screened with mammography. Self examination of breast should also be\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 283, 'page_label': '284'}, page_content='Obstetrics andGy necology\\n276\\nadvised to every woman at 20 years.\\n\\uf0b7 Self breast examination from the age of 20years\\n\\uf0b7 Clinical examination once in 3 years by a physician\\n\\uf0b7 Baseline mammogram from age of 40 years and once in 2 years afterwards\\n\\uf0b7 Annual mammography from the age of 50 years\\n\\uf0b7 In countries with limited resources, mammogram is available for diagnosticpurposes not\\nfor screening.\\nScreening for Cervical Cancer\\n\\uf0b7 Screening for cervical cancer should be approximately 3 years after the onset ofvaginal\\nintercourse, but not later than age of 21 years.\\n\\uf0b7 Annual screening with conventional cytology smears or biennial screening using liquid\\nbased cytology is recommended until the age of 30 years. At or after 30years, a woman\\nwho has had 3 consecutive, technically satisfying normal/negative cytology results may\\nundergo screening every 2â€“ 3 years using conventional or liquidbased cytology.\\n\\uf0b7 After30 years of age, women who have the same history of normal cytology results may\\nundergo HPV DNA testing with conventional or liquid based cytology every 3\\nyears.Average risk for women aged 70 years and older with an intact cervix may choose\\nto cease cervical cancer screening if they have no abnormal /positive cytology tests within\\nthe 10 year period before the age of 70 years.\\n\\uf0b7 Women who are immune -compromised by organ transplantation, chemotherapy or\\ncorticosteroid treatment or HIV+ should be tested twiceduring the first year after\\ndiagnosis and annually thereafter.\\n\\uf0b7 Women with a history or absence of CIN 2/3 before as the indication for the\\nhysterectomy, should continue until there is a 10 year history of no abnormal positive\\ncytology tests.\\n\\uf0b7 Every woman at 30 years should undergo Papsmear at least once as it helps in diagnosis\\nof early cervical cancer (ICMR guidelines).\\nScreening for cervical cancer\\nAge group- 3 years after sexual activity, not later than 21years.  In countries with limited\\nresources all women around the age of 30 years should have onePap test.\\nMethod\\n\\uf0b7 Pap smear (or)VIA (visual inspection after application of 5%acetic acid) incountries\\nwith limited resources.\\nPrecautions-Prior to a pap smear\\n\\uf0b7 Not to douche for 48 hours,or usevaginal cream for 1 week, abstain from coitus for 24\\nhours,smear to be done on 7th day after menstrual period\\nTechnique\\n\\uf0b7 PAP TEST includes samples from ecto-cervix and endo-cervix\\n\\uf0b7 Use bivalved speculum'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 284, 'page_label': '285'}, page_content='Obstetrics andGy necology\\n277\\n\\uf0b7 Place the endocervical brush or cotton tipped swaband roll it firmlyagainst the canal\\n\\uf0b7 Remove the endocervical brush or cotton tipped swab and place samples on the glass\\nslide\\n\\uf0b7 Place the spatula against the cervix with the longer protrusion in the cervical canal\\n\\uf0b7 Rotate the spatula 360Â° firmly against the cervix, scrape the entire transformation zone\\n\\uf0b7 Place the sample immediately from the spatula onto the glass slide and fix it (spray\\nfixative or placing it in a bottle of fixativeâ€“ 95% ethanol.\\nFollow up-Abnormal smears should be referred for colposcopyand biopsy\\nScreening for Endometrial Cancer\\nWomen at high risk due to known hereditary non polyposis colon cancer (HNPCC)\\nassociated genetic mutation carrier status should consider beginning annual testing for early\\nendometrial cancer detection at an ageof 35. The endometrial biopsy is still the most\\ncommon technique used to obtain endometrial tissue.\\n\\uf0b7 Women at high risk (due to hereditary non-polyposis colon cancer carrierstatus) should\\nconsider annual testing from the age of 35.\\n\\uf0b7 Endometrial biopsy is the most common technique used to obtainendometrial tissue.\\nCONTRACEPTION\\nA method or a system, which allows intercourse and yet prevents conception, is called a\\ncontraceptive method. This contraception may be temporary when the effect lasts only till the\\ncouple uses the method but the fertility returns after the use is discontinued. The permanent\\ncontraceptive methods are surgical and are aimed to achieve sterility after the surgical\\nprocedure.\\nA couple in the reproductive age group, who desires contraception should be provided\\ninformation about all the available methods of contraception and should be counselled and\\nhelped so as to choose a method most suitable for that couple. Various contraceptive\\nmethods available are:\\nI. Temporary methods\\n1.Hormonal contraceptives\\n- Combined oral contraceptive pills.\\n- Injectable hormonal contraceptives (DMPA and NET-EN)\\n- Progesterone only pill [ketodesogestrel]\\n2. Non-hormonal contraceptive pills\\n- Centchroman.\\n3. Intrauterine contraceptive device\\n- CuT 200B.\\n- Multiload 250and Multiload 375.\\n- CuT 380A\\n- LNG IUCD [mirena]\\n4. Barrier methods'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 285, 'page_label': '286'}, page_content='Obstetrics andGy necology\\n278\\n- Male condoms.\\n- Vaginal diaphragms with spermicidal jelly.\\n- Contraceptive sponge.\\nII. Permanent methods\\n1. Female sterilization\\n- Postpartum sterilization.\\n- Interval ligation (laparoscopic or minilapligation).\\n- Ligation concurrent with MTP.\\n2. Male sterilization\\n- Vasectomy (traditional or non scalpel).\\nTEMPORARY CONTRACEPTIVE METHODS\\nI. Hormonal contraceptives\\n(i) Combined oral contraceptive pills\\nLow dose combined oral contraceptive pill containing 30 mcg ethinyl oestradiol and a\\nprogestin (0.3 mg Norgestrel or 0.15 mg Norgestrel or 0.15 mg Desogestrel) can be\\nprescribed. One tabletto be taken daily with meals ata consistent time. It should be started\\nduring first seven days of the menstrualcycle or at any other time when it is reasonably\\ncertain that she is not pregnant. If started after first 7 days of menstrual cycle, back up\\nmethod (abstinence or barrier method) should be used for 7 days. Pills should be taken for\\nthree weeks followed by1 week of pill-free interval during which placebo tablets are to be\\ntaken if pack contains 28 tablets.\\nIn women >40 years of agevery low dose pills containing ethinyl oestradiol 20 mcg and\\ndesogestrel 0.15 mg can be used. After age 50 years, if woman onoral pills, check FSH\\nduring5 -7 days of pill free interval. If FSH >30 IU/1 change to HRT regimens.\\nContraindications\\n\\uf0b7 Combined oral contraceptive pills are contraindicated in cases with current or history of,\\nthromboembolic disease, cerebrovascular disease, coronary artery disease, complicated\\nvalvular heart disease, acute liver disease., current or past breast cancer., undiagnosed\\nvaginal bleeding, pregnancy, heavy smokers over 35 years of age, migraine with\\nneurological symptoms, diabetes >20 years or with vascular disease, current gall bladder\\ndisease, uncontrolled hypertension (BP > 160/100).\\n\\uf0b7 Combined oral contraceptive pills should not be taken during first 6 months postpartum if\\nbreastfeeding and first 3 weeks postpartum in non-breastfeeding females.Pills can be\\nstarted immediately after spontaneous or induced abortion; can be used with caution in\\ncases with controlled hypertension, diabetes, migraine without neurological symptoms,\\nnon-smokers with age more than 35 years of age without any other medical illness.\\nFollow up\\nFirst follow up should be within 3 months and then annually. Follow up involves history,\\nblood pressure, urinalysis, breast examination, liver palpation and pelvic examination.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 286, 'page_label': '287'}, page_content='Obstetrics andGy necology\\n279\\nPatient education\\n\\uf0b7 Common side effects are nausea, vomiting, GI upset, breast changes, weight gain, acne,\\nbreakthrough bleeding, amenorrhoea, rash, vaginal candidiasis. Side effects decrease\\nusually after2 -3 months of use.\\n\\uf0b7 Report immediately in case of symptoms like chest pain, leg pain, severe headache,\\nsevere stomachache, swelling of one or both legs, visual impairment.\\n\\uf0b7 It is one of the most effective contraceptive methods with failure rate of about 0.1%.\\n\\uf0b7 It has non-contraceptive health benefits like regular periods with less pain and bleeding,\\nimproves premenstrual symptoms, and decreases functional ovarian cysts, pelvic\\ninflammatory disease, ovarian and endometrial cancer, endometriosis.\\n\\uf0b7 Forgotten pill-if one pill is forgotten, take as soon as remembered and next day take next\\npill and continue the schedule. Use back up method for 7 days.\\n\\uf0b7 If 2 pills are forgotten take 2 pills and next day again take 2 pills, and then continue as per\\nschedule. Use back up method for 7 days.\\n\\uf0b7 If 3 pills are forgotten, this cycle is not protected, use back up method till next cycle and\\nthen restart with new pack.\\n\\uf0b7 Should be discontinued at least 4 weeks prior to any planned major surgery.\\n\\uf0b7 Medicines like rifampicin, barbiturates, phenytoin, carbamazepine, primidone,\\ngriseofulvin interfere with the effects of oral pills. So use alternative method during their\\nintake.\\n(ii) Injectable hormonal contraceptives\\nHighly effective oestrogen free long acting contraceptive can be given when oestrogens are\\ncontraindicated like sickle cell disease, seizure disorders, age >35 years who smoke;\\nbreastfeeding females after first 6 weeks. In non-breastfeeding females, injections can be\\nsafely given immediately postpartum.\\nDepot medroxy progesterone acetate- 150 mg injection to be given deep IM every three\\nmonths. Next injection can be delayed by 2weeks Or Norethisterone enanthate- 200 mg\\ninjection to be given deep IM every 2 months. Next injection can be delayed by 1 week.\\nAbsolute contraindications\\n\\uf0b7 Pregnancy\\n\\uf0b7 Unexplained genital bleeding.\\n\\uf0b7 Severe coagulation disorder.\\n\\uf0b7 Previous sex steroid inducedliver adenoma, active liver disease.\\n\\uf0b7 Breast feeding during initial 6 weeks.\\n\\uf0b7 Current or history of thromboembolic disease, cerebrovascular disease, coronary artery\\ndisease.\\n\\uf0b7 Current or past breast cancer\\n\\uf0b7 Diabetes >20 years or with vascular disease\\n\\uf0b7 Uncontrolled hypertension (BP > 180/110).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 287, 'page_label': '288'}, page_content='Obstetrics andGy necology\\n280\\nPatient education\\n\\uf0b7 Common side effects are irregular bleeding, breast tenderness, weight gain, depression,\\nheadache, dizziness, abdominal pain.\\n\\uf0b7 Beneficial effects and efficacy is same as that of oral contraceptive pills.\\n\\uf0b7 Fertility return is slightly delayed after discontinuation of use.\\n\\uf0b7 Drug interactions are same as with oral hormonal pills.\\nII.Non -hormonal oral contraceptive pills (Centchroman)30 mg tablet started on first day\\nof periods. Take twice weekly for three monthsand then continue as once weekly.\\nContraindications\\nPolycystic ovarian disease, cervical intraepithelial neoplasia, severe allergy, recent history\\nof liver disease,and first 6 months of lactation\\nPatient education\\n\\uf0b7 It is a non-steroidal contraceptive pill, has no hormonal effects with failure rate is 1-2%.\\n\\uf0b7 Delayed periods can occur in 6% cases. If delay is >15 days, perform urine pregnancy\\ntest.\\n\\uf0b7 If one tablet is missed take as soon as possible and resume scheduled intake. Add back up\\nmethod till next period. If tablet missed for >7 days, start fresh regimen.\\nIII. Intrauterine contraceptive devices (IUCD)\\nAny of the following devices can be inserted inside uterus by trained health personnel. It\\nshould be inserted during or shortly after menstruation and after immediately after\\nspontaneous or induced abortion. After delivery it should be inserted during 4-8 weeks\\npostpartum. It can be inserted within 5 days of unprotected coitus. These devices need to\\nbe changed after the duration of their lifespan.\\nLifespanof intrauterine contraceptive devices (IUCD)\\nCuT 200B 3 yrs\\nMultiload 250 3 yrs\\nMultiload 375 5 yrs\\nCuT 380 A 10 yrs\\nFollow up-first follow up should be after next period to check for complications and to rule\\nout expulsion, after thatfollow up annually.\\nContraindications\\nPregnancy, postpartum <4 weeks, septic abortion, distorted uterine cavity, uterine fibroids,\\ncurrent or within past 3 months PID or STD, increased risk of STD, HIV positive, AIDS,\\npelvic tuberculosis, unexplained vaginal bleeding, trophoblastic disease, genital tract\\nmalignancy, complicated valvular heart disease.\\nPatient education\\n\\uf0b7 Common side effects are increased menstrual bleeding and dysmenorrhea. These decrease\\nafter initial 2-3 months.\\n\\uf0b7 No protection for STDs.\\n\\uf0b7 Failure rates are 0.5-3%. Ectopic pregnancy can still occur.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 288, 'page_label': '289'}, page_content='Obstetrics andGy necology\\n281\\n\\uf0b7 IUCD may get spontaneously expelled. Therefore monthly palpation of IUCD string is\\nimportant. If not palpable, report immediately.\\n4. Barrier methods\\nThese are cheap, available over the counter, coitus dependant methods. Male condoms,\\nvaginal diaphragm, spermicidal jellies, vaginal sponge can be used.\\nMale condoms\\nAny of the available condoms can be used. For each act of coitus a new condom is to be used.\\nIf during intercourse, condom breaks or if there is spillage or leakage, woman should contact\\na clinician within 72 hours and emergency contraception should be provided to her.\\nContraindication-severe allergy to latex rubber.\\nVaginal diaphragm\\nAvailable in different sizes. Proper size should be checked by a clinician by pelvic\\nexamination. Can be inserted 6 hours prior to intercourse. About a tablespoonful of\\nspermicidal cream or jelly should be placed in the dome of diaphragm prior to insertion;\\nshould be left in place for approximately 6 hours (but not >24 hours) after coitus. Additional\\nspermicide should be placed in vagina before each additional episode of sexual intercourse.\\nAfter removal wash with soap and water, rinse and dry.\\nFollow up.Annually to assess proper fitting of diaphragm.\\nContraceptive sponge\\nContains spermicidal agent Nonoxynol 9. It should be removed at least 6 hours after sexual\\nintercourse. Maximal wear time is 30 hours.\\nPatient education\\n\\uf0b7 Barrier methods provide protection against STDs and PID. Only condom has been proven\\nto prevent HIV infection.\\n\\uf0b7 Other advantages are prevention of diseases like pelvic inflammatory disease, carcinoma\\ncervix, chronic pelvic pain.\\n\\uf0b7 It can be used soon after delivery.\\n\\uf0b7 No hormonal side effects.\\n\\uf0b7 Side effects like vaginal dryness, itching, irritation,allergic reactions can occur.\\n\\uf0b7 Failure rates are very high. Typical failure rates are with condoms 14%, diaphragm with\\nspermicidal jelly 20%, highest with sponge 28%.\\nPERMANENT CONTRACEPTIVE METHODS\\nPermanent contraception is provided by sterilization operation in male or female partners.\\n\\uf0b7 Male client should be <60 years of age.\\n\\uf0b7 Female client should be >22 years and <45 years of age.\\n\\uf0b7 Client must make informed decision voluntarily and must give consent on the consent\\nform for sterilization.\\nI. Female sterilization\\nDone by laparoscopic ligation in interval ligation and first trimester abortions or tubectomy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 289, 'page_label': '290'}, page_content='Obstetrics andGy necology\\n282\\nTiming\\n\\uf0b7 Interval sterilization-within 7 days after menstrual period is over.\\n\\uf0b7 Postpartum sterilization- after delivery till 7 days but preferably within48 hours. Later\\non after 6 weeks postpartum.\\n\\uf0b7 MTP -concurrently\\n\\uf0b7 Spontaneous abortion- concurrently but under antibiotic cover and in the absence of\\ninfection and anaemia.\\nContraindications\\nThere are no absolute contraindications. Relative contraindications are psychiatric disorder,\\nacute febrile illness, jaundice, Hb< 8 g%, chronic systemic disease, malignancy, bleeding\\ndisorder, severe nutritional deficiency. Postpartum sterilization is contraindicated in\\npuerperial sepsis or fever, severe pre-eclampsia/eclampsia, premature rupture of membrane\\n>24 hours, severe APH or PPH, genital tract trauma.\\nPost abortal sterilization is contraindicated in sepsis, fever, haemorrhage, severe trauma,\\nuterine perforation, acute haematometra.\\nFollow-up\\nFirst follow up should be done seven days after the surgery for wound examination. Second\\nfollow up is recommended after one month or next menstrual period whichever is earlier.\\nSubsequent follow-ups if client develops any complication or has query.\\nII. Male sterilization\\nCon traindications\\nThere are no absolute contraindications. Relative contraindications include psychiatric and\\nphysical illness, local genital conditions, including large varicocele, hydrocele, inguinal\\nhernia, filariasis, cryptorchidism, previous scrotal surgery, intra scrotal mass.\\nFollow-up. First follow up after 7 days of surgery for wound examination and stitch removal.\\nSecond follow up after 3 months with semen analysis. Subsequent follow up required in cases\\nof any complication or queries.\\nPatient education\\n\\uf0b7 In non scalpal vasectomy stitches are not required.\\n\\uf0b7 It is a safe and simple procedure.\\n\\uf0b7 It is a permanent method to prevent future pregnancies.\\n\\uf0b7 It does not affect sexual pleasure, ability or performance.\\n\\uf0b7 It has a small chance of failure even if performed under optimum circumstances.\\n\\uf0b7 After vasectomy it is necessary to use a back up contraceptive method either for 20\\nejaculations or for a period of 3 months.\\n\\uf0b7 Sterilization does not provide protection against reproductive tract infections/ STDs or\\nHIV/AIDS.\\n\\uf0b7 Failure rates with female sterilization are < 0.5% and male sterilization < 0.1 %.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 290, 'page_label': '291'}, page_content='Obstetrics andGy necology\\n283\\nEmergency contraception\\nMethod used to prevent pregnancy after a likely fertile unprotected act of sexual intercourse;\\ncan be used in cases of condom rupture, rape or other circumstances of unprotected sex.\\nFirst dose should be taken within 72 hours following unprotected sex and second dose 12\\nhours after the first dose. Any of the following can be used:\\nLevonorgestrel 0.75 mg 1 tablet 12 hourly for 2 doses. Or combined oral contraceptive pills\\ncontaining 50 meg ethinyl oestradiol with 0.5 mg norgestrel 2 tablets 12 hourly for 2 doses.\\nOr  Low dose combined oral contraceptive pills containing 30 mcg ethinyl oestradiol with 0.3\\nmg norgestrel 4 tablets 12 hourly for 2 doses.\\nPatient education\\nâ€¢ Side effects are nausea, vomiting, dizziness, fatigue, headache, lower abdominal pain,\\nbreast tenderness, vaginal bleeding.\\n\\uf0b7 It must be used under medical supervision.\\n\\uf0b7 It decreases risk of pregnancy by 70-90%. Earlier it is taken, success is more.\\n\\uf0b7 If vomiting occurs within 2 hours of the dose, it must be repeated.\\n\\uf0b7 There are no contraindications for emergency contraception.\\n\\uf0b7 After this use a barrier method for each act of intercourse until next menstrual period.\\n\\uf0b7 If period delayed >5 days, rule out pregnancy.\\n\\uf0b7 Use regular contraceptive method.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 291, 'page_label': '292'}, page_content='284\\nChapter 14\\nPSYCHIATRY DISORDERS\\nIntroductionand General Guidelines\\nThe incidence and prevalence ofpsychiatric disorders is on a rise in the 21st century. The\\nawareness, regarding the nature of mental illnesses and the need for treatment,and their\\nacceptanceis also improving. Although psychopharmacology forms the backbone of\\ntreatment in most psychiatric disorders, certain points need to be especially emphasized while\\nmanaging psychiatric patients:\\n1) The formation of a trusting,confidential, non-judgemental andempathetic doctor-patient\\nrelationship is crucial to the practice of psychiatry.\\n2) Knowing the person as a whole rather than only his symptoms endorses patient\\nimprovement.\\n3) The psychotic patient often loses his judgementand realityperception. Such patients\\noften have to be treated against their will.\\n4) Family has an important role in the causationand management of psychiatric disorders.\\n5) All patients do well with holistic treatment which includes psychopharmacology, other\\nbiological treatments,psychotherapyand rehabilitation.\\n6) Psychiatric treatment often continues for a long period, so compliance is a major issue.\\nSCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS\\nSchizophrenia is a chronic debilitating psychiatric disorder of varied and profoundly\\ndisruptive psychopathology affecting cognition, perception, emotion and other aspects of\\nbehavior. Its usual age of presentation is around 25 yrs and affects all social classes equally.\\nSalient features\\n\\uf0b7 The common symptoms of schizophrenia are false, fixed, firm beliefs (delusion),\\nperceptual abnormalities e.g. hearing of voices while alone (hallucinations).\\n\\uf0b7 A bnormalities in speechand behavioras irrelevant speech,talking to self,crying or\\nlaughing for no reason are also prominent.\\n\\uf0b7 schizophrenia has been divided into following subtypes for the ease of practice.\\n- Paranoid schizophrenia- Delusions and hallucinations form predominant features\\nalong with other symptoms.\\n- Catatonic schizophrenia-Characterized by marked psychomotor retardation or\\nagitation.\\n- Hebephrenic schizophrenia-Characterized by marked abnormalities of behavior.\\n- Residual schizophreniaSimple schizophrenia\\nNon -pharmacologicaltreatment\\n\\uf0b7 Cognitive behaviorally oriented psychotherapy-understanding of illness,identification of\\ntarget symptoms, and development of strategies to cope up with these symptoms.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 292, 'page_label': '293'}, page_content='Psychiatry Disorders\\n285\\n\\uf0b7 Rehabilitation of the patients in the form of supported employment, individualized job\\ndevelopment, ongoing job support, integration of vocational and mental health services.\\n\\uf0b7 Social skills training, behaviorbased instructions, corrective feedback, and contingent\\nsocial reinforcement.\\nPharmacologicaltreatment\\n\\uf0b7 Hospitalization is indicated insuicidal patients,non compliant patients,treatment\\nresistant casesand diagnostically difficult cases(Figure 1).\\n\\uf0b7 Antipsychotics(typical and atypical)are the main treatment for such patients(Table 1).\\n\\uf0b7 Co -administration of Tab. trihexyphenidyl (2â€“ 12 mg/day) is recommended with typical\\nantipsychotics.\\n\\uf0b7 Benzodiazepines (Inj. lorazepam 2-4 mg, orally,IM or IV preparation) may be co-\\nadministered in uncooperative patients initially.\\n\\uf0b7 ECT (electro convulsive therapy)- electric shock of 100-120 volts may be given in\\npatients with associated suicidal intention and treatment resistant cases. It is given for 1-3\\nseconds under general anesthesia so that it produces short lasting generalized tonic clonic\\nconvulsions.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 293, 'page_label': '294'}, page_content='Psychiatry Disorders\\n286\\nTable 1. Dosage scheduleand adverse effectsof commonly used antipsychotics\\nDrugs Effective dose Dosage schedule Adverse effect\\nTypical antipsychotics\\nHaloperidol 5 â€“ 20 mg/day,\\navailable as tablets,\\nsyrup, injection and\\ndepot preparation\\n(50 mg/ampoule)\\nStart with 5 mg twice a\\nday or 10 mg HS and\\nincrease the dose by\\n5mg if no response.\\nDepot injection to be\\ngiven once two to three\\nweeks.\\nMore extra-pyramidal side\\neffects viz slowness of\\nmovements, blunted facial\\nexpressions, tremors,\\nrigidity, excessive\\nsalivation, etc.\\nNon specific-sedation,\\nreduction in seizure\\nthreshold, orthostatic\\nhypotension,\\nanticholinergic side effects\\nCVS -cardiac toxicity,\\nsudden death,\\nHematological-leucopenia\\nEndocrinal-\\nhyperprolactinemia\\nSexual-anorgasmia and\\ndecreased libido,\\nGIT -nausea, vomiting,\\nhepatotoxicity\\nTrifluoperazineAvailable as 5mg\\nTab.\\nStart with 5mg/ day and\\ncan be gradua lly\\ntitrated upto a\\nmaximum of 40\\nmg/day\\nFluphenazine\\ndecanoate\\nDepot injection\\n5 mg/2ml\\nOnce in 15-20 days\\nZuclopenthixol\\nDepot injection\\n200mg/ml\\nOne ampoule IM once\\nin 2-3 weeks.\\nAtypical antipsychotics\\nRisperidone 2-10 mg/day,\\navailable as tablets,\\nsyrup and depot\\npreparation (25\\nmg/ampoule)\\nStart with 2mg once a\\nday or twice a day and\\ntitrate it to 8mg/day\\ngradually. Deport\\ninjection to be given\\ndeep IM once every 15\\ndays\\nLess extra-pyramidal side\\neffects\\nNon specific-dizziness,\\nhyperkinesias, somnolence,\\nanti-cholinergic side effects\\nlike dry mouth,\\nconstipation, delirium\\nGIT -nausea, vomiting.\\nEndocrinal-\\nhyperprolactinemia,\\nhyperglycemia.\\nHematological-leucopenia\\nSexual-erectile\\ndysfunction,\\norgasmic dysfunction\\nGeneral-weight gain\\nOlanzapine 5 â€“ 30 mg/day,\\navailable as tablets\\nStart with 5 mg once a\\nday or HS and titrate\\ngradually by 5 mg/day\\nif no improvement.\\nQuetiapine Available as 50,\\n100, 200 mg\\ntablets\\nStart with 50mg twice a\\nday and build upto 300-\\n800 mg/ per day\\nC lozapine 25 â€“ 300 mg/ per\\nday,  available as\\ntablets\\nGet complete blood\\ncounts done before\\nstarting clozapine.\\nStart with 25 mg HS or\\n50mg HS gradually\\ntitrate to 500mg.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 294, 'page_label': '295'}, page_content='Psychiatry Disorders\\n287\\nFigure 1.Treatme nt guidelines for schizophrenia\\nPatienteducation\\n\\uf0b7 B oth, the patient andthe primary caregiver should be explained that although\\nschizophrenia is a chronic illnessand requires longterm treatment, it can be effectively\\ntreated in most cases.\\n\\uf0b7 Mild to moderate side effects may develop to medications, but usually tolerance develops\\nto them.\\n\\uf0b7 Medicines should not be stopped abruptly.\\n\\uf0b7 Family should be encouraged to take up the responsibility for regular treatmentand\\nfollow-up. Family interventionsinclude illness education, crisisintervention, emotional\\nsupportand training for coping skills.\\nOTHER PSYCHOTIC DISORDERS\\nSchizophreniform disorder\\n\\uf0b7 Clinical features similar to schizophrenia\\n\\uf0b7 Differs from schizophrenia in that duration of symptoms is lesser than 6 months\\n\\uf0b7 Pharmacological treatment is similar as schizophrenia\\nBrief psychotic disorder\\n\\uf0b7 Clinical features similar to schizophrenia\\n\\uf0b7 Differs from schizophrenia in that duration of symptoms is less than 1 month\\n\\uf0b7 Pharmacological treatment is similar to schizophrenia'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 295, 'page_label': '296'}, page_content='Psychiatry Disorders\\n288\\n\\uf0b7 Com mon symptoms of depression are(for a minimum period of two weeks):\\n- Persistent sadness of mood anddecreased interest in previously pleasurable activities\\n- Mo re than 5 % weight loss or gain\\n- Sleep disturbanceâ€“ insomnia or hypersomnia\\n- Marked slowing of activity or agitation andeasy fatigability\\n- Lack of concentration\\n- Feelings ofworthlessness, helplessness, hopelessness, guilt andsuicidal thoughts /\\nattempts\\n- Anxiety symptoms often coexist\\nDelusional disorder\\n\\uf0b7 Clinical features-characterized by single or multiple non bizarre (false fixed but feasible\\nbeliefs)delusions of 1 month duration\\n\\uf0b7 Differs from schizophrenia in that duration of delusions is 1 month and functioning and\\nbehavior in other areas of life than delusional one is intact\\n\\uf0b7 Insight oriented psychotherapy forms mainstay of treatment whereas Pharmacological\\ntreatment is similar to schizophrenia\\nSchizoaffective disorder\\n\\uf0b7 Symptoms of schizophrenia are present continuously and features of bipolar affective\\ndisorder overlap\\n\\uf0b7 Differsfrom schizophrenia by prominence of affective features\\n\\uf0b7 Pharmacological treatment is with antipsychotics and mood stabilizers as in schizophrenia\\nand bipolar disorder respectively\\nMAJOR DEPRESSIVE DISORDER\\nMajor depressive disorder (MDD), more commonly known as depression, is one of the most\\ncommon psychiatric disorders with lifetime prevalenceof about 10-20 %. Incidence in\\nfemales are almost twice that in males.\\nSalient features\\nInvestigations\\n\\uf0b7 Diagnosisis based on history and mental state examination (MSE). Test for thyroid\\nfunction can be done to rule out the co morbidity.\\n\\uf0b7 Investigations for associated neurological co-morbidities can be done particularly in\\nelderly patients presenting with depression\\nNon pharmacological treatment\\n\\uf0b7 Psychological factors are very important in the causing, maintaining as well as\\nimproving depression. For holistic management of depression, some form of\\npsychotherapy should be co-administered.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 296, 'page_label': '297'}, page_content='Psychiatry Disorders\\n289\\n\\uf0b7 Psychodynamic approach aims at promoting personality change through understanding of\\nmajor conflicts, achieving insight into defenses, ego distortions, providing role model\\npermitting cathartic relief or aggression.\\n\\uf0b7 Cognitive behavioral approach aims at providing symptomatic relief through alteration of\\ntarget thoughts, identifyingcognitive distortions, modifying erroneous assumptions,\\npromoting self control over thinking patterns.\\n\\uf0b7 Interpersonal approach aims at providing symptoms relief through solving current\\ninterpersonal problems, reducing stress involving family and work, improving\\ninterpersonal communication skills.\\nSupportive approach with techniquessuch as catharsis, realistic problem solving is also\\nuseful.\\nPharmacologicaltreatment\\n\\uf0b7 Hospitalization is needed inseverely suicidal patients,treatmentresistant casesand non\\ncompliant patients.\\n\\uf0b7 SSRIs (selective serotonin reuptake inhibitors) are currently the drug of choice for\\ndepression.\\n- Tab. fluoxetine- start with 20 mg/day increaseto 40 mg/day, if no response in 4-6\\nweeks\\n- Tab. escitalopram- start with 10mg/day depending on tolerability and gradually\\nincrease upto30 mg/day\\n- Tab. sertraline- start with 25 mg/day or 50 mg/day depending on the severity of\\nsymptoms in 1 HS dosage preferably and gradually increase to maximum of\\n300mg/day\\n\\uf0b7 Tab. mirtazepine- start with 7.5 mg/day and gradually increase upto maximum 30\\nmg/day.\\n\\uf0b7 Tricyclic antidepressants like Tab. imipramine for depression with somatic complaints.\\nStart with 25mg twice a day and gradually increase by 25 mg/day to maximum of 300\\nmg/day if no response(should be avoided in patients with heart disease,glaucoma,\\nbenign prostatic enlargement and epilepsy).\\n\\uf0b7 Antidepressant action takesabout 2-3 weeksand needs to be continuedfor 6-9 months in\\nfirst episode and forlonger period in recurrent depression.\\n\\uf0b7 Initiallybenzodiazepines may need to be co-administered to manage insomniaand\\nanxiety.\\n\\uf0b7 In cases ofbipolar depression, there might be a sudden switch to mania in which case\\nanti-depressant should be withdrawn.\\n\\uf0b7 ECT (Electroconvulsive therapy)is a very safe, effective and economical mode of\\ntreatment and is indicated in severe depression with or without suicidal ideas, retarded\\ndepression and resistant depression.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 297, 'page_label': '298'}, page_content='Psychiatry Disorders\\n290\\n\\uf0b7 In manic episode, an elevated, expansive or irritable mood is the hallmark. The\\nelevated mood is euphoric and characterized by euphoria, impaired judgement, denial\\nof illness,overtlyreligious, over familiar behavior,increasedtalkativeness, increased\\nself esteem, increased psychomotor activities and goal directed activities, increased\\nsexual driveand engaging into high risk behavior.\\n\\uf0b7 Patients with depressed mood experience loss of energy and interest, feelings of guilt,\\ndifficulty in concentrating, loss of appetite and thoughts of death or suicide.\\n\\uf0b7 Other signs  and symptoms of mood disorders include change in activity level,\\ncognitive abilities, speech and vegetative functions (e.g. sleep, appetite, sexual activity\\nand other biological rhythms).\\n\\uf0b7 These disorders virtually always result in impaired interpersonal, social and\\noccupational aspects of life.\\nPatient education\\n\\uf0b7 Explain the nature of illness, consequences of untreated depression, suicidal risk, need for\\nadequate does for adequate durationand other supportive measures.\\n\\uf0b7 The therapeutic response takes time to appear but side effects may appear earlier.\\nCommon side effects of tricyclic antidepressants are dry mouth, constipation, postural\\nhypotension (giddiness), blurred vision, sweating, palpitation, tremors,delayed\\nmicturition, sedation, etc.\\n\\uf0b7 Common side effects of fluoxetine are agitation, headache, nausea or heartburn, tremors,\\nchanges in sexual performance, blurred vision, dry mouth andlossof appetite.\\nBIPOLAR MOOD DISORDER\\nBipolar mood disorders are characterized by episodes of mania anddepression or mania\\nalone with intervening periods of normalcy.\\nSalientfeatures\\nNon pharmacologicaltreatment\\n\\uf0b7 Psychoeducation, family therapy and rehabilitation for manic phases\\n\\uf0b7 Psychotherapeutic measures same as in unipolar depression for depressive phases.\\nPharmacologicaltreatment(Figure 2, Table 2)\\n\\uf0b7 Antipsychotics like risperidone and olanzapine are used as an adjuvant in treatment.\\n\\uf0b7 Episode of depressionis to be treated as in major depressive disorder butTab.lamotrigine\\n25-100 mg is the treatment of choice.\\n\\uf0b7 Prophylactic treatment:to be given to prevent recurrent episodes:Tab. lithium carbonate\\n900-1500 mg /day in divided doses orTab. sodium valproate 600- 2000 mg /day in\\ndivided doses orTab. carbamazepine 600-1200 mg / day in divided doses'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 298, 'page_label': '299'}, page_content='Psychiatry Disorders\\n291\\nFigure2. Management of current manic episode\\nTable 2. Dosage schedule of anti-manic drugs\\nDrug treatment of mania :  recommended doses Dosage schedule\\nLithium\\n400 mg / per day. Adjusted after 3â€“\\n4  days according to plasma\\nlevels\\nStart with 600 to 900 mg/day\\nafter getting baseline\\ninvestigations done\\nSodium valproate As sodium valproate slow release:\\nDose is 20â€“ 30 mg/ kg/ day\\nStart with 200mg thrice aday\\nand gradually increase upto\\nthe per kg maximum dose if\\nno or less response\\nOxcarbazepine 300mg, build upto 1500 mg Has lesser side effect than\\ncarbamazepine\\nPatient education\\n\\uf0b7 Emphasize about recurrent course of illness and not to get too much worried regarding\\nrecurrences.\\n\\uf0b7 Relapses can be treated as successfully as the first episode.\\n\\uf0b7 When on lithium, advice to take plenty of fluids especially during summer; not to restrict\\nsalt.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 299, 'page_label': '300'}, page_content='Psychiatry Disorders\\n292\\n\\uf0b7 Difficulty in initiating sleep, frequent awakenings from sleep, early morning insomnia or\\nnon-restorative sleep.\\n\\uf0b7 In the elderly, the physiological reduction in number of hours of sleep does not amount to\\ninsomnia. If the patient is distressed by decreased sleep, treatment may be given to increase\\nthe duration of sleep.\\n\\uf0b7 Stressful situation leading to insomnia or the symptoms of the causative illness can be\\nelicited on careful enquiry.\\n\\uf0b7 Duration of symptoms may vary from few days to many months or years depending on the\\ncause.\\n\\uf0b7 If fever, vomiting or diarrhea develops while on lithium, reduce the dose of lithium to\\nhalf and contact the physician or the psychiatrist.\\nINSOMNIA\\nInsomnia is one of the commonest complaints in psychiatric, medical and general clinical\\npractice. Common causes include recent stress, psychiatric illnesses like depression and\\nanxiety disorders, pain or substance abuse.\\nSalient features\\nNon pharmacological treatment\\nSleep hygiene\\n\\uf0b7 Keep a regular time for going to bed and arising up; avoid day time naps.\\n\\uf0b7 Limit daily in-bed time to the usual amount present before the sleep disturbance\\n\\uf0b7 Avoid large meals near bedtime; eat at regular times daily. No stimulant medication or\\nfood beverages (caffeine, nicotine, alcohol, etc.) especially in the evenings.\\n\\uf0b7 Mild to moderate physical exercise in the morning.\\n\\uf0b7 Avoid evening stimulation: substitute radio or relaxed reading for television.\\n\\uf0b7 Practice meditation or progressive muscular relaxation.\\n\\uf0b7 Maintain comfortable sleeping conditions.\\nTreat the underlying cause. In both primary insomnia (where no cause is identifiable) and\\ninsomnia due to othercauses, management includes introducing good sleep hygiene and\\nmedications for short period, if required.\\nPharmacologicaltreatment\\nIf still sleep is inadequate,\\n\\uf0b7 Tab. nitrazepam 5-10 mg orTab.clonazepam 1-2mg or Tab. zopiclone 7.5-15mg or Tab.\\nzolpidem5-10 mg can be given for 2-6 weeks, Â½ to 1 hr before bedtime.\\n\\uf0b7 Patients must be cautioned regarding risk of dependence in diazepam and nitrazepam.\\nPatienteducation\\nFollow sleep hygiene instructions, look for tapering off benzodiazepines in 4-6 weeks'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 300, 'page_label': '301'}, page_content='Psychiatry Disorders\\n293\\n\\uf0b7 Generalized anxiety or excessive worries along with associated symptoms as shakiness,\\nrestlessness, headaches\\n\\uf0b7 Breathlessness, excessive sweating, palpitations and nausea, GI disturbance, sleep\\ndisturbance, irritability, hypervigilance.\\n\\uf0b7 Diagnosis is based on history and mental status examination\\n\\uf0b7 Investigations for co-morbidities like hyperthyroidism, hypothyroidism, hypo\\nparathyroidism, pheochromocytoma and nutritional deficiencies should be done to rule\\nout organic causes of anxiety.\\nG ENERALIZED ANXIETY DISORDER\\nGeneralized and persistent anxiety that is not restricted to any particular situation or\\nenvironment is an essential feature of this condition.One year prevalence of GAD is 3 to 8%\\nand it is twiceascommon in women as men.\\nSalient features\\nNon pharmacological treatment\\n3 main psycho-therapeutic approaches are used.\\n\\uf0b7 Cognitive behavior therapy aims at finding out the cognitive distortions and altering\\nfaulty coping strategies. Major techniques used are relaxation and biofeedback.\\n\\uf0b7 Supportive therapy aims at offering reassurance and comfort to the patients.\\n\\uf0b7 Insight orientated psychotherapyfocuses on uncovering unconscious conflicts and\\nidentifying ego strengths.\\nPharmacologicaltreatment\\n\\uf0b7 Benzodiazepines are the drug of choicelike diazepam (start from 5mg HS or 10 mg HS),\\nor Tab. clonazepam (start from 0.5mg HS or TDS depending on the severity of\\nsymptoms), orTab.lorazepam (start from 2mg HS increase upto 8mg maximum) .\\n\\uf0b7 SSRIs like sertraline,escitalopram or paroxetine (start with Tab.paroxetine 10 mg or 20\\nmg per day upto maximum 50 mg/day)is effective in GAD.\\n\\uf0b7 Beta blockers(Tab. propranolol 20 mg BD or sustained release preparation upto 80\\nmg/day in divided doses is used) is used for symptomaticrelief.\\nPatient education\\n\\uf0b7 It is a chronic disease though easily treatable, but treatment needs to be taken regularly\\nfor a long time.\\n\\uf0b7 Do not stop treatment without consulting your doctor.\\n\\uf0b7 The drugs are quite safe and do not cause anyseriousside effects even if taken for a long\\ntime.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 301, 'page_label': '302'}, page_content='Psychiatry Disorders\\n294\\n\\uf0b7 Recurrent panic attacks formed an essential feature of panic disorder.Panic attack is\\ncharacterized by intense fear or discomfort reaching a peak within 10 minutes.\\nAssociated with palpitations, sweating, shaking, breathlessness, chest pain, nausea,\\nfainting, feeling of choking, fear of dying or going crazy.\\n\\uf0b7 Persistence concern about having more attacks.\\n\\uf0b7 Change in behavior related to attacks\\n\\uf0b7 Worries about consequences of the attacks\\nPANIC DISORDER\\nAn acute intense attack of anxiety accompanied by feelings of impending doom is known as\\npanic disorder.Life time prevalence of panic disorder is 1 to 4%.Women are 2-3 times more\\noflikely to be affected than men.\\nSalient features\\nNon -pharmacologicaltreatment\\nMain approaches used are cognitive and behavioral therapies which aimat providing psycho\\neducation and correcting cognitive distortions. It also includes educating the patient about\\nrelaxation techniquesand respiratorytraining.\\n\\uf0b7 Family therapy  includes providing psycho education and support\\n\\uf0b7 Insight orientated psychotherapy is focused on helping patients to understandunconscious\\nmeaning of anxiety and resolution of conflicts.\\nPharmacological treatment\\n\\uf0b7 SSRIs particularly paroxetine are effective in treating panic disorders. Other SSRIs like\\nescitalopram, citalopram,fluvoxamine and sertraline are also useful.\\n\\uf0b7 Alprazolam is the most widely used benzodiazepine (start with 0.25mg/day 1 HS upto\\nmaximum of 6 mg/day). Theyare used for providing rapid symptomatic relief.\\n\\uf0b7 Inj. lorazepam 2mg/ml and diazepam 5ml/ml can be used in patients presenting with\\nacute anxiety.\\n\\uf0b7 Tri cyclic anti depressants like amitriptyline are also useful\\nPatient education\\n\\uf0b7 General reassurance about benign nature of symptoms and possibility of spontaneous\\nrecovery of individual\\n\\uf0b7 Continuing with breathing exercises.\\nOBSESSIVE COMPULSIVE DISORDER (OCD)\\nIt is characterized by recurrent irrational intrusive thoughts, images or impulses that are ego\\ndystonic i.e.distressing in nature.Life time prevalence in general population is 2-3%. Men\\nand women are equally affected by this disorder.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 302, 'page_label': '303'}, page_content='Psychiatry Disorders\\n295\\n\\uf0b7 Repetitive intrusive thoughts, images or impulses (obsessions) that creates anxiety and\\nmental and physical actsaredone to relieve the anxiety (compulsions) are the presenting\\nfeatures of this disorder.\\n\\uf0b7 Com monly observed obsessions are\\n- Repetitive thoughts and fear of dirt and contamination or germs\\n- Fearthatsomething terrible will happen\\n- Forbidden or sexual thoughts and images or impulses.\\n\\uf0b7 Commonly observed compulsions areexcessive hand washing, bathing, checking, ordering\\nand arranging.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Behavioral therapy is considered as treatment of choice for OCD. Principle approaches\\nused are exposure and response prevention.Other techniques used aredesensitization,\\nthought stopping, flooding, implosion therapy and aversive conditioning.\\n\\uf0b7 Psychotherapy in form ofC ognitiveB ehaviorTherapy (CBT), psychoanalytical and\\npsychodynamic therapies are also c+onsidered useful in the treatment.\\n\\uf0b7 Resistant cases can also be treated by ECTs or surgeries.\\nPharmacological treatment\\n\\uf0b7 SSRIs like fluoxetine, fluoxamine, paroxetine(start with 10 mg gradually increase to\\n50mg/day), sertraline are agents of choice in treating OCD.\\n\\uf0b7 Tab. clomipramine is start with 75mgsustained release preparation once dailyand\\ndepending on severity of symptoms gradually increase upto 300mg. It is the only\\neffective tricyclic anti-depressant used in treating OCD.\\n\\uf0b7 Augmenting agents like sodium valproate, lithium or carbamazepine are added to enhance\\nthe response to treatment.\\n\\uf0b7 Benzodiazepinesmay be used as adjuvant treatment.\\nPatienteducation\\n\\uf0b7 Reassure the patient that although disease is distressingand disabling,itis treatable.\\n\\uf0b7 The drug takes about 2 weeks for its therapeutic response to manifest.\\n\\uf0b7 Side effects may appear before the onset of therapeutic response. Common side effects of\\nclomipramine are dry mouth, constipation, postural hypotension(giddiness), blurred\\nvision, and sedation. Side effects of fluoxetine include gastrointestinal distress, nausea,\\nheadache, nervousness, anorexia, restlessness and sexual side effects. Patient usually\\nadapts to these side effects with time.\\n\\uf0b7 Advice the patient that treatment may continue for a long time. He/she should not leave\\ndrugs without medical advice.\\n\\uf0b7 In case of any untoward effects of drugs, he/she must immediately get in touch with his\\nclinician.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 303, 'page_label': '304'}, page_content='Psychiatry Disorders\\n296\\n\\uf0b7 Phobia is defined as excessive, irrational fear of specific object, circumstance or\\nsituation.Social phobias are characterized by marked and persistent fear of social or\\nperformance situations exposing a person to unfamiliar people or scrutiny by others.\\nWomen are more likely to be affected by phobia than men.\\n\\uf0b7 Examples of specific phobias are agoraphobia (fear of open spaces), claustrophobia\\n(fear of closed spaces), acrophobia (fear of heights),etc.\\n\\uf0b7 Exposure to phobic stimulus provokes immediate anxiety sometimes leading to panic\\nattack. The patient is aware of the irrational nature of fears and avoids the anxiety\\nprovoking stimulus.\\n\\uf0b7 Causes marked distress in interpersonal, occupational and social areas of life.\\n\\uf0b7 Patient must continue all his regular activities as faras possible.\\n\\uf0b7 Yoga, meditation, physical exercises are useful measures along with drug therapy.\\nPHOBIC DISORDERS\\nSalient features\\nN on-pharmacological treatment\\n\\uf0b7 Systematic desensitizationis the most commonly used behavioral technique which\\nexposes patient to fearful stimulus in a serially graded manner.Imagined or actual\\nexposure to the phobic stimulus is given as long as the patient can tolerate.\\n\\uf0b7 Insight orientated psycho therapyaims atenabling patients to understand the origin of\\nphobia, secondarygains and role of resistance and helps them to seek healthy ways of\\ncoping with phobic stimuli.\\n\\uf0b7 Hypnosis, supportive therapy andfamily therapyareuseful in treatment of phobias.\\nPharmacological treatment\\nFollowing agents are used most commonly in treating phobias.\\n\\uf0b7 SSRIs (e.g.Tab.paroxetine 12.5-50 mg / day in divided doses)\\n\\uf0b7 Benzodiazepinesas mentioned above\\nPatient education\\nWith regular treatment, most patients show improvement but treatment needs to be continued\\nfor a long time, particularly in childhood onset phobias.\\nPOST -T RAUMATIC STRESS DISORDER (PTSD)\\nExposure to a traumatic event consisting of either a direct personal experience or witnessing\\nan event involving threat of death, serious injury or serious harm can lead topost traumatic\\nstressdisorder (PTSD )in 1.3 to 8% of victims.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 304, 'page_label': '305'}, page_content='Psychiatry Disorders\\n297\\nCommon exampl es of such traumatic events arephysical or sexual abuse, domestic/community\\nviolence, kidnapping, terrorist attacks, accidents or disasterslike floods, hurricanes, etc.It is\\ncharacterized by a set of symptoms (for more than 1 month) such as:\\n\\uf0b7 Re-experiencingâ€“ distressing recollections, flashbacks, imageries of the traumatic event\\n\\uf0b7 Persistent avoidanceâ€“ conscious effort to avoid places, situations, or events that will remind\\nthe person of the traumatic event\\n\\uf0b7 Hyperarousalâ€“ vivid dreams, night terrors, startling responses to even minor stimuli leading\\nto palpitations, sweating, tremors and other anxiety features\\n\\uf0b7 Sense of detachment from usual social groups and situations, i.e. (emotional numbing is\\nseen)\\n\\uf0b7 Sleep disturbance, checking for safety and exaggerated startled reactions are also present.\\nIf these symptoms are present for less than 4 weeks it is calledAcute Stress Disorder.\\nSalientfeatures\\nNon -pharmacologicaltreatment\\nFocused Cognitive Behavior Therapy is aimed at givingpsycho education to the patient\\nregarding the nature of typical emotional and physiological reactions to traumatic events and\\nPTSD. It also includes teaching techniques of muscle relaxation, focused breathing, affective\\nmodulation, thought stopping and cognitive coping techniques to deal with the stress.\\n\\uf0b7 Gradual exposure: The reminders of traumatic events are gradually introduced.\\n\\uf0b7 Crisis Intervention/Psychological Debriefing: It consists of encouraging the patient to\\ndescribe the traumatic event in a supportive environment.\\nIf the symptoms persist for more than a year, they do not improve after many years in one\\nthird of patients; so early intervention and treatment is useful.\\nPharmacologicaltreatment\\n\\uf0b7 SSRIs are the agents of choice for treating PTSD, the doses are same as in depression.\\nPropranolol has been used to treat PTSD symptomatically.\\nCONVERSION DISORDER\\nIt isa type of somatoform disordercharacterized by symptoms or deficits affecting voluntary\\nmotor or sensory functions that is judged to be caused by psychological factors.Illness is\\npreceded by conflicts or stressful situations.It is twice more common in women than men\\nand is more commonly seen in lower socio economic strata of the society.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 305, 'page_label': '306'}, page_content='Psychiatry Disorders\\n298\\n\\uf0b7 Paralysis, blindness and mutism are most common symptoms.\\n\\uf0b7 Parasthesias (altered sensations) and anaesthesias (loss of sensations) especially ofthe\\nextremities are also seen.\\n\\uf0b7 Abnormal movements, gate disturbance, weakness and paralysis are possible motor\\nsymptoms.\\n\\uf0b7 Diagnosisis based on history and mental status examination.However conversion\\nepisodes should be differentiated from seizures.Seizures are characterized by\\nrepetitive, involuntary jerky movements or episodes of unresponsiveness associated\\nwith tongue bite,frothing, injuries, fecal or urinary incontinence and amnesia (memory\\nloss) during episodes.Seizures can also occur during sleep and when patient is alone.\\nA bsence of the above features issuggestive of conversion disorder.EEG and other\\ninvestigations can be used to rule out organic cause.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Spontaneous resolution of symptoms occurs but insight orientated, supportive or\\nbehavioral therapies can facilitate the same.\\n\\uf0b7 Hypnosis, psychodynamic and psychoanalytical approaches can also be useful.\\n\\uf0b7 Benzodiazepines are used as an adjuvant therapy.\\n\\uf0b7 SSRIs can be used if co morbid depression is present.\\nDISSOCIATIVE DISORDERS\\nD issociative disorders are characterized by disruption of integrated functions of\\nconsciousness like memory,identityand perception of environmentwhich can be dissociative\\namnesia,dissociative fugue ordissociative identity disorder\\nDissociative amnesia\\n\\uf0b7 Characterized by disturbances in the ability to recall important personal information,\\nusually traumatic in nature.\\n\\uf0b7 The memory loss is too extensive to be explained by simple forgetfulness.The\\ndisturbances cause socio occupational impairment.\\nDissociative fugue\\n\\uf0b7 The disturbance is characterized by sudden, unexpected travel away from home or\\ncustomary places of work etc with inability to recall the past events along with partial or\\ncomplete assumption of new identity.It causes significant socio occupational impairment.\\nDissociative identity disorder\\n\\uf0b7 Presence of two or more personality or identities each with its own patternof reacting to\\nthe environment.\\n\\uf0b7 These personalities take control of personâ€™s behavior and often are accompanied by\\ninability to recallpersonal information.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 306, 'page_label': '307'}, page_content='Psychiatry Disorders\\n299\\n\\uf0b7 Dependence is characterized by compulsion to drink, tolerance, intoxication,\\nwithdrawaland persistence of drinking inspite of overtly harmful consequences.\\n\\uf0b7 Alcohol intoxication is characterized by recent intake of alcohol andbehavioral changes\\nlike slurred speech, unsteady gait, incoordination, nystagmus, impairment in attention\\nand memory, etc. In extreme cases it can lead to stupor and coma.\\n\\uf0b7 Simple alcohol withdrawal is characterized by abrupt cessation of heavy intake of\\nalcohol and development of symptoms like sweating, palpitations, tremors,nausea,\\nvomiting,insomnia,transient visual/tactile/auditory hallucinationsand psychomotor\\nagitation.\\n\\uf0b7 Withdrawal may be complicated in the form ofseizures,delirium tremens, etc.\\nTreatment\\n\\uf0b7 Psychotherapeutic interventions like psychoanalytic psychotherapy,cognitive\\npsychotherapy,behavioral therapy andhypnotherapy are the mainstay of treatment.\\n\\uf0b7 Pharmacological treatment-antidepressants and antipsychotics have been used with\\nlimited benefits.\\nALCOHOL USE DISORDER\\nAlcohol use disorder is acommon lethal condition that often masquerades as other\\npsychiatric syndromes.At any time, one of three men are drinkers, with a ratio of persisting\\nalcohol intake of approximately 1.3 men to 1.0 women.\\nSalientfeatures\\nNon -pharmacologicaltreatment\\n\\uf0b7 Motivation enhancing, individual, group and family therapy\\nPharmacologicaltreatment\\n\\uf0b7 Hospitalization is advised to most patients for smooth detoxification and to avoid or\\nmana ge withdrawal complications including seizures and delirium tremens as well as\\nmedical co-morbidities.\\n\\uf0b7 Tab. chlordiazepoxide start from 25mg TDS and may be increased upto 100 mg/day, used\\nonly if liver function tests are normalor\\n\\uf0b7 Tab. lorazepam startingfrom 2mg TDS increased upto 8 mg is used,preferred when liver\\nfunctions are compromised or not known.\\n\\uf0b7 Tab. thiamine supplementation to prevent and treat vitamin deficiency (start from 75mg\\nBD and can be increased upto 300mg/day)\\n\\uf0b7 Injectable vitamins canbe used when signs of severe vitamin deficiency are present.\\n\\uf0b7 Once the patient is stable, the dose should be gradually tapered off (20% per day) over a\\nperiod of 10 to 14 days.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 307, 'page_label': '308'}, page_content='Psychiatry Disorders\\n300\\n\\uf0b7 Fluid and electrolyte disturbance should be corrected especially if there is vomiting or\\nfever.\\n\\uf0b7 Seizuresâ€“ Rum fits (appearing within 24 hours of abstinence) can be treated with Inj.\\ndiazepam 10 mg or lorazepam 2 mg IV stat especially when seizures are repeated.\\nProphylactic treatment is not recommended for true alcohol withdrawal fits.\\n\\uf0b7 Delirium tremensâ€“ The patient should be preferably treated in an intensive care unit.\\n\\uf0b7 An intravenous line should be started immediately and thiamine 100 mg IV should be\\nadministered. Thiamine along with multivitamin should be continued parenterally till\\nnormal diet is resumed.\\n\\uf0b7 IV dextrose and saline should be given at a rate adequate to replace fluid losses and\\nmaintain blood pressure.\\n\\uf0b7 Hyperthermia should be managed with cold sponge.Tab. paracetamol 500 mg orally4\\ntimes a day may be used in absence of any hepatic dysfunction.\\n\\uf0b7 Inj. diazepam 10 mg should be given slowly IV and should be repeated every 15-20\\nminutes till sedation is achieved.\\n\\uf0b7 Physical restraint may be necessary if the patient is combative.\\n\\uf0b7 Associated medical and surgical problems shouldbe simultaneously investigated and\\ntreated appropriately.\\n\\uf0b7 Tab.disulfiram (250mg to 500mg daily) is used for relapse prevention. Informed consent\\nfor treatment with disulfiram is mandatory before administering it.\\n\\uf0b7 Information about the disulfiram reaction and the potential lethality of the same is\\nexplained.\\nPatient education\\nEducation regarding short-term and long term complications (medical, psychological, social,\\nlegal,etc.) of substance use.\\nOPIOID USE DI SORDERS\\nOpioid use disorders consist of physiological,behavioral,cognitive symptoms which indicate\\nrepeated continued use of opioid drugs despite the problems related to it.\\nSalient features\\n\\uf0b7 Opioid intoxication is characterized by recent opioid intake and development of symptoms as\\ninitial euphoria, later dysphoria,apathy, psychomotor agitation or retardation,impaired\\njudgement,pupillary constrictions with drowsiness,slurred speech,impairment in attention\\nand memory.\\n\\uf0b7 There usually is impaired social or occupational functioning.\\n\\uf0b7 Opioid withdrawal is characterized by cessation of heavy prolonged use of opioid and\\ndevelopment of symptoms as dysphoric mood,lacrimation, nausea vomiting, muscle aches,\\ndiarrhoea, yawning, fever, insomnia, pupillary dilatation, piloerection, sweating.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 308, 'page_label': '309'}, page_content='Psychiatry Disorders\\n301\\nIt is characterized with repetitiveand compulsive consumption of ganja, charas, etc.\\n\\uf0b7 Recent intake of cannabis followed by development of symptoms as impaired motor co\\nordination, euphoria, anxiety, slowed perception of time, impaired judgement, social\\nwithdrawal, conjunctival congestion, increased appetite, dry mouth, tachycardia etc.\\n\\uf0b7 C hronic dependence can lead toapathy.\\n\\uf0b7 Mild cannabis withdrawalis characterized by restlessness, craving for cannabis and\\ndysphoria.Only symptomatic treatment is given for cannabis withdrawal.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Individual counseling, family support and encouraging the patient to join the self help\\ngroups are also important to help him maintain long-term abstinence.\\n\\uf0b7 However opiate dependence is a highly relapsing disorder, and prolonged inpatient stay in\\nsettings that also provide rehabilitative inputs is usually beneficial.\\nPharmacological treatment\\n\\uf0b7 Tab. paracetamol 500mg and dextropropoxyphen 32.5mg - start from BD dosage and\\ngradually increase to 2tabletsTDS.\\n\\uf0b7 Tab.buprenorphine 2mg and naloxone 0.5mg â€“ start from 1 tabletBD to maximum of\\nTDS or QID dosages depending on the severity of withdrawal symptoms.\\n\\uf0b7 Tab. clonidine 50 mcg BD is given for symptomatic management of withdrawal. Careful\\nmonitoring of BP is needed.\\n\\uf0b7 NSAIDs are given for muscular pains.\\nLong term (to be treated by a psychiatrist)\\n\\uf0b7 Tab. naltrexone 50 mg/day orallyis used to reduce craving and thereby to help patient\\nmaintain long-term abstinence (who have remained opioid free for at least 7-10 days).\\n\\uf0b7 Baseline hepatic functions should be assessed, and to be monitored once a month while\\non naltrexone treatment.\\n\\uf0b7 The drug is usually continued for a period of 6 months, however, it may have to be\\nwithdrawn in presence of significant liver disease (i.e. several fold increase in the serum\\nlevels of transaminases).\\nPatient education\\nPatient should be told about nature of illness, course and treatment modalities available\\nthrough individual sessions.\\nCANNABIS USE DISORDERS\\nSalient features\\nPharmacologicaltreatment\\nSymptomatic treatment fornausea, insomnia and anxietymay be given\\nNon -pharmacologicaltreatment\\nM otivation enhancing counseling, individual, family & group counseling'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 309, 'page_label': '310'}, page_content='Psychiatry Disorders\\n302\\n\\uf0b7 Behavioral characteristics include lower intelligence, lack of social smile, poor eye\\ncontact, low level of attachment to caregivers and extreme anxiety when their routine\\nis disturbed.\\n\\uf0b7 There is a notable deficit in interactions with peer group, delay in development of\\nspoken language, repetitive movements like hand or finger flapping, rocking body\\nmovements and head banging.\\n\\uf0b7 Diagnosis is based on delayed history and clinical mental status examination (MSE).\\nAUTISTIC DISORDER\\nIt is characterized by qualitative impairment in social interactions, impairment in\\ncommunications and restricted, repetitive and stereotypical patterns of behavior. Its\\nprevalence is 0.08%and is 4-5 times more common in boys than girls.\\nSalientfeatures\\nNon -pharmacologicaltreatment\\n\\uf0b7 Educational and behavioral interventions are the treatment of choice.\\n\\uf0b7 Structured classroom training in combination with behavioral methods is the most\\neffective treatment for many autistic children.\\n\\uf0b7 B ehavioral therapies to reinforce socially acceptable behaviors and encourage self care\\nskills.\\n\\uf0b7 Training of parents with regards to the concepts and skills of behavioral modification has\\nproved beneficial.\\n\\uf0b7 Language development is added to facilitate communication.\\nPharmacologicaltreatment\\n\\uf0b7 No medication has proven its efficacy in treatment of core symptoms of autism but\\nsymptomatic treatment for hyperactivity, obsessions, compulsions, aggression and self\\ninjurious behavior can be given by using escitalopram, methylphenidate, haloperidol,\\nrisperidone, olanzapine, quetiapine. Lithium can be used in self injurious behaviors.\\n\\uf0b7 G uidelines forTab. risperidone prescribingwith autism spectrum disordersin children\\nand adolescentsare as follows:\\n- Initiating dose at 0.25 mg per day for patients less than20 kg and 0.5 mg per day for\\npatients weighing20 kg or more.\\n- On day 4, the dose may be increased by 0.25 mg for patients beingless than20 kg or\\nmore and by 0.5 mg for patients above 20 kg.\\n- Assess the response after 2 weeks.\\nATTENTION DEFICIT HYPERACTIVITY DISORDER\\nIt is characterized by a pattern of diminished sustained attention and higher levelsof\\nimpulsivity in a child or adolescent than expected for someone of that age and developmental\\nlevel.Age of onset is before 7 years.Incidence of ADHD is2 to 20%. It is2-9 times more\\ncommon in boys.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 310, 'page_label': '311'}, page_content='Psychiatry Disorders\\n303\\n\\uf0b7 Common symptoms include careless mistakes in school work, lack of concentration,\\ninability to follow simple instructions, difficulty in organizing tasks and activities, easily\\ndistractible by external stimulus.\\n\\uf0b7 Hyperactivity is seen as fidgety hands or feet, frequently leaving seat in classroom, running\\nor climbing excessively in inappropriate situations, talking excessively andblurts out before\\nquestions arecompleted\\n\\uf0b7 Diagnosisis based on through case history andMental Status Examination(MSE) .\\nSalient features\\nNon -pharmacologicaltreatment\\nSocial skills training, behavioral therapy and group therapy for patient andfamilies are\\nconsidered beneficial.\\nPharmacological treatment\\n\\uf0b7 Drug of choice is Tab. methylphenidate 5-20mg.\\n\\uf0b7 Other agents are atomoxetine,bupropion, venlafaxine, clonidine,guanfacine.\\nMENTAL RETARDATION\\nIt is characterized by deficits in cognitive abilities and in behaviors required for social and\\npersonal sufficiency also known as adaptive functioning.An assessment of social adaptation\\nas well as Intelligence Quotient (IQ) is necessary to determine the level of mental retardation.\\nPoint prevalence of mental retardation is 1-3% of population.It is 1.5 times more common\\namong men than among women.\\nClassification of mentally retardation\\nAccording to the degrees of severity, mental retardation has been classified into four groups:\\n\\uf0b7 Mild Mental Retardationâ€“ (IQ Range 50â€“ 70)\\nThese people can live independently with adequate support and raise their own families.\\nThey can obtain academic skills approximately upto sixth grade.\\n\\uf0b7 Moderate Mental Retardationâ€“ (IQ Range 35â€“ 50)\\nThese people can acquire language and can communicate adequately during early\\nchildhood.\\nThey are academically challenged and are unable to go beyond second to third academic\\nlevel.\\nAs adults they are able to perform semi-skilled work under appropriate supervision.\\n\\uf0b7 Severe Mental Retardation (IQ Range 20â€“ 35)\\nThese people may fail to develop communication skills in childhood but can learn to\\ncount and recognize words critical to functioning.In adulthood, they may adapt well to\\nsupervise living situations and may be able to perform work related tasks under\\nsupervision.\\n\\uf0b7 Profound Mental Retardation (IQ Range Below 20)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 311, 'page_label': '312'}, page_content='Psychiatry Disorders\\n304\\nThey can be taught some self-care skills and can learn to communicate their needs if they\\nare given appropriate training.\\nInvestigations\\n\\uf0b7 Detailed history, standardized intellectual assessment and assessment of adaptive\\nfunctions in needed for diagnosing mental retardation.\\n\\uf0b7 Examination of physical signs and neurological abnormalities is always necessary to\\nsearch for organic causes of MR.\\n\\uf0b7 Laboratory testsâ€“ tests like chromosomal analysis, urine and blood testing for metabolic\\ndisorder and neuroimaging are done for ascertaining the cause.\\nNon -pharmacologicaltreatment\\nNo treatment measures are available except for those to control behavioural symptoms.\\nPreventive measures form an important strategy.\\n\\uf0b7 Primary prevention\\nIt is aimed at implementing measures such as to increase the knowledge and awareness\\nabout MR, to ensure and upgrade public health policies and laws to provide optimal\\nhealth care to mother and child, to eradicate known disorders associated with CNS\\ndamage, etc.\\n\\uf0b7 Secondary and tertiary prevention\\n- It is aimed at treating the associated disorder if any to shorten the course of illness\\n(secondary prevention) and to minimize the sequelae or consequent disabilities\\n(tertiary prevention).\\n- Specialized educational programmes addressing the training & adaptive skills, social\\nskills and vocation should be developed to improve quality of life.\\n- Group therapyhas also been successful.\\n- Behaviour therapy to reinforce desired behaviours and to reduce objectionable\\nbehaviours is considered useful.\\n- Cognitive therapieslike dispelling false beliefs and relaxation exercises have been\\nrecommended.\\n- Psychodynamic therapyhas been used with patients and families to decrease conflicts\\nabout unrealistic expectations.\\n\\uf0b7 Family Education\\nEducating the family and providing them counseling and supportive help is an important\\naspect of management of MR.\\n\\uf0b7 Social Intervention\\nIt is aimed at improving the quantity and quality of social competence of people with MR.\\nPharmacologicaltreatment\\n\\uf0b7 Methylphenidate is used successfully for patients of MR with Attention Deficit\\nHyperactivity Disorder.\\n\\uf0b7 Antiepileptic agents like sodium valproate and carbamazepine are used for controlling\\naggressive and self-injurious behaviour.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 312, 'page_label': '313'}, page_content='Psychiatry Disorders\\n305\\n\\uf0b7 Antidepressants are used to treat comorbid depression andantipsychotics likehaloperidol,\\nchlorpromazine are used for reducing stereotyped movements.\\n\\uf0b7 Beta-blockers like propranolol are used to control explosive rages or anger outbursts.\\n\\uf0b7 Development of special schools, supportive groups and NGOs form an essential part of\\nsupportive strategies for people with MR.\\nSUICIDAL PATIENT\\nPatients with suicidal ideation need immediate psychiatric intervention. Suicidal ideation can\\noccur in the background of depression, schizophrenia, adjustment disorders and alcohol and\\nother psychoactive substance abuse. About two thirds of all depressed patients contemplate\\nsuicide, and 10 to 15 percent commit suicide.\\nAssessment of suicidal risk can be done with the help of specific questions\\nWhether the patient often feels sad?\\nWhether the patient has lost all hopes in life?\\nThoughts that it is better to be dead than to face the constant miseries of life.\\nThoughts of causing death to self(suicide plans)\\nRisk factors for predicting the risk of suicide\\n\\uf0b7 Male sex, age above 45 years inmen and above 55 years in women\\n\\uf0b7 Suicidal attempt in past\\n\\uf0b7 Presence of psychiatric illnessespecially schizophrenia and depression, substance abuse\\nor dependence\\n\\uf0b7 R ecent bereavement, social isolation, family history of suicide, unemployment\\n\\uf0b7 Physical illnesses like malignancy, chronic pain, epilepsy, AIDS and recent will.\\nNon pharmacological treatment\\nTreatment is specifically directed at the cause, if identifiable. The patient should be referred\\nto a psychiatrist immediately after ensuring the following steps:\\n\\uf0b7 Patient should not be left alone and be kept under constant observation.\\n\\uf0b7 Family shouldbe explained the seriousness of the problem and actively included in\\nmanagement.\\n\\uf0b7 Patient should be offered psychological support and reassurance and not criticized.\\n\\uf0b7 No dangerous or potentially dangerous objects such as knife, blade, sharp edged objects,\\nrope, medication supply, etc. should be available in immediate vicinity of the patient.\\n\\uf0b7 Specific treatment for depression, psychotic disorder or whatever may be the cause\\nshould immediately be started.\\nPatient education\\nFamily should be advised to follow asupportive approach towards the patient and should not\\ncriticize.Suicidal attempt is indicative of distress and needs treatment of the causative illness.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 313, 'page_label': '314'}, page_content='Psychiatry Disorders\\n306\\nPSYCHOTROPIC DRUGS IN SPECIAL POPULATIONS\\nA. Recommendations for use of psychotropic drugs in renalimpairment\\nDrug groups Recommended drugs\\nAntipsychotics Haloperidol, olanzapine\\nAntidepressants Citalopram, sertraline\\nMood stabilizers Valproate, carbamazepine, lamotrigine\\nAnxiolytics and hypnotics Lorazepam, zopiclone\\nB. Recommendations for use of psychotropic drugs in hepatic impairment\\nDrug groups Recommended drugs\\nAntipsychotics Haloperidol, sulpiride/amisulpiride\\nAntidepressants Imipramine, paroxetine, citalopram\\nMood stabilizers Lithium\\nAnxiolytics and hypnotics Lorazepam, oxazepam, temazepam, zopiclone\\nC. Recommendations for use of psychotropic drugs in pregnancy\\nDrug groups Recommended drugs\\nAntipsychotics Chlorpromazine, haloperidol, trifluperazine\\nAntidepressants Nortriptyline, amitriptyline, fluoxetine\\nMood stabilizers Consider using anti-psychotics\\nAnxiolytics and hypnotics Non pharmacological measures preferred\\nD. Recommendations for use of psychotropic drugs during breast feeding\\nDrug groups Recommended drugs\\nAntipsychotics Sulpiride, olanzapine\\nAntidepressants Sertraline, paroxetine,imipramine, nortriptyline\\nMood stabilizers Consider using anti-psychotics\\nAnxiolytics and hypnotics Lorazepam, zolpidem'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 314, 'page_label': '315'}, page_content='Psychiatry Disorders\\n307\\nMANAGEMENT OF WANDERING MENTALLY ILL PATIENT OR A MENTALLY\\nILL PATIENT WITH NO FAMILY MEMBER OR ATTENDANT\\n\\uf0b7 Mental Health Act, 1987 has provision for hospitalization of the mentally ill patients in\\nmental hospital.\\n\\uf0b7 If one happens to come across a psychiatric patient wandering aimlessly or indulging in\\nsocially disorganized behavior in a public place, one can approach the local police station.\\n\\uf0b7 The in charge of the local police station under whose jurisdiction the place lies, has a duty\\nunder the Act to take the patient to the concerned Metropolitan Magistrate (in\\nmetropolitan cities) or the Sub-Divisional Judicial Magistrate or Chief Judicial Magistrate\\nor any Magistrate of first class (in other cities). The Magistrate can issue a reception order\\nfor admission of the patient to a mental hospital after getting him examined by a medical\\nofficer.\\n\\uf0b7 Admission to mental hospital can alsobe made on the request of the patient, if the patient\\nis willing to consent (voluntary admission) or on the request of family members, if they\\nso desire (admission under special circumstances).\\nPERSONALITY DISORDERS\\nA pervasive and enduring pattern of behavior, which beginsin early adulthood and which\\ngives colour to personâ€™s attitude behavior is known as personality. Behavioral patterns that\\ndeviate from personâ€™s sociocultural background are known as personality disorders.\\nClusters of personality disorders\\n\\uf0b7 Cluster A-schizoid,schizotypal,paranoid\\n\\uf0b7 Cluster B-borderline,histrionic,narcissistic,antisocial\\n\\uf0b7 Cluster C-avoidant dependent personality,obsessive compulsive personality disorders.\\nTreatment of personality disorders is difficult.Psychotherapies and pharmacological\\ntreatment for symptomatic management can be used with restricted benefits.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 315, 'page_label': '316'}, page_content='308\\nChapter 15\\nORTHOPEDIC CONDITIONS\\nOSTEOARTHRITIS\\nOsteoarthritis (OA) of the knee is an end result of the degeneration of articular cartilage.\\nSalient features\\n.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Weight reduction (if overweight); cold fomentation for acutely swollen knee, however,\\nhot fomentation may give symptomatic relief to some chronicpatients.\\n\\uf0b7 Supervised non-traumatic muscle conditioning and rehabilitation regimens e.g. isometric\\nquadriceps strengthening exercise (all vigorous exercises to be avoided in acutely\\nswollen/painful knee).\\n\\uf0b7 Compressive bandage or crepe bandage for effusion.\\n\\uf0b7 A ssistive devices like cane (to be held in the hand contralateral to more painful side),\\nwalker for patients with severe deformities or unsteady gait.\\n\\uf0b7 Brace for various instability helps while walking.\\nPharmacological treatment\\n\\uf0b7 Topical applications- containing salicylates, capsaicin, nicotinates, menthol, camphor,\\nNSAlDs in variouscombinationsmay provide symptomatic relief. (Caution: Avoid hot\\nfomentation immediately after topical applications). Non-steroidal anti-inflammatory\\ndrugs (NSAIDs) for pharmacological pain palliation. The choice of NSAID depends upon\\ndosing convenience, physician and patients comfort, price and the past experience on its\\nfrequency and severity of side effects as all are equipotent in full therapeutic dose (Avoid\\nintra-articularor oral steroids).Commonly used NSAlDs for OAknee\\ni. Acute painful situation/moderate pain (for initial 7-14 days), preferably take\\nNSAIDs after meals.\\n- Tab.paracetamol 500 mg 4-6 hourly(maximum daily dose 4000 mg)\\n- Tab. ibuprofen 400-600 mg 2 or 3 times aday (maximum daily dose 3200 mg)\\n- Tab. diclofenac sodium 50 mg 3 times a day or 75 mg 2 times a day(maximum\\ndaily dose 200 mg)\\n- Tab. aspirin 350 mg 2 tablets 4-6 hourly (maximum daily dose 5000 mg).\\nFor mild to moderate pain/chronic pain control (for 3-6 weeks and then SOS)\\n\\uf0b7 Pain, stiffness after rest, difficulty in climbing stairs, difficulty in getting up from\\nsquatting position, grating sensations and off and on episodes of flare and swelling.\\n\\uf0b7 Erythema and palpable warmth are possible but rare. Genu-varum deformity and/or\\nfixed flexion contracture in severe cases.\\n\\uf0b7 Classical radiological triad- joint space narrowing, peripheral osteophyte formation\\nand subchondral sclerosis'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 316, 'page_label': '317'}, page_content=\"Orthopedic Conditions\\n309\\n- All above medicines in reduced frequency of dosages.  Or\\n- Tab.diclofenac sodium 100 mg/75 mg sustained release once a day.O r\\n- Tab.piroxicam 20 mgonce a day.\\n\\uf0b7 All patients do not uniformly respond to a particularNSAID. It is not unusual for several\\ndifferent NSAIDs to be tried before a suitably effective and well-tolerated agent is\\nidentified for a particular patient.\\n\\uf0b7 Caution:NSAIDs may cause dose related gastric irritation, nausea, vomiting and\\ndyspepsia; GI ulceration, perforation and haemorrhage and sometime renal toxicity.\\nHowever, one-third remains asymptomatic. NSAIDs can interfere with antihypertensive\\ntherapy due to salt and water retention)\\n\\uf0b7 In case of epigastric burning or nausea or vomiting either discontinue and switch over to\\nsafer NSAID or administer Cap.omeprazole 20 mg half an hour before breakfast, in\\npatients on prolonged therapy with NSAIDs monitor haemoglobin, stool for occult blood\\nas these drugs may also cause leucopenia, thrombocytopenia and agranulocytosis.\\n\\uf0b7 Refer the patient to an orthopaedic surgeon in case of persistent swelling, presence of\\nconstitutional symptoms or mechanical symptoms like locking or frequent giving away\\nsensations. Surgical intervention may be required for severe deformities, contractures and\\nadvanced disease with intractable pain, severe enough to affect independent performance\\nof activities of daily living, for prolonged periods.\\nPatient education\\n\\uf0b7 There is no curative pharmacological agent for osteoarthritis knee and the disease is\\nirreversible.Non -pharmacological treatment has a major role to play in treatment\\n\\uf0b7 Take minimal possible medication that provide symptomatic relief and to wait for 1-2\\nweeks for drug to show its effect.Topical applications do not penetrate into the joint\\nthrough skin directly.\\n\\uf0b7 Intra-articular steroid injections give only temporary relief and risks of repeated intra-\\narticular injections far outweigh its advantages.\\n\\uf0b7 To avoid activities which exacerbate pain like sitting cross legged or squatting on floor.\\n\\uf0b7 To use ramp instead of stairs wherever feasible.Not to do vigorous exercises with acutely\\ninflamed knee.\\n\\uf0b7 To report back if recurrent effusions in knee or systemic symptoms. Formermay be\\ncaused by mechanical disorder along with OA knee like loose body or meniscal tear.\\nLater situation could be caused by diseases of knee other than OA\\nReferences\\n1. Acetabular Bone Destruction Related to Non Steroidal Anti-inflammatory Drugs. Lancet 1985; 2:11-14.\\n2. Osteoarthritis. In: Harrison's Principles of Internal Medicine. Rasper DL, Braunwald E, Fauci AS et al\\n(eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 2036-2047.\\n3. Osteoarthritis. In: Conn's Current Therapy, Robert E Rakel (ed), 1999, WB Saunders Company,\\nPhiledelphia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 317, 'page_label': '318'}, page_content='Orthopedic Conditions\\n310\\n\\uf0b7 The revised criterion of American College of Rheumatology (1987) aids in diagnosis and\\nclassification.Suspect rheumatoid arthritis if:\\n> 3 swollen joints\\n>30 minutes of morning stiffness andinvolvement of metacarpophalangeal or\\nmetatarsophalangealjoints,symmetric arthritis, rheumatoid nodule\\nRHEUMATOID ARTHRITIS\\nRheumatoid arthritis(RA) is characterized by persistent inflammatory synovitis (usually\\ninvolving small and large peripheral joints in symmetrical fashion) causing cartilage\\ndestruction andbone erosion leading to changes in joint integrity.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Since theetiology of RA is unknown, therapy remains empirical and palliative, aimed at\\nrelieving the signs and symptoms of the disease.\\n\\uf0b7 In acute pain restand splint. Otherwise exercises directed at maintaining muscle strength\\nand joint mobility without exacerbating joint inflammation. A variety of orthotic (splints)\\nand assistive devices (cane, walker) can be helpful in supporting and aligning deformed\\njoints to reduce pain and improve function.\\nPharmacologicaltreatment\\n\\uf0b7 In acute inflammation any of the NSAIDs as given in section on osteoarthritis may be\\ngiven exceptparacetamol. The anti-inflammatory action of the NSAIDs may take 2-4\\nweeks to become evident.Evaluation of persistent polyarthritis.\\n\\uf0b7 Reduced NSAID dosages have to be used in the elderly and in patients with impaired\\nrenal function. Concomitant use of more than one NSAID only increases toxicity, and has\\nno additional benefit. Patient not responding to one NSAID may still show a good\\nresponse to another.\\n\\uf0b7 Topicalapplications-containing salicylates, capsaicin, nicotinates, menthol,camphor and\\nNSAIDs in various combinations may provide symptomaticrelief.\\n\\uf0b7 Refer to a specialist (physician) at a higher centre. Begin disease modifying antirheumatic\\ndrugs (DMARD ) early in the disease. Prediction of response to a particular DMARD is\\nnot possible. It takes 4-6 weeks to show its effect.\\n\\uf0b7 Tab. m ethotrexate 7.5 mg to 15 mg every week. ConcomitantTab. folic acid 1\\nmg/day reduces side effects.\\nCaution: Nausea, mouth sores, liver damage, increases in incidence of chest infection,\\nmacrocytic anaemia. Regular monitoring of LFT is required. Avoid alcohol during\\ntherapy\\n\\uf0b7 For patients with severe disease, affecting activities of daily living and\\nnot responding to adequate trial of NSAIDs and DMARD for sufficient\\nduration consider following treatment,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 318, 'page_label': '319'}, page_content=\"Orthopedic Conditions\\n311\\n\\uf0b7 Tab. prednisolone 40-60 mg/day for 2-4 weeks. Review periodically and possibly taper\\ndown slowly. If requiredfor a longer duration administer at doses of 5-10 mg/day\\n\\uf0b7 Intra-articular corticosteroids:m ethylprednisolone acetate, 20-80 mg may be needed in\\nselected cases with predominantly monoarticular arthritis of a large joint.\\n\\uf0b7 Refer the patient to a higher centreif no response to medical therapy after\\n4-8 weeks, severe extra -articular symptoms, deformities or contractures\\npresent, patient is crippled/or not able to carry out activities of daily living\\ndespite adequate medical treatment.\\nSurgicaltreatment\\nSynovectomy in patients with predominantly monoarticular involvement, not responding to\\nconservative therapy, might be helpful. Reconstructive surgery is indicated for disorganized\\njoints.\\nPatient education\\n\\uf0b7 The disease can be controlled but no curative agentisknown. There canbe remissions\\nand exacerbations.\\n\\uf0b7 At the onset of disease it is difficulttopredict the natural history of an individual patient's\\nillness.No characteristic features of patients have emerged that predictresponsiveness to\\na particular DMARD.\\n\\uf0b7 Life style modification may be required depending on the degree of disability.\\n\\uf0b7 Regular mild exercises as prescribed by the doctor helps in prevention of deformity\\nmaintain range of motion of the joints and muscle strength.\\n\\uf0b7 Magic drug for rheumatic arthritis might contain steroids. Better to consult a qualified\\ndoctor before taking it.\\nReferences\\n1.Rheumatoid Arthritis. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E, Fauci AS et al\\n(eds), 16th Edition, 2005, McGraw Hill CompanyInc., New York, pp 1968-1977\\n2. Rheumatoid Arthritis. In: Conn's Current Therapy. Robert E. Rakel (ed), 1999, WB Saunders Company,\\nPhiladelphia.\\nCERVICAL AND LUMBAR SPONDYLOSIS\\nItis a clinical syndrome resulting from degeneration of intervertebral discs and facet joints.\\nSalientfeatures\\n\\uf0b7 Pain and stiffness with decreased range of movement of gradual onset. Occasional acute\\nflare ups of pain with muscle spasm. Neck pain may radiate to occiput, scapular area and\\ndown to one or both arms (may be associated with paraesthesias).\\n\\uf0b7 Back pain is usually diffuse and may radiate up to knees through back of thighs.\\n\\uf0b7 Radiological narrowing of one or more intervertebral spaces, spur formation (osteophytes)\\nand subchondral sclerosis are the hallmark.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 319, 'page_label': '320'}, page_content='Orthopedic Conditions\\n312\\nNon -pharmacologicaltreatment\\n\\uf0b7 In acute painful situation rest, moist heat in cold weather and light massage (improves\\ntone, circulation and elasticity) to paraspinal muscles. Cervical traction in the position of\\nmaximum comfort to neck (5-10 pounds) for 10-15 minutes. Ultrasonic exposure on\\npainful trigger points in cervical and shoulder muscles. Inter ferential therapy (IFT) for\\nacute neck and back pain. Removable soft cervical collar/back corset/ back belt for\\nsymptomatic relief.\\n(Caution:No exercises in acute painful situation).\\n\\uf0b7 In chronic pain mobilization and strengthening exercises, moist heat and cervical traction.\\nPharmacologicaltreatment\\nSame as described for osteoarthritis of knee.\\nPatient education\\n\\uf0b7 In cervical spondylosis avoid prolonged desk work, if must, then intermittent rest is\\nrequired and proper writing, typing, sitting posture (avoid low table, use tilt table) and\\ncare of the neck.\\n\\uf0b7 In lumbar spondylosis explain the patient how to manage weightsince extra weight puts\\ngreater stress on the back muscles and to maintain proper body alignment while standing\\nwith feet slightly apart. When standing for long periods, use a small stool to keep one foot\\nup with knee bent. Do not tense up or concentrate on standing up straight, just stand\\nnaturally. Try to avoid carrying heavy bags on shoulders.\\n\\uf0b7 Care of back while sitting by using well designed fully adjustable chair to provide plenty\\nof support to the lower back. If chair is uncomfortable use a rolled uptowel or small\\npillow to support the back. When sitting for long periods rest your feet on low stool and\\nuse arm rests to support weight of your body. Try not to sit in the same position for long\\nperiods. If prolonged sitting is must take rest for a minuteor two every hour.\\n\\uf0b7 To lift weight cautiously by keeping the back as much upright (vertical) and straight (not\\nhunched over) as one can. Not to bend over at waist to pick up the object, instead squat,\\nget under or next to object not on top of it. Lift withyour leg muscles rather than back or\\nabdominal muscles. Hold the object close to your body while lifting and carrying and do\\nnot twist your body.\\n\\uf0b7 To sleep safely on a firm bed. While sleeping supine legs should be supported with\\npillows. Not to sleep on your stomach. Sleeping on your side with knees bent and hips\\ntilted forward is probably the best.\\n\\uf0b7 Refer to a higher centre in case of severe pain that disturbs sleep/not responding to\\nconservative treatment for more than 2 weeks/associated with severe restriction of neck or\\nback movements or torticollis or sciatic pain or constitutional symptoms/neurological\\nsymptoms with back or neck pain.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 320, 'page_label': '321'}, page_content=\"Orthopedic Conditions\\n313\\n\\uf0b7 Mild or grade I sprains-partial tearing of ligament fibers,minimal swelling and no joint\\ninstability.\\n\\uf0b7 Moderate or grade II sprains-pain, oedema, ecchymosis, joint tenderness with some loss\\nof joint motion but no joint instability.\\n\\uf0b7 Severe or grade III sprains- gross instability of the joint with complete tearing of all\\nfibers,marked swelling and severe pain.\\nSPRAINS\\nAn injury to a ligament(s), by sudden unnatural or excessive movement of ajoint, is termed\\nis a sprain.Sym ptoms are pain, swelling, discolouration of the skin, especiallybruising and\\nimpaired joint function.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Check sensation and circulation distal to the injury. Obtain X-rays of the involved region\\nto rule out afracture. Stress X-rays may show abnormal opening of the joint in a grade III\\nsprain.\\n\\uf0b7 Protection, support and rest.\\n\\uf0b7 Restrict the movement of the affected area.\\n\\uf0b7 Apply cold compresses immediately (this will help to reduce swelling).\\n\\uf0b7 Avoid using ice directlyon the skin.\\n\\uf0b7 Elevation of the limb above the level of the heart-especially at night while sleeping.\\n\\uf0b7 In a grade I sprain, apply a compression bandage for a period of 5-7 days, patient may be\\nallowed to bear weight after a week.\\n\\uf0b7 In a grade II sprain, splintage (slab later on converted to cast) may be used to restrict joint\\nmotion, but the patient has to remain non-weight bearing for 4-6 weeks.\\nPharmacologicaltreatment\\n\\uf0b7 Tab. ibuprofen 400 mg 3 times a day for 5-7 days. OrTab. diclofenac sodium 50 mg 3\\ntimes a day for 5-7 days.\\nPatient education\\n\\uf0b7 Don't massage or hot fomentation in acute stage; it will increase the swelling.\\n\\uf0b7 To give rest to the injured area until the pain subsides (usually 7 to 10 days for mild\\nsprains and 3 to 5 weeks for severe sprains).Avoid activities that cause pain or swelling.\\nPractice moderation in physical activities. If the pain and swelling decreases within 48\\nhours after a sprain, move the affected joint in all directions. To avoid high heeled shoes\\n(for ankle sprains).\\nReference\\n1.Apley's System of Orthopaedics and Fractures, 6th edition, 1982, Butterworths and Co. London.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 321, 'page_label': '322'}, page_content='Orthopedic Conditions\\n314\\nDiagnosis considered if any of the following two criteria are present,\\n\\uf0b7 Classic symptom of localized pain, fever (with or without chills and rigours), swelling in\\nthe metaphyseal area, warmth, and limited range of motion of the adjacent joint; pus\\naspirated from the bone; positive bone or blood culture for pyogenic organism;\\nradiographic changes typical of acute osteomyelitis (soft tissue swelling, periosteal\\nreaction, lytic areas in the metaphysis).\\n\\uf0b7 The X-ray changes usually appear 7-10 days after the onset of illness.\\nACUTE PYOGENIC OSTEOMYELITIS\\nAcute osteomyelitis is acute infection of the bone, commonly seen in children less than 10\\nyears of age.\\nSalient features\\nNon -pharmacologicaltreatment\\n\\uf0b7 Rest, splintage to the part, elevation of the limb and sponging for fever. If aspiration is\\npositive for pus, drain the pus (must be performed by an orthopaedic surgeon) and send\\nfor culture and sensitivity for antibiotics.\\n\\uf0b7 Postoperative duration of splintage depends upon extent of damage to the bone. Usual\\nduration is 4-6 weeks. Gradually mobilize the limb and permit gradual weight bearing\\nthereafter. In case of extensive destruction, bone might require support for a fewmonths.\\nPharmacologicaltreatment\\nBroad spectrum intravenous antibiotics are started depending upon most likely organism\\npresent. Commonest bacterial pathogen isStaphylococcus aureus(40-80% of cases). The\\nantibiotic later on may be changed depending upon culture report or response to therapy.\\nIntravenous administration of antibiotics is continued till favorable clinical response is\\nachieved, followed by oral antibiotics. Total duration of antibiotic(s) administration ranges\\nfrom 4-6 weeks.\\n\\uf0b7 Inj. cloxacillin 50-100 mg/kg/day in four divided doses for 1-2 weeks.\\n\\uf0b7 Inj. gentamicin 5-7.5 mg/kg/day in 2 divided doses for 1-2 weeks Or Inj. amikacin 15\\nmg/kg/day in 2-3 divided doses if resistantPseudomonas aeruginosa.Or\\n\\uf0b7 Inj. ceftriaxone 100 mg/kg/day in 2 divideddoses for 1-2 weeks (maximum dose 2 g/day)\\nor\\n\\uf0b7 Inj. cefotaxime 100-200 mg/kg/day by IV infusion or IM or IV in 2-4 divided doses for 1-\\n2 weeks. Or\\n\\uf0b7 If patient is hypersensitive to penicillins and cephalosporins, Inj. clindamycin 40\\nmg/kg/day in 4 divided doses for 1-2 weeks. Or\\n\\uf0b7 IfMethicillin resistantStaph, aureussuspected, Inj. vancomycin by IV infusion 500 mg\\nover at least 60 minutes every 6 hours or 1 g over at least 100 minutes every 12 hours;\\nNeonates upto 1 week 15 mg/kg initially then 10 mg/kg every 12 hours; Infants 1-4\\nweeks 15 mg/kg initially then 10 mg/kg every8 hours; Children over1 month 10 mg/kg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 322, 'page_label': '323'}, page_content=\"Orthopedic Conditions\\n315\\nevery6 hours. Alternatively linezolid can be given in appropriate dose.\\n\\uf0b7 OralTab.paracetamol 500 mg for fever.\\n\\uf0b7 Monitor therapy by clinical response. Favourable response characterized by decrease in\\nswelling and fever, improvement in general well being and movements of limb, fall in\\nESR and C-Reactive protein (better indicator than ESR because CRP closely follows the\\nclinical response). After 7-10 days of symptoms, repeat the X-ray to assess the extent of\\ndestruction and damage to bone. Oral therapy usually started 1-2 weeks of IV antibiotic\\ntherapy, if response is favourable.\\n\\uf0b7 The choice of oral antibiotic largely depends on culture and sensitivityreport. In the\\nabsence of culture report give oral: Syr./Cap. cloxacillin 50-100 mg kg day in 4 divided\\ndoses for 3-4 weeks. Or Syr./Cap. cephalexin 25-50 mg/kg/day in 4 divided doses for 3-4\\nweeks. Or\\n\\uf0b7 Refer the patient to an orthopaedic surgeon if aspiration yields pus from bone or acute\\nosteomyelitis suspected in an adult/diabetic/haemodialysis patient/IV drug user/ patient\\nwith orthopaedic implant/immunocompromised host.\\nPatient education\\n\\uf0b7 Antibiotic therapy maybe required for a few weeks depending uponthe response.Plaster\\n(or any other splintage) might be required for prolonged periods. Not to make the child\\nwalk (in case of lower limb bone involvement) unless permitted.\\nReferences\\n1. A Comparative Study of Osteomyelitis and Purulent Arthritis with Special Reference to Aetiology and\\nRecovery. Infection, 1984; 12: 75.\\n2. Osteomyelitis and Suppurative Arthritis. In: Nelson's Textbook of Paediatrics. Berhman, Kliegman, Jenson\\net al (eds), 17th Edition, 2004, W.B. Saundcr Company, Philadelphia, pp 2297-2302.\\n3. Bone and Joint Sepsis. In: Lovell and Winter's Paediatric Orthopaedics. Morissy RT, Weinstein SL (eds),\\nVol. 4, 1996, Lippincott-Raven, Philadelphia.\\nACUTE SEPTIC ARTHRITIS\\nItis inflammation of joint caused by pyogenic microorganisms,usually seen in children <10\\nyears.Hip and knee are the commonest joints to be affected.\\nSalient features\\n\\uf0b7 Inability to movetheaffected joint, refusal to walk or limp, hip pain referred to knee\\nacute local signsof inflammation(warm and painful joint witheffusion) andclinical\\nsigns of sepsis (fever, malaise).M ore than two thirds of infant with septic arthritis are\\nafebrile.\\n\\uf0b7 Neonates present with pseudo paralysis of extremities, discomfort while changing the\\ndiaper, unhappy or out of sorts but rarely appears to be ill or moribund.Ultrasound\\nexamination of suspected septic hip joint greatly aids in diagnosis.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 323, 'page_label': '324'}, page_content=\"Orthopedic Conditions\\n316\\nRefer the patient immediately to an orthopaedic surgeon.\\nNon -pharmacologicaltreatment\\n\\uf0b7 Keep the joint in position of comfort.\\n\\uf0b7 Aspiration of the joint for gramstaining, culture and sensitivity.\\n\\uf0b7 If aspirate is purulent, drainage of the joint on an emergency basis.\\n\\uf0b7 Drain the joint even if the joint aspiration is doubtful in the presence of a strong clinical\\nsuspicion, because the risks of negative arthrotomy are far too less than not draining an\\ninfected joint having pus. The latter situation may be disastrous for the joint resulting in\\nlifelong permanent disability to the patient.\\n\\uf0b7 After drainage splint the joint with a POP slab or skin traction to relieve pain andprevent\\ncontractures till the patient is a febrile, pain free and the joint is clinically quiescent.\\nIntermittent mobilization is permitted to preserve the range of movement of the joint.\\nPharmacologicaltreatment\\nThe choice of antibiotics, durationof therapy and monitoring of the therapy are same as\\nmentioned in the section on acute pyogenic osteomyelitis.\\nReferences\\n1. Osteomyelitis and Septic Arthritis. In: Nelson's Textbook of Paediatrics. Berhman, Kliegman, Jenson et al\\n(eds), 17th Edition, 2004, W.B. Saunder Company, Philadelphia, pp 2297-2302.\\n2. Bone and Joint Sepsis. In: Lovell and Winter's Paediatric Orthopaedics. Morissy RT, Weinstein SL, Vol. 4,\\n1996, Lippincott Raven, Philadelphia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 324, 'page_label': '325'}, page_content='317\\nChapter 16\\nSURGERY\\nPRE -OPERATIVE ASSESSMENT AND PREPARATION S\\nPre operative preparation consists of-\\n\\uf0b7 Gather and record concisely all relevant information\\n\\uf0b7 Devise a plan to minimise risk and maximise the benefit to the patients\\n\\uf0b7 Consider possible adverseevents and how to deal with them\\n\\uf0b7 Ensure that everyone, including the patient, understands the surgical plan.\\nPreoperative assessment of the patient\\nFor achieving the desired optimum result in a surgical patient,apart from evaluating the\\nnature and extent of the diseases and choice ofsurgery fromavailable options the\\nassessment of the patient to withstand the stress of surgery and anaesthesia is very\\nimportant. The factors that must be considered in preoperative assessment are\\n\\uf0b7 The disease(and its extent)for which the surgery is planned.\\n\\uf0b7 The condition of the patient,organ system.\\n\\uf0b7 The relative urgency of the surgery.\\n\\uf0b7 The type of surgery and its alternatives.\\n\\uf0b7 The relative morbidity and mortality of the disease and the surgical procedure.\\n\\uf0b7 All these factors are interdependentand this assessment is the most fundamental task to\\nbe performed in a surgical patient. Surgeon mayat times, need the help of a physician,\\ncardiologist or anesthetist,to take the right decision. The preoperative assessmentshould\\nalso include discussion on drugs being taken by the patient and documentation ofknown\\nallergies.\\nInformed consent\\nInformed consent should be taken after a detailed discussion by the surgeon (or his\\nresponsible assistant)with the patientand his close relatives ,informing them about the nature\\nof the procedure planned, benefits expected, risks involvedand possible alternatives, giving\\nfull opportunity to them to ask questions and clear doubts.\\nPreoperative preparation\\n\\uf0b7 Routine investigations Hb, TLC, DLC, CT, BT,urine routine examination, and in patients\\nover 30 years, chest X-ray and ECGshould be done.\\n\\uf0b7 Special and specific investigations depending upon the nature of the procedure planned\\nand the physicalcondition of the patientfor evaluating fitness forsurgery.\\n\\uf0b7 Lipstick, nail polish and other cosmetics which may mask cyanosis and interfere with\\npulse oximetry should be removed.\\n\\uf0b7 D entures, spectacles, contact lenses,artificial limb s, artificial eyes,hearing aid and\\njew ellery, cash and mobile phones should be removed before shifting the patient to\\noperation theatre.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 325, 'page_label': '326'}, page_content='Surgery\\n318\\n\\uf0b7 Withholdingfeeds before surgery depending upon age of the patient and nature of\\nanaesthesia and surgeryplanned.\\n\\uf0b7 B athing, ifpossible,patient should take aproper bath on the day prior and on the morning\\nof surgery giving specialattentionto the operative area. Patient should wear only clean\\nhospital clothing.\\n\\uf0b7 H air rem ovalshould be done asclose to thetime ofsurgeryaspossible. If\\n\\uf0b7 The skinis to be shaved which isbest doneimm ediately before surgery.These arebest\\nremoved w ith a clipperorchemical depilator.Shaving resultsin damage to skinand leads\\nto abrasions thatmay not be visible and may lead topost operative wound infection.\\n\\uf0b7 One should ask for history of allergic reactions toany chem icalsolutions.\\n\\uf0b7 Wh ile scrubbing, one should work away from the operative site. Visibly soiled skin\\nshould be washed w ith soap and wa ter before using surgical scrub.Preanaesthetic\\nm edicationasperpolicy.\\n\\uf0b7 Skin preparationfor surgery:Preoperative surgical antisepsis aims at blocking infection\\nin to surgical w ound and consists of hand w ashing, gloving along withapplication of\\nantiseptic tosurgical site.Different surgical scrubs available forskin preparation before\\nsurgicalprocedure include anyofthe follow ing:\\nPovidone-iodine:It acts by oxidation/substitution of free iodine. Povidone iodine is used as\\na surgical scrubafter combining with detergent.It is effective againstgram positivebacteria\\nbut weaker against other microorganisms.It has a residualactivityand is active in presence\\nof organic substance. It is absorbed through skin. It can be used on mucus m embranes.\\nPatient skin sensitivity isoccasionallya problem .\\nChlorhexidine gluconate\\nItis a broad spectrumantiseptic thatisbetterthan povidone-iodine as a bactericidal.This has\\na residual activity that continues to kill microorganism s after application.Itis noteffective in\\npresence of organic material like soap sand oils,blood and body fluids.Itshould be avoided\\ninpreparation ofeye.Itm ay be used alone orin combinationw ith cetrimide.\\nAlcohol (70% ethyl orisopropyl alcohol): It is 95% effective against gram negativeand\\ngram positive bacteria,m ycobacteria,fungi andviruses.Itis not completelyeffective against\\nspores.A lltraces of alcohol should be drybefore drapes are put. Alcohol is neverused on\\nmu cusm embranes and open w ounds as itm ay causesdesiccation.\\n\\uf0b7 Drug treatment:e.g. prophylactic antibiotics (see section on antibiotic prophylaxis),\\nantihypertensives, IV fluids, anticoagulants, Vitamin Ketc. whererelevant.\\n\\uf0b7 N on drug treatmente.g.,rectal washouts,stom ach wash,etc.w hererelevant.\\n\\uf0b7 Handling of medicolegal cases:First aid has to be provided in allcases who report in an\\nem ergency state. After stabilizing the patient, patient should be properly guided and\\nhelped in shifting tothe appropriate centre.\\n\\uf0b7 In case where wetreatmedicolegal cases, we mustsend information (induplicate) tothe\\npolice. Prepare a m edicolegal report.Preserve and seal clothes etc. Preserve fluid and\\nstainsamples where indicated.R espond to information sought by thepolice.A rrange to'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 326, 'page_label': '327'}, page_content=\"Surgery\\n319\\ntake dyingdeclaration,whe re indicated.Preserve allX -rays and patientrecords.R espond\\nto court sum mo ns. In case of death, handover the body to the police. In case of\\ndischarge/referral, police needs tobe informed.Care during transfer.This would depend\\non a num ber of factors like nature,patient's condition, and reasons forreferral, readiness\\nof thereferral centre to accept the patient and whether thetransferis an em ergency or\\nelective.\\nEm ergency transfer\\n\\uf0b7 Identify the degreeofemergency.\\n\\uf0b7 R esuscitative measures to be adopted in serious patients withmanag em ent ofshock,\\noxygen etc.\\n\\uf0b7 Transfer in a well equipped am bulance to appropriate referral center withprior intimation\\nand confirmation the readiness at the referralcentre.\\n\\uf0b7 D octor or paramedicalstaff to accompany the sick patient.\\n\\uf0b7 R eferralslipshould contain information on: Condition of the patient when first seen.\\nDiagnosis and resuscitative mea sures taken. Reasons for referral. Where referred\\nPrecautionsadvised during transportation. Any other information(e.g. any staff or\\nequipment sent along with, any com m unication given to referral centre orspecialist\\nconcerned).\\nPOST -OPERATIVE CAR E\\nI. PO STOPER A T IVE PA IN RE LIEF\\n\\uf0b7 Postoperative pain is associated with allsurgicalprocedures.This varies according to the\\nsurgical procedure. Severe pain can prolong gastrointestinalileus,urinary retention,\\nimp air respiratory mov em ents producing atelectasis and predisposes to deep vein\\nthrom bosis due to immobilization.\\n\\uf0b7 Various methods to alleviate postoperativepain are NSAIDs , opioids(intra mu scular,\\ntransdermal or transmucosal),patient controlled analgesia,local infiltration ofanaesthetic\\ndrugs, epidural analgesia and intrapleuralanalgesia. The method used depends uponthe\\nsite and the m agnitude of surgery done, severity of pain,whether the patient isallowed\\norally, facilities and expertise available.It is necessary to give analgesics by\\nintramu scular orintravenous route in the imme diate postoperative period and tillthe\\npatient isableto accept orally.\\nCo mm onlyused agents are\\n\\uf0b7 Inj. diclofenac sodium 75 mg 6-8 hourly Or\\n\\uf0b7 Inj. tram adol (50 mg/ml) IM/IV 4-6 hourly,\\n\\uf0b7 Inj.pentazocine (30m g/ml) 30-60m g IM /IV repeated 3-4hourly.\\n\\uf0b7 Inj. morphine (15 mg/ml)10-15mg ,can be repeated 4-6 times.\\n\\uf0b7 In tertiary care centers, epiduralanalgesia,intravenous patient controlled analgesia,\\nintrapleural analgesia can beused under expert care.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 327, 'page_label': '328'}, page_content='Surgery\\n320\\nW hen patient isable to accept orally,\\n\\uf0b7 Tab.paracetamo l500mg3 -4 times a day.Or\\n\\uf0b7 Tab.ibuprofen 400-600mg 8 hourly.\\nII.POSTOPER A TIV E NAUSEA AND VOMITING\\n\\uf0b7 Post operative nausea and vomi ting lead to significant m orbidity and prolonged\\nhospitalization. It hasan incidence of 20-30% afterabdominalsurgery.\\n\\uf0b7 Predisposing factors are diabetes m ellitus, pregnancy, dehydration, electrolyte\\nimbalance, gastroesophageal reflux,em ergency surgery, use of certain anaesthetic drugs\\nand opioids.\\nN on-pharmacological treatment\\nB owe lobstruction (m echanical or paralytic ileus) should be ruled out as acause ofvom iting\\nby proper examination and investigations. N auseaand vomitingare man aged with bed rest,\\nintravenous fluids,analgesics torelieve postoperative pain,nasogastricdecompression\\nPharmac ologicaltreatment\\n\\uf0b7 Inj. metoclopram ide (5mg/ml)10 mg IM /IV TDS or SOS. Or\\n\\uf0b7 Inj.ondansetron (2m g/ml) 4 mg slow IV or IM  OD\\nIII.PO STOPERAT IVE PN E UMO N IA\\n\\uf0b7 Pulmonary disorders remain the mo st frequent postoperative problem and 10- 15% of\\npatients are considered to have clinically significant chest complication after surgery\\nunder generalanaesthesia.\\n\\uf0b7 Factors predisposing to increased chest complications aresm oking,obesity, chronic\\nrestrictive and obstructivelung disease, prolonged general anaesthesiaand presence of\\nnasogastric tube.Postoperative pneumonia is caused by pathogens such asPseudom onas,\\nSerratia,Klebsiella, Proteusand Streptococcus\\nSalientfeatures\\n.\\nPharmacological treatment\\n\\uf0b7 Antibiotics: Depending upon sputum culture and sensitivity. Initial treatment  can be\\nstarted with amino glycoside and cephalosporin.\\n\\uf0b7 Inj.diclofenac 75mg 1M every6-8 hours.\\n\\uf0b7 Chest physiotherapy\\n\\uf0b7 Nebu lized bronchodilators may be used ifbronchospasm is present.\\nAntibiotic prophylaxis in surgery\\nThe goals ofprophylactic administration of antibioticsto surgicalpatients are to:\\n\\uf0b7 Reduce the incidence of surgicalsite infection;\\n\\uf0b7 Fever,productive cough,dyspnoea,chest pain.\\n\\uf0b7 Bronchial breathingand presence of rales.\\n\\uf0b7 Chest X-ray shows area of  consolidation'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 328, 'page_label': '329'}, page_content=\"Surgery\\n321\\n\\uf0b7 U se antibiotics ina man ner that is supportedby evidence of effectiveness;minimize the\\neffectof antibiotics on the patient's normal bacterial flora; adverse effects.\\nProphylaxis is uniformly recomme nded for allclean-contaminated, contam inated and\\ndirty procedures.It is considered optional for most clean procedures,although it may be\\nindicated for certain patientsand clean procedures that fulfill specific risk criteria. Itis\\nimportant to emphasize that surgical antibiotic prophylaxis is an adjunct to, not a\\nsubstitute for good surgicaltechnique.\\n\\uf0b7 Antibiotics prophylaxis should be regarded as one component of an effective policy for\\nthe control of hospital acquired infection in procedure that requires the insertion of\\nimplants or prosthetic devices,the term.Surgical site infection isused to encom pass the\\nsurgical wound and the implant.Surgical site infection also encompasses infections\\ninvolving the body cavity (e.g. subphrenic abscess), bones, joints, meninges and other\\ntissues involved in the operation. Throughout this guideline the term surgical site\\ninfection (SSl) is used, unless the evidence relates specifically to surgical wound\\ninfection.\\nSURGICAL SITE INFECTION\\nCriteria for defining a surgical site infection (SSI)\\nSuperficialincisionalSSI\\n\\uf0b7 Infection occurs within 30 day after the operation and infection involves only skin of\\nsubcutaneous tissue of the incision and at leastone of the following\\n\\uf0b7 Purulent drainage, with or without laboratory confirmation, from the superficial incision\\n\\uf0b7 Organisms isolated from an aseptically obtained culture of fluid or tissue from the\\nsuperficial incision.\\n\\uf0b7 At least one of the following signs orsymptoms of infection:Pain or tenderness, localized\\nswelling,redness, heat and superficial incision is deliberately opened by a surgeon,\\nunless, incision is culture-negative\\n\\uf0b7 Diagnosis of superficial incisional SSI by the surgeon or attending physician\\nD eep incisionalSSI\\n\\uf0b7 Infection occurs within 30 days after the operation if no implant is left in place or within\\none year if implant is in place and the infection appears to be related to the operation and\\ninfection involves deep soft tissues (e.g. fascialand muscle layers)of the incision and at\\nleast one of the following\\n\\uf0b7 Purulent drainage from the deep incision but not fromthe organ/space component of the\\nsurgical site.\\n\\uf0b7 A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the\\npatient has at least one of the following signs or symptoms:fever (>38Â°C) localized pain\\ntenderness unless site is culture-negative\\n\\uf0b7 An abscess or other evidence of infection involving the deep incision is found on direct\\nexamination,during re-operation,or by histopathologyor radiologic examination.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 329, 'page_label': '330'}, page_content='Surgery\\n322\\n\\uf0b7 Diagnosis of deep incisional SSI by a surgeon or attending physician.\\nOrgan/space SSI\\n\\uf0b7 Infection occurs within 30 days after the operation if no implant is left in place or within\\none year if implant isin place and the infection appears to be related to the operation and\\ninfection involves any part of the anatomy (e.g. organs or spaces), other than the incision,\\nwhich was opened or manipulated during an operation and at least one of the following\\n\\uf0b7 Purulent discharge from a drain that is placed through a stab wound in to the organ/space.\\n\\uf0b7 Organisms isolated from an aseptically obtained culture of fluid or tissue in the\\norgan/space.\\n\\uf0b7 An abscess or other evidence of infection involving the organ/space that is found on\\ndirect examination, during re-operation, or by histopathologic or radiologic examination.\\n\\uf0b7 Diagnosis of an organ/spaceSSIby a surgeon or attending physician.\\nPharmacological treatment\\n\\uf0b7 The antibiotics selected for prophylaxis must cover the commonpathogens. Antibiotics\\nelection is influenced by the organism most commonly causing wound.Infection in the\\nspecific procedure and by the relative costs of available agents.\\n\\uf0b7 Gastrointestinal procedures, oral and intravenous administration of agents with activity\\nagainst gram-negative and anaerobic bacteria are warranted, as well as mechanical\\npreparation of the bowel.Ceftriaxone/cefotaxime provides adequate coverage for most\\nother types of procedures.The antibiotics chosen for prophylaxis can be those used for\\nactive treatment of infection.However, the chosen antibiotics must reflect local disease-\\nspecific information about the common pathogens and their antimicrobial susceptibility.\\nA past history of a serious adverse event should preclude administrationof a particular\\nantibiotic like penicillin.\\nTiming and duration of prophylaxis\\n\\uf0b7 The first dose should always be given before the procedure, preferably within30 minutes\\nbefore incision. Re-administration at one to two half-lives of the antibiotic is\\nrecommended for the duration of the procedure. In general, postoperative administration\\nis not recommended.\\n\\uf0b7 There may be situ ations where overriding factors alter the normal timing of\\nadministration.For example, during a caesarean section prophylaxis should be delayed\\nuntil the cord is clamped in order to prevent the drug reaching the neonate. When a\\ntourniquet is to be applied the necessary tissue concentration must be achieved prior to its\\napplication rather than the time of incision. This probably occurs within10 minutes of\\nadministration of an IV antibiotic injection. Antibioticsshould also be administered\\nimmediatelyafter unexpected contamination of the tissues additional doses during the\\noperation.\\nThe individual surgeon should be free to givean extra dose for prolonged operations with\\nm ajor   blood loss ifthey wish.Howe ver,thereisinsufficientevidence to make a general\\nrecommendation.Antibiotic prophylaxis should be confined to the perioperative period.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 330, 'page_label': '331'}, page_content='Surgery\\n323\\nRoute of administration\\nIntravenous administration of antibiotic prophylaxis immediately before or after induction of\\nanesthesiais the mostreliablem ethod forensuringeffective serum antibiotic concentrations\\nat the time ofsurgery.\\nDose selection\\nA single doseof antibiotic at the therapeutic concentration is sufficient for prophylaxis under\\nmost circumstances.In adults,blood loss of up to1500 ml during surgery or haemodilution up\\nto15 ml/kg does notrequire an additional dose of prophylactic agent.\\nIn theevent of major intraoperativeblood loss(>1500ml) additional doses of prophylactic\\nantibiotic should be given after fluid replacement.Antibiotic prophylaxis in all cardiac\\nsurgeries and interventions isrecommende d.\\nTable 1.Incidence of surgical site infections (SSI) with various types of surgery\\nType of surgery Name of Surgeries SSI\\nrate\\nClean\\nElective,noteme rgency, non traum atic,prim arily closed;no\\nacute inflamm ation ;  no break in technique; respiratory,\\ngastrointestinal,biliary andgenitorurinary  tractsnot entered\\n<2\\nC lean-\\ncontaminated\\nU rgent or emergency  case that is otherwise  clean;elective\\nopening of  respiratory, gastrointestinal, biliary or genitourinary\\ntract with minimalspillage (e.g.appendectom y) not\\nencountering infected urine or bile;minor technique break\\n<10\\nC ontaminated\\nNo npurulent inflammation; gross pillage from gastrointestinal\\ntract;entry into biliary or genitourinary  tract in the presence of\\ninfected bile or urine; major break in technique;penetrating\\ntraum a <4hoursold;chronic open  wounds to be grafted or\\ncovered\\n~20\\nDirty Purulent inflammation (e.g.abscess);preoperativeperforation of\\nrespiratory, gastrointestinal,   biliary  orgenitourinary tract;\\npenetrating trauma >4hours old\\n~40'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 331, 'page_label': '332'}, page_content='Surgery\\n324\\n\\uf0b7 Pain is unusuallysevere for thema gnitude of procedureand lastlong.Fever: 101 to\\n102 Fwithtachycardia is usually present.\\n\\uf0b7 Local exam ination: Wound is warm to touch and m ay be swollen and oedem atous.\\nRedness of thesurrounding areaand cellulitesis often present.\\n\\uf0b7 Wound infections are generally evident between 3rd to 6th postoperative days\\nInfection risk factors:Factors associated with increased risk ofinfection are:\\nSystemic factors: Diabetes, corticosteroid use, obesity, extremes of age, malnutrition, recent\\nsurgery, massive transfusion, multiple(3ormore) preoperative co morbid medical diagnoses\\nLocal factors: foreign body,electrocautery;injection with epinephrine;wound drains; hair\\nremovalwith razor; previous irradiation of site.\\nDevelopment of local guidelines\\nIt isadvisable to make local surgical site infection prevention protocols be developed by local\\nhospital management.\\nPostoperative wound management\\n\\uf0b7 Most postoperative wounds are covered with occlusive dressingsThe occlusive dressing\\n(semi permeable to water vapours and oxygen but impermeable to liquids) consists of a\\nhydrating layer (antibiotic ointm ents or petroleum jelly), anon-adherent contactlayer, an\\nabsorbent and cushioning layer(gauze),and a se\\xad  curing layer like hypo allergic tape.\\nOcclusivedressings should be applied within2 hours of wounding and left on forat least 24\\nhours foroptim alhealing to occurfor acute wounds. These should never be used on infected\\nwounds. Dressing changes can be performed once or twice daily. If other types of occlusive\\nare used,thetiming of the dressing changes will vary between I to7 days, depending on the\\nw ound characteristics.\\nPOSTOPERATIVE WOUND INFEC T ION\\nW ound infections areclassified as\\n\\uf0b7 Mi nore.g.stitch abscess, cellulitis.\\n\\uf0b7 M ajore.g.presence ofdiscrete collection ofpus in wou nd.\\n\\uf0b7 Superficialinfections are limited toskin and subcutaneoustissue.\\n\\uf0b7 D eep infections-involve the areas ofw ound below the fascia.\\nPostoperative cross infection in wards:Staphylococcus aureus is the mostfrequently involved\\norganism . Other lesscommon or ganism s areEnterococci,Pseudomon as, Proteus, E. Coliand\\nKlebsiella.\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 332, 'page_label': '333'}, page_content='Surgery\\n325\\nSuperficial infection\\n\\uf0b7 D rainage:W ounds are managed by opening up the incision to provide adequate drainage.\\n\\uf0b7 D ressing:D aily dressing with povidone-iodine 5% and awick is placed toprevent premature\\nclosureofthe wound.\\n\\uf0b7 Ana lgesics:Tab. ibuprofen 400mg 3 timesa day tillpain isthere.\\nD eep infections\\n\\uf0b7 A ntibiotics are given on the basis of pus culture and sensitivity in addition to drainage of\\nwo und.\\nPrevention\\nPostoperativew ound infection ratecan be minimized by adequate skin preparation,bowel\\npreparation, prophylactic antibiotics, meticulous surgical technique\\nW O UN D C A RE\\nWo unds can be classified as acute or chronic and further as arterial,venous trophic, malignant.\\nAcute wounds heal uneventfully within an expected time frame e.g.burns.For the purpose of\\nguidelines,chronic wo unds can be defined as an ulcerpresentat least for6 weeks.\\nTreatment\\nM eticulous w ound c are includes adequate cleansing, debridemen t, oedema control and\\nprevention of ischemia,\\nAcute wounds\\n\\uf0b7 The overall objective in caring for wounds that are incompletely clottedis to minimize\\nunnecessaryblood loss and to avoid the formation ofa hematoma.\\n\\uf0b7 Irrigate gently with copious quantities of water or normalsaline. Debrisand necrotic tissue\\nshould be remov ed w ithout damaging healthy tissue. Sharp mechanical debridement may be\\nnecessary toexpose viable tissue for large areasof fibrinous exudates or eschar. Chem ical\\ndebridem ent is useful for those areas that are difficult toaccess by sharp debridement.\\nChemical debridement of the wounds may be done using topical antiseptics (chlorhexidine,\\npovidoneiodine, alcohol, hydrogenperoxide, triclosan) and antibacterials (silver sulfadiazine,\\nneomycin, polymyxin, bacitracin, mupirocin).When debridement is complete, dressingscan\\nbe applied.\\n\\uf0b7 Healing of acute wound is further facilitated by closure. Alternatively,closure can be delayed\\nfor several days to allow infection to clear. Wound healing is impaired by malnutrition,\\noedema ,bacterial contamination, ischemia, smoking and immunosuppressant.\\nChronic wounds\\nIdentify and treat the predisposing factors, e.g. diabetes mellitus, peripheral arterial orvenous\\ndisease, severe anem ia, protein deficiency, rheumatoid arthritis, systemic vasculitis, cushingâ€™s\\nsyndrome andconditions requiringsystemic steroid therapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 333, 'page_label': '334'}, page_content='Surgery\\n326\\nNon -pharmacological treatment\\n\\uf0b7 Encourage daily or twice a day bath, to avoid walking bare foot or with slippers and patient\\nshould been courage to wear shoes and socks.\\n\\uf0b7 Patients with leg ulcer to reduce standing or excessive walking. In leg ulcer due to chronic\\nvenous insufficiency or oedema, patients should be advised to wear elastic stockings,\\nelevation of leg and foot end of the bed while a sleep along with some leg exercises to\\nactivate the calf muscle pump.\\nPharma cological treatment\\nIdentify the microorganism and treat accordingly. Tubercular ulcer is treated with anti tubercular\\ndrug (2HRZE+7HR) for at least 9 months.\\nSurgical treatment\\n\\uf0b7 Surgical debridement in ulcer associated with necrotic tissue or slough. Clean the wound\\nwith physiological normal saline or tap water only (antiseptics delay wound healing).\\n\\uf0b7 Daily dressing: Gauze adhere to the wound bed and it may remove viable tissue from the\\nwound surface on removal , resulting in delayed wound healing. Some ofthe commonly used\\ndressings are:\\n\\uf0b7 Occlusive (moist ureretentive) dressings (Hydrocolloid gel) in case of clean and shallow\\nulcers without any pus discharge or other features of infection. Occlusive dressings have\\nbarrier properties that enable to prolong the presence of moisture and wound fluid in the\\nwound bed.\\n\\uf0b7 Calcium alginate dressing: For bleeding wounds and wounds with a cavity.\\nPatient education\\n\\uf0b7 To prevent ulcer in future, explain about the care of leg ulcers, wearing socks, shoes and\\ncompression stocking.\\n\\uf0b7 Good personal hygiene (daily bath) and after bath the healed scar area should be massaged\\nwith an emollient cream such as lanolin or some other oil to keep the scar tissue soft and\\nsupple and prevent further breakdown.\\n\\uf0b7 Regular use of calf muscle activating exercises and leg elevation and to avoid prolonged\\nperiod of standing orsitting with legs down.In case of diabetic patients, control of diabetes is\\nnecessary.\\nSTERILIZATION AND DISINFECTION\\nDefinitions\\nSterilization is removal of all viable micro-organisms, vegetative and spores. Disinfection is the\\nremoval of actively dividing vegetative micro-organisms. Antisepsis is the process whereby the\\nrisk of medical cross-infection by micro-organisms is reduced'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 334, 'page_label': '335'}, page_content='Surgery\\n327\\n\\uf0b7 Time of occurrence of wound and its etiology\\n\\uf0b7 Co morbidities like diabetes mellitus, anemia, scurvy, jaundice\\n\\uf0b7 Number, site, size, depth active bleeding, discharge, foreign material, associated\\nneurovascular injury, tendon injury, bone fracture and make proper documentation of all\\ninjuries to be done in patient records.\\nMethods of Sterilization\\nI. Heat\\n\\uf0b7 Dry heat (e.g. incineration, flaming to red hot) is effective but rarely useful. Dry heat\\nrequires temperatures of 160Ã‚Â°C for at least 60min.\\n\\uf0b7 Moist heat (e.g. autoclave heating using pressurized steam 121Ã‚Â°C at 15lb/in2 for\\n15min) is effective and useful especially inoperating theatres.\\nII. Irradiation, Gamma radiation effective for inorganic material   Filtration: Air or fluids can\\nbe sterilized by ultrafine membrane filters but are rarely useful in hospital practice\\nIII. Chemical\\n\\uf0b7 Acids/alkalis, e.g. bleach. Effective for non-human contact use.;\\n\\uf0b7 Alcohols/phenols, e.g. ethyl alcohol skin swabs, alcohol solutions  hand  disinfection\\ncarbolic; chloroxylenols (Dettol), phenol (Clearsol )\\n\\uf0b7 Oxidizers, e.g. povidone-iodine (Betadine) skin disinfection/surgical scrubbing;\\nH 2O 2 superficial wound cleansing; aldehydes (Cidex) surgical instruments such as\\nendoscopes; Cationic solutions, e.g. Chlorhexidine antiseptic washes.;\\n\\uf0b7 Organic dyes, e.g. Proflavin\\nAntisepsis: Principles of antisepsis include the following.\\n\\uf0b7 Always remove gross contamination with simple soap first.\\n\\uf0b7 Use high potency acid/alkali disinfection on inert surfaces.\\n\\uf0b7 Use less corrosive oxidizers on delicate inert materials.\\n\\uf0b7 Use weak alcohols, oxidizers for skin cleansing.\\nSUTURING OF PRIMARY WOUND\\nSuturing is one of the firstand foremost thing any surgeon will perform in his or her career.\\nConsider following points while suturing primary wounds.\\nSalient features\\nInvestigations\\n\\uf0b7 Usually not required. X-rays of local part are needed if fracture or foreign body is suspected.\\nPha rmacologicaltreatment\\n\\uf0b7 Inj.  tetanus toxoid 0.5 ml IM stat'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 335, 'page_label': '336'}, page_content='Surgery\\n328\\n\\uf0b7 Inj.  diclofenac sodium 3 ml (75mg) IM stat\\n\\uf0b7 Tab. ampicillin 500 mg three times day for  3-5 days\\n\\uf0b7 Tab. diclofenac 50 mg twice day for  3-5 days\\n\\uf0b7 Tab. multivitamins/Iron if patient is deficient of anyfor better healing\\n\\uf0b7 Control of Diabetes mellitus, if present\\n\\uf0b7 Management of local wound: if wound is recent(<6 hrs) cleaning followed by suturing is\\ndone. If duration of injury is >6 hrs, and contamination is present, wound is debrided and\\nwound is closed by secondary suturing at a later date when wound is clean.\\n\\uf0b7 For primary suturing:Thorough cleaning of wound by saline/Hydrogen Peroxide/Betadine.\\n\\uf0b7 Removal of any foreign material and control of active bleeding.\\nChoice ofsuturem aterial\\nThe size of suture material is measured by its width or diameter and is vital to proper wound\\nclosure.\\n\\uf0b7 1-0 and 2-0: Used for high stress areas requiring strong retention, i.e.-deep fascia repair\\n\\uf0b7 3-0: Used in areas requiring good retention, i.e.-scalp, torso, and hands\\n\\uf0b7 4-0: Used in areas requiring minimal retention, i.e.  extremities. Is the most common size\\nutilized for superficial wound closure.\\n\\uf0b7 5-0: Used for areas involving the face, nose, ears, eyebrows, and eyelids.\\n\\uf0b7 6-0: Used on areas requiring little or no retention. Primarily used for cosmetic effects\\nSuture Techniques:Wound layers should be placed in close approximation. Minimal amount of\\ntension across the suture lineshould be kept. Wound edges should be slightly everted. Equal\\nbites, horizontally and vertically are important for wound position and healing. Debride\\ndevitalized tissue.  Alternate day dressing with antiseptic solution till suture removal\\nSuture removal\\n\\uf0b7 Duration will vary according to the location and depth of the wound. However, the average\\ntimeframe is 7-10 days after application. The following general rules can be sued in deciding\\nwhen to remove sutures:\\n\\uf0b7 Face: 4-5 days.\\n\\uf0b7 Body & scalp: 7 days.\\n\\uf0b7 Soles, palms, back or over joints: 10 days\\n\\uf0b7 Any suture with pus or signs of infections should be removed immediately. Once MO\\ndetermines that the sutures should be removed, a suture removal kit, consisting of scissors\\nand a pair of tooth forceps is utilized to remove the sutures.\\n\\uf0b7 Using the tooth forceps, grasp the knot and snip the suture below the knot with the scissors as\\nclose as possible to the skin.  Pull the suture line through the tissue and place on a 4x4.  Once\\nall sutures have been removed count the sutures.  The number of sutures needs to match the'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 336, 'page_label': '337'}, page_content=\"Surgery\\n329\\n\\uf0b7 Vague periumbilical or sometimes epigastic pain of visceral nature from a dilated appendix\\nwhich migrates to right lower quadrant and becomes somatic in nature from contact of\\nserosa of inflammed appendix against the parietal peritoneum.\\n\\uf0b7 Pain followed by anorexia,nausea and occasional vomiting, fever in 50% of cases\\n\\uf0b7 McBurney's sign : migratory nature of pain that settels at McBurney's point (one third of\\nthe distence from the anterior superior iliac spine to the umbilicus\\n\\uf0b7 Rebound tenderness\\n\\uf0b7 Perforated appendicitis may present with more severe abdominal pain ,progressing from\\nfocal peritonitis to generalized peritonitis with rebound tenderness, voluntory guarding\\nfollowed by involuntary guarding and finally rigidity.\\nnumber indicated in the patient's health record.\\nACUTE APPENDICITIS\\nIt is inflammation of appendix caused by luminal obstruction due to fecoliths (50%), lymphoid\\nhyperplasia,malignancy or rarely parasitic infection.\\nSalient features\\nDiagnosis\\n\\uf0b7 Blood counts (neutrophillia),USG Abdomen (shows inflamed appendix)CECT Abdomen, if\\nRIF lump is palpable.\\nPharmacological treatment\\n\\uf0b7 In early catarrhal appendicitis, with minimally inflamed appendix patient can be given\\nmedical and conservative management which includes-\\n- Tab. ciprofloxacin 500mg BD and  Tab. metronidazole 400 mg TDS or a second generation\\ncephalosporin cefotaxim 1 gm BD\\n\\uf0b7 Inj.diclofenac  75 mg IM\\n\\uf0b7 Tab.ranitidine 150 mgBD or Cap. omeprazole 40 mgBD\\nSurgical treatmentAppendicectomy by open or laproscopic approch\\nHERNIA\\nI. INGUINAL HERNIA\\nInguinal hernias are the most common hernias world wide. Most commonly seen in men. Several\\nclassifications are available worldwide but none has been prove to be perfect, besides, most\\nsurgeons in the world commonly classify them as being Direct or Indirect inguinal hernias.\\nDirect inguinal hernia is the one which occurs medial to deep epigastric artery, through\\nHesselbach's triangle. Indirect inguinal hernia occurs through deep ring.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 337, 'page_label': '338'}, page_content='Surgery\\n330\\n\\uf0b7 G roin swellingreducible, impulsile,history ofstrenuousactivity,heavy labour,chronic\\ncough,chronic constipation,urinary complains.Examination of swellingis required.\\n\\uf0b7 Reducible, impulse on coughing present,examination of scrotum and penis\\n\\uf0b7 Per rectal examination, systemic examination ofchest and abdomenis required.\\n\\uf0b7 In history evaluatenature of primary surgery, Wound complications following primary\\nsurgery, presence of malnutritionand associated comorbidities.\\n\\uf0b7 Physical examinationof scar and defectand swelling, reducibleimpulsile on coughing\\nSalientfeatures\\nInvestigations\\n\\uf0b7 Diagnosis of hernia is purely clinical, investigations are required where diagnosis is\\ninconclusive or for evaluation of associated conditions.\\n\\uf0b7 USG -local part for defect. USG-KUB for urinary complains.\\n\\uf0b7 S. PSA if prostate is enlarged\\n\\uf0b7 Prostatic biopsy. Pulmonary function tests for chronic cough\\nPh armacologicaltreatment\\n\\uf0b7 Treatment of predisposing factors if present any\\n\\uf0b7 Treatment of chronic cough according to cause\\n\\uf0b7 Treatment of Chronic constipation\\n\\uf0b7 Treatment of BPH if present, pharmacological as well surgical\\nSurgical treatment\\n\\uf0b7 Herniotomy, for congenital hernias\\n\\uf0b7 Hernioplasty for open gold standard for any type of adult hernia at present. Lichtenstein\\ntension free hernioplasty\\n\\uf0b7 By laparoscopichernioplasty is preferred in small and bilateral hernia.\\n\\uf0b7 TEP -Totally Extra peritoneal meshplasty\\n\\uf0b7 TAPP -Trans Abdominal Preperitoneal meshplasty\\nII.INCISIONAL HERNIA\\nIncisional hernia is defined as hernia occurring through any previous surgical incision.\\nPredisposing factors are improper techniques of wound closure ,wound infection, wound\\ndehiscence, malnutrition,malignancy\\nSalient feature\\nInvestigations\\nUSG local part for defect, Preoperative investigations\\nSurgical Treatment'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 338, 'page_label': '339'}, page_content=\"Surgery\\n331\\n\\uf0b7 Underlay: preperitoneal mesh placement under the defect, preferred route\\n\\uf0b7 Inlay: mesh placement thought the defect\\n\\uf0b7 Onlay/Overlay: Mesh placement above the defect in muscular plane\\n\\uf0b7 Laparoscopic mesh placement under the defect, preferred whenever possible\\nHYDROCOELE\\nH ydrocele is an abnormal collection of serous fluid in apart of the proccessus vaginalis,usually\\nthe tunica. Acquired hydroceleare primary or idiopathic,or secondary to testicular disease.\\nCauses includesexcessive production of fluid within the sac,e.g.secondary hydrocele, by\\ndefective absorption of fluid,e.g.primary hydrocele, by interference with lymphatic drainage  of\\nscrotal structures, by connection with the peritoneal cavity via a patent processus vaginalis.\\nSalient features\\nSurgical treatment\\nCongenital hydrocele requires herniotomy while acquired hydrocele-jaboulay's procedure or\\nLord's procedure\\nC HOLELITHIASIS\\nCholelithiasis or gall bladder stones are common problem in our country.It may lead to\\ncholecystitis, cholangitis, choledocholithiasis with obstructive jaundicegall stone pancreatitis.\\nGall stones may be of cholesterol stones, pigment stones, mixed stones\\n\\uf0b7 Hydroceles are translucent and it is possible to get above swelling. Primary vaginal\\nhydrocele is most common in middle and later life butcan also occur in older children.\\nSwelling is painless. The testis may be palpable within a lax hydrocele, but an ultrasound\\nscan is necessary tovisualizethe testis if the hydrocele sac is tense. Testicular\\nmalignancy is an uncommon cause of hydrocele that can be excluded by ultrasound\\nexamination of the scrotum.\\n\\uf0b7 About 5% inguinal hernia are associated with a vaginal hydrocele of that side. In\\ncongenital hydrocele,pressure onitdoes not always empty it but the hydrocele fluid may\\ndrain into the peritoneal cavity when the childis lying down.\\n\\uf0b7 Encysted hydrocele of cord is smooth oval swelling near the spermatic cord,which is\\nliable to be mistaken for an inguinal hernia.\\n\\uf0b7 The swelling moves downwards and becomes less mobile if the testis is pulledgently\\ndownwards.\\n\\uf0b7 Hydrocele of canal of Nuck is similar condition in female. The cyst lies in relation to the\\nround ligament and is always at least partially within the inguinal canal.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 339, 'page_label': '340'}, page_content='Surgery\\n332\\n\\uf0b7 â€œFatty forty flatulent fertile femaleâ€ is the classical description ofcholelithiasis.\\n\\uf0b7 R ight upper quadrant epigastric pain, dyapepsia, nausea, vomiting.\\n\\uf0b7 Murphyâ€™s sign.\\nSalient features\\nInvestigations\\nUltrasound abdomen, total and differential count, liver function test\\nSurgical treatment\\n\\uf0b7 Definitivetreatment ischolecystectomy in symptomatic and asymptomatic patients\\nw ith diabetes or  asolitarylarge stone or multiple small stones with wide cystic\\nduct or porcelain gallbladder or anxious patients. Ifthe patient comes after48 hours\\nmanage conservatively and cholecystectomy after6-8 weeks.\\n\\uf0b7 In case of acutecholecystitis, empyema gallbladder, andstonesin the CBD following\\ntreatment is instituted.\\nPharmacological treatment\\n\\uf0b7 Maintenance IV fluids\\n\\uf0b7 Inj.ciprofloxacin(infusion 100m g/50 ml) 100 ml IV twicea day and Inj. gentamicin(40\\nmg /ml) 2ml IV 8 hourly.\\n\\uf0b7 In case anaerobicbacterial infectionis suspectedor anticipated, giveInj. metronidazole\\n(500 mg/l00ml) 100 ml IV 8 hourly.\\n\\uf0b7 Inj. diclofenac sodium (25 mg/m l) 2 -3 ml IM SOS or 6 hourlyor Inj. pentazocine (30\\nmg/m l) 1m l IM SOS .\\n\\uf0b7 Inj.hyoscinebutylbromide (20 mg/ml) 1ml IV SO S.\\n\\uf0b7 In patients having obstructivejaundice, addInj. vitaminK (10 mg/ml) 1 ml IM once or\\ntwicea day tillprothrombin time reaches toa satisfactory level.\\n\\uf0b7 Antibiotics areusuallystoppedafter5-7 days unlessthepatienthas evidence ofpersistent\\ninfectionor has indwelling tube(e.g., T -tube).\\nPatient education\\n\\uf0b7 To avoid fattyand fried meals for3 months.\\n\\uf0b7 Althoughambulation isencouraged as early as possible,heavy physical exertionshould be\\navoided for 2 weeks (after laparoscopic cholecystectomy)and for 3 months after\\nconventional cholecystectomy.\\n\\uf0b7 If T -tube has been placed, it should beremoved after 2-3 weeks, after ensuring thatthe\\nCBD ispatent,non dilatedand thereis free flow of contrastinto theduodenum during T-\\ntube cholangiography.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 340, 'page_label': '341'}, page_content='Surgery\\n333\\n\\uf0b7 Disease may be entirely asymptomatic.Abdominal lump in right upper quadrant.Pain\\nmay be characterized as heaviness in abdomen.\\n\\uf0b7 Obstructive jaundice when daughter cyst may communicate with bil iary tree.\\nAnaphylactic shockif cyst ruptures into peritoneal cavity.\\n\\uf0b7 Jaundice, itching, anorexia, weight loss, clay coloured stools, dark urine\\n\\uf0b7 Abdominal lump, abdominal examination, look for palpable mass, liver,\\n\\uf0b7 G eneral examination: Jaundice, cachexia\\nHYDATID DISEASE OF LIVER\\nIt iscaused byEchinococcus granulosusand Echinococcus multilocularis\\nSalient features\\nClassification by WHO\\n\\uf0b7 Group 1-Active group-cysts larger than 2 cm and often fertile\\n\\uf0b7 Group 2- Transition group- cysts starting to degenerate and entering a transitional stage\\nbecause of host resistance or treatment but mat contain viable protoscolices\\n\\uf0b7 Group 3- Inactive group- degenerated, partially or totally calcified cysts, unlikely to contain\\nviable protoscolices\\nInvestigations\\n\\uf0b7 TC and DC show eosinophillia.ELISA can point toward diagnosis.Ultrasound and CT scan\\nare the investigations of choice. CT scan shown smooth space occupying lesion with several\\nsepta\\nPharmacologicaltreatment\\n\\uf0b7 Tab.albendazole 400 mg TDS for 28 days repeated for 3 cycles.\\nSurgical treatment\\n\\uf0b7 PAIR -Puncture, Aspiration, Injection (of a scolicidal agent), Reaspiration\\n\\uf0b7 Radical or partial pericystectomy\\n\\uf0b7 Hepatic segmentectomy\\n\\uf0b7 Scolicidal agents used for surgery: hypertonic saline 15%,cetrimide 3%\\nOBSTRUCTIVE JAUNDICE\\nJaundice, also known as hyperbilirubinemia causes increased levels of bilirubin in the\\nextracellular fluid. Concentration of bilirubin in blood is normally below 1.2 mg/dL. A\\nconcentration higher than 2.5mg/dL (>50Âµmol/L) leads to jaundice. It can be caused by\\ncholedocholithiasis, periampullary mass, billiary atresia, cholangiocarcinoma, Mirizzi syndrome\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 341, 'page_label': '342'}, page_content='Surgery\\n334\\nInvestigations\\n\\uf0b7 S. bilirubin: total, direct, indirect, hyperbilirubinemia with increased direct bilirubin,PT with\\nINR, elevated, SGPT, SGOT- can be normal or elevated, SAP- increased more than 3 folds,\\nCA 19 -9, elevated in periampullary cancers\\n\\uf0b7 USG -Abdomen, MRCP, CECT -Abdomen, ERCP\\nNon pharmacological treatment\\nLow fat, high carbohydrate diet\\nPharmacological treatment\\n\\uf0b7 IV fluids to maintain hydration and Correction of electrolyte imbalance\\n\\uf0b7 Inj. vitamin k\\n\\uf0b7 Fresh frozen plasma  when indicated\\n\\uf0b7 Prophylactic antibiotics, Inj. cefotaxime 1 gm IV 8 hourly\\nSurgical treatment\\n\\uf0b7 ERCP with sphincterotomy and stenting, followed by cholecystectomy\\n\\uf0b7 For choledocholithiasis,cholecystectomy with CBD exploration\\n\\uf0b7 For stones not amenable for retrieved by ERCP\\n\\uf0b7 Whipple procedure (pancreaticoduodenectomy), for resectable periampullary mass\\n\\uf0b7 Bypass procedures (hepaticojejunostomy with/without gastrojejunostomy)for unresectable\\nperiampullary mass\\nINTESTINAL OBSTRUCTION\\nCauses\\n\\uf0b7 Intraluminal-impaction, foreign bodies, bezoars, gall stones\\n\\uf0b7 Intramural-stricture, malignancy\\n\\uf0b7 Extramural-bands/adhesion, hernia, volvulusintussusecption\\n\\uf0b7 A dynamic-paralytic ileus ,mesenteric vascular occlusion ,pseudo obstruction\\nMechanism of obstruction\\nV olvulus, incarceration, obstruction,intussusceptions\\nCauses of strangulation\\n\\uf0a7 External: hernial orifices, adhesion/bands\\n\\uf0a7 Interrupted blood flow: volvulus,intussusceptions\\n\\uf0a7 Increased intraluminal pressure: closed loop obstruction\\n\\uf0a7 Primary: mesenteric infarction'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 342, 'page_label': '343'}, page_content='Surgery\\n335\\n\\uf0b7 A cute-sudden onset severe colicky central abdominal pain,distension,early vomiting,\\nconstipation\\n\\uf0b7 A cute on chronic-shorthistory of distension and vomiting against a background of pain\\nand constipation\\n\\uf0b7 C hronic inlarge bowel obstruction with lower abdominal colic ,absolute constipation\\nfollowed by distensionsubacute implies incomplete obstruction\\n\\uf0b7 O ther manifestation are dehydration, hypokalemia pyrexia, abdominal tenderness,\\nclinical features of strangulation; constant pain, tenderness with rigidity,shock\\n\\uf0b7 The patient resides or recently visited an endemic area. Patient presents in 2nd or 3rd\\nweek of illness.\\n\\uf0b7 Patients present with high temperature and very toxic, Ross spots,abdominal pain,\\nmalena, diarrhoea,abdominal tenderness andguarding.\\nSalientfeatures\\nInvestigations\\n\\uf0b7 X ray abdomen in standing position, shows multiple air fluid levels\\n\\uf0b7 Total and differential counts\\n\\uf0b7 Ultrasound abdomen\\n\\uf0b7 Contrast enhanced ct scan abdomen with pelvis\\nNon surgicaltreatment\\n\\uf0b7 Nasogastric decompression, correction of dehydration, correction of electrolytes imbalance\\nand broad spectrum antibiotics\\nSurgicaltreatment\\n\\uf0b7 Exploratory laprotomy with adhesiolysis, resection of non viable intestine or extirpation of\\nobstructing lesion.\\nTYPHOID PERFORATION\\nIt iscaused bySalmonella typhi.\\nSalient features\\nInvestigations\\nTC and DC shows relative neutropenia, Widal test, Blood and Stool culture, X ray abdomen\\nstanding shows free gas under diaphragm\\nNon pharmacological treatment\\n\\uf0b7 Patient should be admitted to intensive care unit\\n\\uf0b7 Vigorous resuscitation of fluids'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 343, 'page_label': '344'}, page_content='Surgery\\n336\\n\\uf0b7 Weight loss, chronic cough, malaise, evening rise of temperature with sweating, vague\\nabdominal pain with distension, alternating constipation and diahrrea.\\n\\uf0b7 May present with features of peritonitis with perforation orobstruction. Doughy feel of\\nabdomen.\\n\\uf0b7 Inj.ceftriaxone 2 gm loading dose followed by 1 gm IV 8 hourly\\n\\uf0b7 Tab.metronidazol 400 mg IV 8 hourly\\nSurgical treatment\\n\\uf0b7 Emergency exploratory laparotomy\\n\\uf0b7 Commonest site of perforation is terminal ileum\\n\\uf0b7 Having found a perforation, look for others\\n\\uf0b7 In the very ill patient, look for some type of extoriorisation\\n\\uf0b7 Close the peritoneum and leave the wound open forsecondary healing\\nSMALL BOWEL TUBERCULOSIS\\nSalient features\\nInvestigations\\n\\uf0b7 Hemogram shows anemia, raised ESR and CRP, positive sputum culture. Ultrasound of\\nabdomen shows localized collection.\\n\\uf0b7 Chest X Ray show pulmonary infiltrates.\\n\\uf0b7 Barium meal and follow through shows multiple small bowel strictures in ileum and\\nsubhepatic caecum.\\nSurgicaltreatment\\n\\uf0b7 Patient should ideally be treated under combined care of physician and surgeon. Vigorous\\nsupportive and full drug treatment is mandatory in all cases. Symptomatic strictures are\\ntreated by appropriate resections.\\n\\uf0b7 Acute intestinal obstruction from distal illeal stricture is treated by thorough resuscitation\\nfollowed by side to side illeo-transverse bypass.Once the patient has recovered with medical\\ntreatment, then the second stage definitive procedure of right hemicolectomy is done.\\n\\uf0b7 One stage resection and anastomosis can be done if the patientâ€™s general condition permits .\\nPerforation is treated by appropriate local resection and anastomosis or exteriorization if the\\ncondition of the patient is very poor, that is later followed by restoration of bowel continuity\\nafter patient is fully recovered of anti-tuberculous therapy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 344, 'page_label': '345'}, page_content='Surgery\\n337\\n\\uf0b7 Constipation, sharp agonizing pain during defecation, bright streaks of blood in stools.\\n\\uf0b7 Ulcer at the lower end of the anal canal seen when tightly closed puckered anus is\\nstretched apart.\\nANAL FISSURE\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Lignocaine jelly or ointment (5%) applied locally 3-4 times a day;\\n\\uf0b7 Tab. metronidazole 400 mgfor 5 days, twice a day.\\n\\uf0b7 Tab ibuprofen 400 mg one tablet 8 hourly\\n\\uf0b7 Sitz bath (warm water withpovidone iodine) twice a day\\n\\uf0b7 Isapghula husk 1-2 teaspoon in water one or two times a day for control ofconstipation and\\nstraining during defecation Or\\n\\uf0b7 Liquid paraffin (5-15 ml) at bed time for one month, if no relief with local lignocaine,\\napplication\\nSurgicaltreatment\\n\\uf0b7 Aim of therapy is to cause complete relaxation of the anal sphincter that will relievepain and\\nslowly heal the fissure.\\n\\uf0b7 Anal dilation under general anaesthesia.\\n\\uf0b7 Fissurectomy and sphincterotomy if needed.\\nFISTULA IN ANO\\nA fistula-in-ano is a hollow tract lined with granulation tissue, connecting a primary opening\\ninside the analcanal to a secondary opening in the perianal skin. Secondary tracts may be\\nmultiple and can extend from the same primary opening. Fistula-in-ano is nearly always caused\\nby a previous anorectal abscess.\\nSalient features\\n\\uf0b7 Patients often provide a reliable history of previous pain, swelling, and spontaneous or\\nplanned surgical drainage of an anorectal abscess. Signs and symptoms of fistula-in-ano,\\nin order of prevalence, include the following perianal discharge, pain, swelling, bleeding,\\ndiarrhea, skin excoriation, external opening'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 345, 'page_label': '346'}, page_content='Surgery\\n338\\n\\uf0b7 Bleeding per rectum, pruritus ani, something coming out per rectum, constipation.\\n\\uf0b7 Per rectal examination and proctoscopy  shows haemmorrhoid with or without bleeding\\npoints at 3,7,11 clock position. Grade I- punctuate bleeding , non protruding. Grade II-\\nprotrudes during straining, reduces spontaneousl. Grade III-protrudes during straining needs\\nto be manually reduced. Grade IVâ€“ prolapsed haemorrhoids. No other diagnostic modality\\nneeded  other than proctoscopy\\nInvestigations\\nIn selected cases of high fistula, multiple fistulae,and recurrent fistulae.\\n\\uf0b7 Fistulography\\n\\uf0b7 Endoanal/endorectal ultrasonography\\n\\uf0b7 MRI\\n\\uf0b7 Barium enema/small bowel series\\n\\uf0b7 Anal m anometry\\n\\uf0b7 Examination under anesthesia\\n\\uf0b7 Proctosigmoidoscopy/colonoscopy\\nSurgical treatment\\n\\uf0b7 Treatment of underlying cause, if any-surgical procedure for eradication of tract\\n\\uf0b7 Fistulotomyand fistulectomy\\n\\uf0b7 Mucosal advancement flap\\n\\uf0b7 Seton placementâ€“ the following conditions- complex fistulas (i.e., high transsphincteric,\\nsuprasphincteric, extrasphincteric) or multiplefistulas\\n\\uf0b7 Recurrent fistulas after previous fistulotomy\\n\\uf0b7 Anterior fistulas in female patients\\n\\uf0b7 Poor preoperative sphincter pressures\\n\\uf0b7 Patients with Crohnâ€™s disease or patients who are immunosuppressed\\nPatient education\\n\\uf0b7 Most patients can be treated in an ambulatory setting with discharge instructions and close\\nfollow-up care. Sitz baths, analgesics, and stool-bulking agents (eg, bran, psyllium products)\\nare used in follow-up care. Frequent office visits within the first few weeks help to ensure\\nproper healing and wound care.\\nHAEMORRHOIDS\\nHaemorrhoids(commonly calledpiles)arethedilated tortuousveinsoccurringin relation tothe\\nanus. These can be primary or secondaryto carcinomaof rectum,pregnancy,strainingat\\nmicturition,orconstipation.C lassifiedintoexternal,internalor mixed(externo-internal).\\nSalient features'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 346, 'page_label': '347'}, page_content=\"Surgery\\n339\\n\\uf0b7 Major factors are neuropathy, vasculopathy, infection.\\n\\uf0b7 Minor factors arearch collapse, microcirculatory abnormality, glycosylation of skin\\nproteins, reduced host immunity, altered  blood viscosity and rheological properties,\\nassocioted renal oedema,hypertension induced vessel thickness,increased weight bearing\\ndue to obesity.\\nNon pharmacological treatment\\n\\uf0b7 High fiber diet\\n\\uf0b7 Plenty of fluids\\n\\uf0b7 Sitz bath-twice a day with lukewarm water\\nPharmacological treatment\\n\\uf0b7 Bulk forming laxative (esabgol husk),at bed time to relieve constipation.\\n\\uf0b7 Local lignocaine 2% ointment if associated external haemorrhoids\\nSurgical measures\\n\\uf0b7 Grade I-conservative management, injection sclerotherapy for bleeding hemmorrhoids.\\n\\uf0b7 Grade II-conservative management and band ligation.\\n\\uf0b7 Grade III/IVâ€“ hemorrhoidectomy.\\nDIABETIC FOOT\\nIt is infection, ulceration and /or gangrene of foot due to diabetes and/or its complication.\\nPrecipitating factors are moisture, trauma-mechanical causes like ill fitting shoes, in growing toe\\nnail, thorn prick, physical, heat, cold and infection.\\nSalient features\\nClinical classification-Maggit's classifacation\\nGrade 0-foot symptoms without ulcer\\nGrade 1-superficial ulcer\\nGrade 2-deep ulcer\\nGrade 3-deep ulcer with bone involvement\\nGrade 4-forefoot gangrene\\nGrade 5-whole  foot gangrene\\nClinicalclassification ofneuropathy\\nCategory 1-no loss of sensation\\nCategory2-loss of sensation\\nCategory 3-loss of sensation with deformity\\nCategory 4-loss of sensation with ulcers\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 347, 'page_label': '348'}, page_content=\"Surgery\\n340\\n\\uf0b7 Aching in the veins at the end of day, after prolong standing,ankle swelling, itching,\\nbleeding, superficial thrombophlebitis, eczema, lipodermatosclerosis andulceration.\\n\\uf0b7 Tortuous dilated vein are the in subcutaneous tissue indicative of vericose vein.\\nVaricocities in the thigh are indicative of long saphenous incompetence, whereas\\nvaricosities of back of leg are suggestive of short saphenous incompetence.\\nInvestigations\\nHb, TC ,D C ,Blood sugar-FBS, PPBS, BUN, S. creatinine,urine-sugar/ketone bodies.\\nLocalX -ray foot, biopsy from the edge off ulcer,pus swab for culture and sensitivity,Doppler to\\njudge vascularity\\nTreatment\\nAccording to grade\\n\\uf0b7 Grade 0: No specific treatment, take preventive measures to protect the limbs\\n\\uf0b7 Grade 1: Prescribe  special cushioned shoes to protect from pressure sore\\n\\uf0b7 Grade 2:  control of sugar, antibiotics according to culture reports, daily dressing and\\ndebridement.\\n\\uf0b7 Grade 3: Apart from the management described above , drainage of abscess or local\\namputation\\n\\uf0b7 Grade 4: Patientswith forefoot gangrene require amputation\\n\\uf0b7 Grade 5: Amputation and rehabilitation\\nVARICOSE VEINS\\nThese are defined as tortuous dilated vein. Affect 5% or more of the adult population.\\nSalientfeatures\\nInvestigations\\nBrodie Trendelenberg test, tourniquet test,Perthe's test,Perthe's test(modified),Schwartz test,\\nPratt's test,M orrissey's cough impulse test,Fegan's method to indicate the sites of perforators,\\npitting oedema, thickening, redness, tenderness at lower part of leg, lipodermatosclerosis\\nNon pharmacological treatment\\nReassurance, elastic compression stockings- 6â€ elastic compression stockings applied with\\ngraduated pressure,foot end elevation\\nPharmacological treatment\\n\\uf0b7 Injectionsclerotherapy\\n\\uf0b7 Ultrasound guided foam sclerotherapy\\nSurgical treatment\\n\\uf0b7 Saphenofemoral junction ligation and greater saphenous stripping with or without\\nincompetent perforator ligation\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 348, 'page_label': '349'}, page_content=\"Surgery\\n341\\n\\uf0b7 Saphenopopleteal junction ligation and lesser saphenous stripping withor without\\nincompetent perforator ligation\\n\\uf0b7 Split thickness skin grafting for venous ulcers ,if present\\nDEEP VENOUS THROMBOSIS\\nA venous thrombus is the formation of a semisolid coagulum within flowing blood in the venous\\nsystem. Venous thrombosis of the deep veins of the leg is complicated by the immediate risk of\\npulmonary embolus and sudden death.\\nSalient features\\nRisk factors\\nPatient factor:age, obesity, varicose veins, immobility, pregnancy, puerperium, high dose\\noestrogen therapy,previous deepvein thrombosis or pulmonary embolism, thrombophilia\\nDisease or surgical procedure:trauma or surgery of pelvis , hip or lower limb, malignancy\\nespecially pelvic, and abdominal metastatic, heart failure, recent myocardial infarction, paralysis\\nof lower limbs, infection, inflammatory bowel disease, nephrotic syndrome, polycythemia,\\nparaproteinemia, homocystinemia\\nInvestigations\\nD -dimer, PT, APTT, duplex ultrasound\\nPharmacological treatment\\n\\uf0b7 Start with low molecular weight heparin anticoagulated with warfarin.\\n\\uf0b7 Warfarin started at a dose of 10 mg on day one,10mg on day 2, 5mg on day three\\n\\uf0b7 Patient taken on day three guides  maintenence dose of warfarin\\n\\uf0b7 Venous thrombectomy in severecases.\\n\\uf0b7 Venacaval filters in recurrent and high risk cases.\\nProphylaxis\\nM echanicalmethods-graduated elastic compression stockings,external pneumatic compression\\nstockings.\\nLow molecular weight heparin\\nCERVICAL LYMPHADENOPATHY\\nAn enlargedcervicallymph node isthecommones t causeof lump intheneck.Cervical lymph\\nnodes may become enlargedas a resultof inflammationor neoplasticprocess. Tuberculosisisis\\n\\uf0b7 C hanges in the vessel wall (endothelial damage),stasiswhich is diminished blood flow\\nthroughthe veins, coagulability of blood(thrombophilia).\\n\\uf0b7 Pain and swelling in the calf of one of the lower limb, mild pitting oedema of ankle,\\ndilated surface veins, stiff calf and redness over the course of the deep veins, Homan's\\nsign; resistance(not pain) of the calf muscle to forcible dorsiflexion, low grade pyrexia.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 349, 'page_label': '350'}, page_content='Surgery\\n342\\n\\uf0b7 Detailedhistoryand examination areessentialtopinpointspecificetiology.\\n\\uf0b7 Majorityof the lymph nodes are reactiveto viral infectionsof upper respiratorytract,\\ntherefore,do notrequireany treatm ent.\\noneofthecommones tcausesofcervicallymphadenopathy(Table 2).\\nTable 2. Causes and clinical features of cervical lymphadenopathy\\nCondition Causes Clinicalfeatures\\nAcute inflammation Infectionof the digestive  tract,head\\nand neck orother\\nFever ,sore throat,\\nFirm tender 1-2 cm diameter\\nnodes\\nChronic inflammation Tuberculosis,sarcoidosis,\\nHistiocytosisX\\nSwelling in the neck, firm,\\nmatted , fever may or may\\nnot  be present\\nLymphomas Hodgkins / NonH odgkins\\nlymphoma\\nLarge painless rubbery\\nlymph nodes.\\nMetastatic Carcinomas oftheupper digestive\\ntract,,skintumours ofthe head and\\nneck:squam ous cellcarcinom a,basal\\ncellcarcinoma,m elanoma\\nSymptoms relatedtoprimary\\ndisease,\\nSalient features\\nPharmacological treatment\\n\\uf0b7 In case of acute suppurative lymphadenopathy secondary to any focus of bacterial\\ninfection in thedrainagearea:Cap.cephalexin 250-500 mg every 6 hoursfor7 days or C ap.\\namoxicillin250-500 mg every8 hoursfor7 days.\\n\\uf0b7 If lymph nod es persist, perform fine needle aspiration cytology (FNAC) and treat\\naccordingly.If FNAC is non-conclusivetake a biopsy from the enlargedlymph node and\\ntreataccordingly.\\n\\uf0b7 In case of chroniclymphadenopathyperform FNAC and treataccordingly.IfFN A C is non-\\nconclusive,performbiopsy and treataccordingly.\\nTreatment of tubercularlymphhad enopathy\\n\\uf0b7 Startanti-tuberculartherapy\\n\\uf0b7 Reassessthepatientafter6 months.Iflymph nodes areeither notpresentor lessthan 1 cm\\nsize,keep thepatientunderfollow-up and continuetreatment.However, iflymph nodes are\\npalpableand more than 1 cm ,takea biopsyof the node and treat accordinglyand consider\\nsecond line antitubercular drugs.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 350, 'page_label': '351'}, page_content=\"Surgery\\n343\\n\\uf0b7 The patient is euthyroid,the nodules are palpable often visible( smooth, firm),painless\\nand moves with swallowing.\\n\\uf0b7 Tiredness,emotional lability,weight loss,excessive appetite,palpitation,tachycardia, hot\\nmoist palms ,exopthalmos,lid lag/retraction,agitation,thyroid goitre and bruit\\nTHYROID NODULE\\n\\uf0b7 The normal thyroid gland is impalpable. The term goitre is used for generalizedenlargement\\nof thyroid gland. A discrete swelling in one lobe with no palpable abnormality elsewhere is\\ntermed as isolated or solitary swelling. Discrete swellings with evidence of abnormality\\nelsewhere in the gland is termed as dominant\\n\\uf0b7 Cause arephysiological, puberty, pregnancy, Grave's disease,  multinodular, toxic adenoma,\\nneoplastic, benign, malignant, inflammatory,  autoimmune, chronic lymphocytic thyroiditis,\\nH ashimoto's disease, granulomatous, de Quervain 's thyroiditis, fibrosingR iedel's thyroiditis.\\nInfective can be acute (bacterial,viral) or chronic(tubercular, syphilitic),other   amyloid\\netiologyand iodine deficiency.\\nSalient features\\nInvestigations\\nThyroid function test, autoantibody titre, isotope scan, ultrasonography, FNAC, CT scan, MRI,\\nPET scan,laryngoscopy andcore biopsy\\nPrevention and treatment of simple goiter\\n\\uf0b7 Iodised salt\\n\\uf0b7 In hyperplastic goiter,thyroxine 0.15-0.2mg daily for two months\\n\\uf0b7 Multinodular goiter totalor subtotal thyroidectomy. after subtotal resection, thyroxineis\\ngivento suppress TSH secretion\\nSurgical treatment\\n\\uf0b7 Total thyroidectomy = total lobectomy + isthmusectomy\\n\\uf0b7 Subtotal thyroidectomy = subtotal lobectomy + isthmusectomy\\n\\uf0b7 Near total thyroidectomy = total lobectomy + isthmusectomy + subtotal lobectomy\\n\\uf0b7 Lobectomy = total lobectomy + isthmusectomy\\nHYPERTHYROIDISM\\nSalient features\\nInvestigations\\nThyroid function test: normal T4, suppressed TSH, thyroid scan\\nNon pharmacological treatment\\nRest and sedation\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 351, 'page_label': '352'}, page_content='Surgery\\n344\\n\\uf0b7 Noncyclical usually of chestwall origin and more common in peri-menopausal women.\\n\\uf0b7 Cyclical mastalgia is common in child bearing age.\\n\\uf0b7 Benign lumpiness may be bilateral present inupper outer quadrant may confined to one\\nquadrant. Increases before menstrual period.\\n\\uf0b7 Fibroadenoma presents as benign discreet lump\\nPharmacologicaltreatment\\n\\uf0b7 Tab. carbimazole  10 mg four times a day, when patient becomes euthyroidand maintenance\\ndose of 5 mg two or three times a day for 6-24 months\\nSurgical treatment\\n\\uf0b7 Large toxic multinoduler goiter-total thyroidectomy\\n\\uf0b7 Large diffuse toxic goiter- Promote elective surgery after a course of treatment with\\nantithyroid drugs and beta blocker. A subtotal thyroidectomyisperformed.\\n\\uf0b7 Toxic solitary nodular goitre /toxic adenoma/autonomous hot nodule-hemithyroidectomy\\n\\uf0b7 Thyrotoxicosis in pregnancy-subtotal thyroidectomy in mid trimester\\n\\uf0b7 Hashimotoâ€™s disease/lymphedenoid goiter-total thyroidectomy  or total lobectomy\\nBENIGN BREAST DISEASES\\nIt may be cyclical or noncyclical mastalgia and benign breast lump (fibroadenoma)\\nSalient features\\nInvestigations\\nUltrasound of breast and axilla, mammography for patients above 35 years of age.\\nFNAC may show fibroadenoma or changes of fibroadenosis.\\nNon pharmacological treatment\\n\\uf0b7 Reassurance\\n\\uf0b7 Adequate support\\n\\uf0b7 Exclusion of caffeine in some patients\\n\\uf0b7 Evening primrose oil 1000 mg TDS for 3 months\\n\\uf0b7 If does not respond, Tab.danazol 100 mg OD, can be increased upto TDS after discussing\\nside effects of the drugs to the patient (hirtuism, contraception failure)\\n\\uf0b7 For fibroadenoma, no treatment is required.Excision is done on patientâ€™s will, suspicious\\ncytology or large (>5 cm ) lump\\nBREAST ABSCESS\\nUsually the abscess is superficial but deep ones, when they occur, are more difficult to diagnose\\nand to treat.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 352, 'page_label': '353'}, page_content='Surgery\\n345\\n\\uf0b7 Middle age female, lump in breast and/or axilla, skin changes over breast, nipple\\ndischarge, weight loss.\\n\\uf0b7 Examination of breast as whole with nipple areola complex. Examination of axillaas well\\nas theopposite breast and axilla.\\nPharmacological treatment\\nEarly in the infection, non-surgical measures should be applied\\n\\uf0b7 Tab. amoxicillin (PO) : 1-2 gm/ d divided in 2-3 doses  for 5 days or\\n\\uf0b7 Cap. ampicillin (PO) : 2-4 gm/ d divided in 2-3 doses  for 5 days\\n\\uf0b7 Tab. ibuprofen 400 mg thrice daily.\\nNon pharmacological treatment\\n\\uf0b7 Apply constricting bandage, stop breast-feeding from this side\\n\\uf0b7 Expression of milk with a breast pump to avoid engorgement.\\nSurgicaltreatment\\n\\uf0b7 For superficial abscess: radial incision.\\n\\uf0b7 For abscess near nipple: peri-alveolar incision.\\n\\uf0b7 For deep abscess: beneath the breast\\n\\uf0b7 Gentle exploration with finger or Kelly forceps. Abundant lavage with chlorhexidine-\\ncetrimide solution. Insertion of a corrugated drain.\\nCARCINOMA BREAST\\nCarcinoma of breast is most common malignancy in female population world wide and second\\nmost common in India.\\nSalient features\\nInvestigations\\nMammography, look for the non palpable lesion in same breast as well as base line investigation\\nin opposite breast.FNAC ,true cut biopsy,excisional biopsy ifmass < 4 cm in size,incisional\\nbiopsy ifmass > 4 cm size\\nSurgical treatment\\n\\uf0b7 Modified radicalm astectomy is removal of whole breast tissue with nipple areola complex,\\nskin overlying lump, pectoral fascia and axillary dissection.\\n\\uf0b7 For Stage II B, Stage III A:  Breastconservative surgery along with radiotherapy\\n\\uf0b7 Lumpectomy/quadrentectomy/wide excision isindicated in solitary lump, tumor size < 4 cm,\\nnot involving nipple areola complex\\n\\uf0b7 DCIS for Stage I, Stage II A'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 353, 'page_label': '354'}, page_content='Surgery\\n346\\nPharmacological treatment\\n\\uf0b7 Neo adjuvant chemotherapy: Adjuvant chemotherapy given beforesurgery for down staging\\nof locally advanced breast cancer, Stage III B\\n\\uf0b7 Adjuvant chemotherapy:  Post operative chemotherapy for\\n- all node positive cancers\\n- node negative cancer, > 1 cm in size\\n- node negative cancer, > 0.5 cm with adverse prognostic factors\\n- (lymphovascular invasion, high nuclear grade, high histological grade, HER 2/neu over\\nexpression, negative hormone receptor status)\\n\\uf0b7 Commonly used regimen for chemotherapy are-\\n- CMF regimen: cyclophosphamide, methotrexate, 5-fluorouracil- 6 cycle, every 21days\\n- CAF regimen: cyclophosphamide, adriamycin, 5- Fluorouracil 6 cycle, every 21 days\\n- Cyclophosphamide: 600 mg/ sqm body area IV\\n- 5 Fluorouracil: 600 mg/sqm body area IV\\n- Methotrexate: 40 mg/sqm body area IV\\n- Adriamycin: 50 mg/sqm body area IV\\nHormonal regimen\\nTab. tamoxifen 20 mg orally daily, 5 years given to ER/PR positive patients.\\nRENAL STONES\\nRenal stones are common in India and are caused because oflow fluid intake, high salt\\nconcentrate in water. Vitamin A deficiency, renal infections, inadequateurinary drainage and\\nurinary stasis,prolonged immobilization, hyperparathyroidism are also the common causes.\\nTypes of stone: Oxalate stones, phosphate stones,uric acid stones (radiolucent stones), cystine\\nstones,xanthine stones\\nSalient features\\nInvestigations\\nX ray KUB,ultrasonographyof KUB ,intravenous urography,CT -IVP\\nPharmacological treatment\\n\\uf0b7 Inj. diclofenac sodium 3 ml IM stat\\n\\uf0b7 Inj. dicyclomine 2 ml IM stat\\n\\uf0b7 Tab. ciprofloxacin 500 mg BD for 5 days\\n\\uf0b7 Salientcalculus, colicky pain in lumbar region of the affected side, worsened by\\nmovements. hematuria, burning micturition.\\n\\uf0b7 Rigidity of lateral abdominal muscles but not the rectus abdominis.Tenderness in lumbar\\nregion'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 354, 'page_label': '355'}, page_content='Surgery\\n347\\n\\uf0b7 It is also be caused by neurogenic bladder (commonly pelvic splanchic nerve damage,\\ncauda equina syndrome, descending cortical fibers lesion, pontine micturation or storage\\ncenter lesions) orcan be iatrogenicin nature(caused by medical treatment/procedure),\\nscarring of the bladder neck (commonly from removal of indwelling catheters or\\ncystoscopy operations)ordamage to the bladder\\n\\uf0b7 In the prostate the causes may be BPH, prostate cancerand other pelvic malignancies,\\nprostatitis.\\n\\uf0b7 In urethra- congenital urethral valves, phimosis or pinhole meatus, obstruction in the\\nurethra, for example a stricture (usually caused either by injury or STD), a metastasis or a\\nprecipitated pseudo gout crystal in the urine\\n\\uf0b7 STD lesions (gonorrhoea causes numerous strictures, leading to a \"rosary bead\"\\nappearance, whereas chlamydia usually causes a single stricture)\\n\\uf0b7 Inability to pass urine, thinningof urinary stream, dribbling of urine, pain in infraumbilical\\nregionor palpable urinary bladder above pubic symphysisis seen.\\n\\uf0b7 Potassium citrate 5 ml in 100 ml of water 3-4 times/day\\n\\uf0b7 Calculi less than 5 mm can pass spontaneously and require no surgical intervention\\nNon pharmacological treatment\\nHigh fluid intake is advised with avoidance of lithogenic food and beverages\\nSurgical treatment\\nKidney stones\\n\\uf0b7 Percutaneus nephrolithotomy (PCNL)\\n\\uf0b7 Extracorporeal shockwave lithotripsy (ESWL)\\n\\uf0b7 Open pyelolithotomy\\n\\uf0b7 Nephrolithotomy\\nUreteric stones\\n\\uf0b7 Endoscopic removal by uretero renoscopy, dormia basket, ureteric meaotomy or open\\nureterolithotomy\\nURINARY RETENTION\\nUrinary retention, also known as ischuria, is a lack of ability to urinate. It is a common\\ncomplication of BPH-Benign Prostatic Hyperplasia.\\nSalient features\\nTreatment\\n\\uf0b7 Insertion of a low diameter (10 to 12 French) urinary catheter or\\n\\uf0b7 Insertion of Infant Feeding Tube (IFT, 5to 7 French diameter) or\\n\\uf0b7 Suprapubic catheterisation (SPC)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 355, 'page_label': '356'}, page_content='348\\n\\uf0b7 Symptoms of acute lower respiratory tract illness (cough with or without\\nexpectoration, shortness of breath, pleuritic chest pain) for less than 1 week\\n\\uf0b7 Temperature >37.7ÂºC, chills withrigors, and/or severe malaise\\n\\uf0b7 Chest signs- bronchial breath sounds and/or crackles); withno other explanation for\\nthe illness.\\nChapter 17\\nRESPIRATORY DISEASES\\nCOMMUNITY ACQUIRED PNEUMONIA\\nCommunity acquired pneumonia (CAP) can be defined as inflammation of lung parenchyma\\ndue to infection byStreptococcus pneumoniafollowed byStaphylococcus aureus,Klebsiella\\npneumoniae and Haemophilus influenzae.Atypical organisms includeMycoplasma,\\nChlamydia and certain respiratory viruses.\\nSalient features\\nInvestigations\\n\\uf0b7 Chest X ray in all patients suspected with CAP.Itshould be repeated if the patient is not\\nimprovingorhavingpersistence or worsening of symptoms/physical signs.\\n\\uf0b7 Centrilobularnodules favore non-bacterial pneumonia, while airspace nodules are\\ncommon with bacterial pneumonia.\\n\\uf0b7 CT of the chest should be performed in those with non-resolving pneumonia and for the\\nassessment of complications of CAP.\\n\\uf0b7 Legionella urinary antigen test isdesirable in patients with severe CAP.\\nPharmacological treatment\\nInitial empirical antibiotic therapy may be useful in severe disease, co-morbid conditions like\\nchronic heart, lung or renal diseases, diabetes mellitus, malignancies andimmune -\\ncompromised conditions.The antibiotic can then be modified as per the response and sputum\\nculture. The choice of the empirical antibiotic,\\nOutpatients\\n\\uf0b7 Previously healthy and no antibiotics in past 3 months\\nA macrolide [clarithromycin (500 mg orally BD) or azithromycin (500 mg orally once,\\nthen 250 mg qd)] ordoxycycline (100 mg orally BD) for 7 to 14 days\\n\\uf0b7 Co -morbidities or antibiotics in past 3 months: select an alternative from a different class\\nCo -morbidities like alcohol consumption, leucopenia, congestive heart failure, coronary\\nartery disease, diabetes mellitus,immune -compromised state and increasing age.\\nFluoroquinolones [levofloxacin (750 mg orally OD) or moxifloxacin (400 mg orally OD)]\\nfor 10 to 14 days or\\nbeta-lactams [high-dose amoxicillin (1 g TDS) oramoxicillin/clavulanate (2 g TDS);'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 356, 'page_label': '357'}, page_content='Respiratory Diseases\\n349\\n\\uf0b7 Alternatives: ceftriaxone (1â€“2 g IV OD), cefpodoxime (200 mg orally BD), cefuroxime\\n(500 mg orally BD)]plusmacrolide [clarithromycin (500 mg orally BD) or azithromycin\\n(500 mg orally once, then 250 mg OD)] for10 to 14 days\\nInpatients, Non-ICU\\n\\uf0b7 A respiratory fluoroquinolone [levofloxacin (750 mg oral or IV OD), moxifloxacin (400\\nmg oral or IV OD)] for 10 to 14 days\\n\\uf0b7 Alternatively beta-lactams [cefotaxime (1â€“2 g IV TDS), ceftriaxone (1â€“2 g IV OD),\\nampicillin (1â€“2 g IV every 4â€“6 hourly), ertapenem (1 g IV OD in selected patients)]plus\\nmacrolide [oral clarithromycin or azithromycin (as listed above for previously healthy\\npatients) or IV azithromycin (1gm once then 500 mg daily)]â€“ parentally for 5 to 7 days\\nand then after orally for 10 days\\nInpatients, ICU\\n\\uf0b7 Beta-lactams [cefotaxime (1â€“2 g IV TDS), ceftriaxone (2 g IV OD), ampicillin-sulbactam\\n(2 g IV TDS)] for 5 to 7 daysplusazithromycin or fluoroquinolone (as listed above for\\ninpatients, non-ICU) for 5 to 7 days and to continue after discharge oral medication for 10\\ndays\\nSpecialconcerns\\n\\uf0b7 IfPseudomonas is a considered,\\nAn antipseudomonal beta-lactam [piperacillin/tazobactam (4.5 g IV QID), cefepime (1â€“2\\ng IV BD), imipenem (500 mg IV QID), meropenem (1 g IV TDS)] plus either\\nciprofloxacin (400 mg IV BD) or levofloxacin (750 mg IV OD) or aminoglycoside\\n[amikacin (15 mg/kg OD) or tobramycin (1.7 mg/kg OD)]\\n\\uf0b7 If CA -MRSA (methicillin resistantStaphylococcus aureus) is a considered- Add\\nlinezolid (600 mg IV BD) or vancomycin (1 g IV BD).Total duration in above situations\\nis 14 days including IV for 5 days and oral medication for remaining period.\\nRecommendations for use of steroids in CAP- They shouldbe used in septicshock or\\nARDS secondary to CAP.\\nMonitoring\\n- Antimicrobial therapy should be changed according to the specific pathogen(s)\\nisolated.\\n- Diagnostic/therapeutic interventions should be done for complications e.g.\\nthoracocentesis, chesttube drainage, etc asrequired.\\n- If a patient does not respond to treatment within 48-72 hours, he/she should be\\nevaluated for the cause of non-response including development of complications,\\npresence of atypical pathogens, drug resistance, etc.\\n- Non - invasive ventilation should be used in patients with CAP and acute respiratory\\nfailure.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 357, 'page_label': '358'}, page_content='Respiratory Diseases\\n350\\nNew or progressive radiological deterioration along with any two below\\n\\uf0b7 New onset of fever, purulent discharge, leukocytosis and decline in oxygenation,purulent\\nsputum, orincreased respiratory secretions, dyspnea or tachypnoea\\n\\uf0b7 Altered mental status\\n\\uf0b7 Patients withAcute respiartory distress syndrome (ARDS ) as harboring VAP if sustained\\nincrease in PEEP requirement >2.5 cm H2O after being stable or decreasing orFraction of\\ninspiredoxygen (Fio2)  requirementrise by > 0.15after being stable or decreasing.\\n\\uf0b7 H igh risk for developing HAP/VAP e.g. chronic cardiovascular, pulmonary, renal or liver\\ndisease, diabetes mellitus, CSF leak, asplenia, immunocompromised condition/medication,\\ninfluenza, compromised respiratory function or increased aspiration risk.\\n\\uf0b7 B lood should be sent for culture prior to antibiotics. However, appropriate management\\nshould not be delayed in clinically unstable patients for purpose of performing diagnostic\\nsampling.\\nFollow up\\n\\uf0b7 Switch to oral from IV therapy if the patient shows improvement in moderate to severe\\nCAP.\\n\\uf0b7 Patient can be considered for discharge after they start accepting drugs orally, are\\nafebrile, and hemodynamically stable for a period of at least 48 hr\\nHOSPITAL ACQUIRED PNEUMONIA\\nHospital Acquired Pneumonia (HAP)is an inflammatory condition of lung parenchyma\\ncaused by infectious agents, neither present nor incubating at time of hospital admission. It is\\ndefined as pneumonia developing 48 h after admission to the hospital. It can be caused by a\\nwide range of pathogensincluding gram negative bacilli such asP.aeruginosa, E.coli,\\nK.pneumoniae and Acinobacter. Ventilator Associated Pneumonia (VAP) is defined as\\npneumonia (new onset of fever) thatdevelops after 48 hour of endotracheal intubation.\\nSalient features\\nPharmacologicaltreatment\\nRisk factors for pneumonia: Age >60 years, male gender, smoking, alcohol intake,\\nunderling disease, inspired O2 >0.50, renal failure/dialysis, chronic obstructive pulmonary\\ndisease, airway instrumentation, aspiration before intubation, tracheostomy, mechanical\\nventilation >2 days, coma, head trauma, continuous enteral feeding, prior antibiotics,\\nnosocomial maxillary sinusitis, repeat intensive care unit admission\\nPatients withoutriskfactors for MDR pathogens(Treatment duration is 10 to 14 days)\\nceftriaxone (2 g IV OD)or moxifloxacin (400 mg IV OD), ciprofloxacin (400 mg IV TDS),\\nor levofloxacin (750 mg IVOD) or ampicillin/sulbactam (3 g IV QID)\\nPatients withriskfactors for MDR Pathogens(Treatment duration is 10 to 14 days)'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 358, 'page_label': '359'}, page_content='Respiratory Diseases\\n351\\n1. Beta-lactams: ceftazidime (2 g IV TDS) or cefepime (2 g IV BD/TDS) or\\npiperacillin/tazobactam (4.5 g IV QID), imipenem (500 mg IV QID or 1 g IV TDS), or\\nmeropenem (1 g IV TDS)plus\\n2. A second agent active against gram-negative bacteria pathogens:gentamicin or\\ntobramycin (7 mg/kg IV OD) or amikacin (20 mg/kg IV OD)orciprofloxacin (400 mg IV\\nTDS) or levofloxacin (750 mg IV OD)plus\\n3. An agent active against gram-positive bacteria pathogens:linezolid (600 mg IV BD)or\\nvancomycin (15 mg/kg, up to 1 g IV, BD)\\nFollow up\\n\\uf0b7 Clinical improvementusually evident within 48â€“72 h of the initiation of antimicrobial\\ntreatment. Because findings on chestradiography often worsen initially during treatment,\\nthey are less helpful than clinical criteria as an indicator of clinical response in severe\\npneumonia.\\n\\uf0b7 Seriously ill patients with pneumonia, often undergo follow-up chest radiography daily, at\\nleast until they are being weaned off mechanical ventilation. Once a patient has been\\nextubated and is in stable condition, follow-up radiographs may not be necessary for a\\nfew weeks\\nPatient education (to reduce the frequency of nosocomial pneumonia in mechanically\\nventilated patients)\\n\\uf0b7 General methods:Aggressive treatment of patientâ€™s underlying disease, Review need and\\navoid antacids and H2 blockers for stress ulcer prophylaxis, keep patient elevated atâ‰¥ 30Âº,\\nreview nutrition regimen and tube feeding procedures, extubate and remove nasogastric\\ntube as clinically indicated, controlled use of antibiotics.\\n\\uf0b7 Respiratory care equipment: Discriminate between equipment with nebulizers and\\nhumidiï¬ers â‰¥48-h circuit changes (tubing and humidiï¬er) for mechanical ventilators with\\nhumidiï¬ers; no changes for circuits with heat -moisture exchangers, proper removal of\\nrespiratory tubing condensate and education of staff to prevent washing contaminated\\ncondensate into the patientâ€™s trachea, no transfer of equipment or devices between\\npatients, review use and care of in-line medication nebulizers.\\n\\uf0b7 Infection control: Surveillance in the ICUeducation and awareness programs on\\nnosocomial infection, handwashing and/or barrier precautions, review technique for\\nsuctioning patients; type of catheter used, review method of condensate disposal, use\\neffective methods of disinfection of devices and equipment, consider selective\\ndecontamination of the digestive tract with oral nonabsorbable antibiotics to prevent\\nnosocomial infection.\\nBRONCHIAL ASTHMA\\nAsthma is a chronic inflammatory disorder of the airways characterized by episode of\\nwheezing, breathlessness, chest tightness and coughing, particularly at night or in the early'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 359, 'page_label': '360'}, page_content='Respiratory Diseases\\n352\\n\\uf0b7 Precipitating allergens are dust, pollen, fish, nuts, strawberries, cold air, tobacco smoke,\\nviral and bacterial infections, exercise, emotional stress and drugs like NSAIDs, aspirin,\\nbeta-blocker\\n\\uf0b7 Classical symptoms include cough, breathlessness, chest tightness and wheezing. Signs\\ninclude tachypnoea, tachycardia, pulsus paradoxus, use of accessory muscles, silent chest\\nmorning. It is associated with widespread but variable airflow obstruction that is often\\nreversible either spontaneously or with treatment.\\nSalient features\\nDiagnosis\\n\\uf0b7 When asthma is suspected and other disorders have been ruled out (e.g. tumours in adults,\\nforeignbody in children; donâ€™t assume the presence of wheeze means asthma), confirm\\nthe diagnosis with pulmonary function tests (PFTs).\\n\\uf0b7 PFTs suffice as objective evidence of variable airflow obstruction:\\n- A 12 % or greater improvement in forced expiratory volume (FEV1) in children and\\nadults, and > 200 ml in adults from the baseline 15 minutes after use of an inhaled\\nshort-acting beta2 agonist.\\n- Serial measures of peak expiratory flow (PEF): A > 20% change after administration\\nof a bronchodilator.\\n\\uf0b7 When there is some probability of asthma and the above tests are non-diagnostic, the\\nfollowing tests may be used to help diagnosis of asthma:\\n- Methacholine challenge\\n- Exercise challenge\\n- Inhaled corticosteroid trial: appropriate doses of inhaled steroids for 4-6 weeks\\n- Raised value of absolute eosinophil count (>6-8%)\\nNon pharmacologicaltreatment\\n\\uf0b7 Evaluate and assess impact and exposure to allergens and irritants in individual patients.\\n\\uf0b7 Complete cessation of smoking and avoidance of environmental tobacco smoke is\\nstrongly recommended.\\n\\uf0b7 Lifestyle management-refer patients to an asthma education program where available.\\nPharmacological treatment\\n\\uf0b7 If expiratory flows are normal and symptoms are controlled, an inhaled short-acting beta2\\nagonistas needed.\\n\\uf0b7 If rescue beta2 agonist is needed more than 2 times per week (excluding preventative use\\nprior to exercise) or if lung function is abnormal, an inhaled glucocorticosteroidused.\\n\\uf0b7 Use of spacer:Technically, the most efficient way to maximize inhaled drug delivery to\\nthe lungs is through a metered dose inhaler (MDI) and spacing device. For adults,\\nhowever, a dry powdered inhaler (DPI) has demonstrated efficacy and is more convenient'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 360, 'page_label': '361'}, page_content='Respiratory Diseases\\n353\\nfor most people. If using an inhaled corticosteroid MDI, a spacer device, in addition to\\nusual oral hygiene, will minimize the risk of oral thrush.\\nStep wise control of chronic asthma in patients more than 6 years of age(Table 1)\\n\\uf0b7 Patient should start treatment at the step most appropriate to the initial severity of their\\nasthma.\\n\\uf0b7 At each step, review medication adherence, inhaler technique, and patient education.\\nReconsider diagnosis if no or poor response to therapy.\\n\\uf0b7 If symptom control is maintained over 3 months, consider stepping down to the least\\nmedication necessary to maintain control.\\nTab le 1. Step wise control of chronic asthma in patients more than 6 years of age\\nStep 1 Inhaled short-acting beta2 agonist (SABA) as required.\\nStep 2 Add inhaled corticosteroid (ICS). In children age 6-11 years, start at a low dose.\\nStep 3\\nAdd inhaled long-acting beta2 agonist (LABA) in combination with an ICS.\\nAssess control of asthma:\\n\\uf0b7 Good response to LABA/ICS combinationâžž continue\\n\\uf0b7 Benefit from LABA/ICS combination but control still inadequateâžž continue\\nLABA and increase steroid dose to high dose ICS\\n\\uf0b7 No response to LABA/ICS combinationâžž stop LABA combination and\\ncontinue high dose inhaled steroid and proceed to Step 4\\nStep 4\\nConsider the following:\\n\\uf0b7 A short course of oral corticosteroids may be used in adults (i.e. prednisone\\n0.6 mg/kg/day for 5 days) to stabilize the patient\\n\\uf0b7 Referring patient for specialist care\\n\\uf0b7 Adding a third drug (e.g. leukotriene receptor antagonist, theophylline, or low\\ndose daily oral steroids)\\nTable 2 showing control of asthma\\nCharacteristic\\nControlled\\n(all of the\\nfollowing)\\nPartly controlled\\n(any measure\\npresent in any week)\\nUncontrolled\\nDaytime symptom None\\n(twice or less/wk)\\nMore than\\ntwice/week\\nThree or more\\nfeature of\\npartly\\ncontrolled\\nasthma present\\nin any week\\nLimitation of activities None Any\\nNocturnalsymptom\\n/awakening None Any\\nNeed for reliever/rescue\\ntreatment\\nNone\\n(twice or less/wk)\\nMore than\\ntwice/week\\nLung function\\n(PEF of FEV1)* Normal\\n< 80% predicted or\\npersonal best (if\\nknown)\\nExacerbation None One or more/year â€  One in any\\nweekâ€¡\\n* Lungfunction testing is not reliable for children 5 years and younger.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 361, 'page_label': '362'}, page_content='Respiratory Diseases\\n354\\nâ€  Any exacerbation should prompt review of maintenance treatment to ensure that it is\\nadequate.\\nâ€¡ By definition, an exacerbation in any week makes that an uncontrolled asthma week.\\nTable 3. Drugs and recommended dosage\\nDrugs\\nAdult (mcg per day) Children (6-11 years)mcg per\\nday\\nLow Medium High (Max) Low Medium High (Max)\\nBeclomethasone\\ndipropionate pMDI â‰¤ 250 251-500 > 500 (800) â‰¤ 100 101-200b > 200 (200)\\nBudesonide DPI â‰¤ 400 401-800 > 800 (2400) â‰¤ 200 201-400b > 400 (400)\\nCiclesonide pMDI â‰¤ 200 201-400 > 400 (800) 100 101-200b > 200 (200)\\nFluticasone\\npriopionate  pMDI â‰¤ 250 251-500 > 500 (2000) â‰¤ 100 101-200b > 200 (400)\\nFluticasone\\nPriopionateDPI â‰¤ 250 251-500 > 500 (2000) â‰¤ 100 101-200b > 200 (400)\\nFollow up\\n\\uf0b7 A n action plan to increase therapy when asthma is not controlled and to decrease therapy\\nwhen asthma is well controlled\\n\\uf0b7 Periodically discuss adequacy of asthma control with the patient. Identify and eliminate\\nbarriers to effective control.\\n\\uf0b7 Consider measuring peak flow at each visit.\\n\\uf0b7 Encourage the patient/family to actively manage their illness.\\n\\uf0b7 If a patient is not responding to therapy, and compliance and inhaler technique is\\nappropriate, consider an alternative diagnosisand/or referral for further assessment. .\\nPatient education\\n\\uf0b7 Proper use ofprescribed medication, techniques of administration, what constitutes\\nâ€œcontrolâ€ of asthma and how to monitor control with PEF measurement or symptom\\nmonitoring.\\n\\uf0b7 Discuss strategies to assist patients to stop smokingand refer patients to smoking\\ncessation programs.\\nCHRONIC OBSTRUCTIVE PULMONARY DISEASE\\nChronic Obstructive Pulmonary Disease (COPD) is defined as â€œA preventable and treatable\\ndisease characterized by persistent airflowlimitation that is not fully reversible. The airflow\\nlimitation is usually progressive and associated with an abnormal inflammatory response of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 362, 'page_label': '363'}, page_content='Respiratory Diseases\\n355\\n\\uf0b7 Chronic cough, which may be daily and productive, but can also be intermittent and\\nunproductive.Breathlessness on exertion, initially intermittent and becoming persistent\\n\\uf0b7 Sputum production: any pattern of sputum production may indicate COPD.Frequent\\nexacerbations of bronchitis\\n\\uf0b7 A history of exposure to risk factors, especially tobacco smoke, occupational dusts,\\nhome cooking and biomass fuels.\\nthe lung to noxious particles or gases with some significant extra pulmonary effects that may\\ncontribute to theseverity in the individual patientâ€.\\nSalient features\\nDiagnosis\\nDiagnosis is made by spirometry and severity classified as per GOLD (Guidelinesfor\\nObstructive Lung Diseases) criteria(Table 4).\\nTable 4. GOLD criteria for severity of COPD\\nGOLD\\nStage Severity Symptoms Spirometry\\n0 At Risk Chronic cough, sputum\\nproduction Normal\\nI Mild With or without chronic\\ncough or sputum production\\nFEV1/FVC <0.7 and FEV1 80%\\npredicted\\nIIA Moderate With or without chronic\\ncough or sputum production\\nFEV1/FVC <0.7 and 50% FEV1 <80%\\npredicted\\nIII Severe With or without chronic\\ncough or sputum production\\nFEV1/FVC <0.7 and 30% FEV1 <50%\\npredicted\\nIV Very\\nSevere\\nWith or without chronic\\ncough or sputum production\\nFEV1/FVC <0.7 and FEV1 <30%\\npredictedor\\nFEV1 <50% predicted with respiratory\\nfailure or signs of right heart failure\\nNon pharmacological treatment\\n\\uf0b7 General Medical Care- Patients with COPD should receive the influenza vaccine\\nannually. Polyvalent pneumococcal vaccine is also recommended, although proof of\\nefficacyis not definitive.\\n\\uf0b7 Pulmonary Rehabilitation-This refers to a treatment program that incorporates education\\nand cardiovascular conditioning. In COPD, pulmonary rehabilitation has been\\ndemonstrated to improve health-related quality of life, dyspnea, andexercise capacityand\\nreduce rates of hospitalization over a 6-to 12-month period.\\n\\uf0b7 Lung Volume Reduction Surgery (LVRS) offers both a mortality benefit and a\\nsymptomatic benefit in certain patients with emphysema. Patients with upper lobeâ€“'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 363, 'page_label': '364'}, page_content='Respiratory Diseases\\n356\\npredominant emphysema and a low post rehabilitation exercise capacity are most likely to\\nbenefit from LVRS.\\n\\uf0b7 Lung Transplantation- COPD is currently the second leading indication for lung\\ntransplantation Current recommendations are that candidates for lung transplantation\\nshould be <65 years; have severe disability despite maximal medical therapy; and be free\\nof co-morbid conditions such as liver, renal, or cardiac disease.\\nPharmacological treatment(Table 5)\\n\\uf0b7 Bronchodilators-U sed for symptomatic benefit in patients withCOPD. The inhaled route\\nis preferred for medication delivery as the incidence of side effects is lower than that seen\\nwith the use of parenteral medication delivery.\\n\\uf0b7 Theophyllineproduces modest improvements in expiratory flow rates and vital capacity\\nand a slight improvement in arterial oxygen and carbon dioxide levels in patients with\\nmoderate to severe COPD. Nausea is a common side effect; tachycardia and tremor have\\nalso been reported. Monitoring of blood theophylline levels is typically required to\\nm inimize toxicity.\\n\\uf0b7 Supplemental oxygen is the only pharmacologic therapy demonstrated to unequivocally\\ndecrease mortality rates in patients with COPD. Patients with resting hypoxemia (resting\\nO 2 saturation 88% or <90% with signs of pulmonary hypertension orright heart failure)\\nrequire continual oxygen supplementation. Various delivery systems are available,\\nincluding portable systems that patients may carry to allow mobility outside the home.\\nSupplemental O2 are commonly prescribed for patients with exertional hypoxemia or\\nnocturnal hypoxemia.\\n\\uf0b7 Glucocorticoids are not routinely recommended.\\n\\uf0b7 Other agents that can be used as follows: N-acetyl cysteine 600 mg TDS for 10 to 14 days\\nTable 5. Commonly used drugs and dosages for pharmacotherapy of stable COPD\\nDrug category Recommended dose\\nInhaled agents *\\n\\uf0b7 Anti-cholinergics\\n-Short actingIpratropium bromide 20-40 Âµg as needed\\n-Long actingTiotropium 18 Âµg once daily\\n\\uf0b7 Beta-agonists\\n-Short acting Salbutamol 100-200 Âµg as needed\\nLevosalbutamol 45-90 Âµg as needed\\nTerbutaline 250-500 Âµg as needed\\n-Long acting Salmeterol 25-50 Âµg twice daily\\nFormoterol 6-12 Âµg twice daily\\nIndaceterol 150-300 Âµg once daily'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 364, 'page_label': '365'}, page_content='Respiratory Diseases\\n357\\n\\uf0b7 Corticosteroids\\n-Fluticasone 25-500 Âµg twice daily\\n-Budesonide 100-400 Âµgtwice daily\\n-Beclomethasone 100-400 Âµg twice daily\\n-Ciclesonide 80-160 Âµg twice daily\\n-Mometasone 25-500 Âµg twice daily\\nOral agents\\n\\uf0b7 Beta-agonists\\n-Salbutamol 2-4 mg twice/thrice daily\\n-Bambuterol 10-20 mg once daily\\n-Terbutaline 2.5-5 mg TDS\\n\\uf0b7 Methylxanthines\\n-Sustained release theophylline 100-400 mg once daily\\n-Doxophylline 400 mg twice/thrice daily\\n* Recommended doses are those for aMDI. These drugs are also available in DPI and for\\nnebulizer use, for which doses may vary.\\n\\uf0b7 Only three interventionsâ€”smoking cessation, oxygen therapy in chronically hypoxemic\\npatients, and lung volume reduction surgery in selected patients with emphysemaâ€”have\\nbeen demonstrated to influence the natural history of patients with COPD.\\n\\uf0b7 All othertherapies are directed at improving symptoms and decreasing the frequency and\\nseverity of exacerbations. The institution of these therapies should involve an assessment\\nof symptoms, potential risks, costs, and benefits of therapy.\\nAcute exacerbation of COPD (Table 6)\\n\\uf0b7 An exacerbation of COPD is an acute event characterized by a sustained worsening of\\nany of the patientâ€™s respiratory symptoms (cough, sputum quantity and/or character,\\ndyspnea) that is beyond normal day-to-day variation and leads to a change in medication,\\nand where other causes of acute breathlessness have been clinically excluded.\\nTable 6. Severity assessment (indications for hospitalization) of exacerbation of COPD\\nSymptoms\\n\\uf0b7 Marked reduction in activity of daily living due to dyspnea\\n\\uf0b7 Altered sensorium\\n\\uf0b7 New onset cyanosis\\nSigns\\n\\uf0b7 Use of accessory respiratory muscles\\n\\uf0b7 Paradoxical chest wall movements\\n\\uf0b7 Central cyanosis\\n\\uf0b7 Systolic blood pressure <90 mmHg'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 365, 'page_label': '366'}, page_content='Respiratory Diseases\\n358\\n\\uf0b7 RR >30/minute\\n\\uf0b7 Heart rate >110/minute\\n\\uf0b7 Asterixis\\n\\uf0b7 Altered mental status\\nOthers\\n\\uf0b7 Presence ofsevere comorbid conditions\\n\\uf0b7 Lack of social support\\nPulse oximetry\\n\\uf0b7 SpO 2<90%\\n* Presence of any of these qualifies a patient with need for admission. The ultimate decision\\nto admit depends on the overall clinical assessment of the physician\\nTreatment of acute exacerbations\\nPharmacological treatment\\n- Bronchodilators\\n- Corticosteroids\\n- Antibiotics:  First line (Tab. amoxicillin 500-1000 mg TDS or Cap. doxycycline 100\\nmg BD or Tab.azithromycin 500 mg OD);  Second line: Tab. amoxicillin/clavulanic\\nacid (625 mgTDS) or second-generation or third-generation cephalosporin (e.g. Tab.\\ncefixime 200 mg BD)All antibiotics need to be administered for 5-7 days except\\nazithromycin (three days)\\n- Adjunct therapies\\n\\uf0b7 Non -pharmacological treatment\\n- Oxygen therapy\\n- Ventilatorysupport (Noninvasive and invasive ventilation)(Table 7and 8)\\nTable 7:Indications, protocol and parameters of failure of non invasive ventilation in\\nacute exacerbation of COPD\\nIndications\\n\\uf0b7 Respiratory acidosis (arterial pHâ‰¤ 7.35 and/or PaCO2 45 mmHg)\\n\\uf0b7 Severe dyspnea\\n\\uf0b7 Respiratory rate > 30 breaths/ min\\n\\uf0b7 Use of accessory muscles of respiration\\n\\uf0b7 Presence of paradoxical breathing\\nProtocol\\n\\uf0b7 Full face mask better tolerated in the acute setting\\n\\uf0b7 Start with an inspiratory pressure support of 6-8 cm H2O and CPAP of3-4 cm H2O\\n\\uf0b7 Adjustments'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 366, 'page_label': '367'}, page_content='Respiratory Diseases\\n359\\n-Increase inspiratory pressure and CPAP by 2 and 1 cm H2O respectively\\n- Titrate to tidal volume (>5 ml/kg), respiratory rate (<35 breaths/minute) and blood\\ngases\\n- Maximum inspiratory pressure and CPAP generally used is 15-16 cm H2O and 7-8\\ncm H 2O respectively\\n\\uf0b7 Air leaks should be minimized\\nParameters for failure of NIV\\n\\uf0b7 Failure in improvement of clinical parameters and gas exchange at 1 hour\\n\\uf0b7 Development of alteration in sensorium\\n\\uf0b7 Hemodynamic instability\\n\\uf0b7 Inability to tolerate oronasal mask\\nTable 8. Indications and protocol of invasive mechanical ventilation#\\nIndications\\n\\uf0b7 pH â‰¤7.25\\n\\uf0b7 Unable to tolerate NIV/or NIV failure\\n\\uf0b7 Respiratory or cardiac arrest\\n\\uf0b7 Massive aspiration\\n\\uf0b7 Diminished consciousness\\n\\uf0b7 Failure to handle secretions\\n\\uf0b7 Heart rate <50/minute with loss of alertness\\n\\uf0b7 Hemodynamic instability without fluid responsiveness\\n\\uf0b7 Severe ventricular arrhythmias\\n\\uf0b7 Life threatening hypoxia\\nProtocol\\nMode V -ACMV\\nInitial tidal volumes 4-6 ml/kg\\nRespiratory rate 8-12/min\\nPEEP 5-8 cm H2O\\nI:E 1:3-1:6\\nFlow waveform Square waveform\\nGoals\\nPlateau pressure 30 cm H2O\\nPaO 2 55-60 mm Hg\\npH 7.2-7.4\\n#Modified from GOLD 2013'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 367, 'page_label': '368'}, page_content='Respiratory Diseases\\n360\\n\\uf0b7 A preponderance of bronchiectasis on the left side and in the lower lobes has been noted.\\n\\uf0b7 Bronchiectasis is classified based on the pathological changes into:follicular, saccular and\\natelectatic types.\\n\\uf0b7 Patient usually presents with persistent cough productive of distressingly copious volumes of\\nmucopurulent and sometimes fetid sputum, in a breathless and chronically disabled patient.\\n\\uf0b7 Mild cases of bronchiectasis often have no abnormal physical signs. When the disease is\\nsufficiently developed, the characteristicï¬nding is persistent early and mid-inspiratory\\ncrackles which are localized to one or more areas so that they are heard at the same site or\\nsites on repeated examination. These crackles are frequently described as â€˜coarseâ€™ (as\\nopposed to â€˜ï¬neâ€™) and are not shifted by coughing.\\n\\uf0b7 Clubbing of theï¬ngers and/or toes is a feature of gross disease with prolonged bronchial\\ninfection.There may also be cyanosis, with signs of pulmonary hypertension and right heart\\nfailure in such patients.\\nCriteria for hospital discharge (Modified from GOLD 2013)\\n\\uf0b7 Able to use long acting bronchodilators.Inhaled short acting drugs no more than every 4\\nhours\\n\\uf0b7 Patient if previously ambulatory-able to move across room,to eat and get adequate sleep\\n\\uf0b7 Patient is clinically stable for at least 24 hours\\nFollow up\\n\\uf0b7 Motivation to quit smoking\\n\\uf0b7 Assessment of inhaler technique\\n\\uf0b7 Measurement of FEV1\\n\\uf0b7 Compliance with recommended treatment regimen\\n\\uf0b7 Reassessing the need for long-term oxygen therapy and/or home nebulizer\\n\\uf0b7 Status of co-morbidities\\nBRONCHIECTASIS\\nB ronchiectasis is present when one or more bronchi are abnormally and permanently dilated.\\nSalient features\\nDiagnosis\\n\\uf0b7 C linical featurewith radiological presentation of plain x-ray chestand a very specific\\nHigh resolution computed tomography(HRCT) thorax pattern.\\n\\uf0b7 Plain chest radiographic features include evidence of dilated bronchi, parallel â€œtramlinesâ€,\\nsolid tubular opacities, appearances of pulmonary hypertension.\\n\\uf0b7 HRCT has become theinvestigation of choice in bronchiectasis (Table 9).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 368, 'page_label': '369'}, page_content='Respiratory Diseases\\n361\\nTable 9. HRCT findings in bronchiectesis\\nDirect signs Indirect signs\\nBronchial dilatation\\nIncreased bronchoarterial ratio,\\ncontour abnormalities\\nBronchial wall thickening\\nBest assessed visually on images obtained at right\\nangles through vertically oriented airways\\nLack of airway tapering >2 cm\\ndistal topoint of bifurcation\\nMucoid impaction/fluid-filled airways\\nTubular or Y-shaped structures; branching or rounded\\nopacities in cross section +/-air-fluid levels\\nAirway visibility within 1 cm of\\nthecostalpleura of fissures\\nBronchiolitis, clustered ill-defined centrilobular nodules\\nwith a tree-in-bud configuration\\nMosaic attenuation caused by air trappingâ€“Best identified\\non expiratory HRCT images\\nMosaic perfusion of the pulmonary identified on contrast-\\nenhanced dual energy CT of the pulmonary parenchyma\\nBronchial artery hyperplasia\\nPharmacological treatment(Table 10)\\nThe treatment of bronchiectasis may be medical or surgical. Medical treatmentaims to\\nrelieve and control the symptoms, whereas surgical treatment is intended to eliminate the\\ndisease itself.The main arms of medical treatment are control of lower respiratory tract\\ninfection/inï¬‚ammation with appropriate antibiotic treatment and the removal of bronchial\\nsecretions by postural drainage\\nTable 10. Antibacterial agents for the treatment of bronchiectesis\\nRoute Antibiotics Dose and duration\\nOral Amoxicillin/clavulanic\\nacid\\n625 mg BD for 10 days\\nQuinolone (ciprofloxacin) 750 mg BD for 7 to 10 days\\nAzithromycin 500 mg OD for 7 to 10 days\\nDoxycycline 100 mg BD for 10 days\\nIntravenous Cefuroxime 750 mg TDS for 10 days\\nCeftriaxone 2 g BD for 7 to 10 days\\nmoxicillin/clavulanic acid1.2 g TDS for 8 to 10 days\\nIfPseudomonas is\\ncausative organism isolated\\nPiperacillin/tazobactum 4.5 gTDS for 10-14 days\\nCeftazidime 2 g BD for 10 to 14 days'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 369, 'page_label': '370'}, page_content='Respiratory Diseases\\n362\\nInitially I/V followed by\\noral ciprofloxacin 750 mg\\nfor 10-14 days\\nMeropenem +\\nAminog lycoside (dose as\\nper weight)\\nGentamicin or amikacin\\ngiven once daily infusion\\n1 g TDS for 10 to 14 days\\n\\uf0b7 Anti-inflammatory therapy\\n- Corticosteroids-Inhaled and oral\\n- NSAIDs -Inhaled and oral\\nAdditional agents\\n- Long-actingÎ² agonists\\n- Long-acting anticholinergics\\n- Methylxanthines\\n- LT receptor antagonists\\nNon pharmacological treatment\\n\\uf0b7 Surgical treatment plays only a small role in the present day management of\\nbronchiectasis\\n\\uf0b7 Chest Physiotherapy\\nPhysiotherapy techniques available for use in bronchiectasis\\nIndependent techniques-Active cycle of breathingtechniques, Autogenicdrainage\\nDevice-dependant techniques\\n- Positive expiratory pressure\\n- Oscillating positive expiratory pressure\\n- intrathoracic: Flutter, Acapella\\n- extrathoracic:high-frequency chest wall oscillations\\n- Intermittent positive pressure breathing\\n- Noninvasive ventilation\\n- Test of incremental respiratory endurance\\nManual techniques\\n- chest percussion/clapping\\n- chest wall vibrations\\n- overpressure\\n- Gravity-assisted positioning\\n- Mo dified postural drainage\\nComplications\\n\\uf0b7 Infective exacerbations occurring in patients with bronchiectasis are marked by both\\nincreased volume and purulence of sputum. They may follow upper respiratory tract\\ninfections in much the same way as exacerbations of chronic bronchitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 370, 'page_label': '371'}, page_content='Respiratory Diseases\\n363\\n\\uf0b7 Haemoptysis occurs commonly in bronchiectasis. Such episodes are usually small,\\nalthough major (>200mL per 24h) or rarely massive (>1000mL per 24h) haemoptyses\\nmay occur.\\n\\uf0b7 Chronic paranasal sinusitis occurs in a high percentage of patients with bronchiectasis and\\nis very common in severe cases.\\n\\uf0b7 Brain abscess, operative complications include haemorrhage, atelectasis, pneumonia,\\nempyema, bronchopleuralï¬stula and pneumothorax.\\nROLE OF PHYSIOTHERAPY IN PULMONARY REHABILITIATION\\n\\uf0b7 Pulmonary rehabilitation is a multidisciplinary service directed to a person with\\npulmonary disease by an interdisciplinary team of specialist, with the goal of achieving\\nand maintaining the individualâ€™s maximum level of independence and functioning in the\\ncommuni ty.\\n\\uf0b7 The main aim of pulmonary rehabilitation is to promote healthy attitudes and recognition\\nof the benefits of exercise in the management of a variety of conditions.\\n\\uf0b7 Other aims of pulmonary rehabilitation are\\n- Reduce dyspnoea,removal of secretion.\\n- Improving thoracic mobility and increasing lung,increasing endurance and strength\\nof muscles (peripheral and respiratory)\\n- Reduction of fatigue and energy conservation,ensure long term commitment to\\nexercise.\\n\\uf0b7 Techniques to provide relaxation and promote breathing are\\n- Diaphragmatic breathing = ask the patient to recruit diaphragm by placing the hand on\\nabdomen.\\n\\uf0b7 Segmental breathing = keeping the hands on the segment which is to be treated and\\nasking the Patient to fill the air under the hands.\\n- Pursed lip breathing = inhaling through nose and exhaling through pursed lips.\\n\\uf0b7 Techniques to humidify the air mobilize the secretion and provide supplemental O2.\\n- Humidifier = It is used to humidify the inhaled air, it is very important when the upper\\nairway bypassed and Patients who has thick and tenacious secretions.\\n- Nebulizer= Administration of Nebulizer containing Saline water, Bronchodilators or\\nMucolytics are used to liquify the secretions and to dilate the narrowed or spasmodic\\nairways.\\n- Oxygen therapy = It is administered when the patientâ€˜s ventilator system is\\ninsufficient to provide required amount of oxygen to the body either during rest or\\nduring exercise.\\n\\uf0b7 The techniques to remove the secretions are,'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 371, 'page_label': '372'}, page_content='Respiratory Diseases\\n364\\n- ACBT (Active Cycle of Breathing Technique): It consists of repeated cycles of 3\\nventilatory     phases:breathing control, thoracic expansion and FET (Forced\\nExpiratory Techniques)\\n- AD (Autogenic Drainage): It uses diaphragmatic breathing to mobilize secretions by\\nvarying expiratory airflow.\\n- Postural Drainage along with Percussion Vibration and Shaking: In PD Patient is\\nplaced in positions that allow the bronchopulmonary trees to be drained with\\nassistance of gravity.\\n- Manual Hyperinflation: It is used in patients on endotracheal tube or tracheostomy\\ntwo caregivers are needed one to use the bag to hyperinflate the lung during\\ninspiration and provide a quick release to allow rapid exhalation. And second to apply\\nshaking or vibrations at beginning of expiration.\\n- Positive Expiratory Pressure(PEP): It consists of a mouthpiece to which one way\\nvalve is connected which is attached with expiratory resister which provides pressure\\nduring expiration which helps in avoiding the collapsing airway and remove the\\nsecretions.\\n- High Frequency Chest Compression (HFCC): It is used to give oscillations and\\ncompressionsto whole lungs in sitting position helps in mucus clearance.\\n- In diseases like Pleural Effusion the fluid gets accumulated in the pleural cavity so for\\nthat positioning in such a way that gravity assists the drainage of fluid faster through\\nICD occurs likeside lying with sound side up and deep inspiration followed with\\nmaximum expiration eg. ballooning, bubble making etc.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 372, 'page_label': '373'}, page_content=\"365\\nChapter 18\\nPEDIATRIC CONDITIONS\\nNEWBORN CARE\\nSalient features\\nTreatment\\nEstablishment of breathing at birth\\n\\uf0b7 Most newborns cry immediately at birth and therefore needno assistance to establish\\nbreathing. If the baby is preterm, meconium stained or some evidence of infection, not\\ncrying or breathing or with poor muscle tone, then proceed to initial steps of resuscitation.\\n\\uf0b7 For term babies, use 100% oxygen when baby is cyanotic or when positive pressure\\nventilation is required. If room air is being used, supplementary oxygen should be\\navailable to use if there is no appreciable improvement within 90 seconds of birth. If\\nsupplemental oxygen is not available, positive pressure ventilation should be continued\\nwith room air.\\n\\uf0b7 Infants without signs of life (no heart beat and no respiratory effort) after 10 minutes of\\nresuscitation show either a high mortality or severe neurodevelopmental disability. After\\n10 minutes of continuous and adequate resuscitative efforts, discontinuation of\\nresuscitation may be justified if there are no signs of life.\\nHypothermia\\n\\uf0b7 Identification of hypothermia. An axillary (or rectal) temperature <36.0Â°C is\\nhypothermia. Such a baby would feel cold totouch on the abdomen and periphery.\\n\\uf0b7 Identification of cold stress: Baby's peripheries are cold but abdomen is warm. This\\nusually corresponds to axillary temperature of 36-36.4Â°C.\\n\\uf0b7 Prevention of hypothermia.\\n- Dry the baby with warm dry linen at birth. Discardwet linen and wrap in dry linen.\\nPlace baby after birth under a radiant warmer or 200 Watt bulb (placed at a distance of 45 cm\\nabove the baby). If neither is available, place the newborn infant on the mother's chest\\n\\uf0b7 Essential newborn care (ENC) is a comprehensive strategy designed to improve the\\nhealth of newborns through interventions before conception, during pregnancy, at and\\nsoon after birth, andin the postnatal period.\\n\\uf0b7 ENC comprises of:\\n- Basic preventive newborn care such as care before and during pregnancy, clean\\ndelivery practices, eye and cord care, prevention of hypothermia and infection\\n- Early and exclusive breastfeeding on demand day andnight.\\n- Early detection of problems or danger signs (with priority for sepsis and birth\\nasphyxia) and appropriate referral and care seeking.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 373, 'page_label': '374'}, page_content='Pediatric Conditions\\n366\\nand wrap baby and mother together to prevent heat loss from the exposed skin surfaces of\\nthe baby.\\n- Ensure that there are no open windows or fans turning in the delivery\\narea where baby is being delivered or being observed.\\n- Suction mouth and then nose with mucous sucker\\n- Delay bathing of newborn for the first few days; this will prevent hypothermia. However,\\nbaby may be wipedwith warm clean water to remove dried blood, vernix or secretions.\\nCare must be taken to ensure that the room is warm and draught free when the baby is\\nbeing cleaned or bathed. The baby should immediately be wrapped in dry linen after\\nbeing wiped dry.\\n\\uf0b7 After birth and for the first few days thereafter keep mother and baby in close proximity\\nwith baby being adequately clothed. In cold weather, the baby must have 2 layers of\\ncotton vest with a woolen sweater, cap, socks and legs should be covered and baby should\\nbe wrapped in a blanket.  In summer, cotton dress with a cotton diaper wrapped in a\\ncotton cloth.\\nPrevention of infection\\n\\uf0b7 Always clean hands with soap and water and wear sterile gloves if available before\\nconducting the birth of the baby and while examining babies during the first few days of\\nlife.\\n\\uf0b7 A sterilized blade (if that is not available a new razor blade or a blade boiled for at least\\n20 minutes) must be used for cutting the cord at delivery. The cord tie used must be\\nsterile or boiled for 20 minutes before used for tying the cord after birth.\\n\\uf0b7 The surface for conducting delivery and placing the baby after birth must be clean.\\n\\uf0b7 Do not apply anything to the cord or eyes after birth.\\n\\uf0b7 Do not give prelacteal feeds.Give exclusive breast-feeding from birth.\\nExclusive breastfeeding\\n\\uf0b7 Advise mothers to start breast feeding within one hour of birth. Not to give any prelacteal\\nfeeds such as honey, water, etc.\\n\\uf0b7 Give breast feeds to baby on demand. Give the baby exclusive breast feeding for at least\\nfirst 6 months of life. However, there may be situations where it may not be possible to\\nprovide human milk i.e., maternal death, severe maternal illness, HIV positive mothers\\nand documented lactational inadequacy.\\n\\uf0b7 Not to give water to the baby during period of exclusivebreast feeding.\\nEarly identification of high-risk newborns\\n\\uf0b7 Babies born to mothers with eclampsia, antepartum haemorrhage, diabetes etc. are\\nconsidered as high-risk newborns and delivery should be conducted at a centre where all\\nfacilities for the care of the newborn are available. The following examination at birth or\\nduring the first few days would help detect high risk babies who are in need of immediate\\nreferral to an appropriate health facility which has adequate newborn care.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 374, 'page_label': '375'}, page_content=\"Pediatric Conditions\\n367\\n\\uf0b7 Weigh baby. Babies with birth weights <2000 g are at increased risk of morbidity and\\nmortality and need careful assessment by a physician trained in child health.\\n\\uf0b7 Examine for major malformations.Most major and life threatening malformations such\\nas neural tube defects, oesophagealand anal atresias, diaphragmatic hernia, etc. can be\\ndetected at birth by careful examination. Some important clues to an underlying\\nmalformation are non-passage of meconium at 24 h of age or non-passage of urine at 48 h\\nafter birth.\\n\\uf0b7 Sucking, activity andcry.Newborn infants who have poor sucking, are less active than\\nnormal and have a weak cry are very ill and need immediate referral.\\n\\uf0b7 Respiratory distress.Babies who have a respiratory rate of >60 bpm (counted for at least\\n1 minute and persisting on repeat count) or have severe subcostal retractions have\\nrespiratory distress and need immediate referral.\\n\\uf0b7 Identification of severe jaundice.Yellow staining of the skin within 24 h of age or when\\nyellow staining of the skin includes the palms and soles at anyage, this is severe jaundice\\nand needs immediate referral.\\nImmunization\\nAll newborns delivered at a health facility shouldbe given BCG and one dose of oral\\npolio vaccine within 24 hours of birth.\\nLOW BIRTH WEIGHT BABIES\\nSalient features\\nTreatment\\nIndications for hospitalization are:\\n\\uf0b7 Birth weight of less than 1800 g, gestation age of less than 34 weeks, neonate who is not\\nable to take feeds from the breast or by cup (katori) and spoon (irrespectiveof birth\\nweight and gestation),sick neonate (irrespective of birth weight and gestation).\\nKeep the LBW babies warm\\nRoom temperature should be kept between 28-30Â°C. Following methods may be used:\\n\\uf0b7 Maternal-baby skin to skin contact (Kangaroo mother care). Place the naked baby\\nbetween the mother's breasts. Wrap baby and mother with a shawl. Cover the baby's head\\nwith a cap.\\n\\uf0b7 Proper clothing- cap, woollen sweaters, socks and mittens.Blankets,Overhead radiant\\nwarmer, Incubator\\n\\uf0b7 Nutrition-guidelines to provide fluids and nutrients to low birth weight babies are given in\\nfollowing table.\\n\\uf0b7 Low birth weight (LBW) baby is one who weighs less than 2500 g at birth. Low birth\\nweight may result from either prematurity (gestational age <37 weeks) or intrauterine\\ngrowth retardation (IUGR), which is also called small-for-date baby.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 375, 'page_label': '376'}, page_content='Pediatric Conditions\\n368\\nTable 1. Guidelines to provide fluids and nutrients to low birth weight babies (LWB)\\nAge Category of neonates\\nBirth weight <1200 g 1200-1800 g >1800 g\\ngestation <30 weeks 30-34 weeks >34 weeks\\nInitial Intravenous fluids\\n(60 ml/kg/day)with feed\\nGavage\\n(60 ml/kg/day)\\nBreast feeding.Ifnot\\nsatisfactory,spoon feeds\\nAfter 1-3 days Gavage (15-30 ml/kg/d),\\nincrease by 15-30 ml/kg/day\\nto a maximum of 180\\nml/kg/day of expressed\\nbreast milk\\nKatori/spoon\\nmaximum of\\n150-180 ml/kg/d\\nBreast feeding\\nLater\\n(2-4 weeks)\\nKatori/spoon (150-180\\nml/kg/day)\\nBreast feeding Breast feeding\\nVitamin supplementation\\n\\uf0b7 Vitamin K 1.0 mg IM at birth\\n\\uf0b7 Vitamin A 1000 IU orally daily-from 1 week age onwards\\n\\uf0b7 Vitamin D 400 IU orally daily-from 2 weekage onwards\\n\\uf0b7 Iron 2-4 mg/kg/day orally daily-from 4 weeks age onwards\\n\\uf0b7 Vitamin E, calcium and phosphorus supplementation in very LBW (<1500 g, <32 week\\ngestation).\\nEarly detection of sickness by periodic evaluation\\nReferral to higher centre in the presence of any one or more ofthe following signs: Lethargy,\\nrefusal to feed, hypothermia, respiratory distress, grunt, apnoea, abnormal weight gain,\\njaundice over soles and palms, abdominal distension, feed intolerance, cyanosis, pallor,\\nseizures and bleeding.\\nNEONATAL JAUNDICE\\nSalient features\\n\\uf0b7 C haracterized by yelloweyes, mucus membrane or skin.C ommon during the first\\nweek of life. About 60% of newborn develop transient, self-limiting jaundice-\\nPhysiological jaundice. About 5% of newborn develop pathological jaundice.\\n\\uf0b7 Progression of jaundiceis cephalopedal. Yellow colouration of trunk indicates the\\nserum bilirubin to range between 10 and 12 mg/dl whereas staining of palms and\\nsoles is ominous as it indicates a serum bilirubin of more than 15 mg/dl.\\n\\uf0b7 Physiological jaundice is characterized by its characteristic timelineâ€“ appears within\\n3rd day and resolves within 14 days of birth.Pathological jaundice may cause\\nkernicterus when unconjugated bilirubin exceeds 20 mg/dl. Ifpersists> 2 weeks, the\\nbaby should be investigated for cholestatic jaundice.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 376, 'page_label': '377'}, page_content='Pediatric Conditions\\n369\\nTreatment\\nAll neonates need assessment for jaundice. But not all jaundiced neonates require treatment.\\n\\uf0b7 Phototherapy:\\n- Mainstay of treatment and usually initiated when total serum bilirubin level reached\\nphototherapy threshold (10 to 12 mg/dl for preterm and 15 mg/dl for term babies).\\n- The naked infant (with covered eyes) is kept about 45 cm below the phototherapy unit.\\nPhototherapy is administered continuously and interrupted only for nursing and feeding\\npurpose with change in position every 2-4 hours.\\n- Failure of phototherapy is defined as inability to observe a decline in bilirubin of 1-2\\nmg/dl after 4-6 hour and/or to keep the bilirubin level below the exchange transfusion\\nlevel.\\n\\uf0b7 Exchange transfusion:\\n- It is indicated when bilirubin level exceeds threshold levels for age and gestational age or\\nhave features of bilirubin encephalopathy.\\n- Choice of blood:  Group and type specific, compatible packed RBCs with anticoagulant,\\n<7 days old.\\n- Complications include hypothermia, fluid overload, infection, electrolyte imbalance,\\nhypoglycaemia, thrombosis and death.\\n- Monitoring of heart rate, saturation, respiration, temperature, glucose and bilirubin levels\\nis required.\\n\\uf0b7 Adjunct treatment:\\n- Intravenous immunoglobulin\\n- Phenobarbitone\\nFollow up\\n\\uf0b7 Neurodevelopmental assessment at 3, 6, 9 and 12 months of age.\\n\\uf0b7 Hearing assessment (BERA) at 3 month of age.\\n\\uf0b7 Prognosis is excellent in uncomplicated cases.\\n\\uf0b7 Prognosis is guarded if jaundice is severe and requiring exchange transfusion.\\nMANAGEM ENT OF COMMON CLINICAL PROBLEMS IN NEWBORNS\\n\\uf0b7 Regurgitation of feeds and vomiting:N on-projectile expulsion of stomach contents\\nwithout force (regurgitation) is normal andneeds advice regarding feeding technique.\\n\\uf0b7 Bowel disorders: No medication should be prescribed for passage of stools after each feed\\n(exaggerated gastrocolic reflex) as this is normal in some babies. From 3rd to 14th day\\nmany exclusively breast-fed babies pass loose stools (10-15 times/ day) without\\nillness/dehydration. These are transitional stools and require no medication.\\n\\uf0b7 Delayed passage of urine: Non-passage of urine by 48 hours after birth may suggest\\nurinary tract anomalies. Such babies need to be investigated. Crying before passing urine\\nis normal.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 377, 'page_label': '378'}, page_content='Pediatric Conditions\\n370\\n\\uf0b7 Dehydration fever: Transitory moderate fever (up to 38.5Â°C) usually during the second or\\nthird day of life in summer months in an active baby, who sucks well, is normal and\\nresponds to lowering the environmental temperature.\\n\\uf0b7 Excessive crying: Most baby cry when either they are hungry or arehaving discomfort\\nsuch as due to full bladder before passing urine, wet napkin, nose block etc. Excessive\\ninconsolable crying or high-pitched crying is indicative of meningitis or any other painful\\ninflammatory conditions.\\n\\uf0b7 Umbilical sepsis: If there is pus discharge not extending to periumbilical skin, apply 10%\\ngentian violet or povidone iodine locally twice a day. However, if there is periumbilical\\nerythema or induration, administer syrup erythromycin 40 mg/kg/day in 3-4 divided\\ndoses. If the newborn hasany other high risk factor, refer to a higher centre.\\n\\uf0b7 Umbilical granuloma: A red flesh-like nodule at the base of umbilical cord can be\\nmanaged by cautery with silver nitrate or application of common salt for 3 to 4 days.\\n\\uf0b7 Engorgement of breasts in both sexes and vaginal bleeding after 4 days of birth is normal.\\nIMMUNIZATION SCHEDULE\\n\\uf0b7 A number of vaccines available for childhood immunization to protect against are\\nimportant national causes of childhood morbidity and mortality.\\n\\uf0b7 Both killed and live vaccinescan be administered simultaneously without decreasing the\\nefficacy of the individual vaccine. However, vaccines be administered at different sites\\nusing separate needles for each component. A gap of 1 month is recommended between 2\\nlive vaccines if not given together.\\n\\uf0b7 Avoid giving injections if skin is infected or compromised by a skin lesion. Prepare skin\\nwith a disinfectant. Always use a sterile syringe and needle for each injection and to\\nreconstitute each unit of medication. After use syringes and needles should be disposed\\noff carefully as per guidelines together.\\nTable 2. National immunization schedule (Universal Immunization Programme)\\nVaccine Age recommended\\nBCG Birth or 6 weeks.\\nOPV Birth, 6, 10, 14 weeks, 15-18 months.\\nHepatitis B Birth, 6, 10, 14 weeks\\nDPT 6, 10, 14 weeks, 15-18 months.\\nMeasles 9 months.\\nMMR 15-18 months.\\nDT 5 years.\\nTT 10 and 16 years (if given for first time at this age,\\ngive 2 doses at 4 weeks Interval).'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 378, 'page_label': '379'}, page_content='Pediatric Conditions\\n371\\nTable 3. Immunization recommended by the Indian Academy of Pediatrics\\nVaccine Age recommended\\nBOG From birth to 2 weeks\\nOPV At birth; 6,10 and 14 weeks\\nDTP 6,10 and 14 weeks; 15-18 months; 5 years (DT)\\nHepatitis B Birth, 6 and 14 weeks or Birth, 1 and 6 months or 6,\\n10 and 14 weeks\\nHib 6,10 and 14 weeks; 15-18 months\\nMeasles 9 months + (special circumstances (epidemics) may\\nbe given earlier\\nthan 9 months)\\nMMR 15-18 months\\nTyphoid 2 years + (revaccination 3-4 years)\\nTT 10 and 16 years\\n2 doses of TT Pregnant women at I month interval\\nNewer Vaccines\\nVaricella Above 1 year\\nHepatitis A Above 1 year\\n\\uf0b7 If the mother is known to be HBsAg negative, HB vaccine can be given along with DTP at 6, 10\\nand 14 weeks. If the mother\\'s status HBsAg status is not known, it is advisable to start vaccination\\nsoon after birth to prevent perinatal transmission of the disease. If the mother is HBsAg positive\\n(and especially HBsAg positive), the baby should be given Hepatitis B immune globulin (HBIG)\\nwithin 24 hours of birth, along with HB vaccine.\\n\\uf0b7 The only advantage of combinationvaccines is convenience, however, should not be viewed as\\nmore effective than vaccines given separately. The manufacturer\\'s instructions should be strictly\\nfollowed whenever \"mixing\" vaccines in the same syringe prior to injections.\\nImmunization in special circumstances\\n\\uf0b7 Immunization in preterm infants: In general, all vaccines may be administered as per\\nschedule according to the chronological age irrespective of birth weight or period of\\ngestation. Very low birth weight/ preterm babies can be given immunization if they are\\nstable otherwise.\\n\\uf0b7 Children receiving corticosteroids: Children receiving oral corticosteroids in high doses\\n(prednisolone 1-2 mg/kg/day) for more than 14 days should not receive live virus\\nvaccines until the steroid has been discontinuedfor at least one month. Killed vaccines\\nare safe but may not be completely effective in such situations. Patients on topical or\\ninhaled steroids should not be denied their age appropriate vaccine.\\n\\uf0b7 Children awaiting splenectomy: Immunization with pneumococc al, Hib and\\nmeningococcal vaccine should be initiated a few weeks prior to splenectomy.\\n\\uf0b7 Vaccination in children with HIV infection: Immune response may be suboptimal as it\\ndepends on the degree of immunodeficiency at that point of time. Readministration of'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 379, 'page_label': '380'}, page_content='Pediatric Conditions\\n372\\nchildhood immunization may be considered when their immune status has improved\\nfollowing anti-retroviral therapy.\\n\\uf0b7 Lapsed immunization: There is no need to restart a vaccine series regardless of the time\\nthat has elapsed between individuals dose. In case of unknown or uncertain immunization\\nstatus, however, it is appropriate to start the schedule as for an unimmunized child.\\n\\uf0b7 Minor illnesseslike fever, diarrhoea, respiratory infections and malnutrition should not be\\nconstrued as contraindications to immunization.\\nFLUID AND ELECTROLYTES THERAPY IN CHILDREN\\nFluid and electrolyte therapy is divided into three phases: Correction of pre-existing deficits\\nlike rehydration therapy for diarrhea. Provision of maintenance requirements for normal\\nmetabolism, correction of ongoing losses (diarrhea, vomiting) or removal (suction,\\naspiration). The maintenance requirements are as follows:\\nA guideline for estimating daily fluid and electrolyte requirement in a normal child under\\nnormal conditions is:\\nWeight Fluid requirement\\n3-10 kg 100 ml/kg/day\\n10-20 kg 1000 ml + 50 ml/kg/day for each kg above 10.\\n> 20 kg 1500 ml + 20 ml/kg/day for each kg above 20.\\nMaintenance fluid requirement replaces water loss through skin (2/3 of losses), GIT,\\nrespiration, and urine. These losses are affected by ambient humidity, clothing, body\\ntemperature, respiratory rate, and age of the child. Situation specific adjustments are\\nnecessary when calculating maintenance fluids. The most commonly employed intravenous\\nmaintenance fluid employed in children is N/5 (0.18%) sodium chloride in 5% glucose +\\npotassium chloride 20 mEq/ Liter. Commercially it is available as Isolyte P, Kidral etc.\\nMaintenance requirements in newborns\\nThe following table provides the normal fluid electrolyte requirements in newborn babies.\\nTable 4. Normal fluid requirements of newborns\\nAge (days)Total fluids Glucose/Dextrose (ml/kg/day) Electrolyte\\n1 60 10% Dextrose in water None\\n2 70-80 -do- None\\n3 80-90 -do- Sodium 2-3 mmol/kg/day\\nPotassium 2 mmol/kg/day\\n4 90-100 -do- -do-\\n5 100-110 -do- -do-\\n6 110-120 -do- -do-'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 380, 'page_label': '381'}, page_content='Pediatric Conditions\\n373\\n\\uf0b7 From day 3 onwards, fluid containing glucose-electrolyte mixture can be provided using\\ncommercially available paediatric maintenance intravenous solutions provided 5% weight\\nloss has been documented.\\n\\uf0b7 The fluid and electrolyte requirement from day 7-28 remains the same. However, in\\nbabies <1500 g the fluid requirement after day 7 need to be increased by 10-20 ml/kg/day\\ntill a maximum of 150 ml/kg/day.\\nConditions that increase fluid requirement\\n\\uf0b7 Fever: for every 1Â°C increases over 37.5Â°C, the fluid requirement increases by 10\\nml/kg/day.\\n\\uf0b7 Phototherapy: this increases fluid requirement by 10-20 ml/kg/day.\\nConditions that decrease fluid requirement\\n\\uf0b7 Congestive cardiac failure: Fluid requirements are reduced to 2/3rd of the normal need for\\nthat age.\\n\\uf0b7 Renal failure: In cases of decreased urinary output, the fluid regimen is 400 ml/m2/day for\\ninsensible water losses plus urinary output over the day. Potassium should be added with\\ncaution or omitted in suspected cases of acute renal failure.\\nIRON DEFICIENCY ANAEMIA\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 After period of exclusive breastfeeding (6 months), cereal based diet should be added.\\nEncourage green leafy vegetables and fruits.\\n\\uf0b7 Treatment depends on hemoglobin levels and age of the patients\\nPharmacological treatment-Oral Iron Therapy\\n\\uf0b7 Oral ferrous salts (sulphate, gluconate etc) are the preferred therapeutic iron preparations.\\n\\uf0b7 Therapeutic iron dose: 4 mg/kg/day of elemental iron in 2â€“ 3 divided doses to be given\\nbetween meals for 2 months after normal Hb concentration for age is achieved.\\n\\uf0b7 In prematurity start iron syrup from 2nd week of life to 1 year.\\n\\uf0b7 Response to therapyâ€“ decreased irritability and improved appetite is seen within 12â€“ 24\\nhours. Rise in Hb levels seen within 7 days at the rate of 0.25â€“ 0.4 g/dl/day.\\n\\uf0b7 Iron deficiency anaemia occurs mainly due to dietary lack of iron containing food.\\n\\uf0b7 RBC indices like reticulocytecount, serum iron concentration,total iron binding\\ncapacity(TIBC) etc aids in diagnosis of iron deficiency anaemia.\\n\\uf0b7 C linical features are easy tiredness, lack of concentration, decreased school\\nperformance, growth retardation. Severe cases may present withCCF.\\n\\uf0b7 Iron deficiency is uncommon in term breastfed childrenbut prematurity, perinatal\\nblood loss or cow milk feeding may lead to deficiency in infancy.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 381, 'page_label': '382'}, page_content='Pediatric Conditions\\n374\\n\\uf0b7 If the response is inadequate, check for the prescribed dose, compliance, presence of\\ndiarrhoea or malnutrition, infections orÎ² thalas semia trait mistakenly diagnosed as iron\\ndeficiency anaemia.\\nParenteral Iron Therapy\\n\\uf0b7 It is rarely required. However, when oral iron is not tolerated, severe ADRs to oral iron or\\npresence of malabsorption syndromes, parenteral iron therapy may be used.\\n\\uf0b7 Total dose of iron is: Iron(mg) = wt(kg) x Hbdeficit (g/dl) x 4\\n\\uf0b7 Injection iron dextran or iron sorbitol citrate (50 mg/ml) deep gluteal IM injection is\\npreferred.\\nBlood Transfusion\\n\\uf0b7 When Hb is less than 3g% or Hb 4-6 g% in cardiac compromised patient\\n\\uf0b7 PCV 15 ml/kg at rate of 4-5 ml/kg/hour\\nPatient/parent education\\n\\uf0b7 Iron deficiency anaemia occurs generally due to dietary deficiency of iron. Once the diet is\\nmodified, the patient should stick to that diet.\\n\\uf0b7 Iron should be taken between meals and never with tea or milk\\n\\uf0b7 Intake of iron usually causes harmless black discolouration of teeth and stools. The teeth\\ndiscolouration can be prevented by rinsing the mouth with water after doses.\\nMEGALOBLASTIC ANEMIA\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Folic acid Deficiency- Oral folic acid- <6 months of age: 15 mcg/kg for 3 months\\n7 monthsâ€“ 13 year:  1 mg for 3 weeks followed by 0.1-0.5 mg for next 3 months\\n\\uf0b7 Vitamin B12 Deficiency\\n- Oral/sublingual vitamin B12\\n500-1000 mcg/day for 4-6 weeks\\n25-50 mcg/day for next 3 months\\n- Parenteralvitamin B12\\n100 mcg IM for 2 weeks\\n100-250 mcg/day IM till complete correction\\n\\uf0b7 Folic acid and vitamin B12 are two most essential micronutrients.Deficiency of both\\noccurs due to dietary lack. B12 deficiency is especially seen in strict vegetarians as its\\nmain dietary source is non vegetarian food.\\n\\uf0b7 Detailed diet history, Hbconcentration, reticulocyte count, RBC indices help\\nestablishing diagnosis of megaloblastic anemia.\\n\\uf0b7 C linical features are same as iron deficiency anemia. Young child may show tremors\\nand typical pigmentation over knuckles.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 382, 'page_label': '383'}, page_content=\"Pediatric Conditions\\n375\\nPROTEIN ENERGY MALNUTRITION\\nNutritional marasmus and kwashiorkor are two extreme forms of malnutrition. Such extreme\\nforms are rare; most cases suffer from mild and moderate nutritional deficit.\\nSalient features\\nAssessment of nutritional status\\nUndernutrition is classified by WHO into moderate and severe forms as shown in the\\nfollowing table. Reference values for weight for height are also provided.\\nTable 5. WHO classification for severity of undernutrition\\nModerate undernutrition Severe undernutrition\\nSymmetrical edema No Yesa\\nWeight for height\\n(measure of wasting)\\nSD scoreb -2 to-3\\n(70â€“ 79% of expectedc)\\nSD score <-3\\n(<70% of expected)\\nHeight forage\\n(measure of stunting)\\nSD scoreb -2 to-3\\n(85â€“ 89% of expectedc)\\nSD score <-3\\n(<85% of expected)\\na. This includes kwashiorkor and marasmic kwashiorkor\\nb. SD score = Observed valueâ€“ expected value\\nStandard deviation of reference population\\nc. Median (50th percentile of NCHS standards).\\nTable 6. NCHS/WHO Normalized reference values for weight-for-height/length\\nBoys' weight (kg) Length(cm) Girls' weight (kg)\\n-3 SD -2 SD Median Median -2 SD -3 SD\\n2.2 2.5 3.3 50 3.4 2.6 2.3\\n2.7 3.3 4.3 55 4.3 3.3 2.8\\n3.7 4.4 5.7 60 5.5 4.3 3.7\\n5.0 5.7 7.1 65 7.0 5.5 4.8\\n6.3 7.0 8.5 70 8.4 6.8 6.0\\n7.4 8.2 9.8 75 9.6 7.9 7.0\\n8.3 9.2 10.9 80 10.6 8.8 8.0\\n\\uf0b7 Milder forms may just present with failure to thrive i.e. decreased rate of weight gain.\\n\\uf0b7 Marasmus is characterized by gross wasting of muscle and subcutaneous tissues\\nresulting in emaciation, marked stunting, and no oedema.\\n\\uf0b7 Markedly retarded growth, psychomotor changes, and oedema of dependent parts are\\nthree essential clinical features of kwashiorkor.\\n- PEM is usually associated with anaemia due to iron, protein, vitamin B12 or folic acid\\ndeficiency, xerophthalmia due to vitamin A deficiency, andother micronutrient\\ndeficiencies magnesium, copper, zinc,vitamins B, C, D and K.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 383, 'page_label': '384'}, page_content='Pediatric Conditions\\n376\\n8.9 9.9 12.1 85 11.8 9.7 8.6\\n9.8 10.9 13.3 90 12.9 10.7 9.5\\n10.7 11.9 14.5 95 14.1 11.6 10.4\\n11.6 13.0 15.7 100 15.4 12.7 11.3\\n12.7 14.2 17.1 105 16.7 13.8 12.3\\n13.8 15.4 18.7 110 18.2 15.0 13.4\\nSD -standard deviation score (or z score).\\nIndian Academy of Paediatrics (IAP) takes a weight of more than 80% of expected for age as\\nnormal.  Grades of malnutrition are:Grade I (71-80%), Grade II (61-70%), Grade III (51-\\n60%) and Grade IV (< 50%) weight of expected value for that age.\\nTreatment\\nMild to moderate undernutrition\\n\\uf0b7 Domiciliary treatment of malnourished children is economical, offers in-built advantage of\\npractical health education, and is associated with minimal recurrence risk.\\n\\uf0b7 The parents are advised to increase the food intake of the child, adequate amount of calories\\nand protein in the diet, prepared from the locally available, inexpensive foods.\\n\\uf0b7 Keep the child under surveillance by using a growth chart and effort should be made that he\\ndoes not slip down to severe malnutrition.\\nSevere malnutrition\\n\\uf0b7 Initial treatment involves managing complications. The aim is to treat complications and\\nstabilize the child.\\n\\uf0b7 Severely wasted children and those with oedema need hospitalization. Other indications for\\nadmission in an undernourished child are severe dehydration, severe diarrhoea, hypothermia,\\nshock, systemic infection, jaundice, bleeding, age less than one year, or persistent loss of\\nappetite.\\n\\uf0b7 Those with severe stunting alone may be managed in the community.\\n\\uf0b7 Refer, when child fails to (i) regain appetite by day 4, (ii) loose oedema by day 5, or (iii) gain\\nweight by day 10 of therapy.\\n\\uf0b7 Children who fail to respond to treatment should be screened for faulty feeding, inadequate\\nfeeding, persistent diarrhoea, malabsorption, giardiasis, shigellosis, amoebiasis, otitis media,\\npneumonia, UTI, fungal infections, scabies, tuberculosis, helminthiasis, malaria, and\\nHIV/AIDS. If the search proves futile, one should also look for any underlying\\nimmunological disease, inborn errors of metabolism and malignancies.Hospital management\\nof severe malnutrition is given in the following table.\\nTable 7.Hospital management of severe malnutrition\\nProblem Management\\nHypothermia (rectal\\ntemperature <35.5ÂºC)\\n\\uf0b7 Keep under heat source such as radiant warmer, room heater, hot air\\nblower or 200 watt bulb and warm upto rectal temperature 37ÂºC'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 384, 'page_label': '385'}, page_content='Pediatric Conditions\\n377\\nwithin 2â€“ 3 hours\\n\\uf0b7 Ifelectric gadgets are not available, cover the child well. Warm up\\nwith kangaroo technique (placing the naked child against mothers\\nbare chest and covering them both together with cloth and blanket)\\n\\uf0b7 Monitor rectal temperature half hourly. Investigate and treat for\\ninfection and hypoglycemia.\\nHypoglycemia (blood\\nsugar <54 mg/dl)\\n\\uf0b7 10% glucose 5â€“ 10 ml/kg IV immediately followed by IV infusion\\nof a dextrose containing solution.\\n\\uf0b7 Stop IV fluids as soon as blood glucose stabilizes and switch to oral\\nfeeds.\\nDehyd ration (as\\nassessed by WHO\\nclassification)\\n\\uf0b7 Some dehydration is to be corrected with 2/3rd diluted ORS over 12\\nhours.\\n\\uf0b7 Severe dehydration: Administer Ringerâ€™s Lactate or N/2 5% saline\\n30 ml/kg 2 hours. If still pulse is not palpable, consider septic shock\\nand manage accordingly.\\nSevere dehydration\\n(weak pulse, oliguria)\\n\\uf0b7 If pulse improves after 2 hours, give N/6 5% saline at 10 ml/kg/hour\\nin next 10 hours followed by 5 ml/kg/hr in next 12 hours.\\n\\uf0b7 After dehydration is corrected, start on maintenance fluids at 75-100\\nmg/kg/day till feeding is established.\\n\\uf0b7 Add potassium to IV fluids at 30 mEq/l after the child passes urine.\\nSeptic shock (clinical\\nfeatures similar to\\nsevere dehydration)\\n\\uf0b7 Give blood or plasma transfusion at 10 ml/kg over 3 hours.\\n\\uf0b7 Start antibiotics as given in Infections\\n\\uf0b7 Fluid management is similar to that of severe dehydration\\nDyselectrolytemia\\uf0b7 There is a risk of hypernatremia and hypokalemia.\\n\\uf0b7 Restrict sodium intake and do not give hypertonic saline even in face\\nof hyponatremia.\\n\\uf0b7 Potassium supplements should be given at 30â€“ 40 mEq/L per day of\\nfluids provided the child is passing urine freely.\\nInfections \\uf0b7 No apparent signs of infection and no complications, then give\\ncotrimoxazole (5 mg/kg of trimethoprim) twice daily for 5 days.\\n\\uf0b7 Presence of septic shock, hypoglycemia, hypothermia, skin,\\nrespiratory, urinary infections or sick looking, give injection\\nampicillin 50â€“ 100 mg/kg IM or IV 6 hrly + gentamicin 7.5 mg/kg\\nIM or IV once a day for 7 days\\n\\uf0b7 If no response to above antibiotics in 48 hours, add chloramphenicol\\n25 mg/kg IM or IV 8 hourly. Give every 6 hourly if meningitis is\\nsuspected.\\n\\uf0b7 If specific infections are detected such as dysentery, malaria,\\npneumonia, worm infestation, tuberculosis, treat as per STG of that'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 385, 'page_label': '386'}, page_content='Pediatric Conditions\\n378\\nparticular condition.\\nCongestive cardiac\\nfailure (tachycardia,\\ncardiomegaly)\\n\\uf0b7 Restrict fluid intake.\\n\\uf0b7 Give injection furosemide 1 mg/kg stat.\\nSevere anaemia\\n(hemoglobin <4 gm\\n%)\\n\\uf0b7 If JVP is elevated, give a single dose of Inj. digoxin 5 mcg/kg\\n\\uf0b7 Give packed red cells 10 ml/kg in 4â€“ 6 hours, carefully monitoring\\ncardiac status.\\nVitamin A deficiency\\uf0b7 Give a single dose of vitamin A orally to all children less than 6\\nmonths â€“ 50,000 IU, 6 months to 1 yearâ€“ 1,00,000 IU, more than 1\\nyearâ€“ 2,00,000 IU if the dose has not been given in the last month.\\n\\uf0b7 If signs of vitamin A deficiency are present, repeat the above dose\\ntwiceâ€“ the next day and then after 2 weeks.\\nVitamin K deficiency\\nor severe bleeding\\n\\uf0b7 Injection vitamin K 2.5 mg IM single dose.\\nMagnesium\\ndeficiency\\n\\uf0b7 Give 02 ml/kg of 50% solution ofmagnesium sulphate IV single\\ndose.\\nFolic acid deficiency\\uf0b7 Give folic acid 5 mg on day 1 followed by 1 mg/day.\\nInitiation of cure\\nFirst seven days aim: start nutrition\\nStarting point\\nOnce complications are taken care of and child is ready to tolerate feeds.\\nTable 8. Initiation of cure\\nStart feeding \\uf0b7 Initiate feed as early as possible.\\n\\uf0b7 If oral feeding is not possible, give nasogastric feeding.\\n\\uf0b7 Start with a lower volume of feed at frequent intervals, number\\nof feeds varying from 12 feeds on first and second day to 6 to 8\\nfeeds on days 3â€“ 7.\\n\\uf0b7 If tolerated, milk based diets are most suitable (80 kcal/kg/day)\\nand protein (0.7 gm/kg/day). The caloric intake should not\\nexceed 100 kcal/kg/day on the first day. Increased gradually over\\none week to 150 kcal/kg/day of energy and 2â€“ 3 gm/kg/day of\\nproteins. Total amount of fluids should be kept within 100â€“ 125\\nml/kg/day.\\n\\uf0b7 Sugar and oil can be added to provide extra calories.\\nLactose intolerance\\n(stool pH, 5.5 on two\\nseparate\\noccasions)\\n\\uf0b7 Reduce the total lactose load inthe diet by diluting the milk for 3\\nto 4 days or substituting a part of milk feeds by formulae based\\non lactose free milk protein (calcium caesinate), sugar and oil,\\nsoyabean, meat or vegetable protein mixtures.\\nOther nutrients \\uf0b7 Supplement the diet with minerals and trace elements as follows:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 386, 'page_label': '387'}, page_content='Pediatric Conditions\\n379\\npotassium chloride (1.2 to 2.4 g/L of feed), magnesium chloride\\n(300 â€“ 600 mg/L of feed), zinc acetate (20 mg per day), copper\\nacetate (2 mg/L of feed), selenium (6â€“ 10 mcg/kg/day) and folic\\nacid (1 mg/day). Do not give iron at this stage. Add iron only\\nafter one week of therapy.\\n\\uf0b7 Vitamins of B complex are not useful in initial therapy.\\nSigns of\\nimprovement\\n\\uf0b7 During these seven days, a child of kwashiorkar will lose weight\\nand a marasmic child gains little or nothing because the tissue\\ngains are masked by excess water loss.\\nRehabilitative phase\\n(2â€“ 6 weeks)\\n\\uf0b7 Aim: Restore normal weight for height.\\n\\uf0b7 Starting point: Child has started showing signs of recovery of\\nappetite and changes in expression.\\nIntensive feeding\\n(too recover lost\\nweight)\\n\\uf0b7 Replace the initial milk diet with home diet as soon as possible.\\n\\uf0b7 Provide therapeutic diet as follows: fluids 150 ml/kg/day, energy\\n175 â€“ 200 kcal/kg/day, proteins 2â€“ 4gm/kg/day.\\n\\uf0b7 The diet prescribed for the child should be such which thefamily\\ncan afford for the baby within its limited income, can be cooked\\neasily at home, does not perish easily, is culturally acceptable,\\nand easily available in the local market.\\nTreat concurrent\\nnutritional\\ndeficiencies\\n\\uf0b7 Start oral iron 3 mg/kg/day elemental iron once a day. Start other\\nvitamins including B, C, D, E at double the RDA.\\n\\uf0b7 Continue potassium, magnesium, zinc, copper, selenium and\\nfolic acid supplementation.\\n\\uf0b7 Provide vitamin D 400 IU once daily for 4 weeks/.\\nNUTRITIONAL RICKETS\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Encourage the child to play outdoors/ increase exposure to sunlight.\\n\\uf0b7 Enhance dietary sources of vitamin D-dairy products, egg and fish liver oil.\\nPharmacological treatment\\n\\uf0b7 It isdefective mineralization of growing skeleton caused by deficiency of vitamin D\\ncharacterized by skeletal deformities like genu valgum/genu varum, broadening of\\nwrists, susceptibility to fractures, weakness, hypotonia and disturbances in growth.\\nMost often it is nutritional (lack of exposure to sunlight and inadequate dietary intake)\\nand occurs between 2 months to 2 years of age.\\n\\uf0b7 X ray shows thatincreased thickness of epiphyseal growth plate,cupped with hazy\\nmetaphyseal borders. S.calcium is generally normal/low, phosphate is low/normal and\\nalkaline phosphatase is raised in nutritional rickets.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 387, 'page_label': '388'}, page_content='Pediatric Conditions\\n380\\n\\uf0b7 Vitamin D 600,000 IU stat oral or IM (if patient is sick due to intercurrent infection).\\n\\uf0b7 Repeat X-ray wrist after 4 weeks. If the response is positive, i.e. healing line of rickets is\\nseen on X-ray, continue oral vitamin D 400 IU/ day.\\n\\uf0b7 If no response to therapy after 4 weeks refer to a highercentre for evaluation of non-\\nnutritional rickets.\\nPatient education\\n\\uf0b7 Exposure to sunlight is beneficial for a child with rickets.\\n\\uf0b7 No special type of oil is required for massage.\\n\\uf0b7 Consumption of dairy products which are rich in vitamin D should be emphasized.\\n\\uf0b7 Most of the deformities improve in the due course of time.\\nPICA\\nSalient features\\nTreatment\\nPica below two years does not need any intervention.\\nChildren with pica are at increased risk of lead poisoning, iron deficiency, bezoars, and\\nparasitic infections. They should be investigated for these problems and if present, treated\\nsuitably.\\nPRIMARY NOCTURNAL ENURESIS\\nMost common cause in primary enuresis is inappropriate toilet training. Other causes could\\nbe genetic, sleep disorder, reduced ADH at night. Psychological causes may be found in\\nsecondary. Around 3% children have organic pathology, such as obstructive uropathy or UTI.\\nSalient features\\nNon -pharmacological treatment (effective in 30% cases)\\n\\uf0b7 Rule out organic causes. Restrict fluid intakein the evening. Bladder exercises:\\n- hold urine as long as possible during the day.\\n- practice repeated starting and stopping the stream at the toilet bowl.\\n\\uf0b7 Practice getting up from bed and going to the bathroom at bedtime before sleep.\\n\\uf0b7 R epeated and chronic ingestion of non-nutrient substances including mud, plaster, paint,\\nearth, clay, etc.It is self-limiting and represents manifestations of family disorganization,\\npoor supervision, and emotional neglect.\\n\\uf0b7 Involuntary discharge of urine after the age at which bladder control should have been\\nestablished (5 years).In primary nocturnal enuresis, child has never been dry at night\\nwhile in secondary, child has been continent for at least 6 months before the child begins\\nto wet again.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 388, 'page_label': '389'}, page_content='Pediatric Conditions\\n381\\nPharmacological treatment\\n\\uf0b7 Indicated only in children > 6 years where sufficient trial of non-pharmacological\\nmanagement has failed.\\n\\uf0b7 Tab. imipramine: 6-8 year (25 mg), 9-12 year (50 mg), >12 year (75 mg) once a day at\\nbedtime. Ordesmopressin acetate (nasal spray, 10mcg per spray): Start with 10 mcg\\ngiven at bedtime daily and increase gradually by 10 mcg/per week to a maximum of 40\\nm cg per day. If effective, it should be used or 3-6 months.\\n\\uf0b7 Refer the patient to a higher centre if organic cause is suspected or when diagnosis is in\\ndoubt.\\nPatient education\\n\\uf0b7 Reassure the parents that condition is self-limiting.\\n\\uf0b7 Ask the parents to maintain a diary record of dry nights; reward the child for such nights.\\nWHEEZY CHILD\\n\\uf0b7 Wheezing is a clinical symptom present in asthma and other illnesses including\\nbronchiolitis and other viral infection, foreign body inhalation, tuberculosis, pneumonia,\\ncystic fibrosis, hypersensitivity pneumonia and conditions compressing airways.\\nWheezing during infancy could be due to viral infections.\\n\\uf0b7 Wheezing inasthma is recurrent, gets worse in night and after exercise, seasonal and may\\nbe associated with other allergic illnesses like atopic dermatitis, allergic rhinitis etc.\\n\\uf0b7 Clinical features suggestive of other cause of wheezing are: neonatal onset, associated\\nwith difficulty in feeding, choking or vomiting, localized findings in chest or abnormality\\nin cardiovascular system.\\nACUTE BRONCHIOLITIS\\nSalient features\\n\\uf0b7 It is an acute respiratory tract infection caused by respiratory syncytial virus.\\nBronchiolitis commonly occurs in infants below 6 months of ageduringduring winter\\nand early spring.Symptoms -running nose for 2-4 days followed by cough, wheeze and\\nrapid respiration. With increasing severity of illness there may be lower chest indrawing,\\ndifficulty in feeding, excessive crying due to hypoxaemia, cyanosis and respiratory\\nfailure.H istory of viralURTI in other family members in the recent past.\\n\\uf0b7 Normal or minimal increase in total leucocyte counts with relative lymphocytosis. X-ray\\nchest may show hyperinflation and small atelectasis. Clinical judgement remains the\\ngold standard criteria for hospital admission. SpO2 monitoring is the most consistent\\nclinical predictor of worsening.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 389, 'page_label': '390'}, page_content='Pediatric Conditions\\n382\\nNon -pharmacological treatment\\nFor associated nasal block normal saline drops in both nostrils as and when required,\\nespecially before feeds, and use of home remedies (ginger, honey, tulsi) for control of cough\\nand plenty of liquids orally.To be nursed in comfortable environment.\\nPharmacological treatment\\n\\uf0b7 Adequate hydration and oxygenation (humidified O2) remain the backbone of treatment.\\n\\uf0b7 Treatment of mild disease(ambulatory treatment at home)-No antibiotics,Syr. paracetamol\\n10-15 mg/kg 4-6 hourly for fever.\\n\\uf0b7 If patient shows overall improvement with no evidence of chest indrawing, cyanosis,\\ndifficulty in feeding continue treatment as above. If there is partial improvement patient\\nshould be called again after 2 days or earlier if patient deteriorates for reassessment.\\n\\uf0b7 Hospitalize immediately if any of the following develop: chest indrawing, poor feeding,\\ncyanosis, altered sensorium and convulsions and managed as severe disease.\\n\\uf0b7 If there is no improvement or deterioration at any time during the illness, the patient should\\nbe managed as severe disease.\\n\\uf0b7 Treatment of the severe disease (needs hospitalization for management)- oxygen\\nadministration by oxygen hood or nasal catheter and intravenous fluids if child is not able to\\nfeed.\\n\\uf0b7 Adrenaline inhalation (injectable form) 0.3 mg/kg by nebulizer after dissolving the solution\\nin 3 ml saline; can be repeated every 4-6 hourly as required. (No role of antibiotics, steroids,\\nribavirine inhalation in uncomplicated patients).\\n\\uf0b7 If adrenaline not available, salbutamol inhalation (0.15 mg/kg dissolved in 3 ml soln.) may be\\ntried and continued if responseobserved.\\n\\uf0b7 Syr. paracetamol 10-15 mg/kg dose may be given 4-6 hourly.\\n\\uf0b7 Do not use sedatives.\\n\\uf0b7 Monitor improvement in respiratory rate, lower chest indrawing, difficulty in feeding,\\nexcessive crying, cyanosis and oxygen saturation, if available, every 4-6 hours till there is\\nsignificant improvement. If child does not improve/deteriorate look for underlying heart\\ndisease i.e., myocarditis/congenital heart disease and get an X-ray chest and look for massive\\ncollapse of lung/infection/pneumothorax etc. and manageaccordingly.\\nPatient education\\n\\uf0b7 Mother should be educated about the signs of pneumonia i.e., rapid respiratory rate, chest\\nindrawing, difficulty in feeding.\\n\\uf0b7 Mother should be educated about identification of danger signals in a child suffering from\\npneumonia and report immediately to the health care facility.\\n\\uf0b7 Inhaled systemic steroids have not been recommended for the treatment of acute\\nbronchiolitis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 390, 'page_label': '391'}, page_content='Pediatric Conditions\\n383\\nPNEUMONIA\\nIt is the inflammation of lung parenchyma. Pneumonia is responsible for 20% of under 5\\nmortalityin India. The etiological agents vary with the age of the patient. Less than three\\nmonths: Gram negative bacteria andGroup B streptococcus, 3 months to 5 yrs.S.pneumonie,\\nH.influenza, Staph.aureus, viruses, and >5 yearsS.pneumonie, M.pneumonie,viruses.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 For non-severe pneumonia (domicillary oral treatment and follow up)\\n- Patients with age more than 2 months and with absence of features of severe  pneumonia can\\nbe treated at home.\\nTab/Syr. amo xicillin 20-40 mg/kg/day in 3 divided doses for 7- 10 days or Tab/Syr.\\ncephalexin 20-40 mg/kg/day in 3 divided doses for 5-7 days. Or chloramphenicol50-100\\nmg/kg/day in 4 doses for 7-10 days.\\n- For severe pneumonia and children up to 3 months of age (Hospitalisation and IV\\nantibiotics.) Up to 3 months (for 7-10 days)\\n- Inj. cefotaxime 100 mg/kg/day 2 divided dose or Inj. cefuroxime 100 mg/kg/day in 2 divided\\ndoses for 7â€“ 10 days or  Inj. ampicillin 100 mg/kg/day in 3 divided doses PLUS\\n- Inj. gentamicin 5-7.5mg/kg/day 2 divided dose\\n\\uf0b7 For severe pneumoniaâ€“ age 3 months to 5 years, First line for 7 to 10 days\\nInj. ampicillin IV 100 mg/kg/day in 4 divided dose or Inj. chloramphenicol 50-100\\nmg/kg/day in 4 divided doses\\nSecond line-Inj. cefotaxime 150-200 mg/kg/day.\\n\\uf0b7 In all age group, if staphylococcal pneumonia is suspected, treat for 14 days.\\nInj. cefotaxime/ceftriaxone  Plus cloxacillin 100-200 mg/kg/day in 4 doses.\\n\\uf0b7 C lassified as mild to very severe disease.\\n- No pneumonia -no fast breathing and no indicators of severe or very severe pneumonia.\\n- Pneumonia -fast breathing e.g. age below 2 months > 60 RR/min; 2 months-12 months >\\n50 RR/min; 12 months-60 months > 40 RR/min and no indicatorsno indicators of severe\\nor very severe pneumonia.\\n- Severe pneumonia- lower chest indrawing or nasal flaring and no signs of very severe\\npneumonia.\\n- Very severe pneumonia-central cyanosis or not able to breastfeed or drink or convulsions\\nor lethargy or unconsciousness or severe respiratory distress (e.g. head nodding).\\n\\uf0b7 Diagnosis: chest X ray need not be done routinely if no complication (pleural effusion, no\\nimprovement) suspected. Children up to 3 months of age and children with severe\\npneumonia are treated as in patient with parenteral antibiotics.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 391, 'page_label': '392'}, page_content='Pediatric Conditions\\n384\\nFollow up and monitoring\\n\\uf0b7 Mild pneumonia- reassessed at 48 hours or earlier if child deteriorates. If child shows\\nimprovement, continued same treatment for 5-7 days. If deteriorates, patient is\\nhospitalized and treated as severe pneumonia.\\n\\uf0b7 Children who are hospitalized (severe and very severe pneumonia) are monitored more\\nfrequently.  Children with severe/very severe pneumonia (age >2 month) on deterioration\\ncan be treated with cefotaxime/cefuroxime.\\nPatient education\\n\\uf0b7 Explain the signs of pneumonia i.e., rapid respiratory rate, chest indrawing, difficulty in\\nfeeding etc.\\n\\uf0b7 Explain the danger signals in a child suffering from pneumonia.\\nTHRUSH (ORAL CANDIDIASIS)\\nSalient features\\nNon -pharmacological treatment\\nCorrectfaulty sterilization technique offeedingbottle; best to avoid bottle feeding.\\nPharmacological treatment\\n\\uf0b7 Clotrimazole 1%cream, gel or lotion, oral application 3-4 times/day after feeding for 5-\\n7days (or 1-2 days beyond recovery) Or  miconazole gel 25 mg 4 times a day for 5-7\\ndays. Or gentian violet 1% aqueous solution 1-2 times a day, for 5-7 days (can stain\\ntissues and clothes).\\n\\uf0b7 In resistant/chronic cases (patients with major underlying disease) Tab. fluconazole 3-6\\nmg/kg once daily for 5-7 days. Or Tab. ketoconazole 3-6 mg/kg once daily for 5-7 days.\\n\\uf0b7 In resistant recurrent/chronic thrush in a child with no obvious predisposing factor/ source\\nof infection, look for underlying endocrinopathy, immune disorder, AIDS and\\nmalnutrition.\\nPatient education\\n\\uf0b7 Emphasize on bottle hygiene, care/hygiene of the nipple and treatment of vaginal\\ncandidiasis in expectant mother.\\n\\uf0b7 Oral candidiasis may be seen as early as 7-10 days of age (peak 4th week of life)\\nuncommon after 12 months of age, when it is secondary to broad-spectrum antibiotic.\\n\\uf0b7 Thick white patches on anerythematous base in the oral mucosa may spread to involve\\nthe lips, buccal mucosa, tongue and palate.Asymptomatic or may cause pain in the\\nmouth, discomfort, anorexia and decreased feeding. Rarely may cause aspiration\\npneumonia.\\n\\uf0b7 Diagnosis is confirmed bythe fact that on removing the plaques, punctate areas of\\nbleeding are seen on the undersurface.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 392, 'page_label': '393'}, page_content=\"Pediatric Conditions\\n385\\nCONSTIPATI ON\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Dietary modification: Ensure adequate fluid intake in diet. In infants, breast milk should\\ncontinue as it is less likely to be constipating than cow's milk, can add extra sugar in\\ncow's milk if child is not breast-fed.\\n\\uf0b7 Add fiber by cereals (wheat bran, oat), pulses, vegetables, salads and fruits and isabgol.\\n\\uf0b7 Toilet training to achieve regular evacuation. Child is instructed to use bathroom after\\nbreakfast or dinner, to take advantage of meal stimulated increase in colonic motility.\\n\\uf0b7 Maintain calendar to record evacuations.\\n\\uf0b7 Positive reinforcement (reward/appreciation) for successful toileting (no punishment for\\nfailure).\\nPharmacological treatment\\n\\uf0b7 Agarol or lactulose in infants 2.5-10 ml/day; children 40-90 ml/day in 3 -4\\ndivided doses.  Or  mineral oil (liquid paraffin) 5-15 ml/kg/day Or milk of magnesia 0.5-3\\nml/kg/day. Dose is titrated to produce at least one stool/day.\\n\\uf0b7 Enemas may be used in severe cases where sufficient trial of medical therapy\\nhas failed. To empty the bowel of faecoliths, enemas may be required daily or on\\nalternate days for initial few days.\\n\\uf0b7 In severe cases with faecal soiling, in the initial stages: bowel cleaning/ disimpaction may\\nbe required with enemas 1-2/day or suppositories 1-2/day. In very severe cases with\\nmultiple faecoliths, failed medical treatment, mental retardation etc., surgical\\ndisimpaction may be done.\\n\\uf0b7 If a surgical cause is suspected patient should be investigated and treated accordingly.\\nThe main objective of medical management is to dislodge faecal mass, overcome\\nwithholding behaviour and promote regular bowel habits.\\n\\uf0b7 D efined as the passage of hard stools that are difficult to pass irrespective of frequency.\\nHowever, passage of stool less than twice a week is considered asconstipation.Genuine\\nhard stools may result from an inadequate milk intake, hunger stools, use of over-\\nstrength artificial feeds and low roughage diet.\\n\\uf0b7 True constipation may be due to imperforate anus, meconium plug, low intestinal\\nobstruction, Hirschsprung's disease, or hypothyroidism but most of the time it is\\nidiopathic.\\n\\uf0b7 Symptoms include fretfulness, poor appetite, intermittent abdominal pain, distension.\\nRetentive posturing occurs with urge to defaecate, relieved after going to the toilet.\\nThere maybe history of recurrent UTI. Weight gain may be impaired.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 393, 'page_label': '394'}, page_content='Pediatric Conditions\\n386\\nPatient education\\n\\uf0b7 Importance of dietary modifications should be explained. Treatment should not be\\nabandoned early after recovery.\\n\\uf0b7 Bowel training should have only positive reinforcements. Negative reinforcement should\\nbe avoided at all costs.\\nACUTE DIARRHOEA\\nSalient features\\nThe following table lists the investigations that may be done if indication exists.\\nTable 9. Investigationsin acute diarrhoea\\nInvestigations Indications\\nStool microscopy Dehydration or high fever, Diarrhoea persisting beyond 7\\ndays, blood persisting in stool after 48 hour, of treatment\\nBlood urea,\\nS. electrolytes (SE) and\\narterial blood gas (ABG)\\nAll 3 investigations in moderate to severe dehydration, SE in\\npersistent vomiting or signs of dyselectrolytaemia, ABG in\\nrespiratory distress and no chest signs and sepsis (correct it\\nonly if pH <7.25).\\nInfection screening by\\nTLC, DLC, band cell count,\\nESR and CRP\\nFever persisting >72 hours, PEM > grade III or age <3\\nmonths.\\nBlood culture Suspected sepsis, Before starting antibiotics.\\nChest X-ray, CSF and othersAs and when required\\nStool culture No role\\nNon -pharmacological treatment\\n\\uf0b7 Maintain hydration by homeavailable fluids (HAF) in place of or along with ORS. These\\nare rice, kanji, butter milk, dal soup, coconut water or weak tea etc. Soft drinks,\\nsweetened fruit drinks and tea are unsuitable and could be potentially dangerous.\\n\\uf0b7 Acute diarrhoea is defined as passage of 3 loose stools per day for duration of less than\\n7 days, and increased fluidity or volume of stools. It is caused commonly byRotavirus,\\nE. coli, V. cholerae, Giardiaor parenteral infections and invasive diarrhoea byShigella,\\nSalmonella and E. histolytica.\\n\\uf0b7 Clinical features of diarrhoea are frequent stools, vomiting, fever and dehydration.\\n\\uf0b7 Dehydration is categorized into some dehydration and severe dehydration.In some\\ndehydration child is thirsty and drinks voraciously, active and alert but irritable, with\\nsunken eyes, depressed fontanelle, absent tears, loss of skin turgor and some decrease in\\nurine output. In severe dehydration all these are more severeexcept that child is\\nlethargic and does not want to drink water.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 394, 'page_label': '395'}, page_content=\"Pediatric Conditions\\n387\\n\\uf0b7 Maintain nutrition: continue breast feeding. Continue normal light diet e.g. khichri, dalia,\\nbanana or mashed dal etc. Do not dilute or stop milk as there is not much role of lactose\\nintolerance or milk protein allergy. Give extra food during recovery.\\nPharmacological treatment\\n\\uf0b7 Low osm olarity oral rehydration solution (ORS) is used in some dehydration 75 ml/kg in\\n4 hours under observation.\\n\\uf0b7 After 4 hours if dehydration is corrected, or if child was not dehydrated at presentation,\\nsend home with instructions to give ORS in 2:1 dilution asaccepted by the child. Asked\\nto report back if vomiting persists or urine is not passed for >8 hours. As a rough\\nguideline 10 ml/kg of ORS may be added for each large stool.\\n\\uf0b7 If dehydration is not corrected after 4 hours, same amount of ORS may be repeatedin\\nnext 4 hours and if dehydration is corrected, send the patient home. If dehydration does\\nnot improve in 8 hours or if it worsens, abandon oral rehydration therapy (ORT) and give\\nIV fluids.\\n\\uf0b7 Zinc ORS is not superior to supplementation of zinc separately,in malnourished children\\nwith diarrhoea.\\n\\uf0b7 Principles of Oral Rehydration Therapy (ORT)\\n- Give in small sips.\\n- Vomiting is not a contraindication unless persistent.\\n- Contraindicated in altered sensorium or paralytic ileus.\\n- Stop as soon as diarrhoea stops.\\n\\uf0b7 IV fluid therapy in case of severe dehydration or shock or contraindications or\\nfailure of ORT. N/2 saline is given over 8 hours (1:100 ml KG after child passes\\nurine), as follows:\\n- Some dehydration-75 ml/kg.\\n- Severe dehydration-100 ml/kg (half in first 2-3 hours)\\n- Shock-push 20 ml/kg of Ringer's lactate or normal saline over 15 minutes and can repeat\\ntwice more if shock persists use central venous pressure monitoring for further\\nmanagement if shock present after pushing 60 ml/kg.\\n\\uf0b7 Specific therapyis indicated-Frank blood and mucus in the stool or >10 pus cells/HPF\\n- Syr. ciprofloxacin 15-20 mg/kg/day in 2 divided doses (Shigella strains are largely\\nresistant to ampicillin and cotrimoxazole) for 5 days\\nGiardiasis (only if trophozoites are seen on stool microscopy)\\n- Syr. metronidazole 15 mg/kg/day in 3 divided doses for 5 days Or\\n- Syr. tinidazole 50 mg/kg/day single dose (max. 2 g)\\nCholera (suspect in any child with severe watery diarrhoea)\\nMainstay of treatment is fluid therapy and following antibiotic may be usedto prevent\\nspread:Syr. doxycycline 5 mg/kg (max 200 mg) in single dose. OrSyr. furazolidone 5\\nmg/kg/day in 4 divided doses for 3 days. OrSyr. cotrimoxazole (TMP) 8 mg/kg/day in 2\\ndivided doses for 5 days. OrSyr. erythromycin 30 mg/kg/day for 3 days.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 395, 'page_label': '396'}, page_content='Pediatric Conditions\\n388\\n\\uf0b7 Severe infections to be treated by appropriate parenteral antibiotics.\\n\\uf0b7 There is not much role of antiemetics in a child with vomiting. Rule out meningitis, URI\\nand dyselectrolytaemia and give ORS in sips. If vomiting persists give intravenous fluids.\\nHoweve r, occasionally 1 or 2 doses of metoclopramide (0.5 mg/kg) or domperidone (0.5\\nmg/kg) may be tried before giving intravenous fluids. Binding agents e.g., Kaolin pectin\\netc. are not useful.\\n\\uf0b7 Following drugs are contraindicated,\\n- Antimotility agents e.g. diphenoxylate, atropine etc.and antisecretory agents e.g.,\\nloperamide, salicylates etc.\\n\\uf0b7 Keep record of vitals e.g. pulse, BP, capillary filling time (CFT), respiratory rate (1\\nhourly) and temperature (6 hourly). Monitor for improvement or worsening of signs of\\ndehydration. Record urine output and stool frequency and consistency.\\n\\uf0b7 Modifications or step up treatment\\n- Admit if PEM grade III or age <3 months (as higher chances of complications e.g. shock,\\nhypoglycaemia etc.), associated severe systemic infections e.g. septicaemia, meningitis or\\npneumonia.\\n- Investigate for lactose intolerance, incipient infections e.g., Urinary tract infection (UTI)\\nor rare gut organisms, if diarrhoea persists for >7 days.\\n- Exclude parenchymal renal failure, if child has not passed urine after hydration. Give a\\nfluid challenge (20 ml/kg of normal saline) followed by frusemide injection (1-2 mg/kg).\\nIf urine is still not passed then parenchymal renal failure considered and managed\\naccordingly.\\nPatient education\\n\\uf0b7 Inform natural course of diarrhoea to avoid dissatisfaction and ORS only prevents\\ndehydration i.e. purge rate and consistency usually improves by 3-7 days\\n\\uf0b7 Explain the complications in diarrhoea are because of dehydration and thus ORS is the\\nmainstay of therapy. Explain preparation of ORS and method of administration.\\nNutritional advice as mentioned earlier in non-pharmacological section. Education about\\nfood and water hygiene.\\nACUTE VIRAL HEPATITIS\\nItis a systemic infection affecting liver and is caused by Hepatitis A, B, C, D, E viruses etc.\\nCommonest causes for infective hepatitis among children are Hepatitis A and Hepatitis E.\\nBoth of these are spread by faeco-oral route. Hepatitis B and C are more common in children\\nreceivingblood product for certain chronic illnesses.\\nSalientFeatures\\n\\uf0b7 Prodrome constituted by fever, malaise, nausea, emesis, anorexia and abdominal\\ndiscomfort may precede the appearance of jaundice. It may go unnoticed or may be\\nsevere mimicking malaria ortyphoid fever.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 396, 'page_label': '397'}, page_content='Pediatric Conditions\\n389\\nNon -pharmacological treatment\\n\\uf0b7 Rest if the patient feels exhausted or fatigued (forced rest does not help and does not\\nshorten the time to recovery).\\n\\uf0b7 Regular small frequent meals with high caloric content. High carbohydrate diets are\\nacceptable but should be hygienic. Traditionally sugarcane juice is used as home therapy\\nthough it has no established benefit.Maintain adequate hydration in case of vomiting and\\navoid fatty meals.\\nPharmacological treatment\\n\\uf0b7 There is no specific treatment for simple acute viral hepatitis. Uncomplicated cases can be\\ntreated at home.If patient has frequent vomiting, oral metoclopramide 0.1 mg/kg/dose\\ncan be given as and when required but not to be repeated before 6 hours.\\n\\uf0b7 Usually fever abates after jaundice appears.Occasionally if the situation requires,\\nparacetamol may be used sparingly.\\n\\uf0b7 Persistent high grade fever suggests alternative diagnosis. Hospitalization required only in\\nclinically severe illness e.g. alteration in sleep pattern, altered behaviour, abnormal\\nmovements, persistent vomiting, dehydration, decreased urinary output, bleeding from\\nany site or any other complication.\\nPatient education\\n\\uf0b7 Continue breast feeding or other regular feeding.Observe carefully for any danger signs\\nlisted above.Usually a selflimiting disease and fever subsides after the jaundice is\\nevident clinically. Most patients start recovering in 7-14 days time. Total duration of\\nillness is 3 weeks.\\n\\uf0b7 Hepatitis A and B are two different diseases. Getting your child vaccinated with hepatitis\\nB vaccine will not protect you against Hepatitis A.Hepatitis A spreads through\\ncontaminated food and water and close person to person contact.\\n\\uf0b7 Raw or insufficiently cooked food (fruits, vegetables, salads) or cooked food handled by\\nan infected individual can be the source of hepatitis A infection.\\nCHICKENPOX OR VARICELLA\\nVaricella is the primary infection caused by varicella-zoster virus. It is highly infectious and\\nis transmitted by droplet infection. The incubation period is about 14 days.\\nSalient features\\nNon pharmacological treatment\\n\\uf0b7 Begins as crops of small red papules over the trunk appearing within 1 day of fever and\\nsystemic symptoms which quickly develop into clear, often oval vesicles on an\\nerythematous base. Contents becomecloudy in about 24 hours and then scab. Many\\nsuch crops may appear for 3-4 days.\\n\\uf0b7 Bacterial superinfection, thrombocytopenia, arthritis, hepatitis, encephalitis or\\nmeningitis can complicate the disease.The disease is severe in adolescents and adults\\nas well as immune compromised individual. Reactivation disease results in herpes\\nzoster or shingles.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 397, 'page_label': '398'}, page_content=\"Pediatric Conditions\\n390\\nItching is bothersome and scratching effect may be minimized by making the patient wear\\nmittens. Daily change of clothes and good personal hygiene may decrease the risk of\\nsecondary infection.\\nPharmacological treatment\\n\\uf0b7 For management of fever: Aspirin and other salicylates are contraindicated due to risk of\\nReye's syndrome and should not be used.\\n\\uf0b7 Local anti-pruritic agents like calamine lotion may alleviate itching. If itching is not\\nrelieved with above. Tab. pheniramine 25 mg 2 times a day Or Tab. cetirizine: in\\nchildren (2-6 years) 5 mg; (>6 years) 10 mg once a day.\\n\\uf0b7 In case of immuno-compromised children on long term treatment with steroids, anti-\\ncancer drugs or other immunosupressive therapy, HIV positive patients, children older\\nthan 12 years of age, those with chronic cutaneous or pulmonary disorders who are at\\nincreased risk of severe disease, oral acyclovir if started within few hours (<24 h) of the\\nonset of rash may decrease the duration, magnitude of feveras well as the number of skin\\nlesions.\\n\\uf0b7 Tab. acyclovir 20 mg/kg/ day is given 6 hourly for 5 days. In case the patient is severely\\nimmuno -compromised or severe disease in adults, Inj. acyclovir should be started as soon\\nas possible in all cases at the doseof 10 mg/kg 8 hourly IV for 7 days.\\nAssessment of response to therapy\\n\\uf0b7 Most cases will stop having fever after the initial 3-4 days when new crops of vesicle stop\\nappearing. The vesicles normally heal by scabbing in about a week's time. Persistence of\\nfevermay suggest secondary infection.\\nPatient education\\n\\uf0b7 The disease is self limiting in healthy children. Child should be excluded from day care or\\nschool till after 6th day of the rash or till scabs are formed.\\n\\uf0b7 Do not uses â€œover the counterâ€ fever medicines a s they may contain aspirin or other\\nsalicylates.\\n\\uf0b7 An expensive but potent vaccine is available for protection against the disease and can be\\nrecommended only for those at risk of severe form of the disease and are\\nimmunocompetent.\\n\\uf0b7 Post exposure prophylaxiswith Varicella Zoster Immunoglobulin (VZIG, specific\\nimmunoglobulin) is recommended for the contacts that are severely immunocompromised\\nor pregnant (particularly in the first trimester).\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 398, 'page_label': '399'}, page_content='Pediatric Conditions\\n391\\nMEASLES\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Isolate from others particularly unimmunized children for at least four days after the\\nappearance of the rash.\\n\\uf0b7 Bed rest and cold sponging may be required for febrile patients.\\n\\uf0b7 Small frequent feeds and plenty of oral fluids should be continued.\\nPharmac ological treatment\\nNo specific antiviral treatment is available. Fever is managed with oral paracetamol.\\nTreatment of other co-existing problems\\n\\uf0b7 Inj. vitamin A 100,000 IU or high dose oil based oral preparation (50,000 IU) is given IM\\nfor 2 consecutive days. A third dose may be given 4 weeks later particularly if there are\\nmanifesting signs of vitamin A deficiency.\\n\\uf0b7 Treat appropriately secondary bacterial infection like bronchopneumonia and or\\ngastrointestinal infection.\\nPatient education\\n\\uf0b7 The disease leads to marked anorexia and also often precipitates protein energy\\nmalnutrition (PEM) and other deficiencies. Regular frequent feeds must continue. Extra\\nmeal should be added during convalescence.\\n\\uf0b7 The disease usually lasts 10-12 days and the maximum risk of infectivity is 5 days prior\\nto and 4 days after the appearance of rash. The rash usually heals by desquamation and\\noften leaves some hyperpigmented stains on the body which disappears over weeks\\nsubsequently.\\n\\uf0b7 The parents must report to the hospital in case thechild develops any of the following\\nwarning signs:\\n- Stiff neck, convulsions (seizures), extreme drowsiness, loss of consciousness or altered\\nbehaviour.\\n- Rapid and or laboured breathing, difficulty in feeding, cyanosis.\\n- Significant dehydration as evident bysunken eyes or fontanelles, loss of skin turgor,\\ndryness of tongue or lack of tears etc.\\n- Blood in stools.\\n\\uf0b7 It is characterized by fever, cough, coryza, conjunctivitis, an erythematous\\nmaculopapular rash appearing on the 4th day of the illness, and a pathognomonic\\nenanthem (Koplik spots).Rash starts from behind the ears, along the hairline, involve\\nthe face and then the trunk and the limbs.\\n\\uf0b7 Fever usually subsides after the appearance of the rash unless there is some\\ncomplication such as otitis media, bronchopneumonia, laryngotracheobronchitis\\n(croup), and diarrhoea. Acute encephalitis, which frequently results in permanent brain\\ndamage, occurs in approximately 1 in every 1000 cases.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 399, 'page_label': '400'}, page_content=\"Pediatric Conditions\\n392\\n\\uf0b7 Vaccination against measles is recommended at 7- 9 months of life and a subsequent\\nbooster with measles or MMR is mandated at 15 months of age particularly if the primary\\nimmunization was done at less than 9 months of age. There is no role of giving measles\\nvaccination to a child who has already suffered from the disease.\\n\\uf0b7 Unimmunized child below 5 year  in contact with the patient may be immunized. Measles\\nvaccine, if used early, can prevent or decrease the severity of the disease in the secondary\\ncontacts.\\nMUMPS\\nMumps is a disease caused by a virus that can infect many parts of the body, especially the\\nparotid salivary glands.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Child should be encouraged to drink plenty of fluids. Water, decaffeinated soft drinks and\\ntea are better tolerated than acidic fruit juices (like orange juice, grape fruit juice or\\nlemonade) that make parotid pain worse.\\n\\uf0b7 Either warm or cold packs- whichever feels better- may be used to sooth the swollen\\nparotid glands.\\nPharmacological treatment\\n\\uf0b7 Most cases are treated symptomatically on OPD basis.\\n\\uf0b7 Fever treated using non aspirin fever medications such as paracetamol (10-15 mg/kg/day\\nSOS or every 4-6 hours). These medicines will also help relieve pain in the swollen\\nparotid glands. (caution: aspirin is contraindicated in children with viral illnesses due to\\nrisk of Reye's syndrome).\\n\\uf0b7 Being a viral illness, antibiotics have no role. There is no specific therapy available.\\n\\uf0b7 Patients with abdominal pain, testicular swellings or signs of raised intracranial tension\\nneed to be admitted in the hospital.\\nPatient education\\n\\uf0b7 Parents should be explained warning signs e.g. in boys, parents are told to watch for high\\nfever, with pain and swelling of the testicles.\\n\\uf0b7 The parotid glands become swollen and painful over a period of one to three days.\\nThere is often a fever of up to 103Â°F (39.4oC), with headache and loss of appetite.\\n\\uf0b7 Mumps can also involve the brain, pancreas and other organs. The involvement of these\\norgans signifies a severe disease and there is usually a recrudescence of high fever in\\nsuch situations in addition to organ specific symptoms.\\n\\uf0b7 Meningoencephilitis is the commonest complication (250/100 000 cases). Other\\ncomplications are orchitis, epididymitis, oophritis, pancreatitis, thyroiditis, myocarditis,\\ndeafness, optic neuritis and arthritis.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 400, 'page_label': '401'}, page_content='Pediatric Conditions\\n393\\n\\uf0b7 Watch for abdominal pain that can mean involvement of the pancreas in either sex, or\\ninvolvement of the ovaries in girls.\\n\\uf0b7 Severe headache, stiff neck, convulsions (seizures), extreme drowsiness etc suggest CNS\\ninvolvement and need for admission to a tertiary level center.\\n\\uf0b7 Recurrence of high grade fever (above 101Â°F/38.3Â°C) often heralds onset of the above\\ncomplication and can be used as an early referral sign.\\n\\uf0b7 Children usually recover from mumps in about 10-12 days. First attack of mumps almost\\nalways gives lifelong protection against another, therefore, such children do not benefit\\nfrom any immunization later.\\n\\uf0b7 Mumps can be prevented by a vaccine which can be given alone, or as partof the mumps-\\nmeasles-rubella (MMR) vaccine given at the age of 15 months. Mumps vaccine is\\neffective in 75 to 95% of immunized persons.\\nACUTE FLACCID PARALYSIS\\nAcute Flaccid Paralysis (AFP) isdefined as any child aged <15 years, with acute onset of\\nflaccid paralysis without any obvious cause (e.g. severe trauma or electrolyte imbalance like\\nhypokalaemia). AFP is a notifiable disease and all cases must be reported to Nodal Officer\\nand District Surveillance Officer, NPSP Unit, Directorate of Family Welfare.\\nSalient features\\nTreatment for acute polio cases\\nAll cases should be treated as below except patients with isolated single lower limb\\ninvolvement and reporting after 4 days of onset of paralysis and currently not progressing for\\nmore than 48 hours.\\nNon -pharmacological treatment\\n\\uf0b7 Complete bed rest and correct positioning of the affected limbs in the optimal position as\\nfollows: Hip- slight flexion, knee- 5 degrees flexion, foot- 90 degrees with support\\nagainst the soles. Both legs should be supported from the lateral sides with pillows or\\nrolled towels or salt/sand packs to prevent rotation.\\n\\uf0b7 When pain subsides, passive movements of the joints for about 10 minutes, 2-3 times a\\nday.\\n\\uf0b7 Warm water fomentation using hot packs with soaked towels wrapped around the affected\\nparts for about 10 minutes, 2-3 times a day help in relieving pain.If transient urinary\\nretention occurs, alternate hot and cold compresses over the suprapubic region.\\nCaution: No massage or intramuscular injections as it may further precipitate paralysis.\\nWatch for progression, particularly for the involvement of the respiratory muscles.\\n\\uf0b7 The paralysis is of acuteonset (<4 weeks) and the affected limb(s) are flaccid (floppy\\nor limp). If the AFP is due to polio, then sensation is never affected.\\n\\uf0b7 Pseudoparalysis due to pain in osteomyelitis, abscess, scurvy, unrecognized trauma\\nleading to contusions, slipped epiphysis or fractures etc can also mimic AFP.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 401, 'page_label': '402'}, page_content='Pediatric Conditions\\n394\\nPharmacological treatment\\nThere is no specific drug therapy for polio. For fever and pain, use paracetamol or ibuprofen.\\nReferral to a tertiary care level center with a ventilatory support facilities if there is\\nprogression of paralysis, respiratory distress, bulbar involvement, paralysis of upper limbs\\nwhich is <3 days old (there is higher risk of diaphragmatic involvement in such cases),\\nmarked drowsiness or any other complication.\\nPatient education\\n\\uf0b7 No dietary restrictions, however, continue breast feeding or other regular feeding.\\n\\uf0b7 Paralysis progresses usually for about 4-7 days after onset. Recovery may start thereafter\\nover days to weeks with little recovery of strength after 6 months of illness. A regular\\nphysiotherapy facilitates recovery of muscles. Note: Post polio residual paralysis should\\nbe referred for rehabilitative services to an appropriate centre.\\nPERTUSSIS (WHOOPING COUGH)\\nThe causative organism isBordetella pertussiswhich leads to this respiratory disorder.\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Syr./Tab. erythromycin, 40-50 mg/kg/day in 4 divided doses orally for 14 days initiated\\nearly in the coryzal phase of the disease i.e. first 14 days of the illness may shorten the\\ncourse of whooping cough, which otherwise may last for weeks or months. Once the\\nparoxysms start, no antimicrobial have any benefit except for eradication of any\\nsecondary pulmonary infection.\\n\\uf0b7 In patients with severe coughing paroxysms salbutamol 1-2 mg/kg/ day in 3-4 divided\\ndoses for a week or so may be tried.\\n\\uf0b7 Severe cases particularly those <6 months of age and those with respiratory distress need\\nto be admitted for intravenous fluids and oxygen therapy.\\nSupportive therapy\\n\\uf0b7 Oxygen therapy is required in severe cases with respiratory distress. Hydration should be\\nmaintained with intravenous or oral fluids in adequate amounts (cough suppressants are\\nusually not helpful).\\nPatient education\\n\\uf0b7 To continue feeding during the prolonged period of cough, adequate hydration and\\nnutrition to prevent onset of malnutrition.\\n\\uf0b7 Beginning as a mildURTI (catarrhal stage), can progress to severe paroxysms of\\ncough, often with a characteristic whoop, followed by vomiting.\\n\\uf0b7 The child runs out of breath with bulging eyes, flushed face,lacrimation. salivation,\\nprotrusion of tongue and distension of the neck veins etc. Such episodes are\\nexhausting and precipitated by yawning, sneezing andeating.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 402, 'page_label': '403'}, page_content='Pediatric Conditions\\n395\\n\\uf0b7 Antibiotic therapy must be continued for at least 14 days to prevent relapse of the disease,\\neven if they may not be providing any relief in the symptoms. All contacts below 7 years\\nof age must be given erythromycin for 14 days.\\n\\uf0b7 Contact the doctor immediately if the patient develops listlessness, apnoea or seizures.\\nThis is particularly more common in infants below 6 months.\\n\\uf0b7 Immunization against pertussisis as triple antigenDiphtheria Pertussis Tetanus(DPT)\\nand 3 primary doses are routinely advised for all infants followed by a booster after 1.5\\nyears and 4.5 years after the primary immunization.\\nCARDIAC FAILURE\\nCardiac failure is defined as a state in which the heart cannot deliver an adequate cardiac\\noutput to meet the metabolic needs of the body. Clinical presentation is dependent on age and\\ndegree of cardiac reserve. Common causes according to age of presentation are:  Neonate-\\nSevere anaemia, heart block, congenital heart disease e.g. hypoplastic left heart, coarctation,\\nleft to right shunt and large mixing cardiac defects.Infantâ€“ Left to right shunt,\\nsupraventricular tachycardia Childrenâ€“ Rheumatic fever, myocarditis, cardiomyopathy, acute\\nhypertension.\\nSalient features\\nNon -pharmacological treatment\\n\\uf0b7 Restricted activity and bed rest with upright posture depending on cardiac reserve.\\n\\uf0b7 In severe CHF, dietary modifications in infants by increasing calories per feed. Breast-\\nfeed supplementation, naso-gastric feed to avoid the exertion of active feeding.\\n\\uf0b7 No added salt in diet and fluid restriction. Cold sponging in case of fever.\\nPharmacological treatment\\nIdentify and treat the underlying cause.  Algorithm for treatment is shown in figure.\\n\\uf0b7 Elixir/Tab. digoxin (Elixir 0.25 mg/5 ml, Tab. 0.25 mg)\\nMethod of digitalization: 0.5 x digitalization dose initially, 0.25 x digitalizing dose 8 and 16\\nhours later.\\nDigitalizing dose: Newborn = IV, IM: 0.010- 0.030 mg/kg divided or orally: 0.040 mg/kg\\ndivided in fractions.\\nInfants = IV, IM 0.030-0.040 mg/kg or orally 0.050 mg/kg in fractions.\\nChildren = IV, IM, PO: 0.010-0.015 mg/kg in fractions.\\n\\uf0b7 Exertional dyspnoea, poor weight gain, feeding difficulties,fast breathingwith\\nimprovementwhen upright, persistent cough and wheezing, excessive perspiration and\\nirritability, puffiness of face and pedal oedema.\\n\\uf0b7 Tachypnoea, tachycardia, small volume pulse, peripheral cyanosis, pedal/facial/ sacral\\noedema, hepatomegaly, raised JVP (appreciated well inolder children), gallop rhythm,\\ncardiomegaly and failure to thrive.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 403, 'page_label': '404'}, page_content='Pediatric Conditions\\n396\\n\\uf0b7 M aintenancedosage 24 hours after 1st fraction of digitalizing dose. Newborn = PO: 0.005\\n- 0.010 mg/kg/24 hours, divided every 12 hours. In infants and children orally 0.002-\\n0.005 mg/kg/24 hours divided every 12 hours.(Caution: Avoid hypokalaemia during\\ntherapy with digoxin)\\n\\uf0b7 Tab. furosemide 1 -2 mg/kg every 12 hourly (may need K supplement).\\nOr  Tab. chlorothiazide 20-50 mg/kg/day in 2 divided doses. Or Tab. spironolactone 1-3\\nmg/kg/day in 2 divided doses.\\n\\uf0b7 In cases with regurgitant cardiac lesions like severe MR where reduction\\nin after load is required, Tab. captopril 0.1-0.2 mg kg/dose 8-12 hourly (maximum 4\\nm g/kg/day). Or  Tab. enalapril 0.08-0.5 mg/kg/dose 12-24 hourly (maximum 1 mg/kg/\\nday).\\n\\uf0b7 Patients with hypotension and low cardiac output should be referred to a higher center for\\nInj. dopamine infusion (40 mg/ml) 2-20 mcg/kg/min prepared in normal saline or 5%\\ndextrose. Hypovolaemia should be corrected before infusion is started and BP is\\nmonitored during the infusion. Or Inj. dobutamine infusion (250 mg/5 ml) 2- 20\\nmcg/kg/min. Both the drugs can be used simultaneously to have added response.\\nPatient education\\n\\uf0b7 Decreased salt intake, sufficient rest and adequate sleep must be emphasized. Strict bed\\nrest is necessary only in severe cases. Semi-upright position during sleep may make the\\npatient more comfortable.\\nFigure 1. Algorithm for treatment of congestive cardiac failure'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 404, 'page_label': '405'}, page_content='Pediatric Conditions\\n397\\nDIABETES MELLITUS\\nSalient features\\nDiagnosis\\nTable shows the cut off levels of plasma glucose used for diagnosis of DM, while doing oral\\nglucose tolerance test (GTT)-after glucose dose of 1.75 g/kg of ideal bodyweight (maximum\\n75 g).\\nTable 10. Cut off levels of plasma glucose for diagnosis of diabetes mellitus\\nImpaired glucose tolerance Diabetes mellitus (DM)\\nFasting glucose 110-125 mg/dl * Symptoms of DM plus random plasma\\nglucose >200 mg/dl\\n2 h plasma glucose during theOr\\nOGTT <200 mg/dl but < 140 mg/dl\\nFasting plasma glucose >126 mg/dl\\nOr 2 h plasma glucose during the OGTT#\\n>200 mg/dl\\n* Symptoms include polyuria, polydipsia & unexplained weight loss with glycosuria and\\nketonuria # OGTT Oral glucose tolerance test\\nNon -pharmacological treatment\\n\\uf0b7 Diet:\\n- Regularity of eating pattern is very important so that diet and insulin dosing is\\nsynchronized.\\n- General nutritional guidelines are followed. Calorie mixture should have 55%\\ncarbohydrates, 30% fat and 15% proteins.\\n- Avoid carbohydrate with refined sugars to prevent metabolic swings. Carbonated drinks\\nshould be of sugar free variety.\\n- Fats derived from animal sources to be reduced and should be replaced by fats of\\nvegetable origin.\\n- Calorie intake should be split as 20% breakfast, 20% lunch, 30% dinner and 10% each for\\n3 snacks at mid morning, mid afternoon and evening.\\n\\uf0b7 Physical activity and fitness:\\n- Usual exercises advised to diabetic children and adolescents include vigorous walking,\\njogging, swimming, tennisetc.\\n\\uf0b7 Most cases of DM in children are of insulin dependent diabetes mellitus (IDDM)\\nand have hyperglycaemia with glucosuria.While some present with classical\\nsymptoms of polyphagia, polydipsia, polyuria and weight loss, many children at the\\nonset present in the state of diabetic ketoacidosis (DKA).\\n\\uf0b7 Diagnosis is made by demonstration of hyperglycaemia (random plasma glucose\\nmore than 200 mg/dl).Patients during DKA have moderate to severe dehydration\\nwith plasma glucose levels usually more than 300 mg/dl, metabolic acidosis,\\nketonuria and various electrolyte disturbances.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 405, 'page_label': '406'}, page_content='Pediatric Conditions\\n398\\n- Though, diabetics can undertake any exercise, but unusual exercise may require modification\\nin insulin dosing. For the schedule day of unusual exercise, insulin dose may be reduced by\\n10-15%.\\nPharmacological treatment\\n\\uf0b7 Initial therapy:\\nTreatmentis initiated in the hospital with fast acting (regular) insulin. At the onset of DM\\n(or after recovery from DKA) the dose of insulin is 0.5-1.0 unit/kg/day.\\nInj. Regular insulin 0.1-0.25 units/kg subcutaneous injections are given 6-8 hourly before\\nme als.\\n- Simultaneous blood glucose level monitoring is done. One to two days therapy is required\\nto find out total daily insulin requirement. Once the patient stabilizes on 6 hourly insulin\\ninjections, the patient is switched over to \"2 daily injections\" schedule.\\n- In \"2 daily injections\" schedule, the insulin is administered as follows:\\nCombinations of intermediate acting (usually lente) insulin and fast acting (regular)\\ninsulin in the ratio of 2-3:1. Two third of total daily-dose is injected before breakfast and\\none third before dinner. Each injection has combination of both types of insulin e.g., total\\ndose of insulin is 30 units-20 units (14 units lente and 6 units regular) are injected before\\nbreakfast and 10 units (6 units lente and 4 units regular)are injected before dinner.\\n- Blood glucose levels are monitored before each meal and the dose of insulin adjusted\\naccordingly. Blood glucose levels should ideally be 80 mg/dl fasting and 140 mg/dl after\\nmeals (acceptable range between 80-240 mg/dl). Earlymorning 3 AM blood glucose\\nlevel should be more than 70 mg/dl.\\n\\uf0b7 Modification in the insulin doses:\\n- Modification in the insulin doses will be required depending upon the blood glucose\\nlevels. Any increase or decrease in insulin dose is by 10-15% (generally not more than 6\\nunits).\\n- After initial stabilization, newly diagnosed cases may have gradual decline in insulin\\nrequirement even upto 0.5 units/kg/day. This may persist for several weeks to several\\nmonths.\\n- Decrease total dose of insulin by 10% at the timeof discharge from hospital as the\\nincreased activity at home will decrease the insulin requirement.\\n\\uf0b7 Assessment of diabetic control or response to therapy\\n- Blood glucose estimation should be done before each meal and at bed time in the first few\\nweeks afterdiagnosis. After stabilization, it can be reduced to twice a week.\\n- Periodically blood glucose estimation at 3-4 AM is required to detect early morning\\nhypoglycaemia.\\n- Urine for sugar is also monitored initially 3-4 times daily before meals. Urine for ketones\\nonce daily should be done.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 406, 'page_label': '407'}, page_content='Pediatric Conditions\\n399\\n- Glycosylated haemoglobin (HbA1c estimation-once every 3 months.- levels of 6-9%\\nrepresent very good control of diabetes, 9-12% show fair control and above 12%\\nrepresent poor control.\\n- Serum lipids-cholesterol, HDL, LDL, VLDL, triglycerides and urine for protein should\\nbe done once every year. Serum cholesterol should be less than 200 mg/dl, LDL less than\\n130 mg/dl and triglycerides less than 140 mg/dl.\\n- Thyroid function tests should be done once every year to detect concomitant\\nhypothyroidism.\\nPatient education\\n\\uf0b7 Patient/parents should be taught self diabetic care which should include:Technique of\\nmeasuring insulin in the syringe. Importance of drawing insulin always in the same\\nsequence (usually regular insulin first) so thatsame type of insulin is left over in the dead\\nspace of the syringe. Explain technique of subcutaneous injections and importance of\\nrotating the injection sites-arms, thighs (upper and lower), buttocks and abdomen.\\n\\uf0b7 Adherence to diet and regular exercise.Recognizing the symptoms of hypoglycaemia and\\nits home management.\\nHYPOTHYROIDISM\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Thyroxin treatment should be started as soon as the diagnosis has been confirmed by thyroid\\nfunction tests (preferablythe same day as the evaluation).\\n\\uf0b7 There remains some controversy regarding the initial starting dose of thyroxin and how\\nquickly the Thyroid stimulating hormone (TSH) should be normalized. A recommended\\nstarting dose is approximately 10-15 mcg/kg/day.\\n\\uf0b7 The initial dose for first 7 days may be on the higher end (14 mcg/kg/day) and then reduced\\nto lower level (10 mcg/kg/day) and then tapered to 5-7 mcg/kg/day by 1styear.\\n\\uf0b7 Most cases in children are due to congenital hypothyroidism causes such as aplasia,\\nhypoplasia or ectopia of thyroid gland. Common causes of acquired hypothyroidism are\\niodine deficiency, lymphocytic thyroiditis and following irradiation of cervical region\\nfor malignant disorders.\\n\\uf0b7 The diagnosis is quite often missed in the initial months; hence neonatal screeningis\\nimportant.The diagnosis is based on demonstration of low serum T4. Serum T3 levels\\nmay be normal and are not useful for diagnosis. In primary hypothyroidism, TSH is\\nelevated. Radionuclide scans are not essential for diagnosis but help to delineate the\\nexact etiology.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 407, 'page_label': '408'}, page_content='Pediatric Conditions\\n400\\nTable 11. Guideline for dosage of L-thyroxinein children\\nAge Dose in (mcg/kg/day)\\n0-6 months 8-15\\n6-12 months 7-10\\n1-5 years 5-7\\n5-10 years 3-5\\n10 -12 years 2-4\\nAssessment of response\\n\\uf0b7 Early response is evident in initial few weeks withsymptomatic improvement in\\nalertness, relief of constipation, improvement in appetite and feeding.Increased linear\\ngrowth and osseous maturation is seen over next few months.\\n\\uf0b7 The child should be followed clinically every month for 6 months, 3 monthly till 2 years\\nand thereafter once to twice every year. Recurrence of symptoms such as lethargy,\\nconstipation and weight gain suggest under treatment and diarrhoea, palpitations,\\nincreased appetite and weight loss suggest overdosing.Periodic check on thyroid\\nfunction tests is needed (6 monthly or so). Serum T4 level should be maintained in upper\\nnormal range and TSH levels suppressed to normal.\\n\\uf0b7 After few months of starting therapy, sometimes features suggestive of raised intracranial\\ntension such as headache and vomiting may appear. The patient should be immediately\\nadmitted and treated.\\nPatient education\\n\\uf0b7 N eed for life long administration of the drug.Regular follow up at the interval described,\\nimportant for proper monitoring and dose titration.\\n\\uf0b7 Clinical symptoms of under or overdosage, including the danger signs of pseudotumour\\ncerebri should be explained.In infants, thyroxine should be given by crushing the tablet\\nwith little milk or water, using a teaspoon or syringe. It should never be added to a bottle\\nof milk or formula, as this reduces the bioavailability of thyroxin significantly. The\\ndosage shouldbe repeated if the baby vomits or regurgitates immediately afterwards.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 408, 'page_label': '409'}, page_content='Pediatric Conditions\\n401\\nURINARY TRACT INFECTION (UTI)\\nSalient features\\nPharmacological treatment\\n\\uf0b7 Patients less than 3 months of age, systemically toxic with high fever, loin pain and\\nvomiting, and with underlying structural abnormality of urinary tract, are better treated as\\ninpatients and with parenteral antibiotics. All other patients can be treated as outpatients\\nwith oral antibiotics.\\n\\uf0b7 The initial antibiotic choice should be guidedby local culture and sensitivity report\\nreturn. The duration of therapy is 10-14 days for infants and children with complicated\\nUTI, and 7-10 days for uncomplicated UTI.  Adolescents with cystitis may be treated\\nwith shorter duration antibiotics. Hydration must be maintained with oral or IV fluids as\\nrequired.\\n\\uf0b7 Analgesics and antipyretics are used as per necessity.\\n\\uf0b7 Patients with obstructive uropathies may need urgent drainage without which resolution\\nof UTI may be difficult.\\n\\uf0b7 Maintain adequate hydration and encourage liberal fluid intake to alleviate dysuria. The\\nantibiotics suggested for the treatment of UTI is as follows:\\nTable 12. Antibiotics suggested for the treatment of UTI in children\\nMedication Dose, mg/kg/day\\nParenteral\\nCefriaxone 75-100, in 1-2 divided doses IV\\nCefotaxime 100-150, in 2-3 divided doses IV\\nAmikacin 10-15, single dose IV or IM\\nGentamicin 5-6, single doses IV or IM\\nComaxiclav 30-35 of amoxicillin, in 2 divided doses IV\\nOral\\n\\uf0b7 It is a common bacterial infection in infants and children. It can be a presenting feature\\nof underlying structural or functional abnormality of the urinary tract or associated with\\nrenal parenchymal damage, hypertension, and chronic kidney disease. All patients with\\nrecurrent UTI are more at risk and should be investigated and managed thoroughly.\\n- Ask about bowel bladder habits, checking BP and examining the genitals for\\nphimosis/balanitis/labial adhesion and spine.High risk factors for underlyingstructural\\nabnormality, bladder voiding dysfunction and/or chronic kidney disease is: UTI in\\ninfant, severe symptoms (fever, loin pain, vomiting, poor response to initial\\nmanagement) or septicaemia\\n- Recurrent UTI- Indication of bladder anomaly: severe constipation, urinary dribbling,\\npoor urinary stream, straining, palpable bladder,renal disease: stunting, raised\\ncreatinine, hypertension, flank mass'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 409, 'page_label': '410'}, page_content='Pediatric Conditions\\n402\\nCefixime 8-10 in 2 divided doses\\nAmoxicillin 30-50 of amoxicillin, in 3 divided doses\\nCiprofloxacin* 10-20, in 2 divided doses\\nOfloxacin* 15-20, in 2 divided doses\\nCephalexin 50-70, in 2-3 divided doses\\n* Fluoroquinolones should be avoided as first line medication; their use should be guided by\\nresults of culture and sensitivity.\\nMonitoring and follow-up of high risk patients\\n\\uf0b7 An abdominal USG and repeat urine culture are necessary in patients who fail to show\\nclinical response (reduction of fever and toxicity) within 48 hours of initial treatment.\\n\\uf0b7 Ch ild with more than one episode should be worked up for cause of recurrent UTI. Each\\nepisode is treated as mentioned above but child should be investigated in detail with\\nultrasound,Micturating Cystourethrogram(MCU) and DMSA scan.\\n\\uf0b7 High risk patients are likely to have underlying abnormalities. Such patients must be\\nidentified early by careful history and examination and investigated. Many of these\\npatients have recurrent UTI. Underlying vesico-ureteric reflux and bladder-bowel\\nelimination disorders are themost common etiologies, and specific management\\ndepending on cause has to be initiated.\\nAntibiotic prophylaxis\\nAntibiotic prophylaxis has been recommended in the following situations:\\n\\uf0b7 UTI below 1-yr age, while awaiting imaging studies\\n\\uf0b7 Vesico urethral reflux\\n\\uf0b7 Frequent febrile UTI even if the urinary tract is normal.\\nAntibiotic prophylaxis is not advised in patients with urinary tract obstruction, urolithiasis\\nand neurogenic bladder, and inpatients on clean intermittent catheterization.\\nAntibiotics for prophylaxis of urinary tract infections in children\\nDrug Dose (mg/kg/day) Remarks\\nCotrimoxazole\\nNitrofurantoin\\nCephalexin\\n1-2 (trimethoprim)\\n1-2\\n10\\nAvoid in infants <3 months age and G -6PD\\ndeficiency\\nGastrointestinal upset; avoid in infants <3 months\\nage, G-6 PD deficiency and renal insufficiency\\nDrug of choice in first 3-6 months of life\\nLong -term follow-up\\nPatients with recurrent UTI, renal scars, or risk factors mentioned above need long-term\\nmonitoring. Patients are advised to have plenty of oralfluids, void regularly, avoid\\nconstipation and maintain perianal hygiene. They should check a clean midstream urine after\\nlocal cleansing if any recurrence of fever/any urinary or other symptoms suggestive of UTI.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 410, 'page_label': '411'}, page_content='Pediatric Conditions\\n403\\nPOSTSTREPTOCOCCAL ACUTE GLOMERULONEPHRIT IS (AGN)\\nSalient features\\nTreatment\\n\\uf0b7 Monitoring of fluid intake, output, blood pressure, urea, creatinine and electrolytes\\nrequired on regular basis. Complete blood count,Anti Streptolysin O Titre (ASOT), C3,\\nrenal ultrasound should be performed at presentation.\\n\\uf0b7 Fluid restriction to urine output and insensible losses.\\n\\uf0b7 Inj.Procaine penicillin 4 lac units once daily if evidence of sore throat or skin infection.\\n\\uf0b7 Potassium restriction\\n\\uf0b7 Treatment of complications such as hyperkalemia, hypertension and fluid overload. If\\nconservative management of these complications is not sufficient for control, early\\ndialysis should be initiated.\\n\\uf0b7 Treatment of acute hyperkalemia\\n1 Restrict K intake\\n2 Transient reversal of cardiotoxicity with calcium gluconate(10%)1ml/kg in distilled\\nwater, slow IV infusion\\n3 Temporary reduction of potassium in extracellular fluid with:\\nNebulised salbutamol\\nSodium Bicarbonate : 1-2 mmol/kg\\nGlucose (0.5g/kg) + insulin (0.1U/kg) infusion\\n4 Removal of potassium from the body by:\\nFrusemide (1-2 mg/kg)\\nPotassium exchange resins(1g/kg/day)\\nDialysis\\nPatient education\\nParents should be explained the natural course. More than 95% recover within 2â€“ 4 weeks.\\nOnly a few patients may end up with chronic renal insufficiency.\\n\\uf0b7 Commonest type of post infectious acute glomerulonephritis\\n\\uf0b7 Immunological disease occurring after groupA beta hemolytic streptococcal throat or\\nskin infection resulting in diffuse proliferative glomerulonephritis.\\n\\uf0b7 Sudden onset of hematuria, oliguria, edema and hypertension.\\n\\uf0b7 Children between 5-10 years are commonly affected.\\n\\uf0b7 Investigations reveal raised urea,creatinine, positive tests for streptococcal infection,\\nlow C3 level.Renal biopsycan be donein severe and prolonged case of AGN.\\n\\uf0b7 Complications include hyperkalemia, acute renal failure, hypertensive encephalopathy\\nand severe fluid overload causing pulmonary edema.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 411, 'page_label': '412'}, page_content=\"Pediatric Conditions\\n404\\nNEPHROTIC SYNDRO ME\\nNephrotic syndrome is an important chronic disorder in children. It can be primary\\n(idiopathic) or secondary (SLE, Henoch Schonlein purpura, amyloidosis etc). About 90%\\nchildren with idiopathic nephrotic syndrome have 'minimal lesion' on renal histologyand\\nrespond promptly to corticosteroids. Approximately three fourth patients have one or more\\nrelapses. Steroid toxicity and frequent serious infection complicate such cases.\\nSalient features\\nPharmacological treatment\\nDefinitionsuseful for guiding treatment are as follows:\\n- Remission:Urine albumin nil or trace (or proteinuria <4 mg/m2/h) for 3 consecutive days.\\n- Relapse: Urine albumin 3+ or 4+ (or proteinuria >40 mg/m2/h) for 3 consecutive days\\nhaving been in remission previously.\\n- Frequent relapses: Two or more relapses in six months of initial response, or more than\\nthree relapses in any twelve months.\\n- Steroid dependence: Two consecutive relapses when on alternate day steroids or within\\n14 days of its discontinuation.\\n- Steroid resistance: Absence of remission despite therapy with 4 weeks of daily\\nprednisolone in a dose of 2 mg/kg per day\\n\\uf0b7 Steroid Sensitive Nephrotic Syndrome (SSNS)\\n- The first episode:Prednisolone 2 mg/kg/day (or 60 mg/m2/day) after food for 6 weeks,\\nfollowed by 1.5 mg/kg/alternate day (or 40 mg/m2/alternate day) for 6 weeks.\\n- Infrequent relapses:Prednisolone 2 mg/kg/day until remission followed by 1.5\\nmg/kg/day for 4 weeks.\\n- Frequent relapses and steroid dependant (SDNS):the following options are used\\nsuccessively.\\n- Prednisolone for achievement of remission followed by maintenance of a low dose (<than\\n0.5 mg/kg) on alternate day basis for 12-18 months.\\n- Levamisole 2.5 mg/kg/alternate day for 6 to 24 months. Monitoring of CBC is required 1-\\n2 monthly.\\n- Cyclophosphamide (CP) 2-3 mg/kg/day for 2-3 months to achieve a cumulative dose of\\n168 mg/kg. CBC monitoring is required 1-2 weekly.\\n- Mycophenolate mofetil (MMF) 20-30 mg/kg/day\\n- Tacrolimus (TAC) 0/1-0.2 mg/kg/day\\n\\uf0b7 Heavy proteinuria, hypoalbuminemia (S, Albumin <2.5 g/dl), hyperlipidemia (S.\\ncholesterol >200 mg/dl) and oedema. Dipstick or heat coagulation of urine shows\\n3+/4+ proteinuria.\\n\\uf0b7 Investigations which help in diagnosis and management are urine analysis, blood\\ncounts, S. cholesterol, S. proteins, blood urea, S.creatinine, urine culture, X-ray chest,\\nMantoux, HBsAg.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 412, 'page_label': '413'}, page_content='Pediatric Conditions\\n405\\n- Cyclosporine A (CSA) 3-5 mg/kg day\\n- Rituximab (RTX) is a relatively new and potent therapy which is used only rarely for\\nextremely difficult cases that does not respond to other options.\\n- Note: A renal biopsy is advised before starting TAC or CSA. Immuno-suppressive\\ntherapy requires supervision by paediatric nephrologist and monitoringof hemograms\\n(for all), liver function (MMF and TAC) and glucose and magnesium levels (TAC), renal\\nfunction (TAC and CSA) and drug levels (MMF, TAC, CSA).\\nFigure 2. Treatment of steroid sensitive nephritic syndrome without hypertension,\\nhematuria and azotemia\\nSupportive Treatment\\n\\uf0b7 Detect and treat infections rapidly.\\n\\uf0b7 Mobilize the patient early\\n\\uf0b7 Antacids, H2 receptor blockers or proton pump inhibitors are often prescribed along with\\nsteroids but they are no definite evidence to support this in patients who do not have any\\nsymptoms of gastritis.\\n\\uf0b7 Calcium and vitamin D supplements may be used to reduce osteopenic effects of steroids,\\nhowever definitive evidence and guidelines are not yet available.\\n\\uf0b7 Diet: Avoid excessive salt intake in edematous patient. A balanced diet with less than\\n30% fats and at least 2 gm/kg/day protein is advised.\\n\\uf0b7 Edema should be treated cautiously with diuretics while closely monitoring hypovolemia\\nand renal function.\\n\\uf0b7 Hypovolemia should be detected rapidly and treated by fluids and colloids.\\n\\uf0b7 Patients who are chronically nephritic may have hyperlipidemia which is managed by diet\\nand if persistent, with statins.\\n\\uf0b7 Hypertension should be controlled and BP maintained below 90th percentile of age.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 413, 'page_label': '414'}, page_content='Pediatric Conditions\\n406\\n\\uf0b7 Complete immunization when the patient is in remission. Vaccinate for varicella and\\npneumococcus. Avoid live vaccines during immunosuppressive therapy and for 3 months\\nafter cessation.\\n\\uf0b7 Stress dose of hydrocortisone (2-4 mg/kg/day) should be used in patients who have\\nreceived high dose steroids for 2 weeks or more in the past year, when they present with\\nserious infections or other critical illnesses, or if undergoing major surgery.\\nFollow up and monitoring\\n\\uf0b7 Monitor urinary protein at home and attend if it is 2+ or more\\n\\uf0b7 Monitor blood pressure, growth and eye examination yearly\\n\\uf0b7 Urine output and weight record\\nParent education\\n\\uf0b7 Assurance that despite a relapsing course, progression to end stage renal disease is rare\\n\\uf0b7 Urine examination by sulfosalicylic acid (SSA), dipstick or boiling should be taught.\\n\\uf0b7 Maintain adiary showing proteinuria and medication received.\\n\\uf0b7 Ensure normal activity.\\n\\uf0b7 Protection against infection\\nFEBRILE SEIZURES\\nFebrile seizures are brief (2-5 min), generalized tonic-clonic and self limited seizures\\nfollowed by a brief post-ictal period of drowsiness, in a febrile child of 6 months to 5 years of\\nage, without any underlying neurological disease. They occur rarely before 6 months and\\nafter 5 year of age. The peak age of onset is approximately 14-18 months of age, found in 3-\\n4% of young children.There is a strong family history of febrile convulsions in siblings and\\nparents, suggesting a genetic predisposition. Except for the cases at high risk, simple febrile\\nseizures rarely develop into epilepsy.\\nSalient features\\n\\uf0b7 Febrile seizures usually occur when the temperature is rising rapidly, to generally 39Â°C\\n(102Â°F) or more of core temperature.\\n- They are of two types: Typical (Simple) febrile seizure occurs on day 1 of fever, does\\nnot last  for more than 10 minutes; Atypical or complex febrile seizure may persist for\\nmore than 15 minutes; itcould be focal in nature; more than one episode of seizure in\\n24 hours;associated with abnormal neurological findings or deficits. An organic cause\\nsuch as an infectious or toxic process should be considered and investigated.\\n\\uf0b7 Examination of CSF is to rule out possibility of meningitis in cases with first episode of\\nfebrile seizures.\\n\\uf0b7 EEG is not required in a simple case of febrile seizures.However, in cases with atypical\\nfebrile seizure or in a child with high risk for developing epilepsy, it may be helpful.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 414, 'page_label': '415'}, page_content='Pediatric Conditions\\n407\\nNon -pharmacological treatment\\nClear the airway, semi-prone lateral position and oxygen therapy.\\nPharmacological treatment\\nMost febrile seizures are brief and would be over by the time a childis brought to the doctor\\nor health facility.Careful search for the cause of fever and treat fever.\\n\\uf0b7 In cases presenting with seizures, the mainstay of management is prompt administration\\nof anticonvulsants.\\n\\uf0b7 The best drug is diazepam in a dose of 0.3 mg/kg by slow intravenous or rectal route. It\\ncan be repeated if seizures do not subside (per rectal dose may be given up to 0.5\\nmg/kg/dose). Lorazepam can be used as an alternative.\\nIntermittent prophylaxis (during febrile illness)\\nTab/Syr. diazepam 0.3 mg/kg/dose every 8 hours (1 mg/kg/day) for 2-3 days of febrile\\nillness, started on theday of onset of fever. Dose can be adjusted if over sedation or ataxia\\nnoted.\\nContinuous prophylaxis\\nPhenytoin and carbamazepine are ineffective for prophylaxisand phenobarbitone has serious\\neffects on cognitive function. Sodium valproate is effective butpotential risk does not justify\\nits use.\\nPatient education( parents/care taker)\\n\\uf0b7 Assure the benign nature of the disease with  no neurological deficit or mental retardation\\nas a result of simple febrile seizure.  Teach to control of fever and to give diazepam per\\nrectally at home.\\n\\uf0b7 Routine immunization as per schedule should be followed. After DPT vaccination, oral\\nparacetamol 15 mg/kg/dose every 6 h for 2 or 3 days and similarly, after measles\\nvaccination, oral paracetamol in the same dose started on the 4th day from the day of\\nvaccination and given for 3 to 4 days to avoid precipitation of febrile seizures.\\nACUTE PYOGENIC MENINGITIS (CSF or clinically proven)\\nAcute meningitis is an acute inflammatory process involving brain tissue, due to infectious\\ncauses. The common aetiological agents are viruses and bacteria. Children of any age may be\\naffected.\\nSalient features\\n\\uf0b7 Fever, headache, vomiting, irritability, altered state ofconsciousness, signs of\\nmeningeal irritation and seizures. CSF examination differentiates the viral from\\nbacterial causes.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 415, 'page_label': '416'}, page_content=\"Pediatric Conditions\\n408\\nDiagnosis\\nTable 13. CSF findings in meningitis\\nPressure\\n(mmH 20) Leucocytosis (mm3) Protein\\n(mg/dl) Glucose (mg/dl)\\nNormal 50-80 <5,>75% Lymphos 20-45 >50 or 75%\\nserum glucose\\nAcute bacterial\\nmeningitis\\nUsually elevated\\n(100-300)\\n100-10,000 PMN's*\\npredominate 100-500 Decreased (<40)\\nAcute viral\\nmeningo-\\nencephalitis\\nNormal or elevated\\nRarely >1000 PMN's\\nearly but Lymphos\\npredominate in the most\\nof the course\\n50-200 Normal rarely-\\ndecreased\\nTubercular\\nmeningo-\\nencephilitis\\nUsually elevated\\n100-500 PMN's early but\\nlater lymphocytes\\npredominate\\n100-3000 <50\\nPharmacological treatment\\nSupportive treatment is the mainstay of therapy and isstarted immediately.\\n\\uf0b7 Maintain airway, breathing and circulation.\\n\\uf0b7 Control seizures with IV injection of diazepam 0.2 to 0.4 mg/kg stat followed by inj.\\nphenytoin 10â€“ 20 mg/kg stat followed by 5 mg/kg/day in divided doses.\\n\\uf0b7 Increased intracranial tension istreated by proper positioning of the patient with head\\nelevated at 15â€“ 30Âº position, fluid restriction to 2/3rd of maintenance, 20% mannitol 5\\nml/kg over 10â€“ 15 mins. followed by 3 ml/kg every 6 hours for 48 hours and then SOS\\nOr glycerine 1 ml/kg/day through feeding tube may be added if increased intracranial\\ntension persists.\\n\\uf0b7 Fever is controlled as given in section of fever (do not give aspirin).\\n\\uf0b7 The intravenous fluid is two thirds of the maintenance requirement initially.\\n\\uf0b7 Feeding: Initially thepatient is kept nil orally for the first 24â€“ 48 hours. Later on the\\nfeeding is guided by the level of sensorium. Tube feeding is helpful for feedings as well\\nas giving medicines.\\nSpecific Management\\n\\uf0b7 Untila bacterial cause is excluded, parenteral antibiotic therapy should be administered.\\nThe choice of antibiotics depends upon age of the patient and prevalence of organism in\\nthe area.\\nAge 0-3 months\\n\\uf0b7 Inj.cefotaxime 200 mg/kg/day IV in 4 divided doses for 14 days.\\n\\uf0b7 Inj.ampicillin 300 mg/kg/day IV in 4 divided doses for 14 days.\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 416, 'page_label': '417'}, page_content='Pediatric Conditions\\n409\\nAge 3 months-12 years\\n\\uf0b7 Inj. ceftriaxone 100 mg/kg/day IV in 2 divided doses for 10 days\\nOr Inj.cefotaxime 200 mg/kg/day IV in 3 divided doses for 10 days  Or Inj ampicillin\\n300 mg/kg/day IV in 4 divided doses for 10 days\\n\\uf0b7 Inj.chloramphenicol 100 mg/kg/day in 4 divided doses for 10 days\\n\\uf0b7 IfMeningococciis suspected/isolated Inj.penicillin G 300,000-400,000 IU/kg/ day in 4\\ndivided doses for 7-10 days.\\nAdvice at discharge\\n\\uf0b7 Regular follow up for neurological assessment including deafness is advised.\\n\\uf0b7 Anticonvulsant therapy to be continued if seizures are recurrent during course of\\nmeningitis. Children with sequelae would require assessment of handicap and\\nmultidisciplinary management. Physiotherapy may be taught during hospital stay itself.\\nTUBERCULAR MENINGITIS (TBM)\\nIt is the inflammation of the meninges due to lymphohematogenous spread of the primary\\ninfection of tuberculosis.\\nSalient Features\\nDiagnosis\\n\\uf0b7 CSF on lumbar puncture which shows lymphocytic leucocytosis with elevated proteins\\nand a low sugar level. Demonstration of AFB in the CSF confirms the diagnosis but the\\nyield is very poor.\\nNon -pharmacological treatment\\n\\uf0b7 Nutrition rehabilitation should be done as given in section on protein energy malnutrition.\\n\\uf0b7 Skin care and prevention of bedsores. Care of bowel and bladder.\\n\\uf0b7 Physiotherapy and occupational therapy should be instituted early to prevent deformities\\nand contractures.\\nPharmacological treatment\\n\\uf0b7 Appropriate fluid therapy to correct dehydration due to frequent vomiting and decreased\\noral intake.\\n\\uf0b7 Clinical progression is in three stages:1st stageâ€“ lasts for 1â€“ 2 weeks, characterized\\nby non specific symptoms, fever, headache,irritability, drowsiness, malaise. 2nd stage\\nâ€“ begins more abruptlywith common featuresof lethargy, neck rigidity, seizures,\\npositive Kernig or Brudzinskiâ€™s sign, cranial nerve palsies and other focal\\nneurological signs. 3rd stageâ€“ marked by coma, hemiplagia or paraplegia, decerebrate\\nposturing, deterioration of vital signs and eventually death.\\n\\uf0b7 Complications include motor deficits, cranial nerve deficits, mental retardation,\\nseizures, hydrocephalus, blindness etc.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 417, 'page_label': '418'}, page_content='Pediatric Conditions\\n410\\n\\uf0b7 Inj. dexamethasone: 0.15 mg/kg IV 6 hourly for 2 weeks followed by Tab. prednisolone\\n1.5 mg/kg/day orally through feeding tube for 4 weeks. This should be tapered over\\nanother 2 weeks. A total of 6-8 weeks therapy with steroid is recommended.\\n\\uf0b7 Mannitol (20% solution) 1.5 to 2 g/kg or 8-10 ml/kg over 30-60 minutes. Repeated every\\n6-8 hours for 7 days. Lower doses (0.25 g/kg/dose) can also be tried. Or Glycerol 1\\nml/kg/dose every 6-8 hours, diluted in orange juice or water, given through feeding tube.\\nOr Tab. acetazolamide 50 mg/kg/day, in 3 divided doses for 2-3 weeks.\\n\\uf0b7 Presence of seizures necessitates treatment with phenytoin or carbamazepine in\\nappropriate doses.\\n\\uf0b7 Specific antitubercular therapy-as given in management of tuberculosis\\n\\uf0b7 Surgical Treatment-Ventriculoperitoneal Shunt (VP Shunt): TBM shows some degree of\\nhydrocephalus by 4 weeks. Obstructive hydrocephalus should be shunted immediately.\\nNon obstructive hydrocephalus with increased intracranial pressure as shownby\\nventricular tap or CT scan will also be benefited by VP shunt. An early shunt is\\npreferable.\\nFollow up\\n\\uf0b7 Patient should be kept under follow up after discharge from the hospital and assessed for\\nneurological deficit and features of increased intracranialpressure (ICP). One of the\\ncommon causes of increased ICP is untreated hydrocephalus or blocked shunt.\\n\\uf0b7 Check compliance to drugs and ensure that occupational therapy/physiotherapy is being\\ncontinued.\\n\\uf0b7 Assess physical, mental, visual and auditory handicap and consider rehabilitation from\\nspecialists.\\nPatient education\\n\\uf0b7 Seriousness of disease must be explained. Contact survey must be done and any other\\nmembers of the family found to have active TB should be counselled to attend TB clinic\\nfor therapy.\\n\\uf0b7 Need forcompliance must be explained.\\nSTATUS EPILEPTICUS\\nIt is a single epileptic seizure of >30 minute in duration or a series of epileptic seizures during\\nwhich consciousness is not regained between ictal events in a >30 min period (International\\nLeague against Epilepsy).\\nPharmacological treatment\\n\\uf0b7 Inj.Lorazepam 0.1 m g/kg (max 4 mg) @ 2 mg/m in Or Inj. Midazolam 0.15-0.2mg /kg\\niv/im (max 5 mg),If ivaccessis notavailable,buccalm idazolam 0.3 mg/kg (max 5mg)\\nor perrectal diazepam 0.5mg /kg (max 10 mg)\\n\\uf0b7 Establishairway,breathing,circulation. Monitor cardiorespiratory status / oxygenation\\n\\uf0b7 Investigations:'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 418, 'page_label': '419'}, page_content='Pediatric Conditions\\n411\\n- Glucose,sodium, potassium,C alcium, mag nesium, C R P,A ED level,LFT ,RFT ,\\nAfter 10 minutes,\\n\\uf0b7 Inj. phenytoin 20 mg/kg in NS(max. 1000mg)@1 mg /kg/m inOr Inj. fosphenytoin PE 20\\nmg/kg in NS@ 3 mg/kg/m in\\nIf no response,\\n\\uf0b7 RepeatInj. phenytoin 20 mg/kg in NS(max. 1000mg)@1 mg /kg/m in\\n(Seizersoccurring even after 10 mins.of phenytoin/ fosphenytoinadministration refers to\\nrefractory status)\\nAt 25-30 mins.\\n\\uf0b7 Inj.valproate 20 mg/kgiv @ 6 mg/kg/m in orInj.phenobarbitone 20m g/kgiv @ 1.5\\nmg/kg/m in\\nIf no response after 35-45-mins.,\\n\\uf0b7 Inj.phenobarbitone 10 mg/kg iv\\nHYPOVOLEMIC SHOCK\\nHypovolemic shock, the most common cause in children is most frequently caused by\\ndiarrhea, vomiting or hemorrhage. The etiology of hypovolemic shock includes blood Loss:\\nhemorrhage, burns, nephrotic  syndrome,  water/electrolyte loss-vomiting, and diarrhea\\nPharmacological treatment\\n\\uf0b7 IV or intraosseous access\\n\\uf0b7 Rapid administration of 20 ml/kg of isotonic saline over 5-10 minutes.\\n\\uf0b7 Repeat up to 60-80 ml/kg of isotonic saline if required; not unusual for severely affected\\npatient to require this volume in first hour.\\n\\uf0b7 Shock refractory to this requires inotropic therapy with dopamine, dobutamine or nor-\\nepinephrine.\\n\\uf0b7 Inj. dopamine: 3-20 microgram/kg/min IV or Inj. dobutamine: 1-10 microgram/kg/min IV\\nor  Inj. nor-epinephrine: 0.05-1.5 microgram/kg/min\\n\\uf0b7 In case of heamorrhagic shock stop ongoing blood loss, PCV may be required\\n\\uf0b7 In case of nephrotic syndrome IV albumin is required.\\n\\uf0b7 Treat diarrhea and vomiting with appropriate antibiotics, anti-emetics and  H2 receptor\\nblockers or proton pump inhibitors.\\nDIPHTHERIA\\nDiphtheriais caused byCorynebacterium diphtheriae,\\nSalient features\\n\\uf0b7 Fever of 38Â°C (100.4Â°F), chills,fatigue, sore throat, hoarseness, cough, difficulty\\nswallowing, painful swallowing, difficulty breathing, foul-smelling bloodstained nasal\\ndischarge'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 419, 'page_label': '420'}, page_content='Pediatric Conditions\\n412\\nNon -pharmacological treatment\\n\\uf0b7 Hydration and maintain Airwayâ€“ tracheotomy if hypoxia\\nPharmacological treatment\\n\\uf0b7 Inj. diphtheria Antitoxin 20000to 100000 IU after test dose\\n\\uf0b7 Inj. crystalline penicillin 1,00,000-1,50,000 IU/Kg/Day IV in 4 divided doses for 14 days\\nif patient allergic to penicillin erythromycin 40 mg/kg/day in 4 divided doses for 14 days\\nPrevention\\n\\uf0b7 DTP as per immunization schedule\\nSE VERE MALARIA\\nSalient features\\nMinor Criteria\\nPharmacological treatment\\nChoice of antimalarial drugs\\nSupportive therapy\\n\\uf0b7 Preferably manage the patients  in ICU.\\n\\uf0b7 Clinical assessment with special attention to level of consciousness, BP, rate and depth of\\nrespiration and pallor should be made.\\nDrug Dose Duration\\nArtesunate 2.4mg/kg IV f/b 1.2mg/kg after 12 & 24 hrs & then\\ndaily till orally can be started(4mg/kg/day)\\n5 â€“ 7 days\\nQuinine 20mg/kg IV loading of salt f/b 10mg/kg/dose q 8 hrly\\ntill orally can be started\\n7 days\\nPrimaquine 0.75mg/kg orally 1 day\\n\\uf0b7 CerebralMalaria-failure to localize or respond to noxious stimuli (GCS </=8).\\n\\uf0b7 Convulsion-More than 2 generalized convulsions within 24 hours despite   cooling.\\n\\uf0b7 Severe Normocytic   normochromic anaemia - Hematocrit <15%,or hemoglobin\\n<5g/dl\\n\\uf0b7 Acidosisâ€“ Arterial pH<7.25,plasmaHCO 3 <15mMo1/L, venous lactate > 6mMo1/L\\n\\uf0b7 Renal failure- Urine output<0.5ml/kg/hr with no improvement on rehydration and\\nS.creat >3mg/dl\\n\\uf0b7 Hypoglycemia- Whole blood glucose <40 mg/dl, Macroscopic hemoglobinuria\\n\\uf0b7 Minor criteria-Impaired consciousness-Less severe alteration of sensorium should be\\nconsidered as correlate of cerebral malaria. Profound weakness unable to sit or walk\\nwith no neurological explanation\\n\\uf0b7 Hyperparasitemia-Parasite count >2,50,000/Âµl or >5% RBCâ€™s parasitized\\n\\uf0b7 Jaundice-Detected clinically or S.bilirubin >3 mg/dl\\n\\uf0b7 Hyperpyrexiaâ€“ Rectal temperature > 400'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 420, 'page_label': '421'}, page_content='Pediatric Conditions\\n413\\n\\uf0b7 A good airway, semilateral position and nasogastric tube insertion in unconscious patients,\\nventilatory support for children with Balyntyre score < 11 is necessary.\\n\\uf0b7 Oxygen, IV fluids and ionotropes for management of shock.\\n\\uf0b7 Anti-convulsants. Anti-pyretics.\\n\\uf0b7 Blood products to be given as indicated.\\n\\uf0b7 Fluid input and output, daily weight of the patient to be done.  Temperature and vitals\\nmonitoring.  Frequent change of positions 2 hourly to avoid bed sores.\\nHYPERTENSIVE ENCEPHALOPATHY\\nMost commonly associated with renal disease in children, including acute\\nglomerulonephritis, chronic pyelonephritis and end-stage renal disease. In some cases may be\\nthe initial manifestation of underlying renal disease. Cerebral vasoconstriction which is\\ncaused by systemic hypertension leads to focal areas of cerebral edema and hemorrhage.\\nSalient features\\nPharmacological Treatment\\nAnti-hypertensives\\nDrug Dosage & route Side-effects\\nNifidipine 0.25-0.5 mg/kg per dose (maximum dose 10 mg)\\nsublingual or oral q 6 hr\\nFlushing,headache,\\ntachycardia\\nHydralazine 0.1-0.2 mg/kg IM or IV repeat after 4-6 hr. For\\nmaintenance 1.5-3.5 mg/kg/day in 4 divided doses\\nPO\\nFlushing,headache,\\ntachycardia\\nReserpine 0.02 mg/kg/doseIM or PO q 12 hr, upto maximum\\nof 0.07 mg/kg or 1 mg\\nDrowsiness, nasal\\ncongestion, GI bleeding\\nDiazoxide 1 mg/kg IV bolus, repeat q 15 min till blood\\npressure is controlled or maximum dose of 5 mg/kg\\nis given\\nHyperglycemia\\n\\uf0b7 Anti-convulsants\\nDrug Dosage & route Side-effects\\nPhenytoin 20 mg/kg IV slowly @ 25 mg/min\\nfollowed by maintenance dose of 5\\nmg/kg q 12 hr\\nWatch for hypotension and\\narrhythmia\\nPhenobarbitone 20 mg/kg loading dose IV @\\n2mg/kg/min followed by maintenance\\ndose of 5 mg/kg q 12 hr\\nWatch fo r respiratory\\ndepression\\n\\uf0b7 Acute seizures and coma or may manifest with headache, drowsiness and lethargy,\\nnausea and vomiting,blurredvision, transient cortical blindness and hemiparesis.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 421, 'page_label': '422'}, page_content='Pediatric Conditions\\n414\\nDiazepam 0.2-0.5 mg/kg IV bolus over 1-2 min Watch for respiratory\\ndepression and hypotension\\nLorazepam 0.05-0.1 mg/kg(max upto 4 mg) IV over\\n1-2 min\\nAlthough little but there is risk\\nof respiratory depression and\\nhypotension\\nMi dazolam 0.2 mg/kg IV bolus. Respiratory depression.\\n\\uf0b7 Treat underlying condition.\\nACUTE SEVERE ASTHMA\\nAn acute exacerbation of asthma that does not respond to conventional therapy is called\\nstatus asthmatics.\\nSalient features\\nSymptoms/signs Mild Mode rate Severe\\nRespiratory rate Normal Increased Increased\\nAlertness Normal Normal Restless/drowsy\\nDyspnoea Absent or mild moderate Severe\\nPulsus paradoxus <10mmHg 10 â€“ 20mm Hg 20 â€“ 40mmHg\\nAccessory muscle\\nuse\\nNo or mild\\nintercostals\\nretractions\\nModerate intercostals\\ninteractions with\\ntracheosternal\\nretractions\\nSevere intercostal\\ninteractions with\\ntracheosternal\\nretractions with nasal\\nflaring\\nColour Pink Pale G rey or cyanotic\\nAuscultation End expiratory\\nwheeze only\\nWheeze during\\nexpiration&\\ninspiration\\nBreath sounds\\ninaudible\\nOxygen saturation >95% 90 â€“ 95% <90%\\nPaco2 <35mm Hg 35 â€“ 40 mmHg >40 mmHg\\nPEFR 70 â€“ 90% of\\npredicted orbest\\n50 â€“ 70% of predicted\\nor personalbest\\n<50% of predicted or\\npersonal best\\n\\uf0b7 Assessment of severity of acute attack of asthma\\nLife threatening asthmaSilent chest, Cyanosis,  Poor respiratory effort, Hypotension\\nExhaustion, Confusion,  Spo2 <92% , PEFR <33% best/predicted\\nAcute severe asthma Canâ€™t complete sentences in one breath or breathless to talk or feed\\nSpo2 <92%,  PEFR 33â€“ 35% best or predicted\\nPulse >140/min in 2 to 5 years\\n>125/min in >5 years\\nRespiration >40breaths/min in 2 to 5 years, 30/min in 5 to 7 years'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 422, 'page_label': '423'}, page_content='Pediatric Conditions\\n415\\nModerate asthma\\nexacerbation\\nAble to talk in sentences\\nSpo2 >/=92% , PEFR 50% best or predicted\\nPulse </=140/min in 2 to 5 years\\n</=125/min in >5 years\\nRespiration </=40breaths/min in 2 to 5 years\\n</=30/min in 5 to 7 years\\nPharmacological treatment\\nInitialassessment-\\nImp endingrespiratory failure, Moderate to severeattack-\\n\\uf0b7 Oxygen\\n\\uf0b7 N ebulizersalbutamol + ipratropium\\n\\uf0b7 Inj. terbutaline /adrenaline SC\\n\\uf0b7 IV corticosteroids\\n\\uf0b7 Transfer to ICU-Good response\\nLife threatening attack\\n\\uf0b7 Same as above+ Reassessafter 1 hr.\\nIf poor/ partial response,\\n\\uf0b7 Co rrectacidosis\\n\\uf0b7 Trial of Mg So4/ terbutaline\\nIf no response after 2-4 hrs.\\n\\uf0b7 Continue above treatment and add Inj.amoniphylline infusion'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 423, 'page_label': '424'}, page_content='416\\nChapter 19\\nDENTAL CONDITIONS\\nTOOTH AVULSION\\nOne of the commonest sequelae of facial trauma is tooth avulsion, exfoliation or articulation.\\nSalient features\\nTreatment\\n\\uf0b7 Immediately refer to a dentist.Best result is observed if tooth is reimplanted within 5-20\\nminutes.\\n\\uf0b7 Fixation of implanted tooth with periodontal wiring, arch bar wiring or composite resin;\\nfixation period 6 to 8 weeks; root canal treatment done after reimplantation only (to avoid\\ndesiccation of periodontal ligament).\\nInterim storage\\n\\uf0b7 Best method is to place back the tooth in the socket immediately. Other storage media are\\nsaliva, milk (placed in ice since this minimizes the adverse effects on the periodontal\\nligament) and saline.\\nPharmacological treatment\\n\\uf0b7 Cap. amoxycillin 250-500 mg 3 times a day for 5 days Or Tab. ciprofloxacin 250-500 mg\\ntwice a day for 5 days.\\n\\uf0b7 Tab. diclofenac Potassium 50 mg b.d. or Tab. ibuprofen 400 mg 3 times for 3-5 days.\\nTOOTHACHE\\nDirect causes are dentalcaries, periodontal pocket, abrasion, attrition & erosion,peridontitis,\\nthird molar eruption (Impacted Tooth). The indirect causes of toothache are maxillary\\nsinusitis (recent bout of common cold) & trigeminal neuralgia.\\nPharmacologicaltreatment\\n\\uf0b7 Cap. amoxycillin 250-500 mg 3 times a day for 5 days. Or Tab. ciprofloxacin 250-500\\nmg 2 times a day for 5 days.\\n\\uf0b7 Tab. diclofenac potassium 50 mg b.d. or Tab. ibuprofen 400 mg 3 times for 3-5 days.\\nSurgicaltreatment\\n\\uf0b7 Excavation of caries and sedative dressing with clove oil. Removal of plaque & calculus\\nby scaling & local medicaments.Removal of irritant like high filling and high spot on\\ncrown or bridge.Anaesthetize the tooth and extirpate the pulp (if pulp is exposed).\\n\\uf0b7 History of fall, interpersonal violence, sports injury, assault or accident.\\n\\uf0b7 Children are morecommon.\\n\\uf0b7 Central incisors and developing teeth are more frequently avulsed.\\n\\uf0b7 Patient presents extreme pain with a bleeding socket, clot in the socket and a raw\\nwound with or without Lip & Labial mucosa injury.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 424, 'page_label': '425'}, page_content='Dental Conditions\\n417\\n\\uf0b7 Removal of Impacted third molar.\\n\\uf0b7 Treatment should be with radiographs to ruleout cause & radiograph after 6 weeks to\\nassess bone loss and root resorption.\\nPatient education\\n\\uf0b7 Maintenance of oral hygiene.\\n\\uf0b7 Importance of tooth preservation should be explained.\\n\\uf0b7 Pit and fissure sealing in pediatric patient.\\n\\uf0b7 Not to bite anything hard from anterior teeth during fixation period.\\nTOOTH FRACTURE/ MANDIBLE OR MAXILLARY BONE FRACTURE\\nSalient features\\nTreatment\\n\\uf0b7 Perform primary treatment for bleeding & pain\\n\\uf0b7 Primary sutures for soft tissue trauma\\n\\uf0b7 Radiographs for fracture suspected sites\\n\\uf0b7 Refer to oral maxilla facial surgeon for bone fractures\\nDENTAL CARIES\\nThis is a multifactorial infectious disease of hard tissues of teeth characterized by\\ndemineralization of inorganic and destruction of organic part of the tooth. (Enamel & Dentin)\\nSalient features\\nTreatment\\n\\uf0b7 Examine for stage of caries and treat accordingly.\\n\\uf0b7 Careful assessment of oral cavity for presence of any white/ brown or black spot.\\nNon -pharmacologicaltreatment\\n\\uf0b7 In non-cavitated lesion and low risk patient with good oral hygiene practices, no\\ntreatment is given.\\n\\uf0b7 In cavitated lesion, restoration is done.\\nPharmacologicaltreatment\\n\\uf0b7 Patients with caries is likely to progress (in high risk patient) pit and fissure sealant.\\n\\uf0b7 Topical 2% sodium fluoride.\\n\\uf0b7 Pain, mobility of fractured segment of tooth or bone\\n\\uf0b7 Step deformity,Painful or restricted TMJ movement\\n\\uf0b7 Bleeding from traumatic site\\n\\uf0b7 Usually asymptomatic in early stages.\\n\\uf0b7 Patient presents with tooth sensitivity and tooth ache only on cold & sweet intakes\\nwhich may disappear on removal of stimuli.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 425, 'page_label': '426'}, page_content='Dental Conditions\\n418\\n\\uf0b7 Mouth wash with 0.2% chlorhexidine twice a day.\\n\\uf0b7 Advisefluorinated toothpaste or fluorinated mouthwashes.\\nAssessment of response to therapy\\n\\uf0b7 For caries active patient-follow up visit every 3 months and to check the progression of\\nwhite / brown or black spot on the teeth.\\n\\uf0b7 For normal patients-follow up every6 months to 1 year to check the development of the\\nwhite spot cavitation.\\nPatient education/prevention\\n\\uf0b7 For caries active/high risk patient preferably.\\n\\uf0b7 Diet control and avoidance of sugar containing food.\\n\\uf0b7 Frequent ingestion of food containing sucrose shouldbe substituted by sugar free foods.\\n\\uf0b7 Oral hygiene: (a) brushing of teeth twice a day (b) flossing (c) thorough rinsing after\\nevery meal.\\n\\uf0b7 Fluoride application using Topical 2% sodium fluoride (by dentist) 4 applications at\\nweekly intervals at the age of 3,7, 11 and 13 years.\\n\\uf0b7 0.05% sodium fluoride daily rinse (should not be swallowed).\\n\\uf0b7 0.2% sodium fluoride supervised weekly rinse in school (age of children >7 years) only if\\nthese children have been identified as caries active patients.\\nReferences\\n1. Sturdevant CM. Roberson TM, Heymann HO, Sturdevant JR. In: The Art andScience of Operative Dentistry,\\n3rd Edition, Mosby 1995, pp 100-20.\\n2. Mitchell DA, Mitchel L. In: Oxford Handbook of Clinical Dentistry, 2nd Edition, reprint 1996, pp 28.\\nDENTAL ABSCESS\\nPatient presents with pain and swelling. The most common types of dental abscesses are\\nperiapical abscess and lateral periodontal abscess.\\nI. PERIAPICAL ABSCESS\\nSalient features\\nImmediate treatment\\n\\uf0b7 To give antibiotics as given below and refer to a dentist.\\nPh armacologicaltreatment\\n\\uf0b7 Cap. amoxycillin 250-500 mg 3 times a day for 5 days. Or Tab. ciprofloxacin 250-500\\nmg two times a day for 5 days.\\n\\uf0b7 Tab. diclofenac potassium 50 mg b.d. or Tab. ibuprofen 400 mg 3 times a day for 3-5\\ndays.\\n\\uf0b7 Presence of caries or trauma.Severe throbbing pain, disturbed sleep\\n\\uf0b7 Tooth is tender to touch & extruded from socket.Tooth may be mobile and associated\\nwith localized or diffuse swelling.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 426, 'page_label': '427'}, page_content=\"Dental Conditions\\n419\\nSurgicaltreatment\\n\\uf0b7 Drainage of pus by entering the pulp chamber (pulpectomy) & relieve occlusion.\\n\\uf0b7 If fluctuant swelling of soft tissue is present drain by incision.\\n\\uf0b7 Extraction or root canal treatment should be done when acute symptoms subside.\\n\\uf0b7 Spread of infection should be closelyobserved to prevent complications like Ludwig's\\nangina or osteomyelitis.\\nPatient education\\n\\uf0b7 Maintenance of oral hygiene (see details in section on oral hygiene).\\n\\uf0b7 Control of diabetes mellitus, if present.\\n\\uf0b7 No hot fomentation over the skin.\\nII.LATERAL PERIDONTA L ABSCESS\\nSalient features\\nPharmacologicaltreatment\\n\\uf0b7 Cap. amoxycillin 250-500 mg 3 times a day for 5 days.\\n\\uf0b7 Tab. metronidazole 400 mg 3 times a day for 5 days.\\n\\uf0b7 Tab. diclofenac potassium 50 mg b.d. or Tab. ibuprofen 400 mg 3 times/dayfor 3-5 days.\\nSurgicaltreatment\\n\\uf0b7 D ebridement of pocket and drainage of pus and irrigation with chlorhexidine. Spread of\\ninfection to be closely observed to prevent complications like Ludwig's angina.\\nPatient education\\n\\uf0b7 Maintenance of oral hygiene.No hot fomentation over the skin.Control of diabetes\\nmellitus if present.\\nADULT TYPE PERIODONTITIS\\nMost common dental disease of the gums & periodontium.\\nSalient features\\n\\uf0b7 Same as in acute periapical abscess,often associated with bad taste.\\n\\uf0b7 Tooth is usually mobile and tender on percussion, associatedwithlocalized or diffuse\\nswelling of the adjacent periodontium.\\n\\uf0b7 Vitality test usually positiveif no associated pulpal problem.\\n\\uf0b7 Radiograph shows vertical or horizontal bone loss in relation to the tooth.\\n\\uf0b7 Swollen gums, bleeding from gums either spontaneously or while brushing. Pain on\\neating something hard, difficulty in chewing food, dull pain in the gums, pus\\ndischarge from gum on pressing, loosening of teeth, recession of gums.\\n\\uf0b7 There is slowly progressive destruction of periodontitum, loss of periodontal\\nattachment and presence of periodontal pocket.\\n\\uf0b7 Bad breath (Halitosis),sensitivity to hot & Cold intakes\"),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 427, 'page_label': '428'}, page_content='Dental Conditions\\n420\\nNon -pharmacologicaltreatment\\n\\uf0b7 Refer to a dentist for oral prophylaxis in form of thorough scaling androot planning.\\n\\uf0b7 Advise brushing twice daily once after breakfast and once after dinner with super soft\\ntooth brush for at least 3 minutes.\\nPharmacologicaltreatment\\nLocal therapy\\n\\uf0b7 Advise antiplaque toothpast containing antibiotics.\\n\\uf0b7 Gel metronidazole to be massaged on the gums twice daily.\\n\\uf0b7 Rinsing with 0.2% chlorhexidine mouthwash twice daily which is effective after scaling.\\nSystemic therapy\\n\\uf0b7 In adults, Cap. tetracycline 250 mg 4times a day for 5-7 days.\\n\\uf0b7 In very deep pockets: Combination of drugs i.e., Tab. ciprofloxacin 500 mg twice daily &\\nTab. tinidazole 300 mg twice daily for 5-7 days.\\n\\uf0b7 Recheck the depth of periodontal pockets, if it persists, refer to dentist for further\\nmanagement.\\nReferences\\n1. Ramford and Ash. Peridontology and Periodontitis. In: Moderntherapy and practice. 1st Indian Edition,\\nAITBS Publishers 1996, pp 163.\\n2. Mitchell D A, Mitcchell L. In: Oxford Handbook of Clinical Dentistry, 2nd Edition reprint. 1996, pp. 212.\\nJUVENILE PERIODONTITIS\\nIt is characterized by rapid destruction of periodontal tissues.\\nSalient features\\nPharmacologicaltreatment\\n\\uf0b7 Cap. tetracycline 250 mg 4 times a day for 14 days.\\nSurgicaltreatment\\n\\uf0b7 Extraction of badly involved teeth. Refer the patient to periodontist for further\\nperiodontical management at the earliest\\nPatient education\\n\\uf0b7 Proper brushing twice daily with super soft tooth brush.\\nINFLAMMATORY GINGIVAL ENLARGEMENTS\\nThe gingival enlargement can be acute which is very painful or they can be chronic which\\nmay be painless. There are many causes for gingival enlargements. Before giving treatment,\\n\\uf0b7 Common in the age group of 13-25 years.\\n\\uf0b7 Mobility in incisors and molars, spacing in upper incisors, distolabial migration of\\nupper incisors, arc shaped bone loss extending from distal surface of second premolar\\nto mesial surface of second molar.'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 428, 'page_label': '429'}, page_content='Dental Conditions\\n421\\netiological factor must be evaluated.\\nSalient features\\nPharmacologicaltreatment\\n\\uf0b7 Tab. ciprofloxacin 500 mg 2 times a day for 3-5 days.\\n\\uf0b7 Tab. diclofenac potassium 50 mg b.d. or Tab. ibuprofen 400 mg 3 times a day for 3-5\\ndays.\\n\\uf0b7 Rinsing with 0.2% chlorhexidine mouthwash twice daily.\\n\\uf0b7 Refer to a periodontist for surgical management and drainage of pus.\\nPatient education\\n\\uf0b7 Proper brushing twice daily with super soft tooth brush.\\n\\uf0b7 Shafer, Hine, Levy. In: A textbook of oral pathology. 4th Edition, Saunders, pp 782.\\nDENTAL FLUOROSIS\\nSalient features\\nTreatment\\n\\uf0b7 Oral hygiene maintainance as patients are more caries susceptible\\n\\uf0b7 Bleaching of teeth (Whitening of teeth)\\n\\uf0b7 Veneers or laminates for better esthetics\\nTRIGEMINAL NEURALG IA\\nIt is sudden, sharp, severe or short duration, like electric shock like pain.\\nSalient features\\nTreatment\\n\\uf0b7 Diagnostic dose of carbamazepine given to establish diagnosis\\n\\uf0b7 Evaluation of any primary lesion in brain by MRI\\n\\uf0b7 Acute enlargements may be localized or generalized, very painful, deep red in color,\\nsoft friable with shiny surface.\\n\\uf0b7 Chronic type may be localized or generalized, often painless and slowly progressive.\\n\\uf0b7 Mainly seen in patients who are drinking fluorinated water (> 3PPM) during tooth\\ndevelopment time.\\n\\uf0b7 White chalky/ brown spots on crowns of teeth\\n\\uf0b7 Brownish discoloration on enamel mainly, involves anterior teeth & first molars\\n\\uf0b7 Presenceof trigger zones involving trigeminal nerve areas\\n\\uf0b7 Unilateral sharp, shooting, lancinating type of pain may provoke on touch, washing\\nface, shaving, on cold wind exposure.\\n\\uf0b7 Pain will be in recurrent bouts of attacks, may persist for second to minute'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 429, 'page_label': '430'}, page_content='Dental Conditions\\n422\\n\\uf0b7 Tab. carbamazepine 200 mg. t.d.s as per intensity & frequency of pain & attacks.\\n\\uf0b7 Refer to Dentists for further evaluation & treatment.\\nORAL CANCER (HABIT RELATED DISEASE)\\nOral cancer is most commonand associated with smokingand tobacco containing habit.\\nAdults are more commonly involved.\\nSalient features\\nTreatment\\n\\uf0b7 Refer to Oncologist after thorough clinicaland histopathological examination.\\n\\uf0b7 Advice symptomatic treatment if required.\\nORAL SUBMUCUS FIBROSIS (OSMF)\\nSalient features\\nTreatment\\n\\uf0b7 Quit habit as soon as possible, m outh opening exercises (physical exercises)\\n\\uf0b7 Oral Hygiene prophylaxis\\n\\uf0b7 Local medicaments in form of steroids\\nCYST OR TUMOR OF JAW\\nSalient features\\n\\uf0b7 Long standing (> 2 weeks) non-healing chronic ulcer in oral cavity.Bleeding& non\\npainful ulcer or growth\\n\\uf0b7 Regional lymphadenopathy,mobility or exfoliation of teeth.\\n\\uf0b7 Decreased appetite, reduced weight, Poor Oral Hygiene, history of tobacco habit since\\nlong time.Altered speech, difficulty in opening of mouth (Trismus)\\n\\uf0b7 Most common disease related with tobacco, limeand Betelnut\\n\\uf0b7 Gradually reduced mouth opening (Trismus)\\n\\uf0b7 Blanching (White opaque)oral mucosa\\n\\uf0b7 Recurrent ulcers & burning sensations on taking spicy food.\\n\\uf0b7 Change of voice, difficulty in deglutition.\\n\\uf0b7 Poor oral hygiene withgingivitis &periodontitis\\n\\uf0b7 Small shrunken uvulaand decreased mobility of soft palate\\n\\uf0b7 Facial asymmetry,Non tender swelling or growth,Paresthesia of jaw\\n\\uf0b7 Displacement of teeth, improper occlusion\\n\\uf0b7 May be having discharge,Discoloration of teeth,Absence ofteeth in arch'),\n",
       " Document(metadata={'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'creator': 'Nitro Pro', 'creationdate': '2013-11-16T11:06:14+05:30', 'author': 'abc', 'moddate': '2014-01-03T12:44:35+05:30', 'title': 'STANDARD TREATMENT GUIDELINES', 'source': 'Data\\\\Medical_Book.pdf', 'total_pages': 431, 'page': 430, 'page_label': '431'}, page_content='Dental Conditions\\n423\\nTreatment\\n\\uf0b7 Refer to oral maxilla facial surgeon for bone fractures\\nGENERAL MEASURES FOR GOOD O RAL HYGIENE\\n\\uf0b7 Select the right quality of tooth brush which should be short, soft and have uniformly\\ntrimmed bristles. Change the brush at least after every 3 months\\n\\uf0b7 Brush teeth at least twice a day for 2-3 minutes particularly at night before going to sleep.\\n\\uf0b7 Use right technique of teeth brushing.Never use force while brushing.Use flossing at\\nleast once a day.\\n\\uf0b7 Avoid too much sugar and aerated drinks.Avoid eating in between meals, if cannot be\\navoided rinse your mouth or preferably brush your teeth.\\n\\uf0b7 Do notingest or swallow fluorinated toothpaste while brushing.\\n\\uf0b7 Ensure regular dental checkup at 6 monthly interval.\\nANTIBIOTIC PROPHYLAXIS IN DENTAL PROCEDURE\\n\\uf0b7 If patient is in the high or moderate risk groups, then antibiotic prophylaxis is\\nrecommended for thefollowing dental procedures:\\n\\uf0b7 Dental extractions.\\n\\uf0b7 Periodontal procedures including surgery, scaling and root planing, probing, and recall\\nmaintenance.\\n\\uf0b7 Dental implant placement and reimplantation of avulsed teeth.\\n\\uf0b7 Endodontic (root canal) instrumentation or surgery only beyond the apex.\\n\\uf0b7 Sub gingival placement of antibiotic fibers or strips.\\n\\uf0b7 Prophylactic cleaning of teeth or implants where bleeding is anticipated.\\nAntibiotic prophylaxis not recommended for the following dental procedures\\n\\uf0b7 Restorative dentistry(operative and prosthodontic) with or without retraction cord.\\n\\uf0b7 Local anesthetic injections (nonintraligamentary). Intracanal endodontic treatment; post\\nplacement and buildup.\\n\\uf0b7 Placement of rubber dams, postoperative suture removal, taking of oral impressions, and\\nfluoride treatments.\\n\\uf0b7 Placement of removable prosthodontic or orthodontic appliances and orthodontic\\nappliance adjustment.\\n\\uf0b7 Taking of oral radiographs.\\n\\uf0b7 Shedding of primary teeth.')]"
      ]
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Extracted_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "6cb67b34",
   "metadata": {},
   "outputs": [],
   "source": [
    "#split the data into Text Chunks \n",
    "\n",
    "def text_split(Extracted_data):\n",
    "    text_splitter=RecursiveCharacterTextSplitter(chunk_size=500,chunk_overlap=20)\n",
    "    text_chunks=text_splitter.split_documents(Extracted_data)\n",
    "\n",
    "    return text_chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "a2d8c5bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2039\n"
     ]
    }
   ],
   "source": [
    "text_chunks=text_split(Extracted_data)\n",
    "print(len(text_chunks))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ff91ab47",
   "metadata": {},
   "outputs": [],
   "source": [
    "#text_chunks\n",
    "from langchain.embeddings import HuggingFaceEmbeddings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "44e749ae",
   "metadata": {},
   "outputs": [],
   "source": [
    "def download_Hugging_face_embeddings():\n",
    "    embeddings=HuggingFaceEmbeddings(model_name='sentence-transformers/all-MiniLM-L6-v2')\n",
    "    return embeddings\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "3a0b1070",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\veera\\AppData\\Local\\Temp\\ipykernel_18580\\409687088.py:2: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings=HuggingFaceEmbeddings(model_name='sentence-transformers/all-MiniLM-L6-v2')\n",
      "c:\\Users\\veera\\anaconda3\\envs\\medichatbot\\lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "embeddings=download_Hugging_face_embeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ddf32fb8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Length 384\n"
     ]
    }
   ],
   "source": [
    "query_results=embeddings.embed_query(\"Hello World\")\n",
    "print(\"Length\",len(query_results))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "5da1f34c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[-0.034477200359106064,\n",
       " 0.031023219227790833,\n",
       " 0.0067349993623793125,\n",
       " 0.02610897459089756,\n",
       " -0.03936201333999634,\n",
       " -0.16030248999595642,\n",
       " 0.06692397594451904,\n",
       " -0.006441470701247454,\n",
       " -0.04745051637291908,\n",
       " 0.014758859761059284,\n",
       " 0.07087533175945282,\n",
       " 0.05552757531404495,\n",
       " 0.019193289801478386,\n",
       " -0.026251329109072685,\n",
       " -0.010109508410096169,\n",
       " -0.026940548792481422,\n",
       " 0.022307483479380608,\n",
       " -0.022226618602871895,\n",
       " -0.14969265460968018,\n",
       " -0.01749304309487343,\n",
       " 0.007676269859075546,\n",
       " 0.05435226485133171,\n",
       " 0.003254482988268137,\n",
       " 0.03172600269317627,\n",
       " -0.0846213772892952,\n",
       " -0.02940598875284195,\n",
       " 0.051595672965049744,\n",
       " 0.04812409356236458,\n",
       " -0.003314794274047017,\n",
       " -0.05827922374010086,\n",
       " 0.041969284415245056,\n",
       " 0.022210709750652313,\n",
       " 0.1281888633966446,\n",
       " -0.022338956594467163,\n",
       " -0.011656241491436958,\n",
       " 0.06292833387851715,\n",
       " -0.032876305282115936,\n",
       " -0.09122610837221146,\n",
       " -0.03117538057267666,\n",
       " 0.05269957706332207,\n",
       " 0.047034792602062225,\n",
       " -0.08420304954051971,\n",
       " -0.0300561785697937,\n",
       " -0.020744718611240387,\n",
       " 0.009517784230411053,\n",
       " -0.003721792483702302,\n",
       " 0.007343328557908535,\n",
       " 0.03932436183094978,\n",
       " 0.09327410906553268,\n",
       " -0.0037885827478021383,\n",
       " -0.052742086350917816,\n",
       " -0.05805819109082222,\n",
       " -0.0068643949925899506,\n",
       " 0.005283229053020477,\n",
       " 0.08289298415184021,\n",
       " 0.019362755119800568,\n",
       " 0.0062844837084412575,\n",
       " -0.010330805554986,\n",
       " 0.009032356552779675,\n",
       " -0.037683770060539246,\n",
       " -0.04520607367157936,\n",
       " 0.02401638962328434,\n",
       " -0.0069442023523151875,\n",
       " 0.013491633348166943,\n",
       " 0.10005491971969604,\n",
       " -0.071683868765831,\n",
       " -0.02169504575431347,\n",
       " 0.03161846846342087,\n",
       " -0.05163463577628136,\n",
       " -0.08224768191576004,\n",
       " -0.06569331139326096,\n",
       " -0.00989536102861166,\n",
       " 0.0058163986541330814,\n",
       " 0.07355453819036484,\n",
       " -0.03405030816793442,\n",
       " 0.02488601580262184,\n",
       " 0.01448806282132864,\n",
       " 0.026457400992512703,\n",
       " 0.009656714275479317,\n",
       " 0.030217286199331284,\n",
       " 0.052803970873355865,\n",
       " -0.07535988092422485,\n",
       " 0.009897174313664436,\n",
       " 0.029836837202310562,\n",
       " 0.017555566504597664,\n",
       " 0.023091990500688553,\n",
       " 0.0019339261343702674,\n",
       " 0.0014001254457980394,\n",
       " -0.04717599228024483,\n",
       " -0.011194380931556225,\n",
       " -0.11420133709907532,\n",
       " -0.019812004640698433,\n",
       " 0.04026623070240021,\n",
       " 0.0021929889917373657,\n",
       " -0.07979222387075424,\n",
       " -0.02538231387734413,\n",
       " 0.09448292851448059,\n",
       " -0.02898111194372177,\n",
       " -0.14500252902507782,\n",
       " 0.23097743093967438,\n",
       " 0.027731100097298622,\n",
       " 0.032111480832099915,\n",
       " 0.031064996495842934,\n",
       " 0.04283281788229942,\n",
       " 0.06423777341842651,\n",
       " 0.03216314688324928,\n",
       " -0.00487674493342638,\n",
       " 0.055699415504932404,\n",
       " -0.03753236308693886,\n",
       " -0.0215055663138628,\n",
       " -0.028342649340629578,\n",
       " -0.028846941888332367,\n",
       " 0.03835311904549599,\n",
       " -0.01746867224574089,\n",
       " 0.05248536914587021,\n",
       " -0.07487605512142181,\n",
       " -0.03125976398587227,\n",
       " 0.021841533482074738,\n",
       " -0.03989564999938011,\n",
       " -0.008587109856307507,\n",
       " 0.026956573128700256,\n",
       " -0.04849550500512123,\n",
       " 0.011469874531030655,\n",
       " 0.029618263244628906,\n",
       " -0.020572170615196228,\n",
       " 0.013103901408612728,\n",
       " 0.028833406046032906,\n",
       " -3.194200554190157e-33,\n",
       " 0.0647820383310318,\n",
       " -0.018130239099264145,\n",
       " 0.051789943128824234,\n",
       " 0.12198273092508316,\n",
       " 0.028780145570635796,\n",
       " 0.0087220324203372,\n",
       " -0.07052115350961685,\n",
       " -0.01690724864602089,\n",
       " 0.040739696472883224,\n",
       " 0.042116180062294006,\n",
       " 0.02544722706079483,\n",
       " 0.03574619069695473,\n",
       " -0.04914474114775658,\n",
       " 0.002129100728780031,\n",
       " -0.015546616166830063,\n",
       " 0.05073058605194092,\n",
       " -0.048185259103775024,\n",
       " 0.03588063269853592,\n",
       " -0.004067067988216877,\n",
       " 0.10172475874423981,\n",
       " -0.05597001686692238,\n",
       " -0.010680987499654293,\n",
       " 0.011235800571739674,\n",
       " 0.09068652987480164,\n",
       " 0.004234495107084513,\n",
       " 0.035138655453920364,\n",
       " -0.009702835232019424,\n",
       " -0.09386523813009262,\n",
       " 0.09285551309585571,\n",
       " 0.00800494384020567,\n",
       " -0.007705416064709425,\n",
       " -0.052086714655160904,\n",
       " -0.012587959878146648,\n",
       " 0.0032668698113411665,\n",
       " 0.0060135237872600555,\n",
       " 0.007581581827253103,\n",
       " 0.010517198592424393,\n",
       " -0.08634552359580994,\n",
       " -0.06987876445055008,\n",
       " -0.0025338700506836176,\n",
       " -0.09097661077976227,\n",
       " 0.04688737168908119,\n",
       " 0.05207647755742073,\n",
       " 0.007193892262876034,\n",
       " 0.010903597809374332,\n",
       " -0.005229538772255182,\n",
       " 0.013937323354184628,\n",
       " 0.02196837216615677,\n",
       " 0.03420856222510338,\n",
       " 0.060224637389183044,\n",
       " 0.00011661044845823199,\n",
       " 0.014731992967426777,\n",
       " -0.07008922845125198,\n",
       " 0.02849903516471386,\n",
       " -0.027601642534136772,\n",
       " 0.010768351145088673,\n",
       " 0.03483092412352562,\n",
       " -0.022487878799438477,\n",
       " 0.00976911373436451,\n",
       " 0.07722778618335724,\n",
       " 0.021588344126939774,\n",
       " 0.11495622247457504,\n",
       " -0.06800113618373871,\n",
       " 0.023761043325066566,\n",
       " -0.015983911231160164,\n",
       " -0.01782696507871151,\n",
       " 0.06439494341611862,\n",
       " 0.03202573582530022,\n",
       " 0.05027022957801819,\n",
       " -0.005913649220019579,\n",
       " -0.03370799124240875,\n",
       " 0.017840316519141197,\n",
       " 0.01657339744269848,\n",
       " 0.06329654157161713,\n",
       " 0.03467720001935959,\n",
       " 0.04647345840930939,\n",
       " 0.09790614992380142,\n",
       " -0.006635494064539671,\n",
       " 0.02520708367228508,\n",
       " -0.0779883861541748,\n",
       " 0.01692640222609043,\n",
       " -0.0009457881096750498,\n",
       " 0.02247185818850994,\n",
       " -0.038253240287303925,\n",
       " 0.09570475667715073,\n",
       " -0.00535071175545454,\n",
       " 0.010469038039445877,\n",
       " -0.11524058878421783,\n",
       " -0.013262532651424408,\n",
       " -0.010709351859986782,\n",
       " -0.08311721682548523,\n",
       " 0.07327357679605484,\n",
       " 0.049392201006412506,\n",
       " -0.008994361385703087,\n",
       " -0.09584556519985199,\n",
       " 3.366149296434549e-33,\n",
       " 0.12493181973695755,\n",
       " 0.019349709153175354,\n",
       " -0.0582258477807045,\n",
       " -0.03598824888467789,\n",
       " -0.050746746361255646,\n",
       " -0.04566233605146408,\n",
       " -0.08260342478752136,\n",
       " 0.14819477498531342,\n",
       " -0.08842117339372635,\n",
       " 0.06027441471815109,\n",
       " 0.05103025957942009,\n",
       " 0.010303089395165443,\n",
       " 0.14121423661708832,\n",
       " 0.030813878402113914,\n",
       " 0.06103307381272316,\n",
       " -0.05285125970840454,\n",
       " 0.13664892315864563,\n",
       " 0.009189915843307972,\n",
       " -0.017325272783637047,\n",
       " -0.012848668731749058,\n",
       " -0.00799528043717146,\n",
       " -0.05098002031445503,\n",
       " -0.052350591868162155,\n",
       " 0.007593057118356228,\n",
       " -0.015166228637099266,\n",
       " 0.016960326582193375,\n",
       " 0.021270541474223137,\n",
       " 0.02055799402296543,\n",
       " -0.1200280711054802,\n",
       " 0.014461806043982506,\n",
       " 0.02675984986126423,\n",
       " 0.025330591946840286,\n",
       " -0.0427546426653862,\n",
       " 0.006768474821001291,\n",
       " -0.01445858832448721,\n",
       " 0.045261986553668976,\n",
       " -0.09147657454013824,\n",
       " -0.019439177587628365,\n",
       " -0.017833461984992027,\n",
       " -0.05491012707352638,\n",
       " -0.052641063928604126,\n",
       " -0.010459036566317081,\n",
       " -0.05201602354645729,\n",
       " 0.020892051979899406,\n",
       " -0.07997025549411774,\n",
       " -0.012111312709748745,\n",
       " -0.05773141607642174,\n",
       " 0.02317824214696884,\n",
       " -0.00803161971271038,\n",
       " -0.025989310815930367,\n",
       " -0.07995670288801193,\n",
       " -0.02072887495160103,\n",
       " 0.048817772418260574,\n",
       " -0.02038920484483242,\n",
       " -0.049176573753356934,\n",
       " 0.01415967382490635,\n",
       " -0.06362210959196091,\n",
       " -0.007807392161339521,\n",
       " 0.016431482508778572,\n",
       " -0.02568255178630352,\n",
       " 0.01338108442723751,\n",
       " 0.026248762384057045,\n",
       " 0.009978335350751877,\n",
       " 0.06322894990444183,\n",
       " 0.0026721502654254436,\n",
       " -0.006582724861800671,\n",
       " 0.016632026061415672,\n",
       " 0.03236645832657814,\n",
       " 0.03794251009821892,\n",
       " -0.036376021802425385,\n",
       " -0.006910946220159531,\n",
       " 0.00015967455692589283,\n",
       " -0.001633585779927671,\n",
       " -0.02727823331952095,\n",
       " -0.028038015589118004,\n",
       " 0.04968152567744255,\n",
       " -0.028867164626717567,\n",
       " -0.002418051240965724,\n",
       " 0.014774874784052372,\n",
       " 0.009764568880200386,\n",
       " 0.005797559395432472,\n",
       " 0.013486078940331936,\n",
       " 0.005567895248532295,\n",
       " 0.0372270792722702,\n",
       " 0.007232493255287409,\n",
       " 0.04015621170401573,\n",
       " 0.08150321245193481,\n",
       " 0.07199164479970932,\n",
       " -0.01305615995079279,\n",
       " -0.04288202524185181,\n",
       " -0.011011214926838875,\n",
       " 0.004897830542176962,\n",
       " -0.009229752235114574,\n",
       " 0.03519146889448166,\n",
       " -0.05103498697280884,\n",
       " -1.5714373802211412e-08,\n",
       " -0.08862444013357162,\n",
       " 0.0239093154668808,\n",
       " -0.01623874343931675,\n",
       " 0.03170047700405121,\n",
       " 0.027284175157546997,\n",
       " 0.05246879905462265,\n",
       " -0.04707096517086029,\n",
       " -0.058847445994615555,\n",
       " -0.0632082149386406,\n",
       " 0.04088853672146797,\n",
       " 0.049827940762043,\n",
       " 0.10655166208744049,\n",
       " -0.07450233399868011,\n",
       " -0.012495458126068115,\n",
       " 0.018370643258094788,\n",
       " 0.039474066346883774,\n",
       " -0.024797869846224785,\n",
       " 0.01451625395566225,\n",
       " -0.03706921264529228,\n",
       " 0.020015696063637733,\n",
       " -4.8594301915727556e-05,\n",
       " 0.00986657477915287,\n",
       " 0.024838784709572792,\n",
       " -0.05245809629559517,\n",
       " 0.029314136132597923,\n",
       " -0.08719196915626526,\n",
       " -0.014499745331704617,\n",
       " 0.026019057258963585,\n",
       " -0.018746383488178253,\n",
       " -0.07620513439178467,\n",
       " 0.035043250769376755,\n",
       " 0.10363949090242386,\n",
       " -0.02805054932832718,\n",
       " 0.012718234211206436,\n",
       " -0.07632549107074738,\n",
       " -0.018652433529496193,\n",
       " 0.02497669868171215,\n",
       " 0.08144541829824448,\n",
       " 0.06875890493392944,\n",
       " -0.0640566349029541,\n",
       " -0.08389392495155334,\n",
       " 0.061362382024526596,\n",
       " -0.033545587211847305,\n",
       " -0.10615341365337372,\n",
       " -0.04008050262928009,\n",
       " 0.03253019228577614,\n",
       " 0.07662486284971237,\n",
       " -0.07301613688468933,\n",
       " 0.0003375994274392724,\n",
       " -0.04087162762880325,\n",
       " -0.0757884681224823,\n",
       " 0.027527686208486557,\n",
       " 0.07462546974420547,\n",
       " 0.01771729253232479,\n",
       " 0.09121839702129364,\n",
       " 0.11022018641233444,\n",
       " 0.0005698270397260785,\n",
       " 0.05146332085132599,\n",
       " -0.014551276341080666,\n",
       " 0.03323199599981308,\n",
       " 0.023792244493961334,\n",
       " -0.022889798507094383,\n",
       " 0.03893755376338959,\n",
       " 0.030206795781850815]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "2c877129",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\veera\\anaconda3\\envs\\medichatbot\\lib\\site-packages\\google\\protobuf\\runtime_version.py:98: UserWarning: Protobuf gencode version 5.29.0 is exactly one major version older than the runtime version 6.30.2 at db_data_2025-01.proto. Please update the gencode to avoid compatibility violations in the next runtime release.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{\n",
       "    \"name\": \"medibot\",\n",
       "    \"metric\": \"cosine\",\n",
       "    \"host\": \"medibot-byv43qo.svc.aped-4627-b74a.pinecone.io\",\n",
       "    \"spec\": {\n",
       "        \"serverless\": {\n",
       "            \"cloud\": \"aws\",\n",
       "            \"region\": \"us-east-1\"\n",
       "        }\n",
       "    },\n",
       "    \"status\": {\n",
       "        \"ready\": true,\n",
       "        \"state\": \"Ready\"\n",
       "    },\n",
       "    \"vector_type\": \"dense\",\n",
       "    \"dimension\": 384,\n",
       "    \"deletion_protection\": \"disabled\",\n",
       "    \"tags\": null\n",
       "}"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from pinecone.grpc import PineconeGRPC as Pinecone\n",
    "from pinecone import ServerlessSpec\n",
    "\n",
    "pc = Pinecone(api_key=\"pcsk_2QypYs_82hSkXuTXQxPybBZrAd4DVy3ftjFr1VvwWvJUQQpXx3QadiWEdaNjoq5QA3o6rR\")\n",
    "index_name = \"medibot\"\n",
    "\n",
    "pc.create_index(\n",
    "    name=index_name,\n",
    "    dimension=384, # Replace with your model dimensions\n",
    "    metric=\"cosine\", # Replace with your model metric\n",
    "    spec=ServerlessSpec(\n",
    "        cloud=\"aws\",\n",
    "        region=\"us-east-1\"\n",
    "    ) \n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "2cbfc70a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "b0c166ae",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_pinecone import PineconeVectorStore\n",
    "\n",
    "docsearch=PineconeVectorStore.from_documents(\n",
    "    documents=text_chunks,\n",
    "    index_name=index_name,\n",
    "    embedding=embeddings,\n",
    "\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "0d6c2fb9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "d403625b",
   "metadata": {},
   "outputs": [],
   "source": [
    "PINECONE_API_KEY=os.environ.get('PINECONE_API_KEY')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "4b72e109",
   "metadata": {},
   "outputs": [],
   "source": [
    "os.environ[\"PINECONE_API_KEY\"]= \"pcsk_2QypYs_82hSkXuTXQxPybBZrAd4DVy3ftjFr1VvwWvJUQQpXx3QadiWEdaNjoq5QA3o6rR\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "42912245",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Existing index \n",
    "\n",
    "docsearch=PineconeVectorStore.from_existing_index(\n",
    "    index_name=index_name,\n",
    "    embedding=embeddings\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "66d549db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<langchain_pinecone.vectorstores.PineconeVectorStore at 0x1c3df4f6fb0>"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docsearch"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "1b31dc29",
   "metadata": {},
   "outputs": [],
   "source": [
    "retriever=docsearch.as_retriever(search_type=\"similarity\",search_kwargs={\"k\":3})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "5f2361ed",
   "metadata": {},
   "outputs": [],
   "source": [
    "retrieved_docs=retriever.invoke(\"What is fever ?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "0c384e7a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='21b21be0-f4db-46fb-b1ea-3e2ac59afaf8', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 26.0, 'page_label': '27', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content='11\\nChapter 2\\nCOMMON CONDITIONS\\nFEVER\\nA body temperature greater than 37.7Â°C is defined as fever. Fever may be continuous,\\nintermittent or remittent.\\nInvestigations\\nA meticulous history of chronology of symptoms, any associated focal symptom(s), exposure to\\ninfectious agents and occupational history may be useful. A thorough physical examination\\nrepeated on a regular basis may provide potentially diagnostic clues.'),\n",
       " Document(id='e4f61db0-2554-41b5-a93a-df45f32eb283', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 27.0, 'page_label': '28', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content=\"\\uf0b7 Prolonged unexplained fever, often with no localizing clue on history, physical examination\\nand basic laboratory investigations.\\nReferences\\n1. Alterations in Body Temperature. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E,\\nFauci AS et al (eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 104-25.\\n2. Physiological Changes in Infected Patients. In: Oxford Textbook of Medicine. Warrell DA, Cox TM, Firth\"),\n",
       " Document(id='41bff00b-1db9-4827-be1a-df04ea195aa2', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 27.0, 'page_label': '28', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content='JD, Benz EJ Jr (eds), 4th Edition, 2003. Oxford University Press, 1289-92.\\nFEVER OF UNKNOWN ORIGIN (FUO)\\nFUO is defined as thepresence of fever of 38.3Â°C or more recorded on several occasions,\\nevolving for at least 3 weeks with no diagnosis reached even after one week of relevant and\\nintelligent investigations. FUO is usually an uncommon presentation of common diseases.\\nSalient features\\nInvestigations\\n\\uf0b7 A detailed clinical history, repeated physical examination to provide potentially')]"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retrieved_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "4f5b7137",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import OpenAI\n",
    "llm=OpenAI(temperature=0.4,max_tokens=500)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "id": "2882721a",
   "metadata": {},
   "outputs": [],
   "source": [
    "#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"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "id": "91bdfe7c",
   "metadata": {},
   "outputs": [],
   "source": [
    "os.environ[\"OPENAI_API_KEY\"]= \"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\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "9ddfb30b",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain_core.prompts import ChatPromptTemplate\n",
    "\n",
    "\n",
    "system_prompt=(\n",
    "    \"You are an assisstant for question-anwering tasks.\"\n",
    "    \"Use the following pieces of retrieved context to answer\"\n",
    "    \"the question. If you don't know the answer, say that you\"\n",
    "    \"Don't know. Use three sentences maximum and keep the\"\n",
    "    \"answer concise.\"\n",
    "    \"\\n\\n\"\n",
    "    \"{context}\"\n",
    "\n",
    ")\n",
    "\n",
    "prompt=ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\"system\",system_prompt),\n",
    "        (\"human\",\"{input}\")\n",
    "    ]\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "f9167b12",
   "metadata": {},
   "outputs": [],
   "source": [
    "question_answer_chain=create_stuff_documents_chain(llm,prompt)\n",
    "rag_chain=create_retrieval_chain(retriever,question_answer_chain)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "b3c0965a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Document(id='21b21be0-f4db-46fb-b1ea-3e2ac59afaf8', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 26.0, 'page_label': '27', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content='11\\nChapter 2\\nCOMMON CONDITIONS\\nFEVER\\nA body temperature greater than 37.7Â°C is defined as fever. Fever may be continuous,\\nintermittent or remittent.\\nInvestigations\\nA meticulous history of chronology of symptoms, any associated focal symptom(s), exposure to\\ninfectious agents and occupational history may be useful. A thorough physical examination\\nrepeated on a regular basis may provide potentially diagnostic clues.'), Document(id='e4f61db0-2554-41b5-a93a-df45f32eb283', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 27.0, 'page_label': '28', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content=\"\\uf0b7 Prolonged unexplained fever, often with no localizing clue on history, physical examination\\nand basic laboratory investigations.\\nReferences\\n1. Alterations in Body Temperature. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E,\\nFauci AS et al (eds), 16th Edition, 2005, McGraw Hill Company Inc., New York, pp 104-25.\\n2. Physiological Changes in Infected Patients. In: Oxford Textbook of Medicine. Warrell DA, Cox TM, Firth\"), Document(id='41bff00b-1db9-4827-be1a-df04ea195aa2', metadata={'author': 'abc', 'creationdate': '2013-11-16T11:06:14+05:30', 'creator': 'Nitro Pro', 'moddate': '2014-01-03T12:44:35+05:30', 'page': 27.0, 'page_label': '28', 'producer': 'Nitro Pro 8  (8. 1. 1. 3)', 'source': 'Data\\\\Medical_Book.pdf', 'title': 'STANDARD TREATMENT GUIDELINES', 'total_pages': 431.0}, page_content='JD, Benz EJ Jr (eds), 4th Edition, 2003. Oxford University Press, 1289-92.\\nFEVER OF UNKNOWN ORIGIN (FUO)\\nFUO is defined as thepresence of fever of 38.3Â°C or more recorded on several occasions,\\nevolving for at least 3 weeks with no diagnosis reached even after one week of relevant and\\nintelligent investigations. FUO is usually an uncommon presentation of common diseases.\\nSalient features\\nInvestigations\\n\\uf0b7 A detailed clinical history, repeated physical examination to provide potentially')]\n"
     ]
    }
   ],
   "source": [
    "response=rag_chain.invoke({\"input\":\"Explain in simple words:What is fever ?\"})\n",
    "print(response['context'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "17036794",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_google_genai import ChatGoogleGenerativeAI\n",
    "import os\n",
    "\n",
    "os.environ[\"GOOGLE_API_KEY\"] = \"AIzaSyBBMcJm9ZXNf9OTMzwP_VOvYKHUFUPJjS0\"\n",
    "\n",
    "llm = ChatGoogleGenerativeAI(\n",
    "    model=\"gemini-2.0-flash\",\n",
    "    temperature=0.4,\n",
    "    max_output_tokens=500\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d1b1ff6f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_google_genai import ChatGoogleGenerativeAI\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "686cd8af",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.prompts import PromptTemplate\n",
    "\n",
    "prompt = PromptTemplate(\n",
    "    input_variables=[\"context\", \"question\"],\n",
    "    template=\"\"\"\n",
    "You are a helpful medical assistant. Use the following context to answer the question in **simple and clear words**, suitable for a normal person with no medical background.\n",
    "    \"You are an assisstant for question-anwering tasks.\"\n",
    "    \"Use the following pieces of retrieved context to answer\"\n",
    "    \"the question. If you don't know the answer, say that you\"\n",
    "    \"Don't know. Use three sentences maximum and keep the\"\n",
    "    \"answer concise.\"\n",
    "    \"\\n\\n\"\n",
    "Context:\n",
    "{context}\n",
    "\n",
    "Question:\n",
    "{question}\n",
    "\n",
    "\"\"\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "1b256b3f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains import RetrievalQA\n",
    "\n",
    "qa_chain = RetrievalQA.from_chain_type(\n",
    "    llm=llm,  # Your Gemini or OpenAI model\n",
    "    retriever=retriever,\n",
    "    chain_type=\"stuff\",\n",
    "    chain_type_kwargs={\"prompt\": prompt}\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "e2fe4cfb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'To treat a fever, rest and use cold sponging to keep your temperature down. You can also take medicine to lower your temperature, but avoid aspirin or ibuprofen. Dengue fever is treated with symptom relief and support.'"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_chain.run(\"What is tretment for fever ?\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0e2e8a51",
   "metadata": {},
   "source": [
    "qa_chain.run(\"What is downfall?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "d65e4e83",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"Newborn care involves several important steps. This includes drying and warming the baby immediately after birth. If the mother has complications, it's important to deliver the baby at a facility equipped to handle newborn care.\""
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_chain.run(\"New Born Care\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0b891b26",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medichatbot",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
